Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.756711727382253,-2.9118344400754412,0.0,0.0,0.0,72/91,17.48%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;SRP9;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;RPL31;RPS27;RPL29;SIL1;RPLP2;RPLP0;RPL35A;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;SEC62;RPS26;RPS16;RPS5;UBA52;RPL13A;RPL36A;ARL6IP1;RPL12
prerank,protein targeting to ER (GO:0045047),-0.7512950502439789,-2.900597272014513,0.0,0.0,0.0,71/99,15.60%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;SRP9;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;RPL31;RPS27;RPL29;RPLP2;RPLP0;RPL35A;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;SEC62;SRPRB;RPS26;SEC61G;RPS16;RPS5;UBA52;RPL13A;ZFAND2B
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7652951087046613,-2.897982167716259,0.0,0.0,0.0,68/87,15.60%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;SRP9;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;RPL31;RPS27;RPL29;RPLP2;RPLP0;RPL35A;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;RPS26;RPS16;RPS5;UBA52;RPL13A;ZFAND2B
prerank,cytoplasmic translation (GO:0002181),-0.7487106515981606,-2.887028233302051,0.0,0.0,0.0,67/91,15.49%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;EIF3I;RPL27;RPL31;RPS27;RPL29;RPLP0;RPL35A;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;GSPT2;RPS26;RPS16;RPS5;UBA52;RPL13A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.70915106675781,-2.8136786699220813,0.0,0.0,0.0,72/110,15.49%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;PABPC1;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;RPL31;RPS27;RPL29;PYM1;RPLP2;RPLP0;RPL35A;EIF4G1;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;RBM8A;GSPT2;RNPS1;RPS26;RPS16;RPS5;UBA52;RPL13A
prerank,peptide biosynthetic process (GO:0043043),-0.6280973884658759,-2.636312086869941,0.0,0.0,0.0,79/153,15.49%,EEF1A1;RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;WARS1;MRRF;RPS25;RPS18;RPL3;SARS1;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;MRPL32;RPL31;RPS27;RPL29;RPLP2;RPLP0;RPL35A;EIF4G1;FURIN;MRPS14;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;GSPT2;RRBP1;MRPS16;RSL24D1;RPS26;RPS16;MRPS5;RPS5;MRPL23;RPL13A
prerank,translation (GO:0006412),-0.5853666298706779,-2.56473346209398,0.0,0.0,0.0,95/208,17.48%,EEF1A1;RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;EEF2;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;WARS2;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;LARS2;RPS20;WARS1;MRRF;EEF1D;RPS25;RPS18;RPL3;SARS1;RPL32;RPL36;RPS27A;RPL14;RPL5;NDUFA7;RPS2;RPL27;MRPL32;RPL31;RPS27;RPL29;RPLP2;RPLP0;APEH;RPL35A;EIF4G1;MRPS14;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;GSPT2;YARS1;EEF1G;RRBP1;MRPS16;RSL24D1;RPS26;RPS16;MRPS5;RPS5;IARS1;MRPL23;UBA52;RPL13A;NARS1;EEF1E1;MRPL24;EEFSEC;RPL36A;EEF1B2;RPL12
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5727033978306122,-2.4315345435469986,0.0,0.0,0.0,86/168,18.21%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;PAN2;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;PABPC1;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;RPL31;RPS27;PATL1;RPL29;CNOT6L;DDX5;PYM1;RPLP2;RPLP0;RPL35A;EIF4G1;ZFP36L1;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;RBM8A;GSPT2;RNPS1;RPS26;RPS16;TNKS1BP1;RPS5;UBA52;RPL13A;POLR2G;PPP2R2A;RPL36A;DCPS;RPL12;ZC3H12A;PELO;SMG5
prerank,rRNA metabolic process (GO:0016072),-0.5359286094151872,-2.285148680327306,0.0,0.0,0.0,82/160,21.81%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPS7;RPL8;RPS19;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS14;RPL18;RPS6;RPL23A;RPS25;RPL3;RPL32;RPL36;RPL14;RPL5;DCAF13;RPS2;RPL27;RPL31;RPS27;RPL29;DDX52;TEX10;RPLP2;IMP3;RPLP0;RPL35A;TRIR;PDCD11;BMS1;RPL7A;RPS28;RPL7;POP5;PIH1D1;RPS17;DDX54;RPL30;DHX37;WDR3;FBL;POP4;RPF1;RPS16;UBA52;RPL13A;RPL36A;RPL12;TBL3;UTP18;MRM2;UTP15;MTREX;RPL9;EBNA1BP2;NOLC1;EXOSC10;NOP53;RPL35;RPL22;PWP2;WDR74
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.6663916651637963,-2.173094151541166,0.0,0.00044597156151826643,0.004,22/39,15.08%,EFNA5;ACTN4;ACER2;THBS1;JAG1;ADAM15;CORO2B;NOTCH1;SEMA3E;FZD4;KANK1;CORO1C;AP1AR;NEXMIF;MYOC;AJAP1;RHOA;GCNT2;CASK;SPRY4;SPOCK1;RCC2
prerank,ncRNA processing (GO:0034470),-0.4911912558938453,-2.16279622761811,0.0,0.0006081430384339997,0.006,93/200,21.81%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPS7;RPL8;RPS19;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS14;RPL18;RPS6;RPL23A;RPS25;RPL3;SARS1;RPL32;RPL36;RPL14;RPL5;DCAF13;RPS2;RPL27;RPL31;RPS27;RPL29;DDX52;TEX10;RPLP2;IMP3;RPLP0;RPL35A;PDCD11;BMS1;ADAR;SSB;RPL7A;RPS28;RPL7;POP5;PIH1D1;RPS17;DGCR8;DDX54;RPL30;INTS11;DHX37;WDR3;FBL;POP4;RPP21;RPF1;INTS6;RPS16;UBA52;RPL13A;LIN28B;INTS1;RPL36A;RPL12;RPP30;TBL3;UTP18;MRM2;UTP15;MTREX;RPL9;EBNA1BP2;NOLC1;EXOSC10;NOP53;AGO3;RPL35;METTL3;RPL22;PWP2;WDR74
prerank,ribosome biogenesis (GO:0042254),-0.4976401091127475,-2.1526243217149066,0.0,0.0006503751938808052,0.007,87/187,21.81%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPS7;RPL8;RPS19;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS14;RPL18;RPS6;RPL23A;RPS25;RPL3;RPL32;RPL36;RPL14;RPL5;DCAF13;RPS2;RPL27;RPL31;RPS27;RPL29;DDX52;TEX10;RPLP2;IMP3;RPLP0;RPL35A;PDCD11;BMS1;RPL7A;RPS28;RPL7;POP5;PIH1D1;RPS17;DDX54;RPL30;DHX37;RBIS;WDR3;FBL;POP4;RPF1;RPS16;UBA52;RPL13A;DHX29;RPL36A;EIF2A;RPL12;TBL3;UTP18;MRM2;HEATR3;UTP15;MTREX;RPL9;EBNA1BP2;NOLC1;EXOSC10;NOP53;RPL35;NOC2L;RPL22;EIF6;PWP2;WDR74
prerank,rRNA processing (GO:0006364),-0.4969845028169735,-2.1162862617897815,0.0,0.0009434013801347944,0.01,88/172,21.81%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPS7;RPL8;RPS19;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS14;RPL18;RPS6;RPL23A;RPS25;RPL3;RPL32;RPL36;RPL14;RPL5;DCAF13;RPS2;RPL27;RPL31;MAK16;RPS27;RPL29;DDX52;TEX10;RPLP2;IMP3;RPLP0;RPL35A;PDCD11;BMS1;RPL7A;RPS28;RPL7;POP5;RSL1D1;PIH1D1;RPS17;DDX54;RPL30;DHX37;WDR3;FBL;POP4;RPF1;RPS16;UBA52;RPL13A;TSR3;RPL36A;RPL12;TBL3;UTP18;MRM2;UTP15;MTREX;RPL9;EBNA1BP2;NOLC1;EXOSC10;THUMPD1;NOP53;RRP15;RPL35;NHP2;RPL22;EIF6;PWP2;WDR74
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.7827406416436523,2.070785216398644,0.0,0.09199374485904988,0.08,6/23,2.80%,TGFBR3;ADAMTS9;FGFR2;TPM1;TNNC1;TNNT2
prerank,cellular response to copper ion (GO:0071280),-0.7910701956048254,-2.0662492371533157,0.0,0.0018316689133785942,0.022,9/16,6.77%,MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;MT2A
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.7131942513343003,-2.063606029988456,0.0,0.0017838862460730655,0.023,11/22,9.59%,SLIT2;TMSB4X;KANK3;GSN;TMSB10;KANK1;HIP1R;CYRIB;SSH2;SSH1;KANK4
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.6253926054966465,-2.0603170997436697,0.0,0.0018814425251551866,0.026,18/39,10.79%,SLIT2;COL4A1;TIE1;KDR;RASIP1;ENG;PKD1;SEMA3E;TGFBR2;CTNNB1;LRP5;MET;SIX1;VEGFA;NOTCH4;NPNT;PAK1;BMP2
prerank,regulation of glucose import (GO:0046324),0.7305269495572101,2.052059320317494,0.0,0.0635839118878727,0.108,7/30,3.96%,IGF1;PRKAG2;OSBPL8;APPL2;PID1;SORBS1;GRB10
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.7899228761361126,-2.0301385822134526,0.0,0.0036071229240448024,0.05,8/14,9.24%,THBS1;KLF4;MEOX2;NOTCH1;HDAC5;CARD10;PDCD10;RHOA
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.8107859000368083,2.028026465402712,0.0,0.061629796392500734,0.154,4/18,3.44%,IGF1;IGFBP2;IL18;IGF2
prerank,response to copper ion (GO:0046688),-0.7363693492531729,-2.02319170748372,0.0,0.003964191657940146,0.057,10/20,6.77%,MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;ATP5F1D;MT2A
prerank,cellular response to zinc ion (GO:0071294),-0.7809488328365466,-2.0071213009391564,0.0,0.005398603113115856,0.079,9/15,6.77%,MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;MT2A
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.4437512234412243,-1.9941344257267815,0.0,0.0070240520939126964,0.105,123/306,21.28%,ST3GAL4;EEF1A1;PTMA;RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;EEF2;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;PTMS;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;B4GALT5;RPS20;WARS1;EXT1;MRRF;EEF1D;RPS25;RPS18;RPL3;SARS1;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;MRPL32;RPL31;RPS27;RPL29;SET;ING4;RPLP2;RPLP0;RPL35A;EIF4G1;MRPS14;RPL7A;BCL3;RPS28;RPL7;KIN;RPS17;RPS10;RPA1;RPL30;RPS4X;GSPT2;EEF1G;RRBP1;POLR2C;DONSON;XAB2;RAD17;RNPS1;MCM4;MRPS16;RSL24D1;RPS26;TOPBP1;RPS16;MRPS5;RPS5;MRPL23;RPL13A;POLR2G;TOP3A;FAM111A;NR4A2;MRPL24;EEFSEC;RPL36A;EEF1B2;MCM8;POLA1;RPL12;RAD9A;CDK2;ATR;RPL9;INHA;MRPL13;MRPL35;POLE;RPL35;POLD3;RBBP8;GTPBP2;PAX8;RPL22
prerank,retinoic acid metabolic process (GO:0042573),0.8440266484937737,1.9833863945308354,0.0,0.11025720891194947,0.321,3/14,6.13%,CYP26B1;ALDH1A2;SCPEP1
prerank,response to progesterone (GO:0032570),-0.7252947373900929,-1.9759697501991014,0.0,0.009609625313667408,0.152,7/18,8.78%,ABHD2;CAV1;THBS1;TGFB2;UBE3A;TGFB1;WBP2
prerank,retinoid metabolic process (GO:0001523),0.6133184219537426,1.9752382338966397,0.0,0.10227539869623781,0.352,12/71,6.18%,CYP26B1;ALDH1A1;ALDH1A2;RBP4;ABCA4;SDC2;GPC6;RBP1;GPC3;LRP2;SCPEP1;NAPEPLD
prerank,ribosome assembly (GO:0042255),-0.5740087400388952,-1.9747073831399913,0.0,0.009426217095726995,0.156,27/47,23.47%,RPL11;RPL6;RPS15;RPSA;RPS19;RPL24;RPS14;RPL23A;RPL3;RPL5;RPS27;RPLP0;RPS28;DHX37;ERAL1;RPS27L;RSL24D1;RPS5;DHX29;EIF2A;NOP53;NLE1;EIF6;PWP2;PPAN;MRPS2;MRPS11
prerank,epithelial tube morphogenesis (GO:0060562),-0.6413452517988949,-1.9661366424672548,0.0,0.011052338698496169,0.191,14/32,8.40%,MEF2C;SLIT2;PODXL;COL4A1;ACVRL1;RASIP1;HES1;PKD1;SOX17;RHOB;CTNNB1;MET;RYR2;PAK1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.5697107494351009,-1.9591580451777117,0.0,0.011985485715803412,0.208,20/47,15.08%,EFNA5;ACTN4;LIMS2;RAC1;CARMIL1;PTK2;DOCK1;LIMS1;FLNA;KANK1;CORO1C;AP1AR;CALR;FERMT2;MYOC;CRK;S100A10;SPRY4;NEDD9;RCC2
prerank,skeletal system morphogenesis (GO:0048705),0.6452093714778098,1.9414286054755137,0.0,0.1572311390891604,0.544,11/42,6.20%,CYP26B1;FGFR2;HOXC4;WWOX;FBN2;HOXB4;LTF;HOXB3;HOXA3;PDGFRA;ANKRD11
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.7927696276988132,-1.9345135948914534,0.0,0.018061848241489792,0.295,4/12,2.20%,PODXL;PROM1;IQGAP1;JAG1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.5927054787391552,-1.9231171166234737,0.0022271714922048997,0.02088347600571113,0.344,18/39,16.22%,RPS24;RPS15;RPSA;RPS7;RPS19;RPS14;RPS6;RPS25;RPS27;DDX52;RPS28;RPS17;ERAL1;WDR3;RPS27L;RPS16;RPS5;TSR3
prerank,regulation of activated T cell proliferation (GO:0046006),0.6933222204665509,1.9228417218868505,0.0,0.1859201314168193,0.637,4/30,3.44%,IGF1;IGFBP2;IL18;IGF2
prerank,response to zinc ion (GO:0010043),-0.6668277940612705,-1.9187051351293853,0.0,0.021431411150738915,0.365,11/25,6.77%,MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;SLC30A5;CRIP1;MT2A
prerank,organic anion transport (GO:0015711),-0.5081110747265586,-1.9025879862515176,0.0,0.026439742575725796,0.437,24/76,16.21%,ABCC4;SLC4A10;ABCG2;SLC26A7;LRRC8C;SLCO1C1;LRRC8D;SLCO2A1;SLCO2B1;CA4;SLC39A8;SLC4A8;SLCO3A1;LRRC8A;CA2;SLC4A2;SLC26A6;SLC52A3;CYB5R1;SLC25A42;SLC35B2;SLC16A2;CFTR;SLC17A9
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.6119659108834172,1.9008110990057439,0.0016778523489932886,0.23099899903945242,0.765,4/49,1.24%,IL31RA;IGF1;IL18;KIT
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.6086416651281782,-1.896476984461489,0.0,0.027911668419160464,0.462,20/33,27.77%,MEF2C;THBS1;ACVRL1;KLF4;MEOX2;NOTCH1;TGFB1;HDAC5;CARD10;PDCD10;RHOA;JUP;CSNK2B;DLL4;ATP2B4;GADD45A;RGCC;ANGPT4;FGF2;VASH1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.7701298147154578,-1.891500863096227,0.0,0.02909964438906688,0.487,8/13,8.08%,COL4A1;KDR;ENG;SEMA3E;TGFBR2;CTNNB1;VEGFA;NOTCH4
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.723334205347545,1.8911688152417563,0.0,0.21266789252709764,0.806,4/21,2.18%,EYA4;EYA1;EYA2;BCL2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.723334205347545,1.8911688152417563,0.0,0.21266789252709764,0.806,4/21,2.18%,EYA4;EYA1;EYA2;BCL2
prerank,cellular zinc ion homeostasis (GO:0006882),-0.653791512019914,-1.8888387346979183,0.0,0.02927587508676362,0.499,17/26,16.19%,SLC39A10;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;SLC30A5;MT2A;SLC39A8;SLC30A1;SLC39A7;SLC39A14;MT3;ATP13A2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.5111943634828289,-1.8840482525002644,0.0,0.03104380166506058,0.531,31/71,22.88%,ELMO1;ACTB;ACTG1;MYO10;RAC1;HSP90AA1;HSP90AB1;PTK2;DOCK1;PLCG2;FYN;NCKAP1;WIPF1;ARPC1B;NCK1;ARPC3;WIPF3;PAK1;CRK;ACTR2;PRKCE;YES1;ARPC4;ARPC1A;CYFIP2;PRKCD;NCKAP1L;ABI1;MAPK3;ACTR3;FCGR2B
prerank,energy reserve metabolic process (GO:0006112),0.7375359054214279,1.879542947507512,0.004081632653061225,0.22596681001028648,0.854,4/19,1.70%,PRKAG2;LEPR;PID1;PHKB
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.5127639420310696,-1.8785841613433645,0.0,0.03273836690236365,0.555,31/70,22.88%,ELMO1;ACTB;ACTG1;MYO10;RAC1;HSP90AA1;HSP90AB1;PTK2;DOCK1;PLCG2;FYN;NCKAP1;WIPF1;ARPC1B;NCK1;ARPC3;WIPF3;PAK1;CRK;ACTR2;PRKCE;YES1;ARPC4;ARPC1A;CYFIP2;PRKCD;NCKAP1L;ABI1;MAPK3;ACTR3;FCGR2B
prerank,regulation of smoothened signaling pathway (GO:0008589),0.6040894204585543,1.8724102888996976,0.0,0.22915762097650577,0.88,17/50,11.24%,DCDC2;RORA;ZIC1;FGFR2;TULP3;INTU;MGRN1;TEDC2;TTC23;GPC3;GLI3;ARMC9;SUFU;HERC4;FBXL17;WDR11;IFT122
prerank,sodium ion transport (GO:0006814),0.5432869853232707,1.869448713065508,0.0,0.21936969927927275,0.889,12/85,3.73%,SCN7A;ATP1A2;SLC6A13;SLC24A3;SLC8A3;SLC5A5;SLC6A12;SLC6A9;NALCN;ATP1B3;SLC8A1;SLC6A1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.7370295526940224,1.8614205904708157,0.0,0.21104447350017322,0.903,10/20,14.26%,ACADSB;MCCC2;IVD;DBT;HSD17B10;BCKDHA;ALDH6A1;BCKDHB;AUH;HIBCH
prerank,branched-chain amino acid catabolic process (GO:0009083),0.7370295526940224,1.8614205904708157,0.0,0.21104447350017322,0.903,10/20,14.26%,ACADSB;MCCC2;IVD;DBT;HSD17B10;BCKDHA;ALDH6A1;BCKDHB;AUH;HIBCH
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.7800460422287612,1.8608499207213445,0.00819672131147541,0.19965799282521732,0.905,3/13,3.44%,IGF1;SORBS1;IGF2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.5010757812956137,-1.856993085879379,0.0,0.04485949236448444,0.676,30/73,21.78%,ELMO1;ACTB;ACTG1;MYO10;RAC1;HSP90AA1;HSP90AB1;PTK2;DOCK1;PLCG2;FYN;NCKAP1;WIPF1;ARPC1B;NCK1;ARPC3;WIPF3;PAK1;CRK;ACTR2;PRKCE;YES1;ARPC4;ARPC1A;CYFIP2;PRKCD;NCKAP1L;ABI1;MAPK3;ACTR3
prerank,neuron projection organization (GO:0106027),-0.716605617895965,-1.8553250645584496,0.0,0.04472457659797471,0.685,11/15,23.28%,LGMN;GSK3B;ARF1;APP;ATP1A3;PICK1;ABCD2;PSEN1;INSR;DCTN1;MAP1A
prerank,gene expression (GO:0010467),-0.39785294507157765,-1.8543608736347015,0.0,0.04419454293656709,0.688,126/348,19.63%,EEF1A1;PTMA;RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;HNRNPK;RPL19;RPL21;RPS9;ADARB1;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;ADARB2;RPL34;RPL28;RPL18A;RPL26;RPL24;SRSF2;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;WARS1;MRRF;RPS25;RPS18;SRSF1;RPL3;SARS1;RPL32;RPL36;RPS27A;GALNT2;RPL14;RPL5;RPS2;HNRNPU;RPL27;MRPL32;RPL31;RPS27;RPL29;DDX20;TSPAN17;SRSF5;RPLP2;RPLP0;RPL35A;DDX39B;EIF4G1;ADAR;MRPS14;RPL7A;BCL3;RPS28;RPL7;CPSF3;HHEX;RPS17;SRSF9;RPS10;DDX54;RPL30;RPS4X;RBM8A;GSPT2;HSPD1;RRBP1;POLR2C;XAB2;DNAJB11;RNPS1;SRSF6;MRPS16;NUP37;RSL24D1;RPS26;AGFG1;RPS16;MRPS5;RPS5;SYMPK;MRPL23;RPL13A;CLP1;POLR2G;PRPF4;NXT1;BICD1;NR4A2;CPSF2;MRPL24;RPL36A;RPL12;NUP54;SMG5;NUP85;DDX17;RPL9;HNRNPUL1;YTHDC1;THOC3;MRPL13;MRPL35
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.7928341112788185,1.853438091343016,0.004098360655737705,0.20823266930321266,0.928,3/12,3.44%,IGF1;SORBS1;IGF2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.504219667851975,-1.8438441904955092,0.0,0.05008140102995667,0.74,30/69,18.29%,COX4I1;COX6C;NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;UQCRH;COX6A1;NDUFA13;COX7C;NDUFS1;UQCR11;NDUFB11;SDHAF2;COX8A;NDUFB10;COX5A;NDUFA1;UQCRQ;UQCC3;NDUFB4;COA6;NDUFS7;UQCRC2;UQCRC1
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.6862460800793466,-1.8437316632920357,0.0,0.04879280965821559,0.74,10/19,12.24%,TEK;PTPRJ;KDR;RAC1;LIMS1;FERMT2;MYOC;VEGFA;COL16A1;S100A10
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.7488998589464012,1.8398296020298555,0.00784313725490196,0.23399280418941332,0.958,4/15,8.84%,IGF1;ROCK2;PRKCA;CAMK2D
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5725356129212537,1.8387484746438956,0.001669449081803005,0.22490524413941088,0.96,4/57,1.24%,IL31RA;IGF1;IL18;KIT
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.7927325232677016,-1.837110221484697,0.001890359168241966,0.05194425174863398,0.771,6/10,9.97%,FAP;CST3;NOTCH1;TGFB1;TNFRSF1B;DPP4
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.8421614255938666,1.8348575941405865,0.0,0.2252493899857618,0.966,4/10,5.87%,APPL2;PID1;GRB10;PRKCB
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.59161574284555,-1.834198956414953,0.0020964360587002098,0.05245740492358608,0.785,14/28,23.48%,OCLN;RAC1;RPS3;CLIP1;MET;PAK1;NAV3;GIT1;TOGARAM1;CKAP5;MAPRE1;NUMA1;DCTN1;HSPA1B
prerank,hemidesmosome assembly (GO:0031581),-0.7530545830615847,-1.8287123680088635,0.0,0.055610478250296025,0.818,4/11,6.24%,ITGA6;ITGB4;PLEC;LAMA3
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.6127656630768059,-1.8269726759407514,0.0,0.05561371555837906,0.829,15/27,22.51%,MAP3K5;UBB;IKBKB;RPS27A;UBC;MAPK8;CHUK;MAP2K7;CUL1;MAP3K8;UBA52;CCDC88C;SKP1;MAPK3;MAPK11
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6746987148446396,1.8262116594490936,0.00186219739292365,0.23797261450233212,0.975,4/26,2.18%,EYA4;EYA1;EYA2;BCL2
prerank,sodium ion transmembrane transport (GO:0035725),0.5342785502025027,1.8233613791833228,0.0,0.2351497863242023,0.978,11/84,3.73%,SCN7A;ATP1A2;SLC6A13;SLC24A3;SLC8A3;SLC6A12;SLC6A9;NALCN;ATP1B3;SLC8A1;SLC6A1
prerank,negative regulation of growth (GO:0045926),-0.4503979437727731,-1.8201654178179032,0.0,0.05994687501338558,0.854,33/121,11.08%,APBB2;SLIT2;PTPRJ;ACVRL1;TGFB2;ADAM15;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;NOTCH1;NDRG3;RACK1;SH3BP4;FHL1;BMPR2;SOX17;CCDC85B;RERG;CCN3;TGFB1;OSGIN2;MT2A;APBB1;ING4;RTN4;SESN2;CDKN1B;NDUFA13
prerank,cell projection organization (GO:0030030),-0.5832366950170207,-1.8189931324616808,0.0,0.059369964127119215,0.856,7/30,4.32%,RHOJ;PARVB;RAC1;GSN;ITGB1;PACSIN2;NCKAP1
prerank,entry into host (GO:0044409),-0.7271973671004899,-1.8167808232401765,0.004016064257028112,0.05973541304558557,0.862,5/13,6.69%,CDH1;CBL;PPIA;CTNNB1;MET
prerank,aerobic electron transport chain (GO:0019646),-0.4984754134160993,-1.8133632479600204,0.0,0.061054476275245274,0.873,29/68,18.29%,COX4I1;COX6C;NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;UQCRH;COX6A1;NDUFA13;COX7C;NDUFS1;UQCR11;NDUFB11;SDHAF2;COX8A;NDUFB10;COX5A;NDUFA1;UQCRQ;UQCC3;NDUFB4;NDUFS7;UQCRC2;UQCRC1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.49314474917425233,-1.80893465120984,0.0,0.06355094751635297,0.893,24/67,14.52%,UTRN;FN1;LIMS2;RAC1;VIT;CARMIL1;DOCK1;PTK2B;LIMS1;FLNA;CALR;FERMT2;FBLN2;GSK3B;MYOC;ECM2;EMP2;NPNT;CDK6;CRK;S100A10;CDH13;JUP;NEDD9
prerank,neurotransmitter biosynthetic process (GO:0042136),0.763789222867084,1.8023220421417427,0.00202020202020202,0.28739222338958925,0.995,2/14,0.70%,MOXD1;SLC22A2
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.6787203005581058,1.7956075906231759,0.005660377358490566,0.2981529296207932,0.998,4/24,3.44%,IGF1;SORBS1;PPP1R3G;IGF2
prerank,vasodilation (GO:0042311),-0.734909492905385,-1.7955787798374763,0.0020161290322580645,0.07472346423980537,0.928,7/13,12.75%,NOS3;KLF2;KCNMA1;SOD1;NOS1;GPER1;ADRB2
prerank,modulation by symbiont of host process (GO:0044003),-0.7948336300254897,-1.7937411357113497,0.0,0.07499603401858194,0.93,7/10,15.45%,B2M;UBB;RPS27A;UBC;HGS;MRC1;UBA52
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.594214408474831,-1.7888210776029203,0.0022222222222222222,0.07784433606301341,0.94,12/26,21.14%,OCLN;RAC1;RPS3;CLIP1;MET;STMN2;PAK1;NAV3;TOGARAM1;MAPRE1;NUMA1;DCTN1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.6032297761687533,1.7829786603364741,0.005291005291005291,0.33092494964394686,1.0,9/40,3.12%,BMP6;ADGRV1;OSR1;WNT4;WNT6;BMP7;FBN2;SLC8A1;KL
prerank,regulation of plasminogen activation (GO:0010755),-0.7270198925318607,-1.7829494785994353,0.0057692307692307696,0.0822642640192763,0.948,5/12,6.76%,THBS1;RUNX1;SERPINE2;PLGRKT;CLEC3B
prerank,neurotransmitter uptake (GO:0001504),0.781675360175968,1.7825054786829297,0.0020161290322580645,0.3198968005618996,1.0,3/12,2.16%,ATP1A2;SLC22A2;SLC1A3
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.5308979155186054,-1.7767694664032452,0.004651162790697674,0.08803650151894239,0.958,18/42,14.64%,RAC1;VIT;ATXN3;PTK2;CORO2B;NOTCH1;MINK1;FZD4;LIMS1;CORO1C;FBLN2;ECM2;EMP2;NPNT;RHOA;GCNT2;SPOCK1;NF1
prerank,chloride transport (GO:0006821),-0.47421651808096016,-1.776444258332877,0.0,0.08683823612959453,0.958,20/74,11.74%,SLC4A10;SLC12A7;SLC12A2;SLC26A7;ANO1;ANO4;CLIC4;GABRB3;SLC12A6;SLC1A1;CLIC5;GABRB1;TTYH3;SLC12A8;SLC4A8;ANO3;LRRC8A;SLC12A4;GABRG3;SLC26A6
prerank,regulation of fatty acid oxidation (GO:0046320),0.7252775447005482,1.7703595058745913,0.0102880658436214,0.3537116065041681,1.0,4/16,5.18%,PRKAG2;APPL2;PPARA;ACADL
prerank,thyroid hormone generation (GO:0006590),0.78262014903435,1.7676608371294675,0.004454342984409799,0.35215952820167795,1.0,3/10,2.60%,CPQ;SLC5A5;DUOX2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.6195375826478914,-1.7675825675004422,0.0043859649122807015,0.0955741832531507,0.971,12/24,12.24%,TEK;PTPRJ;KDR;RAC1;IQSEC1;LIMS1;FERMT2;MYOC;VEGFA;COL16A1;DUSP3;S100A10
prerank,establishment of endothelial barrier (GO:0061028),-0.5764229226137454,-1.766271086357214,0.0,0.09545818559952349,0.975,12/29,11.40%,PECAM1;RAP1A;TJP2;PDE4D;MSN;F11R;PPP1R16B;ROBO4;PDE2A;TJP1;SOX18;RAB1A
prerank,regulation of dendritic spine development (GO:0060998),-0.6429872333074481,-1.7622767119403118,0.004008016032064128,0.09797437742104416,0.976,11/19,25.51%,MEF2C;SHANK3;PPFIA2;GRIN3A;LLPH;KIF1A;CAMK2B;PSEN1;FMR1;SHANK1;FOXO6
prerank,negative regulation of vascular permeability (GO:0043116),-0.7323951837616782,-1.7599950064443377,0.007518796992481203,0.09832890525229497,0.979,10/12,7.87%,SLIT2;PTPRJ;CLDN5;PDE3A;RAMP2;FERMT2;CEACAM1;DDAH1;PDE2A;VEGFA
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.6483741512716258,-1.7581939492164127,0.010080645161290322,0.09897877458006696,0.98,7/18,11.02%,FN1;CD200;CD34;TGFB2;ITGB8;PTGS2;LTBP1
prerank,bicarbonate transport (GO:0015701),-0.5876170855597376,-1.7570901295081531,0.0020876826722338203,0.09841609713504794,0.981,10/25,15.43%,SLC4A10;SLC26A7;CA4;SLC39A8;SLC4A8;CA2;SLC4A2;SLC26A6;CYB5R1;CFTR
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.48572084972856894,-1.7567228671945931,0.0,0.0971288896689991,0.982,24/57,23.06%,RPL11;RPS24;RPS15;RPL38;RPS7;RPS19;RPL26;RPS6;RPS25;RPL14;RPL5;RPL35A;RPS28;RPL7;RPS17;DHX37;RBIS;RPS16;HEATR3;EBNA1BP2;NOC2L;WDR74;NOP16;NIP7
prerank,regulation of small molecule metabolic process (GO:0062012),0.6416476177621445,1.7566565507364111,0.0035714285714285713,0.3819077710848994,1.0,6/28,6.13%,RORA;PPARA;PRKN;PDK1;ACADL;EPHX2
prerank,embryonic organ morphogenesis (GO:0048562),0.5844413693490225,1.755164470062716,0.0055147058823529415,0.3749797319042251,1.0,10/42,4.40%,EFEMP1;FBN1;FGFR2;HOXC4;RBP4;FBN2;HOXB4;HOXB3;HOXA3;PDGFRA
prerank,alpha-amino acid catabolic process (GO:1901606),0.6334424742919124,1.7507786512964447,0.009523809523809525,0.38071794599162767,1.0,11/29,15.20%,DDO;ALDH4A1;ACADSB;CBS;FAH;HSD17B10;HOGA1;THNSL2;PRODH;AADAT;GSTZ1
prerank,triglyceride homeostasis (GO:0070328),0.6326780579220269,1.7498697007820516,0.007380073800738007,0.37220263315214847,1.0,5/26,7.52%,RORA;C1QTNF3;IL18;APOC4;LIPC
prerank,bone development (GO:0060348),0.5906889248942038,1.7464506074082833,0.003656307129798903,0.37308574303948,1.0,10/39,5.41%,CYP26B1;RANBP3L;FGFR2;GNAS;LTF;SH3PXD2B;AKAP13;GJA1;SULF1;LRRC17
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.70998210929769,1.7447365574983404,0.009765625,0.3691156169877967,1.0,3/16,1.90%,RORA;PRKN;PDK1
prerank,response to cadmium ion (GO:0046686),-0.5976594910796557,-1.7443269235802334,0.006593406593406593,0.11101767478122747,0.989,12/26,10.31%,MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;MT2A;JUN;MAPK8;CHUK
prerank,glycerolipid catabolic process (GO:0046503),-0.6354979870158576,-1.7423748471303533,0.0019801980198019802,0.11154683855233091,0.99,9/19,15.14%,GPCPD1;ABHD2;MGLL;SMPD4;GDPD1;GDPD3;LYPLA2;PNPLA6;PLA2G4A
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.7046727642129935,-1.738736257638024,0.0,0.11444833683883449,0.99,7/13,20.25%,NOS3;HSP90AA1;CALM1;GCH1;MTHFD1L;QDPR;AKT1
prerank,cellular response to cadmium ion (GO:0071276),-0.6101039046803123,-1.7374759321847952,0.006622516556291391,0.11403632194135048,0.991,12/24,10.31%,MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;MT2A;JUN;MAPK8;CHUK
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.542807045420493,-1.7370335438108704,0.002288329519450801,0.11274504130229099,0.991,12/34,14.52%,LIMS2;RAC1;CARMIL1;DOCK1;LIMS1;FLNA;CALR;FERMT2;MYOC;CRK;S100A10;NEDD9
prerank,positive regulation of protein polymerization (GO:0032273),-0.48191940119752524,-1.7360499031415415,0.0,0.11223617631543038,0.991,28/65,21.14%,OCLN;RAC1;CARMIL1;HSP90AA1;PTK2B;RPS3;CDC42EP3;CLIP1;NCKAP1;NCK1;MET;BAIAP2L1;PAK1;NAV3;NCK2;BIN1;TOGARAM1;CDC42EP5;TPPP;TPPP3;PRKCE;CDC42EP2;EVL;PINK1;NCKAP1L;MAPRE1;NUMA1;DCTN1
prerank,sterol metabolic process (GO:0016125),0.5426798422813901,1.7351656692268198,0.0,0.39644923379733393,1.0,12/60,12.24%,PRKAG2;CYP26B1;CYP27A1;LIPA;INSIG2;ABCA1;FDXR;ABCA5;PMVK;SOAT2;RXRA;GBA2
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.6568929184675123,-1.734826414370868,0.007751937984496124,0.11202539373660335,0.992,8/18,9.39%,SPTBN1;ACTB;STX7;VTI1B;VAMP8;ZDHHC2;ZDHHC7;APPL1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.6429479520621475,-1.7295365728174419,0.0,0.1171167229384183,0.994,9/18,11.74%,NOS3;ACVRL1;TGFB2;ENG;NOTCH1;TGFBR2;TBX2;BMP2;HEYL
prerank,endocardial cushion development (GO:0003197),-0.617712624286288,-1.7285861824547744,0.009652509652509652,0.1169059509994441,0.994,13/21,24.12%,NOS3;ACVRL1;TGFB2;ENG;NOTCH1;BMPR2;TBX2;BMP2;HEYL;ACVR1;BMP4;HEY1;FOXF1
prerank,maintenance of blood-brain barrier (GO:0035633),-0.576304985908017,-1.7274622919136888,0.0021645021645021645,0.11674898378317472,0.996,17/30,8.15%,SLC12A2;PECAM1;ACTB;CLDN5;ESAM;ACTG1;OCLN;TJP2;JAM2;LSR;ITGB1;MBP;F11R;SLC1A1;WNK3;TJP1;MFSD2A
prerank,cellular amino acid catabolic process (GO:0009063),0.5110449962814471,1.727284756827114,0.0,0.4185064019254979,1.0,27/87,15.20%,DDO;ALDH4A1;ABAT;ACADSB;CBS;MCCC2;AASS;FAH;ALDH7A1;IVD;DBT;HSD17B10;BCKDHA;HOGA1;HMGCL;GCDH;ALDH6A1;BCKDHB;PRODH;AUH;PIPOX;SHMT1;AADAT;HIBCH;HMGCLL1;ASPA;GSTZ1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.5379965912199112,-1.727115423986083,0.0022222222222222222,0.11552861894682698,0.996,16/32,12.33%,RHOJ;KDR;THBS1;KLF4;MEOX2;NOTCH1;GATA2;HDAC5;JCAD;CARD10;PDCD10;VEGFA;PTGS2;RHOA;PIK3C2A;MAP3K3
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.5271120922688775,-1.725320655450705,0.0021008403361344537,0.11616939772604286,0.997,16/38,18.10%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;NDUFA13;NDUFS1;NDUFB11;NDUFB10;NDUFA1;NDUFB4;NDUFS7
prerank,positive regulation of bone mineralization (GO:0030501),0.6036460225006526,1.7233771173695367,0.01282051282051282,0.42333210571465796,1.0,9/35,3.12%,BMP6;ADGRV1;OSR1;WNT4;BMP7;FBN2;LTF;SLC8A1;KL
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5707626140508897,1.722380216387841,0.007067137809187279,0.4166063476550315,1.0,9/46,6.34%,ALDH1A1;NPR3;LGR4;RBPJ;ADAMTS5;NOVA1;MAP2K6;TLE3;NRDC
prerank,positive regulation of stem cell differentiation (GO:2000738),0.6998699942665284,1.721473148756152,0.00631578947368421,0.4094623545687122,1.0,4/16,5.91%,SOX5;HOXB4;SOX6;PTN
prerank,positive regulation of tissue remodeling (GO:0034105),0.7703409035537931,1.7183218505478608,0.01050420168067227,0.41178474567667345,1.0,2/10,1.22%,ROCK2;IL18
prerank,acylglycerol homeostasis (GO:0055090),0.6520904340684301,1.7163373371789477,0.01953125,0.4095063496642927,1.0,4/20,7.52%,RORA;IL18;APOC4;LIPC
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.6959968093316815,1.714267061516839,0.012170385395537525,0.40785181981977925,1.0,4/16,1.00%,IGF1;TGFBR3;RBPJ;FGFR2
prerank,neutrophil degranulation (GO:0043312),-0.3681021747185284,-1.7128112304243597,0.0,0.13205034660571682,0.998,147/425,24.59%,PTPRB;PECAM1;PTPRJ;FTH1;EEF1A1;B2M;RAP1A;ATP8A1;HSPA8;ADGRE5;ADAM10;RAC1;HSP90AA1;IQGAP1;CST3;GSN;HSP90AB1;FTL;PRG2;MAGT1;OSTF1;EEF2;RAB31;PSAP;PPIA;CTSD;PKM;PTPRN2;CD55;RAB27A;PLEKHO2;ATG7;CKAP4;NRAS;AP2A2;CD93;VAT1;ATP6V0A1;PGLYRP1;DOCK2;ACTR10;CD44;CTSB;PTPRC;VAMP8;STOM;CEACAM1;NDUFC2;TNFRSF1B;PPIE;GOLGA7;LAMP1;TMC6;ERP44;CD63;ATP11B;CPNE3;GRN;HEXB;PDAP1;PSMD13;RHOA;HMOX2;MAN2B1;APEH;TMEM30A;SCAMP1;ATP6V0C;ARL8A;TUBB4B;LAMTOR1;TMBIM1;HRNR;IMPDH1;TOLLIP;CAP1;DBNL;FUCA2;STK10;ATP11A;TCIRG1;LRG1;DGAT1;PSMC3;ACTR2;SNAP25;PSMD12;SVIP;JUP;IMPDH2;ALDOA;GDI2;LPCAT1;CD47;CSNK2B;CTSZ;LAMTOR2;CYBB;CDA;CYB5R3;GM2A;RHOG;RNASE3;QPCT;MIF;ALDOC;PRCP;RAB37;DSP;TIMP2;BRI3;S100A11;PADI2;BST2;PLAUR;PSEN1;ACLY;IRAG2;TYROBP;DDOST;PRKCD;NCKAP1L;CD300A;CTSC;SLC11A1;ADGRG3;ENPP4;VAPA;VCP;HPSE;CPPED1;PYGL;C3;MANBA;SLC2A3;GCA;GHDC;HSPA1B;NPC2;RAB7A;RAB3A;ARSB;CD68;FABP5;SRP14;LCN2;HUWE1
prerank,macrophage differentiation (GO:0030225),0.7305335213515967,1.7113074969981232,0.016260162601626018,0.41082569096083216,1.0,3/13,7.99%,IL31RA;MMP9;CSF1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.6476695110767757,1.7106019746277432,0.017208413001912046,0.4042969303921345,1.0,2/22,0.39%,IGF1;ROCK2
prerank,carnitine shuttle (GO:0006853),0.7698816457720226,1.7073713624951412,0.01652892561983471,0.4093821857278764,1.0,3/11,5.76%,PRKAG2;PRKAA2;CPT2
prerank,cellular protein metabolic process (GO:0044267),-0.36291161629514845,-1.7068782263086826,0.0,0.13915518047914555,0.999,136/396,15.96%,FN1;ST3GAL6;EEF1A1;ST8SIA4;IGFBP6;STK38;RPL37A;RPL41;ADAM10;RPL11;RPL13;RPL27A;RPS21;RPLP1;GAS6;CST3;RPL17;RPL23;RPS24;SPARCL1;RPL19;RPL21;RPS9;CDH2;RPL6;RPS15;RPL38;RPL37;RPL4;DAB2IP;RPSA;RPS7;RPS8;SFTPA2;SFTPA1;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;MSLN;DENND3;RPL24;RPS29;RPS14;LGMN;RPL18;CKAP4;RPS6;RPL23A;RPS12;RPS20;WARS1;SPP1;IGFBP5;LAMB2;MRRF;PDIA6;RPS25;RPS18;HSP90B1;RPL3;CHRM3;SARS1;FBXW2;NEDD8;ADPRH;RPL32;LGALS1;RPL36;RPS27A;FAM20C;RPL14;PCMT1;RPL5;RPS2;APP;RPL27;MRPL32;RPL31;PRSS23;RPS27;CHEK2;RPL29;MSRB3;ZDHHC2;NUCB1;RPLP2;MAN2B1;RPLP0;RPL35A;EIF4G1;FURIN;MRPS14;RPL7A;RPS28;RPL7;RPN1;PLOD2;LTBP1;RPS17;SCG2;MEN1;RPS10;CHGB;STOML2;RPL30;FUCA2;CALU;RPS4X;MMP15;GSPT2;CDKL3;RRBP1;VCAN;ERO1A;IDE;MRPS16;CCN1;RSL24D1;RPS26;RPS16;MRPS5;RPS5;MRPL23;UBE2G1;UBA52;RPL13A;VGF;WFS1;FBXL2;ST8SIA2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.6408472848493388,1.7068752363482655,0.019027484143763214,0.3938038448054697,1.0,5/20,8.42%,IGF1;ZBTB20;PRKAA2;PRKAA1;ARNT
prerank,positive regulation of glycolytic process (GO:0045821),0.6408472848493388,1.7068752363482655,0.019027484143763214,0.3938038448054697,1.0,5/20,8.42%,IGF1;ZBTB20;PRKAA2;PRKAA1;ARNT
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.7164733883184987,-1.705621887437131,0.009057971014492754,0.13914312719369912,0.999,6/12,10.62%,ACTB;ACTG1;LAMA5;LAMA3;ZDHHC7;VANGL2
prerank,neutrophil activation involved in immune response (GO:0002283),-0.3667684762943826,-1.7051901778411036,0.0,0.13797245184471366,0.999,147/428,24.59%,PTPRB;PECAM1;PTPRJ;FTH1;EEF1A1;B2M;RAP1A;ATP8A1;HSPA8;ADGRE5;ADAM10;RAC1;HSP90AA1;IQGAP1;CST3;GSN;HSP90AB1;FTL;PRG2;MAGT1;OSTF1;EEF2;RAB31;PSAP;PPIA;CTSD;PKM;PTPRN2;CD55;RAB27A;PLEKHO2;ATG7;CKAP4;NRAS;AP2A2;CD93;VAT1;ATP6V0A1;PGLYRP1;DOCK2;ACTR10;CD44;CTSB;PTPRC;VAMP8;STOM;CEACAM1;NDUFC2;TNFRSF1B;PPIE;GOLGA7;LAMP1;TMC6;ERP44;CD63;ATP11B;CPNE3;GRN;HEXB;PDAP1;PSMD13;RHOA;HMOX2;MAN2B1;APEH;TMEM30A;SCAMP1;ATP6V0C;ARL8A;TUBB4B;LAMTOR1;TMBIM1;HRNR;IMPDH1;TOLLIP;CAP1;DBNL;FUCA2;STK10;ATP11A;TCIRG1;LRG1;DGAT1;PSMC3;ACTR2;SNAP25;PSMD12;SVIP;JUP;IMPDH2;ALDOA;GDI2;LPCAT1;CD47;CSNK2B;CTSZ;LAMTOR2;CYBB;CDA;CYB5R3;GM2A;RHOG;RNASE3;QPCT;MIF;ALDOC;PRCP;RAB37;DSP;TIMP2;BRI3;S100A11;PADI2;BST2;PLAUR;PSEN1;ACLY;IRAG2;TYROBP;DDOST;PRKCD;NCKAP1L;CD300A;CTSC;SLC11A1;ADGRG3;ENPP4;VAPA;VCP;HPSE;CPPED1;PYGL;C3;MANBA;SLC2A3;GCA;GHDC;HSPA1B;NPC2;RAB7A;RAB3A;ARSB;CD68;FABP5;SRP14;LCN2;HUWE1
prerank,mesoderm development (GO:0007498),-0.6417747678163788,-1.7049295046485404,0.00631578947368421,0.13668738768611802,0.999,7/18,11.94%,TIE1;TBX1;BMX;TBX3;VEGFA;IKZF1;MESD
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6909669136345767,1.7011448244015899,0.013725490196078431,0.4076585556499073,1.0,6/17,7.40%,BMP6;SASH1;LTF;TRIM5;CACTIN;PRKCA
prerank,regulation of lipid biosynthetic process (GO:0046890),0.6025466126555372,1.699439856442771,0.007155635062611807,0.4054682283913585,1.0,6/32,5.20%,PRKAG2;PPARA;SORBS1;ZBTB20;AVIL;PRKAA2
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5852760572167688,-1.6992027183091196,0.0,0.14365430106598004,1.0,6/24,5.90%,PECAM1;MSN;ITGB1;F11R;SEMA4D;ITGA4
prerank,glycolipid metabolic process (GO:0006664),-0.4983493878462128,-1.6976250484321056,0.0066518847006651885,0.1442492193126013,1.0,12/47,10.98%,ST3GAL4;ST6GALNAC3;ST3GAL6;ESYT2;PSAP;SUMF1;SMPD4;HEXB;HEXA;ST8SIA6;CERK;GLTP
prerank,mesenchyme morphogenesis (GO:0072132),-0.6377453399435173,-1.695885214606974,0.005714285714285714,0.14520555310808805,1.0,8/17,11.74%,NOS3;ACVRL1;TGFB2;ENG;NOTCH1;TBX2;BMP2;HEYL
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.6001601094133914,1.694521533417211,0.007707129094412331,0.4173629938330776,1.0,7/31,4.40%,OSR1;FGFR2;HOXC4;HOXB4;HOXB3;HOXA3;PDGFRA
prerank,regulation of urine volume (GO:0035809),0.7540588655901048,1.694150968949592,0.018633540372670808,0.41066488718124877,1.0,4/10,11.08%,NPR3;ADM;NPR1;TFAP2B
prerank,substantia nigra development (GO:0021762),-0.528945872227734,-1.6935543761855245,0.012987012987012988,0.1470192052029816,1.0,19/37,25.98%,ACTB;GNB4;CALM1;PLP1;MBP;NDRG2;RHOA;S100A1;HSPA5;INA;CKB;CALM2;YWHAQ;YWHAH;PADI2;CALM3;SEC16A;CNP;SYNGR3
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.7238393942984058,1.691257928115526,0.012875536480686695,0.40546336639966357,1.0,2/12,4.96%,IGF1;CAMTA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.7238393942984058,1.691257928115526,0.012875536480686695,0.40546336639966357,1.0,2/12,4.96%,IGF1;CAMTA1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.7718228286770412,1.6908795062550792,0.014675052410901468,0.3993911439387181,1.0,4/10,3.79%,ATP1A2;OSR1;NEDD4;PCSK9
prerank,sphingolipid metabolic process (GO:0006665),-0.42281590196891883,-1.690769656153426,0.0,0.14964521359969635,1.0,25/108,9.70%,ST6GALNAC3;CERT1;ELOVL7;SGMS1;SGMS2;ACER3;ESYT2;ELOVL5;ACER2;SPTLC2;PLPP1;SERINC1;DEGS2;PSAP;KDSR;PRKD3;SUMF1;PPM1L;SMPD4;SPNS2;SGPL1;HEXB;HEXA;ELOVL6;CERK
prerank,negative regulation of axon extension (GO:0030517),-0.5469443403133217,-1.6898698775978653,0.011185682326621925,0.14923927856831146,1.0,13/30,13.96%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;SEMA4B;SEMA5B;RTN4;SEMA6C;SEMA3G;CDKL3;MT3
prerank,positive regulation of dendritic spine development (GO:0060999),-0.5985256903702223,-1.6890139744335781,0.007889546351084813,0.14878991680415973,1.0,11/20,25.51%,SHANK3;LRP8;LLPH;RELN;DBNL;CAMK2B;PSEN1;DBN1;FMR1;SHANK1;FOXO6
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.7332535009244022,1.6864252648082136,0.015503875968992248,0.40838007521742925,1.0,6/12,9.43%,DPYD;CTPS1;DPYSL3;CTPS2;DPYS;ALDH6A1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.4398439573886831,-1.6845088329159073,0.0,0.15464719736177532,1.0,32/86,21.14%,OCLN;RAC1;CARMIL1;PTK2B;RPS3;CDC42EP3;CLIP1;NCKAP1;WDR1;NCK1;MET;BAIAP2L1;STMN2;APP;PAK1;NAV3;COLGALT1;EDN1;NCK2;BIN1;CLU;TOGARAM1;CDC42EP5;PRKCE;CDC42EP2;CFL2;EVL;PSEN1;NCKAP1L;MAPRE1;NUMA1;DCTN1
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5186205050971158,-1.6843341955770306,0.0022471910112359553,0.15326383140316702,1.0,17/35,11.39%,SEMA6A;NRP2;SEMA7A;SEMA6D;RAC1;PLXND1;SEMA3C;SEMA4D;SEMA3E;PLXNA4;FLNA;ARHGDIA;MET;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,neutrophil mediated immunity (GO:0002446),-0.3612713813557749,-1.6807964367937878,0.0,0.1575253573040957,1.0,148/432,24.59%,PTPRB;PECAM1;PTPRJ;FTH1;EEF1A1;B2M;RAP1A;ATP8A1;HSPA8;ADGRE5;ADAM10;RAC1;HSP90AA1;IQGAP1;CST3;GSN;HSP90AB1;FTL;PRG2;MAGT1;OSTF1;EEF2;RAB31;PSAP;PPIA;CTSD;PKM;PTPRN2;CD55;RAB27A;PLEKHO2;ATG7;CKAP4;NRAS;AP2A2;CD93;VAT1;ATP6V0A1;PGLYRP1;DOCK2;ACTR10;CD44;CTSB;PTPRC;VAMP8;STOM;CEACAM1;NDUFC2;TNFRSF1B;PPIE;GOLGA7;LAMP1;TMC6;ERP44;CD63;ATP11B;CPNE3;GRN;HEXB;PDAP1;PSMD13;RHOA;HMOX2;MAN2B1;APEH;TMEM30A;SCAMP1;ATP6V0C;ARL8A;TUBB4B;LAMTOR1;KMT2E;TMBIM1;HRNR;IMPDH1;TOLLIP;CAP1;DBNL;FUCA2;STK10;ATP11A;TCIRG1;LRG1;DGAT1;PSMC3;ACTR2;SNAP25;PSMD12;SVIP;JUP;IMPDH2;ALDOA;GDI2;LPCAT1;CD47;CSNK2B;CTSZ;LAMTOR2;CYBB;CDA;CYB5R3;GM2A;RHOG;RNASE3;QPCT;MIF;ALDOC;PRCP;RAB37;DSP;TIMP2;BRI3;S100A11;PADI2;BST2;PLAUR;PSEN1;ACLY;IRAG2;TYROBP;DDOST;PRKCD;NCKAP1L;CD300A;CTSC;SLC11A1;ADGRG3;ENPP4;VAPA;VCP;HPSE;CPPED1;PYGL;C3;MANBA;SLC2A3;GCA;GHDC;HSPA1B;NPC2;RAB7A;RAB3A;ARSB;CD68;FABP5;SRP14;LCN2;HUWE1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.5674380817439483,-1.678385061603439,0.00423728813559322,0.15944750288941428,1.0,11/24,11.39%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;VEGFA;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.7524793763509385,1.678039965634911,0.03941908713692946,0.4331211100305371,1.0,3/11,5.40%,IGF1;PLCB1;IGF1R
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.6310652892300683,-1.678026416545357,0.011976047904191617,0.1582322133016074,1.0,13/17,31.08%,RAB27A;KCNB1;STX1A;CACNA1G;SLC4A8;CACNA1H;SYT10;SYT4;CACNA1I;RAB3A;DOC2B;UNC13D;RAB15
prerank,negative regulation of protein polymerization (GO:0032272),-0.5645154408895499,-1.6772472137675867,0.006263048016701462,0.15782438038174207,1.0,13/27,20.87%,SLIT2;KANK3;KANK1;HIP1R;STMN2;CYRIB;SSH2;SSH1;KANK4;STMN1;TUBB4A;PRKCD;MAPRE1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.7011831414813395,-1.6771033248748743,0.005802707930367505,0.15628607798700567,1.0,4/11,4.38%,NOS3;HSP90AA1;CALM1;GCH1
prerank,ketone body metabolic process (GO:1902224),0.7574854854779556,1.676202119876893,0.008492569002123142,0.4320889550414403,1.0,7/10,16.54%,ACSS3;HMGCL;BDH1;BDH2;HMGCLL1;HMGCS2;OXCT1
prerank,secretion (GO:0046903),0.7163156475759641,1.67275485532465,0.019455252918287938,0.43861858709249824,1.0,3/14,1.75%,SLC22A4;SLC22A2;FBLN5
prerank,positive regulation of T cell proliferation (GO:0042102),0.5324534923912422,1.6723418506369865,0.01048951048951049,0.43314103698590534,1.0,8/55,7.56%,IGF1;IGFBP2;IL18;IGF2;ANXA1;IL6;PDCD1LG2;CCL19
prerank,arachidonate transport (GO:1903963),0.7604892439936491,1.6709148782780732,0.019148936170212766,0.42402581305250586,1.0,3/10,5.24%,BDKRB2;ANXA1;ACE
prerank,arachidonic acid secretion (GO:0050482),0.7604892439936491,1.6709148782780732,0.019148936170212766,0.42402581305250586,1.0,3/10,5.24%,BDKRB2;ANXA1;ACE
prerank,endothelial cell differentiation (GO:0045446),-0.6871315676354396,-1.6700122835149998,0.009487666034155597,0.1661607630428519,1.0,6/12,11.16%,TIE1;KDR;ACVRL1;JAG1;BMPR2;SOX18
prerank,neuromuscular junction development (GO:0007528),0.6263953326574195,1.6677697707866836,0.027237354085603113,0.42892592677323604,1.0,9/24,8.66%,UNC13C;PDZRN3;LRP4;NEDD4;PPFIBP2;CACNB4;LRRK2;DNAJA3;MUSK
prerank,smooth muscle cell differentiation (GO:0051145),-0.6779474950551614,-1.6676090708461218,0.017786561264822136,0.1686659650268949,1.0,7/12,23.10%,MEF2C;MRTFB;TMEM204;HEY2;APLNR;BMP4;HEY1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.6776664810024102,1.6673758379911465,0.026923076923076925,0.4236064286304521,1.0,2/16,0.39%,IGF1;ROCK2
prerank,ethanol metabolic process (GO:0006067),0.7386035889819582,1.6671939190092204,0.01972386587771203,0.41746671227090887,1.0,1/12,0.14%,ALDH1A1
prerank,regulation of catabolic process (GO:0009894),-0.6276382263225876,-1.6664667525970536,0.011787819253438114,0.1688168413587629,1.0,9/18,10.91%,FAP;ITGB1;NEDD4L;FAF1;CHEK2;ZDHHC2;ZDHHC7;FURIN;HGS
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.6905062437390279,-1.665365741168574,0.009328358208955223,0.168952805253078,1.0,4/11,9.21%,CD200;CD34;THBS1;PTGS2
prerank,body fluid secretion (GO:0007589),0.6938160604197304,1.6649606750002421,0.02414486921529175,0.41909186571987067,1.0,2/15,0.70%,SLC22A4;SLC22A2
prerank,cell junction assembly (GO:0034329),-0.42200639601114476,-1.664762131833775,0.002793296089385475,0.16804069071895306,1.0,23/100,5.99%,DNM3;FN1;SHANK3;SPOCK2;ADGRL3;ACTB;CLDN5;ACTG1;ITGA6;LIMS2;CDH11;CTNND2;PKP4;CDH1;PLXND1;CDH2;GJC1;KIRREL3;LIMS1;FLNA;NRCAM;FERMT2;VMP1
prerank,mesonephros development (GO:0001823),0.738176004672446,1.6644212632942261,0.02663934426229508,0.41442280159542566,1.0,3/11,5.51%,OSR1;BMP7;FGF1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.6112903199772419,1.6642091188943808,0.02028397565922921,0.4089508295021854,1.0,5/23,8.42%,IGF1;ZBTB20;PRKAA2;PRKAA1;ARNT
prerank,cellular response to fluid shear stress (GO:0071498),-0.6713324166767974,-1.6635808507451044,0.022181146025878003,0.16856115849653033,1.0,4/12,3.12%,MEF2C;KLF2;KLF4;SREBF2
prerank,positive regulation of nuclear division (GO:0051785),0.6222881583299232,1.6624424398909257,0.017857142857142856,0.40890529902025774,1.0,7/25,11.42%,IGF1;DMRT1;PDGFRB;IGF2;PHIP;NPM2;TGFA
prerank,regulation of Rac protein signal transduction (GO:0035020),0.6943251605664233,1.6611270954921582,0.021032504780114723,0.4073971355167471,1.0,3/16,3.32%,ARHGAP24;AUTS2;ALS2
prerank,regulation of receptor binding (GO:1900120),-0.7042104476716982,-1.6599078449861362,0.009433962264150943,0.17314390802924737,1.0,4/10,7.36%,B2M;ADAM15;ATP2A2;ATP2A3
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.43262122330482156,-1.658918315784147,0.0,0.17301669443447293,1.0,33/91,10.01%,ABCG2;FTH1;SLC39A10;TFRC;SCARA5;FTL;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;ATOX1;IREB2;SLC40A1;SLC30A5;SOD1;NEDD8;SLC31A1;MT2A;SLC22A17;ARF1;APP;SLC39A8;ISCU;FBXL5;HMOX2;FRRS1;SLC30A1;SLC39A7;ATP6V1A
prerank,negative regulation of signaling receptor activity (GO:2000272),0.6253689520877912,1.65840210087785,0.016333938294010888,0.41117596354157676,1.0,5/25,3.94%,ERRFI1;PPARA;SLC6A9;SNX6;CRHBP
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.6731379748680683,1.657376900578072,0.01972386587771203,0.40920829838296496,1.0,3/16,3.89%,IGF1;IGFBP2;IGFBP4
prerank,cardiac myofibril assembly (GO:0055003),0.6831879679924254,1.6570265687355392,0.01768172888015717,0.40457706583028225,1.0,5/15,4.40%,CSRP3;PDGFRB;NEBL;OBSL1;PDGFRA
prerank,zinc ion homeostasis (GO:0055069),-0.5605599177255264,-1.6567021390055605,0.00646551724137931,0.17545636159032396,1.0,17/28,16.19%,SLC39A10;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;SLC30A5;MT2A;SLC39A8;SLC30A1;SLC39A7;SLC39A14;MT3;ATP13A2
prerank,negative regulation of response to stimulus (GO:0048585),-0.4697707850785226,-1.6560807055445836,0.0,0.17484513769524312,1.0,26/60,20.04%,SLIT2;KLF7;CD34;KLF4;MCTP1;HHIP;VPS13C;UBASH3B;SOCS5;DDAH1;KIF26A;YBX1;AQP11;CDK6;LPCAT3;TLE5;PTPN1;MAP3K3;CASK;CLU;NR1H2;COL3A1;WFS1;ACVR1;SH2B3;THY1
prerank,macrophage activation involved in immune response (GO:0002281),-0.6787982618525428,-1.6557766575909374,0.013779527559055118,0.17359005805077424,1.0,8/13,19.88%,PLCG2;LBP;SBNO2;GRN;DYSF;IFI35;CX3CR1;TYROBP
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5913490477082364,-1.6552568831494128,0.006172839506172839,0.17278150643093615,1.0,10/20,11.39%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,positive regulation of cell junction assembly (GO:1901890),-0.47809591230257736,-1.6551787599873746,0.0025252525252525255,0.17130239378606682,1.0,19/56,12.24%,TEK;CAV1;PTPRJ;CLDN5;KDR;RAC1;LIMS1;FERMT2;CLSTN2;MYOC;VEGFA;IL1RAP;NRXN1;SYNDIG1;COL16A1;EPHB1;ACE2;CLSTN3;S100A10
prerank,regulation of sequestering of triglyceride (GO:0010889),0.6749501283529712,1.654870300863901,0.02594810379241517,0.4064354317255121,1.0,3/15,5.02%,OSBPL8;PPARA;APOC4
prerank,modified amino acid transport (GO:0072337),0.681160317573938,1.6535708827606084,0.024229074889867842,0.40572069059524524,1.0,6/15,10.58%,SLC6A13;SLC16A12;PDPN;FOLR1;FOLR2;SLC19A1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.47041130036347645,-1.6533572074353102,0.011990407673860911,0.17281398008832824,1.0,27/54,24.46%,CAV1;RPL11;RPS3;DNAJA1;IVNS1ABP;UBXN1;PINX1;SOX4;CTNNB1;ARRB1;RPL5;CHP1;OGT;ISG15;CAMLG;COPS9;NXN;PRMT3;SPOPL;N4BP1;PRKCG;ARRB2;AKT1;SIRT7;TNFAIP3;HSPA1B;SPRY2
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.6732105224738917,-1.653228100380419,0.007782101167315175,0.1714360962543921,1.0,7/13,15.78%,KCNB1;STX1A;CACNA1G;CACNA1H;SYT10;SYT4;CACNA1I
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.646697888483064,1.6529406959949373,0.022044088176352707,0.4026680453078805,1.0,2/20,6.22%,IGF1;NIBAN2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.6928027035635869,1.6527045848430317,0.04032258064516129,0.3981055416391313,1.0,5/13,7.83%,SORBS1;IGF2;PRKCZ;ECHDC3;GKAP1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.6504283862713687,-1.65234295602774,0.01037344398340249,0.17154275274007522,1.0,5/14,10.16%,GAB1;KDR;FLT4;VEGFA;PIK3CD
prerank,aspartate family amino acid catabolic process (GO:0009068),0.6522073530226182,1.6519969433004802,0.03131115459882583,0.39558247327790824,1.0,7/19,14.79%,DDO;AASS;ALDH7A1;GCDH;PIPOX;AADAT;ASPA
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.5014213749576334,-1.6497443151092972,0.0117096018735363,0.17413537730764161,1.0,13/43,11.43%,MEF2C;MICAL2;ENG;NOTCH1;HES1;SOX17;TGFBR2;TBX2;TBX3;RYR2;VANGL2;SOX18;NDRG4
prerank,cardiac muscle tissue development (GO:0048738),0.5292928140904417,1.6487057631758761,0.015025041736227046,0.4020968423169255,1.0,12/50,7.19%,ADAMTS9;GJB6;NOTCH2;BMP7;RBP4;CSRP3;CBY1;AKAP13;SIK1;GJA1;MAML1;NDUFV2
prerank,monocarboxylic acid metabolic process (GO:0032787),0.4644153607793208,1.6482767540639969,0.0031746031746031746,0.398479730771938,1.0,14/117,6.86%,IGF1;CYP26B1;ALDH1A2;PCCA;PPARA;ALDH4A1;ABAT;ACADSB;MCCC2;ACOT4;SCPEP1;ECHDC3;PTGR1;HOGA1
prerank,regulation of cell junction assembly (GO:1901888),-0.5586056734677232,-1.6477512541940638,0.006726457399103139,0.1758007621058359,1.0,8/27,3.00%,MEF2C;PRKCH;CLDN5;RAP1A;OCLN;RUNX1;CBFB;F11R
prerank,membrane organization (GO:0061024),-0.37371752931100133,-1.6475065871646684,0.0,0.17465868063824472,1.0,88/227,24.76%,DNM3;SPTBN1;CERT1;HIP1;SGIP1;ACTB;ACTG1;SH3KBP1;HSPA8;TFRC;FNBP1L;CBL;STON2;REEP3;REEP1;UBB;REPS2;SH3GLB1;FNBP1;PACSIN2;FZD4;CHMP5;CHMP2B;SYNJ1;CORO1C;AP2A2;ARPC3;ATP2C1;CCDC88A;VTI1B;VAMP8;ARRB1;RPS27A;UBC;CHP1;HIP1R;DNM2;LEMD2;AMPH;DYSF;AP2M1;TOR1B;LPCAT3;PIK3C2A;HGS;GLTP;NECAP1;TMEM43;NSFL1C;BIN1;DNM1;EPN2;ADRB2;ACTR2;PICK1;PIP5K1C;AGFG1;CFTR;UBA52;M6PR;TLCD2;DVL2;SYT2;SGCZ;ARPC4;CHMP1B;SUN1;SH3GL2;ARRB2;ARPC1A;AP2B1;ANK3;CHMP1A;CTDNEP1;VAPA;ACTR3;MFN2;CHMP3;GCA;AP2A1;CHRNB1;TIMM50;CHMP7;PDCD6IP;SCARB2;HUWE1;OTOF;SYP
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.4496329027104113,-1.6469548299122934,0.002512562814070352,0.1741297970828979,1.0,26/73,20.29%,NTRK3;CAV1;FNIP2;TFRC;BCAR3;HSP90AA1;GAS6;HSP90AB1;NGF;TGFB1;MTCP1;CD44;APP;PDCD10;VEGFA;PAK1;EIF4G1;NOS1;TERF2IP;TNKS1BP1;RAF1;PRKD1;MIF;PINK1;AKT1;ATP2B4
prerank,cellular glucan metabolic process (GO:0006073),0.7312942853363978,1.646072716721183,0.02092050209205021,0.4012325220016648,1.0,2/11,1.70%,PRKAG2;PHKB
prerank,membrane lipid biosynthetic process (GO:0046467),-0.46751490613976904,-1.6453106112863913,0.0072992700729927005,0.17556148345839614,1.0,18/58,9.43%,ST3GAL4;CERT1;ELOVL7;SGMS1;SGMS2;ACER3;ELOVL5;ACER2;SPTLC2;PLPP1;DEGS2;KDSR;PRKD3;PPM1L;SPNS2;SGPL1;ELOVL6;ST8SIA6
prerank,negative regulation of metabolic process (GO:0009892),0.534895742994236,1.6432565601820497,0.008695652173913044,0.40532029779219725,1.0,9/54,6.34%,ALDH1A1;NPR3;LGR4;RBPJ;ADAMTS5;NOVA1;MAP2K6;TLE3;NRDC
prerank,positive regulation of glucose import (GO:0046326),0.627233492838634,1.6431501227804712,0.03710575139146568,0.4007513256437519,1.0,3/21,2.08%,IGF1;OSBPL8;SORBS1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.46090431616265937,1.642750184380085,0.0047169811320754715,0.3973030112545996,1.0,22/108,7.29%,DCDC2;WLS;PTK7;TRABD2B;FGFR2;RNF43;PRKN;WWOX;DKK1;MACF1;GRB10;VGLL4;CBY1;SULF1;GPC3;LRRK2;ITGA3;APCDD1;TCF7L1;GNAQ;SALL1;FOLR1
prerank,dicarboxylic acid transport (GO:0006835),0.5934641007065008,1.6402534717941781,0.018832391713747645,0.4003789385847304,1.0,12/28,10.58%,SLC13A3;SLC1A3;PDPN;SLC25A18;GJA1;SLC13A5;FOLR1;FOLR2;ABCC2;SLC25A22;SLC22A6;SLC19A1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5618588158665634,1.63986563755312,0.017964071856287425,0.39692064679208044,1.0,8/32,8.88%,IGF1;PPARA;PID1;ZBTB20;PRKAA2;PRKAA1;ARNT;NUPR1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.678939498989545,-1.638149203106034,0.012844036697247707,0.1855378617009437,1.0,7/12,15.08%,EFNA5;ACTN4;KANK1;CORO1C;AP1AR;SPRY4;RCC2
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.678939498989545,-1.638149203106034,0.012844036697247707,0.1855378617009437,1.0,7/12,15.08%,EFNA5;ACTN4;KANK1;CORO1C;AP1AR;SPRY4;RCC2
prerank,negative regulation of complement activation (GO:0045916),-0.7122924306046036,-1.6367536009693917,0.009505703422053232,0.18662940346144843,1.0,4/10,15.98%,CD55;SUSD4;A2M;CR2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5826078537885011,1.636585608009125,0.0150093808630394,0.403285391992107,1.0,7/31,5.73%,TGFBR3;RBPJ;FGFR2;TPM1;TNNC1;TNNT2;LRP2
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.5639085895672582,-1.636361415718289,0.004098360655737705,0.1858855603397257,1.0,11/24,22.51%,MEF2C;CDH2;CDON;CTNNB1;OLFM2;BNIP2;BOC;TCF3;CTNNA1;SPAG9;MAPK11
prerank,regulation of mitotic nuclear division (GO:0007088),0.5219081146889885,1.633809455220454,0.012027491408934709,0.4080524887471176,1.0,12/55,11.42%,IGF1;BMP7;DMRT1;PDGFRB;IGF2;OBSL1;TOM1L2;CCDC8;CUL9;CUL7;PHIP;TGFA
prerank,ganglion development (GO:0061548),-0.6914856614630824,-1.6329072384580543,0.011342155009451797,0.19029072888799703,1.0,4/11,6.01%,NRP2;UNC5C;TUBB3;CTNNB1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.6686261918594536,1.632427485745346,0.030303030303030304,0.4078942793722511,1.0,2/15,5.21%,MOXD1;AANAT
prerank,cellular response to organonitrogen compound (GO:0071417),-0.4159014023603809,-1.6317686566923588,0.0,0.19085126209973438,1.0,31/99,15.43%,MEF2C;SLIT2;ACTB;RAP1A;PDE3A;CDH1;SH3BP4;GABRB3;IGFBP5;CAPN2;CTNNB1;HSP90B1;GABRB1;AHR;PDE2A;KCNQ1;MTOR;SSH1;SESN2;CPEB1;ZFP36L1;XBP1;LAMTOR1;SLC26A6;SPAAR;HCN1;HRH1;JUP;NR1H4;LAMTOR2;CFTR
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.5867426662536959,1.6308844263551314,0.027522935779816515,0.4082969788627427,1.0,5/29,2.80%,TGFBR3;FGFR2;TPM1;TNNC1;TNNT2
prerank,limb development (GO:0060173),0.5896987193653469,1.6303098030741134,0.018315018315018316,0.4057445245749532,1.0,7/28,6.81%,LRP4;DKK1;INTU;SMOC1;ZNRF3;GLI3;SALL1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.6796733289895486,-1.6280999094884894,0.011811023622047244,0.19655540733385946,1.0,6/12,11.43%,PTPRJ;APOD;CBL;F3;HGS;NDRG4
prerank,receptor internalization (GO:0031623),-0.48726149710827577,-1.628059971367383,0.011737089201877934,0.19502893849645686,1.0,16/44,14.46%,DNM3;CAV1;TFRC;CD9;ITGB1;RAMP2;RAB31;ACKR3;ARRB1;CEACAM1;DNM2;RAMP1;AP2M1;DNM1;CD81;CALCRL
prerank,myoblast differentiation (GO:0045445),0.6929797601879617,1.6277870634685523,0.02569593147751606,0.40965066324704896,1.0,3/14,1.05%,IGF1;TCF7L2;EPAS1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.5103384260091461,1.6264317902891001,0.010033444816053512,0.40938392852876415,1.0,18/61,16.40%,EYA4;EYA1;EYA2;FGFR4;SMOC2;PDGFRB;USP7;STPG4;CEBPG;RTEL1;NPAS2;PRKD2;MRE11;BABAM2;WRN;RAD51;PML;HGF
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5016780748349472,-1.6263564368561747,0.006382978723404255,0.19689091583723795,1.0,15/37,20.09%,RPL11;RPL23;HSP90AB1;RPS7;UCHL5;UBXN1;PDCL3;BAG6;RPL5;OGT;CAMLG;RYBP;N4BP1;TLK2;NOP53
prerank,ear morphogenesis (GO:0042471),0.6233867253736484,1.6260813907945606,0.025896414342629483,0.40634934675722634,1.0,3/20,1.00%,OSR1;ZIC1;FGFR2
prerank,endothelial cell migration (GO:0043542),-0.5007216212534108,-1.6243833231190343,0.018867924528301886,0.19891428295095465,1.0,22/37,24.36%,NOS3;ID1;FAP;PLXND1;PXN;CCN3;MYH9;VEGFA;EMP2;NR4A1;RHOA;DPP4;SOX18;SCG2;CDH13;CYP1B1;ADGRA2;PLEKHG5;PRKX;PTP4A3;EGR3;STAT1
prerank,chloride transmembrane transport (GO:1902476),-0.47493482159040246,-1.6242983564552091,0.009302325581395349,0.19741493167289278,1.0,17/48,16.89%,SLC12A7;SLC12A2;ANO1;ANO4;GABRB3;SLC12A6;SLC1A1;GABRB1;SLC12A8;SLC4A8;ANO3;LRRC8A;SLC12A4;GABRG3;ANO2;CFTR;GLRA3
prerank,negative regulation of cell development (GO:0010721),0.6067864933358331,1.6235996612005696,0.01876172607879925,0.40995168299881357,1.0,4/25,2.73%,IGF1;FBN1;APPL2;LTF
prerank,diterpenoid metabolic process (GO:0016101),0.5308062106445997,1.6235037409837128,0.006756756756756757,0.40608260501558296,1.0,9/55,6.18%,ALDH1A1;RBP4;ABCA4;SDC2;GPC6;RBP1;GPC3;LRP2;NAPEPLD
prerank,monocarboxylic acid catabolic process (GO:0072329),0.6164642497929174,1.6190082883590478,0.03137254901960784,0.4170063677551723,1.0,4/21,6.86%,CYP26B1;CEL;FAH;HOGA1
prerank,positive regulation of dendrite extension (GO:1903861),-0.6072279311592359,-1.6190004291256435,0.02286902286902287,0.20532674554095026,1.0,13/17,29.94%,NEDD4L;ITSN2;RNF157;SYT4;CPNE9;SYT2;RASAL1;PLAA;CPNE5;RIMS2;SYT17;SYT1;SMURF1
prerank,skeletal system development (GO:0001501),0.43220936390321774,1.6181052644740817,0.0,0.4154316272793965,1.0,25/148,7.92%,IGF1;SOX5;BMP6;NPR3;FBN1;FGFR2;BMP7;RBP4;WWOX;GNAS;COL9A2;SOX6;IGF2;COL1A2;SH3PXD2B;COL13A1;AKAP13;GJA1;SULF1;PRELP;ANKRD11;SUFU;EN1;EXTL1;DYM
prerank,primary alcohol metabolic process (GO:0034308),0.6007840868093287,1.6179665561128374,0.019230769230769232,0.41161586960442825,1.0,3/25,6.18%,IGF1;RBP4;NAPEPLD
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6665025414138883,-1.617698924295748,0.009689922480620155,0.20644915525803592,1.0,9/12,18.75%,CAV1;CTNNA3;RYR2;CACNA1C;BIN1;JUP;DSG2;DSP;TRPM4
prerank,acylglycerol metabolic process (GO:0006639),-0.5045909664780632,-1.6170802144710852,0.024774774774774775,0.20602293386567058,1.0,10/37,12.83%,ABHD2;CAV1;DGKH;MGLL;DGKB;DGKI;LYPLA2;DGKZ;DGKG;DGAT1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.4143300758455861,1.6156316022205386,0.0,0.41526548543375624,1.0,43/248,10.26%,BICC1;IGFBP2;RNF220;WLS;LRRK1;TCF7L2;PTK7;LGR4;FGFR2;MCC;PRKN;LRP4;ZEB2;DAB2;DKK3;RBMS3;DKK1;TBL1XR1;IGFBP4;PRICKLE1;INVS;LYPD6;TMEM64;TLE3;ZNRF3;GPC3;LRRK2;FRAT1;GLI3;PSME4;PSMA2;GNAQ;PSMA3;FOLR1;SIAH2;AMFR;TLE1;USP34;PSMD8;AXIN2;DVL3;LATS1;SMURF2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.5062286328462297,-1.6150552241229952,0.01079913606911447,0.2084302522355646,1.0,11/34,8.44%,GAB1;SEMA6A;KDR;RAMP2;MT1G;DAB2IP;NOTCH1;HSPB1;FLT4;VEGFA;NR4A1
prerank,cardiac muscle contraction (GO:0060048),0.5756111669982533,1.6143114917315735,0.014571948998178506,0.4154599859737385,1.0,7/34,3.07%,ATP1A2;TPM1;DMD;CSRP3;TNNC1;TNNT2;SLC8A1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5687720536981783,-1.6122089486038071,0.029411764705882353,0.21249848075780522,1.0,5/21,2.22%,PRKCH;FOXP1;SLC39A10;RUNX1;CBFB
prerank,cell projection assembly (GO:0030031),-0.5552762950337544,-1.6118792047176638,0.017391304347826087,0.21150806305184142,1.0,5/22,4.32%,RHOJ;PARVB;RAC1;GSN;NCKAP1
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.6254821610159772,-1.6115145167784153,0.017716535433070866,0.21069583368883177,1.0,7/15,15.23%,NTRK3;KDR;F3;VEGFA;SCG2;CDH13;CXCL12
prerank,regulation of epithelial cell proliferation (GO:0050678),0.47096680880935016,1.6099851910263716,0.00980392156862745,0.4253482866308603,1.0,8/85,1.29%,IGF1;TGFBR3;BMP6;TCF7L2;OSR1;FGFR2;MCC;ANGPT1
prerank,positive regulation of protein secretion (GO:0050714),0.48664218628219885,1.609812174299469,0.013179571663920923,0.42176178739252396,1.0,8/69,2.23%,IGF1;BMP6;WLS;TCF7L2;C1QTNF3;RBP4;FRMD4A;NLGN2
prerank,receptor metabolic process (GO:0043112),-0.4558738878123653,-1.6094543253816873,0.002421307506053269,0.21318121513186142,1.0,20/53,14.46%,DNM3;CAV1;TFRC;CD9;ITGB1;RAMP2;RAB31;ACKR3;SH3GLB1;LGMN;TGFB1;DNM2;RAMP1;AP2M1;DNM1;LMTK2;EHD3;MVB12A;CD81;CALCRL
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6091219587280329,1.608324429473725,0.020366598778004074,0.42242168660672796,1.0,5/24,5.90%,SOX5;ADAMTS12;EFEMP1;SOX6;ADAMTS7
prerank,embryonic skeletal system development (GO:0048706),0.5581327495312186,1.6068147391245526,0.023985239852398525,0.42293014168844295,1.0,9/35,6.09%,OSR1;HOXC4;RBP4;HOXB4;HOXB3;HOXA3;PDGFRA;SULF1;SLC2A10
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6916557320531675,-1.6063979063163702,0.01904761904761905,0.21765608274174636,1.0,5/10,11.43%,PTPRJ;APOD;PTPN12;HGS;NDRG4
prerank,regulation of dendrite extension (GO:1903859),-0.5950627974929588,-1.605377699166229,0.01910828025477707,0.2180314726227179,1.0,13/18,29.94%,NEDD4L;ITSN2;RNF157;SYT4;CPNE9;SYT2;RASAL1;PLAA;CPNE5;RIMS2;SYT17;SYT1;SMURF1
prerank,positive regulation of ossification (GO:0045778),0.5525616320243945,1.6043187195961577,0.025594149908592323,0.42697638311844166,1.0,8/39,3.12%,BMP6;ADGRV1;OSR1;WNT4;BMP7;FBN2;SLC8A1;KL
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.689538182748132,-1.6038569818602308,0.019083969465648856,0.21967427550756102,1.0,3/10,1.94%,IL33;KDR;NAMPT
prerank,regulation of osteoblast differentiation (GO:0045667),0.4778024443020739,1.6035428831246363,0.0065040650406504065,0.425381730875712,1.0,15/82,7.50%,IGF1;RANBP3L;BMP6;WNT4;FGFR2;BMP7;FBN2;SMAD6;LTF;SMOC1;CCN4;TMEM64;SUFU;IL6;DDR2
prerank,mesenchymal cell differentiation (GO:0048762),0.5136261600854185,1.6026353885438611,0.029982363315696647,0.42460077913961686,1.0,8/51,2.97%,RANBP3L;TGFBR3;ROCK2;WNT4;RBPJ;FGFR2;BMP7;LOXL3
prerank,endoderm formation (GO:0001706),-0.5111725584031286,-1.6025824396477732,0.017543859649122806,0.22049164350767922,1.0,12/35,13.27%,COL8A1;FN1;COL12A1;COL6A1;SOX17;ITGA5;ITGA4;LAMA3;SOX7;MMP15;COL4A2;ITGA7
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.591292793929505,-1.6013475979833276,0.024242424242424242,0.22132978341673085,1.0,10/18,27.92%,JAM2;ITGB1;ITGA4;ADD2;SLC39A8;CX3CR1;PODXL2;SELPLG;SELP;ITGB7
prerank,regulation of macrophage cytokine production (GO:0010935),-0.6536771430351815,-1.6011587102401592,0.0163265306122449,0.2200723169083387,1.0,7/13,16.11%,SEMA7A;TGFB2;PLCG2;TGFB1;CD74;IRAK3;LAPTM5
prerank,regulation of centrosome cycle (GO:0046605),-0.5687482680543168,-1.5986763159283661,0.02044989775051125,0.22323623580273946,1.0,15/21,35.77%,CHMP5;CHMP2B;CHMP1B;CHMP1A;GEN1;CHMP3;PDCD6IP;CHMP4C;VPS4B;CEP131;AURKA;ATF5;NPM1;PKHD1;XRCC3
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.6702252020816946,-1.598373421307856,0.020754716981132074,0.2222638843466036,1.0,4/12,3.07%,CAV1;PDE4D;CALM1;GJD3
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.43848323422768026,-1.5983314903128432,0.004830917874396135,0.22073203161788907,1.0,22/67,10.85%,ELMO1;NRP2;KDR;RAC1;HSP90AA1;PTK2;DOCK1;CLEC14A;FYN;PTK2B;DAB2IP;NCKAP1;PXN;HSPB1;BCAR1;NCK1;FLT4;VEGFA;RHOA;PAK2;NCK2;CRK
prerank,embryonic eye morphogenesis (GO:0048048),0.7085844048217764,1.5940618484869453,0.035398230088495575,0.4483525932949826,1.0,4/11,4.95%,EFEMP1;FBN1;FBN2;KDM2B
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5703761210203747,1.5937690458635594,0.035580524344569285,0.44529837804276734,1.0,3/29,3.68%,IL31RA;FER;STAT5B
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.4442333464952038,-1.5927755040122868,0.005063291139240506,0.2302051430936399,1.0,26/64,12.45%,UTRN;LIMCH1;EFNA5;ACTG1;ACER2;THBS1;JAG1;PTK2;ADAM15;SLK;PTK2B;MINK1;SEMA3E;CORO1C;NEXMIF;GSK3B;GPM6B;MYOC;EMP2;AJAP1;PEAK1;RHOA;CDK6;DUSP3;CDH13;CASK
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6705286042511056,-1.5925219407231108,0.017110266159695818,0.22902367038602658,1.0,3/11,1.99%,MECOM;CD34;RUNX1
prerank,cellular response to sterol (GO:0036315),0.6753410471611045,1.5921508165582694,0.042643923240938165,0.4465960150381094,1.0,3/13,3.74%,RORA;INSIG2;GRAMD1C
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.6599878943764141,1.5921349175658475,0.043478260869565216,0.4426213788373734,1.0,5/16,3.96%,ATP1A2;DMD;GSTM2;SLC8A1;ANK2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.7011129024256315,-1.5910471075472108,0.01098901098901099,0.23035366757092973,1.0,7/10,20.19%,PRKG1;CD9;SERPINE2;CEACAM1;ALOX12;SH2B3;PRKCD
prerank,myotube differentiation (GO:0014902),0.6357471434522229,1.5908233258025686,0.038834951456310676,0.44279237119787945,1.0,4/17,2.21%,IGF1;ADAM12;ADAMTS5;ADAMTS15
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6602939988300436,1.590150873582281,0.04811715481171548,0.44098892859207217,1.0,2/15,1.37%,IGF1;PRKN
prerank,retina homeostasis (GO:0001895),-0.549129403518773,-1.5890259186382236,0.012295081967213115,0.2329814280841346,1.0,6/23,6.09%,ACTB;POTEF;B2M;ACTG1;HSPB1;SOD1
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.6134020001068081,1.5879652906842725,0.038314176245210725,0.4442329521483066,1.0,3/20,4.99%,WNT4;C1QTNF3;SIK1
prerank,negative regulation of TOR signaling (GO:0032007),0.538354715315595,1.5873552261810906,0.019572953736654804,0.44232286530694054,1.0,14/36,11.36%,NPRL3;FNIP1;DEPTOR;SZT2;SESN1;PRKAA2;NPRL2;PDCD6;UBR2;RNF152;PRKAA1;EPM2A;FLCN;AKT1S1
prerank,T cell migration (GO:0072678),-0.6383444349169873,-1.586545779977548,0.027944111776447105,0.23687241248502952,1.0,4/13,10.16%,SLC12A2;MSN;S1PR1;PIK3CD
prerank,steroid metabolic process (GO:0008202),0.48046018956062997,1.5854787703324507,0.011627906976744186,0.44455868353201095,1.0,8/72,5.73%,CYP26B1;CYP27A1;LIPA;HSD17B1;NR1I2;FDXR;HSD17B10;LRP2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.7143275294695853,1.5854210266221649,0.049107142857142856,0.4409825843934696,1.0,2/10,2.75%,SOX5;SOX6
prerank,response to prostaglandin E (GO:0034695),0.7140001879551616,1.5849500641313905,0.04883227176220807,0.43883523272535296,1.0,5/10,18.81%,TGFBR3;CCL19;PTGER4;GNG2;SFRP1
prerank,lipid oxidation (GO:0034440),-0.6492541531508947,-1.582459288321352,0.01509433962264151,0.24359669248067087,1.0,3/12,12.63%,ADIPOR2;PPARGC1A;ALOX12
prerank,regulation of bone mineralization (GO:0030500),0.5080108881775243,1.582259705552606,0.025684931506849314,0.44360569124609056,1.0,14/55,8.63%,BMP6;ADGRV1;OSR1;WNT4;BMP7;FBN2;BMP2K;SLC8A1;KL;ECM1;PTN;BCOR;DDR2;ATRAID
prerank,stem cell differentiation (GO:0048863),0.5425948962964601,1.581187238335835,0.027972027972027972,0.44320842600802046,1.0,11/39,9.37%,OSR1;FGFR2;KIT;HOXB4;JARID2;EPOP;ACE;UFL1;SETD6;MTF2;FBXL17
prerank,neural crest cell migration (GO:0001755),-0.4915158145404448,-1.5811423752510423,0.008849557522123894,0.24457899565101252,1.0,13/36,11.39%,FN1;SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;TBX1;SEMA3E;CORO1C;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,presynapse assembly (GO:0099054),0.6579401154630096,1.5799245326230962,0.04536082474226804,0.44386124717319403,1.0,6/16,7.48%,LRP4;CEL;NLGN2;IL1RAPL1;PTPRD;PTEN
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.7253807071838096,1.5793848882723942,0.04139433551198257,0.4420859800961139,1.0,5/10,9.30%,IVD;ACADL;ACAD11;ACADS;GCDH
prerank,negative regulation of platelet activation (GO:0010544),-0.6088858132740291,-1.5790921446160466,0.024253731343283583,0.24721288450647683,1.0,9/16,20.19%,PRKG1;NOS3;CD9;SERPINE2;CEACAM1;THBD;ALOX12;SH2B3;PRKCD
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.5278753555454098,1.5778465421821462,0.03146853146853147,0.4434558984206614,1.0,10/43,8.63%,IGF1;BMP6;WNT4;BMP7;FBN2;LTF;CCN4;IL6;DDR2;ATRAID
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.5414649112756499,1.577554470921506,0.02857142857142857,0.4407960874002102,1.0,4/34,3.44%,IGF1;DMRT1;PDGFRB;IGF2
prerank,regulation of glycolytic process (GO:0006110),0.4772115633701844,1.5772055045519873,0.01391304347826087,0.4383303524652657,1.0,10/68,10.15%,IGF1;PRKAG2;PPARA;ZBTB20;PRKAA2;NDC1;PRKAA1;ARNT;NUPR1;NUP107
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.6548693155123048,1.5771819449882414,0.032119914346895075,0.4349159615340702,1.0,5/17,10.56%,IGF1;PDGFRB;CCN4;VTN;FGF9
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.620810972253097,-1.5771589336546834,0.024029574861367836,0.24950462663196435,1.0,4/14,14.24%,ENTPD1;ENTPD7;ENTPD2;NUDT1
prerank,regulation of striated muscle contraction (GO:0006942),0.5723962804915288,1.5770248443421389,0.041584158415841586,0.43201694262431983,1.0,4/27,3.96%,ATP1A2;SLC8A3;DMD;ANK2
prerank,negative regulation of potassium ion transport (GO:0043267),-0.6353384470155204,-1.5759184564236317,0.02536997885835095,0.25042789751122385,1.0,5/13,11.81%,CAV1;NEDD4L;PTK2B;NOS1;BIN1
prerank,activation of protein kinase B activity (GO:0032148),0.5594055822562075,1.5752197541081714,0.040983606557377046,0.4340109304793226,1.0,6/29,5.51%,IGF1;OSBPL8;IL18;PDPK1;RICTOR;FGF1
prerank,bone morphogenesis (GO:0060349),0.6562800769187448,1.5751375629309632,0.058823529411764705,0.43086324019065714,1.0,3/14,2.73%,CYP26B1;FGFR2;LTF
prerank,heart looping (GO:0001947),-0.4941962698967487,-1.574122343083682,0.01818181818181818,0.252261894027675,1.0,11/39,11.43%,MEF2C;MICAL2;ENG;NOTCH1;SOX17;TGFBR2;TBX2;TBX3;VANGL2;SOX18;NDRG4
prerank,glycoprotein catabolic process (GO:0006516),0.6235859987988462,1.5738785385489993,0.06369426751592357,0.4314548260018335,1.0,6/17,13.42%,ADAMTS12;ADAMTS9;FBXO44;FBXO6;EDEM1;NGLY1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.41799373220836056,1.573807981185569,0.002890173410404624,0.42838158903007045,1.0,38/186,11.06%,BICC1;IGFBP2;TCF7L2;TRABD2B;MCC;RNF43;PRKN;WWOX;LRP4;DAB2;DKK3;RBMS3;DKK1;RNF213;IGFBP4;GRB10;VGLL4;PRICKLE1;CBY1;INVS;TMEM64;TLE3;ZNRF3;APCDD1;GLI3;PSME4;PSMA2;PSMA3;SIAH2;AMFR;TLE1;PSMD8;WIF1;AXIN2;DVL3;LATS1;HDAC1;PSMD3
prerank,maturation of 5.8S rRNA (GO:0000460),0.6267187959335542,1.5737302285013297,0.03868471953578337,0.4253617488265114,1.0,5/17,10.51%,NSA2;MPHOSPH6;FTSJ3;NOL9;PRKDC
prerank,regulation of intracellular pH (GO:0051453),-0.5029522452016524,-1.5728637364990743,0.011547344110854504,0.25285413928713285,1.0,12/34,18.98%,SLC4A10;SLC9A2;SLC9A8;CHP1;SLC4A8;CA2;SLC4A2;SLC26A6;SLC9B1;CFTR;ATP5F1B;TMEM165
prerank,lipid phosphorylation (GO:0046834),-0.6847347653691004,-1.5708210056530296,0.0299625468164794,0.25581424292645,1.0,7/10,24.15%,DGKH;DGKB;DGKI;DGKZ;DGKG;DGKE;DGKQ
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.5922043577657079,-1.5700850604400072,0.02584493041749503,0.25596306099802446,1.0,13/17,28.23%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;ATP5F1E;STOML2;ATP5PD;ATP5F1B;VPS9D1;ATP5MC2;ATP5MF;ATP5MC1;ATP5PF
prerank,nucleoside catabolic process (GO:0009164),0.6935977041605095,1.5686291876077192,0.053830227743271224,0.43828923127487623,1.0,6/11,12.28%,DPYD;UPB1;NT5M;DPYS;DERA;UPP2
prerank,male meiosis I (GO:0007141),0.6359934232823287,1.5683564979518967,0.05357142857142857,0.4357857037158986,1.0,3/16,6.30%,MYBL1;SLC25A31;HSF2BP
prerank,kidney development (GO:0001822),0.47388456236675924,1.5683168759846424,0.013029315960912053,0.4326979569376138,1.0,13/65,7.04%,OSR1;GREB1L;WNT4;BMP7;LRP4;CTSH;PCSK9;PYGO1;ARL3;ACE;SULF1;SALL1;KANK2
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.5832606034104579,-1.5678981823174156,0.04276985743380855,0.25941158700959294,1.0,6/18,11.15%,PLCG2;LBP;DOCK2;SBNO2;DYSF;IFI35
prerank,metal ion homeostasis (GO:0055065),-0.4696804430128969,-1.5672712316978572,0.01694915254237288,0.2590780305294416,1.0,16/40,21.60%,TMTC2;SLC12A7;SLC12A2;CAV1;SLC12A6;SLC12A8;GRIN1;SLC12A4;KCNA1;MT3;WFS1;COX11;LETM1;JPH2;ANK3;KCNH2
prerank,inner mitochondrial membrane organization (GO:0007007),-0.45990847300235144,-1.5670729487680366,0.017114914425427872,0.25793205550804066,1.0,26/47,25.49%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;GHITM;CHCHD3;ATP5F1E;NDUFA13;TIMM9;ROMO1;ATP5PD;MTX3;TIMM10B;TIMM13;IMMT;UQCC3;APOO;ATP5F1B;LETM1;TIMM29;HSPA9;TIMM22;SPG7;ATP5MC2;ATP5MF;ATP5MC1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.5077005371507839,-1.5668353490762716,0.02207505518763797,0.2567723604513715,1.0,18/29,34.18%,RPS21;RPS8;RPS19;RPS14;DCAF13;BMS1;DHX37;RPS16;TBL3;KRI1;PWP2;TSR1;MRPS11;ABT1;UTP20;UTP4;HELB;RPP40
prerank,regulation of acrosome reaction (GO:0060046),0.7115952846339277,1.5658476533074444,0.05150214592274678,0.4374212378101881,1.0,3/10,3.93%,PLA2G10;PLCB1;SPINK13
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.5740697944422413,1.5646951543819267,0.054844606946983544,0.4380663921680089,1.0,3/26,2.08%,IGF1;OSBPL8;SORBS1
prerank,liver development (GO:0001889),0.5522516947943615,1.56437718775449,0.015817223198594025,0.43594421405783335,1.0,10/32,12.46%,TGFBR3;WNT4;ARID5B;ANXA1;PRKCSH;PCSK9;IL6;CEBPG;COBL;PKD2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.46917568287271344,-1.5633071743073466,0.014018691588785047,0.26291986948313517,1.0,18/42,14.36%,UTRN;TEK;PTPRJ;KDR;RAC1;PTK2B;LIMS1;FERMT2;GSK3B;MYOC;VEGFA;EMP2;COL16A1;CDK6;S100A10;CDH13;JUP;GFUS
prerank,macrophage activation (GO:0042116),-0.49439553212073445,-1.5629470175493427,0.029213483146067417,0.26195951425244046,1.0,11/34,14.27%,FOXP1;PLCG2;LBP;CD93;SBNO2;APP;DYSF;IFI35;CLU;C1QA;IFNGR1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5645621463102255,-1.5607950174305207,0.03497942386831276,0.2650345279879983,1.0,8/19,7.89%,PRKCH;CLDN5;OCLN;RUNX1;CBFB;F11R;IKBKB;TJP1
prerank,response to muramyl dipeptide (GO:0032495),-0.6418645541577923,-1.560654868112308,0.026365348399246705,0.263591216144284,1.0,6/12,18.69%,VIM;NOD1;CHMP5;ARHGEF2;ERBIN;IRF5
prerank,thymus development (GO:0048538),-0.628067376862144,-1.5603897133081341,0.025193798449612403,0.26251445643419546,1.0,4/13,6.87%,TBX1;HES1;SOD1;SIX1
prerank,positive regulation of behavior (GO:0048520),-0.6645693400573045,-1.560383683911519,0.02594810379241517,0.2609137585291089,1.0,3/10,4.40%,MEF2C;SGIP1;STRA6
prerank,heart contraction (GO:0060047),0.5333723571834297,1.5596723931390795,0.02112676056338028,0.4472123621572262,1.0,8/41,5.24%,ATP1A2;TPM1;DMD;CSRP3;TNNC1;TNNT2;SLC8A1;ACE
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.4069230044893104,-1.5582928219209307,0.008021390374331552,0.2637178500444682,1.0,32/93,16.76%,NTRK3;CAV1;FNIP2;PDE4D;RASSF2;TFRC;BCAR3;HSP90AA1;GAS6;HSP90AB1;NGF;RACK1;TGFB1;NCK1;MTCP1;CD44;APP;PDCD10;VEGFA;PAK1;CNKSR3;DDIT4;EIF4G1;NCK2;NOS1;SPTBN4;NLRP2B;TERF2IP;TNKS1BP1;RAF1;PRKD1;MIF
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.5332457156164944,-1.558180856712351,0.02834008097165992,0.26237098010767407,1.0,9/23,23.02%,SLC12A7;SLC12A2;SLC12A6;SLC12A8;SLC12A4;PDK2;ATP6V0A4;KCNH2;CLCN3
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5046299959184136,-1.5579748432834313,0.038901601830663615,0.26122717453722644,1.0,13/30,22.91%,NOS3;BMP5;TNFSF10;BCL2L1;GSK3B;TMBIM1;ARHGEF2;RNF34;FAS;CASP8;TNFRSF10B;TNFAIP3;FAIM
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5749193197181546,1.5578488861007729,0.02857142857142857,0.4501251359097712,1.0,3/26,4.96%,IGF1;FHL2;CAMTA1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.47789488152429827,-1.557062190706262,0.020454545454545454,0.26159019405305817,1.0,11/42,11.43%,MEF2C;MICAL2;ENG;NOTCH1;SOX17;TGFBR2;TBX2;TBX3;VANGL2;SOX18;NDRG4
prerank,peptidyl-tyrosine modification (GO:0018212),0.4947949533724738,1.5568898661059298,0.020942408376963352,0.44997746929108884,1.0,11/56,4.40%,EFEMP1;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;TPST1;FER;EPHA4;ABI2;PDGFRA
prerank,neurotransmitter secretion (GO:0007269),-0.4728960158148965,-1.5557873682849228,0.011494252873563218,0.26291870770987386,1.0,24/44,32.67%,HSPA8;LIN7A;PTPRN2;STX1A;NRXN1;SYT10;PCLO;GAD1;CPLX2;SNAP25;SYN2;PIP5K1C;CDK5;PPFIA3;RAB3A;OTOF;CPLX1;SNAPIN;RIMS2;SNPH;SYT1;SLC32A1;GRM4;SYN1
prerank,negative regulation of cell adhesion (GO:0007162),-0.4216945827187426,-1.5557477823249344,0.004662004662004662,0.26146394475071655,1.0,20/72,6.03%,PODXL;SEMA6A;ACER2;ADAM10;ACVRL1;JAG1;CDH1;PLXND1;PTK2;CORO2B;NOTCH1;SEMA4D;TGFBI;ARHGDIB;FZD4;PLXNA4;TGFB1;ARHGDIA;NEXMIF;PTPRC
prerank,manganese ion transport (GO:0006828),-0.6111049954736648,-1.554847266028511,0.035856573705179286,0.2619170116630158,1.0,11/14,29.83%,TRPC3;TRPC6;ATP2C1;SLC39A8;TRPC4;SLC39A14;TRPC1;TMEM165;SLC11A1;TRPC7;ATP2C2
prerank,platelet degranulation (GO:0002576),-0.38728469244100533,-1.5516062212035786,0.0031645569620253164,0.2673106868298004,1.0,31/118,9.01%,PCDH7;ABCC4;VWF;FN1;PECAM1;TMSB4X;ACTN4;THBS1;TGFB2;GAS6;CD9;CALM1;LHFPL2;PSAP;TAGLN2;FLNA;ACTN1;WDR1;ENDOD1;TGFB1;CD109;FAM3C;SOD1;VTI1B;CLEC3B;APP;VEGFA;CYRIB;CD63;SRGN;A2M
prerank,receptor signaling pathway via STAT (GO:0097696),0.5763217282653723,1.551109628611903,0.04868913857677903,0.46565323145134224,1.0,2/25,3.68%,IL31RA;STAT5B
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.618786561526523,-1.5489007866086024,0.03339882121807466,0.27199753979593116,1.0,4/13,9.30%,IL33;KDR;NAMPT;EDN1
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.4887086989072401,-1.5481338767990873,0.02564102564102564,0.2720554678008988,1.0,17/33,12.45%,SEMA6A;RHOJ;BMPER;KLF2;THBS1;KLF4;PKM;PPP1R16B;CREB3L1;ITGA5;CEMIP2;CEACAM1;VEGFA;TJP1;S100A1;SYNJ2BP;EPN2
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.6181813017459543,1.5465604302287268,0.053465346534653464,0.47787426670954003,1.0,1/19,0.03%,IGF1
prerank,cAMP biosynthetic process (GO:0006171),0.7113856757839565,1.5456118166207393,0.056451612903225805,0.4777373962836156,1.0,2/10,0.71%,ADCY5;ADCY1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.6644795233692863,1.5455172151212353,0.0778688524590164,0.4746727954816451,1.0,8/12,22.98%,SORBS1;IGF2;PRKCZ;GKAP1;PTPN11;C1QTNF12;IRS1;SNX5
prerank,striated muscle contraction (GO:0006941),0.4993505390383885,1.5445872207670777,0.03185840707964602,0.47434969649722813,1.0,13/53,13.74%,ATP1A2;TPM1;DMD;CSRP3;TNNC1;TNNT2;SLC8A1;ARHGEF11;RCSD1;DTNA;SCN3B;SCN2B;CCDC78
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.579049398021812,1.5435581565479455,0.03732809430255403,0.4745218230551311,1.0,4/23,4.46%,PRKAG2;CEMIP;BMP7;SPHK1
prerank,signal release from synapse (GO:0099643),-0.46887005016426836,-1.5432139084010554,0.020179372197309416,0.2820642706156887,1.0,23/43,32.67%,HSPA8;LIN7A;PTPRN2;STX1A;NRXN1;SYT10;PCLO;GAD1;CPLX2;SNAP25;SYN2;PIP5K1C;CDK5;PPFIA3;RAB3A;OTOF;CPLX1;SNAPIN;SNPH;SYT1;SLC32A1;GRM4;SYN1
prerank,negative regulation of reproductive process (GO:2000242),0.6293543403424,1.542845280863569,0.04938271604938271,0.4738140997801302,1.0,4/17,5.24%,IGF1;SPINK13;GJA1;SULF1
prerank,endoplasmic reticulum organization (GO:0007029),-0.419331263713162,-1.5421202963436003,0.002680965147453083,0.28286253075161405,1.0,39/72,33.56%,REEP3;REEP1;CAV2;RTN3;REEP5;SHTN1;STX1A;APP;SMPD4;CCDC47;TOR1B;RTN4;LPCAT3;LMAN2;BNIP1;LMAN2L;SEC61G;ATL2;SEC16B;SPTSSB;GET4;VAPA;TLE6;OTOF;SEC16A;REEP2;ZBED3;RNF112;SEC31A;WDR83OS;ATL3;TMEM33;STX5;SEC61B;UBE2J2;RAB18;TRDN;SEC31B;DOP1B
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.49810011612214694,-1.54199134168366,0.031512605042016806,0.2815100996583735,1.0,16/30,28.21%,TPT1;ACKR3;RPS3;CD44;BCL2L1;DDX39B;CD74;CLU;CXCL12;MIF;CDKN2D;PTTG1IP;SNAI2;PSMD10;YJU2;TMEM161A
prerank,hepaticobiliary system development (GO:0061008),0.601556680028468,1.5409995888635726,0.04678362573099415,0.47673558001702643,1.0,5/20,3.79%,TGFBR3;WNT4;ARID5B;PRKCSH;PCSK9
prerank,regulation of cellular pH (GO:0030641),-0.5071322238457757,-1.5409743451227014,0.028634361233480177,0.282133385470046,1.0,9/29,12.01%,SLC4A10;SLC9A2;SLC9A8;CHP1;SLC4A8;CA2;SLC4A2;SLC26A6;SLC9B1
prerank,leukocyte tethering or rolling (GO:0050901),-0.5778539128137195,-1.5409208682290783,0.035856573705179286,0.2806568797549101,1.0,9/17,27.92%,JAM2;ITGB1;ITGA4;ADD2;CX3CR1;PODXL2;SELPLG;SELP;ITGB7
prerank,regulation of cardiac conduction (GO:1903779),0.4940980151512162,1.540401284447902,0.022413793103448276,0.4753190530942791,1.0,11/54,5.95%,ATP1A2;ITPR1;SLC8A3;STIM1;CORIN;ATP1B3;SLC8A1;DMPK;ANK2;NPR2;TMEM65
prerank,maturation of SSU-rRNA (GO:0030490),-0.4908542242553865,-1.540169392918203,0.013215859030837005,0.28078865037147294,1.0,14/34,23.47%,RPS8;RPS19;RPS14;DCAF13;DDX52;BMS1;RPS28;DHX37;WDR3;RPS16;TSR3;PWP2;TSR1;MRPS11
prerank,basement membrane organization (GO:0071711),0.6293476731761442,1.5396118740316687,0.06517311608961303,0.47464400225387066,1.0,5/14,5.00%,NID2;FLRT2;PXDN;NID1;NTNG2
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.6273703073748507,1.5387372398649506,0.048638132295719845,0.47451185307811383,1.0,5/16,8.36%,DPYD;UPB1;DPYSL3;NT5M;DPYS
prerank,proteoglycan metabolic process (GO:0006029),0.5702665206592382,1.5378947575209478,0.03483606557377049,0.47419279877589066,1.0,4/26,5.24%,IGF1;ADAMTS12;GAL3ST3;SULF1
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.5974313484071502,-1.537366010786678,0.0186219739292365,0.2857544300943699,1.0,4/15,9.23%,ENTPD1;CMPK1;ENTPD7;ENTPD2
prerank,regulation of focal adhesion assembly (GO:0051893),-0.4459623248196282,-1.5357035047324386,0.019184652278177457,0.28815398778428863,1.0,24/54,12.24%,TEK;LIMCH1;EFNA5;PTPRJ;APOD;ACTG1;KDR;THBS1;RAC1;ACVRL1;PTK2;SLK;LIMS1;CORO1C;FAM107A;FERMT2;GPM6B;MYOC;VEGFA;PEAK1;RHOA;COL16A1;DUSP3;S100A10
prerank,protein localization to membrane (GO:0072657),-0.3543139367706493,-1.5351284718573286,0.0031645569620253164,0.2878161548863992,1.0,53/187,13.95%,SPTBN1;BSG;SHANK3;CAV1;RAP1A;DLG2;EFR3B;LIN7A;GAS6;CDH1;SLMAP;AGRN;KCNB2;EHD4;RAMP2;F11R;RAB3C;ATP1B1;SH3GLB1;KCNB1;FLNA;RFTN1;MAP7;IKBKB;ZDHHC15;NKD2;FERMT2;ITGA4;EHD1;WNK3;PTCH1;RAMP1;TMED2;EMP2;ZDHHC2;NRXN1;TTC7A;TSPAN17;RAB38;C2CD5;ABHD17A;RAB3B;HGS;MYO5A;TM9SF3;S100A10;SPTBN4;SYNJ2BP;EHD3;PICK1;CACNB2;CD81;JUP
prerank,regulation of neuroinflammatory response (GO:0150077),0.6017521802952366,1.5349385089802547,0.036608863198458574,0.48061870802156775,1.0,6/19,8.88%,IGF1;IL18;SPHK1;IL6;MMP9;NUPR1
prerank,dopamine metabolic process (GO:0042417),0.607198257145188,1.5346440523565044,0.07370517928286853,0.47841402291657686,1.0,3/18,2.45%,MOXD1;PRKN;SNCAIP
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.6787554718183852,-1.5341897948058456,0.03501945525291829,0.28848179446091227,1.0,6/10,18.74%,KLF4;PTPRC;TLE5;IRAK3;SIGIRR;SH2B3
prerank,regulation of amyloid-beta formation (GO:1902003),0.5283481518899353,1.5320612988636042,0.038112522686025406,0.4836204594773995,1.0,3/34,3.71%,IGF1;ROCK2;EPHA4
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6596912784077285,-1.5317128633962995,0.039927404718693285,0.2929189429193759,1.0,8/10,25.49%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;ATP5PD;VPS9D1;ATP5MC2;ATP5MC1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.6573586006521496,-1.531212042891037,0.029644268774703556,0.29244105607246856,1.0,3/10,9.76%,FN1;HSP90AB1;FURIN
prerank,negative regulation of cell growth (GO:0030308),-0.3718611136702457,-1.5310023521053215,0.002824858757062147,0.2913243641564911,1.0,42/121,25.56%,APBB2;SLIT2;PTPRJ;ACVRL1;TGFB2;ADAM15;NDRG3;RACK1;SH3BP4;FHL1;BMPR2;SOX17;CCDC85B;RERG;CCN3;TGFB1;OSGIN2;DCC;APBB1;RTN4;SESN2;CDKN1B;NDUFA13;SEMA3G;CDKL3;MT3;JADE1;CDA;BST2;WFDC1;RTN4R;BTG1;ESR2;CDKN1A;CDKN2D;OSGIN1;HYAL2;SIPA1;HSPA1B;DACT3;SPHK2;ULK2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5322639516697721,-1.5304969860803617,0.02335456475583864,0.2909905134177763,1.0,11/22,18.58%,RPL23;RPS15;RPL37;RPS7;UBB;RPS20;SPRED2;DDX5;EEF1E1;EIF5A;ATR
prerank,steroid biosynthetic process (GO:0006694),0.4754312778785679,1.530260403237941,0.01854974704890388,0.4863593365022229,1.0,6/56,5.65%,PRKAG2;CYP27A1;INSIG2;HSD17B1;FDXR;HSD17B10
prerank,regulation of GTPase activity (GO:0043087),-0.35477795088431907,-1.5286106274560027,0.0,0.29351535733998496,1.0,32/177,4.41%,DOCK9;PRKG1;CHN2;FGD5;EFNA5;LRCH1;FGD6;RAP1A;SIPA1L1;RGS6;ITGA6;BCAR3;TBC1D30;PKP4;PLXND1;PTK2;ITGB1;AGRN;F11R;RASIP1;ARHGAP27;CAV2;DAB2IP;CHN1;RACK1;SH3BP4;SEMA4D;NET1;DOCK10;LIMS1;TGM2;PLXNA4
prerank,integrin-mediated signaling pathway (GO:0007229),-0.41372925436336183,-1.5282065298550627,0.007556675062972292,0.29297397568319067,1.0,26/73,16.16%,FN1;SEMA7A;ADAM10;PTK2;ITGB1;ITGB4;ITGB8;ADAM15;DOCK1;PTK2B;ITGA5;BCAR1;LAMA5;FERMT2;LAMA3;CEACAM1;MYH9;CUL3;COL16A1;ISG15;ERBIN;CD47;NEDD9;RCC2;COL3A1;PRKD1
prerank,positive regulation of embryonic development (GO:0040019),0.6129351003293555,1.5278113831362887,0.04938271604938271,0.49093013358511567,1.0,5/19,6.22%,OSR1;WNT4;SCX;PLCB1;NIBAN2
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.6837752100937519,1.5272711303293989,0.07630522088353414,0.4896349769535815,1.0,5/10,12.28%,DPYD;UPB1;NT5M;DPYS;UPP2
prerank,myotube cell development (GO:0014904),0.6718322321216501,1.5253569804867204,0.07974137931034483,0.4927922277458773,1.0,1/10,0.03%,IGF1
prerank,toxin transport (GO:1901998),0.6968975480927122,1.5252551441353654,0.06134969325153374,0.49011233293527784,1.0,3/10,2.94%,SLC22A2;ANTXR1;ANTXR2
prerank,purine ribonucleotide transport (GO:0015868),-0.5875613578102523,-1.5249222351333755,0.044989775051124746,0.2994897504614683,1.0,7/16,16.21%,ABCC4;LRRC8C;LRRC8D;LRRC8A;SLC25A42;SLC35B2;SLC17A9
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6391737512010829,-1.5246108894679964,0.04296875,0.29872545623937735,1.0,4/11,13.76%,RAC1;BCAR1;PAK1;STMN1
prerank,metanephric mesenchyme development (GO:0072075),0.6837769385792052,1.5245719541441047,0.07818930041152264,0.48918581295539787,1.0,2/10,0.73%,OSR1;WNT4
prerank,regulation of protein dephosphorylation (GO:0035304),-0.4652055358409968,-1.5244506478409992,0.03777777777777778,0.297524265969887,1.0,19/37,24.06%,CALM1;PPIA;PPP1R16B;TIPRL;TGFB1;PPP1R2;HSP90B1;YWHAB;PPP6R1;PPP1R16A;SYMPK;CALM2;PPP2R5A;PTBP1;PRKCD;CDCA2;NSMF;CALM3;PPP1R15A
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5426207048551892,-1.52444072111826,0.056842105263157895,0.2960251180701596,1.0,5/21,6.03%,PRKCH;FOXP1;SLC39A10;RPS3;PTPRC
prerank,response to iron ion (GO:0010039),0.6665947964958758,1.5235702796202297,0.05333333333333334,0.48926109078651664,1.0,3/12,3.64%,BMP6;BCL2;TFR2
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.6419615515246727,-1.5233349619759586,0.03875968992248062,0.29713712923772806,1.0,8/11,22.96%,UQCRH;UQCR11;UQCRQ;UQCC3;UQCRC2;UQCRC1;CYCS;UQCR10
prerank,negative regulation of anoikis (GO:2000811),-0.5928827763195882,-1.5229949870269706,0.0410958904109589,0.29636630554976634,1.0,5/14,4.87%,CAV1;PTK2;ITGB1;NOTCH1;ITGA5
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4623425408169258,1.5221450794019078,0.019448946515397084,0.4908862777145211,1.0,6/74,2.18%,IGF1;EYA4;EYA1;TCF7L2;EYA2;BCL2
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.4016381656077262,-1.5219703586855775,0.0079155672823219,0.29731248783298336,1.0,29/88,16.16%,TEK;CAV1;PTPRM;NRP2;TIE1;KDR;THBS1;ACVRL1;F3;CAV2;BMPR2;PPP1R16B;ATP5F1A;NRAS;PDCL3;EMC10;FLT4;VEGFA;NR4A1;PIK3CD;BMP2;SCG2;XDH;SYNJ2BP;CDH13;SPARC;NF1;ATP5IF1;PRKD1
prerank,endothelial cell proliferation (GO:0001935),-0.5703940335638487,-1.5213738585113417,0.04462474645030426,0.29717923144808117,1.0,5/17,3.91%,TEK;BMPER;CD34;ACVRL1;BMPR2
prerank,regulation of phospholipase activity (GO:0010517),0.6988179073108418,1.5203402646786635,0.06860706860706861,0.49358497687297703,1.0,2/10,1.89%,FGFR2;PDPK1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5548650902102246,-1.5202714241944786,0.03773584905660377,0.2983695415660211,1.0,5/19,9.37%,SLCO1C1;KLF2;KLF4;APP;MAPK8
prerank,negative regulation of leukocyte activation (GO:0002695),0.6201471798941248,1.520231403502622,0.07889125799573561,0.4909647268006167,1.0,1/15,0.01%,IL31RA
prerank,ribosomal large subunit assembly (GO:0000027),-0.5147841840422689,-1.5197630778176672,0.046908315565031986,0.2981765860311129,1.0,11/24,21.82%,RPL11;RPL6;RPL24;RPL23A;RPL3;RPL5;RPLP0;RSL24D1;NOP53;NLE1;PPAN
prerank,blood vessel morphogenesis (GO:0048514),-0.43385434868164535,-1.5183022196473264,0.023809523809523808,0.3003596279185648,1.0,21/54,9.37%,CAV1;ID1;COL4A1;KDR;ITGB8;CDH2;LAMA1;RAMP2;RASIP1;ENG;TBX1;HES1;SOX17;SLC1A1;STRA6;TGFBR2;TGFB1;LRP5;FLT4;VEGFA;HEY2
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.5209909227055673,-1.5181432693230894,0.04184100418410042,0.29925906056879814,1.0,6/25,6.03%,SPTBN1;PDE4D;RUNX1;PLCG2;RPS3;PTPRC
prerank,adenine nucleotide transport (GO:0051503),-0.5759707808117138,-1.5178741298296934,0.04329896907216495,0.2984109957139405,1.0,7/17,16.21%,ABCC4;LRRC8C;LRRC8D;LRRC8A;SLC25A42;SLC35B2;SLC17A9
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5808908860344848,1.5173498346765182,0.06563706563706563,0.49742725513606006,1.0,6/21,7.35%,SNTA1;KCNA5;NOS1AP;ANK2;CACNA1D;CACNA2D1
prerank,ceramide metabolic process (GO:0006672),-0.4392968920170385,-1.5169403014612866,0.03131991051454139,0.29904142107884146,1.0,11/49,9.70%,ST6GALNAC3;SGMS1;SGMS2;ACER3;ACER2;SPTLC2;PLPP1;DEGS2;SMPD4;SGPL1;CERK
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6453523190462368,1.5162263819733224,0.066,0.49832092511650594,1.0,5/13,9.66%,IGF1;PLCB1;SLC2A10;CCL19;GOLGA2
prerank,regulation of DNA repair (GO:0006282),0.5057950586914881,1.5161574382223848,0.02877697841726619,0.49561243133281724,1.0,3/44,0.99%,EYA4;EYA1;EYA2
prerank,positive regulation of ERAD pathway (GO:1904294),-0.6054652614013531,-1.5159191882318024,0.04474708171206226,0.29987780437797773,1.0,5/13,15.39%,CAV1;ATXN3;BAG6;HERPUD1;BCAP31
prerank,regulation of microtubule depolymerization (GO:0031114),-0.5205124110455716,-1.5150634574192672,0.03879310344827586,0.3002622607998833,1.0,14/25,27.61%,MAP1B;STMN2;NAV3;APC;ARHGEF2;APC2;TTBK2;MAP1A;CLASP2;SPEF1;CAMSAP3;CAMSAP1;TRPV4;FGF13
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.586501272077151,-1.5149531376287906,0.033932135728542916,0.2990756388457099,1.0,12/16,28.23%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;ATP5F1E;STOML2;ATP5PD;ATP5F1B;ATP5MC2;ATP5MF;ATP5MC1;ATP5PF
prerank,regulation of microtubule polymerization (GO:0031113),-0.45935791884931143,-1.5132605925538283,0.016055045871559634,0.3012452134294059,1.0,17/40,25.07%,OCLN;RAC1;RPS3;CLIP1;MET;PRUNE1;STMN2;PAK1;NAV3;STMN1;TOGARAM1;TUBB4A;MAPRE1;NUMA1;DCTN1;CAMSAP3;CAMSAP1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.6434208633892504,1.5130351508647486,0.052525252525252523,0.502835475071554,1.0,3/14,5.90%,ADAMTS12;EFEMP1;ADAMTS7
prerank,negative regulation of cartilage development (GO:0061037),0.6578369555872128,1.5119671102249401,0.06666666666666667,0.5033073667391671,1.0,3/13,5.90%,ADAMTS12;EFEMP1;ADAMTS7
prerank,regulation of multicellular organism growth (GO:0040014),0.6121160112065533,1.5116852928915765,0.058823529411764705,0.5012987913825174,1.0,2/15,3.68%,IGF1;STAT5B
prerank,clathrin coat assembly (GO:0048268),-0.5771860075405129,-1.5113514719015884,0.026804123711340205,0.3040928575692256,1.0,5/15,11.65%,HIP1;SGIP1;HIP1R;PIK3C2A;NSG2
prerank,atrioventricular valve development (GO:0003171),-0.608385670693876,-1.5107678657109582,0.037848605577689244,0.3041207498439207,1.0,12/14,31.94%,TGFB2;NOTCH1;BMPR2;TGFBR2;BMP2;HEYL;APLNR;ACVR1;GJA5;SLIT3;ZFPM1;TBX20
prerank,lipoprotein catabolic process (GO:0042159),-0.6478478649903159,-1.5101795454612985,0.03557312252964427,0.3041959339460317,1.0,4/11,10.46%,CTSD;ABHD17B;LYPLA2;ABHD17A
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5813348698326922,1.5095360923498133,0.04690431519699812,0.5051418966404645,1.0,7/22,12.63%,SH3D19;TIMP3;SNX9;SNX33;NRDC;PTPN3;PACSIN3
prerank,ribosomal small subunit assembly (GO:0000028),-0.5716328197642648,-1.5084273253331375,0.021611001964636542,0.30698410364321044,1.0,12/16,25.59%,RPS15;RPSA;RPS19;RPS14;RPS27;RPS28;ERAL1;RPS27L;RPS5;PWP2;MRPS11;ABT1
prerank,adherens junction organization (GO:0034332),-0.4432355054883515,-1.508090703798359,0.024943310657596373,0.30641177544784365,1.0,16/48,14.51%,ACTB;CADM1;CDH11;CDH1;CDH2;RAMP2;FERMT2;CTNNB1;CSK;TJP1;PVR;PAK2;CADM3;CDH13;JUP;PIP5K1C
prerank,regulation of amyloid fibril formation (GO:1905906),-0.5787892761111443,-1.5076668865126974,0.0421455938697318,0.3060584039882075,1.0,9/15,27.24%,APP;CRYAB;CLU;IAPP;PFDN6;PFDN5;PSEN1;PFDN4;TREM2
prerank,platelet aggregation (GO:0070527),-0.48357655020666745,-1.5067165296463052,0.03218390804597701,0.3068076914612409,1.0,9/33,7.18%,FN1;ACTB;ACTG1;PPIA;FLNA;ACTN1;HSPB1;UBASH3B;MYH9
prerank,positive regulation of protein processing (GO:0010954),-0.5508124856865196,-1.505909502424014,0.04678362573099415,0.3072248534903613,1.0,6/19,10.21%,GSN;PLGRKT;NKD2;CLEC3B;MYH9;LPCAT3
prerank,cristae formation (GO:0042407),-0.5068489037497388,-1.5046208594302466,0.031180400890868598,0.308974030224222,1.0,18/27,30.48%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;CHCHD3;ATP5F1E;ATP5PD;IMMT;UQCC3;APOO;ATP5F1B;LETM1;SPG7;ATP5MC2;ATP5MF;ATP5MC1;ATP5PF;MICOS13
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5855256899300871,1.5036983687469607,0.05697445972495088,0.5214637541018624,1.0,5/19,4.17%,TGFBR3;RBPJ;FGFR2;RBP4;VGLL4
prerank,carnitine metabolic process (GO:0009437),0.6560109688683551,1.5027178219817234,0.06490872210953347,0.5216792621631633,1.0,6/12,13.69%,ACADL;CPT2;BBOX1;TMLHE;SHMT1;CPT1C
prerank,positive regulation of cartilage development (GO:0061036),0.5986007341472177,1.5010533689648993,0.07535641547861507,0.5241726920614612,1.0,3/17,2.75%,SOX5;SCX;SOX6
prerank,regulation of heart contraction (GO:0008016),0.4375176914584879,1.5003765387926131,0.027597402597402596,0.5233462693576656,1.0,14/90,5.95%,CELF2;ATP1A2;ITPR1;SLC8A3;TPM1;STIM1;CORIN;ATP1B3;TNNT2;SLC8A1;DMPK;ANK2;NPR2;TMEM65
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.6455131935900074,-1.5000138102761404,0.043052837573385516,0.31705727064194744,1.0,2/10,2.97%,KLF4;MBP
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.6455131935900074,-1.5000138102761404,0.043052837573385516,0.31705727064194744,1.0,2/10,2.97%,KLF4;MBP
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.4381475389991895,-1.4997541291822052,0.016129032258064516,0.3162546514202943,1.0,22/54,21.25%,MEF2C;TMSB4X;NOS3;KDR;THBS1;ACVRL1;ETS1;ATP5F1A;HSPB1;GATA2;TGFB1;VEGFA;JUP;CSNK2B;NF1;PRKD1;PRCP;CD40;ATP5F1B;AKT1;ATP2B4;GADD45A
prerank,endodermal cell differentiation (GO:0035987),-0.4899122045671681,-1.4985256127994346,0.04516129032258064,0.3180574332117546,1.0,10/31,13.27%,COL8A1;FN1;COL12A1;COL6A1;ITGA5;ITGA4;LAMA3;MMP15;COL4A2;ITGA7
prerank,protein localization to cell periphery (GO:1990778),-0.3665178312774154,-1.4981517841368293,0.005797101449275362,0.31757896050233764,1.0,38/133,13.95%,SPTBN1;BSG;CAV1;RAP1A;EFR3B;LIN7A;GAS6;CDH1;SLMAP;KCNB2;EHD4;RAMP2;F11R;RAB3C;ATP1B1;KCNB1;FLNA;MAP7;IKBKB;NKD2;EHD1;WNK3;PTCH1;RAMP1;TMED2;EMP2;ZDHHC2;TTC7A;TSPAN17;C2CD5;RAB3B;MYO5A;S100A10;SPTBN4;EHD3;CACNB2;CD81;JUP
prerank,regulation of cellular biosynthetic process (GO:0031326),0.5478526865438058,1.49782088010128,0.0634648370497427,0.528761358903716,1.0,9/28,11.11%,PRKAG2;FGFR4;AVIL;NOS1AP;PRKAA2;MITF;SIRPA;MED1;JAK2
prerank,anterior/posterior pattern specification (GO:0009952),0.4740039489887235,1.496433723440665,0.026981450252951095,0.5303571904843679,1.0,8/53,4.23%,WLS;HOXC6;HOXC4;HOXB4;HOXB3;HOXA3;HOXC5;HOXA7
prerank,regulated exocytosis (GO:0045055),-0.3479896393597892,-1.4956299436456553,0.0035087719298245615,0.32239444171953335,1.0,50/173,14.62%,PCDH7;ABCC4;VWF;FN1;PECAM1;TMSB4X;ACTN4;THBS1;TGFB2;GAS6;CD9;CALM1;LHFPL2;RAB31;PSAP;TAGLN2;FLNA;ACTN1;WDR1;STX1A;ENDOD1;TGFB1;CD109;FAM3C;SOD1;VTI1B;RAB11FIP1;CLEC3B;MYH9;APP;VEGFA;CYRIB;CD63;SRGN;A2M;SYT10;PCLO;CYB5R1;CPLX2;SYT4;CLU;SDF4;CDC37L1;MAGED2;SNAP25;RAB11FIP5;TMED10;ALDOA;PIP5K1C;SPARC
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.5342747305835074,-1.4948375590587448,0.060041407867494824,0.3227271213982464,1.0,12/21,30.27%,CAV1;PLTP;NFKBIA;PTCH1;NR1H2;ABCA3;ZDHHC8;NR1H3;TREM2;GPS2;ABCA7;PPARG
prerank,vascular transport (GO:0010232),0.442267299388373,1.4946714142309152,0.025974025974025976,0.5331929392936238,1.0,16/81,7.75%,ATP1A2;SLC6A13;LEPR;SLC24A3;SLC13A3;SLC22A2;SLC16A12;SLC38A3;SLC5A5;SLC6A9;SLC1A3;SLC6A1;LRP2;SLC2A10;ABCC2;SLC1A5
prerank,positive regulation of neuron migration (GO:2001224),-0.6199479464153705,-1.4942684854893993,0.054307116104868915,0.32273970859162454,1.0,7/11,22.66%,SEMA6A;DAB2IP;SHTN1;ARHGEF2;NSMF;SEMA3A;PLAA
prerank,sphingolipid biosynthetic process (GO:0030148),-0.4047343665614046,-1.493656979715835,0.021791767554479417,0.3225844517269682,1.0,19/71,9.02%,CERT1;ELOVL7;SGMS1;SGMS2;ACER3;ELOVL5;ACER2;SPTLC2;PLPP1;DEGS2;ST6GALNAC5;KDSR;PRKD3;PPM1L;ST8SIA1;SMPD4;SPNS2;SGPL1;ELOVL6
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.5690339105694867,1.4936162447388088,0.06627680311890838,0.533844754047187,1.0,4/21,6.11%,DCDC2;TEDC2;TTC23;ARMC9
prerank,detection of mechanical stimulus (GO:0050982),-0.5373126684945163,-1.4924495901057184,0.045364891518737675,0.3239040370863999,1.0,6/19,7.01%,PIEZO2;PTK2;CDH2;PKD1;CTNNB1;PIEZO1
prerank,positive regulation of DNA repair (GO:0045739),0.4874015693920122,1.4918312081037566,0.040421792618629174,0.5369770627519201,1.0,6/46,8.99%,EYA4;EYA1;EYA2;SLF1;SPIRE2;CEBPG
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5710621161875852,1.491549058592232,0.07142857142857142,0.5349545181466606,1.0,6/23,8.84%,ATP1A2;CACNG1;NOS1AP;ANK2;CACNA2D1;CAMK2D
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.5136437014383736,-1.4910331716300689,0.04216867469879518,0.32589665260290424,1.0,9/21,15.56%,PDE4D;NT5C2;NUDT3;HPRT1;PDE2A;NUDT4;HINT1;XDH;NT5E
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.574964543824189,-1.4907770715195465,0.041749502982107355,0.32507237139139317,1.0,4/15,7.27%,RPL11;RPL23;RPS7;RPL5
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.6322048421891535,1.490531558139282,0.0546875,0.5355175089026948,1.0,5/14,12.28%,DPYD;UPB1;NT5M;DPYS;UPP2
prerank,regulation of actomyosin structure organization (GO:0110020),0.6283551294904491,1.4902676119233795,0.09504132231404959,0.5335247191247854,1.0,5/13,6.35%,ROCK2;FHOD1;ALMS1;AKAP13;ASAP3
prerank,positive regulation of cell aging (GO:0090343),-0.6162594199942583,-1.490215983830252,0.05172413793103448,0.3250502506261669,1.0,5/11,16.93%,B2M;YPEL3;ABI3;LMNA;EEF1E1
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.4182006839175104,-1.4899219144266431,0.009153318077803204,0.32299778686642455,1.0,27/56,34.26%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFAF4;NDUFA12;NDUFV1;NDUFB7;NDUFA13;NDUFS1;NDUFB11;NDUFB10;NDUFA1;NDUFB4;NDUFS7;NDUFAF8;BCS1L;DMAC2;NDUFAF3;NDUFC1;ACAD9;NDUFS2;NDUFS5;NDUFAB1;TMEM126A;NDUFA3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.4182006839175104,-1.4899219144266431,0.009153318077803204,0.32299778686642455,1.0,27/56,34.26%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFAF4;NDUFA12;NDUFV1;NDUFB7;NDUFA13;NDUFS1;NDUFB11;NDUFB10;NDUFA1;NDUFB4;NDUFS7;NDUFAF8;BCS1L;DMAC2;NDUFAF3;NDUFC1;ACAD9;NDUFS2;NDUFS5;NDUFAB1;TMEM126A;NDUFA3
prerank,nuclear migration (GO:0007097),0.6440979069762321,1.4898547929112538,0.0778688524590164,0.5320188536891257,1.0,7/13,18.50%,SYNE2;CLMN;SYNE3;PAFAH1B1;SUN2;CEP120;TMEM201
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5954105810467863,1.4898149182854197,0.0744466800804829,0.5293522837763384,1.0,1/17,0.03%,IGF1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.41612797956643627,1.4897053751124705,0.010542168674698794,0.526862799092631,1.0,30/138,11.42%,IL31RA;EPHA7;EPHA3;FGFR2;FGFR4;BDKRB2;KIT;PDGFRB;FER;EPHA8;EPHA4;PDGFRA;DDR1;NPR2;IGF1R;PTN;CLNK;FRS2;PTPRD;DDR2;RYK;MTSS1;CSF1;MUSK;FRK;AXL;NPR1;EPHA2;JAK2;ERBB2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.49143332042439936,1.4882460481562343,0.03148148148148148,0.5287087333571132,1.0,5/44,5.65%,PRKAG2;CYP27A1;INSIG2;HSD17B1;HSD17B10
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.41664160864824895,-1.4878235051588602,0.021791767554479417,0.3268751431209688,1.0,28/54,23.06%,RPL11;RPL6;RPL26;RPL24;RPL23A;RPL3;RPL14;RPL5;MAK16;RPLP0;RPL35A;RPL7A;RPL7;RSL1D1;RSL24D1;RPF1;HEATR3;EBNA1BP2;NOP53;NLE1;RRP15;NOC2L;NHP2;EIF6;WDR74;PPAN;NOP16;NIP7
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5943267524689525,1.4877096605242885,0.06525911708253358,0.5275542216793129,1.0,7/18,19.77%,KMT2A;SETD7;SETD1A;ASH1L;KMT2B;SETD2;SETD4
prerank,sensory perception of sound (GO:0007605),0.4359395414371542,1.4876796059129933,0.021035598705501618,0.5248913194121304,1.0,16/88,10.88%,DCDC2;EYA1;ADGRV1;CEMIP;KIT;CCDC50;ALDH7A1;RIPOR2;CACNA1D;LRP2;TMC2;BIRC5;WHRN;EML2;GSDME;TFAP2A
prerank,negative regulation of cilium assembly (GO:1902018),-0.6178824273445747,-1.4873772647357533,0.05137614678899083,0.3264740533678591,1.0,4/12,13.86%,TBC1D30;MAP4;LIMK2;ODF2L
prerank,embryonic heart tube development (GO:0035050),-0.5957206219125883,-1.4865255034410465,0.041666666666666664,0.3272197723182429,1.0,9/14,26.87%,HES1;SOX17;TBX2;RYR2;SOX18;NDRG4;ACVR1;MEGF8;CITED2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5040194829387303,-1.4865129528847005,0.053169734151329244,0.325871042059396,1.0,7/25,9.12%,RPL11;RPL23;HSP90AB1;RPS7;PDCL3;RPL5;PSMF1
prerank,transport across blood-brain barrier (GO:0150104),0.43784978609759495,1.4864696807990023,0.028892455858747994,0.525910727478018,1.0,16/83,7.75%,ATP1A2;SLC6A13;LEPR;SLC24A3;SLC13A3;SLC22A2;SLC16A12;SLC38A3;SLC5A5;SLC6A9;SLC1A3;SLC6A1;LRP2;SLC2A10;ABCC2;SLC1A5
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.46491554341434854,-1.4857220676109886,0.038636363636363635,0.32646717779201617,1.0,11/35,8.30%,TEK;NTRK3;ESAM;F11R;PTK2B;ARHGDIB;SEMA3E;ARHGDIA;BAIAP2L1;TJP1;ABI3
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.6068357406829895,1.4856575862476535,0.07569721115537849,0.525765327343884,1.0,4/18,8.62%,FBN1;LTF;LRRC17;FSTL3
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.514494808333358,-1.4855042191157397,0.04487179487179487,0.3255967165101427,1.0,10/24,15.88%,PDE4D;PDE3A;GNAI1;PEX5L;PDE2A;RNF157;UBE2B;PRKAR1A;PDE11A;APLNR
prerank,carbohydrate homeostasis (GO:0033500),0.45121119588466335,1.4852679376936153,0.04180064308681672,0.524505674271666,1.0,11/67,7.95%,LEPR;TCF7L2;APPL2;FGFR4;RBP4;PRKAA2;IGF1R;IL6;PRKAA1;MCU;SLC30A8
prerank,extracellular structure organization (GO:0043062),0.3887406969723381,1.4850391403823742,0.002770083102493075,0.5224541688928243,1.0,34/204,6.29%,COL22A1;ADAMTS12;NID2;ADAMTS9;LAMC3;COL4A5;ADAM12;ITGA9;FBN1;COL4A6;SMOC2;LAMA2;ADAMTS5;THSD4;FBLN5;ADAMTS10;FBN2;ADAMTS15;TNC;PXDN;LOXL1;COL9A2;NID1;NDNF;SMOC1;MMP2;ITGAX;COL1A2;COL13A1;DDR1;ITGA3;ADAMTS7;MMP19;COL18A1
prerank,protein localization to cilium (GO:0061512),0.5202548689854889,1.4848623024251517,0.04710144927536232,0.5203499727966725,1.0,14/32,18.85%,TULP3;TULP1;ARL3;INVS;WDR19;WDR35;ARL6;TCTN1;IFT122;IFT140;ATP6V1D;TULP2;BBS1;RAB29
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.5401605886878947,-1.4844252335763006,0.04175365344467641,0.32681411804691624,1.0,10/20,21.85%,FAR2;ACSL4;ACACA;FAR1;DGAT1;FASN;ACSL3;SCD5;ACLY;SCD
prerank,ganglioside biosynthetic process (GO:0001574),-0.5821434187924809,-1.4843091081015996,0.05473684210526316,0.3257543524664987,1.0,8/15,18.54%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;B4GALT5;ST8SIA6;ST8SIA2;B4GALT6;ST3GAL1
prerank,external encapsulating structure organization (GO:0045229),0.3877283090265639,1.483602429404657,0.0013736263736263737,0.521714500990482,1.0,34/205,6.29%,COL22A1;ADAMTS12;NID2;ADAMTS9;LAMC3;COL4A5;ADAM12;ITGA9;FBN1;COL4A6;SMOC2;LAMA2;ADAMTS5;THSD4;FBLN5;ADAMTS10;FBN2;ADAMTS15;TNC;PXDN;LOXL1;COL9A2;NID1;NDNF;SMOC1;MMP2;ITGAX;COL1A2;COL13A1;DDR1;ITGA3;ADAMTS7;MMP19;COL18A1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.5097295802938694,-1.4831934187976077,0.047244094488188976,0.32707665352013937,1.0,11/24,21.03%,UBE3A;PTK2B;UBB;PKD1;UCHL5;TMF1;PSME3;PSME1;ATP5IF1;PINK1;CTSC
prerank,ceramide biosynthetic process (GO:0046513),-0.45520226305842876,-1.4826776192053261,0.0447427293064877,0.32691834745634984,1.0,14/40,19.44%,ST6GALNAC3;SGMS1;SGMS2;ST8SIA4;SPTLC2;DEGS2;ST6GALNAC5;SMPD4;ST8SIA6;CERS4;ST8SIA2;CLN8;B4GALT6;SPTSSB
prerank,urogenital system development (GO:0001655),0.6585637735102241,1.4824078923397568,0.07933194154488518,0.5227873881569624,1.0,2/11,3.48%,OSR1;ANXA1
prerank,negative regulation of chemotaxis (GO:0050922),-0.47792164182051466,-1.4819426574602066,0.04516129032258064,0.3275138066285689,1.0,14/31,11.39%,SLIT2;SEMA6A;SEMA7A;SEMA6D;THBS1;SEMA3C;NOTCH1;SEMA4D;SEMA3E;SEMA4B;SEMA5B;SEMA6C;DUSP3;SEMA3G
prerank,angiogenesis involved in wound healing (GO:0060055),-0.6188994359134543,-1.478740758161426,0.06321839080459771,0.33385723535625633,1.0,6/11,7.87%,ADIPOR2;CD34;KDR;GATA2;MCAM;VEGFA
prerank,granulocyte differentiation (GO:0030851),-0.5349739017836854,-1.477777107595465,0.050200803212851405,0.33473806276121554,1.0,8/18,22.86%,LEF1;CBFA2T3;LBR;TAL1;CDK2;SPI1;CDKN1A;CEBPA
prerank,regulation of monooxygenase activity (GO:0032768),-0.5081885880849328,-1.4767643937891133,0.05405405405405406,0.3357295669819828,1.0,8/23,11.41%,CAV1;NOS3;NOSTRIN;HSP90AA1;CALM1;DDAH1;DNM2;CYGB
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.6022174446360257,-1.4764932002052675,0.058823529411764705,0.33512867017573045,1.0,10/13,28.67%,CSPG4;BGN;HEXB;HEXA;IDS;VCAN;DCN;ARSB;IDUA;NCAN
prerank,regulation of blood circulation (GO:1903522),0.5170149100865444,1.4764788207302832,0.059845559845559844,0.5395488881527751,1.0,6/34,5.24%,CELF2;BDKRB2;TPM1;TNNT2;DMPK;ACE
prerank,positive regulation of kinase activity (GO:0033674),0.4212251635998765,1.4764734562662454,0.025396825396825397,0.5368962386849813,1.0,22/107,8.66%,PRKAG2;EPHA7;EPHA3;FGFR2;FGFR4;KIT;LMO4;PDGFRB;ALS2;EPHA8;EPHA4;PDGFRA;DDR1;MRNIP;IGF1R;SNX9;XRCC5;DDR2;CCL19;RYK;CSF1;MUSK
prerank,regulation of glucose metabolic process (GO:0010906),0.5173082184975055,1.475187530103548,0.048824593128390596,0.53840705489134,1.0,4/34,3.92%,RORA;PRKN;PDK1;SLC45A3
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5890189378882104,-1.4751265045780655,0.05343511450381679,0.3371041488798961,1.0,7/13,30.77%,TMSB4X;HEY2;PSEN1;SOX11;HEY1;PER2;SIN3A
prerank,negative regulation of stress fiber assembly (GO:0051497),0.5552743963507871,1.4747578239978747,0.06857142857142857,0.5371168468646301,1.0,7/24,10.73%,ARHGAP28;ARHGAP6;CGNL1;PHLDB2;RHPN2;ARHGEF18;PIK3R1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5761759213906084,1.4742130260966266,0.07824427480916031,0.5362525357136733,1.0,5/20,3.96%,ATP1A2;DMD;GSTM2;SLC8A1;ANK2
prerank,monocyte differentiation (GO:0030224),0.6820123193838822,1.4738479021096265,0.09009009009009009,0.5349634327748756,1.0,1/10,0.01%,IL31RA
prerank,ceramide catabolic process (GO:0046514),-0.5901748065219335,-1.4728956313292716,0.0691588785046729,0.34142794687641415,1.0,5/14,15.91%,ACER3;ACER2;HEXB;HEXA;GM2A
prerank,cell-substrate junction assembly (GO:0007044),-0.46845923785359445,-1.4721297708622862,0.032327586206896554,0.342100325125047,1.0,10/33,9.16%,FN1;THSD1;ITGA6;ITGB4;PLEC;ACTN1;FERMT2;LAMA3;BCR;PEAK1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.642605053364186,1.470964975331757,0.08464566929133858,0.5417688055082726,1.0,5/13,11.76%,BMP6;DAB2;RBPMS;JAK2;BMPR1A
prerank,lung development (GO:0030324),0.5198709155512428,1.4708455854382163,0.07649253731343283,0.5394847339149935,1.0,7/33,5.54%,ERRFI1;FGFR2;RBP4;LOXL3;PDPN;FGF1;ITGA3
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.3670122328428749,-1.470742942640128,0.008333333333333333,0.3442998177773142,1.0,28/114,15.79%,TMSB4X;ACTN4;TNFRSF11B;PTK2B;NFKBIA;LIMS1;IKBKB;EDA;ST18;TNFRSF11A;TNFRSF1B;CARD14;BIRC3;PSMD13;AIM2;PSMF1;COMMD7;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;TRAF1;PSME1;PSMB3
prerank,inorganic anion transmembrane transport (GO:0098661),-0.4094840827981656,-1.470662467471689,0.010282776349614395,0.3430972485378822,1.0,23/63,16.89%,SLC12A7;SLC12A2;SLC26A2;ANO1;ANO4;SLC5A6;GABRB3;SLC12A6;SLC1A1;GABRB1;SLC12A8;SLC4A8;ANO3;LRRC8A;SLC12A4;GABRG3;SLC37A3;SLC25A30;XPR1;ANO2;CFTR;SLC25A3;GLRA3
prerank,filopodium assembly (GO:0046847),-0.5555370089610405,-1.4694647971574308,0.046242774566473986,0.3445438791081437,1.0,4/16,5.04%,DNM3;FGD5;FGD6;SPATA13
prerank,response to amyloid-beta (GO:1904645),0.4814244578271157,1.4689327592820525,0.06826568265682657,0.5433268907555763,1.0,8/44,7.35%,IGF1;SNX6;MMP2;EPHA4;GJA1;IGF1R;MMP9;CACNA2D1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.6695738463411184,1.4679560528567455,0.09856262833675565,0.5439277590664495,1.0,1/10,0.21%,ATP1A2
prerank,actin filament bundle organization (GO:0061572),0.5158967298613114,1.4669420238264703,0.053703703703703705,0.544686859161225,1.0,9/33,7.18%,PAWR;RHOD;DPYSL3;SHROOM2;CALD1;BAIAP2;ESPN;BAIAP2L2;LIMA1
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.399166888571534,-1.4662743163200764,0.03535353535353535,0.3512377205666205,1.0,34/68,35.89%,IL33;PLCG2;MBP;LBP;APP;XBP1;STAT3;CD74;HSPD1;ARHGEF2;IFIH1;TIRAP;MYD88;TYROBP;HYAL2;AGER;RAB7B;SPHK2;TLR7;TLR4;LPL;C1QTNF4;IL16;TLR6;DHX9;MAVS;NOD2;TLR1;NOS2;IL1A;TSLP;SYK;F2R;TLR8
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.49608514834462375,-1.4649982194374147,0.05139186295503212,0.3532357103437328,1.0,10/23,17.98%,UBB;COPS7A;RPS27A;UBC;DDB1;RBX1;UBA52;COPS8;COPS6;CETN2
prerank,diacylglycerol metabolic process (GO:0046339),-0.5149440244513516,-1.4644536371820285,0.04008016032064128,0.35320599256964264,1.0,11/23,24.15%,DGKH;DGKB;DGKI;LIPE;DGKZ;DGKG;DGAT1;ANG;GPAM;DGKE;DGKQ
prerank,positive regulation of blood coagulation (GO:0030194),-0.544143994664139,-1.4637576421803273,0.05168986083499006,0.3536233452727475,1.0,3/17,2.38%,ST3GAL4;THBS1;F3
prerank,prostanoid biosynthetic process (GO:0046457),-0.582161960664631,-1.4636103734172479,0.03822937625754527,0.35267621227778334,1.0,7/15,16.76%,PTGIS;PTGS2;EDN1;PTGDS;CD74;PLA2G4A;MIF
prerank,regulation of cell growth (GO:0001558),-0.3323428085189868,-1.4627837550281415,0.0,0.3534367672480284,1.0,62/204,22.84%,APBB2;SLIT2;PTPRJ;LTBP4;TFRC;ADAM10;ACVRL1;TGFB2;ADAM15;NDRG3;RACK1;SH3BP4;NET1;FHL1;BMPR2;CDK11B;SOX17;CCDC85B;SOCS2;RERG;BCAR1;CCN3;TGFB1;FAM107A;OSGIN2;CEACAM1;KIF26A;APBB1;MTOR;MFSD2A;H3-3A;RTN4;SESN2;EIF4G1;CDKN1B;LAMTOR1;NDUFA13;RPS6KA1;EGLN2;MT3;SPOCK1;NRG3;JADE1;LAMTOR2;CDA;CISH;SGK1;AGTR1;BST2;SUPV3L1;AKT1;WFDC1;PAPPA2;PAK5;BTG1;ESR2;CDKN1A;CDKN2D;PTCH2;OSGIN1;HYAL2;SIPA1
prerank,positive regulation of DNA binding (GO:0043388),0.5178166331326489,1.46244043215335,0.05046728971962617,0.5568885581063687,1.0,5/31,8.99%,IGF1;PRKN;NIBAN2;MMP9;CEBPG
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.49496995498123475,1.4614175667985838,0.04712041884816754,0.55740378674586,1.0,5/38,7.68%,BMP6;SASH1;DDX60;PRKCA;POLR3G
prerank,response to amino acid (GO:0043200),-0.47167203451957085,-1.461051516672188,0.041758241758241756,0.35638273591019315,1.0,18/31,27.04%,SH3BP4;CAPN2;MTOR;SESN2;CPEB1;XBP1;GRIN1;LAMTOR1;SPAAR;LAMTOR2;GLRA3;RRAGB;TMBIM6;NSMF;LAMTOR4;GLRA1;MEAK7;RPTOR
prerank,intestinal absorption (GO:0050892),-0.5823374812591561,-1.4600867156961936,0.05805243445692884,0.3574735458097039,1.0,4/13,11.74%,TJP2;F11R;KCNQ1;SLC26A6
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.4475709560446079,1.4597987860955197,0.037037037037037035,0.5601859203572471,1.0,12/67,5.40%,EFEMP1;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;FER;EPHA4;ABI2;PDGFRA;DDR1;IGF1R
prerank,cellular response to acid chemical (GO:0071229),-0.48481590882333325,-1.4596568443375522,0.047520661157024795,0.3572964145820295,1.0,16/27,27.04%,KLF2;SH3BP4;CAPN2;VEGFA;MTOR;SESN2;CPEB1;XBP1;LAMTOR1;SPAAR;LAMTOR2;RRAGB;NSMF;LAMTOR4;GLRA1;RPTOR
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5356145272851797,1.459400578204098,0.07924528301886792,0.5588135176299479,1.0,4/27,1.37%,ARHGAP28;ARHGAP6;CGNL1;PRKN
prerank,response to unfolded protein (GO:0006986),-0.4233841936314391,-1.459004570486222,0.02195121951219512,0.35771412863567337,1.0,16/48,13.06%,HSPA8;HSP90AA1;HSP90AB1;DAB2IP;DNAJA1;STT3B;HSPB1;HSPA14;DERL1;ERP44;TOR1B;HSPA5;PTPN1;HSPB8;HSPD1;HERPUD1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4625103866107441,1.4589703050931717,0.051666666666666666,0.5576098769842024,1.0,8/62,4.86%,IGF1;ROBO1;AUTS2;NOTCH2;LPAR1;ALS2;AKAP13;MAPRE2
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.42005210678942223,-1.4585831039093577,0.035211267605633804,0.3574909726416642,1.0,23/50,24.46%,CAV1;RPS3;DNAJA1;IVNS1ABP;UBXN1;PINX1;SOX4;ARRB1;CHP1;OGT;ISG15;CAMLG;NXN;PRMT3;SPOPL;N4BP1;PRKCG;ARRB2;AKT1;SIRT7;TNFAIP3;HSPA1B;SPRY2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.47508750297288005,-1.4580179946873753,0.04504504504504504,0.3577196796842366,1.0,14/30,24.85%,ST6GAL1;FUT8;MAGT1;STT3B;MCFD2;RPN1;MGAT1;DDOST;MGAT5;ALG5;MGAT2;ALG8;DPM1;UBE2J1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.5126243956435785,-1.457902443215831,0.05942622950819672,0.3566892285116819,1.0,12/22,34.90%,PTPRJ;CEACAM1;DUSP3;DGKZ;LAPTM5;THY1;CD300A;FCGR2B;EZR;GPS2;PTPN22;PHPT1
prerank,eye development (GO:0001654),0.46870407727949354,1.4578915996487418,0.05087719298245614,0.5587120330155948,1.0,11/54,8.52%,EFEMP1;FBN1;RBP4;MEIS1;FBN2;SLC39A5;SHROOM2;SMOC1;SH3PXD2B;PBX4;CHRDL1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.6586530833713644,1.457563621187997,0.09414225941422594,0.5571609174272438,1.0,4/10,8.84%,OSR1;NEDD4;PCSK9;CAMK2D
prerank,purine nucleotide catabolic process (GO:0006195),-0.5844314876859501,-1.4565326652894326,0.05697445972495088,0.3587690884921807,1.0,6/13,15.56%,NT5C2;GDA;NT5C;HINT1;XDH;NT5E
prerank,negative regulation of macrophage activation (GO:0043031),0.5943121219516563,1.4553050268326122,0.08888888888888889,0.5620288308624685,1.0,2/16,4.13%,IL31RA;SYT11
prerank,sodium ion export across plasma membrane (GO:0036376),0.620099048380574,1.4552284661184096,0.09513742071881606,0.559727906242824,1.0,2/13,2.26%,ATP1A2;ATP1B3
prerank,renal system development (GO:0072001),0.4595640088898578,1.4549890106250578,0.0415944540727903,0.5578639391329463,1.0,13/52,11.08%,GREB1L;WNT4;RBP4;LRP4;PCSK9;PYGO1;ARL3;ACE;SULF1;SALL1;IFT27;TFAP2A;TFAP2B
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.6193539808892015,-1.4549054615715191,0.07115384615384615,0.36147409523097623,1.0,7/11,20.51%,NDUFA13;TIMM9;ROMO1;TIMM10B;TIMM13;TIMM29;TIMM22
prerank,regulation of osteoblast proliferation (GO:0033688),0.592282118257615,1.4545441972850717,0.08902691511387163,0.5567261381171431,1.0,3/17,2.73%,NPR3;FGFR2;LTF
prerank,peptide catabolic process (GO:0043171),0.5559148098507856,1.4537088631584094,0.0755813953488372,0.5569576046217589,1.0,5/23,7.13%,CPQ;CTSH;ACE;TPP1;NPEPPS
prerank,negative regulation of gluconeogenesis (GO:0045721),0.6333360491407383,1.452988980099399,0.10020876826722339,0.556833538757108,1.0,5/11,18.00%,C1QTNF3;SIK1;CRY1;GCK;C1QTNF12
prerank,amino acid import across plasma membrane (GO:0089718),0.5369001478588985,1.4517587767261357,0.07663551401869159,0.5581948775262238,1.0,5/24,2.16%,SLC22A4;SLC6A13;SLC22A2;SLC6A9;SLC1A3
prerank,cellular response to glucose starvation (GO:0042149),0.48949262021568585,1.451181564704028,0.0539568345323741,0.5574906296800115,1.0,11/41,8.90%,PRKAG2;PRKAG3;SZT2;SIK1;CPEB4;SESN1;PRKAA2;MTMR3;PRKAA1;ATG14;PIK3R4
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.43833227995854596,-1.4509074743362438,0.051685393258426963,0.3700361992638411,1.0,23/42,28.63%,UBB;TRIM25;RPS27A;UBC;WRNIP1;ISG15;RPA1;UBA52;USP43;POLK;POLA1;FAAP20;POLN;SPRTN;POLE;POLD3;VCP;CDKN2D;POLD1;POLI;DTL;RFC5;USP10
prerank,positive regulation of macrophage activation (GO:0043032),-0.5427365213075196,-1.4504713110191436,0.06097560975609756,0.36966087210291865,1.0,9/17,31.09%,IL33;THBS1;LBP;HSPD1;CEBPA;TREM2;KARS1;TLR4;TLR6
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.4529082723154295,-1.4501644627879346,0.045951859956236324,0.3690373530275692,1.0,13/35,15.88%,MEF2C;CAV1;PTPRM;THBS1;CAV2;ATP5F1A;PDCD10;SCG2;XDH;SYNJ2BP;SPARC;NF1;ATP5IF1
prerank,regulation of T cell migration (GO:2000404),-0.5382329323834609,-1.4496622887985902,0.06653992395437262,0.36897998210652383,1.0,5/18,9.24%,LRCH1;APOD;CD200;APP;RHOA
prerank,regulation of muscle contraction (GO:0006937),0.5340510595686988,1.4492348553859182,0.07058823529411765,0.5613782995104608,1.0,3/26,2.30%,ATP1A2;TPM1;TNNC1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.39602111881879454,-1.4488989149301443,0.0158311345646438,0.36958463764795824,1.0,34/69,33.97%,PTPRJ;IL33;THBS1;PLCG2;LBP;HSPB1;PTPRC;APP;STAT3;OAS2;ARHGEF2;CLU;IFNGR1;IFIH1;MIF;PSEN1;TIRAP;TYROBP;FRMD8;DDT;AGER;CCR2;SPHK2;TLR4;RASGRP1;LPL;FADD;C1QTNF4;DHX9;MAVS;NOD2;TLR1;IL1A;SYK
prerank,negative regulation of locomotion (GO:0040013),-0.5906608982167372,-1.4488505172573034,0.05426356589147287,0.3683415847788003,1.0,5/12,11.76%,FRMD5;CCDC125;CRK;DUSP3;SPINT2
prerank,ganglioside metabolic process (GO:0001573),-0.5282842139008186,-1.4483753396532626,0.058333333333333334,0.36814141545948315,1.0,9/20,18.69%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;HEXB;HEXA;ST8SIA6;GM2A;ST8SIA2;ABCA2
prerank,muscle cell development (GO:0055001),0.5253503761346188,1.4481189104542695,0.07578558225508318,0.5622983965872742,1.0,6/30,3.96%,IGF1;DMD;SLC8A1;MEGF10;NEBL;ANK2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6297542875272983,-1.447307066178058,0.08411214953271028,0.3695141000612353,1.0,6/10,24.46%,SEMA6A;DAB2IP;XDH;CADM4;DCN;SPRY2
prerank,regulation of spindle assembly (GO:0090169),-0.49901408335713954,-1.4466289908600958,0.05450733752620545,0.36975791966494176,1.0,16/25,33.16%,CHMP5;CHMP2B;HNRNPU;CHMP1B;CHMP1A;NUMA1;CHMP3;SPAG5;HSPA1B;PDCD6IP;CHMP4C;DRG1;VPS4B;PLK1;DYNC1H1;HSPA1A
prerank,regulation of membrane repolarization (GO:0060306),-0.5683333922172371,-1.4452076570718142,0.07827788649706457,0.3719049895927327,1.0,4/13,7.61%,CAV1;KCNJ2;NEDD4L;KCNQ1
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.43901041906416427,-1.444942618557397,0.05855855855855856,0.3712513441592293,1.0,14/39,11.76%,PODXL;FXYD5;JAG1;CDH1;KLF4;PTK2;MBP;NOTCH1;TGFB1;NEXMIF;VEGFA;NOTCH4;BMP2;SPINT2
prerank,cell junction organization (GO:0034330),-0.3876012103697356,-1.4448648822721926,0.033766233766233764,0.3701444503933347,1.0,20/71,9.24%,APBB2;ACTB;ACTG1;OCLN;TJP2;LIMS2;TGFB2;CTNND2;AGRN;CXADR;SEMA3E;LIMS1;FLNA;TGFB1;FERMT2;VMP1;PPFIA2;APP;TJP1;RHOA
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.459798901034119,1.444764239714381,0.05638474295190713,0.5703500933750681,1.0,4/53,2.53%,EYA4;EYA1;EYA2;PLA2R1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.5620287146915669,1.4443329011037955,0.09770114942528736,0.5692014070669127,1.0,5/21,3.96%,ATP1A2;DMD;GSTM2;SLC8A1;ANK2
prerank,intraciliary retrograde transport (GO:0035721),0.6375330587463637,1.444075854025185,0.08982035928143713,0.5674601738387912,1.0,6/12,16.39%,DYNC2H1;WDR19;WDR35;IFT122;IFT140;DYNC2I1
prerank,synaptic vesicle cycle (GO:0099504),-0.4788753676914089,-1.443216936679887,0.05043859649122807,0.3729734762085416,1.0,17/30,34.60%,STX1A;SLC17A6;SYNDIG1;SYT10;PCLO;CPLX2;SNAP25;PIP5K1C;SYT7;CDK5;RAB3A;OTOF;CPLX1;SNAPIN;SLC32A1;WNT7A;SLC17A8
prerank,negative regulation of nuclear division (GO:0051784),0.6560934652961318,1.4430440919457996,0.10103092783505155,0.5686044748312732,1.0,3/11,4.75%,BMP7;DMRT1;TOM1L2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.48983516373303726,1.4426242490374463,0.07420494699646643,0.5674782633173526,1.0,5/37,4.46%,PRKAG2;CEMIP;BMP7;PARD3;SPHK1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.4614923164809773,-1.4424386597915515,0.04367816091954023,0.3737225870928692,1.0,19/31,30.52%,PPP1R13B;NMT1;YWHAB;GSK3B;HIP1R;MAPK8;YWHAG;BBC3;CASP8;YWHAQ;YWHAH;PPP3R1;CHCHD10;BAX;YWHAZ;PPP3CC;BID;SFN;PMAIP1
prerank,regulation of establishment of protein localization (GO:0070201),-0.5805343716689699,-1.4421579061153125,0.05649717514124294,0.37315843077638833,1.0,7/13,27.24%,CORO2B;DNAJA1;CTSD;SPIDR;PTP4A3;CEP295;TREM2
prerank,microtubule bundle formation (GO:0001578),-0.44933671381003687,-1.4415675081209944,0.04976303317535545,0.3732813376355884,1.0,22/42,35.91%,NAV1;CLIP1;RP1;CHP1;MTCL1;TOGARAM1;CCDC66;TPPP;TPPP3;LRGUK;GAS2L1;NUMA1;SPEF1;FOXJ1;CFAP46;NCKAP5L;PLK1;DCX;PSRC1;CFAP206;CLASP1;CCDC40
prerank,regulation of stress fiber assembly (GO:0051492),0.43179506367256415,1.44134356063522,0.046849757673667204,0.5690674589015872,1.0,17/74,10.73%,ARHGAP28;ROCK2;ARHGAP6;CGNL1;TPM1;LPAR1;FHOD1;CCN2;ALMS1;PPM1E;PHLDB2;ASAP3;RHPN2;ARHGEF10L;ARHGEF18;ABL1;PIK3R1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.6336018024343535,-1.4412155848830135,0.066543438077634,0.3729026419916157,1.0,6/10,15.45%,UBB;NEDD8;RPS27A;UBC;ISG15;UBA52
prerank,catecholamine metabolic process (GO:0006584),0.6008994092709022,1.4411214857562369,0.08979591836734693,0.5673528221610981,1.0,5/14,16.97%,PRKN;SNCAIP;RNF180;LRTOMT;DRD2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.5576331063278084,-1.4410409245722255,0.05508474576271186,0.3720977757597773,1.0,6/15,17.34%,REEP3;REEP1;RTN3;RTN4;ATL2;ARL6IP1
prerank,negative regulation of receptor binding (GO:1900121),-0.6168991562501461,-1.4404323548226785,0.08932038834951456,0.3723629452495546,1.0,4/10,7.36%,B2M;ADAM15;ATP2A2;ATP2A3
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5478364426303152,1.438868665427524,0.07509881422924901,0.5723631265842871,1.0,9/23,10.26%,TGFBR3;DKK3;ITGA3;SMAD3;FOLR1;NREP;BCL9;LATS1;SMURF2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6577847123101332,1.4381048274443715,0.12903225806451613,0.572525776828675,1.0,2/10,8.60%,ADGRV1;WHRN
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.37112675778045306,-1.4355738916767946,0.01912568306010929,0.38360135468128037,1.0,40/94,23.41%,RPS6KA5;UBB;NFKBIA;NOD1;IKBKB;ST18;IL1R1;RPS27A;UBC;IL1RAP;PSMD13;PSMF1;RBX1;PSMB10;CHUK;PSMB6;TOLLIP;PSME3;PSMB5;MAP3K3;PSMC3;IRAK3;PSMD12;PSMB8;CUL1;MAP3K8;TAB3;PSME1;UBA52;PSMB3;RPS6KA4;IRAK1;PSMD5;MYD88;SKP1;MAPK3;PSMD9;PELI1;PSMB4;RELA
prerank,embryonic limb morphogenesis (GO:0030326),0.49110742672265717,1.435045059100925,0.060109289617486336,0.5802423674575965,1.0,9/34,10.88%,CYP26B1;OSR1;INTU;FBXW4;GLI3;SALL1;WDPCP;HDAC1;TFAP2A
prerank,membrane depolarization during action potential (GO:0086010),0.5305690285794423,1.4346843161148584,0.07636363636363637,0.5789699816580088,1.0,4/26,4.74%,SCN7A;ATP1A2;SLC8A1;CACNA1D
prerank,T cell homeostasis (GO:0043029),-0.6184202518386664,-1.434455736130019,0.07827788649706457,0.385213723089623,1.0,8/10,30.52%,ZC3H8;FAS;JAK3;PPP2R3C;AKT1;NCKAP1L;FADD;PMAIP1
prerank,transcription by RNA polymerase II (GO:0006366),0.3566016556233233,1.4328878531322204,0.0039946737683089215,0.5825436819163906,1.0,52/305,14.27%,GLIS3;RORA;SOX5;MAF;RBPJ;PPARA;NOTCH2;POLR2D;PRRX1;PHAX;ESRRG;CCN2;NR1I2;TBL1XR1;PAX5;CDK7;MAML3;ELOA;SSU72;TEAD1;MAML1;HSF2BP;INTS8;NR6A1;NRBP1;POLR2A;CCNT2;TEAD3;RPRD1B;CCNT1;GTF2F1;SNAPC5;MED1;TAF8;HDAC1;TAF1A;DTX1;RPRD2;RXRA;TAF3;CDC73;ICE2;GMEB2;GTF2I;AR;MAML2;NR1I3;WDR33;TRIM24;CREBBP;MNAT1;NELFB
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.4710811756060885,1.4325787149600222,0.043875685557586835,0.5810723119569373,1.0,8/46,7.05%,IGF1;TCF7L2;IL18;OGN;PDGFRB;CCN4;IL6;XRCC5
prerank,organic cation transport (GO:0015695),0.5584026006124736,1.4324701481667157,0.08893280632411067,0.5789706000489884,1.0,2/20,0.70%,SLC22A4;SLC22A2
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.5803211933960293,-1.4318420472069264,0.06432748538011696,0.390909452000468,1.0,3/13,9.23%,ENTPD1;ENTPD7;ENTPD2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6051795586260348,1.431646897442088,0.10294117647058823,0.5792252806138297,1.0,2/13,3.75%,B3GALT1;GAL3ST3
prerank,lymphocyte mediated immunity (GO:0002449),-0.6041829959394173,-1.431634798575635,0.08159392789373814,0.39008335560875657,1.0,4/12,16.98%,JAG1;CD55;MSH2;BTN3A3
prerank,establishment of skin barrier (GO:0061436),-0.5585459557000823,-1.4313342688750217,0.07584830339321358,0.3881931298621798,1.0,9/15,32.66%,LSR;MET;HRNR;ALOX12;STMN1;UGCG;SFN;ALOXE3;TMEM79
prerank,regulation of water loss via skin (GO:0033561),-0.5585459557000823,-1.4313342688750217,0.07584830339321358,0.3881931298621798,1.0,9/15,32.66%,LSR;MET;HRNR;ALOX12;STMN1;UGCG;SFN;ALOXE3;TMEM79
prerank,response to ATP (GO:0033198),-0.5318053529195303,-1.4312698005594446,0.07214428857715431,0.3870244360740493,1.0,13/18,42.72%,ABCC9;TRPC3;HSP90B1;SSH1;DGKQ;P2RY12;P2RY1;P2RX7;P2RX3;P2RY2;PDXP;CIB2;KCNJ11
prerank,lamellipodium assembly (GO:0030032),-0.4836485037183188,-1.431263304199968,0.05450733752620545,0.3857276065131718,1.0,11/26,12.41%,PARVB;ABLIM1;RAC1;CARMIL1;ITGB1;S1PR1;SPATA13;ARHGEF6;CCDC88A;WHAMM;CDH13
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.5044167022636247,-1.4308095318093719,0.06079664570230608,0.3856900676792602,1.0,5/22,12.42%,B2M;STX7;CD55;CYRIB;HSPD1
prerank,glial cell development (GO:0021782),-0.48354719837240806,-1.4303594197618905,0.062360801781737196,0.38559647209151326,1.0,13/25,22.64%,SOX4;APP;CDK6;NRROS;PICK1;MT3;NF1;EIF2B5;TPPP;EIF2B2;SOX10;DLL1;SOX11
prerank,retrograde axonal transport (GO:0008090),-0.5412790575038735,-1.4296112422385028,0.06827309236947791,0.38613953792933925,1.0,10/16,32.71%,DLG2;ACTR10;SOD1;KIF1A;TMEM108;NEFL;MAP1A;HAP1;KIF5B;DYNC1H1
prerank,actin filament bundle assembly (GO:0051017),0.5009661546572496,1.429339111350365,0.06191369606003752,0.5841625159693288,1.0,9/33,7.18%,PAWR;RHOD;DPYSL3;SHROOM2;CALD1;BAIAP2;ESPN;BAIAP2L2;LIMA1
prerank,positive regulation of programmed cell death (GO:0043068),-0.31697159200017366,-1.4290133342375415,0.003875968992248062,0.38635828932769345,1.0,67/272,15.45%,UNC13B;SLIT2;MAP3K5;MCF2L;ITGA6;TIAM1;RASSF2;TRIO;ARHGEF3;ITGB1;KCNMA1;DAB2IP;NGF;RASGRF2;UBB;RACK1;DNAJA1;CTSD;ARHGEF12;NET1;TNFSF10;PREX1;ATG7;SFRP4;TGM2;RPS6;ARHGEF17;SOX4;ARHGEF6;RHOB;CTNNB1;SOD1;FAF1;ABR;RPS27A;UBC;APBB1;HIP1R;DNM2;JUN;FOXO1;ARHGEF19;DDX20;ARHGEF26;MAPK8;ING4;APC;ARHGEF5;ATF4;BMP2;BIN1;GPER1;RYBP;REST;HSPD1;ARHGEF2;CLU;RNPS1;GADD45G;NLRP2B;IAPP;PLEKHN1;NF1;FAS;CYP1B1;CASP8;UBA52
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.37049905904236957,-1.4287750292388641,0.02168021680216802,0.3856018778074104,1.0,25/88,13.88%,STXBP6;FTH1;HSPA8;EXOC6;FTL;MON2;CLINT1;EXOC4;VPS13A;VPS13C;CLVS2;CLVS1;VAMP8;ARRB1;GOPC;ARF1;DNM2;APP;GOLGA7;EXOC5;SCAMP1;HGS;MYO5A;SCAMP2;AP1S2
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5660002724996777,1.4282779233012233,0.07874015748031496,0.5852585187440086,1.0,7/20,12.56%,IGF1;PDGFRB;CCN4;ACE;VTN;BMPR1A;SERPINE1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.34918568620302504,-1.426948649684076,0.01652892561983471,0.38890275879142316,1.0,33/118,10.03%,FMNL2;MEF2C;EFNA5;SHANK3;SIPA1L1;BMPER;PLXND1;NEDD4L;ETS1;CDH2;PHLDB1;CHN1;SEMA4D;TBX1;WARS1;INF2;TGFB1;ZDHHC15;FERMT2;CTNNB1;PPFIA2;GSK3B;CEACAM1;ZRANB1;FLT4;EMP2;ABI3;PAK1;CYRIB;LFNG;SRCIN1;PAK2;KIF1A
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.5706333704791383,-1.426220273443572,0.08167330677290836,0.38952736280922023,1.0,5/12,12.32%,JAG1;NOTCH1;HES1;HNRNPU;REST
prerank,aminoglycan biosynthetic process (GO:0006023),0.460843047335266,1.4253330944627731,0.07407407407407407,0.592559033755189,1.0,14/49,12.62%,B3GALT1;HS3ST3A1;PXYLP1;SDC2;HS3ST3B1;GPC6;GPC3;HAS1;XYLT2;B3GALT6;NDST2;HS6ST1;UGDH;GPC4
prerank,cellular response to glucagon stimulus (GO:0071377),0.5722506200765214,1.4248202946594268,0.10789980732177264,0.5917748881479217,1.0,2/17,0.71%,ADCY5;ADCY1
prerank,positive regulation of GTPase activity (GO:0043547),-0.3331285181667017,-1.4245218821921184,0.0,0.3925359260696834,1.0,48/188,12.37%,DOCK9;NTRK3;RAP1A;SIPA1L1;RGS6;ITGA6;TIAM1;BCAR3;TBC1D30;PKP4;ARHGAP42;ITGB1;AGRN;TBC1D8;SIPA1L2;F11R;ARHGAP27;CAV2;RACK1;SEMA4D;SIPA1L3;NET1;DOCK10;ARHGEF15;CCDC125;RABGAP1L;LIMS1;TGM2;CORO1C;FERMT2;ADPRH;ABR;GRTP1;GSK3B;SGSM1;BCR;TBC1D8B;TBC1D1;ARHGEF19;TBC1D13;ARHGEF26;ARHGAP25;ARHGEF5;ARHGEF10;EVI5;RANGAP1;S100A10;TBC1D10A
prerank,regulation of blood coagulation (GO:0030193),-0.47808986477115417,-1.4242983512799767,0.06369426751592357,0.3918681694498662,1.0,6/27,3.49%,ST3GAL4;CAV1;CD34;THBS1;FAP;SERPINE2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.435721512357259,1.4241882875847836,0.05324459234608985,0.5912024281542358,1.0,11/65,9.50%,RORA;SLC8A3;EPAS1;BMP7;NDNF;CPEB2;CPEB4;BNIP3;NPEPPS;ACAA2;MDM2
prerank,regulation of fibroblast migration (GO:0010762),-0.5118180638874389,-1.4239987854225773,0.07142857142857142,0.3914423993611519,1.0,9/20,9.39%,PRR5L;THBS1;RAC1;PTK2;ITGB1;CORO1C;TGFB1;GNA12;APPL1
prerank,positive regulation of cell differentiation (GO:0045597),0.36365786449484866,1.4237655755222285,0.006887052341597796,0.5900832398270182,1.0,35/237,8.63%,IGF1;RANBP3L;SOX5;BMP6;TCF4;RIN2;WNT4;IL18;BMP7;MEDAG;FBN2;DAB2;HOXB4;CCN2;ZEB1;PLA2G10;LTF;SOX6;PLCB1;CCN4;PDPN;RIPOR2;MAPK9;GLIPR2;GJA1;TMEM64;PTN;IL6;SMAD3;NBL1;LMO3;DDR2;CSF1;SYAP1;ATRAID
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.3630579727438465,-1.423501284172643,0.03428571428571429,0.3914675697800985,1.0,41/110,22.98%,FNIP2;HSPA8;TFRC;HSP90AA1;GSN;DAB2IP;RPS3;RACK1;SH3GLB1;WARS1;TGFB1;HJURP;MPP7;FAF1;GSK3B;GFAP;VEGFA;CRYAB;NAPB;SPIDR;HSPA5;RALB;PIH1D1;TAL1;CLU;SVIP;IAPP;TPPP;RAF1;CDC42EP2;PREB;PINK1;TIRAP;NOP53;PEX5;MMP1;BIK;VCP;HDAC6;BMF;MTLN
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.568208894532999,-1.4230811468238498,0.07551020408163266,0.3912892015689135,1.0,4/14,5.70%,PRKG1;MEF2C;SLIT2;IGFBP5
prerank,response to ketone (GO:1901654),-0.4820568658369143,-1.4228945222509568,0.07223476297968397,0.39048574905924055,1.0,8/24,8.78%,ABHD2;SLIT2;CAV1;THBS1;TGFB2;UBE3A;TGFB1;WBP2
prerank,cellular response to BMP stimulus (GO:0071773),0.43908154541442174,1.422712582541787,0.05363321799307959,0.5913151064534682,1.0,10/66,7.68%,ADAMTS12;TGFBR3;BMP6;BMP7;SMAD6;SLC39A5;SCX;ADAMTS7;SMAD3;RGMB
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.39389909329358563,1.4226672363175783,0.0213089802130898,0.5890381433167228,1.0,19/129,10.26%,RNF220;WLS;LRRK1;PTK7;LGR4;FGFR2;ZEB2;TBL1XR1;LYPD6;GPC3;LRRK2;FRAT1;PSME4;PSMA2;PSMA3;USP34;PSMD8;AXIN2;SMURF2
prerank,aorta development (GO:0035904),0.5972128789466475,1.4210645374281805,0.10084033613445378,0.5919599063798789,1.0,3/14,2.95%,ADAMTS9;ROBO1;PDGFRB
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.5922412395067223,1.4204390007459886,0.10245901639344263,0.5917107234168885,1.0,3/15,5.21%,DAB2;BMP2K;WASL
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.377154153105407,-1.4203286434936744,0.03412073490813648,0.39598017005519537,1.0,35/72,27.67%,SLIT2;SHANK3;KANK3;HSPA8;KANK1;HIP1R;STMN2;CRYAB;CYRIB;NAV3;SSH2;SSH1;KANK4;APC;ARHGEF2;CLU;STMN1;IAPP;APC2;TUBB4A;PFDN6;PFDN5;PRKCD;MAPRE1;TTBK2;CLASP2;SHANK1;SPEF1;CAMSAP3;PFDN4;CAMSAP1;EMILIN1;TREM2;FGF13;SSH3
prerank,heart morphogenesis (GO:0003007),-0.41628333387746536,-1.4189681442907494,0.04555808656036447,0.39818427008364377,1.0,16/50,11.74%,NOS3;ACVRL1;TGFB2;PTK2;ENG;NOTCH1;TBX1;HES1;SOX17;TBX2;TBX3;VEGFA;RYR2;HEY2;BMP2;HEYL
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.5959560227202271,-1.41801553569645,0.07875457875457875,0.39955323532422693,1.0,3/12,2.97%,FOXP1;KLF4;MBP
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5218954310244138,1.417293577001877,0.08704453441295547,0.5996593504854756,1.0,7/25,8.55%,WNK4;DMD;SLC6A9;ATP1B3;ANK2;TCAF1;COX17
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.6083899503415322,-1.4172190473818658,0.08424908424908426,0.4003666811649322,1.0,5/11,20.29%,NOTCH1;FOXO1;LMNA;GLRX3;ATP2B4
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6032292137899872,1.4170157554751417,0.10663983903420524,0.5983407773235715,1.0,3/13,1.00%,TGFBR3;RBPJ;FGFR2
prerank,regulation of steroid biosynthetic process (GO:0050810),0.6243903234246065,1.4167327782480583,0.10493827160493827,0.5969367154251316,1.0,2/11,1.01%,WNT4;FGFR4
prerank,cellular copper ion homeostasis (GO:0006878),-0.5528571687022421,-1.4167001600566935,0.08754863813229571,0.4003129075602701,1.0,5/14,7.70%,ATOX1;SLC31A1;MT2A;ARF1;APP
prerank,positive regulation of chemotaxis (GO:0050921),-0.43425956793087217,-1.4165380701106998,0.04439252336448598,0.39941795369130784,1.0,11/43,7.87%,NTRK3;TMSB4X;KDR;THBS1;STX3;F3;LGMN;HSPB1;TGFB1;MET;VEGFA
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6201394402699238,-1.4164347428706547,0.08037383177570094,0.39837648542512255,1.0,7/10,15.88%,PDE4D;PDE3A;PDE2A;RNF157;UBE2B;PDE11A;APLNR
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5536567078248633,1.4163910297362057,0.10379241516966067,0.5957098982262558,1.0,1/19,0.03%,IGF1
prerank,positive regulation of cell migration (GO:0030335),-0.3195976641700146,-1.4159520363993576,0.007662835249042145,0.39829423785690293,1.0,66/253,12.50%,LEF1;GAB1;NTRK3;FN1;PECAM1;PODXL;CAV1;ACTG1;SEMA6A;ACTN4;SEMA7A;ITGA6;TIAM1;SEMA6D;KDR;THBS1;ADAM10;TGFB2;CARMIL1;SEMA3C;F3;PTK2;ITGB1;DOCK1;PLCG2;ROR2;PTK2B;DAB2IP;NOTCH1;RACK1;SEMA4D;BMPR2;SEMA3E;SHTN1;BCAR1;TGFB1;FAM107A;FERMT2;PTPRC;PDGFC;MYOC;PDCD10;VEGFA;TJP1;MTOR;PAK1;CPNE3;GRN;SEMA4B;EDN1;SEMA5B;RTN4;SEMA6C;APC;XBP1;PIK3CD;HSPA5;STAT3;BMP2;GCNT2;SEMA3G;TWIST2;GPER1;RIPOR1;CDH13;ARHGEF2
prerank,regulation of proteolysis (GO:0030162),-0.41244106019371995,-1.4155966222951635,0.050970873786407765,0.3978572794869582,1.0,19/48,21.92%,CAV1;LTBP4;CST3;SERPINE2;PERP;NEDD8;BAG6;DNAJC1;OGT;TBC1D10A;CASP8;SPOPL;CLN8;CDK5;PLAUR;CAMK2N1;CYFIP2;AKT1;HDAC6
prerank,protein targeting to mitochondrion (GO:0006626),-0.40678988522519494,-1.4155481940046475,0.034722222222222224,0.3967428925302319,1.0,23/52,29.75%,HSP90AA1;FBXO7;TOMM20;NDUFA13;TOMM22;HSPD1;TIMM9;ROMO1;TIMM10B;TIMM13;BCAP31;TIMM29;TIMM22;TOMM7;MFN2;TIMM50;FIS1;TIMM44;TSPO;AIP;CHCHD4;DNLZ;TOMM34
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.6103476988824146,1.4148815070584073,0.12708333333333333,0.5982482312544141,1.0,1/12,0.09%,CYP26B1
prerank,protein-containing complex disassembly (GO:0032984),-0.40509274934696443,-1.4148731007286892,0.045454545454545456,0.3972397317200753,1.0,17/54,22.45%,CAV1;HSPA8;RPL23;CTNNB1;VTI1B;VAMP8;GSK3B;MAP1LC3B;PYM1;APC;PPP1CA;SNX14;DVL2;GABARAPL1;VCP;CHMP3;LIX1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.5281594080012865,1.414503045184548,0.09426987060998152,0.5970925354886008,1.0,8/28,13.05%,ARHGAP28;NAA80;ARHGAP40;COTL1;ARHGAP35;LATS1;GBA2;FCHSD2
prerank,cellular response to amyloid-beta (GO:1904646),0.4759024871738239,1.413973201592372,0.10497237569060773,0.5967323388309163,1.0,6/35,7.35%,IGF1;SNX6;EPHA4;GJA1;IGF1R;CACNA2D1
prerank,peptidyl-asparagine modification (GO:0018196),-0.4586109587449607,-1.4136966652010108,0.05869074492099323,0.3991654524757946,1.0,14/31,24.85%,ST6GAL1;FUT8;MAGT1;STT3B;MCFD2;RPN1;MGAT1;DDOST;MGAT5;ALG5;MGAT2;ALG8;DPM1;UBE2J1
prerank,amino acid transmembrane transport (GO:0003333),0.47082942115563414,1.4136845644188953,0.07329842931937172,0.5953198057142216,1.0,8/45,6.64%,SLC7A11;SLC22A4;SLC6A13;SLC22A2;SLC38A3;SLC25A18;SLC38A9;LRRC8E
prerank,long-chain fatty acid transport (GO:0015909),0.5053685584271208,1.41269392805708,0.08256880733944955,0.5961035100038999,1.0,6/30,10.77%,PRKAG2;ACSL1;PRKAA2;CPT2;SLC27A1;RPS6KB1
prerank,regulation of hydrolase activity (GO:0051336),-0.38505879246778824,-1.4123803497473533,0.031413612565445025,0.4012702064034683,1.0,14/71,4.41%,PRKG1;CHN2;FGD5;EFNA5;CAV1;FGD6;SIPA1L1;PLXND1;PTK2;RASIP1;ARHGAP27;DAB2IP;CHN1;PLXNA4
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.5983900502725593,1.4123591411220338,0.095703125,0.5949599211594512,1.0,4/15,6.34%,SH3D19;SNX9;SNX33;NRDC
prerank,circulatory system development (GO:0072359),-0.34948843455641704,-1.4122399608434373,0.019886363636363636,0.40046030216581224,1.0,38/118,17.66%,MEF2C;TEK;NTRK3;FN1;HEG1;MICAL2;ACVRL1;TGFB2;RAMP2;NOTCH1;TBX1;CXADR;PKD1;SOX17;STRA6;TGFBR2;SOX4;TGFB1;CRIP1;PDLIM7;FLT4;NOTCH4;LDB3;HEY2;ECE1;CDKN1B;CACNA1C;BMP2;SOX18;SMYD4;NF1;NXN;COL3A1;CASP8;APLNR;DVL2;ACVR1;ID2
prerank,cellular glucose homeostasis (GO:0001678),-0.42990755384817103,-1.4122096250421385,0.05339805825242718,0.3992998782110801,1.0,14/41,13.37%,UNC13B;LRRC8D;GAS6;PPARGC1A;RACK1;KCNB1;SOX4;HK1;FOXO1;LRRC8A;XBP1;GPER1;SLC39A14;FOXK1
prerank,protein localization to cell-cell junction (GO:0150105),-0.5501079953736315,-1.4121067016769944,0.07480314960629922,0.39829458632663384,1.0,8/15,9.55%,ACTB;ACTG1;TJP2;LSR;F11R;MPP7;TJP1;PAK2
prerank,activation of protein kinase A activity (GO:0034199),0.5827748289450503,1.4116616656484469,0.11683168316831684,0.5947717121967758,1.0,2/16,0.71%,ADCY5;ADCY1
prerank,nitric oxide biosynthetic process (GO:0006809),-0.5680490073772276,-1.4114837410671834,0.08481262327416174,0.3987294509515891,1.0,7/13,22.38%,NOS3;GCH1;NOS1;CYP1B1;CYB5R3;AKT1;DDAH2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3806609261447924,1.4106366645347053,0.024963289280469897,0.5958571956955591,1.0,32/161,12.56%,BICC1;IGFBP2;TCF7L2;MCC;PRKN;LRP4;DAB2;DKK3;RBMS3;DKK1;IGFBP4;PRICKLE1;INVS;TMEM64;TLE3;ZNRF3;GLI3;PSME4;PSMA2;PSMA3;SIAH2;AMFR;TLE1;PSMD8;AXIN2;DVL3;LATS1;HDAC1;PSMD3;CYLD;SOX13;TMEM170B
prerank,alcohol catabolic process (GO:0046164),0.6486934991283804,1.410471134524878,0.10208333333333333,0.5940818571655597,1.0,2/10,2.04%,CYP27A1;CEL
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.5119600793338611,-1.4098814118018774,0.09839357429718876,0.40165826763335705,1.0,8/19,18.74%,LIFR;RUNX1;CBFB;KLF4;TLE5;IFIH1;IRAK1;SH2B3
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.4592836185801118,-1.409783299630869,0.05510204081632653,0.40068908209529935,1.0,13/30,23.86%,CAV1;SEMA4D;PTPRC;SRCIN1;CADM4;SAMSN1;SH2B3;INPP5F;THY1;PRKCD;CD300A;HYAL2;SOCS1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.528813709757082,-1.4088633170915963,0.08617234468937876,0.40175171362351697,1.0,6/17,20.04%,PTPRJ;CEACAM1;DUSP3;DGKZ;LAPTM5;THY1
prerank,negative regulation of histone methylation (GO:0031061),0.6507669462322427,1.4087798163777674,0.11992263056092843,0.5973229068709629,1.0,4/10,7.80%,AASS;JARID2;BCOR;MTF2
prerank,intestinal lipid absorption (GO:0098856),0.619435742956213,1.407955993022875,0.11422845691382766,0.5977559056155378,1.0,3/11,10.19%,CEL;LIMA1;SOAT2
prerank,regulation of interleukin-2 production (GO:0032663),-0.42575297866620176,-1.4069127027581632,0.0585480093676815,0.40562740164079714,1.0,8/43,8.53%,SPTBN1;PDE4D;CD34;RUNX1;PLCG2;RPS3;PTPRC;NAV3
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.31929983252869754,1.4062194376290171,0.0,0.6011311902444193,1.0,288/1668,13.20%,IGF1;GLIS3;CREB5;PRDM6;RORA;SOX5;BMP6;MAF;VGLL3;TCF4;TCF7L2;OSR1;AUTS2;AEBP1;ARNT2;RBPJ;ZIC1;ZNF462;HOXC6;FGFR2;FHL2;EPAS1;HLF;PPARA;KDM7A;NR2F2;PID1;NPAS3;IKZF2;IL18;KIT;HOXC4;CDK8;PRKN;WWOX;ATXN1;BRD8;ZEB2;ZKSCAN2;KCNIP3;KMT2A;PRRX1;MEIS1;DAB2;HOXB4;ESRRG;ARID5B;FHOD1;CSRP3;MXI1;FNIP1;CUX1;SMAD6;AASS;SATB1;PRDM5;ZEB1;ZIC2;EBF1;MYBL1;DKK1;DMRT1;SCX;NR1I2;ASCL2;SOX6;TBL1XR1;CITED4;ZBTB20;SP100;PPARGC1B;HOXB3;RNASEL;TSHZ3;HIF3A;PAX5;NFYB;EPOP;MIDEAS;ZIC5;HOXA3;CDK7;BBX;IGF2;SSBP2;HOXC5;PKNOX2;TFR2;VSX2;NCOA2;STAT5B;JAZF1;MAML3;NFAT5;ELOA;ZFP90;HDAC8;HOXA7;FOXD1;ZHX2;SSU72;NFIB;TEAD1;ELF4;MGA;BAZ1B;ARID4A;TEF;ZNF367;RNF2;ARID1B;FIZ1;TNRC6B;IKZF4;GMEB1;KDM2B;CAMTA1;SOX1;SIX5;SALL4;ZFHX2;WASL;DPF2;IRF8;SP110;TNRC6A;ZNF250;FGF1;GLI3;PRKCB;ZNF569;TET1;HIVEP2;MXD1;MYNN;ZBTB32;TCF7L1;ZMIZ1;ZFP37;BAZ1A;MAML1;PHF8;CXXC5;BCOR;SUFU;DLG1;THAP1;WWC1;IL6;WWC2;SALL1;NCOA3;RFXAP;ZNF23;KANK2;SMAD3;SSBP3;PHF14;EN1;PBX4;CHD4;PTEN;NCOA7;NR6A1;GABPB1;GABPB2;MTF2;PHF21A;ZKSCAN5;KDM2A;TCF12;ABRA;CCNT2;TEAD3;PER3;WWP2;LYAR;PIAS1;CBX8;RPRD1B;DNAJA3;RSF1;CCNT1;NFIA;PCGF5;ARNT;CBX2;GTF2F1;FSTL3;KAT8;KDM5B;CDK1;CAMK2D;MITF;KDM6B;KAT6B;CEBPG;KDM3B;EBF4;MDM2;IER5;NFYC;HOXB6;CREB3L2;NSD1;BATF2;IRF3;BCL9;MED1;AKAP8L;BBS7;DVL3;AGO2;ZSCAN29;FRK;SMURF2;IRX1;PHIP;ASXL2;ABL1;MED13;PRKDC;PARP9;SMARCA5;ATOH8;NEUROD2;HDAC1;PIK3R1;TSHZ1;FLCN;TFAP2A;TADA2A;CBX7;SMARCE1;ZNF8;HOXC8;TFAP2B;ARID3A;ZIC4;ZNF568;RXRA;ERBB2;TGFA;ZBTB38;MYB;ZBTB39;NPAS2;TAF3;BMPR1A;BCLAF3;ZBTB37;CRY1;CNOT2;ZNF177;RNF14;CDC73;E2F6;ORC2;SOX13;GMEB2;HSF1;PRKD2;PKD2;AR;HIVEP1;SERPINE1;PHF6;KLF5;CRTC1;MAML2;EZH1;SEBOX;CRTC3;GDNF;ZMIZ2;INO80;SMARCB1;PPIL4;CGGBP1;IFI27;HOXD4;NFATC4;TBK1;HOXA6;BCL2L12;NR1I3;EPC2;FOXK2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5292699432293455,-1.4061924400668402,0.09016393442622951,0.4061719782251969,1.0,9/16,28.21%,TPT1;ACKR3;RPS3;BCL2L1;CLU;CXCL12;CDKN2D;SNAI2;TMEM161A
prerank,acidic amino acid transport (GO:0015800),0.5515121600958679,1.4060706857202416,0.10485436893203884,0.5993020948834569,1.0,7/17,9.27%,SLC6A13;SLC1A3;SLC6A1;SLC25A18;GJA1;LRRC8E;SLC25A22
prerank,response to metal ion (GO:0010038),-0.3881410318260356,-1.4058012536650468,0.033816425120772944,0.40600927597557224,1.0,21/67,15.64%,CAV1;THBS1;TRPC3;CALM1;NEDD4L;MT1A;MT1X;KCNMA1;HOMER1;SLC30A5;CRIP1;ATP5F1D;MT2A;GPHN;PPP1CA;PPP3CA;MT3;ITPR3;AHCYL1;CALM2;TRPC1
prerank,carboxylic acid transport (GO:0046942),0.4403074927654935,1.4050522586505205,0.06741573033707865,0.6003565836413436,1.0,7/55,3.98%,SLC6A13;SLC13A3;SLC16A12;SLC38A3;SLC6A12;SLC6A9;LLGL2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.45736721714999723,-1.404641463048232,0.07111111111111111,0.40785241095505975,1.0,12/32,9.05%,APOD;ACER2;THBS1;ACVRL1;JAG1;ADAM15;SEMA3E;CORO1C;FAM107A;NEXMIF;MYOC;AJAP1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5451356347892465,1.4044920077158292,0.10444874274661509,0.5999034359740917,1.0,6/21,11.76%,IGF1;MMP2;GJA1;MMP9;FGF9;BMPR1A
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5034574807510259,1.4041065734261098,0.10126582278481013,0.5989544262272238,1.0,2/30,1.17%,IGF1;NOTCH2
prerank,positive regulation of cellular senescence (GO:2000774),-0.5915033869300054,-1.403956902933519,0.09560229445506692,0.4083653109253748,1.0,4/10,16.93%,B2M;YPEL3;ABI3;EEF1E1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.390994548926736,1.403878449410391,0.04148148148148148,0.5974420757174022,1.0,12/121,6.79%,IL31RA;IGF1;BMP6;IL34;IL18;KIT;ANGPT1;IGF2;EPHA4;ACE;IL6;ENPP2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5160810817177455,1.4033505848122636,0.09375,0.5970277091752106,1.0,10/23,18.58%,C1QTNF3;PPARA;SIK1;NUPR1;CRY1;PFKFB1;GCK;C1QTNF12;NCOR1;HDAC4
prerank,odontogenesis (GO:0042476),0.5005300349175733,1.4021593424846832,0.07909604519774012,0.5987394517001686,1.0,8/35,10.71%,OSR1;FGFR2;WNT6;COL1A2;ANKRD11;BCOR;AXIN2;HDAC1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.48284640201890255,1.4020492196339918,0.0687732342007435,0.596919697479713,1.0,10/40,12.29%,SLC7A11;SLC13A3;SLC38A3;SLC38A9;SLC25A11;SLC27A1;SLC19A1;SLC36A2;SLC38A7;SLC38A2
prerank,proteasome assembly (GO:0043248),-0.5801004514725073,-1.4017080378902378,0.07196969696969698,0.4129009008898123,1.0,7/11,33.26%,PSMD13;POMP;PSMD5;OTUD6B;PSMD9;PSMD10;PSMG1
prerank,nitric oxide metabolic process (GO:0046209),-0.5556944986640283,-1.4013223764375284,0.08943089430894309,0.41260024176197047,1.0,7/14,22.38%,NOS3;GCH1;NOS1;CYP1B1;CYB5R3;AKT1;DDAH2
prerank,B cell receptor signaling pathway (GO:0050853),-0.45444985913839053,-1.4012907533115317,0.05393258426966292,0.4114718120755178,1.0,10/32,10.16%,MEF2C;PLCG2;BMX;RFTN1;BCAR1;NFATC2;CD38;PTPRC;PLEKHA1;PIK3CD
prerank,positive regulation of histone methylation (GO:0031062),0.5281724070693027,1.400801627135671,0.09737827715355805,0.598655372688363,1.0,9/24,17.39%,AUTS2;KMT2A;JARID2;TET1;MTF2;MYB;SMAD4;PHF1;CTR9
prerank,extracellular matrix organization (GO:0030198),0.3563502813729407,1.4006692770866631,0.004026845637583893,0.5968685967502507,1.0,40/276,6.29%,COL22A1;ADAMTS12;NID2;COL26A1;ADAMTS9;LAMC3;COL4A5;ADAM12;ITGA9;FBN1;COL4A6;SMOC2;LAMA2;ADAMTS5;THSD4;FBLN5;ADAMTS10;FBN2;KLK2;FLRT2;ADAMTS15;TNC;PXDN;LOXL1;COL9A2;SCX;NID1;LOXL3;NDNF;SMOC1;MMP2;ITGAX;COL1A2;SH3PXD2B;COL13A1;DDR1;ITGA3;ADAMTS7;MMP19;COL18A1
prerank,positive regulation of hydrolase activity (GO:0051345),-0.3410302394807045,-1.4003456277725044,0.018867924528301886,0.4129140849404436,1.0,35/137,15.65%,DOCK9;RAP1A;RGS6;ITGA6;CD200;BCAR3;TBC1D30;PKP4;CALM1;ITGB1;AGRN;F11R;ARHGAP27;CAV2;PSAP;RPS3;RACK1;SEMA4D;NET1;DOCK10;LIMS1;TGM2;FERMT2;GSK3B;RHOA;MAPK8;BMP2;NDUFA13;EVI5;S100A10;MTMR9;MTCL1;NF1;CALM2;RGS10
prerank,response to glucagon (GO:0033762),0.5492389305455734,1.399863347106029,0.11005692599620494,0.5973753779050743,1.0,2/19,0.71%,ADCY5;ADCY1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.5292910439047777,-1.3998250219455195,0.08704453441295547,0.4131933114679187,1.0,10/18,29.95%,PTGIS;PTGS2;EDN1;PTGDS;CD74;PLA2G4A;MIF;HPGDS;PRXL2B;CBR1
prerank,protein localization to plasma membrane (GO:0072659),-0.3431849861536415,-1.3991628401123286,0.025139664804469275,0.4136484899356594,1.0,37/129,13.95%,SPTBN1;BSG;RAP1A;EFR3B;GAS6;CDH1;SLMAP;KCNB2;EHD4;RAMP2;F11R;RAB3C;ATP1B1;KCNB1;FLNA;MAP7;IKBKB;NKD2;EHD1;CCDC88A;WNK3;PTCH1;RAMP1;TMED2;EMP2;ZDHHC2;TTC7A;TSPAN17;C2CD5;RAB3B;MYO5A;S100A10;SPTBN4;EHD3;CACNB2;CD81;JUP
prerank,activation of adenylate cyclase activity (GO:0007190),0.4715185014363195,1.3987971911180954,0.08540925266903915,0.5985573752755426,1.0,3/35,0.84%,ADCY5;ADCY1;LGR4
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.4393248114660453,-1.3981914547298282,0.04932735426008968,0.41480601945451934,1.0,15/35,18.96%,ESR1;PLPP1;UBE3A;RBFOX2;KDM3A;DDX5;WBP2;TMF1;DDX54;GPER1;EGLN2;NCOA4;NR3C2;DDX17;PADI2
prerank,positive regulation of signal transduction (GO:0009967),0.357283912676579,1.3967206759737225,0.01098901098901099,0.6027812826221294,1.0,37/238,7.87%,IGF1;DCDC2;ROBO1;BMP6;SASH1;WLS;RBPJ;FGFR2;SMOC2;SORBS1;NLGN2;BMP2K;LOXL3;IGF2;MAML3;MACF1;GRB10;CCBE1;TEDC2;TTC23;SULF1;LRRK2;PRKCZ;FGF1;PRKCB;PDE6G;ARMC9;ZMIZ1;MAML1;IL6;SALL1;LMO3;PRKCA;PTEN;RWDD3;GKAP1;VTN
prerank,protein insertion into ER membrane (GO:0045048),-0.42623836467657616,-1.3966979762743792,0.07962529274004684,0.41748692629871265,1.0,20/37,32.46%,STX1A;EMC10;BAG6;APP;CCDC47;EMC7;EMC1;CAMLG;SEC61G;EMC3;EMC6;EMC9;GET4;VAPA;OTOF;WDR83OS;STX5;SEC61B;UBE2J2;EMC4
prerank,glycoprotein biosynthetic process (GO:0009101),0.4180920026949222,1.3965589953523467,0.04777070063694268,0.6011368521347439,1.0,9/79,3.93%,IGF1;B3GALT1;ST3GAL3;GALNTL5;LARGE1;B3GNT5;GAL3ST3;GAL3ST2;ST3GAL5
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.5643069538799151,1.3959706691853013,0.10956175298804781,0.6008249512136986,1.0,3/17,1.28%,ATP1A2;TFPI;BMP7
prerank,midbody abscission (GO:0061952),-0.5292790601560474,-1.3946340176392111,0.08365758754863813,0.42160938696252076,1.0,10/17,30.92%,CHMP5;CHMP2B;CHMP1B;CHMP1A;CHMP3;CHMP7;PDCD6IP;CHMP4C;CEP55;VPS4B
prerank,microvillus organization (GO:0032528),-0.5663637879562842,-1.3943496553046162,0.09003831417624521,0.4210888187819521,1.0,3/13,4.05%,RAP1A;FXYD5;MINK1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.44388122091675136,-1.3939338407536737,0.061946902654867256,0.4210833665989439,1.0,12/32,16.67%,PPP1R13B;BAG6;DDX5;DDIT4;BCL3;HINT1;MSH2;PDK2;MYBBP1A;AEN;RPS27L;USP28
prerank,positive regulation of developmental growth (GO:0048639),-0.40707973910222583,-1.3936652252966937,0.049019607843137254,0.4206190477493476,1.0,25/49,29.94%,SEMA7A;AGRN;NEDD4L;NGF;SEMA4D;SHTN1;ITSN2;RNF157;PPIB;DBNL;SYT4;CPNE9;SYT2;RASAL1;DBN1;INSR;L1CAM;DLL1;PLAA;CPNE5;RIMS2;SYT17;SYT1;ISLR2;SMURF1
prerank,response to ethanol (GO:0045471),-0.5434615510058878,-1.3936592997855388,0.09486166007905138,0.4194259421267384,1.0,5/14,12.88%,SOD1;GRIN3A;ADCY7;GRIN1;SDF4
prerank,metal ion export (GO:0070839),0.4924471036696183,1.3935538211879306,0.1038961038961039,0.6065289799100898,1.0,5/31,4.07%,ATP1A2;KCNA5;ATP1B3;KCNT2;KCND3
prerank,catecholamine biosynthetic process (GO:0042423),0.6145533121256201,1.3928195333944826,0.1384297520661157,0.6068671865965843,1.0,1/11,0.10%,MOXD1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.37527527869112376,1.3919300512146837,0.028023598820058997,0.6077694760545175,1.0,23/152,10.26%,RNF220;WLS;LRRK1;PTK7;LGR4;FGFR2;ZEB2;TBL1XR1;MACF1;LYPD6;SULF1;GPC3;LRRK2;FRAT1;PSME4;PSMA2;SALL1;PSMA3;WNT5B;USP34;PSMD8;AXIN2;SMURF2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.37727573579328866,-1.3909001871067304,0.026881720430107527,0.4255012098004503,1.0,34/73,33.97%,PTPRJ;IL33;THBS1;PLCG2;LBP;HSPB1;PTPRC;APP;STAT3;OAS2;ARHGEF2;CLU;IFNGR1;IFIH1;MIF;PSEN1;TIRAP;TYROBP;FRMD8;DDT;AGER;CCR2;SPHK2;TLR4;RASGRP1;LPL;FADD;C1QTNF4;DHX9;MAVS;NOD2;TLR1;IL1A;SYK
prerank,diol metabolic process (GO:0034311),-0.5058202913255878,-1.390737133982688,0.08731808731808732,0.4246821863294095,1.0,6/19,4.38%,NOS3;PLPP1;HSP90AA1;CALM1;DEGS2;GCH1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.43114263766901967,-1.3900707092119666,0.0625,0.42524794031791546,1.0,11/36,11.41%,CAV1;NOS3;NOSTRIN;HSP90AA1;CALM1;SCARB1;GCH1;DDAH1;DNM2;S100A1;CYGB
prerank,protein O-linked mannosylation (GO:0035269),0.5572356636929381,1.3884588254350536,0.11507936507936507,0.6167730904467439,1.0,4/18,4.37%,TMTC4;LARGE1;TMTC1;CRPPA
prerank,activation of protein kinase activity (GO:0032147),0.3898494729267037,1.3879150048684006,0.04409448818897638,0.6162613013453567,1.0,8/106,1.89%,IGF1;ADCY5;OSBPL8;ADCY1;NRK;IL18;ANGPT1;PDPK1
prerank,neural crest cell development (GO:0014032),-0.41566748617361104,-1.3875027137364224,0.051643192488262914,0.4308626821162583,1.0,13/44,11.39%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;CDH2;SEMA4D;TBX1;SEMA3E;CORO1C;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,cytoplasmic translational initiation (GO:0002183),-0.5248520024330311,-1.387099517090393,0.10462776659959759,0.43063890676435856,1.0,9/17,23.59%,EIF3I;EIF4G1;EIF3D;EIF4H;DHX29;EIF2D;EIF3A;EIF4B;EIF5
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.4967351764828861,1.386932649805821,0.08239700374531835,0.6173000744354544,1.0,12/30,13.00%,TGFBR3;DKK3;ITGA3;SMAD3;FOLR1;NREP;FSTL3;BCL9;LATS1;SMURF2;TFAP2B;FSTL1
prerank,regulation of cell migration (GO:0030334),-0.2978751226121835,-1.386745061480338,0.0,0.43032138051356644,1.0,100/382,12.41%,LEF1;FRMD5;NTRK3;SLIT2;PECAM1;LIMCH1;PODXL;CAV1;PTPRJ;TMSB4X;CLDN5;TMEFF2;ACTG1;SEMA6A;ACTN4;SEMA7A;PRR5L;ITGA6;TIAM1;CLIC4;SEMA6D;KDR;THBS1;ADAM10;RAC1;ACVRL1;CARMIL1;DACH1;JAG1;CDH1;PLXND1;SEMA3C;F3;PTK2;ITGB1;ADAM15;ADARB1;ROR2;SLK;ENG;PTK2B;NOTCH1;SERPINE2;RACK1;SEMA4D;DOCK10;MCTP1;TMSB10;MINK1;SEMA3E;PLXNA4;SRGAP1;FLNA;KANK1;CORO1C;BCAR1;SPATA13;RHOB;TGFB1;FAM107A;IGFBP5;FERMT2;ROBO4;GNA12;CEACAM1;PDGFC;MYOC;PDCD10;VEGFA;TJP1;ABI3;PAK1;CYRIB;NAV3;FGF7;SRCIN1;CPNE3;GRN;SEMA4B;RHOA;PODN;EDN1;APPL1;SEMA5B;SEMA6C;APC;XBP1;PIK3CD;HSPA5;STAT3;BMP2;GCNT2;YTHDF3;DUSP3;SEMA3G;TWIST2;GPER1;RIPOR1;CD74;CDH13
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.5421044217231908,1.386263652106874,0.1270718232044199,0.6172986874312877,1.0,7/21,13.12%,BMP6;DAB2;RBPMS;SLC2A10;JAK2;BMPR1A;VEPH1
prerank,cellular modified amino acid catabolic process (GO:0042219),0.5754721152771652,1.3847347219749981,0.13552361396303902,0.6200807583242711,1.0,6/15,18.18%,ALDH4A1;GGACT;HOGA1;PRODH;ABHD12;ABHD16A
prerank,histone H3-K36 demethylation (GO:0070544),0.6269002339067672,1.3846633834008917,0.14705882352941177,0.6181947421695239,1.0,4/10,7.94%,KDM7A;KDM2B;PHF8;KDM2A
prerank,regulation of histone methylation (GO:0031060),0.6084915141326518,1.3840756240154561,0.12962962962962962,0.6180049836780772,1.0,7/13,17.84%,AASS;JARID2;MTHFR;TET1;NSD1;CTR9;NNMT
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5928019122409032,1.3833112465068762,0.1268939393939394,0.6182536184979551,1.0,2/13,1.91%,ERRFI1;SNX6
prerank,positive regulation of dephosphorylation (GO:0035306),-0.4510010552727124,-1.3831861092560274,0.07883817427385892,0.4383565655209538,1.0,14/27,23.45%,CALM1;PPIA;PPP1R16B;TGFB1;BMP2;MTMR9;SYMPK;CALM2;PPP2R5A;PTBP1;PRKCD;CDCA2;NSMF;CALM3
prerank,ureteric bud development (GO:0001657),0.5652033684746228,1.382966984496555,0.12048192771084337,0.6171293066239802,1.0,5/17,6.81%,OSR1;FGFR2;BMP7;GPC3;SALL1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.5843681024389944,1.380927487433131,0.14979757085020243,0.6215310189804102,1.0,5/14,11.50%,IL18;ANXA1;PRKCZ;CCL19;MYB
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.34963294317931365,-1.380880826603937,0.03254437869822485,0.4433889578428075,1.0,44/107,24.25%,MAP3K5;THBS1;NIBAN1;DAB2IP;RASGRF2;CREB3L1;NCK1;TMEM117;HSP90B1;BAG6;GSK3B;ATP2A2;ATP2A3;JUN;TMX1;DERL1;ERP44;CCDC47;UBXN6;HSPA5;ATF4;SELENOK;ERO1A;HERPUD1;ERLEC1;BBC3;EIF2B5;BCAP31;CFTR;DNAJC10;WFS1;RNF5;DNAJB9;TNFRSF10B;ATF3;VCP;MBTPS1;BRSK2;CEBPB;TRIB3;BAX;PPP1R15A;THBS4;PPP1R15B
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.6022356475856592,-1.3807105292634083,0.09486166007905138,0.4425262741732979,1.0,2/10,6.20%,CAV1;KCNAB1
prerank,toll-like receptor signaling pathway (GO:0002224),-0.36236013920042986,-1.380673905867321,0.03439153439153439,0.44139596846083534,1.0,29/84,21.03%,PLCG2;LBP;SFTPA2;SFTPA1;UBB;LGMN;RFTN1;IKBKB;CTSB;HSP90B1;RPS27A;UBC;BIRC3;MAP3K1;S100A1;CHUK;HSPD1;IRAK3;PIK3C3;PIK3AP1;TAB3;NR1H4;CASP8;UBA52;UBE2D1;IRAK1;TIRAP;MYD88;CTSL
prerank,regulation of intracellular protein transport (GO:0033157),-0.44656991557447107,-1.3805129190215477,0.07860262008733625,0.4405749308578773,1.0,11/32,21.67%,PRR5L;PTPN14;TGFB1;PDCD10;OAZ1;PTPN1;RIPOR1;ATP13A2;BMP4;SIRT7;UHMK1
prerank,regulation of protein localization to membrane (GO:1905475),-0.46615344740861003,-1.3804485347849529,0.1,0.4395653918112617,1.0,11/28,12.06%,SPTBN1;ACTB;GSN;FYN;STX7;VTI1B;VAMP8;ZDHHC2;ZDHHC7;APPL1;GPC1
prerank,myelination (GO:0042552),-0.3996707016345692,-1.3802634385763648,0.053613053613053616,0.43882856297027195,1.0,21/46,19.12%,ADGRG6;ACER3;PLP1;MAL;MBP;MARVELD1;B4GALT5;TNFRSF21;CMTM8;SCN8A;MYOC;PLLP;ARHGEF10;GPC1;ABCD2;NF1;EIF2B5;TPPP;EIF2B2;B4GALT6;SOX10
prerank,regulation of macrophage migration (GO:1905521),-0.6096557289705178,-1.380125526779898,0.10805500982318271,0.4379719466335325,1.0,5/10,15.75%,MTUS1;CD200;PTK2B;CD81;CX3CR1
prerank,cation transport (GO:0006812),0.3683927674151946,1.3793786301498465,0.0323943661971831,0.6241479424404595,1.0,13/167,4.07%,TRPM3;SCN7A;ATP1A2;SLC22A4;SLC22A2;SLC8A3;SLC5A5;SLC6A9;KCNQ4;KCNA5;SLC41A1;SLC8A1;KCND3
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.5088883621346133,-1.37926954463195,0.10743801652892562,0.4391090351353469,1.0,9/18,13.76%,HEG1;RASIP1;CCDC125;KANK1;MET;CUL3;MYOC;KCTD13;STMN1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3634981931814551,1.378951352576185,0.026836158192090395,0.6233613246744015,1.0,27/199,6.78%,ALDH1A1;ROBO1;ROCK2;NPR3;LGR4;RBPJ;MCC;LRP4;ADAMTS5;NOVA1;SMAD6;DKK1;SLAMF8;ADM;CRHBP;SYT11;HOXA7;DUSP10;MAP2K6;NFIB;GJA1;TLE3;CHSY1;SFMBT1;NRDC;WWC1;WWC2
prerank,connective tissue development (GO:0061448),0.4683681461887997,1.378937699828082,0.10237659963436929,0.6213058262476849,1.0,6/35,5.24%,SOX5;ARID5B;SCX;SOX6;SH3PXD2B;SULF1
prerank,lysine catabolic process (GO:0006554),0.6002011741763269,1.3788089469581255,0.1440329218106996,0.6175666358312334,1.0,5/12,13.41%,AASS;ALDH7A1;GCDH;PIPOX;AADAT
prerank,lysine metabolic process (GO:0006553),0.6002011741763269,1.3788089469581255,0.1440329218106996,0.6175666358312334,1.0,5/12,13.41%,AASS;ALDH7A1;GCDH;PIPOX;AADAT
prerank,positive regulation of apoptotic process (GO:0043065),-0.303232904257261,-1.378730812138797,0.00392156862745098,0.4393528261197667,1.0,75/293,15.45%,UNC13B;SLIT2;MAP3K5;MCF2L;ITGA6;TIAM1;RASSF2;TRIO;TGFB2;FAP;ARHGEF3;ITGB1;KCNMA1;DAB2IP;NGF;RASGRF2;UBB;RPS3;RACK1;DNAJA1;CTSD;ARHGEF12;NET1;TNFSF10;PREX1;ATG7;SFRP4;TGM2;RPS6;ARHGEF17;TPD52L1;SOX4;ARHGEF6;RHOB;CTNNB1;SOD1;FAF1;ABR;RPS27A;UBC;APBB1;HIP1R;DNM2;JUN;FOXO1;ARHGEF19;GRN;PTGIS;DDX20;ARHGEF26;MAPK8;ING4;APC;ARHGEF5;TLE5;ATF4;BMP2;BIN1;GPER1;RYBP;REST;MYBBP1A;HSPD1;ARHGEF2;CLU;RNPS1;GADD45G;NLRP2B;IAPP;PLEKHN1;NF1;FAS;CYP1B1;CASP8;UBA52
prerank,epithelial cell morphogenesis (GO:0003382),0.5662795224397076,1.3786400298457533,0.13188976377952755,0.6160302905527816,1.0,1/17,0.01%,COL22A1
prerank,renal water homeostasis (GO:0003091),0.5111593805596887,1.3783461817825409,0.12,0.6149610423201756,1.0,2/23,0.71%,ADCY5;ADCY1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5392993755975987,-1.378125423691088,0.11090225563909774,0.4397887739608541,1.0,9/15,21.78%,ARPC1B;ARPC3;WHAMM;ACTR2;ARPC4;ARPC5L;ARPC1A;TRIM27;ACTR3
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.4243568109868128,-1.377969144947955,0.08210526315789474,0.43897875193759195,1.0,12/40,12.65%,RPL11;RPL23;PTK2;UBE3A;PTK2B;RPS7;PDCL3;GNA12;RPL5;FOXF2;UBQLN4;CLU
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.5094541250565853,1.3775503011041066,0.10693069306930693,0.6152859315283181,1.0,5/24,8.42%,RORA;CCBE1;SULF1;IL6;ARNT
prerank,heart process (GO:0003015),-0.5429552115755887,-1.377385425754459,0.08559498956158663,0.4392453328986553,1.0,3/14,6.09%,SGCD;FYN;SOD1
prerank,histone monoubiquitination (GO:0010390),0.5052064765040105,1.3772921905241113,0.11046511627906977,0.6140748608715679,1.0,11/24,17.61%,DDB2;RNF2;KDM2B;BCOR;CUL4B;CDC73;RNF20;PCGF1;CTR9;UBE2E1;DTX3L
prerank,epithelial to mesenchymal transition (GO:0001837),0.44338322919863427,1.3768931629140988,0.11327433628318584,0.6133655585788628,1.0,6/47,2.97%,TGFBR3;ROCK2;WNT4;RBPJ;BMP7;LOXL3
prerank,regulation of kinase activity (GO:0043549),0.404865201351309,1.3766315099295945,0.06584992343032159,0.6121185736196718,1.0,18/89,8.66%,EPHA7;EPHA3;FGFR2;FGFR4;KIT;LMO4;PDGFRB;SLAMF8;EPHA8;EPHA4;PDGFRA;DDR1;NPRL2;IGF1R;DDR2;RBL2;RYK;MUSK
prerank,cardiac ventricle morphogenesis (GO:0003208),0.45436190197453474,1.3750736488794069,0.09272727272727273,0.6150807423961939,1.0,6/41,2.80%,TGFBR3;RBPJ;FGFR2;TPM1;TNNC1;TNNT2
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6247453763757362,1.3744954690896531,0.13829787234042554,0.6148992388976007,1.0,3/10,7.52%,PLA2G10;ENPP2;LIPC
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.512703809615413,1.3740665199807487,0.11891891891891893,0.6142519072226088,1.0,5/26,5.20%,PRKAG2;LPGAT1;SLC45A3;ACADL;PRKAA2
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.3313890029787946,-1.3734685848529322,0.020710059171597635,0.4488472251389853,1.0,53/132,23.59%,RPL11;HSP90AA1;HSP90AB1;RPL6;RPS15;RPL38;RPSA;RPS19;RPL24;LUC7L2;RPS14;RPL23A;SRSF1;RPL3;RPL5;SF3B1;CPSF7;RPS27;KHDC4;DDX20;SRSF5;RPLP0;DDX39B;RPS28;SRSF9;CPSF6;CLNS1A;USP39;STRAP;XAB2;PRPF18;ERAL1;SNRPC;SRSF6;EIF4H;RPS27L;SRPK1;RSL24D1;RPS5;CLP1;DHX29;YTHDC1;NOP53;NLE1;EIF2D;EIF3A;EIF6;PWP2;PPAN;EIF4B;SNRPG;MRPS11;EIF5
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5404501446292732,1.3734429792451188,0.12903225806451613,0.614292449858293,1.0,2/19,1.05%,BMP6;AFDN
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.3852089945638982,1.3728587996388635,0.06924315619967794,0.6141297318913098,1.0,15/113,8.79%,IGF1;BMP6;TCF7L2;OSR1;FGFR2;NOTCH2;STXBP4;JAML;ECM1;FGF1;PTN;PDCD6;PRKCA;ARNT;VEGFB
prerank,transepithelial transport (GO:0070633),-0.5321842506109281,-1.3722666390110898,0.1089866156787763,0.45089304605273234,1.0,4/15,4.32%,ABCG2;SLC12A2;CXADR;SLC1A1
prerank,positive regulation of cell motility (GO:2000147),-0.3149979097645388,-1.372047217707309,0.009900990099009901,0.4502919110204746,1.0,63/205,15.23%,LEF1;NTRK3;PECAM1;PODXL;CAV1;SPOCK2;ACTG1;SEMA6A;ACTN4;SEMA7A;ITGA6;TIAM1;SEMA6D;KDR;THBS1;ADAM10;CARMIL1;CAVIN1;SEMA3C;F3;PTK2;ITGB1;ROR2;PTK2B;NOTCH1;RACK1;SEMA4D;SEMA3E;BCAR1;TGFB1;FAM107A;FERMT2;PDGFC;MYOC;PDCD10;VEGFA;TJP1;PAK1;CPNE3;GRN;SEMA4B;EDN1;SEMA5B;SEMA6C;APC;XBP1;PIK3CD;HSPA5;STAT3;BMP2;GCNT2;SEMA3G;TWIST2;GPER1;RIPOR1;CDH13;PPP3CA;CCN1;RET;COL1A1;NEDD9;CSF1R;CXCL12
prerank,membrane fusion (GO:0061025),-0.4389128698968367,-1.371910037009913,0.06981981981981981,0.44943418624387566,1.0,8/33,11.96%,DNM3;NSF;VTI1B;CHP1;DNM2;DYSF;NSFL1C;DNM1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.45526721675293946,1.3717289674516713,0.07939189189189189,0.6155666159659406,1.0,8/43,7.32%,IGF1;IL18;PDGFRB;CCN4;MMP2;GJA1;IL6;MMP9
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.517130725929354,-1.3715926046696008,0.11776859504132231,0.4490993890916175,1.0,9/17,19.98%,EMC10;BAG6;EMC7;EMC1;CAMLG;EMC3;EMC6;EMC9;GET4
prerank,positive regulation of protein binding (GO:0032092),-0.3862656799046359,-1.3708083056109652,0.0535279805352798,0.4500646428308532,1.0,16/56,13.03%,CAV1;CLDN5;B2M;EPB41;TIAM1;RPL11;PKD1;GSK3B;ADD2;HIP1R;APP;DERL1;RALB;BMP2;MEN1;IDE
prerank,protein K11-linked ubiquitination (GO:0070979),0.4939570176032163,1.370719648817764,0.10467289719626169,0.6168819414237472,1.0,10/27,19.94%,PRKN;UBE2E2;ANAPC13;UBE2L3;CDC26;UBE2A;UBE2H;ANAPC2;ANAPC5;CDC23
prerank,positive regulation of phospholipase activity (GO:0010518),0.51886617979103,1.3704557412974663,0.12098298676748583,0.6157474414312106,1.0,5/22,4.40%,FGFR2;KIT;PDPK1;PDGFRB;PDGFRA
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.5252515590133532,1.3700729552287367,0.1225296442687747,0.6149465463223471,1.0,3/22,5.73%,ALDH1A2;RBP1;LRP2
prerank,negative regulation of viral transcription (GO:0032897),-0.5658641282732992,-1.3700601951184603,0.11594202898550725,0.4509737559818013,1.0,7/13,20.74%,TRIM14;LARP7;TRIM13;MID2;TRIM27;IFITM3;UBP1
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.5088026531017087,-1.368864260022381,0.09939148073022312,0.45296602166540273,1.0,13/19,33.16%,CHMP5;CHMP2B;HNRNPU;CHMP1B;CHMP1A;CHMP3;HSPA1B;PDCD6IP;CHMP4C;DRG1;VPS4B;PLK1;HSPA1A
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5203766202879367,-1.3687858948273277,0.09533073929961089,0.45200231331607027,1.0,2/16,2.52%,CLDN5;CLDN11
prerank,neuron development (GO:0048666),-0.333014995888855,-1.3686215620092068,0.0125,0.45121916022546465,1.0,23/141,7.71%,FRY;MEF2C;PTPRM;PBX3;TGFB2;RUNX1;STX3;PLP1;MAP4;TENM2;VSX1;B4GALT5;BLOC1S2;EHD1;GSK3B;RP1;ETV1;GPM6B;ATP8A2;TENM4;STMN2;APP;MYOC
prerank,regulation of protein metabolic process (GO:0051246),-0.4054806400745425,-1.3685810649987782,0.06807511737089202,0.4501673710897315,1.0,14/44,10.91%,LTBP4;KLF2;HSP90AB1;KLF4;NEDD4L;FAF1;NEDD8;APP;CHEK2;ZDHHC2;SSH1;MAPK8;FURIN;HGS
prerank,negative regulation of cell motility (GO:2000146),-0.3440527120142795,-1.3681220893392427,0.03170028818443804,0.45025974960978815,1.0,20/108,5.70%,FRMD5;SLIT2;LIMCH1;PTPRJ;CLDN5;TMEFF2;CLIC4;ACVRL1;DACH1;JAG1;CDH1;ADAM15;ADARB1;ENG;MCTP1;CCDC125;SRGAP1;KANK1;RHOB;IGFBP5
prerank,fat cell differentiation (GO:0045444),0.4374452900421778,1.3677076531006938,0.08260105448154657,0.6206552419039769,1.0,11/57,11.08%,TCF7L2;OSBPL8;C1QTNF3;PID1;SMAD6;CBY1;WNT5B;TMEM120B;MED1;BBS7;TFAP2B
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.4813722525759371,-1.367675926779657,0.07462686567164178,0.4502425061021186,1.0,11/23,19.57%,ELOVL7;FAR2;ELOVL5;ACSL4;FAR1;ELOVL6;DGAT1;ELOVL1;ACSL3;TECR;ACSL5
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.5906670192113394,1.3675912866940896,0.14867617107942974,0.6190842737165156,1.0,4/12,15.86%,ROCK2;PICALM;RANBP9;FLOT2
prerank,bile acid and bile salt transport (GO:0015721),-0.4672176881595028,-1.3674920691987162,0.08531746031746032,0.4495458058932314,1.0,5/24,6.94%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;CEACAM1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.5274409942035533,1.3673743883185507,0.12473572938689217,0.6178465082798303,1.0,2/21,3.31%,IGF1;CTSH
prerank,negative regulation of mRNA processing (GO:0050686),-0.5392970883318361,-1.3671122996415148,0.1157684630738523,0.4493750286982742,1.0,7/15,28.92%,SRSF9;RNPS1;SRSF6;PCBP4;PTBP1;BARD1;SRSF7
prerank,negative regulation of ossification (GO:0030279),0.5282051739947045,1.3665925085312485,0.10934393638170974,0.61830155666345,1.0,7/23,6.35%,RBPJ;LRP4;SMAD6;DKK1;ECM1;CHSY1;BCOR
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5799027589769961,-1.3663106871580375,0.11355311355311355,0.45041664552053834,1.0,4/11,9.37%,TGFB2;JAG1;SOX4;HEY2
prerank,cation transmembrane transport (GO:0098655),0.4578383859425732,1.3650295769299892,0.0812720848056537,0.6214594593728793,1.0,3/44,1.60%,TRPM3;ATP1A2;SLC6A9
prerank,regulation of macrophage activation (GO:0043030),0.48244145237381975,1.3643031268681427,0.11877394636015326,0.6218554627745339,1.0,5/30,6.76%,IL31RA;PLA2G10;SPHK1;MYO18A;IL6
prerank,anterior/posterior axis specification (GO:0009948),0.5469956658911647,1.3642117136837404,0.13690476190476192,0.620226735069071,1.0,1/15,0.46%,WLS
prerank,regulation of keratinocyte proliferation (GO:0010837),0.518861607806792,1.3641631028099526,0.134765625,0.618432180086421,1.0,3/22,1.27%,FGFR2;NOTCH2;STXBP4
prerank,stress-activated MAPK cascade (GO:0051403),-0.384297441439827,-1.3640559817487699,0.05813953488372093,0.45511864838867383,1.0,22/61,23.57%,MAP3K5;UBB;NOD1;MINK1;IKBKB;ARHGEF6;RPS27A;UBC;MAPK8;ZFP36L1;CHUK;MAP2K7;MAP3K12;CUL1;MAP3K8;TAB3;UBA52;IRAK1;SKP1;MAPK3;MAPK11;MAPK10
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5225207526996758,-1.3635944600833052,0.10204081632653061,0.4552112073163015,1.0,9/16,21.67%,ESR1;RBFOX2;DDX5;DDX54;EGLN2;NCOA4;DDX17;PADI2;ESR2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.4138955960870189,1.363493905085498,0.07269789983844911,0.6186362217827174,1.0,16/72,14.50%,FGFR2;FGFR4;FGFBP1;POLR2D;FLRT2;KL;FGF1;HNRNPH1;FRS2;POLR2A;GTF2F1;FGF9;CEP57;MAPK1;FIBP;FGF20
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.4995507688280637,-1.3630322229160565,0.12474437627811862,0.4555181402570168,1.0,7/19,16.67%,BAG6;DDIT4;BCL3;MSH2;AEN;RPS27L;USP28
prerank,diol biosynthetic process (GO:0034312),-0.5257908389024708,-1.362856610977959,0.11545988258317025,0.4548099070101739,1.0,4/15,4.38%,ACER3;ACER2;SPTLC2;GCH1
prerank,striated muscle tissue development (GO:0014706),-0.4464639998338633,-1.362562575317951,0.09699769053117784,0.45445773022125,1.0,9/29,6.87%,MEF2C;PGM5;CAV1;SGCD;BMP5;MYL6;BMPR2;TBX2;SIX1
prerank,T cell mediated immunity (GO:0002456),-0.5519531456084688,-1.3624145646879513,0.11089866156787763,0.4536233733231276,1.0,4/13,8.12%,CADM1;JAG1;CD55;EMP2
prerank,proteoglycan biosynthetic process (GO:0030166),0.4822991189348068,1.3623144685495745,0.10986964618249534,0.620631706455572,1.0,4/31,3.75%,IGF1;PXYLP1;HS3ST3B1;GAL3ST3
prerank,pore complex assembly (GO:0046931),0.5510128378356015,1.362136696212163,0.142570281124498,0.6193116729570393,1.0,5/19,10.15%,PLEKHA7;AFDN;NDC1;GSDMD;NUP107
prerank,sphingoid biosynthetic process (GO:0046520),-0.5770987446618815,-1.360993193408622,0.11877394636015326,0.4551718745804363,1.0,3/11,1.86%,ACER3;ACER2;SPTLC2
prerank,sphingosine biosynthetic process (GO:0046512),-0.5770987446618815,-1.360993193408622,0.11877394636015326,0.4551718745804363,1.0,3/11,1.86%,ACER3;ACER2;SPTLC2
prerank,sodium-independent organic anion transport (GO:0043252),-0.5965554070292552,-1.360259603516554,0.13257575757575757,0.45580008862403437,1.0,6/10,18.03%,SLCO1C1;SLCO2A1;SLCO2B1;SLCO3A1;SLC16A2;SLCO4A1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4119729406588715,1.3597394402927627,0.07484076433121019,0.6247349989290198,1.0,9/66,5.51%,ROBO1;SASH1;IL34;KIT;DKK1;PDGFRB;PDGFD;LRRK2;FGF1
prerank,oligodendrocyte development (GO:0014003),-0.5083560283066264,-1.3592581152551968,0.1075050709939148,0.45730904827399926,1.0,7/15,19.12%,PLP1;B4GALT5;EIF2B5;TPPP;EIF2B2;B4GALT6;SOX10
prerank,receptor-mediated endocytosis (GO:0006898),-0.33154340793694403,-1.3582927571113852,0.020958083832335328,0.45866525462449104,1.0,37/132,15.68%,DNM3;CAV1;SGIP1;TFRC;FNBP1L;HSP90AA1;CD9;SCARB1;ITGB1;RAMP2;ARHGAP27;CAV2;RAB31;ACKR3;SCARF1;AP2A2;STAB1;CALR;HSP90B1;PDLIM7;HIP1R;DNM2;RAMP1;AP2M1;LMBR1L;LRP3;DNM1;CANX;ADRB2;CD81;MRC1;CALCRL;PIP5K1C;SPARC;PI4KB;M6PR;TMEM108
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.418344822609678,-1.3581447067172925,0.07600950118764846,0.4578896692150745,1.0,13/39,19.49%,EFR3B;SOCS2;SOCS5;PIK3C2B;TTC7A;PIK3CD;PIK3C2A;PIK3C3;ITPKB;PI4KB;CISH;PIK3R3;PIP4K2A
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.3876099486627476,-1.3580755892379923,0.06766917293233082,0.45690012859049706,1.0,11/56,6.64%,PLCG2;LBP;SFTPA2;SFTPA1;UBB;NOD1;LGMN;CTSB;HSP90B1;RPS27A;UBC
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.528709120388363,-1.3578951520528446,0.1252408477842004,0.45622890743318656,1.0,7/14,26.33%,THBS1;ITGA4;PDCD4;GPER1;CD40;RGCC;CCL2
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.42212033073908833,1.3566434703495427,0.09215017064846416,0.6325284879362864,1.0,15/63,13.14%,IGF1;TCF7L2;WWOX;DEPTOR;SP100;SH3RF1;NOL3;SIAH2;BIRC6;FEM1B;PHIP;CYLD;CFLAR;AR;BCL2L12
prerank,keratan sulfate catabolic process (GO:0042340),0.616849553221172,1.3565354292795904,0.1368421052631579,0.6309513172491995,1.0,4/11,5.37%,FMOD;OGN;OMD;PRELP
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.4454177673091616,-1.3564925663070102,0.06932773109243698,0.4588748927457804,1.0,12/30,20.09%,RPL11;HSP90AB1;UCHL5;UBXN1;BAG6;OGT;CAMLG;RYBP;SVIP;N4BP1;TLK2;NOP53
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5171401956118525,1.3559877927946395,0.1154562383612663,0.630774816762749,1.0,4/23,6.25%,IGF1;EFNB2;NIBAN2;MAML1
prerank,monosaccharide transmembrane transport (GO:0015749),0.5510726929314116,1.3558458701220777,0.15789473684210525,0.6292914922897721,1.0,3/16,6.09%,SLC2A12;SLC45A3;SLC2A10
prerank,negative regulation of signal transduction (GO:0009968),0.34826507469974455,1.3557249876105593,0.03314917127071823,0.6277709219075666,1.0,48/249,11.42%,CYP26B1;ADAMTS12;LEPROT;TRABD2B;LGR4;RNF43;PID1;WWOX;TULP3;DKK3;BCL2;DKK1;LTF;MGRN1;NEDD4;CRHBP;GRB10;VGLL4;CBY1;CACTIN;SULF1;GPC3;LRRK2;PRKCZ;APCDD1;GLI3;PRKCB;SLC2A10;NIBAN2;SUFU;PDCD6;KANK2;NTN1;HERC4;PTEN;SIAH2;WWP2;TLE1;FSTL3;YTHDF2;RPGRIP1L;PTGIR;WIF1;TNS2;RPS6KB1;APLN;IFT122;ERBB2
prerank,lipid translocation (GO:0034204),-0.48065640455095704,-1.3555553160420808,0.11368421052631579,0.46029432577357593,1.0,8/21,12.13%,ATP10A;ATP8B1;ATP8A1;ATP8A2;ATP11C;ATP11B;TMEM30A;ATP11A
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.3817843532714746,-1.3554001838095782,0.06711409395973154,0.45954119872928706,1.0,22/57,22.24%,MAP3K5;FYN;CTSD;TNFSF10;NOD1;LGMN;PERP;AIM2;SOX7;GRIN1;NDUFA13;USP50;GPER1;REST;TBC1D10A;BCAP31;CASP8;FOXL2;CYFIP2;ACVR1C;CYCS;CASP1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.5732425368944072,-1.355309210500087,0.10474308300395258,0.4586213939680984,1.0,3/11,11.81%,CAV1;NEDD4L;BIN1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.34560025024903046,-1.3551217296756553,0.043731778425655975,0.4579793458121457,1.0,46/107,21.38%,CAV1;SLC39A10;TPT1;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;ATP1B1;SLC10A7;SLC30A5;CALR;ATP2C1;MT2A;ATP2A2;ATP2A3;SLC39A8;RYR2;HTR2A;SLC24A2;ATP13A4;EDN1;SLC30A1;SLC39A7;STIM2;RMDN3;STOML2;ATP2B1;SLC39A14;ATP13A5;MT3;SLC24A5;CXCL12;ATP13A2;CD40;CCL13;NPTN;TMEM165;ATP2B2;ATP2B4;SLC39A6;SLC11A1;TMEM203
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.4756728643402793,-1.3549854836368962,0.10728744939271255,0.45722372429547603,1.0,5/22,7.64%,NTRK3;RAP1A;NGF;EHD1;STMN2
prerank,positive regulation of histone acetylation (GO:0035066),-0.46708678553555505,-1.3549495158181366,0.09853249475890985,0.45618896968140876,1.0,7/23,11.15%,RPS6KA5;PPARGC1A;ARRB1;WBP2;GLYR1;NOS1;PIH1D1
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.4897374653846431,-1.3543869971313227,0.12424849699398798,0.45652603736933456,1.0,3/18,3.28%,MTUS1;SLIT2;PTK2B
prerank,positive regulation of hemostasis (GO:1900048),-0.5907888522446189,-1.3543602446524805,0.11132075471698114,0.45436243386090636,1.0,2/10,1.81%,ST3GAL4;THBS1
prerank,positive regulation of coagulation (GO:0050820),-0.5907888522446189,-1.3543602446524805,0.11132075471698114,0.45436243386090636,1.0,2/10,1.81%,ST3GAL4;THBS1
prerank,T-helper cell differentiation (GO:0042093),-0.5433631084321344,-1.3528391431102944,0.12007874015748031,0.4573954635867146,1.0,2/14,0.81%,LEF1;FOXP1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.39187673730369504,1.3509759331124271,0.0763239875389408,0.6405436214642587,1.0,26/95,12.62%,HS3ST3A1;CEMIP;PXYLP1;ANGPT1;ST3GAL3;FMOD;UST;SDC2;HS3ST3B1;OGN;GPC6;OMD;B4GALT1;PRELP;GPC3;CHSY1;CHST3;HAS1;XYLT2;B3GALT6;NDST2;CHST15;HS6ST1;UGDH;B4GALT2;GPC4
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.5057614828797877,1.3508195982125255,0.11776061776061776,0.6392279925959429,1.0,1/25,0.03%,IGF1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.515892485204804,-1.350682153617517,0.10633946830265849,0.4620133886942552,1.0,9/16,24.17%,TRIB2;TNFRSF21;CD274;JAK3;TYROBP;DLL1;FCGR2B;AGER;VSIR
prerank,regulation of steroid metabolic process (GO:0019218),0.5176153932187616,1.3494784342358697,0.1232876712328767,0.6416489667395942,1.0,3/23,6.13%,RORA;ACADL;EPHX2
prerank,organic hydroxy compound transport (GO:0015850),-0.4220664119444948,-1.349346194012983,0.0684326710816777,0.46429683903996677,1.0,7/36,6.94%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;SLC16A1;STRA6;CEACAM1
prerank,cyclooxygenase pathway (GO:0019371),-0.5865202448990168,-1.3492256006004018,0.11695906432748537,0.46348875744929563,1.0,5/10,29.95%,PTGIS;PTGS2;PTGDS;HPGDS;CBR1
prerank,glucose homeostasis (GO:0042593),0.39556644700964927,1.3489070927983204,0.06923076923076923,0.6415994648307439,1.0,12/83,7.95%,LEPR;TCF7L2;APPL2;FGFR4;RBP4;HK2;PRKAA2;IGF1R;IL6;PRKAA1;MCU;SLC30A8
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.6079057039283349,1.3484822472100952,0.17540322580645162,0.6409668321256561,1.0,3/10,8.46%,IGF2;PCGF5;PRMT7
prerank,regulation of ERAD pathway (GO:1904292),-0.574043171717515,-1.3484161515565727,0.12115384615384615,0.46452017140312063,1.0,5/11,13.06%,ATXN3;UBXN1;BAG6;AQP11;HERPUD1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.45046623137550446,1.3479273799045415,0.12072072072072072,0.6408395910293786,1.0,7/40,6.43%,ARHGAP6;KIT;LPAR1;PDGFRB;PDGFRA;LPAR2;GNAQ
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.3615912734186036,-1.3474883406795022,0.051630434782608696,0.46590464566690526,1.0,28/72,16.12%,ARHGEF28;HEG1;RAC1;ARHGEF3;PRAG1;F11R;RASIP1;NET1;ARHGDIB;CCDC125;GPR4;EPS8L2;KANK1;ARHGDIA;ARRB1;MET;BCR;CUL3;MYOC;PDCD10;EPS8;KCTD13;LPAR6;ARHGEF2;STMN1;COL3A1;ADGRG1;RAF1
prerank,cardiac cell development (GO:0055006),-0.579767802543053,-1.3474040332746329,0.146,0.4650390106836651,1.0,5/11,7.87%,JAG1;NOTCH1;CXADR;MYH11;VEGFA
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.5870721459104278,-1.3471373816233094,0.11764705882352941,0.4646202996960399,1.0,5/10,23.86%,CD55;TGFBR2;CD81;NCKAP1L;SOCS1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.3368030070062362,-1.3470055439384023,0.04843304843304843,0.46384274075881726,1.0,30/113,12.87%,UNC13B;FNIP2;ESR1;TFRC;HSP90AA1;RASIP1;DAB2IP;RPS3;RACK1;SH3GLB1;WARS1;TGFB1;FERMT2;MPP7;FAF1;GSK3B;PIEZO1;VEGFA;SPIDR;DDB1;RBX1;EIF4G1;ISG15;GBP5;PIH1D1;USP50;RPA1;TAL1;CLU;PSMC3
prerank,cognition (GO:0050890),-0.40873736001268923,-1.3454554304272266,0.08,0.4668623739421582,1.0,12/42,15.99%,ST3GAL4;SHROOM4;MAGT1;STRA6;CHMP2B;FAM107A;APP;MFSD2A;SLC1A4;DGCR2;NF1;PTCHD1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.41117057958229236,-1.3454455791766702,0.09601873536299765,0.46577495014842546,1.0,9/37,8.54%,CAV1;RPS7;UBB;RPS3;RACK1;NCK1;SOD1;BCL2L1;SFPQ
prerank,regulation of fatty acid metabolic process (GO:0019217),0.547265608745355,1.3445385009090727,0.15730337078651685,0.6495219180519035,1.0,3/17,5.20%,PRKAG2;PPARA;PRKAA2
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.42273977473458013,-1.3442117206287822,0.08296943231441048,0.46793592829208275,1.0,14/36,20.09%,RPL11;HSP90AB1;UCHL5;UBXN1;BAG6;AQP11;PSMF1;OGT;CAMLG;RYBP;N4BP1;PRKCG;TLK2;NOP53
prerank,amino sugar metabolic process (GO:0006040),-0.5885210783520596,-1.3438767748247893,0.11507936507936507,0.46776335372881805,1.0,2/10,0.56%,CSGALNACT1;ST6GAL1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3635960884915079,1.3425434263292308,0.05674846625766871,0.6541450252591279,1.0,28/138,14.18%,RORA;RBPJ;PPARA;NOTCH2;POLR2D;ESRRG;CCN2;NR1I2;TBL1XR1;CDK7;MAML3;TEAD1;MAML1;NR6A1;NRBP1;POLR2A;TEAD3;GTF2F1;MED1;TAF8;HDAC1;RXRA;TAF3;AR;MAML2;NR1I3;CREBBP;MNAT1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.5081182572456483,-1.3418148863273176,0.12424849699398798,0.4722375834976626,1.0,13/16,34.29%,SRSF1;SFPQ;DDX5;SRSF9;SRSF6;DDX17;RBM17;HNRNPM;PUF60;SCNM1;CELF4;DHX9;PQBP1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6040719605628556,1.3412694341881115,0.1774193548387097,0.656400310659943,1.0,2/10,3.19%,OXSR1;CXCL13
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5891125103860657,1.3410553238044474,0.18340611353711792,0.6551824888632796,1.0,3/12,2.26%,WNK4;DMD;ATP1B3
prerank,histone modification (GO:0016570),0.3767060082871213,1.3409103094599772,0.061128526645768025,0.6537167119530048,1.0,14/109,10.71%,EYA4;EYA1;EYA2;BRD8;PRDM5;TBL1XR1;MIDEAS;BAZ1B;UFL1;PRMT7;KAT8;KAT6B;NSD1;HDAC1
prerank,regulation of cartilage development (GO:0061035),0.5377248418652499,1.3405347987834888,0.142570281124498,0.6530643498330122,1.0,3/18,2.75%,SOX5;SCX;SOX6
prerank,fatty acid beta-oxidation (GO:0006635),0.43534914514338174,1.340312737258929,0.10053859964093358,0.6518328026254638,1.0,16/51,14.16%,IVD;EHHADH;ACADL;ECI2;HSD17B10;CPT2;ACAD11;ECHDC1;ACADS;ACAA2;GCDH;ACAT2;AUH;AMACR;ACOX1;BDH2
prerank,visual perception (GO:0007601),0.3958758099565406,1.3402145479405358,0.08482871125611746,0.6502747235208391,1.0,18/84,16.67%,EYA4;ADGRV1;EFEMP1;ZIC2;CRYGS;TULP1;COL18A1;GPR143;EML2;DHRS3;IMPG2;CRYZ;MYO9A;RGS16;TULP2;KIFC3;CHRNB2;DNAJC19
prerank,Rac protein signal transduction (GO:0016601),-0.5011043823449529,-1.3402012850052958,0.109979633401222,0.47549063154257076,1.0,8/18,15.95%,ELMO1;TIAM1;RAC1;NCKAP1;EPS8;DBNL;CDH13;RHOG
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.41607287262626386,-1.3400185297976241,0.097799511002445,0.4748961541245758,1.0,12/38,15.46%,NOS3;THBS1;BMP5;TNFSF10;BCL2L1;GSK3B;TMBIM1;ARHGEF2;RNF34;FAS;CASP8;MADD
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.5569842109608377,-1.3395175257543745,0.15700934579439252,0.4751023816444537,1.0,2/11,2.22%,RUNX1;CBFB
prerank,camera-type eye development (GO:0043010),0.49561029123586237,1.339452381417972,0.128060263653484,0.6509894703163549,1.0,4/25,2.90%,EFEMP1;FBN1;FBN2;SHROOM2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.5870885324858122,1.3386616414752408,0.16115702479338842,0.6515264678090806,1.0,8/12,19.43%,SZT2;EPHA4;NFIB;PAFAH1B1;MYCBP2;GLI2;CHRNB2;EPHB2
prerank,positive regulation of angiogenesis (GO:0045766),-0.33490069382580834,-1.338576878815931,0.045584045584045586,0.4764568279516013,1.0,30/108,10.16%,GAB1;TEK;NOS3;BMPER;TIE1;CD34;KDR;THBS1;RUNX1;F3;KLF4;ITGB1;ETS1;ITGB8;RAMP2;PKM;PIK3R6;HSPB1;ITGA5;GATA2;RHOB;PDCL3;EMC10;VEGFA;TJP1;GRN;PTGIS;S100A1;XBP1;PIK3CD
prerank,regulation of mitotic spindle organization (GO:0060236),-0.42328681256733225,-1.3385763514497029,0.08552631578947369,0.4753331090177532,1.0,18/35,33.85%,CHMP5;CHMP2B;GNAI1;HNRNPU;CHMP1B;CHMP1A;NUMA1;DCTN1;CHMP3;HSPA1B;PDCD6IP;CHMP4C;DRG1;VPS4B;PLK1;DYNC1H1;HSPA1A;PSRC1
prerank,cardiac conduction system development (GO:0003161),0.4931054280197351,1.337911948798755,0.13595706618962433,0.6518949966474016,1.0,4/24,6.25%,GJB6;NOTCH2;GJA1;MAML1
prerank,response to acidic pH (GO:0010447),-0.5389995261840457,-1.3378372154229317,0.1267056530214425,0.47635271830616666,1.0,4/13,13.52%,GPR4;LGMN;CHP1;RAB11FIP5
prerank,regulation of actin filament bundle assembly (GO:0032231),0.49248315744055826,1.336333021801893,0.13320463320463322,0.6549619642736573,1.0,5/26,6.35%,ROCK2;PRKN;FHOD1;ALMS1;ASAP3
prerank,regulation of MAPK cascade (GO:0043408),0.35966356567544244,1.335977657191533,0.05459770114942529,0.654182880248169,1.0,18/157,6.76%,IGF1;EPHA7;TGFBR3;ROCK2;KSR1;FGFR2;NRK;KIT;PELI2;LPAR1;TRIM5;IGF2;EPHA8;GFRAL;IGF1R;WWC1;ADRA1D;IL6
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5426348202535234,1.3358173201840549,0.13692946058091288,0.6528394112455885,1.0,4/17,7.35%,SNTA1;NOS1AP;ANK2;CACNA2D1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.4531044964784718,-1.3357928222694284,0.11063829787234042,0.48054220914793067,1.0,13/26,25.12%,NOS3;ACER3;ACER2;SPTLC2;GCH1;NOS1;CYP1B1;CYB5R3;ABCA2;AKT1;DDAH2;SPTLC1;SPHK2
prerank,cellular response to ketone (GO:1901655),0.4621079272071723,1.3352329879696603,0.10265486725663717,0.6528168013368837,1.0,3/35,0.71%,ROCK2;ADCY5;ADCY1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3063736518678517,1.3350230796473064,0.0010822510822510823,0.6516554800198863,1.0,173/1082,13.20%,IL31RA;IGF1;GLIS3;CREB5;RORA;BMP6;TCF4;TCF7L2;OSR1;AUTS2;WNT4;ARNT2;RBPJ;ZIC1;ZNF462;FGFR2;EPAS1;HLF;PPARA;NR2F2;PID1;NPAS3;IL18;HOXC4;CDK8;BMP7;PRKN;WWOX;BRD8;ZEB2;KMT2A;MEIS1;DAB2;HOXB4;ESRRG;FHOD1;CSRP3;ZIC2;MYBL1;DMRT1;SCX;NR1I2;ASCL2;TBL1XR1;CITED4;PLCB1;SP100;PPARGC1B;HOXB3;RNASEL;NFYB;CDK7;IGF2;TP53INP2;SSBP2;TFR2;NCOA2;STAT5B;MAML3;NFAT5;MYRFL;ZFP90;HDAC8;HOXA7;NFIB;TEAD1;ELF4;ARID1B;FIZ1;SOX1;NDP;WASL;DPF2;IRF8;FGF1;MSANTD1;GLI3;TET1;ZMIZ1;NIBAN2;MAML1;PHF8;ARHGEF11;IL6;SALL1;NCOA3;RFXAP;SMAD3;SSBP3;BLM;PBX4;NCOA7;NEK4;GABPB1;GABPB2;RGMB;MTF2;TRIM56;TCF12;ABRA;CCNT2;LYAR;RPRD1B;RSF1;CCNT1;NFIA;PCGF5;ARNT;GTF2F1;FSTL3;KAT8;BRCA2;MITF;KDM6B;KAT6B;CEBPG;RASL11A;MAP3K2;PICALM;IER5;CREB3L2;NSD1;IRF3;BCL9;MED1;AKAP8L;DVL3;AGO2;PHIP;ASXL2;ABL1;MED13;PRKDC;PARP9;SMARCA5;ATOH8;HDAC1;PIK3R1;FLCN;TFAP2A;TFAP2B;TRIM45;RXRA;ERBB2;ZBTB38;MYB;NPAS2;BMPR1A;KMT2B;BCLAF3;RNF14;ICE2;HSF1;RNF20;PRKD2;PKD2;AR;HIVEP1;SERPINE1;KLF5;CRTC1;MAML2;CRTC3;GDNF;ZMIZ2;INO80;SMARCB1;FZD2;HOXD4;TBK1;BCL2L12;NR1I3;FOXK2
prerank,response to interleukin-4 (GO:0070670),-0.5802189953263821,-1.3348713227435232,0.1350844277673546,0.4818686167158842,1.0,4/10,19.40%,LEF1;XBP1;TCF7;JAK3
prerank,genitalia development (GO:0048806),-0.5491394769624918,-1.3344707922076835,0.13618677042801555,0.4818264246767794,1.0,4/12,11.20%,PKD1;STRA6;TBX3;FOXF2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.575464782690182,1.3341290812329478,0.16210526315789472,0.6526881251174793,1.0,5/13,13.00%,FBN1;FBN2;NBL1;CHRDL1;FSTL1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6065224986504121,1.3340933930097123,0.1746031746031746,0.6509510016746135,1.0,2/10,5.49%,IL18;PRKCZ
prerank,melanocyte differentiation (GO:0030318),0.604553479025827,1.3338314173720118,0.16204690831556504,0.6499486664438887,1.0,2/11,1.24%,LRMDA;KIT
prerank,positive regulation of leukocyte activation (GO:0002696),-0.4931411768062937,-1.3330521853327375,0.13934426229508196,0.48461203457568824,1.0,10/18,33.75%,IL33;THBS1;LBP;HSPD1;CEBPA;CRLF2;KARS1;TLR4;TLR6;TSLP
prerank,regulation of adaptive immune response (GO:0002819),-0.4952077803265673,-1.3330172282792168,0.15145228215767634,0.48359133701866486,1.0,10/18,35.65%,AHR;ADCY7;SAMSN1;TRIM27;FCGR2B;SKAP1;FADD;IL4I1;SASH3;IL6ST
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.548456303097882,-1.332811929395565,0.13193116634799235,0.48306687585801084,1.0,10/12,42.67%,CRYAB;CLU;IAPP;PFDN6;PFDN5;PFDN4;TREM2;VBP1;LDLR;PFDN1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.45467213976305204,1.332768594827941,0.11565836298932385,0.6513578358338082,1.0,7/37,7.00%,ALCAM;ADGRL1;JAML;FAT4;IL1RAPL1;AMIGO3;PTPRD
prerank,neutrophil activation (GO:0042119),-0.5456870304878869,-1.3326762615819006,0.12350597609561753,0.48240031493742347,1.0,5/12,20.19%,PREX1;KMT2E;IL15;TYROBP;PRKCD
prerank,cardiac muscle cell action potential (GO:0086001),0.47309118880596196,1.3322699604174648,0.1323529411764706,0.6510834807719138,1.0,7/30,7.35%,ATP1A2;DMD;SLC8A1;ANK2;KCND3;CACNA1D;CACNA2D1
prerank,cholesterol homeostasis (GO:0042632),0.4225665466028515,1.3320448769546256,0.09705372616984402,0.6499338032081664,1.0,10/64,8.39%,RORA;FGFR4;IL18;PLA2G10;PCSK9;ABCA1;EPHX2;LIMA1;LIPC;ABCA5
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.47845475725193365,-1.331782113235921,0.1108695652173913,0.48382249658938953,1.0,11/21,27.61%,STMN2;NAV3;APC;ARHGEF2;APC2;TTBK2;CLASP2;SPEF1;CAMSAP3;CAMSAP1;FGF13
prerank,epithelial cell-cell adhesion (GO:0090136),0.5951299266904972,1.3317285994828305,0.16600790513833993,0.6490952920964261,1.0,2/11,1.24%,PLEKHA7;KIT
prerank,positive regulation of B cell proliferation (GO:0030890),-0.4482246725103231,-1.3316396225415081,0.1016597510373444,0.4831238698286188,1.0,11/29,20.80%,MEF2C;TFRC;NFATC2;CD38;PTPRC;CD74;CD81;MIF;CD40;TIRAP;NCKAP1L
prerank,cellular response to lipid (GO:0071396),0.3487779634539463,1.3313546476647957,0.04827586206896552,0.64846072844042,1.0,19/191,7.27%,RORA;ATP1A2;ROCK2;ADCY5;PTK7;ADCY1;TFPI;EPHA3;WNT6;PID1;CXCL13;CRHBP;CACTIN;SSTR2;IL6;NCOA3;PDCD1LG2;UBE2L3;WNT5B
prerank,sterol homeostasis (GO:0055092),0.41983260505863296,1.330457829115545,0.09671848013816926,0.6496235216356548,1.0,10/65,8.39%,RORA;FGFR4;IL18;PLA2G10;PCSK9;ABCA1;EPHX2;LIMA1;LIPC;ABCA5
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.4884939275786011,1.3294168342238095,0.14734774066797643,0.6509855787559995,1.0,5/24,10.80%,LEPR;PID1;COQ10A;GFPT2;ADRB3
prerank,embryonic digit morphogenesis (GO:0042733),0.5382445576039216,1.329415795154705,0.1541501976284585,0.6492020566224215,1.0,6/18,10.71%,OSR1;INTU;GLI3;SALL1;WDPCP;HDAC1
prerank,positive regulation of phosphorylation (GO:0042327),0.3417699905224327,1.3292691210610332,0.03382949932341001,0.6479112649213844,1.0,44/240,11.69%,IGF1;EPHA7;LEPR;ROCK2;IL34;EPHA3;FGFR2;FGFR4;KIT;ANGPT1;PELI2;DAB2;LMO4;FNIP1;ZBTB20;PDGFRB;IGF2;EPHA8;EPHA4;FAM20A;PDGFRA;DDR1;PRKAA2;IGF1R;LRRK2;FGF1;MMP9;DDR2;PRKAA1;ATG14;RYK;ARNT;MUSK;VEGFB;AXIN2;DVL3;AXL;ABL1;FGF9;FLCN;EPHA2;FXR1;ERBB2;RAP2A
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.5248485086536334,-1.3289597198082503,0.15120967741935484,0.4892564335350508,1.0,9/14,31.43%,RCC1L;UQCC2;RPUSD4;FASTKD3;TRUB2;TRMT10C;MRPS27;COA3;MPV17L2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.6028895818475961,1.3280005293002064,0.1574642126789366,0.6498689390796224,1.0,3/10,10.86%,PRKAA2;PRKAA1;FLCN
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5783591860114086,-1.3279977501081324,0.13157894736842105,0.49068379060741146,1.0,2/10,3.36%,RAP1A;NGF
prerank,negative regulation by host of viral process (GO:0044793),0.5935976566808678,1.3278355876335832,0.2028688524590164,0.6485661946740447,1.0,2/10,2.73%,PRKN;LTF
prerank,negative regulation of interleukin-1 production (GO:0032692),0.5142695888947141,1.3276196733983299,0.154,0.6474220498763102,1.0,1/23,0.03%,IGF1
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.48097616409211463,-1.3275700026314299,0.12375249500998003,0.49068352728261205,1.0,6/20,18.10%,HSP90AA1;HSP90AB1;HSPD1;CLU;TMEM35A;PFDN6
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.5164221662161386,-1.3275073156376036,0.1279527559055118,0.4897617942397204,1.0,6/15,7.87%,TMSB4X;KDR;LGMN;HSPB1;MET;VEGFA
prerank,vasculogenesis (GO:0001570),-0.4243881131589172,-1.3272922815266808,0.09662921348314607,0.4892633111631432,1.0,13/32,11.16%,CAV1;KDR;ITGB8;RAMP2;RASIP1;ENG;NOTCH1;SOX17;TGFBR2;TGFB1;VEGFA;HEY2;SOX18
prerank,smooth muscle contraction (GO:0006939),0.5711378431659632,1.3272575903411177,0.15984405458089668,0.646808166357946,1.0,4/14,3.07%,ROCK2;BDKRB2;MYLK;SLC8A1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.5534153591019347,1.3269680713236536,0.1540130151843818,0.6459496306082548,1.0,2/14,4.13%,IGF1;SYT11
prerank,tight junction assembly (GO:0120192),-0.3845828244627503,-1.326225750690468,0.0821917808219178,0.49099188386767006,1.0,9/49,3.00%,PECAM1;CLDN5;ESAM;ACTG1;OCLN;CLDN11;LSR;RAMP2;F11R
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.366886590060034,-1.3255200042364583,0.06297229219143577,0.4917089284084419,1.0,18/65,13.25%,HIP1;PTPRJ;SH3KBP1;BCAR3;CBL;DAB2IP;MVB12B;PTPN12;CCDC88A;CEACAM1;RHBDF2;HIP1R;SHKBP1;HGS;DUSP3;GPER1;CDH13;MVB12A
prerank,amino acid import (GO:0043090),0.5150937810403239,1.3254287146339463,0.14814814814814814,0.649023337320207,1.0,5/21,3.73%,SLC22A4;SLC6A13;SLC22A2;SLC1A3;SLC6A1
prerank,actin polymerization or depolymerization (GO:0008154),0.4321507117834782,1.3252221170872591,0.10921501706484642,0.6479410137696365,1.0,13/50,11.11%,MICAL3;ARHGAP6;GAS7;AVIL;ABI2;WASF1;WASL;WASF3;SPIRE2;CORO7;PSTPIP2;COBL;JAK2
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.5532280427634213,-1.3250374842296062,0.1470019342359768,0.49190814583279785,1.0,4/11,17.60%,FAP;BCL2L1;PTGIS;ZC3H12A
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.5505803100843562,-1.3248726315450496,0.15576923076923077,0.4911802926669832,1.0,4/12,15.23%,JAM2;APP;RHOA;CXCL12
prerank,vitamin transport (GO:0051180),0.4792627335768284,1.3248361421570365,0.13409961685823754,0.6474239450898751,1.0,9/29,10.58%,SLC35F3;PDPN;TCN2;SLC2A10;FOLR1;FOLR2;SLC27A1;SLC19A2;SLC19A1
prerank,peptide metabolic process (GO:0006518),0.39944938691185367,1.3247824617140374,0.10569105691056911,0.645861025671607,1.0,10/75,8.19%,CPQ;AEBP1;DMD;GSTM2;GSTT4;GSTT1;ACE;TPP1;NPEPPS;CPXM1
prerank,eye morphogenesis (GO:0048592),0.5192974154089021,1.324579975869026,0.1595959595959596,0.6447645653905264,1.0,4/19,2.90%,EFEMP1;FBN1;FBN2;SHROOM2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.454343892533903,-1.3231702454952148,0.1337448559670782,0.4947195678457107,1.0,17/24,36.53%,UBB;RPS27A;UBC;RPA1;UBA52;POLK;LIG4;POLE;POLD3;POLB;POLD1;LIG3;RFC5;RPA3;RPA2;XRCC1;RFC2
prerank,xenobiotic transport (GO:0042908),0.5385415882253063,1.3230764669256458,0.16046966731898238,0.6476331887324515,1.0,5/17,7.33%,SLC22A4;SLC22A2;NR1I2;GJA1;ABCC2
prerank,membrane repolarization during action potential (GO:0086011),-0.5421564924396528,-1.3227831981548672,0.14925373134328357,0.4947202619253502,1.0,5/13,14.72%,KCNJ2;ATP1A1;ATP1B1;KCNQ1;KCNIP2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5361058008487747,1.3227584155905783,0.1442495126705653,0.6468098429907176,1.0,7/17,12.39%,ATP1A2;SLC8A1;ANK2;CACNA1D;CACNA2D1;SCN3B;SCN2B
prerank,regulation of angiogenesis (GO:0045765),-0.30300970162587293,-1.322667509957653,0.013245033112582781,0.4939135043814801,1.0,41/192,8.87%,GAB1;TEK;CLDN5;PTPRM;NOS3;SEMA6A;RHOJ;BMPER;TIE1;CD34;KDR;THBS1;TGFB2;RUNX1;PLXND1;F3;KLF4;ITGB1;ETS1;ITGB8;RAMP2;DAB2IP;SEMA3E;PPP1R16B;PIK3R6;HSPB1;WARS1;STAB1;GATA2;RHOB;PDCL3;CTNNB1;SARS1;CEMIP2;EMC10;CEACAM1;SERPINF1;VEGFA;EMP2;GRN;PTGIS
prerank,positive regulation of cellular catabolic process (GO:0031331),0.36243726898658485,1.3226519274975637,0.0622154779969651,0.6454363761868276,1.0,22/132,9.79%,IGF1;SH3D19;PPARA;DAPK1;ZBTB20;TRIM5;VGLL4;PRKAA2;UFL1;NPRL2;LRRK2;SNX9;SNX33;NRDC;BNIP3;OPTN;RNF152;PRKAA1;DAGLB;ARNT;PLEKHF1;ITCH
prerank,iron ion transmembrane transport (GO:0034755),-0.5766432327411517,-1.3225142956799643,0.15955473098330242,0.49325252863314484,1.0,4/10,13.34%,SCARA5;SLC40A1;SLC39A8;SLC39A14
prerank,intracellular lipid transport (GO:0032365),0.5141112229848568,1.3222900001745985,0.16292134831460675,0.6449008350260916,1.0,4/21,6.61%,PRKAG2;PRKAA2;CPT2;SGPP1
prerank,regulation of protein kinase A signaling (GO:0010738),0.5194938665218021,1.3221249824588932,0.16699801192842942,0.6437029246638581,1.0,3/20,5.48%,ADGRV1;AKAP7;LRRK2
prerank,negative regulation of myotube differentiation (GO:0010832),-0.54662175809006,-1.3221211377569093,0.15134099616858238,0.49327889083132853,1.0,4/12,10.15%,NOTCH1;CCN3;HDAC5;XBP1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.582917371383674,-1.3219246604516406,0.15019011406844107,0.4927066993764807,1.0,8/10,38.19%,NCK1;JUN;DNAJB1;VHL;CITED2;HIF1AN;HSPA1A;BAG3
prerank,JNK cascade (GO:0007254),-0.40331900793727704,-1.321802736456675,0.09523809523809523,0.49195122951079967,1.0,12/40,15.45%,MAP3K5;UBB;NOD1;MINK1;ARHGEF6;RPS27A;UBC;MAPK8;MAP2K7;MAP3K12;TAB3;UBA52
prerank,negative regulation of cell migration (GO:0030336),-0.3224879573074857,-1.3211479320524016,0.04559270516717325,0.4926799134214046,1.0,25/137,5.73%,SLIT2;LIMCH1;PTPRJ;PTPRG;CLDN5;TMEFF2;CLIC4;RAC1;ACVRL1;DACH1;JAG1;CDH1;ADAM15;ADARB1;ENG;DAB2IP;MCTP1;ARHGDIB;SRGAP1;KANK1;CORO1C;RHOB;CALR;IGFBP5;NEXMIF
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.42692143774991664,-1.3210171466002238,0.10675381263616558,0.4919475788586368,1.0,10/29,9.59%,SLIT2;SHANK3;KANK3;KANK1;HIP1R;TJP1;CYRIB;SSH2;SSH1;KANK4
prerank,anion transmembrane transport (GO:0098656),0.4086947889647974,1.320667042500474,0.11538461538461539,0.6468248209326527,1.0,15/67,11.51%,SLC6A13;SLC13A3;SLC13A4;SLC16A12;SLC6A9;SLC1A3;SLC25A18;SLC13A5;LRRC8E;SLC25A11;SLC25A22;SLC27A1;SLC13A1;SLC19A1;SLC35A1
prerank,positive regulation of phosphatase activity (GO:0010922),-0.4693992524881184,-1.3203599212961739,0.12170385395537525,0.4927025882210662,1.0,11/21,24.25%,MEF2C;CALM1;HSP90AB1;MTOR;BMP2;MTMR9;CALM2;CD300A;CALM3;PPP1R15A;PPP1R15B
prerank,cellular response to hexose stimulus (GO:0071331),-0.46056839121362675,-1.3202067601387364,0.13800424628450106,0.49203482462067905,1.0,9/23,13.34%,UNC13B;GAS6;RACK1;KCNB1;SOX4;XBP1;SLC26A6;GPER1;SLC39A14
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.5184684554624899,-1.3201525186999215,0.12692307692307692,0.4911053537798321,1.0,4/14,6.19%,TMSB4X;NFKBIA;PKD1;FAF1
prerank,inorganic cation transmembrane transport (GO:0098662),0.3320545227996731,1.3198021385046068,0.02526595744680851,0.6478511009737973,1.0,19/268,4.74%,TRPM3;SCN7A;ATP1A2;SLC6A13;SLC24A3;KCNK2;SLC8A3;SLC6A12;SLC6A9;KCNQ4;NALCN;KCNA5;SLC41A1;SLC1A3;ATP1B3;SLC8A1;SLC6A1;KCND3;CACNA1D
prerank,activation of GTPase activity (GO:0090630),-0.3459122402402526,-1.3197157749860127,0.038356164383561646,0.4911653024344048,1.0,28/89,12.37%,NTRK3;SIPA1L1;TIAM1;TBC1D30;ARHGAP42;TBC1D8;SIPA1L2;SIPA1L3;ARHGEF15;CCDC125;RABGAP1L;CORO1C;ADPRH;ABR;GRTP1;SGSM1;BCR;TBC1D8B;TBC1D1;ARHGEF19;TBC1D13;ARHGEF26;ARHGAP25;ARHGEF5;ARHGEF10;EVI5;RANGAP1;TBC1D10A
prerank,positive regulation of telomerase activity (GO:0051973),-0.41807151061378034,-1.3196586669443948,0.0912863070539419,0.49022716395777055,1.0,7/33,10.52%,NEK7;HSP90AA1;HSP90AB1;KLF4;CTNNB1;PARM1;MAP2K7
prerank,negative regulation of mitochondrion organization (GO:0010823),0.4563246112019203,1.319591637818666,0.14579439252336449,0.6469461046691286,1.0,6/33,10.86%,IGF1;PRKN;BNIP3;NOL3;ACAA2;FLCN
prerank,protein K48-linked deubiquitination (GO:0071108),-0.45148739446917935,-1.3193970572383853,0.1290983606557377,0.48991387951480697,1.0,14/23,25.91%,ATXN3;OTUD7A;MINDY2;MINDY1;USP50;USP37;OTUD3;OTUB1;USP8;OTUD7B;TNFAIP3;USP5;USP33;YOD1
prerank,sensory perception of light stimulus (GO:0050953),0.38963250116494835,1.319343315735358,0.08637873754152824,0.6459731891680127,1.0,19/87,16.67%,EYA4;ADGRV1;EFEMP1;ZIC2;CRYGS;TULP1;COL18A1;GPR143;WHRN;EML2;DHRS3;IMPG2;CRYZ;MYO9A;RGS16;TULP2;KIFC3;CHRNB2;DNAJC19
prerank,cellular response to glucose stimulus (GO:0071333),-0.4271421761018959,-1.3190317053064264,0.10816777041942605,0.48984243500727187,1.0,10/30,13.52%,UNC13B;GAS6;RACK1;PTPRN2;KCNB1;SOX4;XBP1;GPER1;SLC39A14;RAB11FIP5
prerank,protein mono-ADP-ribosylation (GO:0140289),0.6009018315503267,1.318532209322709,0.17970401691331925,0.6468464980322113,1.0,6/11,20.04%,PARP4;PARP10;PARP12;PARP9;TIPARP;PARP14
prerank,sensory perception of mechanical stimulus (GO:0050954),0.38607837390684874,1.318508678901248,0.10016420361247948,0.6452403137604569,1.0,14/85,10.88%,DCDC2;EYA1;ADGRV1;CEMIP;CCDC50;ALDH7A1;RIPOR2;CACNA1D;LRP2;BIRC5;WHRN;EML2;GSDME;TFAP2A
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3883952532815958,1.3181209401762508,0.09006211180124224,0.6447070220684702,1.0,15/90,6.84%,LEPR;APPL2;EPAS1;IL18;ACSL1;ESRRG;GNAS;ALMS1;PPARGC1B;GRB10;GJA1;ACADL;IGF1R;CPT2;PTH2R
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.351708349209531,-1.3180408957177918,0.0691358024691358,0.49153094978923845,1.0,19/70,10.97%,MEF2C;TEK;FN1;TMEFF2;PARVB;RAC1;SIPA1L3;ACTN1;PXN;LAMA5;LAMB2;FERMT2;ITGA4;SRCIN1;PEAK1;RHOA;RELN;ATF4;ITGA8
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.45521695082206143,-1.3177887334996177,0.13765182186234817,0.4912168759048376,1.0,11/23,23.79%,HSP90AA1;NDUFA13;TOMM22;TIMM9;ROMO1;TIMM10B;TIMM13;TIMM29;TIMM22;BMF;BAX
prerank,potassium ion homeostasis (GO:0055075),-0.4553239189611362,-1.317569288758585,0.12008281573498965,0.4907666054841866,1.0,10/23,11.54%,SLC12A7;SLC12A2;KCNJ2;ATP1A1;KCNMA1;ATP1B1;SLC12A6;SLC12A8;SLC12A4;ATP1A3
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.43969685254535856,1.3175560363674357,0.12099644128113879,0.6446958179402112,1.0,5/40,7.32%,IGF1;PRKN;BNIP3;NOL3;MMP9
prerank,protein hydroxylation (GO:0018126),-0.504981764710314,-1.3169945730884702,0.142,0.4912935418602496,1.0,8/15,29.22%,P3H2;EGLN3;PLOD2;PLOD3;JMJD7;PLOD1;VPS33B;HIF1AN
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3195676140184609,-1.3163098756534881,0.03125,0.49201043608017364,1.0,45/149,19.88%,PRKCH;CAV1;TFRC;RPS6KA5;UBB;NFKBIA;RPS3;PPIA;NOD1;ROR1;TRIM14;IKBKB;EDA;TRIM25;RPS27A;UBC;TNFRSF11A;APP;CARD14;IL1RAP;AIM2;SLCO3A1;ZBTB7A;CHUK;RTKN2;STAT3;ARHGEF2;CLU;IRAK3;TAB3;TERF2IP;TRIM13;TRAF1;UBA52;CX3CR1;CARD16;PRKD1;RPS6KA4;CD40;IRAK1;RNF25;TIRAP;MID2;TRIM27;MYD88
prerank,positive regulation of B cell activation (GO:0050871),-0.3887445648906721,-1.3159003832583815,0.08227848101265822,0.4921511974045127,1.0,25/50,34.69%,MEF2C;SH3KBP1;TFRC;NFATC2;CD38;PTPRC;XBP1;CD74;CD81;MIF;CD40;TIRAP;PPP2R3C;NCKAP1L;KMT5C;CLCF1;SHLD3;RIF1;SHLD2;NOD2;BST1;VAV3;IL7;SYK;SASH3
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.4747427180520093,-1.3146320123318818,0.14145383104125736,0.4945858112955714,1.0,8/19,11.74%,TGFB2;NOTCH1;BMPR2;TGFBR2;SOX4;HEY2;BMP2;HEYL
prerank,regulation of cell differentiation (GO:0045595),-0.3141533609403708,-1.3144468126037196,0.03741496598639456,0.49401855121609894,1.0,42/148,18.71%,SLC6A6;SPOCK2;LTBP4;TRPS1;ZFHX3;TIAM1;RUNX1;CBFB;HSP90AB1;KLF4;PTK2;PHLDB1;NGF;TBX1;TGFB1;SIX1;NOTCH4;EMP2;PTHLH;RUNX2;DDX5;HEY2;ZFP36L1;APC;CDK6;YWHAG;UQCC2;ATF4;MCRIP1;RPS6KA1;BIN1;REST;NF1;NR1D2;RAF1;BCL6B;APC2;YWHAH;ID2;CASZ1;GREM1;DDX17
prerank,histone H3-K4 trimethylation (GO:0080182),0.5798167704092624,1.313042602427599,0.16973415132924335,0.656580493882267,1.0,6/11,21.65%,KMT2A;SETD1A;CTR9;WDR82;BEND3;TET3
prerank,serine family amino acid metabolic process (GO:0009069),0.5264008064799701,1.312863024536599,0.16632443531827515,0.6554041091975291,1.0,5/16,13.02%,CBS;SRR;THNSL2;CDO1;SHMT1
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.48371778903898527,-1.3125864723428926,0.14915966386554622,0.4980230179691884,1.0,9/18,30.67%,CD34;PTPRC;NAV3;LAPTM5;TRIM27;HDAC7;TNFAIP3;EZR;ZFP36
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.34592181633247393,-1.3119000960524432,0.06267029972752043,0.49886531015249574,1.0,27/84,10.16%,TEK;TMSB4X;FOXP1;NOS3;NRP2;KDR;THBS1;RAC1;SCARB1;ETS1;PTK2B;BMPR2;LGMN;ATP5F1A;HSPB1;BCAR1;GATA2;RHOB;TGFB1;CALR;EMC10;MET;FLT4;VEGFA;GRN;EDN1;PIK3CD
prerank,copper ion homeostasis (GO:0055070),-0.4897394801345738,-1.3107078368516498,0.13438735177865613,0.5010775156356565,1.0,5/17,7.70%,ATOX1;SLC31A1;MT2A;ARF1;APP
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5461462616732401,-1.3106774624617046,0.149812734082397,0.500087038523941,1.0,6/11,18.32%,CAV1;ATG7;FOXO1;ATP6V1A;FAS;ATP6V0A2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.42033634301293993,-1.310561670450317,0.13577586206896552,0.4993960255376447,1.0,20/33,39.62%,PTPRJ;RPS3;CEACAM1;DUSP3;DGKZ;CD81;LAPTM5;THY1;CD300A;RELA;EZR;CARD11;PTPN22;KCNN4;PHPT1;RC3H1;TRAT1;CD226;TESPA1;LCK
prerank,actin filament polymerization (GO:0030041),0.4721492289183527,1.3103555283160286,0.14882032667876588,0.6614305160392716,1.0,10/29,11.11%,ARHGAP6;GAS7;WASF1;WASL;WASF3;SPIRE2;CORO7;PSTPIP2;COBL;JAK2
prerank,negative regulation of cellular protein localization (GO:1903828),0.46126488797255694,1.309533880708306,0.120817843866171,0.6622925414449663,1.0,9/34,11.92%,LEPROT;ROCK2;RIPOR2;SNX33;UBXN2B;PICALM;LATS1;FLCN;ACTN2
prerank,negative regulation of angiogenesis (GO:0016525),-0.34541240564654097,-1.3093421626497355,0.06561679790026247,0.5016072209607382,1.0,23/84,14.62%,TEK;SLC12A2;CLDN5;PTPRM;SEMA6A;KLF2;THBS1;TGFB2;KLF4;DAB2IP;SEMA3E;CREB3L1;STAB1;CTNNB1;SARS1;SERPINF1;HGS;HHEX;SYNJ2BP;EPN2;COL4A2;ISM1;SPARC
prerank,regulation of cholesterol efflux (GO:0010874),-0.4306377734489642,-1.3089838941638394,0.10572687224669604,0.5015627634429642,1.0,18/30,30.79%,CAV1;PLTP;SREBF2;NFKBIA;PTCH1;LAMTOR1;NR1H2;ABCA3;ABCA2;ZDHHC8;NR1H3;TTC39B;TREM2;GPS2;ABCA7;PPARG;NAXE;SHH
prerank,nucleus organization (GO:0006997),-0.3864565946357017,-1.3088379157167174,0.08932461873638345,0.500912910678572,1.0,21/47,26.80%,SYNE1;REEP3;RPS19;CHMP5;CHMP2B;LEMD2;BIN1;NUP54;CHMP1B;SUN1;PITPNB;IRAG2;CHMP1A;CTDNEP1;NUP133;NUMA1;CHMP3;CHMP7;PDCD6IP;CHMP4C;CEP55
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.513759026659551,1.3084351371278746,0.1710794297352342,0.6640749813958062,1.0,2/17,2.68%,LPGAT1;PLA2G10
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.523728104052304,-1.3083746227752442,0.15145631067961166,0.5010691930392442,1.0,6/14,28.92%,SRSF9;RNPS1;SRSF6;PCBP4;PTBP1;SRSF7
prerank,"transcription, DNA-templated (GO:0006351)",0.3413750089937085,1.3082081560004792,0.04552129221732746,0.6631289982174058,1.0,28/207,12.36%,GLIS3;SOX5;MAF;POLR2D;SCX;PAX5;CDK7;ELOA;GTF3C5;HSF2BP;THAP1;POLR3GL;POLR3G;POLR2A;CCNT2;RSF1;CCNT1;GTF2F1;SMN1;SMARCA5;TAF1A;DTX1;GTF3C3;TAF3;CDC73;GMEB2;HIPK3;HSF1
prerank,serine family amino acid catabolic process (GO:0009071),0.5949247033002367,1.3081618427851134,0.19556451612903225,0.6615819713777823,1.0,4/10,18.82%,CBS;THNSL2;SHMT1;DLD
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.3515682810923441,-1.3081244069777072,0.06315789473684211,0.5006825486275853,1.0,22/76,21.08%,TEK;NTRK3;CARMIL1;PTK2B;CDC42EP3;NCKAP1;WDR1;NCK1;BAIAP2L1;EDN1;NCK2;BIN1;SORBS3;NES;CDC42EP5;PRKCE;CDC42EP2;CFL2;CDK5;EVL;NCKAP1L;NUMA1
prerank,dicarboxylic acid catabolic process (GO:0043649),0.5586694046201469,1.308124108520198,0.1862348178137652,0.6600472816983555,1.0,5/13,17.36%,DDO;ACOT4;ASPA;MTHFS;QPRT
prerank,lamellipodium organization (GO:0097581),-0.42833429409391804,-1.30807645903387,0.12210526315789473,0.4997563849337983,1.0,9/29,6.15%,PARVB;ABLIM1;RAC1;CARMIL1;ITGB1;S1PR1;SPATA13;ARHGEF6;CCDC88A
prerank,chondrocyte differentiation (GO:0002062),0.47230154902317917,1.3077989416490647,0.14206642066420663,0.6594403321191202,1.0,7/32,7.27%,SOX5;OSR1;SCX;SOX6;NFIB;SULF1;WNT5B
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.2972071419114191,1.307785854737442,0.0,0.6578350678497678,1.0,283/1646,14.18%,IL31RA;IGF1;GLIS3;CREB5;RORA;SOX5;MAF;VGLL3;TCF4;TCF7L2;OSR1;EFEMP1;WNT4;ARNT2;RBPJ;DENND4A;ZIC1;HOXC6;EPAS1;HLF;PPARA;KDM7A;NR2F2;NPAS3;IKZF2;KIT;HOXC4;BMP7;ATXN1;ZEB2;TULP3;ZKSCAN2;KMT2A;PRRX1;MEIS1;HOXB4;SNX6;DKK3;ESRRG;ARID5B;RUNX1T1;MXI1;CUX1;SMAD6;SATB1;PRDM5;ZEB1;ZIC2;EBF1;MYBL1;DMRT1;SCX;NR1I2;ASCL2;SOX6;TBL1XR1;ZBTB20;PLCB1;SP100;LOXL3;PPARGC1B;HOXB3;TSHZ3;HIF3A;PAX5;NFYB;JARID2;EPOP;MIDEAS;ZIC5;HOXA3;BBX;IGF2;TP53INP2;SSBP2;HOXC5;PKNOX2;VSX2;NCOA2;STAT5B;NFAT5;ELOA;MYRFL;VGLL4;ZFP90;PRICKLE1;HOXA7;FOXD1;ZHX2;CBY1;NFIB;BEND5;TEAD1;ELF4;L3MBTL2;MGA;BAZ1B;ARID4A;TEF;ZNF367;ARID1B;IKZF4;GMEB1;KDM2B;CAMTA1;SOX1;SIX5;SALL4;ZFHX2;NDP;DPF2;PERM1;IRF8;SP110;ZNF250;MSANTD1;GLI3;PRKCB;ZNF569;METTL4;SFMBT1;HIVEP2;MXD1;MYNN;ZBTB32;TCF7L1;ZMIZ1;NIBAN2;ZFP37;BAZ1A;PHF8;BCOR;ARHGEF11;SUFU;THAP1;WWC1;TYMS;IL6;WWC2;SALL1;GPBP1;UBE2L3;RFXAP;ZNF23;XRCC5;SMAD3;BLM;PHF14;EN1;GPBP1L1;PBX4;CHD4;NCOA7;NR6A1;NEK4;POLR3G;RGMB;MTF2;ZKSCAN5;TRIM56;KDM2A;TCF12;POLR2A;CCNT2;BIRC5;TEAD3;WWP2;PIAS1;RSF1;CCNT1;NFIA;PCGF5;ARNT;ZMYND15;TLE1;FSTL3;ZNF628;KAT8;KDM5B;CAMK2D;BRCA2;MITF;KAT6B;CEBPG;KDM3B;MAP3K2;PICALM;EBF4;MDM2;MBTD1;NFYC;HOXB6;CREB3L2;NSD1;BATF2;IRF3;MED1;BBS7;DVL3;NUP107;ZSCAN29;SMURF2;IRX1;PHIP;ABL1;MED13;SCMH1;PARP9;L3MBTL3;SMARCA5;ATOH8;NEUROD2;ASCC2;HDAC1;ZBTB11;TSHZ1;TFAP2A;TADA2A;SMARCE1;ZNF8;HOXC8;TFAP2B;ARID3A;ZIC4;ZNF568;TRIM45;RXRA;ERBB2;TGFA;ZBTB38;MYB;ZBTB39;NPAS2;KMT2B;ZBTB37;CRY1;CNOT2;ZNF177;RNF14;E2F6;SOX13;GMEB2;HSF1;RNF20;CCNE1;CBFA2T2;PSPC1;AR;HIVEP1;PHF6;KLF5;SEBOX;ZMIZ2;SMARCB1;FZD2;HOXD4;NFATC4;HOXA6;NONO;EPC2;FOXK2;SRCAP;SNAI1;ZNF697;HOXB9;SCML4;TFDP2;RRP8;MLXIP;CLOCK;ZNF148;ZFX;SRF;POLR3C;DMRTA2;KDM5C;UBE2V1;MTDH;CDKN1C;BATF;CREBBP;NLK;MNAT1
prerank,negative regulation of cell differentiation (GO:0045596),0.3469077344318044,1.307766175097098,0.07423580786026202,0.6562355751531135,1.0,24/181,8.93%,RANBP3L;RORA;ADAMTS12;ADGRV1;OSR1;EFEMP1;PPARA;BMP7;MEIS1;RUNX1T1;SMAD6;IGF2;ANKRD26;ABCA1;TMEM64;ADAMTS7;SUFU;IL6;SMAD3;PTEN;IQCB1;ABCA5;YTHDF2;USF3
prerank,regulation of organelle assembly (GO:1902115),0.39578079867665145,1.307238543647265,0.11058451816745656,0.6559935354764961,1.0,9/72,6.56%,DCDC2;NPRL3;SPICE1;ODAD3;ALMS1;NPRL2;MTMR3;TBC1D9B;SDCCAG8
prerank,positive regulation of metabolic process (GO:0009893),0.37747377406762944,1.306664817355633,0.09287925696594428,0.6560510895995149,1.0,16/103,6.84%,LEPR;APPL2;EPAS1;IL18;ACSL1;ESRRG;CAMK1D;GNAS;ALMS1;PPARGC1B;GRB10;GJA1;ACADL;IGF1R;CPT2;PTH2R
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.43228844809801276,-1.3061098505257296,0.11802575107296137,0.5039944168707057,1.0,11/27,18.75%,CAV1;PDE4D;ATP2A2;CTNNA3;RYR2;CACNA1C;JUP;DSG2;PLN;DSP;TRPM4
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.4189801267183248,-1.3060609605987636,0.11471861471861472,0.5030559213926045,1.0,14/31,20.58%,SHANK3;SIPA1L1;ZDHHC15;PPFIA2;LRP8;ABI3;SRCIN1;KIF1A;RELN;DBNL;CAMK2B;CDK5;CFL1;DBN1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.4455375174325936,-1.3058732644033673,0.11967545638945233,0.5025292855361754,1.0,8/26,12.65%,KLF2;HSP90AA1;HSP90AB1;KLF4;DDAH1;PTGS2;EDN1;CLU
prerank,mononuclear cell differentiation (GO:1903131),0.4947832914287983,1.3057874818714865,0.1673728813559322,0.6569498325277179,1.0,1/24,0.01%,IL31RA
prerank,phospholipid catabolic process (GO:0009395),-0.44640290659901904,-1.3057732739879142,0.12745098039215685,0.5017180067080497,1.0,6/24,15.14%,GPCPD1;SMPD4;GDPD1;GDPD3;PNPLA6;PLA2G4A
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3119101038230124,1.3053652385486925,0.02023809523809524,0.6566274549330726,1.0,103/572,13.15%,GLIS3;PRDM6;BMP6;TCF7L2;OSR1;AEBP1;RBPJ;FGFR2;FHL2;PPARA;NR2F2;PRKN;WWOX;ATXN1;ZEB2;KCNIP3;DAB2;ARID5B;MXI1;FNIP1;CUX1;AASS;SATB1;PRDM5;ZEB1;DKK1;DMRT1;NR1I2;ASCL2;TBL1XR1;SP100;IGF2;NEDD4;VSX2;JAZF1;ZFP90;HDAC8;HOXA7;ZHX2;NFIB;RNF2;KDM2B;SOX1;DPF2;IRF8;GLI3;MXD1;ZBTB32;ZFP37;CXXC5;BCOR;SUFU;DLG1;THAP1;WWC1;WWC2;SALL1;KANK2;SMAD3;EN1;NR6A1;MTF2;PHF21A;PER3;WWP2;LYAR;CBX8;DNAJA3;CBX2;MITF;MDM2;NSD1;MED1;FRK;SMURF2;IRX1;PARP9;HDAC1;FLCN;TFAP2A;CBX7;ZNF8;TFAP2B;ZNF568;RXRA;MYB;TAF3;CRY1;CNOT2;ZNF177;CDC73;E2F6;ORC2;SOX13;HSF1;AR;HIVEP1;PHF6;EZH1;CGGBP1;IFI27;NFATC4;NR1I3
prerank,regulation of neuron migration (GO:2001222),-0.4344461765710205,-1.3051378206932793,0.1290983606557377,0.5025028427893966,1.0,12/26,22.66%,SEMA6A;DAB2IP;SHTN1;NEXMIF;ARHGEF2;CAMK2B;COL3A1;ADGRG1;NTNG1;NSMF;SEMA3A;PLAA
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.4952678898555066,-1.3047440798865546,0.15353535353535352,0.5025357748089743,1.0,4/16,8.51%,STX7;PTPRC;CEACAM1;CYRIB
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5606692867559471,1.30433437643316,0.17721518987341772,0.6581193758943358,1.0,1/12,0.68%,B3GALT1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5210264563122972,1.3040064078157534,0.18590998043052837,0.6575668987122624,1.0,6/20,11.92%,OSR1;NEDD4;PCSK9;MMP9;CAMK2D;ACTN2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.45357007397911475,-1.3039984836706549,0.1120162932790224,0.5034444223920714,1.0,8/25,12.65%,KLF2;HSP90AA1;HSP90AB1;KLF4;DDAH1;PTGS2;EDN1;CLU
prerank,protein deneddylation (GO:0000338),-0.5584462354357989,-1.3032754325545772,0.188,0.5044709175816192,1.0,3/10,17.76%,COPS7A;COPS8;COPS6
prerank,regulation of platelet aggregation (GO:0090330),-0.49364649908039654,-1.3032695694514351,0.1685185185185185,0.5034556474431235,1.0,5/17,6.94%,PRKG1;CD9;F11R;SERPINE2;CEACAM1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.5574118687324165,1.3027526957921967,0.1935483870967742,0.6595145336803383,1.0,2/14,1.68%,AUTS2;KMT2A
prerank,fatty acid transmembrane transport (GO:1902001),0.5090569023204927,1.3022596828973942,0.18568665377176016,0.6594962953849158,1.0,3/19,5.76%,PRKAG2;PRKAA2;CPT2
prerank,central nervous system myelination (GO:0022010),-0.5514023321970356,-1.3019210263135779,0.16227180527383367,0.5059241216914265,1.0,7/11,19.12%,PLP1;B4GALT5;TENM4;CLU;B4GALT6;ABCA2;SOX10
prerank,calcium-mediated signaling (GO:0019722),0.3790062275885742,1.301858655951955,0.10082644628099173,0.6591650173666467,1.0,16/93,8.22%,RCAN2;ADGRL1;ACKR2;CCR9;CXCR5;PDPK1;SLC8A1;DMPK;ANK2;CXCR6;SPHK1;LRRK2;PPP1R9A;PRKAA1;MCU;GPR143
prerank,cardiac ventricle development (GO:0003231),-0.4656804883902644,-1.3016563384729178,0.14516129032258066,0.5056715582810184,1.0,7/20,11.74%,ENG;NOTCH1;HES1;STRA6;PDE2A;HEY2;HEYL
prerank,postreplication repair (GO:0006301),-0.3912116984251013,-1.3014855716021148,0.1111111111111111,0.5051674602144869,1.0,21/45,24.80%,UBB;TRIM25;RPS27A;UBC;UBE2B;ISG15;RPA1;MSH2;UBA52;USP43;POLK;FAAP20;UBE2V2;POLN;SPRTN;POLD3;VCP;POLD1;NSMCE1;POLI;DTL
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.44420668000877883,-1.3006874206095138,0.13725490196078433,0.5052327520937958,1.0,15/23,30.52%,PPP1R13B;NMT1;YWHAB;MAPK8;YWHAG;BBC3;CASP8;YWHAQ;YWHAH;PPP3R1;YWHAZ;PPP3CC;BID;SFN;PMAIP1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.44420668000877883,-1.3006874206095138,0.13725490196078433,0.5052327520937958,1.0,15/23,30.52%,PPP1R13B;NMT1;YWHAB;MAPK8;YWHAG;BBC3;CASP8;YWHAQ;YWHAH;PPP3R1;YWHAZ;PPP3CC;BID;SFN;PMAIP1
prerank,protein polymerization (GO:0051258),0.4170240036587104,1.3006465702273673,0.13050847457627118,0.6612506860860858,1.0,13/55,11.11%,ARHGAP6;PRKN;GAS7;WASF1;WASL;ARL6;WASF3;SPIRE2;RNF135;CORO7;PSTPIP2;COBL;JAK2
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5164315475116867,1.3005574548257657,0.18255578093306288,0.659924881570701,1.0,8/17,20.59%,PPARA;PID1;NUPR1;FLCN;PFKFB1;NCOR1;HDAC4;PDE12
prerank,wound healing (GO:0042060),0.40090312208956275,1.2997931718449773,0.12331081081081081,0.6605713035688457,1.0,10/62,8.87%,IGF1;TPM1;JAML;MACF1;SYT11;PDGFRA;FGF1;SMAD3;MIA3;DCBLD2
prerank,aorta morphogenesis (GO:0035909),0.5197554210898673,1.2997576011562897,0.1837160751565762,0.6590919649894226,1.0,4/17,2.95%,ADAMTS9;RBPJ;MYLK;PDGFRB
prerank,hematopoietic stem cell differentiation (GO:0060218),0.5957671716044095,1.2997053577223634,0.20454545454545456,0.6576589859931593,1.0,3/10,5.28%,HOXB4;ACE;UFL1
prerank,regulation of cellular senescence (GO:2000772),-0.43984221680538677,-1.2995907633491657,0.12472647702407003,0.5071637446397737,1.0,8/28,16.93%,B2M;YPEL3;YBX1;ABI3;CDK6;RSL1D1;MAP3K3;EEF1E1
prerank,cellular response to interleukin-4 (GO:0071353),-0.5643158615286064,-1.2988359673826204,0.17523809523809525,0.508098379200014,1.0,4/10,19.40%,LEF1;XBP1;TCF7;JAK3
prerank,mesonephric tubule development (GO:0072164),0.54578526760482,1.298287655122682,0.18036072144288579,0.6604207689637899,1.0,3/15,1.28%,OSR1;FGFR2;BMP7
prerank,regulation of T cell chemotaxis (GO:0010819),0.5768753593392725,1.2981086941466617,0.1962809917355372,0.6593253612914836,1.0,2/11,3.19%,OXSR1;CXCL13
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.42015643967140603,-1.2978597470912236,0.12210526315789473,0.5098063091192219,1.0,15/32,33.48%,CEPT1;MFSD2A;LPCAT3;GPAT4;LPCAT1;LPIN3;CSNK2B;LPIN1;LCAT;SLC44A5;SLC44A2;PEMT;CHPT1;STARD10;ACHE
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.4425403276106486,1.2976942134722744,0.145985401459854,0.6590505936948112,1.0,5/35,3.00%,ADCY1;KSR1;IRAG1;PDE7B;PDE7A
prerank,histone H3-K4 methylation (GO:0051568),0.4760748074339424,1.2976481890590612,0.13863216266173753,0.6575839579980043,1.0,12/26,22.91%,KMT2A;ASH2L;SETD1A;KMT2B;KDM6A;CTR9;WDR82;DYDC2;SETD4;BEND3;TET3;DPY30
prerank,positive regulation of MAPK cascade (GO:0043410),0.33298674760623537,1.297080829216782,0.054304635761589407,0.6577516164842567,1.0,32/245,7.93%,IGF1;ROBO1;ROCK2;IL34;KSR1;FGFR2;FGFR4;NOTCH2;KIT;ANGPT1;PELI2;MTURN;LPAR1;CCN2;PDGFRB;TRIM5;IGF2;EPHA8;GFRAL;PDGFRA;GLIPR2;PDGFD;IGF1R;LRRK2;PRKCZ;FGF1;WWC1;ADRA1D;IL6;PRKCA;CCL19;RYK
prerank,positive regulation of vasoconstriction (GO:0045907),-0.5301575050071038,-1.2966087749146336,0.16155419222903886,0.5121030299651788,1.0,3/13,7.85%,CAV1;ADRA1B;ADRA1A
prerank,protein oxidation (GO:0018158),0.5791435153151938,1.2965785283117823,0.18426501035196688,0.657881971142456,1.0,2/11,2.97%,LOXL1;LOXL3
prerank,regulation of cellular component size (GO:0032535),-0.42391110550683664,-1.2960533788605402,0.12128146453089245,0.5125666911723471,1.0,17/30,27.51%,MSN;RAC1;RIN3;MTOR;EPS8;AP2M1;PPP1CA;RAB3B;ATP13A2;PEX11B;RAP1GAP2;HP1BP3;LAMTOR4;PPP1R15A;EZR;RPTOR;NEB
prerank,intracellular pH reduction (GO:0051452),-0.41166369327414626,-1.2956931078375793,0.1206896551724138,0.512435204825459,1.0,19/33,26.57%,DMXL1;ATP6V0A1;RAB38;ATP6V1A;ATP6V0C;TCIRG1;ATP6V1E1;DMXL2;ATP6V0A4;ATP6V0A2;RAB39A;SLC11A1;ATP6V0D2;CLCN3;RAB7A;ATP6V0E2;ATP6V1B2;TMEM9;ATP6V1H
prerank,negative regulation of secretion by cell (GO:1903531),-0.3961516596171554,-1.2951973420272815,0.13849765258215962,0.512722064526073,1.0,11/38,13.88%,STXBP6;GRM7;NOTCH1;VAMP8;RHBDF2;TNFRSF1B;SLC30A1;RSAD2;SYT4;CHGA;CYP51A1
prerank,apoptotic process (GO:0006915),-0.2992327301098572,-1.2946874327887679,0.025089605734767026,0.5131371085407249,1.0,68/203,22.36%,HIP1;EFNA5;ELMO1;SEMA6A;FAP;ADAM15;MAL;PPARD;PTK2B;NFKBIA;PPIA;TBX1;CDK11B;NCKAP1;MAGI3;CIT;TGFBR2;ARHGEF6;RHOB;TNFRSF21;DCC;BCL2L1;BAG6;EGLN3;PLAGL1;AHR;GAPDH;PDCD4;APP;ADRA1A;MTOR;FOXO1;DDIT4;ING4;PAEP;RTN4;BNIP2;OGT;NDUFS1;YARS1;HSPD1;BNIP1;BBC3;DAP;IAPP;PRUNE2;FAS;JADE1;RFK;CASP8;AHCYL1;AKAP1;RAF1;PRKCE;CDK5;LIG4;TNFRSF10B;CYFIP2;MYD88;PDE1B;PRKCD;AKT1;GADD45A;PAK5;BIK;BMF;CASP1;TRAIP
prerank,fatty acid catabolic process (GO:0009062),0.3975740045599843,1.294612190077677,0.1314878892733564,0.6621398781734631,1.0,17/67,14.65%,PCCA;CEL;EHHADH;ACADL;ECI2;HSD17B10;CPT2;ACAD11;ECHDC1;ACADS;PHYH;ACAA2;ACAT2;AUH;ACOX1;BDH2;HACL1
prerank,regulation of mitochondrial fusion (GO:0010635),0.5694942980777702,1.2945261725157875,0.1829787234042553,0.6608422510482751,1.0,3/11,6.51%,PID1;PRKN;BNIP3
prerank,histone H2A monoubiquitination (GO:0035518),0.5133611920314358,1.2940430465216497,0.184,0.6607703490886392,1.0,7/17,14.81%,DDB2;RNF2;KDM2B;BCOR;PCGF5;CUL4B;PCGF1
prerank,cellular defense response (GO:0006968),0.4344539316685029,1.2939719045072806,0.14678899082568808,0.6594203863479147,1.0,2/40,1.52%,DCDC2;CCR9
prerank,negative regulation of lipid storage (GO:0010888),0.5088729388190026,1.2939515560962036,0.1746031746031746,0.6579282282267743,1.0,4/19,6.76%,OSBPL8;PPARA;ABCA1;IL6
prerank,embryonic appendage morphogenesis (GO:0035113),0.5558236697339262,1.2937899838013647,0.18711018711018712,0.6568792053283551,1.0,2/12,4.65%,CYP26B1;FBXW4
prerank,Golgi localization (GO:0051645),-0.5390703123715517,-1.2932569941774372,0.15619047619047619,0.5160563039678411,1.0,4/11,12.04%,COPG1;PDCD10;STK25;RIPOR1
prerank,carbohydrate transport (GO:0008643),-0.5476143465614651,-1.2930061482872055,0.17904761904761904,0.5157456779358852,1.0,3/11,11.74%,AQP11;SLC50A1;SLC26A6
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.44879240964867695,1.2914849715140029,0.15101289134438306,0.6621864112829101,1.0,5/33,3.11%,TCF7L2;PPARA;ANGPT1;PDPK1;NDNF
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4221126271485851,1.2914700465392381,0.12874779541446207,0.660683498846846,1.0,6/48,3.96%,JPH1;CEMIP;DMD;PDPK1;GSTM2;ANK2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.3484924000131339,-1.291446527780588,0.07828282828282829,0.5189096340993802,1.0,28/72,24.60%,LIFR;RUNX1;GAS6;CBFB;HSP90AB1;RACK1;IKBKB;PTPRC;CDC37;BIRC3;CHUK;PTPN1;CD74;IRAK3;IFNGR1;TRAF1;CASP8;MADD;SIGIRR;IRAK1;SHARPIN;JAK1;RBCK1;TNFAIP3;OTULIN;SOCS1;STAT1;TRIM44
prerank,cAMP metabolic process (GO:0046058),0.5574514514211664,1.2910265166203974,0.20388349514563106,0.6604405815219146,1.0,2/13,0.71%,ADCY5;ADCY1
prerank,regulation of protein localization to nucleus (GO:1900180),-0.3905620248052883,-1.2905401620791217,0.11818181818181818,0.5203797928834868,1.0,24/43,36.09%,TFRC;LIMK2;TGFB1;FERMT2;GSK3B;CARD10;SESN2;WWTR1;ATP13A2;SUMO3;CTNNA1;AKT1;BMP4;OTUD7B;BYSL;SIN3A;SHH;MFHAS1;PLK1;NGFR;PARK7;CDK5RAP3;TESK1;LIF
prerank,insulin receptor signaling pathway (GO:0008286),-0.3525763550666204,-1.2904848095364259,0.07323232323232323,0.51951271356863,1.0,21/69,13.34%,GAB1;GRB14;BCAR3;NAMPT;AP3S1;CAV2;BCAR1;ATP6V0A1;GSK3B;FOXO1;APPL1;C2CD5;ATP6V1A;APC;ATP6V0C;PIK3C2A;PDK2;TCIRG1;ATP6V1E1;IDE;SLC39A14
prerank,regulation of protein catabolic process (GO:0042176),-0.3278155949593608,-1.2903612026256213,0.05277777777777778,0.5188407587068563,1.0,26/99,13.88%,EEF1A1;WWP1;NSF;NEDD4L;DAB2IP;ATG7;FLNA;PLK2;FAF1;GSK3B;GFAP;FOXO1;CHEK2;ZDHHC2;DDB1;FURIN;OAZ1;APC;CDKN1B;HGS;NDUFA13;AZIN1;EGLN2;IRAK3;IDE;CYP51A1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.34696421981211206,1.2900966583781672,0.07296137339055794,0.6617425103290067,1.0,18/170,9.06%,IGF1;PRDM6;ROCK2;AFF2;ZNF462;IGF2BP1;NOVA1;PRDM5;DKK1;SLC8A1;TRIM5;CACTIN;MTMR3;ZUP1;ATRAID;KDM6B;SIRPA;FUBP1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.41715040829445044,-1.2898088848625322,0.11699779249448124,0.5192424020420688,1.0,10/29,18.40%,UBB;IKBKB;RPS27A;UBC;BIRC3;CHUK;CASP8;UBA52;CD40;UBE2D1
prerank,brain development (GO:0007420),0.35299181289675785,1.2895972035040102,0.08955223880597014,0.6617347240065816,1.0,21/136,8.84%,EPHA7;AFF2;ARNT2;ZIC1;ATXN1;MEIS1;ZIC2;B3GNT5;SOX6;SHROOM2;PAFAH1B3;NFIB;ZFHX2;SYNJ2;PHF8;SETD1A;AMIGO3;PBX4;PTEN;CDK5RAP1;PAFAH1B1
prerank,mesenchyme development (GO:0060485),0.5323801273354902,1.289510320822372,0.21413721413721415,0.6604701601334264,1.0,2/15,1.28%,FGFR2;BMP7
prerank,lipoxygenase pathway (GO:0019372),-0.5127890642122501,-1.2890823319263556,0.1619047619047619,0.5201033599109952,1.0,4/14,12.63%,GPX4;PTGS2;PON2;ALOX12
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.46975648844062473,1.2882822949563,0.16287878787878787,0.662666982705756,1.0,7/27,8.39%,PPARA;IL18;PLA2G10;ABCA1;MAPK9;CSF1;ABCA5
prerank,endoderm development (GO:0007492),-0.5229233965792289,-1.2878665040009616,0.17898832684824903,0.5224482368564234,1.0,8/13,40.59%,SOX17;SOX7;DUSP1;DUSP4;TBX20;DUSP5;DUSP2;GATA4
prerank,regulation of protein modification process (GO:0031399),-0.3760742791152257,-1.287804816347903,0.10864745011086474,0.5215943470870893,1.0,17/50,15.53%,FN1;FNIP2;PTK2;ATG7;PPP1R16B;HSPB1;CORO1C;WARS1;CCDC88A;SPRED2;PPIB;SESN2;CADM4;MT3;RABL3;PPP1R16A;CCDC88C
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5600789970423443,-1.2875491789070268,0.16856060606060605,0.521225989739042,1.0,5/11,23.01%,CREB3L1;HSPA5;ATF4;ATF3;CEBPB
prerank,positive regulation of lipid metabolic process (GO:0045834),0.5047451999742094,1.2874184767439147,0.18350515463917524,0.6637522837144268,1.0,3/22,2.79%,PPARA;SORBS1;ZBTB20
prerank,regulation of cell killing (GO:0031341),-0.4932168219618498,-1.2868578035346105,0.1522198731501057,0.5220807023709273,1.0,5/16,16.37%,RAC1;TGFB2;CD55;MAPK8;DVL2
prerank,regulation of interleukin-4 production (GO:0032673),-0.4600233548671753,-1.2863961152998356,0.1680161943319838,0.5223061577912005,1.0,2/21,1.62%,LEF1;SLC7A5
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.4996992404355176,-1.286362066636975,0.1544885177453027,0.5213876084582815,1.0,6/15,6.69%,TMSB4X;THBS1;NOTCH1;LGMN;HSPB1;MET
prerank,positive regulation of response to stimulus (GO:0048584),-0.3930501278083488,-1.2857050007573592,0.11320754716981132,0.5220356916830445,1.0,26/40,40.11%,B2M;TGFB2;YPEL3;HOMER1;ABI3;RSAD2;IFIH1;EEF1E1;IL15;PRKCD;FMR1;NSMCE4A;NSMCE1;FCGR2B;CD80;CGAS;DHX9;ACOX2;MAVS;ILK;BCLAF1;ARG2;ANKLE1;GATA3;HMGA1;CDKN2AIP
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3824727179836099,1.28566868496251,0.13227513227513227,0.6676937931184035,1.0,14/77,12.50%,IGF1;TCF7L2;PRKN;BCL2;SH3RF1;NOL3;MMP9;SIAH2;BIRC6;ACAA2;BCL2L2;PHIP;CFLAR;AR
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.446157372084327,-1.28524125404412,0.1544885177453027,0.5223204235640414,1.0,13/24,28.97%,ABCG2;ABCB10;SUCLA2;RSAD1;ATP5IF1;UROD;UROS;FECH;FLVCR1;HMBS;COX15;TSPO;ABCB6
prerank,respiratory tube development (GO:0030323),0.47465841405264875,1.2851395082799122,0.1569767441860465,0.6677696694643606,1.0,6/28,5.54%,FGFR2;RBP4;LOXL3;PDPN;FGF1;ITGA3
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.4860467891403399,1.284146703115246,0.15447154471544716,0.669230037308183,1.0,6/24,11.08%,EPHA7;PCSK9;SRPK2;NUPR1;TFAP2A;TFAP2B
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.465161227578474,-1.2834990377136752,0.14090019569471623,0.5260976416353418,1.0,9/19,28.94%,LBP;PIK3AP1;NR1H4;PRKCE;IRAK1;TIRAP;TRIL;ITGB2;TLR4
prerank,protein prenylation (GO:0018342),-0.5611206063822127,-1.2831599780041059,0.16666666666666666,0.5260225958618348,1.0,5/10,21.05%,PGGT1B;RABGGTB;PTAR1;RCE1;RABGGTA
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.498192649760011,1.2828046412536294,0.1825242718446602,0.6716803562996381,1.0,3/21,5.30%,ADCY5;ADCY1;NPR2
prerank,regulation of nervous system process (GO:0031644),0.5050571992030449,1.2826579304882044,0.17254901960784313,0.6705920374556105,1.0,2/18,0.88%,ROCK2;SLC8A3
prerank,translesion synthesis (GO:0019985),-0.3892734895630486,-1.2825392921847196,0.14099783080260303,0.5266954216684201,1.0,20/42,28.63%,UBB;REV3L;TRIM25;RPS27A;UBC;ISG15;RPA1;UBA52;USP43;POLK;FAAP20;POLN;SPRTN;POLD3;VCP;POLD1;POLI;DTL;RFC5;USP10
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.40519157891086693,-1.282486750269924,0.12636165577342048,0.5258176237824023,1.0,8/35,7.60%,HIP1;SGIP1;B2M;RAC1;CBL;HNRNPK;ARF1;HIP1R
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.30580384558975193,-1.2821443763795373,0.05345911949685535,0.5257135878947307,1.0,51/163,23.41%,MEF2C;PTPRJ;PDE4D;PLCG2;FYN;INPP5D;BMX;DENND1B;RFTN1;BCAR1;IKBKB;NCK1;NFATC2;CD38;PTPRC;TNFRSF21;CSK;PAK1;PSMD13;PSMF1;PAK2;PSMB10;PLEKHA1;PIK3CD;CHUK;PSMB6;STOML2;PSME3;PSMB5;MOG;PSMC3;PSMD12;PSMB8;CUL1;NFKBIZ;PSME1;EIF2B5;PSMB3;EIF2B2;BTN3A3;ZC3H12A;PSMD5;THY1;SKP1;TXK;NCKAP1L;FYB2;RBCK1;PSMD9;PSMB4;RELA
prerank,regulation of T cell cytokine production (GO:0002724),-0.5036132656589888,-1.281816824782738,0.16237623762376238,0.5255736406668501,1.0,3/15,7.06%,B2M;CD55;TNFRSF1B
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.49223045760278006,-1.2816753993542866,0.16631578947368422,0.5249183341650445,1.0,7/15,30.25%,TGFB2;TGFB1;IRAK3;JAK3;TGFB3;SMAD7;CUEDC2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.560124935507909,1.2814478640876201,0.21487603305785125,0.6726571145373335,1.0,1/12,0.06%,UNC13C
prerank,heart trabecula morphogenesis (GO:0061384),0.49886790839334333,1.281364546998804,0.19718309859154928,0.6713915456412036,1.0,4/18,1.34%,TGFBR3;RBPJ;BMP7;RBP4
prerank,organonitrogen compound catabolic process (GO:1901565),0.40535373288578946,1.2810806738197587,0.12824675324675325,0.6707234472903657,1.0,9/57,7.52%,CPQ;CLPX;PLA2G10;GGACT;ACE;TPP1;ENPP2;NPEPPS;LIPC
prerank,Rho protein signal transduction (GO:0007266),0.41119426649460294,1.2807697134563165,0.15114235500878734,0.6701214777881579,1.0,10/53,7.96%,ROCK2;ARHGAP6;ARHGAP29;RHOD;PDPN;COL1A2;ARHGEF11;NTN1;EPS8L1;MYO9B
prerank,T cell receptor signaling pathway (GO:0050852),-0.31418826582514414,-1.2806533054000249,0.05014749262536873,0.5266273057094542,1.0,45/138,23.41%,PTPRJ;PDE4D;PLCG2;FYN;INPP5D;DENND1B;RFTN1;BCAR1;IKBKB;NCK1;PTPRC;TNFRSF21;CSK;PAK1;PSMD13;PSMF1;PAK2;PSMB10;PIK3CD;CHUK;PSMB6;STOML2;PSME3;PSMB5;MOG;PSMC3;PSMD12;PSMB8;CUL1;NFKBIZ;PSME1;EIF2B5;PSMB3;EIF2B2;BTN3A3;ZC3H12A;PSMD5;THY1;SKP1;TXK;FYB2;RBCK1;PSMD9;PSMB4;RELA
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.2967179607487473,1.2799853380141402,0.006688963210702341,0.6709136638460741,1.0,137/834,13.20%,IGF1;GLIS3;RORA;BMP6;TCF4;TCF7L2;OSR1;AUTS2;ARNT2;RBPJ;ZNF462;FGFR2;EPAS1;HLF;PPARA;NR2F2;PID1;IL18;HOXC4;CDK8;PRKN;WWOX;BRD8;ZEB2;KMT2A;MEIS1;DAB2;HOXB4;FHOD1;CSRP3;MYBL1;DMRT1;SCX;NR1I2;ASCL2;TBL1XR1;CITED4;PPARGC1B;HOXB3;RNASEL;NFYB;CDK7;IGF2;SSBP2;TFR2;NCOA2;STAT5B;MAML3;NFAT5;HDAC8;HOXA7;NFIB;TEAD1;ELF4;FIZ1;SOX1;WASL;DPF2;IRF8;FGF1;GLI3;TET1;ZMIZ1;MAML1;WWC1;IL6;SALL1;NCOA3;RFXAP;SMAD3;SSBP3;NCOA7;GABPB1;GABPB2;MTF2;TCF12;ABRA;CCNT2;RPRD1B;RSF1;CCNT1;NFIA;PCGF5;ARNT;GTF2F1;FSTL3;KAT8;MITF;KDM6B;KAT6B;CEBPG;IER5;IRF3;BCL9;MED1;AKAP8L;DVL3;AGO2;PHIP;ASXL2;ABL1;MED13;PRKDC;SMARCA5;ATOH8;HDAC1;PIK3R1;FLCN;TFAP2A;APLN;TFAP2B;RXRA;ZBTB38;MYB;NPAS2;BMPR1A;BCLAF3;CDC73;HSF1;PRKD2;PKD2;AR;HIVEP1;SERPINE1;KLF5;CRTC1;MAML2;CRTC3;GDNF;ZMIZ2;INO80;SMARCB1;HOXD4;TBK1;BCL2L12;NR1I3;FOXK2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5036709214542593,-1.279364349974798,0.18271119842829076,0.5291537524378329,1.0,4/15,13.20%,GRM3;GRM7;HOMER1;GRM8
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5354524580980004,1.279041843147771,0.2,0.6723650336143472,1.0,6/16,17.39%,AUTS2;KMT2A;BCOR;MYB;SMAD4;CTR9
prerank,regulation of fibrinolysis (GO:0051917),-0.5131891849790812,-1.2789651273791698,0.17008196721311475,0.5293135568953421,1.0,3/13,12.47%,THBS1;FAP;THBD
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.4828536510136443,-1.2787341947455475,0.1873767258382643,0.5288676891035142,1.0,11/16,32.68%,NOS3;GUCY1B1;GUCY1A1;DDAH1;NOS1;KCNC2;DDAH2;MAFA;CD36;AGT;NOS2
prerank,lipid modification (GO:0030258),-0.3948635348748148,-1.2784948703705759,0.13646055437100213,0.5284974164768692,1.0,10/37,12.63%,DGKH;PLPP1;MBOAT1;DGKB;DGKI;LPCAT3;PORCN;DGKZ;DGKG;ALOX12
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.40430851378990124,-1.2784814438154957,0.14224137931034483,0.52754684170997,1.0,17/32,24.25%,CALM1;HSP90AB1;PPIA;PPP1R16B;TGFB1;MTOR;SYMPK;CALM2;PPP2R5A;PTBP1;PRKCD;CDCA2;CD300A;NSMF;CALM3;PPP1R15A;PPP1R15B
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.5431679612670395,-1.2781229234336065,0.19813084112149532,0.5275422844872867,1.0,5/11,14.72%,KCNJ2;ATP1A1;ATP1B1;KCNQ1;KCNIP2
prerank,negative regulation of developmental process (GO:0051093),-0.34937578144896236,-1.277724701012669,0.10050251256281408,0.5276658247741643,1.0,18/69,10.79%,KLF7;NOS3;TFRC;GAS6;CST3;NOTCH1;TBX1;ARHGEF15;KANK1;TBX2;VAT1;TGFB1;DCC;GRIN3A;NOTCH4;HEY2;CDK6;BMP2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.49337135263432613,-1.2767859747504304,0.1593625498007968,0.5293292629251699,1.0,7/15,10.14%,BMPER;KLF4;PKM;ITGA5;VEGFA;TJP1;S100A1
prerank,homeostasis of number of cells (GO:0048872),-0.536366839579309,-1.2763555405834441,0.19284294234592445,0.5294280689755566,1.0,5/12,15.75%,NOS3;NOTCH1;CCN3;LPCAT3;CX3CR1
prerank,glycogen metabolic process (GO:0005977),0.47357613821707417,1.276100667715487,0.147117296222664,0.6794356445407392,1.0,4/27,9.46%,PRKAG2;PHKB;GYS1;NHLRC1
prerank,regulation of lipid metabolic process (GO:0019216),0.37346006116843283,1.275450409570959,0.13237639553429026,0.679840513533422,1.0,14/88,11.41%,PRKAG2;RORA;FGFR4;PPARA;TBL1XR1;NFYB;NCOA2;CHD9;PMVK;APOC1;NFYC;MED1;FDPS;RXRA
prerank,response to sterol (GO:0036314),0.5652753761749982,1.2747791209116772,0.19868995633187772,0.6803804705289038,1.0,1/11,0.14%,RORA
prerank,positive regulation of vacuole organization (GO:0044090),-0.5506427584789817,-1.2747063420989166,0.18236472945891782,0.5328086552219472,1.0,4/10,19.49%,SH3GLB1;GRN;RALB;PIP4K2A
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4314207664349964,1.2744440008585214,0.15488215488215487,0.6799257320969118,1.0,16/42,17.78%,RBBP4;HNRNPC;ARID1B;CECR2;NASP;CHD4;SMARCA5;HDAC1;SMARCE1;INO80;SMARCB1;SRCAP;SMARCA2;SMARCC1;ACTR6;SMARCA1
prerank,regulation of protein kinase C signaling (GO:0090036),0.5439092255411564,1.2743395137806952,0.21341463414634146,0.6786853558634061,1.0,2/14,2.01%,ADGRV1;GPD1L
prerank,regulation of ossification (GO:0030278),0.4378939619876189,1.2742664661600738,0.17810760667903525,0.6773864873233951,1.0,9/36,7.50%,RBPJ;LRP4;BMP2K;SMAD6;DKK1;ECM1;CHSY1;PTN;DDR2
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5302766788882204,1.2742360107600408,0.1987704918032787,0.6759716494693497,1.0,3/16,3.63%,RANBP3L;PLCB1;RIPOR2
prerank,lipid transport (GO:0006869),-0.32408489167549304,-1.274013615373516,0.05759162303664921,0.5335841335640115,1.0,31/97,19.43%,ABCC4;PITPNC1;CERT1;ATP8B1;SLCO1C1;ATP8A1;PLTP;SCARB1;SLCO2A1;SLCO2B1;PPARD;LBP;TNFAIP8L3;CEACAM1;SPNS2;MFSD2A;SLCO3A1;GLTP;ABCD3;ABCD2;STARD5;NR1H4;GM2A;ABCA3;PRELID3B;MTTP;CLN8;ABCA2;PITPNA;PITPNB;ABCG1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.4669722061378005,1.2739742267352592,0.16,0.6752638718480147,1.0,5/26,8.42%,RORA;CCBE1;SULF1;IL6;ARNT
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.3282316615293531,-1.273819986376059,0.06267806267806268,0.5331211441345481,1.0,31/95,24.30%,MEF2C;LBP;DAB2IP;VIM;CHMP5;SBNO2;TNFRSF1B;DEFA6;PDCD4;CYRIB;RHOA;MAPK8;XBP1;CD180;GIT1;CX3CR1;CARD16;CD274;ZC3H12A;ADAM9;IRAK1;TIRAP;MYD88;NR1H3;CASP1;TNFAIP3;PLAA;FCGR2B;RELA;CD80;CD68
prerank,cell chemotaxis (GO:0060326),0.3949445290817595,1.2727583707507928,0.15448504983388706,0.6772748433814062,1.0,9/60,4.40%,KIT;ACKR2;CCR9;LPAR1;CXCR5;PDGFRB;RAB13;CXCR6;PDGFRA
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.4072553232816327,-1.2727262175298504,0.12121212121212122,0.5350703678078143,1.0,10/30,18.40%,UBB;IKBKB;RPS27A;UBC;BIRC3;CHUK;CASP8;UBA52;CD40;UBE2D1
prerank,microtubule anchoring at centrosome (GO:0034454),0.560182852078005,1.2726856873254049,0.21626984126984128,0.6760202264425668,1.0,2/10,7.13%,NINL;CEP19
prerank,heart development (GO:0007507),-0.3037901874840644,-1.2721312114734438,0.05475504322766571,0.5356052138360547,1.0,34/150,11.43%,MEF2C;TEK;NTRK3;FN1;HEG1;SGCD;MEF2D;MICAL2;BMP5;ACVRL1;TGFB2;PTK2;RAMP2;NOTCH1;TBX1;BMPR2;CXADR;PKD1;SOX17;STRA6;TGFBR2;TBX2;SOX4;TGFB1;CRIP1;PDLIM7;VEGFA;LDB3;ECE1;CDKN1B;CACNA1C;BMP2;SOX18;NDRG4
prerank,nucleocytoplasmic transport (GO:0006913),0.42599207756425217,1.2720434724677938,0.1410488245931284,0.6764127274536873,1.0,10/40,19.87%,ATXN1;PHAX;NUTF2;SMN1;NEMF;NXT2;LSG1;RSRC1;GEMIN5;SNRPF
prerank,negative regulation of interferon-beta production (GO:0032688),0.5813376844278794,1.2715835173360752,0.2222222222222222,0.676233162937916,1.0,3/10,9.05%,CACTIN;NLRC3;SIRPA
prerank,SNARE complex assembly (GO:0035493),-0.5492559803786482,-1.2714245427904654,0.18773234200743494,0.5365703946487792,1.0,2/10,6.22%,STXBP6;VAMP8
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.39441717533810516,-1.2712670324984576,0.11936936936936937,0.536055752261801,1.0,19/38,22.38%,CAV1;KLF2;CD34;RAC1;HSP90AA1;HSP90AB1;KLF4;DDAH1;PTGIS;PTGS2;EDN1;CLU;CD47;CX3CR1;ZC3H12A;AKT1;ATP2B4;INSR;DDAH2
prerank,protein mannosylation (GO:0035268),0.4862547204705689,1.2707463924416298,0.19281663516068054,0.6772221257331866,1.0,4/22,4.37%,TMTC4;LARGE1;TMTC1;CRPPA
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.523074051751292,-1.2706988773390324,0.18181818181818182,0.5365981762029511,1.0,7/13,30.32%,LGMN;PERP;TBC1D10A;CASP8;CYFIP2;NLRC4;FADD
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5209955363249374,-1.2704444562538713,0.1834319526627219,0.5363445717220579,1.0,3/12,9.30%,TMEFF2;TGFB1;EDN1
prerank,membrane repolarization (GO:0086009),0.529385511193049,1.2699899375228565,0.19198312236286919,0.6779788483043152,1.0,3/15,4.07%,ATP1A2;ATP1B3;KCND3
prerank,regulation of cellular component biogenesis (GO:0044087),-0.389684583025828,-1.2695731799241534,0.14018691588785046,0.5377755877017066,1.0,10/39,7.89%,RAP1A;MSN;HSPA8;TIE1;HSP90AA1;DAB2IP;NOTCH1;HJURP;GFAP;TJP1
prerank,electron transport chain (GO:0022900),-0.4858581267456721,-1.269042820850307,0.17208413001912046,0.5382606213306173,1.0,8/15,32.56%,PDIA5;PPARGC1A;NDUFA5;ENOX2;CYB561;ETFB;POR;ETFA
prerank,cellular response to organic cyclic compound (GO:0071407),0.3490009419414514,1.2690034877927252,0.11419753086419752,0.6795420296397718,1.0,16/141,7.29%,RORA;ATP1A2;ROCK2;ADCY5;ADCY1;TFPI;IL18;SLC5A5;CRHBP;AANAT;SSTR2;LRRK2;NCOA3;UBE2L3;BLM;FOLR1
prerank,regulation of histone modification (GO:0031056),0.5464831502234226,1.268363788757786,0.19884169884169883,0.6799578492669801,1.0,6/13,19.37%,IGF2;MTHFR;AKAP8L;FLCN;NNMT;CDK9
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.4987734977893528,-1.2676427047448613,0.18255578093306288,0.5402014318379638,1.0,4/14,15.56%,ABCG2;SLCO2B1;HMOX2;BLVRB
prerank,heme catabolic process (GO:0042167),-0.4987734977893528,-1.2676427047448613,0.18255578093306288,0.5402014318379638,1.0,4/14,15.56%,ABCG2;SLCO2B1;HMOX2;BLVRB
prerank,B cell activation (GO:0042113),-0.3463632018352364,-1.2663173186683399,0.09951456310679611,0.5429581465809888,1.0,24/68,21.42%,MEF2C;PTPRJ;TPD52;KLF6;ITGB1;PLCG2;HDAC5;ITGA4;PTPRC;ZBTB7A;PIK3CD;HHEX;MSH2;HSPD1;RABL3;CASP8;FLT3;TCF3;CR2;CD40;DNAJB9;JAK3;ADGRG3;HDAC9
prerank,potassium ion import across plasma membrane (GO:1990573),-0.38480365958939167,-1.2660163337680415,0.11946902654867257,0.5427974400958934,1.0,12/41,13.92%,SLC12A7;SLC12A2;KCNJ2;ATP1A1;ABCC9;ATP1B1;SLC12A6;SLC12A8;SLC12A4;ATP1A3;KCNJ8;KCNJ15
prerank,regulation of B cell proliferation (GO:0030888),-0.3886569344238888,-1.2654960119797978,0.15254237288135594,0.5432100147835492,1.0,15/44,20.83%,MEF2C;TFRC;NFATC2;CD38;PTPRC;TNFRSF21;AHR;CD74;CD81;MIF;CD40;TIRAP;TYROBP;NCKAP1L;CD300A
prerank,regulation of anoikis (GO:2000209),-0.4573350557479462,-1.264936563775269,0.18962075848303392,0.5437751521026837,1.0,8/19,16.05%,CAV1;PTK2;ITGB1;NOTCH1;ITGA5;TLE5;MYBBP1A;BRMS1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.46211825650332494,-1.2647946912358676,0.17473684210526316,0.543199027629667,1.0,9/18,33.00%,ATXN3;NCK1;BAG6;XBP1;FCGR2B;BAX;ERN1;PMAIP1;RNF185
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.3233671400452791,-1.2645104833628227,0.1008174386920981,0.5429037227901102,1.0,36/101,22.08%,MSN;THBS1;NIBAN1;HSP90AA1;KLF4;EEF2;VIM;NFKBIA;ATG7;RPL26;SOX4;TGFB1;PERP;FAF1;RPL5;MTOR;PYM1;EIF4G1;EIF3D;BCL3;OGT;YTHDF3;RPS4X;TBC1D10A;RPS27L;NR1H2;CASP8;EIF3C;VPS11;AGTR1;CYFIP2;AKT1;METTL3;FMR1;EIF6;NR1H3
prerank,organic acid transport (GO:0015849),0.3647893907492099,1.2643159383674887,0.1406003159557662,0.6905250702991618,1.0,21/94,11.41%,SLC7A11;SLC6A13;SLC13A3;SLC38A3;SLC6A12;ACSL1;PDPN;NCOA2;SLCO1B1;SLC43A1;SLC13A5;FOLR1;FOLR2;ABCC2;SLC1A5;SLC25A11;SLC27A1;SLC22A6;SLC19A1;SLC36A2;RXRA
prerank,detection of visible light (GO:0009584),0.5303149571756911,1.2638826232723355,0.2003853564547206,0.6902219031283979,1.0,3/16,6.43%,ABCA4;TULP1;GNAQ
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.3705048493421566,-1.2637405711090741,0.11990950226244344,0.5439482071038978,1.0,15/48,12.33%,TMSB4X;NOS3;RHOJ;KDR;THBS1;ETS1;ATP5F1A;HSPB1;GATA2;TGFB1;JCAD;VEGFA;PTGS2;PIK3C2A;MAP3K3
prerank,regulation of axon extension (GO:0030516),-0.3816072547336834,-1.2635666189740733,0.14027149321266968,0.5434151402057796,1.0,14/37,22.40%,SEMA7A;SHTN1;NRCAM;GSK3B;DNM2;RTN4;SEMA3G;DBNL;CDKL3;MT3;DBN1;L1CAM;RTN4R;SEMA3A
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.49884878878622796,-1.2634401069567835,0.18823529411764706,0.5428076567949625,1.0,4/14,19.40%,THBS1;IRAK3;CMKLR1;JAK3
prerank,negative regulation of cellular process (GO:0048523),-0.2662900169809015,-1.2633850817526846,0.005917159763313609,0.5419697475100108,1.0,105/521,12.79%,ZBTB7C;APBB2;SLIT2;PODXL;PTPRJ;FTH1;NOS3;IGFBP6;CD200;CD34;JAM2;ADAM10;BMP5;PLPP1;ACVRL1;TGFB2;PTPN14;CD9;CBFA2T3;PLXND1;TES;KLF4;PPP2R5C;ETS1;ADAM15;PPP1R13B;ADARB1;WNT9A;ROR2;PDE8A;PTK2B;DAB2IP;NGF;NOTCH1;NDRG3;RACK1;SH3BP4;SEMA4D;TGFBI;TBX1;FHL1;ARHGDIB;P3H2;BMPR2;SFRP4;SOX17;PLXNA4;CCDC85B;ACTN1;RERG;VPS13C;CCN3;WARS1;PINX1;SOX4;RHOB;TGFB1;NCK1;ARHGDIA;OSGIN2;FERMT2;CTNNB1;VAMP8;TNFRSF21;ST18;TOB1;TNFRSF1B;ATP8A2;DDAH1;MYH9;APBB1;PDCD4;APP;ADRA1A;CRYAB;NOTCH4;PTHLH;WNT16;AQP11;NR4A1;PODN;DYSF;ING4;RTN4;SESN2;APC;CDK6;SOX7;LPCAT3;CDKN1B;NCK2;BTG3;BMP2;NOS1;HGS;NDUFA13;IFI35;MEN1;PBRM1;GPER1;REST;CDH13;CASK;CLU;LMNA
prerank,cellular component assembly (GO:0022607),-0.282051181202169,-1.2626582555649533,0.0199203187250996,0.5430184161730695,1.0,49/253,11.66%,SPTBN1;ACTB;SLC2A1;ACTG1;OCLN;RHOJ;PARVB;LIMS2;RAC1;LIN7A;GAS6;GSN;PPARGC1A;PTK2B;STX7;REPS2;RTN3;HES1;NCKAP1;LIMS1;WIPF1;FLNA;PLS3;CAPZA2;TGFB1;FAM107A;SKAP2;FERMT2;VMP1;BAG6;RP1;GPM6B;BAIAP2L1;LRRTM3;ADD2;CARD10;PDCD10;IL1RAP;SHROOM1;STK25;MICAL1;EPS8;RHOA;RTN4;APC;CD2AP;ST13;YTHDF3;PCLO
prerank,activation of phospholipase C activity (GO:0007202),0.4521732024064704,1.2626568073061284,0.16793893129770993,0.6925538223839958,1.0,4/29,6.43%,ARHGAP6;LPAR1;LPAR2;GNAQ
prerank,lipid catabolic process (GO:0016042),0.49393196808323026,1.26257640817704,0.20318725099601595,0.6913088449850726,1.0,4/18,7.52%,CEL;ACADL;LIPH;LIPC
prerank,vacuolar acidification (GO:0007035),-0.4477369193225083,-1.261375139260295,0.16182572614107885,0.5453600803939008,1.0,13/21,26.57%,DMXL1;ATP6V0A1;GRN;TCIRG1;DMXL2;ATP6V0A4;ATP6V0A2;SLC11A1;ATP6V0D2;CLN5;ATP6V0E2;TMEM9;ATP6V1H
prerank,histone lysine demethylation (GO:0070076),0.4766289380844593,1.2609613005985938,0.21335807050092764,0.6947277344393243,1.0,12/25,18.39%,KDM7A;KDM2B;PHF8;KDM2A;KDM5B;KDM6B;KDM3B;KDM5C;KDM6A;PHF2;RIOX2;KDM4D
prerank,ERBB signaling pathway (GO:0038127),-0.3475205070710423,-1.2609356400670737,0.10858585858585859,0.5456011296799858,1.0,15/64,10.64%,GAB1;RPS6KA5;HSP90AA1;IQGAP1;CBL;PTK2;PTK2B;REPS2;PTPN12;BCAR1;TGFB1;CDC37;CPNE3;NCK2;PIK3C2A
prerank,B cell differentiation (GO:0030183),-0.3730365487644191,-1.260168037315261,0.1425287356321839,0.546709369865147,1.0,20/46,21.42%,PTPRJ;TPD52;KLF6;ITGB1;PLCG2;HDAC5;ITGA4;PTPRC;ZBTB7A;HHEX;MSH2;RABL3;FLT3;TCF3;CR2;IRF2BP2;DNAJB9;JAK3;ADGRG3;HDAC9
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.531537524318902,-1.260149399438565,0.17058823529411765,0.5457865156434598,1.0,5/11,24.02%,P3H2;EGLN3;EGLN2;P4HA2;P4HA1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.3430207705273103,-1.2598831714317131,0.11168831168831168,0.5455315384524043,1.0,18/70,15.79%,B2M;IKBKB;CALR;VAMP8;MFSD6;PSMD13;PSMF1;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;CYBB;PSMB3
prerank,negative regulation of protein binding (GO:0032091),-0.3403272158400001,-1.2598117278572598,0.11655011655011654,0.5447645601393222,1.0,26/71,21.70%,CAV1;ACTB;B2M;ADAM15;RACK1;ITGA4;GSK3B;ATP2A2;ATP2A3;MAPK8;CTNNBIP1;PPP1CA;RALB;TLE5;NES;ADRB2;DISC1;CTSZ;SYMPK;CARD16;TMBIM6;ARRB2;PRKCD;AKT1;TTBK2;CDKN1A
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.33596947253409276,1.2597700355248103,0.08978328173374613,0.6968052048196618,1.0,34/166,14.18%,RORA;RBPJ;PPARA;NOTCH2;POLR2D;ESRRG;CCN2;NR1I2;TBL1XR1;CDK7;MAML3;TEAD1;MAML1;NR6A1;NRBP1;POLR2A;TEAD3;RSF1;GTF2F1;MED1;TAF8;SMARCA5;HDAC1;TAF1A;POLR1F;RXRA;POLR1A;TAF3;AR;MAML2;NR1I3;TAF1D;CREBBP;MNAT1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.45950726918836765,1.2590474365997764,0.19038461538461537,0.6974130283389144,1.0,5/24,6.88%,ERRFI1;ROCK2;HOXA7;SGPP1;NCOA3
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.33726141071278,-1.2590415160727544,0.10209424083769633,0.5459929404993821,1.0,34/79,28.46%,CTSD;LGMN;AP2A2;CAPZA2;ACTR10;DYNLL2;ARF1;KIF26A;DNM2;MFSD6;AP2M1;DCTN3;CD74;CANX;SEC23A;AP1S2;DCTN4;KIF3B;SH3GL2;KIF11;AP2B1;KIF15;CTSL;DCTN1;AP2A1;FCGR2B;CAPZA1;RAB7A;KIF4A;KLC2;CTSE;SEC31A;KLC1;KIF23
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.5631254170679525,-1.2589233619712028,0.2037735849056604,0.5453107401837135,1.0,5/10,22.88%,PTPRC;CEACAM1;CX3CR1;ARRB2;FCGR2B
prerank,cellular response to ATP (GO:0071318),-0.49971257017613663,-1.258195884747983,0.1656686626746507,0.5462147010681916,1.0,9/14,42.35%,HSP90B1;SSH1;P2RY12;P2RY1;P2RX7;P2RX3;P2RY2;PDXP;CIB2
prerank,sulfur amino acid metabolic process (GO:0000096),0.47847333606300835,1.2579573244627802,0.22201492537313433,0.6992047672513712,1.0,5/24,10.60%,CBS;MSRA;MTHFR;AHCY;CDO1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.4652657297151861,-1.2576820401657909,0.1879049676025918,0.5466022521366916,1.0,4/17,8.27%,TGFB2;MID1;PDCD10;STK25
prerank,regulation of postsynapse organization (GO:0099175),-0.4150764708601014,-1.2570036791482613,0.14465408805031446,0.5474202772486737,1.0,10/28,10.46%,SHANK3;SIPA1L1;HOMER1;ZDHHC15;PPFIA2;ABHD17B;ABI3;SRCIN1;KIF1A;ABHD17A
prerank,negative regulation of transposition (GO:0010529),0.5044317569727172,1.2569392142495126,0.18404907975460122,0.7008430426814036,1.0,7/16,21.92%,MYBL1;UBR2;MOV10;TUT4;DDX4;PIWIL4;TUT7
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3861445376109626,-1.2568411075405814,0.12663755458515283,0.546906917743789,1.0,9/39,8.75%,UTRN;FXYD5;NEDD4L;FHL1;HOMER1;TRPC6;CHRM3;WNK3;FXYD6
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.4252024587429543,-1.2568065444026195,0.16837782340862423,0.5460178484855308,1.0,11/25,25.99%,HSPA8;BAG1;HSPA14;HSPA5;ST13;ERO1A;DNAJC7;DNAJB1;HSPA9;HSPA1B;HSPE1
prerank,protein autoubiquitination (GO:0051865),0.39522891024321843,1.2567344916406915,0.1424,0.6999295114608926,1.0,18/61,18.36%,RNF220;PRKN;RNF213;DDB2;SH3RF1;RNF181;WWP2;AMFR;MDM2;ITCH;SH3RF2;UBE2A;RNF122;RAD18;TRIM17;OBI1;DTX3L;TRAF6
prerank,phosphate ion homeostasis (GO:0055062),0.5830149066641918,1.255831708802703,0.23620309050772628,0.7010682329584335,1.0,3/10,11.08%,FGFR4;SLC34A3;TFAP2B
prerank,translational elongation (GO:0006414),-0.31884479627001766,-1.2555245081629793,0.07908163265306123,0.548390766055559,1.0,38/101,29.09%,EEF1A1;EEF2;RACK1;EEF1D;GFM1;MRPL32;MRPL33;MRPS14;MRPL38;EEF1G;ERAL1;MRPS16;MRPL50;MRPS5;MRPL23;MRPL24;EEFSEC;EEF1B2;MRPS35;MRPS28;MRPL13;MRPL35;GTPBP2;MRPL34;MRPS23;MRPS2;MRPS11;MRPS27;TUFM;MRPL57;MRPL11;MRPS18C;MRPL18;MRPL14;EEF1A2;AURKAIP1;GTPBP1;CHCHD1
prerank,telomere maintenance (GO:0000723),0.3992064608353189,1.2554809613752878,0.14930555555555555,0.7006099914716273,1.0,19/50,21.85%,SP100;HUS1B;ACD;XRCC5;BLM;TEP1;PRKDC;DCLRE1B;RTEL1;MRE11;APEX1;WRN;STN1;RAD51;TPRKB;POLD2;RAD50;NBN;TERF2
prerank,response to peptide hormone (GO:0043434),0.4158047230600793,1.255365776860792,0.17081260364842454,0.6994725020449636,1.0,4/43,3.68%,TGFBR3;ROCK2;ANXA1;STAT5B
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.38590177900908007,1.2551489784135943,0.15181518151815182,0.6986018275746174,1.0,16/66,12.12%,TGFBR3;ROBO1;FGFR2;MCC;NR2F2;DUSP10;NFIB;SULF1;NLRC3;MTSS1;NUPR1;BRCA2;MED1;ATOH8;CDC73;APOH
prerank,homocysteine metabolic process (GO:0050667),0.568531910960161,1.2550611123927022,0.24048096192384769,0.6973729147685462,1.0,2/11,5.55%,CBS;MTHFR
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.4265860139546448,1.2536016173557898,0.16493055555555555,0.7001935213949153,1.0,6/43,9.05%,IGF1;LTF;SYT11;CACTIN;NLRC3;SIRPA
prerank,neuron projection morphogenesis (GO:0048812),0.3449694962715186,1.2528108182127577,0.11879699248120301,0.7011287150998631,1.0,22/137,9.11%,DCDC2;ALCAM;FGFR2;NRK;BMP7;LRP4;GAS7;SDC2;PARD3;ALS2;DTNBP1;BAIAP2;NTNG2;WASL;LRRK2;LRP2;ARC;NBL1;PTEN;RYK;FARP1;MYO16
prerank,regulation of cellular localization (GO:0060341),0.4066029744663654,1.2525709420101012,0.16906474820143885,0.7003748265426497,1.0,10/46,11.21%,ADCY5;STXBP4;PARD6G;PRKN;FER;LRRK2;WWC1;CAMK2D;DVL3;MAD1L1
prerank,glycosphingolipid metabolic process (GO:0006687),-0.3779129075896001,-1.2525532503059162,0.15384615384615385,0.5557589225432504,1.0,11/42,10.98%,ST6GALNAC3;ESYT2;PSAP;ST6GALNAC5;SUMF1;ST8SIA1;SMPD4;HEXB;HEXA;CERK;GLTP
prerank,sterol biosynthetic process (GO:0016126),0.437478381276412,1.252375261017336,0.1685823754789272,0.6995188575841612,1.0,6/33,11.27%,PRKAG2;INSIG2;PMVK;ACAA2;ACAT2;FDPS
prerank,gland development (GO:0048732),0.3963953145843673,1.2521525101107804,0.14893617021276595,0.6987245743245468,1.0,10/59,7.10%,TGFBR3;WNT4;FGFR2;DKK3;ARID5B;ANXA1;PRKCSH;PCSK9;SALL1;ARHGAP35
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.406106493786696,-1.2518955197173114,0.16258351893095768,0.5566141483534025,1.0,12/34,17.60%,PDE4D;CALM1;ATP1B1;ATP2A2;KCNQ1;ADRA1A;RYR2;NOS1;CHGA;CALM2;PLN;ZC3H12A
prerank,cell-cell junction assembly (GO:0007043),-0.3514463449434567,-1.2518442146097453,0.10891089108910891,0.5557881737724398,1.0,17/63,9.55%,ACTB;CLDN5;ACTG1;CDH11;CTNND2;CD9;PKP4;CLDN11;CDH2;RAMP2;GJC1;GJD3;WDR1;CTNNB1;TJP1;RHOA;PAK2
prerank,synapse assembly (GO:0007416),-0.3433390856058153,-1.2505072687821153,0.09975062344139651,0.5584785524485898,1.0,12/67,8.78%,DNM3;SHANK3;SPOCK2;ADGRL3;CDH1;PLXND1;CDH2;GABRB3;KIRREL3;NRCAM;LRRTM3;NRXN1
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.3771146289670814,-1.2499667347434174,0.10930232558139535,0.5590458701520016,1.0,17/44,20.80%,CARMIL1;GSN;PTK2B;CDC42EP3;NCKAP1;NCK1;BAIAP2L1;NCK2;BIN1;WHAMM;CDC42EP5;SPIRE1;PRKCE;ARPC4;CDC42EP2;EVL;NCKAP1L
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4725567331596532,1.2495004654522492,0.1739961759082218,0.7053209293060946,1.0,3/22,4.78%,ROCK2;PPP4R4;PTPA
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.4305356090786757,-1.2490270770899492,0.18907563025210083,0.5606585203171991,1.0,9/24,20.47%,B2M;CALR;MFSD6;CANX;IDE;SEC23A;BCAP31;TAPBP;TAPBPL
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3865052182163017,1.248577200312849,0.14128440366972478,0.7066802403917916,1.0,7/59,8.27%,ALDH1A2;CYP27A1;HSD17B10;HOGA1;LIPH;LIPC;SRR
prerank,import into cell (GO:0098657),0.4242181458052181,1.2485063312562148,0.1763668430335097,0.7054381784007963,1.0,5/41,2.16%,ATP1A2;SLC22A4;SLC6A13;SLC22A2;SLC1A3
prerank,calcium ion import across plasma membrane (GO:0098703),0.5244414471920558,1.248419248493556,0.2345924453280318,0.7042495875642885,1.0,3/14,7.35%,SLC8A3;SLC8A1;CACNA2D1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.2997572297492885,1.2479640123301272,0.05054151624548736,0.7042331612167462,1.0,67/476,11.89%,IL31RA;IGF1;CREB5;RORA;TCF4;WNT4;ARNT2;ZIC1;PPARA;NR2F2;NPAS3;BMP7;KMT2A;ESRRG;ZIC2;MYBL1;SCX;NR1I2;TBL1XR1;PLCB1;SP100;TP53INP2;MYRFL;ZFP90;NFIB;TEAD1;ELF4;ARID1B;NDP;MSANTD1;GLI3;ZMIZ1;NIBAN2;PHF8;ARHGEF11;IL6;SALL1;SMAD3;BLM;PBX4;NEK4;RGMB;TRIM56;RSF1;KAT8;BRCA2;MITF;KAT6B;MAP3K2;PICALM;CREB3L2;NSD1;MED1;DVL3;PHIP;MED13;PARP9;ATOH8;HDAC1;TFAP2A;TFAP2B;TRIM45;RXRA;MYB;NPAS2;KMT2B;RNF14
prerank,regulation of endothelial cell migration (GO:0010594),-0.32228539258386535,-1.2478799389810271,0.0881542699724518,0.5628076232879956,1.0,28/85,10.16%,TEK;SLIT2;FOXP1;PTPRM;NRP2;RHOJ;BMPER;KDR;THBS1;RAC1;ACVRL1;SCARB1;PTK2;ETS1;PTK2B;DAB2IP;BMPR2;BCAR1;RHOB;CALR;EMC10;CEACAM1;FLT4;VEGFA;EMP2;GRN;EDN1;PIK3CD
prerank,phospholipid transport (GO:0015914),-0.35440835177804253,-1.2476768975600867,0.15914489311163896,0.5623843885976568,1.0,19/52,19.43%,ATP10A;PITPNC1;ATP8B1;ATP8A1;PLTP;SCARB1;TNFAIP8L3;ATP8A2;MFSD2A;ATP11C;ATP11B;TMEM30A;ATP11A;ABCA3;PRELID3B;MTTP;PITPNA;PITPNB;ABCG1
prerank,protein heterooligomerization (GO:0051291),-0.45998696448318555,-1.247417228917949,0.19367588932806323,0.5621663762059091,1.0,8/17,21.70%,PKD1;MAT2A;CPSF7;GRIN1;CPSF6;TMEM120A;FARSA;KCNC2
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.504253673083767,1.2464968199998592,0.20784313725490197,0.707037321582479,1.0,3/15,3.92%,PPARA;ADM;SLC45A3
prerank,nucleotide catabolic process (GO:0009166),-0.4675400865143734,-1.2460889448716348,0.20967741935483872,0.5649081854913328,1.0,8/16,26.75%,NT5C2;NUDT3;GDA;NT5C;XDH;NT5E;VCP;NT5C1A
prerank,regulation of T cell mediated immunity (GO:0002709),-0.539402475195871,-1.24605535137772,0.19845857418111754,0.5640275900840941,1.0,4/10,24.03%,TNFRSF1B;TRPM4;AGER;CCR2
prerank,muscle tissue morphogenesis (GO:0060415),0.5202328626589545,1.2453858809104403,0.21611001964636542,0.7089558123477429,1.0,2/16,2.34%,TGFBR3;MYLK
prerank,negative regulation of calcium ion transport (GO:0051926),0.530397742158373,1.2442798341759622,0.22267206477732793,0.7108019033939688,1.0,1/15,0.21%,ATP1A2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.5107311956035565,-1.2440995343259853,0.21814671814671815,0.5683976397932016,1.0,10/13,29.24%,RACK1;NCK1;HSPA5;PTPN1;WFS1;DNAJB9;PPP1R15A;PPP1R15B;BFAR;ABCA7
prerank,ERBB2 signaling pathway (GO:0038128),-0.40014917542024236,-1.2438430722320704,0.16741071428571427,0.5681192776034556,1.0,7/31,12.98%,GAB1;HSP90AA1;PTPN12;CDC37;MYOC;CPNE3;ERBIN
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.3280927548118719,-1.2435763590790403,0.09,0.5679314425638942,1.0,28/84,23.00%,UBB;BUB3;RPS27A;UBC;CUL3;ECRG4;PSMD13;PSMF1;PSMB10;FBXO31;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PTTG1;PSME1;ANAPC16;UBA52;PSMB3;CDK2;BUB1B;UBE2D1;PSMD5;ANAPC7;PSMD9;PSMB4
prerank,protein K63-linked ubiquitination (GO:0070534),0.4215074624659106,1.243420476030358,0.1996615905245347,0.7120330576979592,1.0,9/41,9.79%,PRKN;UBE2E2;TRIM5;NEDD4;RNF152;TRIM56;RNF135;WWP2;ITCH
prerank,cellular sodium ion homeostasis (GO:0006883),0.5152412616132781,1.2430437978847058,0.22127659574468084,0.7117015377653283,1.0,3/15,3.07%,ATP1A2;ATP1B3;SLC8A1
prerank,negative regulation of secretion (GO:0051048),-0.541287439534861,-1.242875418699317,0.2099236641221374,0.5688534696761963,1.0,7/10,30.72%,VAMP8;CD74;PTGER3;NR1H3;SPX;VAMP3;EGF
prerank,lymphocyte differentiation (GO:0030098),-0.33729284848433766,-1.2418852327836951,0.10886075949367088,0.570513108744641,1.0,27/68,21.42%,PTPRJ;TPD52;KLF6;ITGB1;PLCG2;SOX4;HDAC5;ITGA4;PTPRC;JAG2;LFNG;ZBTB7A;LMBR1L;PIK3CD;HHEX;IKZF1;MSH2;RABL3;FLT3;TCF3;CR2;TOX;DNAJB9;JAK3;DLL4;ADGRG3;HDAC9
prerank,regulation of telomerase activity (GO:0051972),-0.3679763055372502,-1.2417269880089343,0.15186915887850466,0.5699581024881555,1.0,9/45,11.31%,NEK7;HSP90AA1;HSP90AB1;KLF4;PINX1;CTNNB1;PARM1;MAP2K7;MEN1
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.4289190291550663,-1.241638716888565,0.16032064128256512,0.569228939397137,1.0,11/25,20.76%,CD200;ITGB1;CXADR;ITGA5;ITGA4;CTNNA3;ITGA7;JUP;DSG2;DSP;JAM3
prerank,regulation of pseudopodium assembly (GO:0031272),-0.5415683297599205,-1.241188092723939,0.2111111111111111,0.5685760106852383,1.0,4/10,18.41%,CDC42EP3;APC;CDC42EP5;CDC42EP2
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.5415683297599205,-1.241188092723939,0.2111111111111111,0.5685760106852383,1.0,4/10,18.41%,CDC42EP3;APC;CDC42EP5;CDC42EP2
prerank,mitochondrion morphogenesis (GO:0070584),0.5538581017316417,1.2408544984883847,0.22365591397849463,0.716788261618062,1.0,2/11,4.45%,PID1;WASF1
prerank,response to lipopolysaccharide (GO:0032496),-0.300017932498348,-1.2404243460881068,0.06752411575562701,0.5695893037266109,1.0,43/138,24.30%,MEF2C;FOXP1;NOS3;SCARB1;LBP;DAB2IP;VIM;CHMP5;GCH1;SBNO2;TNFRSF11A;TNFRSF1B;DEFA6;PDCD4;RHOA;MAPK8;XBP1;NOS1;CD180;GIT1;IRAK3;ERBIN;HNRNPA0;CX3CR1;CARD16;CD274;ZC3H12A;ADAM9;IRAK1;TIRAP;MYD88;SLC11A1;LIAS;NR1H3;CASP1;TNFAIP3;GGT1;PLAA;PELI1;IFNAR1;RELA;CD80;CD68
prerank,gonad development (GO:0008406),0.4107880973668062,1.2404238132530434,0.16987740805604204,0.7166185763419615,1.0,8/41,12.50%,WNT4;NR2F2;KIT;LRP2;SALL1;NUP107;FGF9;AR
prerank,regulation of protein binding (GO:0043393),-0.30856132060745173,-1.2400757788539207,0.0975609756097561,0.569519973198234,1.0,31/114,16.03%,CAV1;ACTB;CLDN5;B2M;EPB41;TIAM1;RPL11;RACK1;PKD1;HDAC5;GSK3B;ADD2;HIP1R;APP;PRMT8;DERL1;MAPK8;CTNNBIP1;PPP1CA;RALB;TLE5;BMP2;CRK;MEN1;MARK2;NES;IDE;DISC1;CTSZ;SYMPK;CARD16
prerank,tyrosine metabolic process (GO:0006570),0.5436288609093729,1.2399758776407752,0.21810699588477367,0.7164331466841152,1.0,3/11,15.20%,FAH;DCT;GSTZ1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.4684759898720558,1.2398684635203083,0.21223709369024857,0.7153174144718467,1.0,5/26,12.46%,ATP1A2;GSTM2;THADA;GNB5;PKD2
prerank,vasoconstriction (GO:0042310),-0.520517565635713,-1.2397495775663792,0.20939334637964774,0.5694565070600394,1.0,4/11,10.64%,EDNRA;ACTA2;EDN1;PIK3C2A
prerank,zinc ion transport (GO:0006829),-0.4401581754269066,-1.239729505910032,0.20041753653444677,0.5685500307127157,1.0,6/21,13.96%,SLC30A5;SLC39A8;SLC30A1;SLC39A7;SLC39A14;MT3
prerank,exit from mitosis (GO:0010458),-0.5090134864671502,-1.239608148140528,0.196,0.5679197164000377,1.0,8/12,40.21%,EPS8;PPP2R2D;SIRT7;CHMP7;CLASP2;CLASP1;UBE2C;UBE2S
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.4573477660090194,1.2395508554887178,0.2,0.7148116902926541,1.0,3/25,3.96%,CEMIP;PDPK1;ANK2
prerank,2-oxoglutarate metabolic process (GO:0006103),0.5330338563051102,1.2393754077410353,0.20507399577167018,0.7139232875681195,1.0,4/13,13.41%,ADHFE1;IDH2;PHYH;AADAT
prerank,microvillus assembly (GO:0030033),-0.4931471061716175,-1.2392579538603625,0.21923076923076923,0.5679358193410194,1.0,3/14,4.05%,RAP1A;FXYD5;MINK1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.4925358420856151,1.2382793165369552,0.22178217821782178,0.7159524210597046,1.0,5/18,13.42%,ADAMTS9;FBXO44;FBXO6;DERA;NGLY1
prerank,postsynaptic membrane organization (GO:0001941),0.4957703127935801,1.2382222869636046,0.21138211382113822,0.7147092325259108,1.0,6/17,11.34%,LRP4;CEL;NLGN2;DNAJA3;MUSK;DLG4
prerank,potassium ion transport (GO:0006813),0.3406916077982742,1.2380764806839126,0.12576687116564417,0.7137253523938037,1.0,9/120,4.07%,ATP1A2;SLC24A3;KCNK2;KCNQ4;NALCN;KCNA5;SLC1A3;ATP1B3;KCND3
prerank,regulation of metal ion transport (GO:0010959),0.5112565732870812,1.2377368465480048,0.24173553719008264,0.7133340648435108,1.0,5/16,7.35%,STIM1;BCL2;ANK2;DLG1;CACNA2D1
prerank,regulation of signal transduction (GO:0009966),0.3245614737269605,1.237531433120644,0.11221590909090909,0.7124862000281839,1.0,32/190,11.33%,DCDC2;IGFBP2;RORA;SLC8A3;ZIC1;FGFR2;TULP3;NCAM1;PLCB1;INTU;SP100;TRIM5;DTNBP1;IRAK2;IGFBP4;LLGL2;SULF1;LRRK2;ITGA3;TCF7L1;GRK3;ZDHHC3;AMFR;GRK5;GRK4;FBXL17;IGFBP7;WDR11;DHRS3;GNG7;DTX1;LLGL1
prerank,axonogenesis (GO:0007409),-0.28046305327713456,-1.2362648779921037,0.04814814814814815,0.575355518387504,1.0,55/237,12.43%,SPTBN1;GAB1;SLIT2;BSG;EFNA5;SHANK3;KLF7;ACTB;SEMA6A;NRP2;SEMA7A;SH3KBP1;SEMA6D;RPS6KA5;HSP90AA1;MAP1B;SEMA3C;HSP90AB1;S100A6;PTK2;UNC5C;LAMA1;TNR;UNC5D;FYN;NOTCH3;NOTCH1;SEMA4D;SEMA3E;SHTN1;B4GALT5;NRCAM;LAMA5;TUBB3;ROBO4;LAMA3;DCC;PDLIM7;APBB1;APP;NRXN1;GFRA2;SEMA4B;SEMA5B;SEMA6C;PIK3CD;LYPLA2;RELN;SEMA3G;EPHB1;SLITRK5;EFNB3;GPC1;SPTBN4;LMTK2
prerank,calcium ion import into cytosol (GO:1902656),0.506879529922961,1.2362370600024928,0.2455795677799607,0.7148620074965893,1.0,3/15,7.35%,SLC8A3;SLC8A1;CACNA2D1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.4579931179206308,-1.2358611570941411,0.22567287784679088,0.5754075481125079,1.0,11/17,35.63%,PKD1;CCNY;CCNYL1;AKT1;RGCC;PSMD10;PSRC1;PROX1;CCND1;ADAM17;CCND3
prerank,protein dephosphorylation (GO:0006470),0.33648915253648437,1.235446005773969,0.1299093655589124,0.7158093270954652,1.0,15/135,5.50%,EYA4;EYA1;PTPN13;PPP2R2B;EYA2;LHPP;PPM1M;PTPN4;DUSP10;SSU72;PPM1E;CDC14B;PTPRA;MTMR3;PTPN9
prerank,response to X-ray (GO:0010165),0.520779236654233,1.2354042807184793,0.23790322580645162,0.7145311861662335,1.0,4/14,7.25%,ANXA1;XRCC5;BLM;XRCC4
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.2967331867754822,-1.2352161814960088,0.0975609756097561,0.5762472874971106,1.0,36/151,14.86%,TEK;NTRK3;RAP1A;SEMA7A;BMPER;KDR;GAS6;ROR2;PDE8A;PTK2B;NOTCH1;ACKR3;ROR1;TNFAIP8L3;TGFB1;CD44;FERMT2;PTPRC;ARRB1;TNFRSF11A;PDGFC;APP;FLT4;ADRA1A;NPNT;HTR2A;MAP2K7;BMP2;GCNT2;NDRG4;GPER1;CD74;MAP3K12;MT3;DSTYK;CSF1R
prerank,regulation of smooth muscle contraction (GO:0006940),-0.44122744445658435,-1.2350979549189702,0.19532908704883228,0.5756205403860996,1.0,5/20,12.75%,CAV1;KCNB2;CHRM3;ATP2B1;ADRB2
prerank,regulation of wound healing (GO:0061041),-0.37954002453565083,-1.2345401916157972,0.16780045351473924,0.5761904421740422,1.0,12/42,13.40%,CAV1;ACTG1;OCLN;PTK2;ITGB1;KANK1;CD109;AJAP1;CRK;CASK;SRSF6;CADM4
prerank,metal ion transport (GO:0030001),-0.32059619128400224,-1.2345206113856801,0.11235955056179775,0.5752903715686357,1.0,32/86,19.26%,CAV1;TPT1;TRPC3;RAMP2;MAGT1;FYN;SLC30A5;ATP2C1;SLC3A2;GRIN3A;CACNA1E;ATP2A3;NIPAL3;RAMP1;SLC39A8;TRPC4;RYR2;CACNG3;SLC30A1;CACNA1C;NDFIP2;NIPAL4;SELENOK;PANX1;MT3;CALCRL;TRPC1;CACNA1B;NIPAL2;NIPA2;CACNB3;PSEN1
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.3911302319929964,-1.2341534175464357,0.19686800894854586,0.5753660752571217,1.0,13/34,25.74%,MEF2C;GSK3B;GRIN1;GABRG3;INSYN2A;ARRB2;AKT1;GABRA5;GRID2;GABRE;MAPK8IP2;GABRG2;GLRA1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5525947142385137,1.2338614576418725,0.2330508474576271,0.7175643997345803,1.0,1/11,0.45%,COLEC12
prerank,metanephros development (GO:0001656),0.4557765728447057,1.2337326707892167,0.2100371747211896,0.7165262109488973,1.0,4/26,4.24%,OSR1;BMP7;CTSH;FOXD1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.4303720460980391,-1.2336516126376031,0.15145631067961166,0.5757161144816219,1.0,9/23,14.98%,SLIT2;MSN;THBS1;BMP5;PTK2;STK10;CMKLR1;CSF1R;AKIRIN1
prerank,regulation of actin nucleation (GO:0051125),-0.515333179059468,-1.2334469564820034,0.2111801242236025,0.5753805866588267,1.0,8/12,34.40%,GSN;ARF1;WHAMM;PICK1;ARFIP2;ARFIP1;CORO1A;SCIN
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.34045152438341236,-1.2323452105936907,0.12628865979381443,0.5776048068074203,1.0,27/72,23.41%,CARD10;CARD14;BIRC3;PSMD13;PSMF1;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;COPS8;PSMB3;IRAK1;TNFRSF10B;TIRAP;PSMD5;AKT1;SKP1;PSMD9;PSMB4;NFKB2;RELA
prerank,BMP signaling pathway (GO:0030509),0.3846675291819029,1.2317000762411905,0.1840277777777778,0.7211822429210021,1.0,6/62,2.67%,TGFBR3;BMP6;BMP7;SMAD6;SLC39A5;SCX
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.48884242231581326,1.2315377549526927,0.22645290581162325,0.7202597433262129,1.0,3/18,9.40%,ROCK2;EPHA4;PICALM
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.44047099824934655,-1.2315376810908496,0.20253164556962025,0.5787361217728818,1.0,12/20,35.63%,HSP90AB1;PKD1;CCNY;CCNYL1;AKT1;RGCC;PSMD10;PSRC1;PROX1;CCND1;ADAM17;CCND3
prerank,axonal fasciculation (GO:0007413),0.5277952977442122,1.2311437586047054,0.25,0.7200553072231652,1.0,3/12,7.10%,EPHA3;EPHA4;ARHGAP35
prerank,myoblast fusion (GO:0007520),0.5546562857267568,1.2311023780553492,0.24110671936758893,0.7187785697519951,1.0,3/12,2.21%,ADAM12;ADAMTS5;ADAMTS15
prerank,inner ear morphogenesis (GO:0042472),0.46906853303581897,1.2309178830169047,0.2414486921529175,0.7178978775052968,1.0,2/22,1.00%,ZIC1;FGFR2
prerank,dendrite morphogenesis (GO:0048813),0.4227498050533033,1.2308235099140268,0.22264150943396227,0.7167780025277913,1.0,8/35,9.00%,DCDC2;LRP4;SDC2;WASL;PTN;ARC;PTEN;FARP1
prerank,regulation of transmembrane transport (GO:0034762),-0.4006623049288288,-1.2299351773881464,0.18336886993603413,0.5823718537634159,1.0,5/31,2.60%,ACTB;SLC2A1;OCLN;KCNJ2;NEDD4L
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3037743541970514,1.229868943572629,0.07360406091370558,0.7182471113122602,1.0,34/348,6.13%,IGF1;ROBO1;BMP6;SLC24A3;ROCK2;OSR1;SLC22A2;RBPJ;FGFR4;AFDN;WNT6;PID1;BMP7;ANGPT1;PRKN;RBMS3;DKK1;SCX;NOS1AP;CTSH;DTNBP1;PCSK9;SRPK2;ITGAX;ANK2;MBIP;FOXD1;MAPK9;TNRC6B;GJA1;TNRC6A;FGF1;SLC2A10;EPHX2
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.39608941909086237,-1.229445935977045,0.16952789699570817,0.582691089160436,1.0,15/30,33.16%,HSPA8;SELENOF;BAG1;HSPA14;HSPA5;ST13;ERO1A;DNAJC7;DNAJB1;HSPA9;HSPA1B;HSPE1;CHCHD4;UGGT1;HSPA1A
prerank,regulation of cellular respiration (GO:0043457),-0.46649746907160444,-1.2292845585577588,0.21200750469043153,0.5822209828925888,1.0,9/17,35.50%,CBFA2T3;PRDM16;IDE;NOP53;VCP;IFNAR1;NOS2;PRELID1;IFNLR1
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.5158889743785511,-1.2292353431217644,0.220675944333996,0.5814099184198759,1.0,5/11,17.34%,RTN4;LPCAT3;BNIP1;ATL2;ARL6IP1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.49321266039400197,-1.2282523728163934,0.21212121212121213,0.5831405552173818,1.0,5/13,6.37%,NFKBIA;PKD1;FLNA;YWHAB;GOPC
prerank,chordate embryonic development (GO:0043009),0.38950613334364426,1.2277924990713875,0.18568994889267462,0.7231692554651775,1.0,7/55,5.24%,ALDH1A2;ARNT2;FGFR2;BMP7;RBP4;IGF2;SULF1
prerank,histone lysine methylation (GO:0034968),0.4314359691646311,1.2274650577576454,0.2101313320825516,0.7228007541571188,1.0,10/33,18.52%,KMT2A;PRDM5;ASH2L;SETD6;SMYD3;KMT2B;KDM6A;N6AMT1;WDR82;DYDC2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.4047125421775871,1.2272009498783178,0.19148936170212766,0.7221807278606707,1.0,3/41,5.83%,PRKAG2;LACC1;NDC1
prerank,calcium ion transmembrane transport (GO:0070588),0.3620271782782675,1.2267441792361315,0.1619047619047619,0.7221307001672305,1.0,13/86,10.46%,TRPM3;SLC24A3;SLC8A3;NALCN;SLC8A1;CACNA1D;MAIP1;TRPC4AP;CACNA2D1;MCU;YME1L1;MCOLN3;MICU1
prerank,regulation of vacuole organization (GO:0044088),0.48169475535966577,1.2266491446520067,0.2178988326848249,0.7210225670491484,1.0,3/20,5.39%,NPRL3;NPRL2;MTMR3
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.40005946472303133,-1.2257355118288549,0.18201284796573874,0.5891400541743992,1.0,11/27,19.88%,UBB;RPS27A;UBC;MAP3K1;HSPD1;IRAK3;TAB3;UBA52;IRAK1;TIRAP;MYD88
prerank,actin-myosin filament sliding (GO:0033275),0.4114753728796001,1.2256254225531789,0.20106761565836298,0.7213655002438661,1.0,4/38,2.80%,TPM1;DMD;TNNC1;TNNT2
prerank,muscle filament sliding (GO:0030049),0.4114753728796001,1.2256254225531789,0.20106761565836298,0.7213655002438661,1.0,4/38,2.80%,TPM1;DMD;TNNC1;TNNT2
prerank,autophagosome maturation (GO:0097352),-0.396799551074644,-1.2255711382139811,0.18604651162790697,0.5886534549236878,1.0,11/32,22.45%,CALM1;VMP1;VTI1B;VAMP8;ATP2A2;MAP1LC3B;SNX14;GABARAPL1;VCP;CHMP3;LIX1
prerank,histone H2B ubiquitination (GO:0033523),0.5542981904233295,1.2252200412615177,0.24476987447698745,0.7211360010852024,1.0,7/10,22.88%,CDC73;RNF20;CTR9;UBE2E1;DTX3L;PAF1;WAC
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.46483111131563576,-1.2251006806419513,0.2158859470468432,0.5890209217641924,1.0,10/17,28.35%,COX4I1;COX6C;NDUFA4;COX6A1;COX7C;COX8A;COX5A;CYCS;COX15;COX4I2
prerank,heterochromatin organization (GO:0070828),-0.4826701996700086,-1.2242702692808043,0.2124756335282651,0.5903684071801916,1.0,4/14,11.47%,MECOM;PRDM16;SMCHD1;BAHD1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.4051526293147306,-1.2241548763685843,0.20085470085470086,0.5897089895961177,1.0,14/29,24.27%,ELOVL7;ELOVL5;ACSL4;ACACA;ELOVL6;ELOVL1;FASN;ACSL3;TECR;SCD5;ACLY;ACSL5;SCD;ACSF3
prerank,regulation of programmed cell death (GO:0043067),-0.2930567569859246,-1.2239438630105324,0.08832807570977919,0.5894137392896385,1.0,48/161,22.41%,MECOM;HIP1;ACTN4;ACER3;ACER2;TPT1;HSP90AA1;TARDBP;PPP1R13B;SLK;RPS3;TGM2;ACTN1;BCAR1;PERP;CALR;CTSB;LGALS1;LRP8;BIRC3;MAGED1;ZBTB7A;RTN4;BCL3;RSL1D1;CLU;FAS;MADD;FLT3;WFS1;BRMS1;RAF1;SGK1;RTKN;DCPS;RABGGTB;CDK5;TIGAR;PINK1;TNFRSF10B;JAK3;NOP53;AKT1;RABGGTA;PAX8;VCP;CASP1;OSGIN1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.2927908783094235,-1.223747085617738,0.08950617283950617,0.5890636949583127,1.0,42/151,11.33%,MEF2C;NTRK3;EEF1A1;RAP1A;SEMA6A;PDE3A;KDR;ACVRL1;IQGAP1;KLF4;RAMP2;MT1G;PDE8A;DAB2IP;NOTCH1;RACK1;TBX1;BMPR2;PTPN12;LIMS1;LGMN;HSPB1;BCAR1;TGFBR2;TGFB1;CD44;EHD1;CTNNB1;CLEC3B;PDE2A;SMAD9;STMN2;FLT4;VEGFA;RUNX2;NR4A1;CPNE3;APPL1;ZFP36L1;BMP2;NOS1;DUSP3
prerank,pancreas development (GO:0031016),0.5239183939735232,1.2235052968625992,0.23625254582484725,0.7248046888798214,1.0,1/12,0.51%,TCF7L2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.32829447257583333,-1.2234881389887549,0.11842105263157894,0.5878812180851459,1.0,33/78,28.46%,CTSD;LGMN;AP2A2;CAPZA2;ACTR10;DYNLL2;ARF1;KIF26A;DNM2;AP2M1;DCTN3;CD74;CANX;SEC23A;AP1S2;DCTN4;KIF3B;SH3GL2;KIF11;AP2B1;KIF15;CTSL;DCTN1;AP2A1;FCGR2B;CAPZA1;RAB7A;KIF4A;KLC2;CTSE;SEC31A;KLC1;KIF23
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.32829447257583333,-1.2234881389887549,0.11842105263157894,0.5878812180851459,1.0,33/78,28.46%,CTSD;LGMN;AP2A2;CAPZA2;ACTR10;DYNLL2;ARF1;KIF26A;DNM2;AP2M1;DCTN3;CD74;CANX;SEC23A;AP1S2;DCTN4;KIF3B;SH3GL2;KIF11;AP2B1;KIF15;CTSL;DCTN1;AP2A1;FCGR2B;CAPZA1;RAB7A;KIF4A;KLC2;CTSE;SEC31A;KLC1;KIF23
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.39213961394526825,-1.223463503257204,0.19383259911894274,0.5870038042028912,1.0,15/32,27.61%,STMN2;NAV3;APC;ARHGEF2;STMN1;APC2;TUBB4A;FKBP4;MAPRE1;TTBK2;CLASP2;SPEF1;CAMSAP3;CAMSAP1;FGF13
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5127114571084624,-1.2232918611853731,0.23224568138195778,0.5865633815888847,1.0,3/12,5.70%,PRKG1;MEF2C;IGFBP5
prerank,ATP transport (GO:0015867),-0.5309239199233523,-1.223130297939432,0.22440944881889763,0.5860726356261068,1.0,5/10,27.57%,SLC25A42;CD47;SLC17A9;SLC25A4;ABCC6
prerank,muscle tissue development (GO:0060537),-0.4955875267209162,-1.2229562981671287,0.232421875,0.5856208593101424,1.0,5/13,7.93%,PGM5;ENG;STRA6;PTCH1;CSRP2
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.5035248593674421,-1.2226675866899466,0.22330097087378642,0.5855421670348882,1.0,6/12,29.09%,MAOA;DDC;AMD1;SRM;SMS;ODC1
prerank,respiratory system development (GO:0060541),0.4390419249378817,1.2218509027217934,0.19744058500914077,0.7283974114909907,1.0,6/32,5.54%,FGFR2;RBP4;LOXL3;PDPN;FGF1;ITGA3
prerank,cellular response to mechanical stimulus (GO:0071260),-0.36295359941542216,-1.2216987136152648,0.1506172839506173,0.5872568435134302,1.0,15/46,22.24%,PIEZO2;F11R;PIEZO1;PDE2A;MAPK8;MAP3K1;CASP8AP2;FAS;CASP8;CD40;TNFRSF10B;MYD88;GADD45A;MAPK3;CASP1
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.3135801000522957,-1.221570596743577,0.13736263736263737,0.5866688535177653,1.0,40/98,22.08%,SLCO1C1;NSF;THBS1;KLF4;PPARD;NFKBIA;SFRP4;CHCHD2;TGFBR2;TGFB1;ARRB1;GHITM;ACACA;VEGFA;CD63;ECE1;EIF4G1;RAB1A;XDH;ACE2;PICK1;ROMO1;MT3;NR1H2;FASN;ZC3H12A;AGTR1;GREM1;RAB1B;INPP5F;ARRB2;ACLY;AKT1;INSR;FMR1;ATAD1;PAX8;GADD45A;CDKN1A;NR1H3
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.5085614227655668,-1.221553384364227,0.2339622641509434,0.5857836460542429,1.0,7/12,36.46%,PLCG2;RAB27A;GRIN1;TLR4;CD36;TLR6;ADGRB1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4197142126810592,1.2214022045434803,0.21288014311270126,0.7283413632425066,1.0,6/38,9.38%,LEPROT;PRKN;LRRK2;UBE2L3;NPEPPS;HSPA1L
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.5183030800391137,-1.2209328347351651,0.21284403669724772,0.5865515511280774,1.0,3/11,7.28%,PTPRC;CEACAM1;AHR
prerank,regulation of developmental growth (GO:0048638),0.44227826705631124,1.2205945901328785,0.20593692022263452,0.7294583403300079,1.0,6/29,10.44%,IGF1;PLCB1;STAT5B;MUSK;LATS1;ABL1
prerank,cellular response to inorganic substance (GO:0071241),-0.4376254096574985,-1.2204712941733586,0.2182952182952183,0.5868989277836411,1.0,8/21,21.98%,GUCY1B1;FOXO1;SPIDR;MT3;CDK2;FMR1;KCNC2;RTF2
prerank,positive regulation of translation (GO:0045727),-0.31315459649303357,-1.2201256959297238,0.11479591836734694,0.586887654643341,1.0,32/94,22.06%,THBS1;NIBAN1;RPS9;EEF2;VIM;PKM;RPL26;SOX4;YBX3;RPL5;MTOR;RCC1L;PYM1;EIF3D;UQCC2;BCL3;YTHDF3;RPUSD4;RPS4X;RPS27L;EIF2B5;EIF3C;POLR2G;EIF5A;EIF5AL1;FASTKD3;TRUB2;METTL3;FMR1;EIF6;UHMK1;TRMT10C
prerank,regulation of coagulation (GO:0050818),-0.5118120766155383,-1.2198902430802165,0.23754789272030652,0.5865757028023022,1.0,3/11,17.68%,CAV1;HS3ST5;PROCR
prerank,negative regulation of protein secretion (GO:0050709),-0.3859890394430773,-1.2197210993699814,0.1826086956521739,0.5860733519898749,1.0,11/38,14.03%,CD200;KCNB1;CCN3;RAB11FIP1;RHBDF2;REST;RSAD2;CHGA;RAB11FIP5;CYP51A1;SIRT4
prerank,positive regulation of biosynthetic process (GO:0009891),0.407688589543138,1.2161806973716394,0.18691588785046728,0.7415170915885966,1.0,5/40,2.79%,WNT4;PPARA;SORBS1;SCX;ZBTB20
prerank,sphingolipid catabolic process (GO:0030149),-0.48103551537040695,-1.215968784407128,0.24266144814090018,0.5955280545521023,1.0,4/15,7.97%,ACER3;ACER2;SMPD4;SGPL1
prerank,regulation of secretion (GO:0051046),-0.4829486127669377,-1.2158585501431871,0.2198019801980198,0.5949012090772451,1.0,5/13,17.75%,KCNQ1;OAS2;POFUT2;SGK1;ACSL3
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3327111542679014,1.2157888964179233,0.14407988587731813,0.7413374416279961,1.0,19/140,7.96%,ARHGAP28;ARHGAP24;ARHGAP6;GMIP;ARHGAP29;CGNL1;FGD4;RHOD;ARHGAP20;SYDE2;ARHGAP26;SOS2;AKAP13;ARHGAP12;ARHGAP40;ARHGEF11;ARHGAP35;ARHGAP9;MYO9B
prerank,histone H2A ubiquitination (GO:0033522),0.48335451688539244,1.2151637181026291,0.23711340206185566,0.7418148627293829,1.0,9/17,17.61%,DDB2;RNF2;KDM2B;BCOR;UBR2;CUL4B;UBE2A;PCGF1;DTX3L
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.4050996098257074,-1.2144478026880499,0.19665271966527198,0.5978692656668919,1.0,8/25,20.80%,ITGA6;THBS1;APP;KCTD20;MIF;PSEN1;ANG;NCKAP1L
prerank,supramolecular fiber organization (GO:0097435),-0.26369752557314197,-1.2142802299006104,0.056338028169014086,0.597425667365176,1.0,106/333,19.34%,COL8A1;PGM5;HIP1;COL25A1;MYO1D;ELMO1;COL6A3;COL12A1;B2M;TLL1;SHROOM4;ITGA6;COL8A2;COL4A1;ADAM10;RAC1;TGFB2;CARMIL1;ITM2B;CST3;GSN;HSP90AB1;ITGB4;COL5A2;COL6A2;PLEC;SLK;VIM;UBB;TGFBI;P3H2;COL15A1;CLIP1;COL6A1;ACTN1;TNXB;MYH11;CORO1C;BCAR1;COLGALT2;CLIP2;RHOB;LUM;CCDC88A;LAMA3;COL27A1;RPS27A;UBC;COL14A1;ADAMTS14;GFAP;MARCKS;CHP1;HIP1R;STMN2;APP;EMP2;SHROOM1;COLGALT1;H3-3A;RHOA;PPIB;FURIN;ARHGAP25;COL16A1;CD2AP;MFAP4;PLOD2;MTM1;ERMN;MYO5A;WHAMM;ARHGEF2;COL4A2;STMN1;IAPP;ALDOA;INPPL1;COL1A1;NF1;HOOK1;MARCKSL1;TPM3;CYP1B1;TPM4;COL3A1;UBA52;CCDC88C;TPPP;RHOG;STMN4;P4HA2;COL5A3;TPPP3;TMOD1;USP9X;COL28A1;DSP;GREM1;PLOD3;CDC42EP2;STMN3;EVL;ADAMTS3;CKAP5;FLII
prerank,stabilization of membrane potential (GO:0030322),0.49656654295964975,1.2140435657857138,0.25256673511293637,0.7438390265965307,1.0,1/16,0.38%,KCNK2
prerank,motor neuron axon guidance (GO:0008045),-0.46077836252384813,-1.2139149584250706,0.24271844660194175,0.5974851733148608,1.0,4/15,7.56%,SLIT2;RAC1;CHN1;TMEFF1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.44751458016500983,1.2136805926176975,0.23282442748091603,0.743538822873548,1.0,5/29,3.92%,PPARA;LPGAT1;SORBS1;ZBTB20;SLC45A3
prerank,protein phosphorylation (GO:0006468),0.2932214508621931,1.213596317521199,0.07151819322459223,0.7423937931678665,1.0,93/479,14.24%,PRKAG2;TGFBR3;ROCK2;OXSR1;EFEMP1;EPHA3;FGFR2;FGFR4;NRK;WNK4;KIT;CDK8;DAPK1;PRKAG3;PDPK1;PDK1;CAMK1D;BMP2K;PDGFRB;RNASEL;DMPK;FER;MAP4K5;CDK7;EPHA8;EPHA4;FAM20A;SRPK2;ABI2;MAP2K6;PDGFRA;MAPK9;BAZ1B;DDR1;SIK1;RICTOR;PRKAA2;IGF1R;LRRK2;PRKCZ;PRKCB;MAML1;STK17B;TTK;PRKCA;GRK3;DDR2;PRKAA1;NEK4;NRBP1;RYK;BIRC5;GRK5;BIRC6;CCNT1;PKN2;MUSK;CDK1;CAMK2D;PIK3R4;NEK10;GRK4;CLSPN;VRK2;LATS1;FRK;ABL1;PRKDC;RPS6KB1;JAK2;COQ8B;ERBB2;IKBKE;BMPR1A;MAPKAPK2;CRY1;PRKAG1;HIPK3;CCNE1;PRKD2;STK24;TBK1;ROS1;MAPK1;DCLK1;MAP3K7;PRKACB;MORC3;STK26;NIM1K;CDKL5;NLK;CDK15
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.4432948158789245,1.2135176676240431,0.22444889779559118,0.741236138818315,1.0,4/27,7.50%,IGF1;PDGFRA;SPHK1;DDR2
prerank,synapse organization (GO:0050808),0.33930140769240597,1.213423078775104,0.16286644951140064,0.7401334887617995,1.0,21/125,9.00%,UNC13C;PDZRN3;SDK1;SLC8A3;LRP4;NLGN2;GPC6;DKK1;NEDD4;SLC6A1;OBSL1;PPFIBP2;IGFN1;CACNB4;LRRK2;PTPRD;PTEN;RYK;MUSK;PCDHB10;FARP1
prerank,amide transport (GO:0042886),-0.41136233671167405,-1.213372559032032,0.19393939393939394,0.5980976096537933,1.0,7/26,10.98%,ABCG2;CERT1;PLTP;SLC5A6;SLC38A5;AQP11;GLTP
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.28254600426247434,1.2129733797417928,0.04044943820224719,0.7401088111459426,1.0,149/807,14.11%,GLIS3;PRDM6;BMP6;TCF7L2;OSR1;AEBP1;WNT4;RBPJ;FGFR2;FHL2;PPARA;NR2F2;BMP7;PRKN;WWOX;ATXN1;ZEB2;KCNIP3;DAB2;SNX6;DKK3;ARID5B;RUNX1T1;MXI1;FNIP1;CUX1;AASS;SATB1;PRDM5;ZEB1;ZIC2;DKK1;DMRT1;NR1I2;ASCL2;TBL1XR1;PLCB1;SP100;LOXL3;TSHZ3;JARID2;MIDEAS;IGF2;VSX2;JAZF1;VGLL4;ZFP90;PRICKLE1;HDAC8;HOXA7;FOXD1;ZHX2;CBY1;BEND5;L3MBTL2;ARID4A;RNF2;IKZF4;KDM2B;SOX1;DPF2;IRF8;GLI3;SFMBT1;MXD1;ZBTB32;NIBAN2;ZFP37;CXXC5;BCOR;SUFU;DLG1;THAP1;WWC1;WWC2;SALL1;KANK2;XRCC5;SMAD3;EN1;NR6A1;MTF2;PHF21A;KDM2A;BIRC5;PER3;WWP2;LYAR;CBX8;DNAJA3;RSF1;CBX2;ZMYND15;TLE1;KAT8;MITF;KAT6B;MDM2;MBTD1;NSD1;MED1;FRK;SMURF2;IRX1;SCMH1;PARP9;L3MBTL3;ATOH8;HDAC1;FLCN;TFAP2A;CBX7;SMARCE1;ZNF8;TFAP2B;ZNF568;RXRA;ZBTB38;MYB;TAF3;CRY1;CNOT2;ZNF177;CDC73;E2F6;ORC2;SOX13;HSF1;CBFA2T2;PSPC1;AR;HIVEP1;PHF6;EZH1;CGGBP1;IFI27;NONO;NR1I3;FOXK2;SNAI1;SCML4;TFDP2;CLOCK;DICER1;ZNF148;KDM5C;MTDH;CDKN1C;CREBBP
prerank,telomere capping (GO:0016233),0.4899242344109298,1.2129265817946309,0.2692307692307692,0.73885925768827,1.0,9/16,21.85%,ACD;PRKDC;DCLRE1A;DCLRE1B;MRE11;STN1;RAD50;NBN;TERF2
prerank,limb morphogenesis (GO:0035108),0.4764606221647712,1.2128393795913495,0.2489451476793249,0.7377722324542456,1.0,3/20,5.68%,CYP26B1;FBXW4;GLI3
prerank,positive regulation of cell population proliferation (GO:0008284),0.29460637192469225,1.2120785865071968,0.07749077490774908,0.7387679755847697,1.0,48/423,8.55%,IL31RA;IGF1;TGFBR3;BMP6;TCF7L2;OSR1;IL34;RBPJ;FGFR2;FGFR4;PID1;EFNB2;IL18;MEIS1;BCL2;SCX;LTF;PDGFRB;FER;MEGF10;CTSH;IGF2;CCN4;SRPK2;ITGAX;IL13RA1;ASH2L;PDGFRA;SPHK1;GJA1;PDGFD;UFL1;IGF1R;FGF1;PTN;TET1;TTK;ADRA1D;CDC123;IL6;FOLR2;PTEN;DDR2;CSF1;BIRC5;GRK5;RPRD1B;COX17
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.479072845060795,1.2120522885067435,0.2294455066921606,0.7374810126856703,1.0,5/20,10.46%,SLC8A3;MAIP1;MCU;YME1L1;MICU1
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.35204637998419747,-1.2117695727611135,0.16706443914081145,0.6017229614200021,1.0,25/49,35.95%,F3;LBP;NOD1;STAT3;RAB1A;CD74;TIRAP;MYD88;HYAL2;AFAP1L2;RELA;HSPA1B;TLR7;TLR4;FADD;MAVS;NOD2;TLR1;NOS2;HSPA1A;SYK;PARK7;F2R;TLR8;RIPK1
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.35814355722974933,-1.2114991636698462,0.19221967963386727,0.601543157439652,1.0,23/46,29.75%,FBXO7;TOMM20;HK1;TOMM22;HSPD1;TIMM9;ROMO1;TIMM10B;TIMM13;BCAP31;PINK1;AKT1;TIMM22;TOMM7;MFN2;TIMM50;FIS1;TIMM44;TSPO;AIP;CHCHD4;DNLZ;TOMM34
prerank,microglial cell activation (GO:0001774),-0.43459193412145114,-1.211213320562989,0.2066115702479339,0.601410655770425,1.0,10/21,27.83%,APP;GRN;CLU;C1QA;IFNGR1;CX3CR1;TYROBP;AGER;TREM2;ITGB2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.44033992589894544,-1.211088009821809,0.19456066945606695,0.6008291362536808,1.0,8/18,33.25%,HHEX;ENY2;NUP133;DDX25;THOC2;ZC3H11A;NUP93;IWS1
prerank,negative regulation of ATPase activity (GO:0032780),0.4934894321779949,1.2110814407678165,0.2533081285444234,0.7390180872185513,1.0,4/16,11.46%,LTF;TNNT2;THADA;OXA1L
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.38307598754133276,-1.2105766311652455,0.19870410367170627,0.6013298280880354,1.0,8/33,10.61%,TGFB2;KLF4;ETS1;GATA2;TGFB1;GNL3;JUN;STAT3
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3504708437662741,1.2102672261026373,0.16640746500777606,0.7400360135396733,1.0,12/87,8.49%,FGFR2;FGFR4;FGFBP1;POLR2D;FLRT2;NDNF;KL;FGF1;HNRNPH1;FRS2;POLR2A;GTF2F1
prerank,protein heterotetramerization (GO:0051290),-0.485506742323751,-1.2100081830140468,0.2338403041825095,0.602063331278259,1.0,8/13,33.59%,PKD1;CPSF7;GRIN1;CPSF6;FARSA;HSD17B8;GRIN2B;KRT10
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5227715789234109,-1.2096851020211274,0.2215909090909091,0.6020117115400762,1.0,3/10,19.24%,SEC14L1;RNF125;GPATCH3
prerank,regulation of interleukin-12 production (GO:0032655),-0.35873056294983413,-1.2096503460887411,0.18243243243243243,0.6011820339375744,1.0,14/47,23.69%,FOXP1;THBS1;PLCG2;HSPD1;IRAK3;CD47;CMKLR1;LAPTM5;CD40;IRF5;JAK3;TIRAP;MAPK11;AGER
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.505423245781551,1.209431646004406,0.2701612903225806,0.7411916254722472,1.0,4/15,8.60%,ADGRV1;KIT;TMC2;WHRN
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.4978988568375118,-1.20838456663445,0.22504892367906065,0.6038369179195497,1.0,5/12,17.60%,ESR1;TGFB1;STAT3;LIN28B;ZC3H12A
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.4388640093069233,-1.2078091737671406,0.22016460905349794,0.6044884195038508,1.0,6/20,10.82%,RPS6KA5;PPARGC1A;SOX4;ARRB1;GLYR1;NOS1
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3602554199796779,-1.2073362029633226,0.19014084507042253,0.6049652112377655,1.0,18/44,25.67%,PTPRJ;STK38;DAB2IP;DNAJA1;UCHL1;PDCD4;PTPN1;SPRY4;IRAK3;NF1;DUSP1;SH2B3;PRKCD;BMP4;CD300A;HYAL2;SPRY2;SORL1
prerank,positive regulation of cellular component movement (GO:0051272),-0.41317265684038434,-1.2073255829323306,0.23780487804878048,0.6040660897235588,1.0,6/24,7.87%,SPOCK2;ACTN4;CAVIN1;ETS1;RPS19;VEGFA
prerank,signal transduction by p53 class mediator (GO:0072331),-0.3904957604875492,-1.2073182966522094,0.20863309352517986,0.6031577843266331,1.0,8/30,12.41%,ACER2;PPP1R13B;DDX5;SESN2;BCL3;HINT1;PDK2;MYBBP1A
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.36609832783433477,-1.207219202901811,0.1797752808988764,0.6025297079711005,1.0,10/39,11.93%,TEK;KDR;THBS1;GAS6;RAMP2;GATA2;ITGA4;PDCD4;SCG2;GPER1
prerank,ameboidal-type cell migration (GO:0001667),-0.3541806812402474,-1.2071598590647923,0.18295739348370926,0.6017590816093005,1.0,15/51,11.39%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;TBX1;SEMA3E;CORO1C;CCN3;ITGA4;SGPL1;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,regulation of TOR signaling (GO:0032006),0.36850411869684496,1.2067424432807554,0.1886178861788618,0.7477842749833428,1.0,15/67,11.36%,NPRL3;FNIP1;DEPTOR;ARAF;RICTOR;PRKAA2;NPRL2;SLC38A9;PDCD6;UBR2;PRKAA1;EPM2A;MLST8;FLCN;AKT1S1
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.42905601493551376,-1.2063030531937051,0.22718052738336714,0.6032562959465732,1.0,5/21,10.32%,CAV1;CTNNB1;GSK3B;APC;PPP1CA
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.31732046493026245,-1.2060309944487033,0.12564102564102564,0.603105371278745,1.0,37/87,33.04%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFAF4;NDUFA12;NDUFV1;NDUFB7;UQCC2;NDUFA13;NDUFS1;NDUFB11;SDHAF2;SMIM20;NDUFB10;NDUFA1;UQCC3;NDUFB4;NDUFS7;FASTKD3;NDUFAF8;BCS1L;DMAC2;COA3;COA8;NDUFAF3;COX16;COA5;CHCHD4;SDHAF1;NDUFC1;ACAD9;NDUFS2;NDUFS5;NDUFAB1;TMEM126A
prerank,potassium ion export across plasma membrane (GO:0097623),0.5145736027103338,1.2059160189483729,0.2691511387163561,0.7488003682654659,1.0,3/13,4.07%,KCNA5;KCNT2;KCND3
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.3308682823265541,-1.2057836452509885,0.16876574307304787,0.6028533936748135,1.0,17/67,15.79%,B2M;IKBKB;CALR;VAMP8;PSMD13;PSMF1;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;CYBB;PSMB3
prerank,regulation of tube diameter (GO:0035296),0.5043540257131633,1.2054588642469348,0.2542016806722689,0.7473789741830319,1.0,4/13,10.63%,ROCK2;ACE;SCPEP1;NPR1
prerank,vascular process in circulatory system (GO:0003018),0.5043540257131633,1.2054588642469348,0.2542016806722689,0.7473789741830319,1.0,4/13,10.63%,ROCK2;ACE;SCPEP1;NPR1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.30409949297569216,-1.2051055892428078,0.1396011396011396,0.6037965049954144,1.0,20/100,8.27%,GAB1;TEK;NTRK3;FN1;PIP5K1B;KDR;TGFB2;CBL;PPP2R5C;PTK2;ROR2;DAB2IP;PIK3IP1;SEMA4D;ROR1;PPP1R16B;CEACAM1;PDGFC;MYOC;WNT16
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.42765113491713946,1.2049114671411962,0.2485981308411215,0.7463563644961247,1.0,9/29,11.52%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ
prerank,CENP-A containing chromatin organization (GO:0061641),0.42765113491713946,1.2049114671411962,0.2485981308411215,0.7463563644961247,1.0,9/29,11.52%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ
prerank,positive regulation of cell projection organization (GO:0031346),0.34189384056256616,1.2048419292135937,0.17262830482115085,0.7452005888467071,1.0,17/115,7.10%,PLXNA2;ROBO1;PTK7;EPHA3;CAMK1D;CUX1;DPYSL3;AVIL;IL1RAPL1;NDNF;GRIP1;OBSL1;PLXNC1;PLK5;PTN;PTPRD;ARHGAP35
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.5238514191267369,-1.2045941485365526,0.2514177693761815,0.6042965260489476,1.0,3/10,1.54%,LRCH1;APOD;CD200
prerank,regulation of protein phosphorylation (GO:0001932),-0.2684233666916878,-1.204142682780876,0.053497942386831275,0.6045440932523709,1.0,73/256,17.60%,TEK;NTRK3;FN1;SLIT2;PECAM1;LIMCH1;EFNA5;OCLN;FNIP2;PRR5L;BMPER;TFRC;KRAS;KDR;NIBAN1;RAC1;HSP90AA1;GAS6;PPP2R5C;PTK2;TARDBP;PDE8A;FYN;ENG;DAB2IP;RACK1;PPIA;SEMA4D;TBX1;HSPB1;LIMK2;CORO1C;WARS1;TGFB1;PDCL3;CAMKK2;SOD1;CCDC88A;ARRB1;CHP1;APP;FLT4;CARD14;VEGFA;PAK1;FGF7;SLCO3A1;SESN2;WWTR1;RALB;ATF4;BMP2;MEN1;XDH;GPER1;SPTBN4;CD74;IBTK;CADM4;CCN1;MT3;TERF2IP;CSF1R;FAS;CCDC88C;DNAJC10;AKAP8;DVL2;PPP2R5A;ANKRD54;KNDC1;CD40;ZC3H12A
prerank,positive regulation of proteolysis (GO:0045862),0.3901419002382185,1.2032090727289404,0.19796954314720813,0.7486929783251561,1.0,8/55,7.78%,SH3D19;FGFR4;CTSH;CCBE1;SNX9;SNX33;NRDC;WDR48
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4228594192029673,1.2025093474041844,0.2402135231316726,0.7494227981652148,1.0,10/29,11.95%,TCF7L2;PYGO1;ASH2L;TLE3;TCF7L1;TLE1;AXIN2;BCL9;HDAC1;CDC73
prerank,sodium ion homeostasis (GO:0055078),0.46433330380885934,1.2009237717552597,0.24742268041237114,0.7527870493237436,1.0,3/21,3.07%,ATP1A2;ATP1B3;SLC8A1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.37648275388705876,1.2004033871302946,0.21035058430717862,0.7529735150337784,1.0,7/61,7.12%,PRKAG2;FGFR4;PPARA;OAZ3;PSME4;PSMA2;PSMA3
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.36482850592741883,-1.2002581298777115,0.1645021645021645,0.614475492164018,1.0,19/39,32.12%,UBB;RPS27A;UBC;DDB1;RBX1;RPA1;OGG1;UBA52;POLK;POLD3;NTHL1;POLD1;GTF2H2;XPA;ERCC5;RFC5;ERCC3;GTF2H5;RPA3
prerank,mitochondrial fusion (GO:0008053),-0.4521513984842539,-1.2001344701277616,0.25101214574898784,0.6139329142994117,1.0,8/18,27.15%,CHCHD3;MIEF1;STOML2;MIEF2;MFN2;BAX;SPG7;FIS1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5026970562396276,1.2000546636618927,0.26719056974459726,0.7525862595504381,1.0,3/16,11.64%,LEPROT;VTA1;CHMP6
prerank,sensory organ development (GO:0007423),0.3864595785381812,1.1999624824065809,0.21340388007054673,0.751522756204748,1.0,9/51,8.52%,RBP4;MEIS1;SLC39A5;ASCL2;SHROOM2;SMOC1;SH3PXD2B;PBX4;CHRDL1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3154181005732472,1.199800883658892,0.15459610027855153,0.7506869311541817,1.0,30/190,9.50%,RORA;NPRL3;C1QTNF3;ITPR1;CGNL1;PPARA;BMP7;GPD1L;BCL2;FNIP1;DEPTOR;MGRN1;VGLL4;ARHGAP12;CACTIN;UACA;PRKAA2;NPRL2;WWC1;PDCD6;WWC2;UBR2;MMP9;NLRC3;PTEN;PRKAA1;TLE1;BCL2L2;EPM2A;MDM2
prerank,axon guidance (GO:0007411),-0.2789449516425068,-1.199337199365396,0.06463878326996197,0.6152261520385371,1.0,50/201,12.31%,SPTBN1;GAB1;SLIT2;BSG;EFNA5;SHANK3;KLF7;PTPRM;SEMA6A;NRP2;SEMA7A;SH3KBP1;SEMA6D;RPS6KA5;RAC1;PLXND1;SEMA3C;PTK2;UNC5C;LAMA1;TNR;UNC5D;FYN;NOTCH3;CHN1;NOTCH1;SEMA4D;SEMA3E;PLXNA4;LAMA5;TUBB3;ROBO4;LAMA3;DCC;PDLIM7;TMEFF1;VEGFA;NRXN1;GFRA2;SEMA4B;SEMA5B;SEMA6C;PIK3CD;LYPLA2;RELN;SEMA3G;EPHB1;EFNB3;GPC1;SPTBN4
prerank,ncRNA transcription (GO:0098781),-0.48953056200458195,-1.1992865699333985,0.23647294589178355,0.6144430107110301,1.0,7/13,25.43%,CAVIN1;BRF1;GTF3C1;SPIN1;ANG;SIRT7;SNAPC2
prerank,protein homotetramerization (GO:0051289),0.3905754053937657,1.1991549934497532,0.2333931777378815,0.7511818587190754,1.0,10/49,13.99%,ALDH1A2;APPL2;UPB1;CBY1;HSD17B10;SSBP1;GOLGA2;PKD2;SHMT1;CRYZ
prerank,cellular response to lectin (GO:1990858),-0.30750495933057215,-1.199009926944825,0.12256267409470752,0.6134245361590023,1.0,31/104,23.41%,KRAS;RPS6KA5;PLCG2;FYN;NRAS;IKBKB;PAK1;PSMD13;PSMF1;PAK2;PSMB10;CHUK;PSMB6;PSME3;PSMB5;ICAM2;PSMC3;PSMD12;PSMB8;CUL1;TAB3;PSME1;PSMB3;RAF1;PSMD5;TYROBP;PRKCD;SKP1;PSMD9;PSMB4;RELA
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.30750495933057215,-1.199009926944825,0.12256267409470752,0.6134245361590023,1.0,31/104,23.41%,KRAS;RPS6KA5;PLCG2;FYN;NRAS;IKBKB;PAK1;PSMD13;PSMF1;PAK2;PSMB10;CHUK;PSMB6;PSME3;PSMB5;ICAM2;PSMC3;PSMD12;PSMB8;CUL1;TAB3;PSME1;PSMB3;RAF1;PSMD5;TYROBP;PRKCD;SKP1;PSMD9;PSMB4;RELA
prerank,epithelium development (GO:0060429),0.3383467681795987,1.1988101919190073,0.19938176197836166,0.750858777176213,1.0,10/107,7.04%,ALDH1A2;ERRFI1;OSR1;WNT4;FGFR2;LOXL3;TPP1;PTER;SALL1;KANK2
prerank,autonomic nervous system development (GO:0048483),-0.45024622903656264,-1.198313053407829,0.24897119341563786,0.6144974817120263,1.0,7/17,22.64%,FN1;SOX4;KIF26A;NF1;SOX10;SEMA3A;SOX11
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5407331927798018,1.197338608918618,0.27405857740585776,0.7539266382581988,1.0,4/11,8.84%,CACNG1;NOS1AP;CACNA2D1;CAMK2D
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.4880963436361736,-1.1969941198317373,0.2693032015065913,0.6173411262506325,1.0,4/12,16.27%,STX3;STX1A;SNAP25;STX2
prerank,positive regulation of immune response (GO:0050778),-0.333369388679312,-1.1967042522382672,0.15217391304347827,0.6172020434764646,1.0,26/64,35.89%,TGFB2;PTPRC;GRN;XBP1;GBP5;IFI35;CD74;RSAD2;CD81;IL15;POLR3D;FCGR2B;POLR3F;SPHK2;SKAP1;SLC15A4;ITGB2;KARS1;FADD;DHX9;NOD2;NLRP3;SASH3;CCL5;IL6ST;TLR8
prerank,regulation of neuron projection development (GO:0010975),-0.28384522106005766,-1.1965858859839624,0.12040133779264214,0.6166519127817713,1.0,62/163,22.40%,NTRK3;SHANK3;RAP1A;SIPA1L1;ITGA6;FBXO7;CDH2;PRAG1;ROR2;PTK2B;DAB2IP;CHN1;ROR1;SERPINI1;MBOAT1;SCARF1;KANK1;RTN4RL1;ZDHHC15;CCDC88A;DCC;PPFIA2;GSK3B;EFHC2;STMN2;RTN4IP1;MFSD2A;ABI3;PAK1;MARK1;SRCIN1;PAK2;KIF1A;RELN;NDRG4;TENM3;MARK2;RET;MT3;SPOCK1;DISC1;CAMK2B;PRKD1;KNDC1;SCN1B;TOX;NTNG1;ITM2C;NPTN;CDK5;PSEN1;PLXNB3;FKBP4;RIT2;CFL1;AKT1;DBN1;CRMP1;RTN4R;FUT9;BRSK2;SEMA3A
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.30571982161936456,-1.196328345849049,0.1298342541436464,0.6164861042834618,1.0,31/105,23.41%,KRAS;RPS6KA5;PLCG2;FYN;NRAS;IKBKB;PAK1;PSMD13;PSMF1;PAK2;PSMB10;CHUK;PSMB6;PSME3;PSMB5;ICAM2;PSMC3;PSMD12;PSMB8;CUL1;TAB3;PSME1;PSMB3;RAF1;PSMD5;TYROBP;PRKCD;SKP1;PSMD9;PSMB4;RELA
prerank,apical junction assembly (GO:0043297),-0.3386625524668209,-1.1956521529821214,0.16435185185185186,0.6175614356884808,1.0,12/53,10.02%,PECAM1;CLDN5;ESAM;OCLN;CLDN11;RAMP2;F11R;WDR1;MPP7;RHOA;PAK2;APC
prerank,lung epithelium development (GO:0060428),0.5312152989648278,1.1953887335857496,0.28361344537815125,0.7583508866953074,1.0,1/10,0.35%,ERRFI1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.4833245489655118,1.1947021874910368,0.24055666003976142,0.7589813521975317,1.0,2/16,3.14%,NPR3;NOS1AP
prerank,regulation of MAP kinase activity (GO:0043405),0.34881334572289746,1.1943276439251378,0.17901234567901234,0.7587590282967531,1.0,9/92,5.51%,ROBO1;IL34;KSR1;KIT;BMP7;PDGFRB;PDGFD;LRRK2;FGF1
prerank,sphingosine metabolic process (GO:0006670),-0.44211039983439193,-1.1942791464764797,0.26305220883534136,0.6204769300473157,1.0,4/17,1.89%,ACER3;ACER2;SPTLC2;PLPP1
prerank,negative regulation of cell population proliferation (GO:0008285),-0.25833184893523686,-1.1932735791284557,0.022222222222222223,0.6223513349350063,1.0,69/351,12.41%,ZBTB7C;PTPRJ;APOD;FTH1;B2M;NOS3;IGFBP6;CD200;BMP5;PLPP1;ACVRL1;TGFB2;FAP;PTPN14;CBFA2T3;TES;KLF4;PPP2R5C;ETS1;ADARB1;WNT9A;ROR2;PTK2B;DAB2IP;NGF;NOTCH1;SH3BP4;P3H2;BMPR2;HES1;SFRP4;RERG;CCN3;WARS1;PINX1;GATA2;SOX4;TGFB1;IGFBP5;CTNNB1;ST18;TOB1;TBX3;ATP8A2;DDAH1;APP;ADRA1A;PTHLH;PAK1;AQP11;MAGED1;PODN;ING4;CTNNBIP1;APC;CDK6;SOX7;CDKN1B;NCK2;BTG3;BMP2;HGS;IFI35;MEN1;NDRG4;PBRM1;GPER1;REST;CDH13
prerank,muscle cell differentiation (GO:0042692),0.42247702407370663,1.1930199001386699,0.23357664233576642,0.7613873683144087,1.0,5/32,3.73%,RORA;DMD;SPEG;MEGF10;NEBL
prerank,cellular response to drug (GO:0035690),-0.40511529724984885,-1.1928999862180025,0.22746781115879827,0.6225453387814329,1.0,7/25,12.32%,MEF2C;ACER2;TFRC;GAS6;KCNQ1;AIM2;REST
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5259727018148717,-1.1922011859737558,0.26264591439688717,0.6235149450392147,1.0,2/10,2.22%,RUNX1;CBFB
prerank,axonemal dynein complex assembly (GO:0070286),0.43577136884616247,1.1920234358041064,0.24220183486238533,0.7630341275672559,1.0,8/27,15.00%,ODAD3;DNAI4;SPAG1;TTC12;CCDC65;ODAD1;DNAAF3;ODAD2
prerank,regulation of phosphatase activity (GO:0010921),-0.40645349522012303,-1.191728799349078,0.24130434782608695,0.6239217678379243,1.0,8/24,13.76%,TIPRL;PPP1R2;HSP90B1;CHP1;BMP2;MTMR9;ZCCHC9;PPP6R1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.4463942562356479,-1.191309016767502,0.2217573221757322,0.6242667288498136,1.0,3/17,7.10%,TEK;NTRK3;BAIAP2L1
prerank,protein kinase B signaling (GO:0043491),0.4443925601613431,1.1910481542793643,0.2475633528265107,0.7646590947615194,1.0,1/23,0.03%,IGF1
prerank,oligosaccharide metabolic process (GO:0009311),-0.35104550136710877,-1.1909562144988861,0.2023529411764706,0.6243192562832898,1.0,9/46,9.51%,ST3GAL4;ST6GALNAC3;ST3GAL6;ST8SIA4;FUT8;ST6GALNAC5;ST8SIA1;ST8SIA6;MAN2B1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5353848370829345,1.1904075202038076,0.2838709677419355,0.7651724574342038,1.0,4/11,11.92%,LEPROT;SNX33;PICALM;ACTN2
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5159197581696643,1.1902869848153772,0.26418786692759294,0.7642015220089897,1.0,2/12,7.99%,RBP4;MUC13
prerank,positive regulation of cholesterol transport (GO:0032376),-0.4001597650579324,-1.189738261038602,0.22269807280513917,0.626885941486811,1.0,13/27,30.27%,CAV1;PLTP;NFKBIA;PTCH1;LPCAT3;NR1H2;ABCA3;ZDHHC8;NR1H3;TREM2;GPS2;ABCA7;PPARG
prerank,long-term synaptic potentiation (GO:0060291),0.4546063338745793,1.1895872825489446,0.2633587786259542,0.7649727023916912,1.0,4/21,6.89%,SLC8A3;TSHZ3;PRKCZ;ARC
prerank,regulation of gene expression (GO:0010468),0.2768995208592795,1.1894347006169705,0.056353591160221,0.7640546676855182,1.0,134/903,12.54%,IGF1;PRDM6;RORA;ROBO1;BMP6;SLC24A3;ROCK2;OSR1;EFEMP1;SLC22A2;WNT4;AFF2;ARNT2;RBPJ;DENND4A;ZNF462;FGFR4;AFDN;WNT6;PID1;NOTCH2;BMP7;ANGPT1;IGF2BP1;PRKN;ATXN1;TULP3;NOVA1;ESRRG;RBMS3;PRDM5;MYBL1;DKK1;SCX;NR1I2;LTF;SOX6;PPARGC1B;SLC8A1;NOS1AP;NFYB;ZC3H7B;TRIM5;CTSH;IGF2;DTNBP1;PTBP2;SSBP2;CCN4;NCOA2;SRPK2;ITGAX;ANK2;MBIP;FOXD1;MAPK9;TNRC6B;SOX1;GJA1;CACTIN;PRKAA2;PERM1;TNRC6A;FGF1;HNRNPH1;SON;METTL4;SLC2A10;EPHX2;TCF7L1;ZUP1;ZFP37;SUFU;THAP1;WWC1;IL6;WWC2;GPBP1;UBE2L3;SMAD3;ABCC2;GPBP1L1;PRKAA1;MTF2;RBL2;ZKSCAN5;ATG14;CSF1;POLR2A;WWP2;NFIA;TLE1;ATRAID;ZNF628;MUSK;YTHDF2;BRCA2;MITF;KDM6B;KAT6B;SIRPA;FUBP1;PICALM;NFYC;PARP10;NSD1;MED1;NUP107;AGO2;ABL1;PARP9;FGF9;ATOH8;ASCC2;HDAC1;ZBTB11;FLCN;TFAP2A;APLN;PCBP2;ZBTB38;MYB;BMPR1A;RNF14;SOX13;TRIM26;TRIM43;PRKAG1;SLC38A2;RNF20;PSPC1;AR;SNX12;ADNP2
prerank,superoxide anion generation (GO:0042554),0.508060090088108,1.1892610342655245,0.26954732510288065,0.7632189681414197,1.0,4/13,13.64%,DUOX2;TAFA4;NCF2;DUOX1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5316160109984417,1.189243637196913,0.27872340425531916,0.7619407742917813,1.0,5/10,12.45%,GRB10;PRKCB;VTN;ARNT;PRKD2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2943767554058555,-1.1887915947636978,0.13450292397660818,0.6286468673867258,1.0,38/119,19.49%,PIP5K1B;EFR3B;PITPNM2;PLCG2;INPP5D;BMX;PIK3R6;INPP4A;SOCS2;SYNJ1;SOCS5;PIK3C2B;ARF1;CDS1;CDIPT;PGAP4;TTC7A;PLEKHA1;PIK3CD;PIK3C2A;MTM1;MTMR6;PITPNM3;PIK3R5;PIK3C3;MTMR9;INPPL1;SACM1L;PIP5K1C;SBF1;ITPKB;PI4KB;CISH;PIGZ;MTMR12;PIK3R3;INPP5F;PIP4K2A
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.3307879863461741,-1.1887226681050185,0.16751269035532995,0.6279380646984261,1.0,26/75,20.48%,TEK;NRP2;KDR;F3;BMPR2;PPP1R16B;NRAS;GATA2;PDCL3;ITGA4;EMC10;JCAD;FLT4;VEGFA;NR4A1;PIK3CD;BMP2;SCG2;CDH13;APLNR;PRKD1;AGTR1;PLXNB3;ANG;AKT1;BMP4
prerank,amyloid fibril formation (GO:1990000),-0.34793047386230425,-1.188722055029437,0.19902912621359223,0.6270213667937568,1.0,12/51,9.76%,B2M;ADAM10;ITM2B;CST3;GSN;UBB;TGFBI;RPS27A;UBC;APP;H3-3A;FURIN
prerank,"phototransduction, visible light (GO:0007603)",0.5065752957889204,1.1884885869271389,0.27450980392156865,0.7627420491069558,1.0,3/14,6.43%,ABCA4;PDE6G;GNAQ
prerank,phagolysosome assembly (GO:0001845),-0.4824920115632951,-1.1884149840139848,0.2354014598540146,0.6269345992212179,1.0,8/12,31.45%,SYT7;RAB39A;RAB7A;RAB7B;RAB14;RAB20;PLA2G5;CORO1A
prerank,regulation of protein polymerization (GO:0032271),0.41643937307358525,1.1881790143849933,0.23905109489051096,0.7623143846053676,1.0,7/35,13.05%,ARHGAP28;ARHGAP40;COTL1;LATS1;ABL1;GBA2;FCHSD2
prerank,regulation of dendrite morphogenesis (GO:0048814),0.42913998308761336,1.1880675324915249,0.2644320297951583,0.7612927051802424,1.0,11/32,14.09%,SDC2;CUX1;IL1RAPL1;NEDD4;OBSL1;PTPRD;CUL7;ADGRB3;RAP2A;LZTS1;CDKL5
prerank,negative regulation of cell junction assembly (GO:1901889),0.43629570637619924,1.1878429606840035,0.25,0.760624359560851,1.0,5/25,7.48%,ROCK2;ARHGAP6;ACE;PHLDB2;PTEN
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.34924765379080225,-1.1873543449147674,0.19285714285714287,0.6289302586045956,1.0,9/45,5.38%,GAB1;RPS6KA5;IQGAP1;CBL;PTK2;PTK2B;REPS2;BCAR1;TGFB1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.4093892311345091,-1.1873037394663903,0.22085889570552147,0.6281538613636335,1.0,8/23,15.53%,MYO10;MAP6;CCDC88A;KIF1A;TUBA1B;TUBA1A;HOOK1;CCDC88C
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.36299600002853544,-1.1872029322044468,0.19825708061002179,0.6275415362342265,1.0,13/40,10.85%,LEF1;TIAM1;TGFB2;JAG1;NOTCH1;TGFBR2;TGFB1;FERMT2;CTNNB1;MTOR;WWTR1;BMP2;GCNT2
prerank,muscle organ development (GO:0007517),0.3794264167367485,1.187177611059959,0.2120689655172414,0.7612188017123932,1.0,8/54,4.90%,IGF1;VAMP5;DMD;LAMA2;LARGE1;SOX6;SPEG;SGCE
prerank,cartilage development (GO:0051216),0.38596733161957963,1.1869600057604053,0.22086956521739132,0.7605669685537321,1.0,7/49,7.27%,SOX5;OSR1;SCX;SOX6;NFIB;SULF1;WNT5B
prerank,regulation of mitochondrial translation (GO:0070129),-0.42770099579720805,-1.1863524913551828,0.25158562367864695,0.6291349903440022,1.0,9/21,26.00%,RCC1L;UQCC2;RPUSD4;FASTKD3;TRUB2;MTG1;TRMT10C;MRPS27;COA3
prerank,pharyngeal system development (GO:0060037),-0.46267479039983117,-1.1861366980618093,0.24795081967213115,0.6288328097454305,1.0,6/15,7.46%,BMP5;TGFB2;TBX1;BMPR2;HES1;PTCH1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.3447195714097959,-1.186110296158112,0.1832579185520362,0.6279965944143978,1.0,14/46,10.97%,TEK;FN1;TMEFF2;PARVB;RAC1;PXN;LAMA5;LAMB2;FERMT2;ITGA4;SRCIN1;PEAK1;RHOA;ITGA8
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.5067027283204885,1.1860409429227459,0.26597938144329897,0.7619802128200662,1.0,7/14,16.87%,FTSJ3;DDX18;NOL9;NIFK;ZNHIT3;BOP1;ZNHIT6
prerank,sprouting angiogenesis (GO:0002040),-0.34920463605857355,-1.185718019927129,0.19900497512437812,0.6281490137856579,1.0,15/51,9.71%,TEK;SLIT2;BMPER;RSPO3;KDR;THBS1;ACVRL1;RAMP2;ENG;PTK2B;SEMA3E;FLT4;VEGFA;NR4A1;ESM1
prerank,defense response to tumor cell (GO:0002357),0.5374944942203161,1.185697598192472,0.27054108216432865,0.7616517569382718,1.0,3/10,4.73%,DAPK1;RBMS3;PLK5
prerank,positive regulation of cell development (GO:0010720),-0.3763876277320074,-1.1853463263277417,0.23408624229979466,0.6282977808564133,1.0,11/31,22.91%,PDE3A;TGM2;SERPINF1;GPER1;CX3CR1;SPEN;LIG4;TYROBP;BMP4;SOX11;FAIM
prerank,meiosis I (GO:0007127),0.4579353364441489,1.1852659812472095,0.2605210420841683,0.7615856735063796,1.0,3/23,6.30%,MYBL1;SLC25A31;HSF2BP
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.3196202821802722,-1.1851738996125583,0.18546365914786966,0.627900686975468,1.0,19/75,14.62%,TEK;CLDN5;PTPRM;SEMA6A;THBS1;TGFB2;KLF4;DAB2IP;SEMA3E;STAB1;CTNNB1;SARS1;SERPINF1;HGS;HHEX;SYNJ2BP;COL4A2;ISM1;SPARC
prerank,myofibril assembly (GO:0030239),0.39541778752109935,1.1851505013746464,0.21607142857142858,0.7606349936459236,1.0,6/42,4.40%,TPM1;CSRP3;TNNT2;PDGFRB;OBSL1;PDGFRA
prerank,glutamate receptor signaling pathway (GO:0007215),-0.3701510092824173,-1.185063547145293,0.21016166281755197,0.6273012916821373,1.0,14/37,21.18%,GRM3;GRM7;PTK2B;KCNB1;HOMER1;GRIK4;GRIN3A;APP;GRIN1;GRM8;GRIA2;GRIK2;FMR1;GRID2
prerank,carbohydrate derivative transport (GO:1901264),-0.43451446405221683,-1.1849026957540987,0.2546583850931677,0.6268443820905581,1.0,5/18,8.15%,PLTP;SCARB1;LBP;SLC10A7;MFSD2A
prerank,negative regulation of cell communication (GO:0010648),-0.421745585780511,-1.1847650302647719,0.22687224669603523,0.6263392647957776,1.0,6/21,17.24%,HHIP;UBASH3B;SOCS5;KIF26A;PTPN1;ACVR1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.3941646650703972,-1.1846511869846195,0.22391304347826088,0.6257813615952181,1.0,15/27,27.55%,FBXO7;MBOAT1;HOMER1;CCDC88A;GSK3B;EFHC2;MARK1;DISC1;NTNG1;PSEN1;AKT1;BRSK2;FCGR2B;TREM2;FRMD7
prerank,skeletal muscle tissue development (GO:0007519),-0.38063840439902324,-1.184642157947593,0.23059866962305986,0.6249080940440097,1.0,6/32,7.79%,MEF2C;CAV1;MYL6;CAV2;SIX1;LEMD2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3231798937233978,1.1834759999047295,0.1757754800590842,0.7644450228921451,1.0,20/150,6.43%,PRKAG2;ERRFI1;PTPN13;PID1;PRKN;DMD;PLPP3;PDPK1;GPD1L;SMAD6;PARD3;DEPTOR;DKK1;DTNBP1;PPM1E;CACTIN;LRRK2;PRKCZ;FBLN1;GNAQ
prerank,regulation of interleukin-10 production (GO:0032653),-0.3586792609693808,-1.183370307938447,0.18925233644859812,0.6275554673919432,1.0,15/44,24.17%,CD34;PLCG2;TRIB2;TNFRSF21;ISG15;STAT3;HSPD1;CD47;CD274;JAK3;TYROBP;DLL1;FCGR2B;AGER;VSIR
prerank,muscle contraction (GO:0006936),0.32689133228079215,1.1832674660995557,0.18168389955686853,0.763749501386056,1.0,13/126,4.61%,ROCK2;BDKRB2;TPM1;DMD;SNTA1;SORBS1;TNNC1;MYLK;TNNT2;SLC8A1;CALD1;TLN1;CHRNE
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.40554336008267555,1.1828409230886991,0.23374340949033393,0.7637096211716439,1.0,5/41,9.05%,IGF1;SYT11;CACTIN;NLRC3;SIRPA
prerank,relaxation of muscle (GO:0090075),0.5133451189670889,1.182714616817405,0.276,0.7628034371354278,1.0,3/13,3.07%,ATP1A2;GSTM2;SLC8A1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.2899698548228448,1.1823214846547883,0.10427135678391959,0.7626560329671965,1.0,48/390,8.79%,IL31RA;IGF1;EPHA7;ROCK2;EPHA3;FGFR2;FGFR4;FGFBP1;COL4A6;EFNB2;BDKRB2;KIT;ANGPT1;POLR2D;SDC2;SORBS1;FLRT2;PLCB1;PDGFRB;KL;FER;IGF2;EPHA8;MMP2;EPHA4;GRB10;GFRAL;BAIAP2;PDGFRA;DDR1;WASL;SULF1;PDGFD;IGF1R;FGF1;HNRNPH1;CLNK;FRS2;MMP9;DDR2;RYK;MTSS1;CSF1;POLR2A;ANGPT2;GTF2F1;MUSK;VEGFB
prerank,monocarboxylic acid transport (GO:0015718),-0.35035775921318985,-1.1821655718540163,0.18807339449541285,0.6299793007432782,1.0,17/51,14.60%,ABCC4;ABCG2;ATP8B1;SLCO1C1;SLC16A9;SLCO2A1;SLCO2B1;SLC16A1;SLC5A6;CEACAM1;SLC6A8;SLCO3A1;SLC16A4;SLC26A6;STARD5;SLC16A2;NR1H4
prerank,positive regulation of neuron death (GO:1901216),0.38535039586705466,1.1819239589420838,0.23616236162361623,0.7625644434307792,1.0,10/46,11.33%,EPHA7;EFNB2;DKK1;PCSK9;SRPK2;NUPR1;PICALM;TFAP2A;TFAP2B;EIF2S1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4657439689314528,1.1812796612330487,0.27102803738317754,0.763128116221297,1.0,5/20,6.48%,ROCK2;FHOD1;RAB13;LLGL2;DLG1
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5227937217823712,-1.1811897060312413,0.25925925925925924,0.6317745426337447,1.0,4/10,19.58%,ACTN4;TBX1;RARB;RXRB
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.40517321669584266,-1.1810936568109736,0.2510548523206751,0.6311257774281512,1.0,11/25,18.75%,CAV1;CALM1;CXADR;ATP2A2;CTNNA3;RYR2;CACNA1C;JUP;DSG2;DSP;TRPM4
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.4805933157280541,-1.180993916698876,0.24906367041198502,0.6304804341506641,1.0,7/13,22.88%,AQP11;LPCAT3;CLU;NR1H2;WFS1;NR1H3;FCGR2B
prerank,positive regulation of gene expression (GO:0010628),0.2846998709363166,1.1807581420535347,0.10268948655256724,0.7634249707570477,1.0,63/442,11.61%,IGF1;ROBO1;BMP6;SLC24A3;ROCK2;OSR1;SLC22A2;C1QTNF3;RBPJ;FGFR4;AFDN;WNT6;PID1;BMP7;ANGPT1;PRKN;RBMS3;PLA2R1;DKK1;SCX;NOS1AP;CTSH;DTNBP1;TFR2;PLD1;SRPK2;ITGAX;ANK2;MBIP;FOXD1;MAPK9;BAZ1B;TNRC6B;GJA1;TNRC6A;FGF1;SLC2A10;EPHX2;IL6;SMAD3;PRKAA1;CSF1;POLR2A;TLE1;MUSK;MITF;FUBP1;SAMD4A;MED1;AGO2;PRKDC;FGF9;SMARCA5;PIK3R1;TAF1A;RPS6KB1;METTL14;TFAP2A;POLR1F;FXR1;ERBB2;LARP6;POLR1A
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5149893872383613,1.1806686968180913,0.2874251497005988,0.7624214723274366,1.0,4/11,12.36%,IL34;PRKCA;CSF1;HSF1
prerank,cellular metal ion homeostasis (GO:0006875),0.33979992770237916,1.1806632495224327,0.19032761310452417,0.7611421014710719,1.0,10/102,3.96%,ATP1A2;SLC24A3;SLC8A3;STIM1;CSRP3;SLC41A1;ATP1B3;SLC8A1;DMPK;ANK2
prerank,regulation of cellular response to heat (GO:1900034),-0.31631110308110094,-1.1804411320977588,0.1674641148325359,0.6310308089154213,1.0,22/77,21.48%,HSPA8;CD34;HSP90AA1;HSP90AB1;GSK3B;CHORDC1;BAG1;CRYAB;MTOR;RPA1;HSPB8;DNAJC7;NUP37;CAMK2B;DNAJB1;NUP54;NUP85;ATR;FKBP4;NUP133;POM121;MAPK3
prerank,negative regulation of leukocyte migration (GO:0002686),-0.518158832446166,-1.1802786991790013,0.2658486707566462,0.6305750868467309,1.0,3/10,1.84%,SLIT2;CD200;BMP5
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4315058222867817,1.1802549065947892,0.24906367041198502,0.7610172793200475,1.0,7/28,10.77%,APPL2;PID1;GRB10;PRKCZ;PRKCB;TNS2;RPS6KB1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.37363506111377914,-1.1796051302136568,0.2219626168224299,0.6315395093916809,1.0,19/33,35.68%,HIP1;BCAR3;CBL;CCDC88A;HIP1R;SHKBP1;GPER1;PDE6H;PLAUR;AKT1;AFAP1L2;ARAP1;HAP1;BTC;EGF;AGT;NCF1;ADAM17;CNOT9
prerank,bicellular tight junction assembly (GO:0070830),-0.3429944776098217,-1.1784748686912265,0.20224719101123595,0.6338205701668067,1.0,10/46,10.02%,PECAM1;CLDN5;ESAM;OCLN;CLDN11;RAMP2;F11R;MPP7;PAK2;APC
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.4835352636073745,-1.178192851608211,0.2529411764705882,0.6336188069942762,1.0,6/13,23.86%,RUNX1;CBFB;TGFBR2;NKAP;NCKAP1L;SOCS1
prerank,negative regulation of heart contraction (GO:0045822),0.5207563738812196,1.1780165996383067,0.2942430703624733,0.7664654913402754,1.0,1/11,0.21%,ATP1A2
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.2997222526143709,-1.1779432427729188,0.13535911602209943,0.6334427011899675,1.0,32/107,16.38%,MEF2C;SLC12A2;GRM3;ITGB1;GRM7;CDH2;NGF;MCTP1;HOMER1;GRIK4;CLSTN2;ABR;DLGAP1;LRP8;DGKI;BCR;BTBD9;APP;SLC4A8;KCNMB4;PXK;RELN;KCTD13;DGKZ;CLSTN3;CPLX2;GRM8;NRG3;CNTNAP4;TMEM108;CX3CR1;CACNA1B
prerank,mRNA transport (GO:0051028),-0.30122679301659594,-1.1779003033691906,0.12834224598930483,0.632659516448771,1.0,46/101,35.96%,SRSF2;SRSF1;SRSF5;DDX39B;ZFP36L1;CPSF3;HHEX;SRSF9;RBM8A;RNPS1;SRSF6;NUP37;AGFG1;SYMPK;NXT1;CPSF2;NUP54;SMG5;NUP85;YTHDC1;THOC3;NUP133;MAGOH;FMR1;POM121;THOC6;EIF4E;DDX25;THOC2;NUP153;EIF4A3;SMG6;KIF5C;SRSF7;ALYREF;ZFP36;NUP42;CPSF1;ZC3H11A;NUP93;DHX38;U2AF1L4;CHTOP;NUP35;SRSF3;NCBP2
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.3952209240986143,1.1775900906691452,0.25476603119584057,0.7664232284855422,1.0,5/41,3.29%,AFDN;BMP7;PLPP3;CXCL13;MEGF10
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.4753067269642197,-1.177124041276492,0.26129666011787817,0.6338707016836168,1.0,9/13,32.29%,TMEM30A;CD81;SEC16B;BRSK2;INSIG1;SEC16A;SORL1;TM9SF4;TMEM30B
prerank,epiboly involved in wound healing (GO:0090505),-0.44367272031722393,-1.1770836589704838,0.2662835249042146,0.6330984804471984,1.0,7/16,13.57%,TMEFF2;FLNA;CD44;CEACAM1;PDCD10;RHOA;CCN1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.34880946862493345,1.1770601753651386,0.20189274447949526,0.7667024567419064,1.0,10/86,6.30%,BMP6;RBPJ;BMP7;ZEB2;DAB2;RBPMS;FOXD1;SULF1;SLC2A10;TTK
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.5004622742275178,-1.1764126806603104,0.2803030303030303,0.6340514912124122,1.0,5/10,30.15%,HSPA5;ATF4;HERPUD1;CCL2;NFE2L2
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.28487433902013704,-1.1763795692327008,0.125,0.633251588417016,1.0,32/151,15.14%,ST3GAL4;CERT1;ELOVL7;SGMS1;SGMS2;ACER3;ELOVL5;ACER2;CEPT1;SPTLC2;PLPP1;DEGS2;GCH1;B4GALT5;KDSR;PRKD3;PPM1L;GPHN;SPNS2;SGPL1;MFSD2A;ELOVL6;FURIN;LPCAT3;GPAT4;ELOVL1;TYW1;LPCAT1;LPIN3;CSNK2B;CERS4;PLA2G4A
prerank,collagen fibril organization (GO:0030199),0.3454551805156324,1.1763417620232723,0.21978021978021978,0.767640526789859,1.0,11/88,4.43%,COL22A1;COL26A1;COL4A5;COL4A6;PXDN;LOXL1;COL9A2;SCX;LOXL3;COL1A2;COL13A1
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.477551464818129,-1.1761167261598473,0.25,0.6330494786142902,1.0,8/13,31.19%,SOD1;ZC3H8;CAMK4;TOX;BMP4;FOXJ1;SHH;VNN1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.36784400868180905,1.1760083388410665,0.24027072758037224,0.7673789644894988,1.0,13/54,12.62%,HS3ST3A1;PXYLP1;SDC2;HS3ST3B1;GPC6;GPC3;HAS1;XYLT2;B3GALT6;NDST2;HS6ST1;UGDH;GPC4
prerank,inositol lipid-mediated signaling (GO:0048017),0.37926253253470776,1.1757347141714898,0.2292418772563177,0.7669282446518745,1.0,14/50,16.08%,IGF1;ADAP2;PLCB1;PDGFRB;PDGFRA;IGF1R;GPR143;PIK3R1;RPS6KB1;PLCD1;GAB2;PLCL1;PLCE1;EXOC1
prerank,chromatin remodeling (GO:0006338),0.3376781578703546,1.1757216242850261,0.1901840490797546,0.7656810218529678,1.0,37/100,20.72%,SATB1;JARID2;RBBP4;BAZ1B;HNRNPC;ARID1B;CECR2;BAZ1A;CHD4;RSF1;KDM5B;KDM6B;SMARCA5;HDAC1;NPM2;TADA2A;SMARCE1;MYB;EZH1;INO80;SMARCB1;SRCAP;KDM5C;SMARCA2;SMARCC1;INO80C;KDM6A;SMARCD3;BAZ2B;MPND;SMARCA1;KDM4D;HDAC4;BRDT;KAT2B;RUVBL2;CBX3
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.4944156465699143,-1.1755654153319715,0.25981308411214954,0.6337035387915041,1.0,8/12,38.90%,HSPA5;SEC62;SEC61G;SEC63;SEC61B;SEC61A2;SGTB;SEC61A1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.4798902047577221,-1.1751441175075483,0.23564356435643563,0.6339836197513808,1.0,3/13,2.30%,CAV1;PDE4D;CALM1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.3818665124751685,1.1749843984464794,0.21797004991680533,0.7664867714020004,1.0,8/47,9.87%,ROCK2;WNT4;C1QTNF3;SIK1;ACADL;SIRPA;APOC1;SLC27A1
prerank,cellular response to amino acid stimulus (GO:0071230),-0.37113489129821325,-1.1749146224627889,0.22832980972515857,0.6337627532142498,1.0,17/33,27.04%,SESN3;FYN;SH3BP4;CAPN2;MTOR;SESN2;CPEB1;XBP1;LAMTOR1;SPAAR;LAMTOR2;RRAGB;NSMF;LAMTOR4;CASTOR1;GLRA1;RPTOR
prerank,cellular response to starvation (GO:0009267),0.31806524357057026,1.1744621476504664,0.1893491124260355,0.7667090823655305,1.0,32/147,13.97%,PRKAG2;NPRL3;PPARA;PRKAG3;FNIP1;SZT2;PCSK9;SIK1;CPEB4;SESN1;PRKAA2;NPRL2;MTMR3;LRRK2;SLC38A9;WIPI1;RNF152;PRKAA1;LAMP2;ATG14;PIK3R4;ATP6V0D1;ATP6V0E1;MLST8;FLCN;EIF2S1;PRKAG1;STK24;MAPK1;RRP8;STK26;NIM1K
prerank,cell-cell junction organization (GO:0045216),-0.31415219931482846,-1.1744545273649598,0.19321148825065274,0.6342213534203094,1.0,19/79,10.39%,CLDN5;CADM1;OCLN;TJP2;LIMS2;TGFB2;CDH11;CTNND2;PKP4;CDH1;CDH2;GJC1;CXADR;LIMS1;TGFB1;CSK;TJP1;PVR;CADM3
prerank,nucleoside salvage (GO:0043174),-0.5028844331066694,-1.1742572476322786,0.2523719165085389,0.6338602451507128,1.0,7/10,31.87%,HPRT1;UCKL1;CDA;DCK;UCK1;UCK2;UPP1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.5407834414770999,1.173989618427441,0.2676056338028169,0.7655600809251192,1.0,3/10,19.26%,TULP1;CACNA2D4;GNAT1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.5407834414770999,1.173989618427441,0.2676056338028169,0.7655600809251192,1.0,3/10,19.26%,TULP1;CACNA2D4;GNAT1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.4041560076425035,1.1738198905871762,0.23867595818815332,0.7647778909307162,1.0,10/37,11.76%,IGF1;TPM1;MMP2;GJA1;TAFA5;MMP9;PTEN;FGF9;APLN;BMPR1A
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.32637526775650894,-1.1737078485099477,0.2020460358056266,0.6327075434908183,1.0,29/61,30.98%,NSF;CUL3;TMED2;MCFD2;RAB1A;TRAPPC6B;SEC23A;PPP6R1;TMED10;CNIH1;CTSZ;ANKRD28;SEC16B;PREB;CNIH3;RAB1B;TRAPPC2;CTSC;TRAPPC4;TRAPPC9;SEC16A;COL7A1;SEC31A;TRAPPC1;STX5;TRAPPC5;GRIA1;GORASP1;PEF1
prerank,vesicle coating (GO:0006901),-0.32637526775650894,-1.1737078485099477,0.2020460358056266,0.6327075434908183,1.0,29/61,30.98%,NSF;CUL3;TMED2;MCFD2;RAB1A;TRAPPC6B;SEC23A;PPP6R1;TMED10;CNIH1;CTSZ;ANKRD28;SEC16B;PREB;CNIH3;RAB1B;TRAPPC2;CTSC;TRAPPC4;TRAPPC9;SEC16A;COL7A1;SEC31A;TRAPPC1;STX5;TRAPPC5;GRIA1;GORASP1;PEF1
prerank,COPII vesicle coating (GO:0048208),-0.32637526775650894,-1.1737078485099477,0.2020460358056266,0.6327075434908183,1.0,29/61,30.98%,NSF;CUL3;TMED2;MCFD2;RAB1A;TRAPPC6B;SEC23A;PPP6R1;TMED10;CNIH1;CTSZ;ANKRD28;SEC16B;PREB;CNIH3;RAB1B;TRAPPC2;CTSC;TRAPPC4;TRAPPC9;SEC16A;COL7A1;SEC31A;TRAPPC1;STX5;TRAPPC5;GRIA1;GORASP1;PEF1
prerank,protein O-linked glycosylation (GO:0006493),0.33804812430519854,1.1736399721616317,0.1883614088820827,0.7639684718301991,1.0,11/96,6.04%,TMTC4;ST3GAL3;GALNT15;GALNT14;GALNT18;LARGE1;GXYLT2;TMTC1;B3GNT5;CRPPA;TET1
prerank,cellular calcium ion homeostasis (GO:0006874),-0.2855603654854821,-1.1736261876840872,0.1242603550295858,0.6320525812758657,1.0,45/133,20.29%,CAV1;TPT1;TRPC3;SLC35G1;CAV2;ATP1B1;SLC10A7;TRPC6;CALR;ATP2C1;ATP2A2;ATP2A3;TRPC4;RYR2;HTR2A;SLC24A2;ATP13A4;CCDC47;EDN1;SMDT1;SLC30A1;KCTD17;STIM2;RMDN3;STOML2;ATP2B1;GPER1;SELENOK;HERPUD1;MCUB;ATP13A5;SLC24A5;CXCL12;TRPC1;WFS1;ATP13A2;PLN;CD40;CCL13;NPTN;LETM1;TMEM165;PSEN1;ATP2B2;ATP2B4
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.4952221609777257,-1.1736012510772569,0.26369168356997974,0.631247594250671,1.0,7/12,29.16%,HNRNPU;LARP7;NELFCD;NELFE;RNF168;EAPP;RNF8
prerank,regulation of cell-cell adhesion (GO:0022407),-0.3622441652665592,-1.1736003505464685,0.2255125284738041,0.6303804959069201,1.0,13/39,12.09%,EFNA5;PODXL;PTPRG;JAG1;CDH1;PTK2;MINK1;TGFB1;CEACAM1;ZDHHC2;DPP4;SPINT2;TENM3
prerank,nitrogen compound transport (GO:0071705),0.3204002792579847,1.1733684948898637,0.17341040462427745,0.7635635604726516,1.0,16/141,8.41%,SLC7A11;SLC22A4;SLC6A13;SLC22A2;SLC38A3;SLC6A12;SLC35F3;PDPN;TCN2;LRP2;NDC1;SLC43A1;ZG16;ABCC2;SLC1A5;MIA3
prerank,regulation of cellular component organization (GO:0051128),-0.2874132737968847,-1.1729830685681975,0.14329268292682926,0.6311614053782195,1.0,32/135,15.26%,HIP1;LTBP4;RAP1A;HSPA8;TFRC;HSP90AA1;STON2;DAB2IP;SEMA4D;NET1;PACSIN2;CDK11B;STK38L;SOCS2;BCAR1;FAM107A;HJURP;GFAP;CEACAM1;HIP1R;HNRNPU;TJP1;MTOR;PTPN1;LAMTOR1;ERMN;EGLN2;CDH13;IRAK3;SPOCK1;NRG3;LAMTOR2
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.5252101921812229,1.1725572773169013,0.2967479674796748,0.7646502718177329,1.0,3/11,7.27%,DAB2;DKK1;WNT5B
prerank,Ras protein signal transduction (GO:0007265),0.3254535728376487,1.1721058264643227,0.19090909090909092,0.7647247051116896,1.0,17/137,7.96%,IGF1;ROCK2;ARHGAP6;KSR1;ARHGAP29;RHOD;RRAS2;PDPN;PLD1;COL1A2;ABI2;WASF1;HACD3;ARHGEF11;NTN1;EPS8L1;MYO9B
prerank,cAMP-mediated signaling (GO:0019933),0.43557627989498926,1.1719489794862037,0.2611218568665377,0.7638925516474488,1.0,4/24,3.00%,ADCY1;KSR1;PDE7B;PDE7A
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5277005587905064,1.1719279112990828,0.29012345679012347,0.762684624487014,1.0,2/11,1.78%,IGF2BP1;NOVA1
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.3053359521774525,-1.171908504859203,0.18018018018018017,0.6332231072608144,1.0,26/92,10.16%,TEK;FOXP1;NRP2;KDR;THBS1;RAC1;TGFB2;SCARB1;ETS1;DOCK1;PLCG2;PTK2B;BMPR2;IQSEC1;BCAR1;RHOB;CALR;EMC10;FLT4;VEGFA;MTOR;FGF7;GRN;EDN1;RTN4;PIK3CD
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.31435601125355955,-1.1716857910211007,0.15113350125944586,0.6329806760903515,1.0,18/74,12.39%,LEF1;TIAM1;BMP5;TGFB2;PHLDB1;DAB2IP;IL17RD;TGFBR2;TGFB1;FERMT2;CTNNB1;SPRED2;MTOR;WWTR1;BMP2;GCNT2;MCRIP1;SDHAF2
prerank,response to retinoic acid (GO:0032526),0.3697857690240154,1.1714629114300046,0.22586520947176686,0.7628017642177181,1.0,5/59,3.31%,PTK7;EPHA3;WNT6;RBP4;CTSH
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.44902924286790935,1.1714390050497339,0.2838709677419355,0.7616128300914092,1.0,2/21,2.68%,OSBPL8;PLA2G10
prerank,neural tube closure (GO:0001843),0.40783224523528905,1.1701661766609224,0.2222222222222222,0.764138363020346,1.0,9/34,11.24%,LMO4;PRICKLE1;KDM2B;MTHFR;LRP2;FOLR1;DVL3;COBL;IFT122
prerank,calcium ion transport (GO:0006816),0.3279830900963722,1.1699439438548298,0.19728915662650603,0.7634975524581213,1.0,10/113,4.91%,TRPM3;SLC24A3;ITPR1;SLC8A3;STIM1;NALCN;SLC8A1;ANK2;CACNA1D;CACNG7
prerank,pulmonary valve development (GO:0003177),-0.4272114591572645,-1.169156472253036,0.2701612903225806,0.6389715426475837,1.0,11/18,11.74%,SLIT2;NOS3;TGFB2;JAG1;NOTCH1;BMPR2;STRA6;NFATC1;TNFRSF1B;HEY2;HEYL
prerank,chromatin remodeling at centromere (GO:0031055),0.40989034771602717,1.1685763961584161,0.26492537313432835,0.7661320609438816,1.0,9/31,11.52%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ
prerank,regulation of gastrulation (GO:0010470),0.49857698315996013,1.1685717749688864,0.2745490981963928,0.7649015171682172,1.0,3/14,6.08%,OSR1;SCX;PHLDB2
prerank,regulation of extracellular matrix organization (GO:1903053),0.5013887103630748,1.1683143822564175,0.3022312373225152,0.764402913454682,1.0,6/15,9.87%,AEBP1;FGFR4;DDR1;SLC2A10;DDR2;RIC1
prerank,protein modification by small protein conjugation (GO:0032446),0.2868001109931438,1.1677750898799568,0.14015151515151514,0.7647538255879752,1.0,57/361,12.61%,ASB2;PDZRN3;RNF220;EYA1;TRIM63;EPAS1;RNF43;PRKN;SPSB1;HIF3A;TRIM5;MGRN1;NEDD4;RNF213;ATG10;RNF138;UFL1;ZNRF3;NDC1;TRPC4AP;CAND1;UBE2L3;RNF181;UBR2;RNF152;KLHL7;CUL9;RNF135;WWP2;AMFR;PIAS1;BIRC6;CRBN;USP7;TRAF7;CUL7;FBXL17;MDM2;ITCH;UBA7;NUP107;SMURF2;TRIM35;PRKDC;NEUROD2;UBA3;DTX1;FBXO4;MYCBP2;CUL4B;RNF14;CDC73;TRIM26;TRIM43;RNF20;FBXO11;RCHY1
prerank,organelle fission (GO:0048285),-0.4089430383722126,-1.1672520663793684,0.2320675105485232,0.6435482190333252,1.0,8/24,18.65%,DNM3;CORO1C;DNM2;MIEF1;DNM1;PEX11B;SEC16B;MTFR1L
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.36419543943712857,1.1669610395616663,0.2457627118644068,0.7658699999044334,1.0,13/59,14.15%,ROCK2;OXSR1;PDPK1;LRRK2;PRKCA;CDK1;CAMK2D;PRKDC;HIPK3;PRKD2;TBK1;MAPK1;NLK
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.3937591534966155,1.1669516458169797,0.23885918003565063,0.7646696379481773,1.0,6/39,7.95%,TCF7L2;RBP4;NLGN2;TFR2;MCU;SLC30A8
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.4437472897714962,1.1665058068027991,0.2704280155642023,0.7647526482103529,1.0,11/26,21.20%,LTF;CACTIN;NLRC3;LYAR;ITCH;PCBP2;MAPKBP1;TRAFD1;TRAF3IP1;ILRUN;NFKBIL1
prerank,ion transport (GO:0006811),0.32401893845236107,1.1660242056164964,0.20249221183800623,0.764962991482019,1.0,8/111,3.07%,TRPM3;SLC24A3;SLC8A3;WNK4;SLC5A5;SLC1A3;SLC20A2;SLC8A1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.38462603019260466,1.1645869947953449,0.2483108108108108,0.7677871545564738,1.0,9/43,10.77%,PID1;SORBS1;IGF2;GRB10;PRKCZ;PRKCB;GKAP1;TNS2;RPS6KB1
prerank,RNA destabilization (GO:0050779),0.4655465523652269,1.16446543306929,0.29206963249516443,0.7668949387214478,1.0,3/18,10.80%,ROCK2;YTHDF2;METTL14
prerank,mammary gland epithelium development (GO:0061180),0.4942710824679273,1.1644530325244768,0.2832980972515856,0.7657126410326799,1.0,4/14,11.11%,WNT4;LATS1;EPHA2;JAK2
prerank,positive regulation of locomotion (GO:0040017),-0.3831494649298447,-1.164411867189337,0.2474437627811861,0.6505351927607324,1.0,5/27,5.38%,SPOCK2;THBS1;STX3;CAVIN1;TGFB1
prerank,regulation of apoptotic process (GO:0042981),-0.23815914421681733,-1.1635694418420672,0.007352941176470588,0.6520377273210229,1.0,147/676,15.54%,LEF1;MEF2C;UNC13B;TEK;SLIT2;HIP1;MAP3K5;ACTN4;MCF2L;PTMA;ITGA6;TIAM1;ACER2;RASSF2;TFRC;KDR;TRIO;THBS1;ADAM10;TPT1;HSP90AA1;ARHGEF3;GAS6;RNF144B;CBL;HNRNPK;PTK2;ITGB1;TARDBP;PPP1R13B;KCNMA1;SLK;PTK2B;DAB2IP;NGF;RASGRF2;UBB;NFKBIA;RPS3;RACK1;DNAJA1;PPIA;CTSD;SEMA4D;ARHGEF12;NET1;TNFSF10;PREX1;ATG7;SFRP4;TGM2;FLNA;ACTN1;SOCS2;RPS6;HSPB1;BCAR1;ARHGEF17;IKBKB;SOX4;ARHGEF6;RHOB;PERP;ARHGDIA;CD38;CALR;CD44;CTSB;PLK2;CTNNB1;HSP90B1;SOD1;FAF1;ABR;BCL2L1;LGALS1;RPS27A;UBC;GSK3B;TBX3;LRP8;WNK3;EGLN3;SIGMAR1;SERPINB9;APBB1;HIP1R;DNM2;RNF157;FLT4;PDCD10;BAG1;CARD14;VEGFA;TJP1;CRYAB;BIRC3;JUN;FOXO1;ARHGEF19;MAGED1;DDX20;ARHGEF26;ZBTB7A;MAPK8;ING4;RTN4;PAK2;BNIP2;HYPK;APC;XBP1;HSPA5;ARHGEF5;BCL3;ATF4;BMP2;RSL1D1;RPS6KA1;BIN1;GPER1;RYBP;EGLN2;REST;CD74;HSPD1;ARHGEF2;CLU;BNIP1;HIGD2A;RNPS1;GADD45G;NLRP2B;MT3;IAPP;DSTYK;NR1H4;PLEKHN1;NF1;CIAPIN1;FAS;CYP1B1;CASP8;UBA52;MADD;SIX4;FLT3
prerank,leukotriene biosynthetic process (GO:0019370),-0.4631122547683408,-1.1634136879505619,0.3211538461538462,0.6515471820989708,1.0,8/14,37.39%,PLA2G4A;GGT1;LTA4H;GGTA1;PLA2G5;ALOX5AP;MGST2;GGT5
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.3429953298464098,-1.1633400694579419,0.2136150234741784,0.6508688688680581,1.0,18/47,24.20%,KLF4;NFKBIA;TGFB1;APP;EDN1;SSH1;EIF4G1;NR1H2;EIF2A;AGTR1;NOLC1;AKT1;PUM3;NR1H3;EIF4E;PCIF1;RBM4B;DDX25
prerank,cellular response to cytokine stimulus (GO:0071345),0.28394227640472164,1.163256774269693,0.1385390428211587,0.7680192561037714,1.0,35/416,5.50%,IL31RA;RORA;ADAMTS12;LEPR;OXSR1;PTPN13;IL34;PID1;IL18;KIT;DAPK1;BCL2;ZEB1;DUOX2;PTPN4;DPYSL3;IL1RAPL1;FER;CNTFR;ANXA1;RIPOR2;MMP2;STAT5B;IRAK2;ITGAX;CRHBP;GRB10;NFAT5;IL13RA1;COL1A2;ZFAND6;CACTIN;NPR2;IRF8;PTPN9
prerank,regulation of transposition (GO:0010528),0.4876880189726247,1.1631696703019592,0.28958333333333336,0.7670518250784593,1.0,2/13,7.14%,MYBL1;UBR2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.27533261787185725,-1.1630434462359092,0.14332247557003258,0.650783094699267,1.0,68/173,31.36%,SPTBN1;NSF;GAS6;CD55;MIA2;CAPZA2;ACTR10;DYNLL2;TMED5;VTI1B;COPG1;GOPC;CUL3;TMED2;BET1L;MCFD2;LMAN2;DCTN3;RAB1A;TRAPPC6B;WHAMM;SPTBN4;ARFGAP2;LMAN2L;SEC23A;TMED10;TMED3;CNIH1;DCTN4;CTSZ;ATL2;BCAP31;TRIP11;GBF1;TEX261;SEC16B;PREB;CNIH3;RAB1B;TRAPPC2;ANK3;CTSC;DCTN1;VAPA;TRAPPC4;TMEM115;TMED7;CAPZA1;RAB2A;SEC16A;COL7A1;USE1;KDELR3;SEC31A;COPA;TRAPPC1;ATL3;STX5;TRAPPC5;MPPE1;RANGRF;GRIA1;GORASP1;TMED1;SPTBN5;BCAP29;PEF1;DYNC1I1
prerank,regulation of protein transport (GO:0051223),-0.37701570300468085,-1.1629468268636105,0.2210065645514223,0.6501574382581875,1.0,15/27,30.92%,HSPA8;DNAJA1;RHBDF2;CHP1;DNAJC1;PTPN1;NDFIP2;ATP13A2;NDFIP1;DISP1;ARFIP1;SNX3;PPM1F;LCP1;STXBP5L
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.41127144682325223,-1.1626262617415437,0.2612244897959184,0.650145177016869,1.0,7/21,14.55%,CSGALNACT1;CSPG4;BGN;CHST9;CHST11;VCAN;CHSY3
prerank,negative regulation of cell activation (GO:0050866),-0.4692168288764267,-1.1623863026586008,0.2819047619047619,0.6498997316222365,1.0,4/14,12.47%,NOS3;CD200;GPER1;THBD
prerank,chromatin assembly or disassembly (GO:0006333),0.5157050344258445,1.1622810874422689,0.31223628691983124,0.768428392430339,1.0,2/11,4.38%,HDAC8;RBBP4
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3177840242745098,1.1622673317835786,0.19940476190476192,0.7672382706428615,1.0,21/140,11.34%,ADCY5;JPH1;BDKRB2;ACKR2;CCR9;LPAR1;CXCR5;SLC8A1;CXCL13;CXCR6;PDGFRA;LPAR2;ADRA1D;CACNA2D1;F2RL2;PTGIR;GLP1R;ABL1;PTGER1;F2RL3;DLG4
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.44574944133427724,-1.1619589198018916,0.26597938144329897,0.6501177484825342,1.0,9/16,19.73%,THBS1;PPP1R16B;GATA2;JCAD;PDCD10;VEGFA;APLNR;AGTR1;DLL4
prerank,clathrin-dependent endocytosis (GO:0072583),-0.39209806245065076,-1.1619248649361273,0.26785714285714285,0.649340295764182,1.0,12/26,22.71%,SGIP1;FNBP1L;AP2A2;ITSN2;AP2M1;CANX;PIP5K1C;SNAP91;INPP5F;AP2B1;DLL1;AP2A1
prerank,negative regulation of translational initiation (GO:0045947),0.49118706317074773,1.1617436107534955,0.3129251700680272,0.7674749239446232,1.0,6/13,22.86%,EIF4EBP1;AGO2;LARP1;RBM4;TPR;PAIP2B
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.43235678680442013,-1.1614172915862124,0.26380368098159507,0.6498626862395444,1.0,6/18,20.48%,ESR1;TGFB1;DDX5;ZC3H12A;MAP2K2;BMP4
prerank,response to cytokine (GO:0034097),0.31293101203183094,1.1613862853183323,0.19486404833836857,0.767346351146938,1.0,17/141,7.89%,ALDH1A2;PTPN13;PID1;TIMP3;BCL2;PTPN4;DPYSL3;SP100;IL1RAPL1;ANXA1;IRAK2;NFAT5;SPHK1;PTPN9;SMAD3;PRKCA;TRIM56
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.32698986638625016,-1.160657366195419,0.215,0.6509912731632158,1.0,17/59,13.34%,HMCN1;PECAM1;BSG;PTPRM;CADM1;CDH1;ITGB1;CDH2;PKD1;KIRREL3;ROBO4;CEACAM1;PVR;CADM3;TENM3;CDH13;CNTN6
prerank,negative regulation of translation (GO:0017148),0.33778176216070144,1.1606408285980194,0.22022838499184338,0.7682513738464092,1.0,25/87,19.33%,ROCK2;IGF2BP1;DAPK1;CPEB2;EIF4EBP1;CPEB4;TYMS;YTHDF2;SAMD4A;AGO2;METTL14;UNK;FXR1;SHMT1;CNOT8;CNOT7;LARP1;TSC1;ENC1;CNOT10;GIGYF2;DDX3X;RBM4;DHFR;LSM14A
prerank,regulation of interleukin-6 production (GO:0032675),-0.29875875442737493,-1.1603718267098158,0.16758241758241757,0.6509107383721279,1.0,45/96,33.97%,IL33;CD200;GAS6;PLCG2;MBP;LBP;ARRB1;APP;XBP1;STAT3;CD74;HSPD1;ARHGEF2;IRAK3;CD47;IFIH1;ZC3H12A;TIRAP;MYD88;TYROBP;NCKAP1L;TNFAIP3;HYAL2;AFAP1L2;AGER;RAB7B;SPHK2;TLR7;TREM2;FOXJ1;TLR4;LPL;C1QTNF4;IL16;TLR6;DHX9;MAVS;NOD2;PTPN22;TLR1;C5AR2;NOS2;IL1A;TSLP;SYK
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.33636100162379123,-1.160314100052313,0.21379310344827587,0.6493328049146005,1.0,19/51,26.70%,REEP3;CHMP2B;LEMD2;LBR;RANGAP1;LMNA;NUP37;VRK1;PPP2R2A;CC2D1B;NUP85;NUP133;POM121;CHMP3;CCNB2;CHMP7;BANF1;CHMP4C;UBE2I
prerank,mitotic nuclear membrane organization (GO:0101024),-0.33636100162379123,-1.160314100052313,0.21379310344827587,0.6493328049146005,1.0,19/51,26.70%,REEP3;CHMP2B;LEMD2;LBR;RANGAP1;LMNA;NUP37;VRK1;PPP2R2A;CC2D1B;NUP85;NUP133;POM121;CHMP3;CCNB2;CHMP7;BANF1;CHMP4C;UBE2I
prerank,fatty acid biosynthetic process (GO:0006633),-0.3208984504325201,-1.16019074307772,0.19080459770114944,0.6487903772725616,1.0,17/63,21.85%,ABHD2;ELOVL7;ELOVL5;GPX4;ACACA;ELOVL6;PTGS2;XBP1;ABCD3;ALOX12;ELOVL1;TECRL;TECR;SCD5;ACLY;LIAS;SCD
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4408416859816711,-1.160163505488635,0.27054108216432865,0.6480085714610149,1.0,4/16,12.56%,MEF2C;MCTP1;KCNMB4;CPLX2
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.30237430441574265,-1.160061935770975,0.19623655913978494,0.6474203601104705,1.0,23/87,10.85%,EFNA5;ESAM;RAC1;IQGAP1;CORO2B;F11R;PTK2B;ARHGDIB;SEMA3E;RHOB;ARHGDIA;FAM107A;CCDC88A;GPM6B;HIP1R;MTOR;ABI3;PAK1;ARHGEF19;EPS8;RHOA;ARHGEF5;CRK
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.47108905462027784,-1.160003770827009,0.28893058161350843,0.6467136210757422,1.0,5/13,13.69%,CD9;ITGB1;SREBF2;CDH13;CD81
prerank,megakaryocyte differentiation (GO:0030219),0.5118421056867276,1.1599369434784,0.3081632653061224,0.7690495265523015,1.0,4/11,17.55%,KIT;MED1;CDKN2B;IL11
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.43065196000435796,-1.1592392030053844,0.29518072289156627,0.6478817805023299,1.0,10/16,38.80%,TARDBP;ZFP36L1;PLEKHN1;ZC3H12A;RBM24;CPEB3;ZFP36;ZC3H12D;RC3H1;TRIM71
prerank,positive regulation of viral life cycle (GO:1903902),-0.41208008949051306,-1.1591840565680849,0.2803921568627451,0.6471733467724688,1.0,7/22,22.28%,CHMP2B;LGALS1;DDB1;CD74;TYRO3;FMR1;CHMP3
prerank,dendritic spine organization (GO:0097061),-0.39138164450714236,-1.1591716124844467,0.2564102564102564,0.6463575118884076,1.0,8/26,13.07%,SHANK3;CTNND2;FYN;DOCK10;LGMN;ARF1;EPHB1;PICK1
prerank,intracellular protein transmembrane transport (GO:0065002),-0.35421438638224356,-1.1590533986362264,0.2565217391304348,0.6458225675236395,1.0,19/42,29.88%,TOMM20;C2CD5;HSPA5;HSPD1;SEC62;ROMO1;SEC61G;ZFAND2B;PEX1;PEX5;PEX10;TIMM50;PEX16;SEC63;TIMM44;RTN2;CHCHD4;DNLZ;SEC61B
prerank,cellular response to nitrogen compound (GO:1901699),0.44534070847869034,1.1590099788740251,0.28654970760233917,0.7704170282759668,1.0,3/20,12.36%,ROCK2;BLM;HSF1
prerank,relaxation of cardiac muscle (GO:0055119),0.5019947246594909,1.158960438817208,0.2988505747126437,0.7693273404408361,1.0,3/13,3.07%,ATP1A2;GSTM2;SLC8A1
prerank,negative regulation of histone acetylation (GO:0035067),-0.4853376935179644,-1.158807503895663,0.27052238805970147,0.6456101124452082,1.0,7/11,36.85%,SET;CTBP1;SPI1;NOC2L;SIN3A;THAP7;TAF7
prerank,regulation of cell cycle (GO:0051726),-0.2594385297657956,-1.1587539945584182,0.08178438661710037,0.6449040014280981,1.0,89/271,26.21%,MECOM;APBB2;NEK7;THBS1;ADAM10;TGFB2;FAP;IQGAP1;RPL23;HSP90AB1;TARDBP;TTC28;PPP1R13B;ADARB1;DAB2IP;NOTCH1;RACK1;FBXL3;PKD1;CDK11B;RHOB;TGFB1;CALR;PTPRC;TBX3;PLAGL1;LIN54;APBB1;HNRNPU;PDCD4;BIRC3;JUN;NR4A1;ING4;APC;CDK6;CDKN1B;STAT3;BMP2;MEN1;JUNB;BIN1;GPER1;WHAMM;MYBBP1A;TMEM8B;GADD45G;MASTL;NLRP2B;MADD;GBF1;DUSP1;MIF;CTBP1;ZBTB17;SOX2;ID2;GAS2L1;CDK5;CAMK2N1;INHA;NOP53;TFAP4;CHMP1A;L3MBTL1;BMP4;MYBL2;METTL3;GADD45A;UHMK1;CDKN1A;CDKN2D;MFN2;CCNB2;GMNC;UHRF2;SIPA1;AFAP1L2;GADD45B;RGCC;PPP1R15A;CHEK1;DTL;HRAS;NUPR2;CDKN3;HBP1;ERN1;CDC14A
prerank,protein deacylation (GO:0035601),-0.40675643285112545,-1.1585616591253967,0.2634989200863931,0.6445699250694739,1.0,11/23,30.77%,HDAC5;ABHD17B;LYPLA2;ABHD17A;SIRT7;HDAC7;HDAC6;LYPLA1;SIRT6;HDAC3;SIN3A
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.45891213659529323,1.1581934820235504,0.2714570858283433,0.7704447770327206,1.0,3/17,3.96%,SNTA1;GPD1L;ANK2
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.36104358479831583,-1.1578399047455097,0.22826086956521738,0.6456333230123373,1.0,10/37,26.41%,ENTPD1;ENTPD7;ENTPD2;NUDT1;RNASE3;MTREX;SUPV3L1;NUDT16;RNASEH2C;HNRNPD
prerank,sarcomere organization (GO:0045214),0.4220588424837279,1.1577954714327063,0.27392120075046905,0.770343901835985,1.0,3/27,2.80%,TPM1;CSRP3;TNNT2
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.42960258908833104,-1.1577253733927149,0.287109375,0.6450706131742662,1.0,11/17,30.12%,CALM1;SPRED2;DDIT4;EIF4G1;CADM4;CALM2;CALM3;DGKQ;SPRY2;SPRED3;SMAD7
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.4717147130447158,1.1576189960023253,0.289738430583501,0.7696269977773278,1.0,6/16,17.39%,PIGG;PIGV;PIGX;PIGC;PIGQ;PIGN
prerank,RNA metabolic process (GO:0016070),0.3213411490800721,1.1575106420514842,0.21745788667687596,0.7687514352988668,1.0,21/127,11.94%,CELF2;POLR2D;ATXN1;RBMS1;NOVA1;RNASEL;ADAD1;RBPMS;HNRNPC;HNRNPH1;RBMS2;RBM5;POLR2A;GTF2F1;NOL9;TENT2;SND1;AGO2;METTL14;PCBP2;RBM39
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.45968377472553495,1.1574626071192076,0.29865125240847784,0.7677193673298504,1.0,3/19,4.05%,ROBO1;SMOC2;CCBE1
prerank,visual system development (GO:0150063),0.39994576593485015,1.1573728761784399,0.3026315789473684,0.7668129302327621,1.0,7/37,8.52%,RBP4;MEIS1;SLC39A5;SMOC1;SH3PXD2B;PBX4;CHRDL1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.46353381879329947,-1.157364087518318,0.2896825396825397,0.6452087713620354,1.0,7/13,37.59%,GLRX5;GLRX3;ISCA2;ISCA1;CIAO2B;BOLA2;YAE1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.4359060456290267,1.1573428237053711,0.2876190476190476,0.7656999975823143,1.0,6/23,7.38%,TULP3;MGRN1;GPC3;GLI3;SUFU;HERC4
prerank,regulation of sodium ion transport (GO:0002028),0.39900274423355375,1.157191054848765,0.2620817843866171,0.7649678375910894,1.0,7/34,6.48%,WNK4;SNTA1;GPD1L;NKAIN4;NEDD4;SIK1;DLG1
prerank,cellular response to retinoic acid (GO:0071300),0.3835014219693869,1.1568843261366002,0.2722222222222222,0.7646734960033683,1.0,3/42,1.12%,PTK7;EPHA3;WNT6
prerank,cellular response to alkaloid (GO:0071312),0.47177133861210707,1.15684258153041,0.2876712328767123,0.7636040140795342,1.0,4/17,7.25%,GSTM2;SLC8A1;CRHBP;BLM
prerank,triglyceride catabolic process (GO:0019433),0.45027170046475073,1.1563279866255018,0.280561122244489,0.7639730640568044,1.0,4/19,16.17%,LIPH;LIPC;FABP7;FABP4
prerank,endothelial cell development (GO:0001885),-0.39342315096515873,-1.1558492541076348,0.27455357142857145,0.6484210240415618,1.0,9/25,7.28%,PECAM1;RAP1A;PDE4D;MSN;COL15A1;PPP1R16B;ROBO4;MET;PDE2A
prerank,cellular response to metal ion (GO:0071248),-0.2863315925724452,-1.1557105272067272,0.1531791907514451,0.647953190821469,1.0,29/123,10.93%,MEF2C;SLC12A2;B2M;DLG2;CLIC4;IQGAP1;CDH1;PLCG2;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;LGMN;CPNE8;MT2A;JUN;ADCY7;CPNE2;CPNE3;MAPK8;CDKN1B;CHUK;CACNA1H;KCNA1;SYT10
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3376303893553095,1.1553741924358782,0.222397476340694,0.765460332219462,1.0,9/86,7.87%,IGF1;EPHA7;BMP6;ANGPT1;IGF2;PRKCZ;IL6;ENPP2;VTN
prerank,regulation of epidermal cell differentiation (GO:0045604),0.4468608969647644,1.1552966544422434,0.2976190476190476,0.7644878392976888,1.0,2/21,0.39%,ERRFI1;ROCK2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.38807582190076495,-1.1551975295245471,0.24312896405919662,0.6484994899603019,1.0,14/25,25.13%,HIP1;BCAR3;CBL;CCDC88A;HIP1R;RTN4;SHKBP1;GPER1;PDE6H;PLAUR;AKT1;AFAP1L2;ARAP1;HAP1
prerank,nucleosome assembly (GO:0006334),0.40441420821979635,1.155105759475927,0.26371681415929205,0.7638532550901829,1.0,8/31,16.51%,RBBP4;NASP;RSF1;KAT6B;SMARCA5;NAP1L3;NAA60;NAP1L1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.3535085391314331,-1.154353579870191,0.21868365180467092,0.6499948177883005,1.0,19/37,34.04%,UBB;RPS27A;UBC;DDB1;RBX1;RPA1;UBA52;POLK;POLD3;NTHL1;POLD1;GTF2H2;XPA;ERCC5;RFC5;ERCC3;GTF2H5;RPA3;RPA2
prerank,excitatory postsynaptic potential (GO:0060079),-0.4147795015734242,-1.1543155619413472,0.26954732510288065,0.6492520277795455,1.0,7/19,22.77%,MEF2C;GSK3B;GRIN1;ARRB2;AKT1;GRID2;MAPK8IP2
prerank,heme biosynthetic process (GO:0006783),-0.4124413977521314,-1.1541149278153182,0.28775510204081634,0.6490250846613651,1.0,11/22,28.97%,ABCG2;ABCB10;ATP5IF1;UROD;UROS;FECH;FLVCR1;HMBS;COX15;TSPO;ABCB6
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.4085128939456932,-1.1540244266969706,0.28509719222462204,0.6484000250772453,1.0,5/22,17.18%,APOD;CEACAM1;GPER1;PPP2R5A;BSCL2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.2990825934430891,-1.153217545245477,0.15877437325905291,0.649725542666732,1.0,42/96,35.96%,SRSF2;SRSF1;SRSF5;DDX39B;CPSF3;HHEX;SRSF9;RBM8A;RNPS1;SRSF6;NUP37;AGFG1;SYMPK;NXT1;CPSF2;NUP54;SMG5;NUP85;YTHDC1;THOC3;NUP133;MAGOH;POM121;THOC6;EIF4E;DDX25;THOC2;NUP153;EIF4A3;SMG6;SRSF7;ALYREF;NUP42;CPSF1;ZC3H11A;NUP93;DHX38;U2AF1L4;CHTOP;NUP35;SRSF3;NCBP2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.4596176990480906,-1.1529043544685253,0.2916666666666667,0.6497591631246225,1.0,6/14,19.43%,CARD10;CARD14;COPS8;IRAK1;TNFRSF10B;TIRAP
prerank,protein localization to cell surface (GO:0034394),0.4267075665211837,1.1527111609518264,0.27599243856332706,0.7694562175580149,1.0,5/26,7.91%,ANGPT1;FBLN5;PIGU;ANK2;GGA2
prerank,negative regulation of cytokine production (GO:0001818),-0.27260007362259053,-1.1526881222680117,0.15047021943573669,0.6495370715917256,1.0,56/163,24.17%,LEF1;FN1;TMSB4X;APOD;CD200;CD34;THBS1;RPS6KA5;RAC1;GAS6;KLF4;TRIB2;TRIM25;PTPRC;SARS1;TNFRSF21;ARRB1;CEACAM1;RNF125;PDCD4;ADCY7;NAV3;SRGN;NLRC5;BCL3;ISG15;ATP2B1;IRAK3;ABCD2;ASB1;NR1H4;CMKLR1;IFIH1;LAPTM5;RPS6KA4;SIGIRR;CD274;N4BP1;ZC3H12A;NPTN;GPATCH3;INHA;JAK3;TRIM27;TYROBP;NCKAP1L;SLC11A1;HDAC7;HDAC9;OTUD7B;TNFAIP3;DLL1;FCGR2B;AGER;RGCC;VSIR
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3864080752612677,-1.1526208596971597,0.2559241706161137,0.6488453518058256,1.0,17/28,25.95%,MAP3K5;DAB2IP;TMEM117;BAG6;ATP2A3;ATF4;SELENOK;ERO1A;BBC3;DNAJC10;TNFRSF10B;BRSK2;CEBPB;TRIB3;BAX;PPP1R15A;ERN1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3389251452732419,1.152312062163714,0.2141732283464567,0.7694296859629053,1.0,24/95,14.11%,TGFBR3;PPARA;ZEB2;DAB2;PDPK1;SNX6;DKK3;SMAD6;ITGA3;SLC2A10;SMAD3;FOLR1;NREP;LEMD3;BCL9;LATS1;SMURF2;FLCN;HTRA4;LDLRAD4;VEPH1;ADAMTSL2;CDKN1C;CREBBP
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.44388451176331356,1.1521844609819942,0.2894248608534323,0.7686189152109077,1.0,3/26,5.06%,LGR4;APPL2;CACTIN
prerank,macroautophagy (GO:0016236),0.3222816562251285,1.152138797807814,0.22424242424242424,0.767579973450922,1.0,24/118,15.63%,PRKAG2;PRKN;PRKAG3;ATG10;PRKAA2;MTMR3;WIPI1;PRKAA1;LAMP2;ATG14;VTA1;PIK3R4;UVRAG;STAM2;FUNDC1;CHMP6;VPS37A;VPS37C;PRKAG1;STX17;TMEM74;VPS39;AMBRA1;ATG3
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.41374956912304184,-1.1521195937064121,0.27309236947791166,0.6493150030885653,1.0,10/20,13.96%,NOTCH1;SMAD9;SMAD5;VEGFA;RUNX2;SESN2;XBP1;ATF4;BMP2;MT3
prerank,regulation of vasculogenesis (GO:2001212),-0.45720695772299474,-1.1514357741259416,0.2854251012145749,0.6503488192185648,1.0,7/14,11.52%,RAP1A;CD34;KDR;CEACAM1;EMP2;HEY2;XDH
prerank,potassium ion transmembrane transport (GO:0071805),0.31249173119070967,1.1513849027564698,0.20610687022900764,0.7685741721920989,1.0,10/135,4.07%,ATP1A2;SLC24A3;KCNK2;KCNQ4;NALCN;KCNA5;SLC1A3;ATP1B3;KCNT2;KCND3
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3144575430587413,1.1512518808787042,0.20875912408759123,0.7678234988514033,1.0,12/142,4.52%,ATP1A2;ADCY5;BDKRB2;ACKR2;CCR9;LPAR1;CXCR5;SLC8A1;CXCL13;CXCR6;PDGFRA;LPAR2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5011756166792135,-1.151057391484298,0.2994350282485876,0.6505567050726172,1.0,5/10,24.76%,SHANK3;APP;CAMK2B;NPTN;SYP
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.2931005669972879,-1.1510083846777617,0.1830238726790451,0.649827056375979,1.0,36/109,23.57%,RAC1;CALM1;PLCG2;IKBKB;NFATC2;NFATC1;JUN;PAK1;PSMD13;PSMF1;MAPK8;PAK2;MAP3K1;PSMB10;CHUK;MAP2K7;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PPP3CA;CUL1;TAB3;PSME1;PSMB3;PPP3R1;NFATC3;PSMD5;SKP1;MAPK3;PSMD9;PSMB4;RELA;MAPK10
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.44663452581197716,1.1508306129431938,0.2827868852459016,0.7678615264824451,1.0,4/20,3.68%,ATP1A2;ATP1B3;SLC8A1;LACC1
prerank,actin nucleation (GO:0045010),-0.41132986094132906,-1.1505968865621228,0.2803180914512923,0.650112464276226,1.0,10/21,21.78%,ARPC1B;ARPC3;WHAMM;ACTR2;SPIRE1;ARPC4;ARPC5L;ARPC1A;TRIM27;ACTR3
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5025953150213668,1.150050171908915,0.2975206611570248,0.7688013378114553,1.0,3/12,6.76%,DOCK11;NOTCH2;IL6
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.5048167786042299,-1.14986243704576,0.31588785046728973,0.6512759152202858,1.0,6/10,28.81%,RPUSD4;TSR3;RPUSD1;NHP2;RPUSD2;NOP10
prerank,cellular response to fatty acid (GO:0071398),0.4981827795941288,1.149572785393947,0.33195020746887965,0.7690323986172889,1.0,1/12,1.17%,PID1
prerank,cell-matrix adhesion (GO:0007160),0.33342621385645344,1.149562364687854,0.24803767660910517,0.7678914330499312,1.0,11/95,5.54%,ADAMTS12;NID2;ADAMTS9;FBLN5;RHOD;SORBS1;FERMT1;COL13A1;DDR1;SGCE;ITGA3
prerank,cellular respiration (GO:0045333),-0.34615290063192056,-1.1491893677687723,0.25054466230936817,0.6523320370465696,1.0,17/41,29.96%,PPARGC1A;ATP5F1D;NDUFA5;UQCRH;NDUFS1;COQ10B;NDUFS7;UQCRC2;UQCRC1;MTFR1L;CYCS;UQCR10;MTLN;ETFB;COX15;COX4I2;NR4A3
prerank,icosanoid secretion (GO:0032309),0.5004035935004717,1.1490352919664828,0.31901840490797545,0.7682461586050012,1.0,3/12,5.24%,BDKRB2;ANXA1;ACE
prerank,regulation of neuron death (GO:1901214),-0.3025042100208465,-1.1489759027791804,0.2010178117048346,0.6521448996397536,1.0,33/82,23.75%,MEF2C;MAP3K5;CD200;CD34;PPARGC1A;FYN;UBB;DCC;GSK3B;EGLN3;SIGMAR1;TNFRSF1B;CHP1;DDIT4;EIF4G1;EPHB1;EGLN2;REST;CLU;CHGA;C1QA;CTSZ;NENF;ATP13A2;CDK5;TRIM2;TYROBP;AKT1;GRID2;NSMF;FCGR2B;SARM1;SNCG
prerank,cardiac atrium morphogenesis (GO:0003209),-0.4351963908208327,-1.1487488400468333,0.2846153846153846,0.6519525378840864,1.0,6/16,10.79%,TGFB2;ENG;NOTCH1;BMPR2;HEY2;BMP2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.47158859802824543,1.1483403411910906,0.30105263157894735,0.7690964695641747,1.0,4/15,7.99%,IL18;PLA2G10;MAPK9;CSF1
prerank,hydrogen peroxide metabolic process (GO:0042743),0.4626440850363162,1.1482657061160995,0.28517110266159695,0.7681349631456973,1.0,5/19,14.16%,PXDN;DUOX2;DUOX1;ACOX1;MAOB
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.4571899088503334,-1.1478567918990386,0.2978723404255319,0.6535533820203606,1.0,6/13,18.60%,ELOVL7;ELOVL5;ELOVL6;ELOVL1;TECRL;TECR
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.38624971396398644,-1.1477877235095244,0.259656652360515,0.6529003751182709,1.0,13/29,24.76%,SLC4A10;MCTP1;APP;ZDHHC2;CAMK2B;NCDN;GRIK2;DBN1;PPFIA3;NSMF;SHISA6;RAB3A;SYP
prerank,regulation of necroptotic process (GO:0060544),-0.40174456549553333,-1.1476286015288422,0.27645788336933047,0.6524990032491395,1.0,10/23,23.77%,HSP90AA1;YBX3;CDC37;BIRC3;OGT;ARHGEF2;CASP8;SLC25A4;PELI1;PDCD6IP
prerank,ceramide transport (GO:0035627),-0.4752466112658973,-1.147592971089193,0.3013182674199623,0.6517667272836342,1.0,3/12,3.46%,CERT1;PLTP;PSAP
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.36092363704643077,-1.1475739586552347,0.2766884531590414,0.6509895617350356,1.0,8/36,5.38%,MEF2C;SLIT2;PTPRM;THBS1;ACVRL1;DAB2IP;NOTCH1;TGFB1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.44572156053673523,1.147546701395211,0.2938856015779093,0.7690699379645128,1.0,7/21,17.82%,PPARA;PRKN;TFAP2A;SLC30A10;PLIN5;ABCB7;TRAP1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.5048781648002723,-1.1475178481217585,0.2947761194029851,0.6503247296706927,1.0,4/10,22.56%,APC;RCC2;KNSTRN;SPAG5
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.36473802545193756,1.147412286070962,0.2704507512520868,0.7683001688491883,1.0,7/56,6.30%,BMP6;BMP7;DAB2;SMAD6;DKK1;RBPMS;TTK
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.417327208209337,-1.147325772338337,0.2874743326488706,0.6500784447429128,1.0,8/19,17.56%,CSGALNACT1;NDST3;HS6ST2;EXT1;EXTL3;XYLT1;HS6ST3;HS3ST5
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.327617530428678,-1.1472118225695458,0.23529411764705882,0.6495406437224366,1.0,19/55,23.00%,FHL1;PINX1;PSMD13;PSMF1;RBX1;PSMB10;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;PSMB3;PSMD5;SKP1;PSMD9;PSMB4
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.4694408874185675,1.1471114538822706,0.32264150943396225,0.7680060425151604,1.0,4/18,8.84%,ATP1A2;SLC43A1;MMP9;CAMK2D
prerank,histone exchange (GO:0043486),0.3934969363141761,1.1469188436309596,0.27056672760511885,0.7674094578834775,1.0,12/37,16.00%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ;SRCAP;CENPX;ACTR6
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.42619752704652203,-1.1468332513704118,0.2874493927125506,0.6496441237694246,1.0,10/17,23.01%,CAV1;KLF7;CEACAM1;APOLD1;AJAP1;MAFF;DSPP;PRKX;DLL1;CEBPB
prerank,response to UV-B (GO:0010224),-0.47570048651099206,-1.1465784793955034,0.3102836879432624,0.6494742412312734,1.0,6/12,23.41%,CRIP1;MFAP4;MSH2;CDKN1A;HYAL2;RELA
prerank,positive regulation of hormone secretion (GO:0046887),0.46082912572566737,1.1458516803615872,0.2824267782426778,0.7692823780234181,1.0,2/17,3.64%,C1QTNF3;TFR2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.45002677597765534,-1.1457110756037614,0.2771317829457364,0.6509947550455037,1.0,8/15,29.88%,HSP90B1;DERL1;HERPUD1;AUP1;TMEM129;VCP;SYVN1;SEC61B
prerank,regulation of interleukin-8 production (GO:0032677),-0.31176434368947287,-1.145556202448639,0.23425692695214106,0.6505764614830857,1.0,36/69,35.95%,TMSB4X;F3;KLF4;LBP;NOD1;PTPRC;ARRB1;BCL3;STAT3;RAB1A;CD74;TIRAP;MYD88;OTUD7B;HYAL2;AFAP1L2;RELA;HSPA1B;TLR7;TLR4;FADD;TLR6;MAVS;NOD2;PTPN22;TLR1;C5AR2;NOS2;HSPA1A;SYK;PARK7;F2R;CD33;ANXA4;TLR8;RIPK1
prerank,polyol metabolic process (GO:0019751),-0.3379869628201165,-1.14524853386721,0.23222748815165878,0.6505014122472726,1.0,11/46,15.42%,CALM1;PLCG2;PLCB4;INPP5D;INPP4A;SYNJ1;NUDT3;PLCB3;NUDT4;INPPL1;ITPKB
prerank,regulation of DNA biosynthetic process (GO:2000278),0.4236368386013375,1.1452014613991288,0.2965009208103131,0.7699575091469931,1.0,5/27,6.24%,FGFR4;SMOC2;PDGFRB;NIBAN2;PARP4
prerank,"phagocytosis, engulfment (GO:0006911)",-0.3552066176253492,-1.1447093616800819,0.2565947242206235,0.6511520957635171,1.0,7/36,9.80%,ELMO1;THBS1;RAC1;GSN;DOCK1;MYH9;ARHGAP25
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.40840965854541295,-1.1446766531391583,0.27655310621242485,0.6504288186503311,1.0,6/20,11.93%,THBS1;GSN;SFRP4;ITGA4;PDCD4;GPER1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5097425316750068,1.1436319476144001,0.33905579399141633,0.773194766592745,1.0,1/10,0.31%,BMP6
prerank,regulation of autophagosome assembly (GO:2000785),0.40025904669056017,1.1435195895995833,0.27943760984182775,0.7723368906442013,1.0,8/33,13.27%,NPRL3;NPRL2;MTMR3;LRRK2;NUPR1;TMEM39A;FEZ1;RAB3GAP1
prerank,response to histamine (GO:0034776),-0.5016667165579639,-1.1434967270632406,0.3141263940520446,0.6528285963307615,1.0,6/10,36.68%,GABRB3;GABRB1;HRH1;GABRG2;DRD3;GABRB2
prerank,neurotrophin signaling pathway (GO:0038179),-0.4009904808385175,-1.1434733179868357,0.271484375,0.6520882865602708,1.0,4/21,9.32%,RAP1A;NGF;BCAR1;DDIT4
prerank,epidermis development (GO:0008544),0.36332568075696914,1.1433667969080579,0.26897689768976896,0.7716428651979311,1.0,3/56,2.43%,SVEP1;FGFR2;CCN2
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.4264896716582058,-1.1430063532361114,0.2889344262295082,0.6525497697969167,1.0,8/18,19.57%,ELOVL7;ELOVL5;ACSL4;ELOVL6;ELOVL1;ACSL3;TECR;ACSL5
prerank,negative regulation of epithelial cell migration (GO:0010633),0.3970118690878732,1.1423765415989973,0.28205128205128205,0.7733157071599341,1.0,5/33,4.27%,ADAMTS9;MCC;NR2F2;SP100;DUSP10
prerank,regulation of oxidoreductase activity (GO:0051341),0.489690141187581,1.1423509490211792,0.3037190082644628,0.772240356139291,1.0,4/13,11.46%,SZT2;SLAMF8;ABL1;OXA1L
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4945667543962414,1.1423253593553797,0.2936344969199179,0.7711548147736141,1.0,3/13,11.05%,PDPK1;IGF2;APLN
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.38877801615413277,-1.1421238720466744,0.28189300411522633,0.6541236377483729,1.0,8/24,16.76%,TPT1;ACKR3;CD44;BCL2L1;CD74;CLU;CXCL12;MIF
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4801095040057682,-1.1415807157663056,0.2947761194029851,0.6548247148011068,1.0,4/11,11.93%,MEF2C;TGFB2;TGFB1;GPER1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.424082218087887,1.1415796190290632,0.287292817679558,0.7722383846767117,1.0,3/24,2.58%,JPH1;DMD;GSTM2
prerank,organophosphate ester transport (GO:0015748),-0.3840801905025547,-1.1414352325539068,0.2975206611570248,0.6544257782585634,1.0,11/24,23.65%,PITPNC1;PLTP;SCARB1;TNFAIP8L3;ABCA3;PRELID3B;MTTP;PITPNA;PITPNB;OSBPL5;NPC2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.4770279705858401,-1.1413627710325474,0.318,0.6538198249716366,1.0,3/12,18.75%,ANO1;CFTR;TRPM4
prerank,aortic valve development (GO:0003176),-0.35720308803279344,-1.1413394180211385,0.25,0.6530754916689215,1.0,13/34,11.74%,SLIT2;NOS3;TIE1;JAG1;NOTCH1;BMPR2;TGFB1;NFATC1;TNFRSF1B;ELN;HEY2;BMP2;HEYL
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.34639416146224006,1.1409389811981516,0.24464285714285713,0.7728798065591739,1.0,13/69,12.11%,POLR2D;PHAX;CDK7;INTS8;POLR2A;CCNT2;RPRD1B;CCNT1;GTF2F1;SNAPC5;TAF8;RPRD2;ICE2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.2866358605776036,-1.1408664031113651,0.17166212534059946,0.6535018824236665,1.0,28/112,9.82%,MEF2C;CLDN5;ID1;PDE3A;ACVRL1;TGFB2;CBL;PTK2;ITGB1;F11R;ENG;UBB;LIMS1;PXN;TGFBR2;TGFB1;FERMT2;RPS27A;UBC;CLEC3B;PDE2A;SMAD9;SMAD5;JUN;RHOA;APPL1;FURIN;ZFP36L1
prerank,second-messenger-mediated signaling (GO:0019932),0.33929017741787254,1.1406695398604323,0.2474747474747475,0.7725628138838577,1.0,11/82,7.85%,RCAN2;ACKR2;CCR9;CXCR5;PDPK1;NDNF;CXCR6;SPHK1;LRRK2;PPP1R9A;MCU
prerank,regulation of insulin secretion (GO:0050796),0.33053110095864535,1.1406172804336485,0.24569640062597808,0.7715736572836049,1.0,14/101,7.95%,ADCY5;TCF7L2;ITPR1;STXBP4;RBP4;PRKN;KCNA5;NLGN2;CACNA1D;IL6;PRKCA;RAPGEF4;MCU;SLC30A8
prerank,regulation of dopamine secretion (GO:0014059),0.4293436024695255,1.140245878617344,0.2824858757062147,0.7715238488896543,1.0,9/25,18.24%,PRKN;DTNBP1;SYT11;SYT12;GDNF;FGF20;CHRNB2;DRD2;SNCA
prerank,nuclear body organization (GO:0030575),0.4828611440416837,1.1402404284057903,0.2918454935622318,0.7703998655761037,1.0,2/12,3.90%,AFF2;SRPK2
prerank,regulation of translation (GO:0006417),-0.26663271886654477,-1.1399475394293246,0.15838509316770186,0.6552839205167234,1.0,51/173,24.20%,THBS1;NIBAN1;EEF2;VIM;RPS3;RACK1;RPL26;HSPB1;SOX4;CALR;IGFBP5;EIF1B;TOB1;RPL5;EIF4G3;GAPDH;APP;YBX1;MTOR;PYM1;EIF4G1;EIF3D;BCL3;YTHDF3;RPS6KA1;RPS4X;SHFL;EIF4H;RPS27L;EIF3B;RPL13A;RIDA;EIF3C;EIF1;EIF2B2;EIF2A;EIF5B;NOLC1;MRPL13;MTG1;METTL3;FMR1;EIF6;EIF4B;PUM3;EIF4E;EIF5;PCIF1;PUS7;RBM4B;DDX25
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.39860539066871653,-1.1396262233015046,0.2985971943887776,0.6553312000435108,1.0,11/23,29.88%,HSP90B1;DERL1;HERPUD1;AUP1;PREB;TMEM129;VCP;SEC16A;SYVN1;RANGRF;SEC61B
prerank,TOR signaling (GO:0031929),0.4228833407953393,1.1396155563001777,0.3013972055888224,0.7710366290309145,1.0,8/26,10.86%,NPRL3;FNIP1;EIF4EBP1;RICTOR;SYAP1;MLST8;RPS6KB1;FLCN
prerank,RNA export from nucleus (GO:0006405),-0.289149732286802,-1.1392846438332305,0.18867924528301888,0.6554183292355101,1.0,43/100,35.96%,SRSF2;SRSF1;SRSF5;DDX39B;CPSF3;HHEX;SRSF9;RBM8A;RNPS1;SRSF6;NUP37;AGFG1;SYMPK;NXT1;CPSF2;NUP54;SMG5;NUP85;YTHDC1;THOC3;NUP133;MAGOH;POM121;THOC6;EIF4E;DDX25;THOC2;NUP153;EIF4A3;SMG6;SRSF7;ALYREF;NUP42;CPSF1;ZC3H11A;NUP93;DHX38;U2AF1L4;CHTOP;HNRNPA1;NUP35;SRSF3;NCBP2
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.47941796439560186,1.1389192572763203,0.3116883116883117,0.7718355068641071,1.0,5/15,7.50%,FGFR4;PDPN;DDR1;IL6;DDR2
prerank,negative regulation of cell aging (GO:0090344),-0.44008155167652296,-1.138705535689053,0.3229571984435798,0.6562443998632553,1.0,4/16,16.76%,YBX1;CDK6;MAP3K3;MIF
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.3323532983661061,-1.1377230385010633,0.2534562211981567,0.6580953777041696,1.0,23/47,31.75%,THBS1;PLCG2;RAB27A;TGFBR2;TGFB1;SOD1;GRIN1;XDH;ACE2;ROMO1;ZC3H12A;AGTR1;TYROBP;PRKCD;GADD45A;CDKN1A;ITGB2;DCXR;TLR4;CBR1;CD36;TLR6;AGT
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.48774214930755755,-1.137152243615969,0.3248175182481752,0.658861194211378,1.0,6/10,30.28%,GALNT13;GALNT2;GALNT1;POGLUT3;MGAT5B;POGLUT1
prerank,regulation of establishment of planar polarity (GO:0090175),-0.2971748520299016,-1.1368698022440429,0.19796954314720813,0.6588215002995967,1.0,30/88,23.95%,TIAM1;RAC1;ROR2;FZD4;AP2A2;FZD6;ARHGEF19;PSMD13;PSMF1;RHOA;AP2M1;PSMB10;VANGL2;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;DVL2;PRICKLE2;ARRB2;PSMD5;AP2B1;AP2A1;PSMD9;PSMB4;SPEF1
prerank,triglyceride biosynthetic process (GO:0019432),0.4600234356998304,1.136834415117435,0.3106212424849699,0.7766199463542965,1.0,2/18,1.78%,AGMO;LPGAT1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.3730680762848148,-1.1357436534127618,0.25833333333333336,0.6610131314149734,1.0,10/29,21.04%,HSP90AA1;HSP90AB1;PPIA;PINX1;RPA1;TERF2IP;TNKS1BP1;ANKRD28;CDK2;NHP2
prerank,peripheral nervous system development (GO:0007422),-0.3930460948430004,-1.1356615114351183,0.30118110236220474,0.6604373702371059,1.0,6/23,14.64%,ADGRG6;NGF;SERPINI1;SCN8A;GPC1;NF1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3292446690024247,-1.1356091366969627,0.2641025641025641,0.6597783075032583,1.0,12/48,12.31%,LIMS2;RAC1;CARMIL1;DOCK1;LIMS1;FLNA;CALR;FERMT2;MYOC;CRK;S100A10;CDKL3
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.3226283365569781,-1.1353941274517085,0.21967963386727687,0.6595275274362392,1.0,14/54,14.72%,CAV1;KCNJ2;NEDD4L;KCNMA1;FHL1;FLNA;KCNAB1;KCNQ1;CD63;KCNMB4;BIN1;KCNN2;KCNJ15;KCNIP2
prerank,neuron cell-cell adhesion (GO:0007158),0.47394600322468317,1.1347995458429252,0.317907444668008,0.7811490985929496,1.0,2/14,2.23%,CEL;NLGN2
prerank,positive regulation of histone modification (GO:0031058),-0.361457791872015,-1.1347715594865944,0.25925925925925924,0.6604263642714618,1.0,11/33,21.48%,RPS6KA5;PPARGC1A;ARRB1;GLYR1;NOS1;APLNR;AKAP8;RPS6KA4;CTBP1;FMR1;MAPK3
prerank,regulation of cell population proliferation (GO:0042127),-0.23445173205480133,-1.1347401523307594,0.08620689655172414,0.6597152759430055,1.0,131/691,12.79%,LEF1;KITLG;ZBTB7C;NTRK3;FN1;PTPRJ;FTH1;CLDN5;NOS3;ACER3;TIAM1;IGFBP6;ACER2;LIFR;CD200;TFRC;KRAS;KDR;THBS1;ADAM10;BMP5;PLPP1;ACVRL1;TGFB2;NAMPT;RUNX1;STX3;PTPN14;JAG1;CBFA2T3;TES;RPL23;KLF4;RPS9;PPP2R5C;PTK2;ETS1;ADARB1;TBC1D8;WNT9A;ROR2;ENG;PTK2B;DAB2IP;NGF;NOTCH1;SH3BP4;TBX1;P3H2;BMPR2;HES1;SFRP4;LIMS1;LGMN;RPS6;RERG;RBFOX2;TGFBR2;WARS1;PINX1;TBX2;SOX4;TGFB1;CALR;TSPAN31;KDM4C;CTNNB1;JAG2;LRP5;CCDC88A;ST18;TOB1;GNL3;TNFRSF11A;TBX3;EGLN3;SIX1;ATP8A2;DDAH1;CUL3;PDGFC;APP;FLT4;PDCD10;ADRA1A;VEGFA;TJP1;JUN;ECRG4;EMP2;PTHLH;PAK1;AQP11;ELN;CNOT6L;FGF7;RHOA;PODN;EDN1;ING4;ESM1;ZFP36L1;DPP4;APC;CDK6;WWTR1;XBP1;SOX7;CDKN1B;RTKN2;NCK2;BTG3;STAT3;BMP2;GCNT2;HGS;HHEX;IFI35;MEN1;ACE2;JUNB;PBRM1;GPER1;RPS4X;TCIRG1;GLI1;REST;CDH13;ARHGEF2;CLU;LMNA
prerank,regulation of neuron projection arborization (GO:0150011),0.4693279844514414,1.1342765588738075,0.3040816326530612,0.7815584220456849,1.0,7/15,15.34%,GRIP1;MACF1;NTNG2;DVL3;DLG4;MYO9A;MOV10
prerank,positive regulation of cell cycle process (GO:0090068),0.3299388598243268,1.1341816697523603,0.24361158432708688,0.7806557740582895,1.0,11/91,11.42%,IGF1;CXCR5;DMRT1;PDGFRB;IGF2;CDC14B;UBXN2B;PKN2;PHIP;NPM2;TGFA
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.45699125436977706,-1.13417493048508,0.3019230769230769,0.6604716455839987,1.0,7/13,37.54%,TGFB1;SOD1;TYROBP;PRKCD;ITGB2;SYK;CRP
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.48677807375216864,-1.1341316274866935,0.32669322709163345,0.6597961846829958,1.0,7/11,18.96%,SLIT2;RIN3;CCN3;DUSP1;MIF;GREM1;PADI2
prerank,gliogenesis (GO:0042063),-0.43200354040964867,-1.1337069917907443,0.302734375,0.660169478083127,1.0,5/15,10.65%,TGFB2;CD9;CDH2;CDK6;RELN
prerank,cellular response to purine-containing compound (GO:0071415),0.5416451234666476,1.1331954687369574,0.33263598326359833,0.7823209817326804,1.0,2/10,3.07%,GSTM2;SLC8A1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.34026697683178797,-1.1329900310587382,0.2834467120181406,0.6612165114678146,1.0,9/47,9.22%,SPTBN1;STXBP6;NSF;EXOC6;RAB31;EXOC4;GOPC;GOLGA7;EXOC5
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.2643494616878032,-1.1319136325840908,0.15705128205128205,0.663285276786245,1.0,38/175,14.90%,TMSB4X;ACTN4;TNFRSF11B;PTK2B;DAB2IP;NFKBIA;RPS3;LIMS1;IKBKB;EDA;YBX3;TNFRSF21;ST18;TNFRSF11A;TNFRSF1B;SMPD4;CARD14;BIRC3;NPNT;PSMD13;AIM2;PSMF1;COMMD7;ZFP36L1;PSMB10;CHUK;PSMB6;PSME3;PSMB5;GPER1;ARHGEF2;PSMC3;ERBIN;GBP3;PSMD12;PSMB8;TRAF1;PSME1
prerank,cardiocyte differentiation (GO:0035051),0.5139049255964282,1.131910527719477,0.33052631578947367,0.7848530974378182,1.0,4/10,8.94%,CBY1;AKAP13;SIK1;KDM6B
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.39913029267186756,-1.1318777305276295,0.30390143737166325,0.6625704889448684,1.0,7/21,12.73%,SLIT2;TGFB2;DAB2IP;CYRIB;ARHGAP25;CD2AP;SPRY4
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5050831642712508,1.1316725974168205,0.3276955602536998,0.784350151196645,1.0,1/11,0.24%,TGFBR3
prerank,phospholipid translocation (GO:0045332),-0.3707174049413453,-1.130960189041617,0.30022075055187636,0.6643370013116702,1.0,9/28,12.13%,ATP10A;ATP8B1;ATP8A1;ATP8A2;MFSD2A;ATP11C;ATP11B;TMEM30A;ATP11A
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.45589468741465156,-1.1306623784235612,0.304,0.6643708995558606,1.0,6/12,28.49%,DAB2IP;XBP1;PTPN1;BAX;ERN1;TMEM33
prerank,snRNA transcription (GO:0009301),0.3418171179325835,1.1300736937252855,0.25402504472271914,0.7876366405001541,1.0,13/70,12.11%,POLR2D;PHAX;CDK7;INTS8;POLR2A;CCNT2;RPRD1B;CCNT1;GTF2F1;SNAPC5;TAF8;RPRD2;ICE2
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.46379920912723505,-1.1298291684409958,0.31048387096774194,0.6658064562449336,1.0,7/13,29.16%,HNRNPU;LARP7;NELFCD;NELFE;RNF168;EAPP;RNF8
prerank,inositol phosphate metabolic process (GO:0043647),-0.33335934985566285,-1.1296065231865207,0.25542168674698795,0.6656300393727066,1.0,11/46,15.42%,CALM1;PLCG2;PLCB4;INPP5D;INPP4A;SYNJ1;NUDT3;PLCB3;NUDT4;INPPL1;ITPKB
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.488783608535379,-1.129305018639611,0.3205574912891986,0.6656165854295203,1.0,8/10,43.98%,DNAJB1;HSPA1B;SORL1;DNAJB6;HSPA1A;DNAJB2;DNAJA4;DNAJB8
prerank,protein localization to phagophore assembly site (GO:0034497),0.4992453095012948,1.129169405005109,0.3456032719836401,0.7890824092245768,1.0,4/11,13.38%,WIPI1;TRAPPC8;ATG9A;STX17
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.30232236358613845,-1.129066125817275,0.22715404699738903,0.665438138288644,1.0,19/78,11.93%,SPTBN1;PRKCH;ACTB;STX3;ITGB1;STX7;TGFB1;NKD2;VTI1B;VAMP8;BCL2L1;WNK3;ABI3;ZDHHC2;ZDHHC7;AP2M1;APPL1;TMBIM1;GPER1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3952145218086166,1.1285900215524325,0.2892857142857143,0.7895973368318262,1.0,4/33,3.48%,STXBP4;PLCB1;UBE2E2;ANXA1
prerank,nuclear membrane reassembly (GO:0031468),-0.32038971830711743,-1.1284077980907095,0.26036866359447003,0.6663857694812652,1.0,20/54,26.70%,REEP3;CHMP2B;LEMD2;LBR;NSFL1C;RANGAP1;LMNA;NUP37;VRK1;PPP2R2A;CC2D1B;NUP85;NUP133;POM121;CHMP3;CCNB2;CHMP7;BANF1;CHMP4C;UBE2I
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.4192347274625353,-1.127726668918042,0.3072289156626506,0.6674422168042944,1.0,10/17,30.99%,SFRP4;TMEM100;BMP4;BTG1;RFX3;FGF2;FOXJ1;SFN;SULT2B1;AHI1
prerank,regulation of viral entry into host cell (GO:0046596),-0.3681497635258523,-1.1276047680501595,0.2920353982300885,0.6669801482141936,1.0,11/30,22.39%,LY6E;GSN;TRIM14;TRIM25;LGALS1;CD74;HS3ST5;MID2;TRIM27;IFITM3;CIITA
prerank,transition metal ion transport (GO:0000041),-0.3572947749862031,-1.127342382608355,0.26956521739130435,0.6668903842617402,1.0,12/35,9.66%,FTH1;TFRC;TRPC3;ATOX1;IREB2;SLC30A5;TRPC6;ATP2C1;SLC31A1;SLC39A8;TRPC4;SLC30A1
prerank,negative regulation of neuron death (GO:1901215),-0.2953049416439053,-1.1270331371194413,0.2026315789473684,0.6669235305808825,1.0,30/93,19.13%,MEF2C;CD200;CD34;FBXO7;PPARGC1A;PTK2B;NGF;LGMN;SOD1;GSK3B;FOXQ1;SIX1;TNFRSF1B;GRN;SET;EIF4G1;ATF4;MSH2;REST;CHGA;MT3;NENF;SIX4;WFS1;ATP13A2;PRKCG;CDK5;TYRO3;LIG4;PINK1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.457533584212957,1.1266247800312783,0.3307543520309478,0.7940853829005482,1.0,4/16,9.05%,APPL2;PPARA;NLRC3;SIRPA
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.27229883404524935,-1.1266218853678969,0.2032258064516129,0.6672163481588083,1.0,41/136,19.45%,TMSB4X;ID1;ESR1;CD200;GAS6;KLF4;BHLHE40;DAB2IP;NFKBIA;HES1;PKD1;SFRP4;FLNA;FZD6;ARRB1;CHP1;PTCH1;LRRC14;PTGIS;AIM2;COMMD7;NLRC5;CTNNBIP1;CHUK;MEN1;HEYL;IRAK3;ERBIN;NLRP2B;DAP;CMKLR1;CYP1B1;WFS1;BRMS1;SIGIRR;ZC3H12A;ID2;IRAK1;SPI1;HES6;ARRB2
prerank,regulation of macrophage differentiation (GO:0045649),0.47043412846672683,1.126533648232334,0.33595284872298625,0.7932101780088995,1.0,4/15,12.36%,IL34;PRKCA;CSF1;HSF1
prerank,iron ion homeostasis (GO:0055072),-0.31485255830760694,-1.126491631409291,0.22772277227722773,0.6667261540057225,1.0,16/58,10.01%,ABCG2;FTH1;B2M;TFRC;SCARA5;FTL;IREB2;SLC40A1;SOD1;NEDD8;SLC22A17;ISCU;FBXL5;HMOX2;FRRS1;ATP6V1A
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.383827951690309,1.1263607561047353,0.2956204379562044,0.7925853518316811,1.0,6/39,3.79%,OSR1;WNK4;DMD;GPD1L;NEDD4;PCSK9
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.2689361843687956,-1.1256560952215267,0.17142857142857143,0.6683048630261914,1.0,24/159,7.14%,HMCN1;PECAM1;BSG;ADGRL3;CLDN5;PTPRM;CADM1;TGFB2;CDH11;CDH1;CLDN11;ITGB1;CDH2;UNC5D;TENM2;LRFN5;CXADR;PKD1;KIRREL3;TGFBR2;ROBO4;ATP2C1;CEACAM1;TENM4
prerank,negative regulation of wound healing (GO:0061045),-0.3719394173628406,-1.1255165667066656,0.301255230125523,0.6678755957814551,1.0,9/28,12.47%,SLC12A2;CD34;SERPINE2;CD109;AJAP1;EDN1;CRK;CASK;THBD
prerank,regulation of protein autophosphorylation (GO:0031952),0.38776681248837397,1.1250534305723452,0.3100358422939068,0.7952472566629969,1.0,2/36,0.35%,EPHA7;ERRFI1
prerank,apoptotic cell clearance (GO:0043277),-0.3657131342965128,-1.125000780343593,0.2631578947368421,0.6684761066150002,1.0,5/30,4.39%,THBS1;RAC1;GAS6;SCARB1;TGM2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.49540865659072614,-1.1247572503387033,0.3213572854291417,0.6682860014766581,1.0,6/10,19.75%,EMC10;EMC7;EMC1;EMC3;EMC6;EMC9
prerank,regulation of feeding behavior (GO:0060259),0.5014294530095496,1.124533173446777,0.3409090909090909,0.7955270821289379,1.0,1/11,0.35%,LEPR
prerank,positive regulation of protein modification process (GO:0031401),-0.25538168565253766,-1.1244541221404514,0.1453287197231834,0.6682603463909225,1.0,63/203,20.96%,TEK;NTRK3;PECAM1;LIMCH1;EFNA5;TFRC;KRAS;KDR;NIBAN1;RAC1;HSP90AA1;GAS6;CALM1;PTK2;PDE8A;ENG;RACK1;PPIA;SEMA4D;TBX1;ATG7;PPP1R16B;LIMK2;TGFB1;CAMKK2;ARRB1;CHP1;APP;FLT4;CARD14;RAMP1;VEGFA;PAK1;FGF7;SLCO3A1;RALB;BMP2;GPER1;CD74;SVIP;CCN1;MT3;TERF2IP;CSF1R;FAS;SYMPK;CALM2;BRMS1;DVL2;PPP2R5A;KNDC1;CD40;NPTN;PIK3R3;PLAUR;PINK1;PTBP1;PRKCD;AKT1;BMP4;CDCA2;INSR;FMR1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.4189268789450147,1.1243899692734027,0.3104125736738703,0.794790499821208,1.0,6/25,12.06%,ITPR1;LRRK2;GPR143;CCL4;NEUROD2;TMBIM4
prerank,sodium ion import across plasma membrane (GO:0098719),-0.42187037256928905,-1.1241228817530093,0.3045267489711934,0.668336469546613,1.0,2/17,0.54%,SLC12A2;SLC9A2
prerank,regulation of ATP biosynthetic process (GO:2001169),0.4516332941859923,1.123942774303358,0.32108317214700194,0.7949256677284321,1.0,2/16,1.17%,PPARA;PID1
prerank,microtubule nucleation (GO:0007020),0.43311270539928903,1.1235533047865751,0.3254437869822485,0.7948401282879815,1.0,8/19,19.48%,CCDC57;TUBGCP6;GOLGA2;TUBGCP2;RANBP9;TUBG1;AKAP9;TPX2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.43111656599674486,1.1235023643847346,0.31462925851703405,0.7938516468480735,1.0,5/20,10.06%,EPAS1;PRKN;ZMIZ1;ITCH;WASHC1
prerank,negative regulation of MAPK cascade (GO:0043409),-0.2952747269561631,-1.1234574691064318,0.2553763440860215,0.6693690083341857,1.0,40/87,30.54%,CAV1;PTPRJ;SEMA6A;STK38;DAB2IP;PPIA;PTPRC;SPRED2;UCHL1;FOXO1;CNKSR3;PTPN1;DUSP3;GPER1;SYNJ2BP;SPRY4;IRAK3;NF1;DUSP1;WNK2;SH2B3;CAMK2N1;PRKCD;BMP4;CD300A;HYAL2;DUSP6;SPRY2;DUSP4;SORL1;EMILIN1;PSMD10;EZR;PTPRR;DUSP26;SPRED3;TLR4;ABCA7;PEBP1;DUSP7
prerank,error-prone translesion synthesis (GO:0042276),-0.4028007184409982,-1.1234074162991439,0.2963709677419355,0.6687056266501833,1.0,7/21,16.16%,UBB;REV3L;RPS27A;UBC;RPA1;UBA52;POLK
prerank,positive regulation of cation channel activity (GO:2001259),-0.3437699532252335,-1.123364920870294,0.29128440366972475,0.6680122195466732,1.0,15/40,26.69%,SHANK3;TMSB4X;CALM1;RELN;ADRB2;KCNIP2;CALM2;STAC3;JPH2;ANK3;CALM3;CCR2;HAP1;CCL2;CASQ1
prerank,regulation of Notch signaling pathway (GO:0008593),-0.30157971095473657,-1.1232251466138734,0.260989010989011,0.6675978652885732,1.0,19/76,12.45%,NOS3;TGFB2;JAG1;PRAG1;SREBF2;NOTCH3;NOTCH1;CCN3;GATA2;JAG2;ARRB1;PDCD10;NOTCH4;LFNG;ZBTB7A;MFNG;STAT3;SYNJ2BP;EPN2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.29650463300776564,-1.1227692444580053,0.22164948453608246,0.6681129379368335,1.0,29/85,23.00%,TIAM1;RAC1;ROR2;FZD4;AP2A2;FZD6;ARHGEF19;PSMD13;PSMF1;RHOA;AP2M1;PSMB10;VANGL2;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;DVL2;PRICKLE2;ARRB2;PSMD5;AP2B1;AP2A1;PSMD9;PSMB4
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.45599961146034873,1.122575357043092,0.31982942430703626,0.7954252176674382,1.0,5/17,8.68%,CAMK1D;RIPOR2;CCL19;MCU;MOSPD2
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4351447550987342,1.1225212824052122,0.33954451345755693,0.7933025654044001,1.0,3/19,8.04%,POLR2D;ACD;POLR2A
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4351447550987342,1.1225212824052122,0.33954451345755693,0.7933025654044001,1.0,3/19,8.04%,POLR2D;ACD;POLR2A
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.47481875807016566,1.1222450706408793,0.3382352941176471,0.792951283996647,1.0,2/14,3.19%,OXSR1;CXCL13
prerank,endocrine system development (GO:0035270),0.42634348043679504,1.1219701204210486,0.31589147286821706,0.7926942536134718,1.0,3/21,6.81%,WNT4;DKK3;SALL1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4956313640484866,1.1218187763365368,0.33264033264033266,0.7919825357532945,1.0,3/12,8.88%,IL18;IL6;NUPR1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.4901792575069832,1.1216138681013599,0.35450819672131145,0.791429514318579,1.0,3/13,11.22%,LARGE1;CHST3;RENBP
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3938474853884401,-1.1215703441834715,0.2871900826446281,0.6706572809354222,1.0,11/24,15.90%,RACK1;CREB3L1;UBXN1;BCL2L1;AQP11;XBP1;LPCAT3;CLU;HERPUD1;NR1H2;WFS1
prerank,glucose transmembrane transport (GO:1904659),-0.42100911387373363,-1.1214661838974287,0.32220039292730845,0.670166601241211,1.0,2/18,3.07%,SLC2A1;PPARD
prerank,Golgi to endosome transport (GO:0006895),-0.42199867871785207,-1.1214487706885674,0.3040816326530612,0.669419278783315,1.0,8/16,25.06%,MON2;VPS13A;VPS13C;AP1AR;GBF1;SYS1;AP2A1;RAB14
prerank,cellular response to insulin stimulus (GO:0032869),-0.27302654554164685,-1.1210384456968085,0.21690140845070421,0.6697624960930363,1.0,45/124,23.23%,GAB1;GRB14;BCAR3;NAMPT;AP3S1;CAV2;RAB31;PKM;BCAR1;HDAC5;ATP6V0A1;GSK3B;CEACAM1;FOXO1;ZDHHC7;APPL1;C2CD5;CPEB1;ZFP36L1;ATP6V1A;APC;XBP1;ATP6V0C;PIK3C2A;MYO5A;PDK2;TCIRG1;ATP6V1E1;IDE;SLC39A14;LPIN3;LPIN1;ATP6V0A4;ATP6V0A2;PIK3R3;AKT1;INSR;ATP6V0D2;HDAC9;RAB8A;DENND4C;CAPN10;RAB8B;TRIB3;INSIG1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.45105017244168194,-1.120239280531615,0.33969465648854963,0.6711767557861263,1.0,8/13,32.01%,SLC4A10;GRIK2;PPFIA3;SHISA6;RAB3A;SYP;SLC8A2;SHISA8
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.48607165414361186,-1.1202296491832262,0.3229571984435798,0.6704152259200237,1.0,5/10,36.04%,ESR1;PSMC3;THRA;PSMC5;PSMC4
prerank,keratan sulfate biosynthetic process (GO:0018146),0.41431145331704455,1.1201136805752667,0.338768115942029,0.7946179462738673,1.0,6/26,5.37%,ST3GAL3;FMOD;OGN;OMD;B4GALT1;PRELP
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.3733776210190029,-1.119920211348881,0.3023758099352052,0.6704135227849272,1.0,14/28,27.75%,MAP1B;PRUNE1;STMN2;STMN1;STMN4;STMN3;GAS2L1;FKBP4;MAPRE1;MAP1A;CLASP2;CAMSAP3;CAMSAP1;SKA3
prerank,neural crest cell differentiation (GO:0014033),-0.4149362184199957,-1.119436832102791,0.30115830115830117,0.67097904533049,1.0,2/18,2.75%,MEF2C;CDH2
prerank,centromere complex assembly (GO:0034508),0.38384575998654147,1.1193700673758797,0.31123388581952116,0.7956379191518389,1.0,11/36,15.71%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ;CENPX;MIS12
prerank,positive regulation of neutrophil migration (GO:1902624),0.4459732717071556,1.1193319208354122,0.3215767634854772,0.7946102100687519,1.0,5/18,8.68%,CAMK1D;RIPOR2;CCL19;MCU;MOSPD2
prerank,regulation of cellular metabolic process (GO:0031323),0.37496569351138614,1.1192867898989503,0.28620102214650767,0.7936094553506857,1.0,4/45,2.62%,PPARA;PID1;PRKN;DKK1
prerank,cellular senescence (GO:0090398),-0.37313445769403064,-1.1190466546436646,0.2948717948717949,0.6712079912999802,1.0,9/27,25.17%,TBX2;CALR;TBX3;ECRG4;ID2;SPI1;PRKCD;CDKN1A;HRAS
prerank,androgen receptor signaling pathway (GO:0030521),-0.4785991574856593,-1.1187156643607719,0.3233082706766917,0.6713611238022303,1.0,4/11,8.98%,PLPP1;KDM3A;DDX5;TMF1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.48808061242223233,1.118500853436036,0.34393638170974156,0.7946872679850956,1.0,2/12,8.41%,PPARA;MIA3
prerank,regulation of aerobic respiration (GO:1903715),-0.43870142513274896,-1.11814449470333,0.32916666666666666,0.6721128503609329,1.0,6/15,21.92%,CBFA2T3;UQCC2;IDE;PINK1;NOP53;VCP
prerank,negative regulation of fat cell differentiation (GO:0045599),0.3877574550287628,1.1181444514301448,0.31684981684981683,0.7945330024692713,1.0,5/34,7.08%,RORA;RUNX1T1;ANKRD26;IL6;SMAD3
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.3798133865592687,1.118104029153066,0.31951640759930916,0.7935252021240989,1.0,6/39,6.25%,ROBO1;RBPJ;BMP2K;MAML3;ZMIZ1;MAML1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.39341137835354345,1.1180418729013868,0.31226765799256506,0.7926083913918434,1.0,6/33,11.42%,IGF1;IGF1R;PTEN;MYO16;PIK3R1;ERBB2
prerank,carboxylic acid metabolic process (GO:0019752),-0.36277205141836916,-1.1179669698980264,0.28982300884955753,0.6717958140046006,1.0,12/33,22.48%,CSGALNACT1;ST6GAL1;SLC2A1;PTGIS;SIRT4;PLA2G4A;CYB5R3;MIF;ST3GAL1;GSTO2;LIAS;SLC2A3
prerank,protein transport (GO:0015031),-0.2453733972305677,-1.11791902681148,0.12946428571428573,0.6711458106129243,1.0,128/332,28.77%,SPTBN1;TFRC;NSF;STX3;TBC1D30;TBC1D8;RAMP2;RAB31;RAB3C;STX7;MIA2;RABGAP1L;CHMP2B;STX1A;SLC10A7;TANGO6;ATP6V0A1;EHD1;VMP1;TMED5;HSP90B1;COPG1;ADPRH;ARF5;GRTP1;SCG5;STX6;SGSM1;ARF1;MYH9;TBC1D8B;TBC1D1;DNM2;RAMP1;RAB28;OLFM2;TMED2;GOLGA7;SIL1;TBC1D13;NAPB;SYNDIG1;RAB38;SCAMP1;STX12;ATP6V1A;ATP6V0C;RAB3B;SCG2;RAB1A;EVI5;TCIRG1;CD74;TBC1D10A;LMTK2;ARHGEF2;ATP6V1E1;CLU;CANX;SCAMP2;PICK1;LMAN2L;TMED10;TMED3;CALCRL;KIF13A;RABL3;TMEM167A;LAPTM5;STX2;HERC2;ATP6V0A4;RABGAP1;MTTP;YWHAH;SNX1;CHMP1B;KIF3B;ATP6V0A2;PREB;RAB1B;TBC1D10B;ABCG1;SYS1;SCAMP3;ANK3;CHMP1A;EIF2D;ARFIP2;ATP6V0D2;TVP23A;RAB8A;HDAC6;TBC1D22A;CHMP3;NECAB3;AP2A1;RAB8B;TMED7;SCFD2;RAB7A;ARL4A;RAB3A;ATP6V0E2;SNX27;ARRDC3;ZDHHC17;RAB14;ATP6V1B2;RAB5B;MCOLN1;RAB6B;VLDLR;ARFIP1;NEURL1B;ATP6V1H;CTTN;TBC1D5;SEC31A;COPA;TOM1;IL10RA;ARL6IP5;VPS33B;ARF3;STX5;VPS26B;RAB20
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.4241460761640023,1.117772139863305,0.33154121863799285,0.7911831359328239,1.0,9/23,17.07%,ZEB2;DAB2;SLC2A10;FLCN;CDKN1C;CREBBP;SMAD4;CDKN2B;SDCBP
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.4241460761640023,1.117772139863305,0.33154121863799285,0.7911831359328239,1.0,9/23,17.07%,ZEB2;DAB2;SLC2A10;FLCN;CDKN1C;CREBBP;SMAD4;CDKN2B;SDCBP
prerank,iron-sulfur cluster assembly (GO:0016226),-0.3798569692340516,-1.1171682642389729,0.2980132450331126,0.6724209858360047,1.0,13/24,37.71%,ISCU;CIAPIN1;GLRX5;GLRX3;HSCB;ISCA2;HSPA9;ISCA1;CIAO2B;BOLA2;NFS1;NUBP1;NUBP2
prerank,regulation of AMPA receptor activity (GO:2000311),-0.37786409755346556,-1.1169522430810181,0.30952380952380953,0.672265997033571,1.0,11/25,23.72%,MEF2C;SHANK3;MINK1;CACNG3;RELN;ADRB2;CACNG2;CNIH3;SHISA6;MAPK8IP2;SHANK1
prerank,amino acid transport (GO:0006865),0.35895933083913223,1.1168126410324635,0.30354131534569984,0.7927169408407687,1.0,10/49,12.29%,SLC7A11;SLC38A3;SLC6A12;PDPN;SLC38A9;SLC43A1;SLC1A5;SLC36A2;SLC38A7;SLC38A2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.4465089946372056,-1.1168079387716139,0.33131313131313134,0.671897403352033,1.0,7/15,14.72%,KCNJ2;ATP1A1;ATP1B1;KCNQ1;KCNN2;KCNJ8;KCNIP2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.29746834374330233,-1.116796770011199,0.2440944881889764,0.671157588809255,1.0,23/87,10.85%,CLDN5;ID1;ACVRL1;TGFB2;CBL;PTK2;ITGB1;F11R;ENG;UBB;PXN;TGFBR2;TGFB1;FERMT2;RPS27A;UBC;SMAD9;SMAD5;JUN;RHOA;APPL1;FURIN;GCNT2
prerank,central nervous system neuron development (GO:0021954),-0.4264469497762168,-1.1167125560390612,0.3073770491803279,0.6705712243699757,1.0,4/15,9.45%,HSP90AA1;HSP90AB1;B4GALT5;LHX6
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3800795397873978,-1.1158010148758783,0.3025210084033613,0.6723355254766884,1.0,10/23,24.36%,HSP90AB1;CDC37;NLRC5;IFNGR1;NR1H2;JAK1;TXK;NR1H3;SOCS1;STAT1
prerank,chemical synaptic transmission (GO:0007268),-0.24490621176988184,-1.1154161085098664,0.16532258064516128,0.6724932963152142,1.0,89/284,26.59%,UNC13B;SLC12A7;GRM3;DLG2;HSPA8;KCNQ3;LIN7A;CALM1;ATXN3;PLP1;GRM7;MBP;EXOC4;PTPRN2;MINK1;GABRB3;SLC12A6;SLC1A1;HOMER1;STX1A;SYPL1;CAMKK2;GRIK4;GABRB1;CHRM3;DLGAP1;CACNA1E;SLC17A6;HTR2A;NRXN1;NAPB;AMPH;KCNMB4;GRIN1;SLC12A4;KCNA1;SYT10;RPS6KA1;GABRG3;SLC1A4;SYNJ2BP;GAD1;CACNB2;SNAP25;PCDHB14;BSN;PRKAR1A;HRH1;APBA3;SYN2;KCNIP2;KCNQ2;CAMK4;PTCHD1;CACNA1B;GLRA3;GRIA2;STAC3;SLC6A5;CDK5;CACNB3;KCND2;GRIK2;RIT2;CAMKK1;GABRA5;GRID2;PPFIA3;TSPOAP1;HRH2;GABRE;NPTX1;SHISA6;SST;CHRNB1;NPY;SNCG;RAB3A;PNOC;CPLX1;GABRG2;HAP1;KCNC4;HTR2C;GLRA1;CNP;APBA2;CHRM1;KIF1B
prerank,positive regulation of heart rate (GO:0010460),-0.4107234508579415,-1.1153476410870815,0.32608695652173914,0.671902292416391,1.0,7/17,9.30%,PDE4D;ADRA1B;ATP2A2;KCNQ1;ADRA1A;RYR2;EDN1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.296982362943969,-1.1153131779810346,0.25833333333333336,0.6712140812640721,1.0,25/76,19.45%,TMSB4X;CD200;KLF4;DAB2IP;NFKBIA;FAF1;ARRB1;CHP1;LRRC14;PTGIS;AIM2;COMMD7;NLRC5;CHUK;IRAK3;ERBIN;NLRP2B;DAP;CMKLR1;CYP1B1;BRMS1;ZC3H12A;IRAK1;SPI1;ARRB2
prerank,negative regulation of catalytic activity (GO:0043086),-0.3766834591335656,-1.115265893590444,0.2957446808510638,0.6705581346943174,1.0,8/24,16.80%,NOTCH1;NOS1;TMBIM1;NES;APBA3;MT3;ATP5IF1;PLN
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.36532578354479517,-1.115165591471293,0.2642369020501139,0.6700646084395885,1.0,8/33,11.93%,PRKG1;MEF2C;APOD;IGFBP5;PDCD4;CDKN1B;NDRG4;GPER1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5032493930631265,1.114796971797916,0.35789473684210527,0.7973643015051536,1.0,4/11,6.00%,EFNB2;DKK1;SOX6;FRS2
prerank,positive regulation of secretion by cell (GO:1903532),0.33803248853203566,1.1144739866251043,0.27741935483870966,0.7971640392403854,1.0,5/70,3.51%,IGF1;BMP6;FRMD4A;PLA2G10;DTNBP1
prerank,acylglycerol catabolic process (GO:0046464),-0.3708046955760876,-1.1139481935458013,0.31718061674008813,0.6725929800071682,1.0,4/30,10.22%,ABHD2;MGLL;LIPE;LYPLA2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.34271666912475907,-1.1139282255269836,0.3062200956937799,0.6718727220852676,1.0,18/40,22.19%,HIP1;SGIP1;B2M;CBL;HNRNPK;SFRP4;ARRB1;VEGFA;CD63;CLU;PICK1;BICD1;GREM1;ARRB2;INSR;FMR1;ATAD1;C3
prerank,glycolipid biosynthetic process (GO:0009247),0.3776855035249019,1.11386876985754,0.2961608775137112,0.7977413143555036,1.0,10/38,12.88%,LARGE1;B3GNT5;PIGU;A4GALT;ST3GAL5;PIGG;PIGV;GBGT1;PIGC;PIGQ
prerank,neuron maturation (GO:0042551),-0.4180429865528959,-1.1138630663689602,0.33121019108280253,0.6712775653271936,1.0,11/18,27.78%,SCARF1;B4GALT5;ANKS1A;APP;PICK1;C1QA;B4GALT6;CLN5;C3;RND1;ACTL6B
prerank,regulation of monocyte differentiation (GO:0045655),0.46994477199737844,1.1138410604027271,0.3381742738589212,0.7967152790195804,1.0,4/14,7.99%,IL34;HOXA7;ACIN1;CSF1
prerank,cilium organization (GO:0044782),0.2890970293657594,1.113236074705861,0.2452316076294278,0.7972180819549829,1.0,62/209,19.75%,DCDC2;ASAP1;INTU;AVIL;RAB3IP;ARL3;DYNC2H1;CDC14B;CCDC57;IFT80;CC2D2A;ARMC9;WDR19;UBXN10;TTC8;WDPCP;KIF27;WDR35;ARL6;CEP19;IQCB1;TEKT2;TCTN1;SCLT1;ATP6V0D1;PARVA;CEP89;BBS7;FBF1;OFD1;WDR11;IFT122;CFAP126;TTC39C;PKD2;EXOC3;ARMC2;IFT140;CFAP298;CCDC65;WDR90;CEP164;CFAP70;CFAP410;ATP6V1D;EXOC7;EXOC1;DYNC2I1;CFAP20;PDE6D;RAB11FIP3;ARF4;RP2;TMEM237;BBS1;RTTN;TRAF3IP1;IFT81;IFT46;BBS2;CEP78;TTC17
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.4194421768682749,-1.1131886355368248,0.31844660194174756,0.6723478957396836,1.0,9/17,30.73%,HSP90B1;DERL1;HERPUD1;AUP1;TMEM129;VCP;SYVN1;SEC61B;HM13
prerank,cilium assembly (GO:0060271),0.2782506570700271,1.1131585458607203,0.22323759791122716,0.7963237306844262,1.0,82/296,19.71%,DCDC2;ASAP1;NINL;INTU;ALMS1;AVIL;RAB3IP;ARL3;DYNC2H1;CDC14B;CCDC57;IFT80;HAUS4;CEP152;CC2D2A;ARMC9;WDR19;SDCCAG8;UBXN10;TTC8;WDPCP;TBC1D32;KIF27;WDR35;ARL6;CEP19;IQCB1;ARL13A;CDK1;RPGRIP1L;PAFAH1B1;TEKT2;TCTN1;SCLT1;ATP6V0D1;PARVA;CEP89;BBS7;FBF1;OFD1;WDR11;HAUS1;IFT27;IFT122;SFI1;TTC39C;CEP57;CFAP74;EXOC3;KIF3C;TNPO1;IFT140;CFAP298;CCDC65;WDR90;CEP63;CEP164;CFAP70;DNAAF3;CFAP410;ATP6V1D;EXOC7;EXOC1;DYNC2I1;CFAP20;TUBG1;IFT22;PDE6D;RAB11FIP3;CEP97;ARF4;RP2;TMEM237;BBS1;AKAP9;TRAF3IP1;IFT81;IFT46;BBS2;CNTRL;GAS8;CEP78
prerank,regulation of mRNA processing (GO:0050684),-0.3561567151546965,-1.1131548311172577,0.29411764705882354,0.6716557749887502,1.0,11/32,21.22%,HNRNPK;CDK11B;QKI;LARP7;ZFP36L1;KHDRBS3;SRPK1;AHCYL1;SAFB2;YTHDC1;SLTM
prerank,female gonad development (GO:0008585),0.4457943387628902,1.113101641535603,0.34790874524714827,0.795393332333015,1.0,2/19,1.24%,NR2F2;KIT
prerank,transition metal ion homeostasis (GO:0055076),0.3995648913444435,1.1130971524921243,0.33203125,0.7943091808383,1.0,6/28,9.40%,CP;HEPH;PRKN;TFR2;NEO1;PICALM
prerank,proteolysis (GO:0006508),0.28296654436389373,1.1130903176465008,0.22623828647925034,0.7932342021461762,1.0,23/252,9.50%,ADAMTS12;ADAMTS9;CPQ;ADGRV1;AEBP1;TRABD2B;CLPX;CAPN9;CTSH;MMP2;ACE;TPP1;ADAMTS7;MMP19;SUFU;NPEPPS;MMP9;CPXM1;USP25;CUL7;YME1L1;FBXO6;MDM2
prerank,canonical glycolysis (GO:0061621),-0.3823879151976479,-1.1129903193607997,0.33264033264033266,0.6705663873999229,1.0,9/24,17.38%,PKM;HK1;GAPDH;PFKM;FOXK1;TPI1;ALDOA;PFKP;ALDOC
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.3823879151976479,-1.1129903193607997,0.33264033264033266,0.6705663873999229,1.0,9/24,17.38%,PKM;HK1;GAPDH;PFKM;FOXK1;TPI1;ALDOA;PFKP;ALDOC
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3664570905686586,-1.1129701121422728,0.2989247311827957,0.6698508040323141,1.0,10/30,14.55%,CSGALNACT1;CSPG4;BGN;CHST9;CHST11;HEXB;HEXA;IDS;VCAN;CHSY3
prerank,Notch signaling involved in heart development (GO:0061314),0.4888886870306926,1.1127710722087572,0.33771929824561403,0.7929774699576609,1.0,2/11,1.17%,RBPJ;NOTCH2
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.25490047574408403,-1.11272735337834,0.16104868913857678,0.6697082127636294,1.0,73/224,25.79%,UNC13B;SLC12A7;GRM3;DLG2;KCNQ3;CALM1;ATXN3;PLP1;GRM7;MBP;EXOC4;MINK1;GABRB3;SLC12A6;SLC1A1;HOMER1;SYPL1;CAMKK2;GRIK4;GABRB1;CHRM3;DLGAP1;CACNA1E;HTR2A;NRXN1;AMPH;KCNMB4;GRIN1;SLC12A4;KCNA1;SYT10;RPS6KA1;GABRG3;SYNJ2BP;GAD1;CACNB2;SNAP25;PCDHB14;BSN;PRKAR1A;HRH1;APBA3;SYN2;KCNIP2;KCNQ2;CAMK4;PTCHD1;CACNA1B;GLRA3;GRIA2;SLC6A5;CDK5;CACNB3;KCND2;GRIK2;RIT2;CAMKK1;GABRA5;HRH2;GABRE;NPTX1;SST;CHRNB1;NPY;SNCG;PNOC;CPLX1;GABRG2;HAP1;KCNC4;HTR2C;GLRA1;CNP
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.4850006015873867,-1.1125842531037649,0.3339517625231911,0.6692969978551131,1.0,4/10,13.07%,DGKH;PLPP1;PRKD3;PICK1
prerank,negative regulation of hippo signaling (GO:0035331),0.47963844074022727,1.1119107244702402,0.36105476673427994,0.7942756733640842,1.0,3/12,6.78%,VGLL4;WWC1;WWC2
prerank,oligodendrocyte differentiation (GO:0048709),0.43727423436899915,1.1118937703045968,0.33661417322834647,0.7932335293246512,1.0,2/19,2.75%,SLC8A3;SOX6
prerank,peptidyl-lysine monomethylation (GO:0018026),0.5108922186370707,1.1118352014982076,0.34791666666666665,0.792302657744926,1.0,4/10,19.77%,SETD6;SETD7;SETD2;SETD4
prerank,sympathetic nervous system development (GO:0048485),-0.43369625086720087,-1.1117900532750538,0.35887850467289717,0.6705805475932198,1.0,6/15,22.64%,NRP2;SOX4;CTNNB1;NF1;SEMA3A;SOX11
prerank,cellular response to heat (GO:0034605),-0.34664915931476464,-1.111787696079517,0.27616926503340755,0.6698303883003718,1.0,5/35,2.39%,ANO1;THBS1;HSP90AA1;HSP90AB1;ATXN3
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.46831388257521356,1.1117571779641138,0.35625,0.7914260037920147,1.0,3/15,9.50%,PRKN;BCL2;MDM2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.42166786168413145,1.1112588490541764,0.3416506717850288,0.7917399357861713,1.0,2/22,3.71%,ROCK2;EPHA4
prerank,protein targeting to lysosome (GO:0006622),-0.3970573825224281,-1.1108429395603603,0.29313929313929316,0.6715584235913338,1.0,11/20,25.67%,HSPA8;SNX16;HGS;CLU;NCOA4;M6PR;LAPTM5;GNPTAB;RAB7A;SCARB2;SORL1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.29025792028743025,-1.1101288040580968,0.24316939890710382,0.6727634355363549,1.0,30/87,23.78%,KLF4;FHL1;PINX1;FAM107A;PSMD13;PSMF1;RBX1;ZFP36L1;PSMB10;APC;CDK6;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;JADE1;CDK2AP2;PSMB3;PSMD5;SKP1;CDKN1A;CDKN2D;PSMD9;PSMB4;E2F7;RGCC
prerank,neuronal action potential (GO:0019228),0.42908697602109847,1.1099912027820957,0.3255360623781676,0.7941905766160975,1.0,1/22,0.09%,SCN7A
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.29274521288543354,1.1099062816306586,0.24242424242424243,0.7933480168593701,1.0,29/182,11.76%,IGF1;ROBO1;SLC24A3;ROCK2;WNT4;NOTCH2;PRKN;RBMS3;PCSK9;TNRC6B;PRKAA2;TNRC6A;TET1;SLC2A10;OPTN;ABCC2;PRKAA1;RBL2;WWP2;PICALM;PARP10;AGO2;PARP9;ATOH8;HDAC1;FLCN;APLN;DLG4;BMPR1A
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4526019446826829,1.1095456856208559,0.3273809523809524,0.7933154147182723,1.0,3/17,5.06%,ATP1A2;SLC8A1;GJA1
prerank,positive regulation of transferase activity (GO:0051347),0.2999055424259614,1.1094900488057562,0.2540381791483113,0.7924017769322599,1.0,19/142,8.66%,EPHA7;EPHA3;FGFR2;FGFR4;KIT;LMO4;PDGFRB;IGF2;EPHA8;EPHA4;PDGFRA;DDR1;IGF1R;ACD;UBE2L3;XRCC5;DDR2;RYK;MUSK
prerank,positive regulation by host of viral transcription (GO:0043923),-0.4433914093310897,-1.1092246567360637,0.32,0.6743750429754608,1.0,2/15,7.99%,LEF1;JUN
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5001812706612581,1.109204076474796,0.33401639344262296,0.7921764947237254,1.0,3/10,16.12%,KIT;BTLA;LYN
prerank,negative regulation of cellular senescence (GO:2000773),-0.45252621508163376,-1.1091475876946997,0.3716475095785441,0.6738171279941693,1.0,3/13,12.33%,YBX1;CDK6;MAP3K3
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3817377746331517,1.1088377302926842,0.3392857142857143,0.7921492642406508,1.0,3/32,2.58%,CEMIP;PDPK1;GSTM2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.44376914599668005,1.1086815819689955,0.3297413793103448,0.7915439665750524,1.0,5/19,8.68%,CAMK1D;RIPOR2;CCL19;MCU;MOSPD2
prerank,artery morphogenesis (GO:0048844),-0.3627328141220821,-1.1086634013757735,0.2972972972972973,0.6743916811365744,1.0,11/30,9.37%,TGFB2;JAG1;ENG;NOTCH1;TBX1;BMPR2;HES1;STRA6;TBX2;VEGFA;HEY2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.3564439814690099,-1.1082827568238791,0.27350427350427353,0.6746758889556782,1.0,5/29,9.42%,CADM1;STX7;LAMP1;CYRIB;PVR
prerank,positive regulation of phospholipid transport (GO:2001140),-0.4713108526968119,-1.1080257856920264,0.32938856015779094,0.6745719842458414,1.0,7/10,42.61%,TMEM30A;ABCA3;DBI;ABCA7;PRELID1;ABCB4;TRIAP1
prerank,axon development (GO:0061564),-0.2979856812430765,-1.1080190102822576,0.27918781725888325,0.67382532413171,1.0,29/78,25.05%,KLF7;ACTB;MAP1B;S100A6;PLP1;GRM7;SHTN1;RTN4RL1;NRCAM;DCC;APBB1;APP;RTN4;SLITRK5;MARK2;SPTBN4;LMTK2;NTNG1;CDK5;DSCAML1;ANK3;L1CAM;RAB8A;BRSK2;MAP1A;RAB3A;ZPR1;EPHB3;ZDHHC17
prerank,spliceosomal complex assembly (GO:0000245),0.3595471162658752,1.1080074740664911,0.3233743409490334,0.792336907553908,1.0,10/46,13.76%,CELF2;SRPK2;NOL3;RBM5;SF3A3;DDX23;SMN1;SNRNP200;SCAF11;CRNKL1
prerank,regulation of axonogenesis (GO:0050770),0.3500853378272714,1.107894081807578,0.31551724137931036,0.7915921786833666,1.0,8/51,7.48%,PLXNA2;ROBO1;LRP4;KIF13B;EPHA4;PLXNC1;ARHGAP35;PTEN
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.49183794861606756,1.1077192971513867,0.36088709677419356,0.7909682503568608,1.0,2/11,1.82%,PRKN;DAB2
prerank,regulation of tissue remodeling (GO:0034103),0.44249145488319397,1.1076940682947638,0.334,0.7899828160153647,1.0,2/18,1.22%,LEPR;IL18
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.3754902495180413,-1.1076100580250636,0.2894168466522678,0.6741229301068422,1.0,9/25,25.74%,MEF2C;GSK3B;GRIN1;INSYN2A;ARRB2;AKT1;GRID2;MAPK8IP2;GLRA1
prerank,sterol transport (GO:0015918),-0.40245712267974965,-1.1075605436060356,0.3215767634854772,0.6735167163420837,1.0,4/19,23.65%,CAV1;LCAT;OSBPL5;NPC2
prerank,peptidyl-threonine modification (GO:0018210),0.3387418199412626,1.1072880556125548,0.28903654485049834,0.7900300749823056,1.0,15/66,14.32%,ROCK2;OXSR1;PDPK1;LRRK2;PRKCA;CDK1;CAMK2D;GALNT16;PRKDC;HIPK3;PRKD2;TBK1;MAPK1;NLK;GALNTL6
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.4591081348486227,1.1072129657886678,0.3353413654618474,0.7891741005977514,1.0,3/15,3.92%,PPARA;LPGAT1;SLC45A3
prerank,B cell activation involved in immune response (GO:0002312),-0.44470682249972093,-1.1069434627740538,0.34297520661157027,0.6743975980445811,1.0,6/13,29.16%,CD180;MSH2;LIG4;RNF168;FCGR2B;RNF8
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.27919484899137753,-1.106876926233129,0.22608695652173913,0.6738309612648944,1.0,29/108,16.11%,HIP1;MAP3K5;ACER2;GSN;F3;NGF;RPS3;RACK1;CTSD;TNFSF10;NOD1;ST18;EGLN3;ATP2A3;HIP1R;SOX7;NDUFA13;XDH;GPER1;REST;HSPD1;CASP8AP2;RPS27L;BBC3;DAP;FAS;BCAP31;CASP8;LAPTM5
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.2983298406097789,-1.106712747429142,0.2694300518134715,0.6735250743899434,1.0,18/75,13.92%,SLC12A7;SLC12A2;SLC9A2;SLC39A10;KCNJ2;ATP1A1;ABCC9;ATP1B1;SLC12A6;SLC12A8;SLC39A8;SLC24A2;SLC12A4;ATP1A3;KCNJ8;TRPV2;SLC39A14;KCNJ15
prerank,positive regulation of cellular component organization (GO:0051130),0.31288970515782416,1.1065257508346438,0.28751974723538704,0.7900373999818576,1.0,15/107,7.56%,FRMPD4;TRABD2B;ASAP1;BMP7;ADGRL1;LRP4;DAB2;FNIP1;TFR2;CRB3;GPC3;IGF1R;BNIP3;SLF1;CCL19
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.45989008231802114,1.106519980053666,0.3592814371257485,0.789007897296498,1.0,5/16,14.11%,NAA80;AANAT;NAA35;NAA60;CREBBP
prerank,secondary alcohol metabolic process (GO:1902652),0.3715478403013225,1.1064925905508487,0.3071297989031079,0.7880376589844217,1.0,8/42,12.24%,CYP27A1;ABCA1;ABCA5;IDH2;SOAT2;RXRA;IDH3G;GBA2
prerank,positive regulation of T cell migration (GO:2000406),0.4250472575941267,1.105741668258867,0.3425196850393701,0.7891284008987636,1.0,2/20,3.19%,OXSR1;CXCL13
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.3901550252878218,-1.1056873984912532,0.33472803347280333,0.6756084698759048,1.0,8/21,10.48%,CAV1;PDE4D;RASSF2;RACK1;NCK1;CNKSR3;DDIT4;NCK2
prerank,glial cell differentiation (GO:0010001),-0.36746976088730215,-1.1056338174867568,0.3023758099352052,0.675010167415117,1.0,12/28,19.12%,ADGRG6;CDH2;SOX4;STAT3;RELN;GPC1;PICK1;EIF2B5;TPPP;SOX2;CDK5;SOX10
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.365452247342764,-1.1054808840950465,0.32217573221757323,0.674670579512499,1.0,4/27,2.60%,UTRN;FXYD5;SLMAP;NEDD4L
prerank,negative regulation of inflammatory response (GO:0050728),0.2941226584876641,1.1053955805915479,0.2604166666666667,0.7890612828885932,1.0,8/182,3.61%,IGF1;RORA;ADCY5;ADCY1;C1QTNF3;PPARA;SLAMF8;ADM
prerank,anion transport (GO:0006820),-0.3510378387971327,-1.1053030223371123,0.29515418502202645,0.6743614100904758,1.0,6/33,2.70%,ABCG2;SLC26A7;LRRC8C;LRRC8D;LRRC8B;SLCO2B1
prerank,negative regulation of type I interferon production (GO:0032480),0.3773007395314342,1.1050892318508279,0.33220338983050846,0.7888530096324877,1.0,13/40,14.28%,CACTIN;NLRC3;RNF135;RNF216;SIRPA;ITCH;IRF3;UBA7;PCBP2;IKBKE;CYLD;TBK1;NLRX1
prerank,hippo signaling (GO:0035329),0.3972916396975036,1.1049231876362322,0.3235831809872029,0.7882601275177411,1.0,6/26,10.14%,AMOTL2;FAT4;TEAD1;WWC1;TEAD3;LATS1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.4190072248940875,1.1048083073267165,0.34600760456273766,0.787532635106117,1.0,3/22,4.74%,ADGRV1;STIM1;CACNA1D
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.35621193004868756,-1.1046811829459056,0.32142857142857145,0.6752814462034699,1.0,16/32,33.36%,APP;TMED10;NR1H4;EIF2A;TIGAR;NOLC1;PRKCD;PUM3;EIF4E;PCIF1;RBM4B;DDX25;RPL10;ATXN2;METTL18;PGAM1
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.3871675372006371,-1.104560902687526,0.3257261410788382,0.6748403189047285,1.0,8/21,9.37%,NOS3;GAS6;PTK2B;NOTCH1;ASPN;TGFB1;SRGN;HEY2
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.44154956633767783,-1.1045218944968327,0.33861386138613864,0.6741858044516635,1.0,3/13,1.89%,ABHD2;ESR1;PLPP1
prerank,maturation of LSU-rRNA (GO:0000470),0.4007830741406217,1.1042215816785275,0.33773584905660375,0.7880632843817603,1.0,7/26,16.87%,NSA2;FTSJ3;DDX18;NIFK;ZNHIT3;BOP1;ZNHIT6
prerank,protein palmitoylation (GO:0018345),-0.35851509078634264,-1.1038604397020202,0.3204301075268817,0.6751448285117093,1.0,13/30,27.61%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;PORCN;HHAT;SELENOK;ZDHHC4;ZDHHC8;ZDHHC20;ZDHHC17;ZDHHC5
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.4654284828463922,-1.1038505040778839,0.35294117647058826,0.6744348761200827,1.0,5/11,19.10%,GSN;ST18;PIH1D1;FAS;PLAUR
prerank,regulation of vasoconstriction (GO:0019229),-0.3651372510833447,-1.1037788949299632,0.3259423503325942,0.673862783875047,1.0,9/27,11.79%,CAV1;BMPR2;ADRA1B;CHRM3;ADRA1A;KCNMB4;ECE1;ACE2;ATP2B1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.43548939341742776,1.103443960386604,0.32064128256513025,0.7891262845943403,1.0,5/17,15.33%,LPGAT1;PLA2G10;PLA2G4B;SERAC1;PLA2G12A
prerank,glycerolipid metabolic process (GO:0046486),-0.4681681802273855,-1.1031172385779782,0.36617100371747213,0.6748202247418037,1.0,6/11,29.76%,DGKB;DGKZ;DGKG;PGP;DGKQ;PLA2G15
prerank,regulation of actin filament polymerization (GO:0030833),-0.3020179789202836,-1.1029807473745579,0.2779220779220779,0.6744523490175354,1.0,18/69,11.81%,SLIT2;ESAM;KANK3;CARMIL1;PTK2B;CDC42EP3;NCKAP1;KANK1;NCK1;BAIAP2L1;HIP1R;CYRIB;SSH2;SSH1;KANK4;NCK2;DBNL;BIN1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.32831669416100717,-1.1026955275882424,0.2898876404494382,0.6744340786599305,1.0,14/46,14.23%,MEF2C;SHANK3;GRM3;GRM7;CDH2;PTK2B;HOMER1;DGKI;CACNG3;NRXN1;RELN;DGKZ;GRM8;CACNG2
prerank,regulation of epithelial cell migration (GO:0010632),-0.32597591033114925,-1.1025104954992375,0.2942583732057416,0.6742129117482523,1.0,13/51,9.54%,PTPRG;RHOJ;BMPER;TGFB2;PTK2;DOCK1;PLCG2;DAB2IP;BMPR2;CORO1C;CEACAM1;EMP2;RTN4
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.36257108998938214,1.102504535025039,0.30918727915194344,0.7907302373828065,1.0,1/41,0.08%,PRKAG2
prerank,ventricular septum morphogenesis (GO:0060412),0.39397844124275105,1.1024249562915904,0.32730560578661844,0.7899094509033149,1.0,2/27,0.29%,TGFBR3;ROBO1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.4646453971540967,1.1023623569887695,0.35684647302904565,0.7890255553484181,1.0,3/14,11.92%,ATP1B3;ANK2;ACTN2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.4513755656487591,-1.1022520575766834,0.3453815261044177,0.6741668567391657,1.0,9/12,41.36%,UCKL1;CDA;DCK;UCK1;UCK2;UMPS;UPP1;TK2;CAD
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.4149236067420682,-1.1019394456973124,0.32821497120921306,0.674248985149025,1.0,8/17,11.81%,NOTCH1;SERPINE2;HES1;TGFB1;TNFRSF1B;TENM4;BMP2;BIN1
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.3951832306704903,-1.101790964132022,0.3409090909090909,0.673937358047687,1.0,10/21,11.33%,LIMCH1;EFNA5;ACTG1;PTK2;SLK;CORO1C;GPM6B;PEAK1;RHOA;DUSP3
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.4747745902570445,1.1017699266818382,0.3760330578512397,0.7895827553714772,1.0,1/12,1.22%,IL18
prerank,synaptic vesicle localization (GO:0097479),-0.4462076369913571,-1.1007528225538608,0.3384615384615385,0.6759110418706143,1.0,8/13,31.89%,RAB27A;SYNJ1;DNM2;SYNDIG1;CDK5;KIF5C;SNAPIN;KIF5B
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.4297173200443312,-1.1005363040774847,0.32934131736526945,0.675745399060269,1.0,5/14,8.57%,LIMS2;LIMS1;FLNA;EMP2;CD63
prerank,cellular response to hormone stimulus (GO:0032870),0.3373319160968958,1.0997625305446421,0.3110367892976589,0.7940668450345763,1.0,10/69,6.98%,ATP1A2;TFPI;SLC5A5;BRD8;CTSH;NCOA2;STAT5B;CRHBP;NCOA3;UBE2L3
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.30745782957370255,-1.0997602951327263,0.26865671641791045,0.6770703325577427,1.0,24/65,27.48%,FHL1;PINX1;PSMD13;PSMF1;RBX1;PSMB10;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;PSMB3;PSMD5;SKP1;PSMD9;PSMB4;INTS3;CHEK1;PSMD10;CHMP4C;AVEN
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.37575398130025317,-1.099569671019221,0.35269709543568467,0.6768067329276258,1.0,9/25,17.38%,PKM;HK1;GAPDH;PFKM;FOXK1;TPI1;ALDOA;PFKP;ALDOC
prerank,protein deubiquitination (GO:0016579),-0.24925360433270669,-1.0994688680668823,0.20774647887323944,0.6763570769367218,1.0,69/242,23.12%,ACTB;ESR1;IL33;ATXN3;USP38;OTUD7A;MINDY2;UBB;NFKBIA;UCHL5;TOMM20;MINDY1;EIF3F;NEDD8;RHOT1;USP29;RPS27A;UBC;USP31;UCHL1;ZRANB1;BIRC3;PSMD13;PSMF1;RHOA;PSMB10;APC;OGT;HGS;USP50;PSMB6;ENY2;PSME3;USP37;PSMB5;ADRB2;OTUD3;PSMC3;UCHL3;OTUB1;PSMD12;FOXK1;PSMB8;OTUD1;PSME1;CFTR;UBA52;IFIH1;PSMB3;RUVBL1;MYSM1;USP28;USP9X;ZC3H12A;WDR20;USP8;UBE2D1;ARRB2;RCE1;PSMD5;OTUD6B;POLB;OTUD7B;VCP;TNFAIP3;USP5;PSMD9;PSMB4;OTULIN
prerank,positive regulation of response to wounding (GO:1903036),-0.3831520863995152,-1.0988982307636774,0.31446540880503143,0.6771928051791607,1.0,7/24,8.82%,ACTG1;OCLN;PTK2;ITGB1;SCARF1;KANK1;GRN
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3009422187999118,1.0985705008344449,0.28796561604584525,0.7963606740384291,1.0,18/150,6.00%,TCF7L2;OSBPL8;FGFR2;FGFR4;IL18;KIT;ANGPT1;PDPK1;PDGFRB;KL;IGF2;GFRAL;PDGFRA;RICTOR;IGF1R;FGF1;LRP2;FRS2
prerank,actin filament organization (GO:0007015),0.30089700940714975,1.098303129865056,0.25801749271137026,0.7960171711666069,1.0,23/151,8.13%,SHROOM3;CGNL1;TPM1;MYO5C;RHOD;FHOD1;DPYSL3;SHROOM2;AVIL;MYO1H;NEBL;ABI2;BAIAP2;ARHGAP12;WASL;FAT1;BAIAP2L2;DLG1;PPP1R9A;RHOBTB2;SPIRE2;MCU;CORO7
prerank,positive regulation of wound healing (GO:0090303),-0.34306552645111005,-1.0974607173950603,0.3426124197002141,0.6802553691192249,1.0,10/36,10.15%,ST3GAL4;ACTG1;OCLN;THBS1;PTK2;ITGB1;KANK1;FERMT2;MTOR;XBP1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.2743886782431299,1.0969699127386887,0.2483745123537061,0.7986573188020157,1.0,33/308,7.08%,SOX5;LEPR;C1QTNF3;APPL2;EPAS1;IL18;DAB2;ACSL1;ESRRG;GNAS;PLA2R1;SCX;SOX6;PLCB1;ALMS1;PPARGC1B;PDPN;ITGAX;GRB10;ABCA1;FOXD1;GLIPR2;GJA1;ACADL;IGF1R;CPT2;PTN;NIBAN2;ADRA1D;IL6;PTH2R;NCOA3;SMAD3
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.2583500913173321,-1.0963488766646383,0.2459016393442623,0.6824077576010884,1.0,44/172,16.56%,PIP5K1B;DGKH;PITPNM2;CEPT1;PLCG2;INPP5D;BMX;CRLS1;PIK3R6;INPP4A;SYNJ1;DGKB;PIK3C2B;ARF1;CDS1;FAR1;MFSD2A;CDIPT;CPNE3;PLEKHA1;PIK3CD;LPCAT3;PIK3C2A;GPAT4;MTM1;GPAT3;DGKZ;MTMR6;DGKG;PITPNM3;PIK3R5;PIK3C3;MTMR9;INPPL1;LPCAT1;SACM1L;LPIN3;CSNK2B;PIP5K1C;SBF1;PLA2G4A;PI4KB;ETNK1;LPIN1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.49454198120022264,1.0963105251179437,0.36,0.7995503545624018,1.0,6/10,20.01%,MTHFR;TYMS;SHMT1;MTHFS;DHFR;MTHFD2
prerank,negative regulation of protein modification process (GO:0031400),0.32368934186414977,1.0961170327690979,0.31347962382445144,0.7990652828403606,1.0,15/79,9.05%,PTPN13;PID1;PRKN;DMD;SNTA1;PLPP3;PTPA;CACTIN;PRKAA2;LRRK2;FBLN1;PTEN;PRKAA1;ATG14;SIRPA
prerank,glycerophospholipid metabolic process (GO:0006650),-0.2925237471149127,-1.0959526687824974,0.2668213457076566,0.682710545356905,1.0,18/75,17.57%,GPCPD1;DGKH;SERINC1;SERINC5;CRLS1;SYNJ1;SMPD4;FAR1;GDPD1;CPNE3;PLCB3;GDPD3;PNPLA6;CSF1R;PLA2G4A;ABCA3;PGP;PIGZ
prerank,Rap protein signal transduction (GO:0032486),-0.4811640265067757,-1.09593912224648,0.3773946360153257,0.6820062291017152,1.0,2/10,5.89%,RAP1A;PLK2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.2877385834804115,-1.095931876867237,0.28720626631853785,0.681290189752107,1.0,34/86,26.32%,KLF2;UBB;RPS27A;UBC;EGLN3;VEGFA;PSMD13;PSMF1;RBX1;PSMB10;LIMD1;ATF4;PSMB6;PSME3;PSMB5;EGLN2;PSMC3;PSMD12;PSMB8;ELOB;PSME1;UBA52;PSMB3;DNAJB1;PSMD5;ATF3;HIGD1A;PSMD9;PSMB4;VHL;CUL2;CHEK1;PSMD10;EPO
prerank,protein ubiquitination (GO:0016567),0.2659005308502064,1.095748816138674,0.2451219512195122,0.7991052336474047,1.0,73/471,12.61%,ASB2;PDZRN3;RNF220;SASH1;TRIM63;EPAS1;RNF43;PRKN;PELI2;BCL2;SPSB1;UBE2E2;HIF3A;TRIM5;MGRN1;NEDD4;RNF213;FBXW4;RNF138;DDB2;RNF217;ZNRF3;PSME4;PSMA2;FBXO44;SH3RF1;TRPC4AP;CAND1;UBE2L3;RNF181;PSMA3;NPEPPS;UBR2;RNF152;SPOP;KLHL7;CUL9;RNF135;SIAH2;WWP2;AMFR;BIRC6;CRBN;USP7;TRAF7;CUL7;RC3H2;UBE4A;FBXL17;NHLRC1;FBXO6;MDM2;PSMD8;ITCH;SMURF2;TRIM35;PRKDC;NEUROD2;DTX1;PSMD3;SH3RF2;RBBP6;FBXO4;MYCBP2;KLHL22;CUL4B;RNF14;CDC73;TRIM26;TRIM43;RNF20;FBXO11;RCHY1
prerank,negative regulation of cell death (GO:0060548),-0.2862955011971805,-1.0954731374144315,0.26342710997442453,0.6817772205789725,1.0,29/88,20.48%,MECOM;CD200;CD34;PPARGC1A;PDE8A;FYN;CCN3;SOX4;NCK1;FERMT2;GSK3B;TNFRSF1B;WNT16;EIF4G1;CLU;CHGA;SRSF6;CCN1;MT3;NENF;WFS1;PRKD1;ATP13A2;DCPS;CDK5;TIGAR;PINK1;AKT1;BMP4
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.42673306218742635,1.095469838060084,0.3384615384615385,0.7988342829481343,1.0,2/21,2.73%,EPHA7;LTF
prerank,glutathione biosynthetic process (GO:0006750),-0.4660066664366538,-1.0954117777925927,0.36470588235294116,0.6812179559231267,1.0,5/11,32.52%,GCLM;GGT1;CHAC2;MGST2;OPLAH
prerank,positive regulation of endocytosis (GO:0045807),-0.32666581293153385,-1.0952539926860472,0.31353919239904987,0.6808783205350987,1.0,7/45,3.38%,HIP1;SGIP1;B2M;CBL;HNRNPK;NEDD4L;RAB31
prerank,positive regulation of protein export from nucleus (GO:0046827),0.45732417421049826,1.095207949982793,0.3722334004024145,0.7985171840969452,1.0,1/15,0.51%,TCF7L2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.378297848486473,-1.0939230970114402,0.33698030634573306,0.6837415393113868,1.0,4/25,3.90%,B2M;SLC7A5;PLCG2;CD55
prerank,N-glycan processing (GO:0006491),-0.39816814484987023,-1.093818317871175,0.34833659491193736,0.6832789693026331,1.0,7/18,15.96%,ST8SIA4;FUT8;ST8SIA1;ST8SIA6;MAN1A2;MAN2A2;ST8SIA2
prerank,regulation of endocytosis (GO:0030100),0.34535792527627923,1.0934421311080977,0.3187919463087248,0.8024764493466878,1.0,14/61,12.63%,EPHA3;DAB2;TFR2;SYT11;SPHK1;RUFY2;GPC3;SNX33;CCL19;PICALM;ABL1;RUBCN;SNX12;PACSIN3
prerank,myelin assembly (GO:0032288),-0.472263566420007,-1.0932680169342497,0.3611111111111111,0.6839478724206007,1.0,7/10,24.19%,CD9;TENM4;GPC1;TPPP;ABCA2;NCMAP;EPB41L3
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.44663016137220773,1.0931237952170412,0.35647279549718575,0.8023271889046126,1.0,2/17,1.19%,ROBO1;EFNB2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.37633783247570757,-1.0930709548351363,0.3516699410609037,0.6837441914259179,1.0,4/23,9.42%,CADM1;PIK3R6;LAMP1;PVR
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3721049243787801,1.0929547580369205,0.3274021352313167,0.8017594506034931,1.0,14/37,19.11%,DYNC2H1;IFT80;WDR19;WDR35;IFT27;IFT122;KIF3C;TNPO1;IFT140;DYNC2I1;IFT22;TRAF3IP1;IFT81;IFT46
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.31683515405035834,1.0928855042771337,0.3086816720257235,0.800907694355408,1.0,19/94,12.45%,NINL;ALMS1;RAB3IP;HAUS4;CEP152;CC2D2A;SDCCAG8;IQCB1;CDK1;RPGRIP1L;PAFAH1B1;TCTN1;SCLT1;CEP89;FBF1;OFD1;HAUS1;SFI1;CEP57
prerank,response to molecule of bacterial origin (GO:0002237),-0.2945782539654712,-1.0928120881839853,0.27621483375959077,0.6836579305538918,1.0,20/69,22.88%,FOXP1;NOS3;LBP;GCH1;TNFRSF11A;CYRIB;NOS1;IRAK3;ERBIN;HNRNPA0;IRAK1;IRF5;TIRAP;SLC11A1;LIAS;TNFAIP3;GGT1;PELI1;IFNAR1;FCGR2B
prerank,O-glycan processing (GO:0016266),0.34745912294263037,1.0927493227865417,0.34328358208955223,0.8002396798210815,1.0,5/54,2.72%,ST3GAL3;GALNT15;GALNT14;GXYLT2;B3GNT5
prerank,telomere organization (GO:0032200),0.36016112924891486,1.092739176617514,0.3345323741007194,0.7992316879517091,1.0,12/43,15.56%,SP100;HUS1B;ACD;XRCC5;BLM;PRKDC;DCLRE1B;RTEL1;MRE11;APEX1;WRN;STN1
prerank,negative regulation of cell cycle process (GO:0010948),0.3405055338831724,1.0927001130903062,0.3072916666666667,0.7983098643510826,1.0,8/61,6.57%,BMP7;DMRT1;RBBP4;L3MBTL2;MGA;TOM1L2;RNF2;RBBP7
prerank,peptidyl-arginine modification (GO:0018195),-0.4262289983294122,-1.092391307162511,0.38943248532289626,0.6840428669425536,1.0,3/15,8.10%,ART3;KRTCAP2;PRMT8
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.28092128098780234,-1.0923697647616286,0.27851458885941643,0.6833585072847602,1.0,38/100,23.48%,RPL11;RNF144B;CBFA2T3;HSP90AB1;RNF144A;RACK1;TRIB2;UCHL5;UBXN1;NKD2;SOCS5;BAG6;GSK3B;GNA12;ZYG11B;RBX1;OGT;FOXF2;CAMLG;UBQLN4;RYBP;CLU;HERPUD1;ELOB;ARIH2;COP1;RNF19B;N4BP1;TLK2;NOP53;ARIH1;VCP;RNF19A;USP5;CEBPA;TRIB3;MAP1A;HSPA1B
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.31105535397920075,1.0922176605686524,0.32457496136012365,0.798682978468239,1.0,10/102,4.51%,ADCY5;ADCY1;PDPK1;SORBS1;INSIG2;FER;RAB13;PCSK9;CRHBP;CPEB2
prerank,L-glutamate transmembrane transport (GO:0015813),0.49120168600727754,1.0921993232340974,0.35728952772073924,0.7977225463645911,1.0,3/10,9.27%,SLC1A3;SLC25A18;SLC25A22
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.2775182425644397,-1.0912577056386097,0.2607449856733524,0.6856003631710923,1.0,31/104,18.40%,CAV1;BMPER;HTRA3;NOTCH1;UBB;ASPN;BMPR2;PRDM16;IL17RD;TGFBR2;CCN3;TGFB1;CD109;RPS27A;UBC;SPRED2;CRIM1;SMAD9;SMAD5;LEMD2;ZBTB7A;BMP2;STRAP;SKIL;UBA52;ACVR1;TGFB1I1;PPM1A;GREM1;TRIM33;UBE2D1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.43394606685961556,-1.0912504712014721,0.3575757575757576,0.6848932184108628,1.0,8/15,34.32%,SIX1;VEGFA;SIX4;BMP4;PAX8;AGT;NOG;PAX2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.4071953444059377,-1.0909859589134954,0.34325396825396826,0.6848821840853948,1.0,9/17,24.25%,CALM1;HSP90AB1;PTPRC;MTOR;CALM2;CD300A;CALM3;PPP1R15A;PPP1R15B
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3796282944473104,-1.0907194938129108,0.3416666666666667,0.6848450791564878,1.0,4/22,13.11%,ESR1;MED17;PSMC3;MED14
prerank,cellular protein catabolic process (GO:0044257),0.34225329324764453,1.090676073255818,0.3254237288135593,0.8008300621628232,1.0,10/59,9.50%,ADAMTS12;PRKN;CLPX;CTSH;PCSK9;ADAMTS7;BNIP3;SIAH2;YME1L1;MDM2
prerank,cardiac muscle cell contraction (GO:0086003),-0.39226532200239006,-1.0906587454737897,0.33739837398373984,0.6842523658896188,1.0,7/19,17.91%,KCNJ2;ATP1A1;GSN;CACNA1G;CACNA1C;SCN1A;SCN1B
prerank,protein modification process (GO:0036211),-0.29415803536788276,-1.0904937354859559,0.2962962962962963,0.6839639065780634,1.0,22/76,19.38%,ST3GAL6;ST8SIA4;STK38;CHRM3;FBXW2;NEDD8;ADPRH;MAN2B1;RPN1;PLOD2;MMP15;CDKL3;ERO1A;UBA52;FBXL2;ST8SIA2;QPCT;DUSP12;YES1;RABGGTB;ST3GAL1;PPP4R2
prerank,organelle fusion (GO:0048284),-0.3869937002377357,-1.0904405351373943,0.3668763102725367,0.6833863903600319,1.0,9/22,27.15%,CHCHD3;MIEF1;VPS18;MIEF2;VPS11;MFN2;BAX;SPG7;FIS1
prerank,inner dynein arm assembly (GO:0036159),-0.471074237512499,-1.0904121372464295,0.3653483992467043,0.6827309660867905,1.0,8/10,47.14%,CFAP100;CCDC40;DNAAF4;CCDC39;DNAH1;DNAAF1;DNAI3;CFAP73
prerank,membrane assembly (GO:0071709),0.3846475933441505,1.0903029551293197,0.3414179104477612,0.8008012646868968,1.0,8/34,9.40%,LRP4;CEL;NLGN2;IL1RAPL1;PTPRD;UBXN2B;PTEN;PICALM
prerank,DNA biosynthetic process (GO:0071897),-0.4181158718132215,-1.0902391255253108,0.3562753036437247,0.6824662692069873,1.0,8/16,26.39%,PPIA;WRNIP1;POLA1;POLE;POLD3;CDKN2D;POLD1;POLL
prerank,regulation of microtubule nucleation (GO:0010968),-0.4769243553542707,-1.0901442774282986,0.37065637065637064,0.681987631876094,1.0,7/10,33.16%,PAK1;GIT1;CKAP5;DCTN1;HSPA1B;RANGRF;HSPA1A
prerank,zinc ion transmembrane transport (GO:0071577),-0.38648904727010547,-1.0901403119133082,0.3405639913232104,0.6812780719270529,1.0,6/22,13.34%,SLC39A10;SLC30A5;SLC39A8;SLC30A1;SLC39A7;SLC39A14
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.3232275820964816,-1.0901247741209052,0.30158730158730157,0.6806194045242749,1.0,17/45,25.95%,TGFB1;DDX5;BUD23;GRSF1;LIN28B;MAP2K2;UTP15;SUPV3L1;HNRNPLL;BMP4;RBM22;SIRT7;RBM20;RELA;ZPR1;HRAS;ERN1
prerank,COPII-coated vesicle budding (GO:0090114),-0.3019317707569645,-1.0897580844007904,0.3253333333333333,0.6809372474744537,1.0,31/68,30.98%,NSF;CUL3;TMED2;MCFD2;RAB1A;TRAPPC6B;SEC23A;PPP6R1;TMED10;CNIH1;CTSZ;ANKRD28;SEC16B;PREB;CNIH3;RAB1B;TRAPPC2;CTSC;VAPA;TRAPPC4;TRAPPC9;SEC16A;COL7A1;SEC31A;TRAPPC1;SEC23B;STX5;TRAPPC5;GRIA1;GORASP1;PEF1
prerank,protein autophosphorylation (GO:0046777),0.29411651624533736,1.0896512624540278,0.3021897810218978,0.8014864484901545,1.0,27/157,12.60%,OXSR1;FGFR2;FGFR4;KIT;DAPK1;PDPK1;PDGFRB;FER;EPHA8;EPHA4;PDGFRA;DDR1;SIK1;IGF1R;LRRK2;STK17B;DDR2;GRK5;MUSK;CAMK2D;VRK2;ABL1;JAK2;ERBB2;MAPKAPK2;PRKD2;STK24
prerank,cellular response to interleukin-1 (GO:0071347),-0.2606644652005789,-1.0890458588001826,0.23303834808259588,0.6820290034673745,1.0,49/143,23.41%,RPS6KA5;DAB2IP;UBB;NFKBIA;NOD1;IKBKB;ST18;IL1R1;RPS27A;UBC;IL1RAP;PTGIS;PSMD13;PSMF1;RBX1;PSMB10;CHUK;PSMB6;TOLLIP;PSME3;PSMB5;MAP3K3;PSMC3;IRAK3;GBP3;PSMD12;PSMB8;CUL1;MAP3K8;TAB3;CD47;PSME1;UBA52;PSMB3;RPS6KA4;CD40;ZC3H12A;CCL13;IRAK1;PSMD5;MYD88;SKP1;MAPK3;MAPK11;PSMD9;HYAL2;PELI1;PSMB4;RELA
prerank,mitotic cytokinetic process (GO:1902410),-0.3988954929879184,-1.0889647231944768,0.34393638170974156,0.6815041026648037,1.0,12/20,30.92%,CHMP5;CHMP2B;RHOA;CHMP1B;CHMP1A;CHMP3;CHMP7;PDCD6IP;CHMP4C;CEP55;CNTROB;VPS4B
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.49910157988605897,1.0888848981738886,0.34541577825159914,0.8025603596869383,1.0,5/10,13.93%,ACD;DCLRE1A;DCLRE1B;RTEL1;APEX1
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.4759406052911529,-1.0887845558064937,0.375,0.6812566945333471,1.0,6/10,28.69%,ST6GAL1;ST3GAL1;GNPDA1;AMDHD2;GNPDA2;NANP
prerank,sensory perception of smell (GO:0007608),-0.4762868851703681,-1.08877166348216,0.37781954887218044,0.6805781070217882,1.0,2/11,10.93%,ADCY3;SYT10
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4342155280100748,-1.088595150448889,0.3712686567164179,0.6803053083736846,1.0,5/13,10.65%,SHANK3;LGMN;APP;ZDHHC2;RELN
prerank,erythrocyte differentiation (GO:0030218),0.36244940420183086,1.088511087785869,0.34172661870503596,0.8025628264702291,1.0,9/44,12.76%,TGFBR3;KIT;ACIN1;UFL1;LYAR;CEBPG;MED1;JAK2;SLC25A38
prerank,positive regulation of protein depolymerization (GO:1901881),-0.44866765385821294,-1.088367123859996,0.3527054108216433,0.6801544973730062,1.0,4/11,18.61%,WDR1;STMN2;NES;CFL2
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3119428951161689,1.0882464919492112,0.3232169954476479,0.8022631219269093,1.0,9/101,5.51%,ROBO1;IL34;CEMIP;KIT;LTF;PDGFRB;PDGFD;LRRK2;FGF1
prerank,blood circulation (GO:0008015),-0.3176472398082052,-1.0882160458746228,0.3115468409586057,0.6798278990894073,1.0,17/49,19.73%,SGCD;NOS3;ACVRL1;MEOX2;TBC1D8;GUCY1B1;GCLM;GUCY1A1;SOD1;ELN;ACE2;CXCL12;CYB5R3;PLN;SGCZ;AGTR1;DLL4
prerank,modulation by symbiont of entry into host (GO:0052372),-0.4100014040727369,-1.0880086459428642,0.3587174348697395,0.6796499415240419,1.0,6/16,19.83%,CAV1;TRIM14;TRIM25;FUCA2;HS3ST5;TRIM27
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.4067526225541387,-1.087572138744564,0.375,0.6800740446668111,1.0,5/17,11.93%,PRKG1;MEF2C;PDCD4;CDKN1B;GPER1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.43748238661092015,1.087348718941643,0.3747534516765286,0.8037037214415294,1.0,2/18,5.87%,PRKAG2;PRKCB
prerank,negative regulation of insulin secretion (GO:0046676),-0.41043865721963807,-1.08701189653829,0.36072144288577157,0.6808599930772536,1.0,6/17,14.03%,KLF7;KCNB1;CCN3;REST;CHGA;SIRT4
prerank,Wnt signaling pathway (GO:0016055),0.31422672875825536,1.0868001485027698,0.3192868719611021,0.804171146697339,1.0,15/92,10.14%,WLS;TCF7L2;WNT4;WNT6;PLPP3;LRRK2;FRAT1;TCF7L1;ARL6;WNT5B;PTEN;RYK;USP34;BCL9;DVL3
prerank,establishment of epithelial cell polarity (GO:0090162),-0.3876724030830718,-1.08679097345318,0.37160751565762007,0.6807337788237413,1.0,4/19,3.66%,CYTH3;MSN;CYTH1;SIPA1L3
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.339192489175617,-1.086536632428597,0.32096069868995636,0.6807250049945686,1.0,16/35,24.25%,CALM1;HSP90AB1;TIPRL;PPP1R2;HSP90B1;GSK3B;MTOR;MASTL;PPP6R1;CSNK2B;CALM2;BOD1;CD300A;CALM3;PPP1R15A;PPP1R15B
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.3343923797461026,-1.0863550624668326,0.34,0.6805215424874549,1.0,12/35,13.76%,HEG1;TGFB2;RASIP1;DAB2IP;CCDC125;KANK1;MET;CUL3;MYOC;KCTD13;SPRY4;STMN1
prerank,regulation of interleukin-1 production (GO:0032652),-0.4274886459284547,-1.0855236242992914,0.3509803921568627,0.6820134723377358,1.0,4/15,13.99%,FOXP1;GAS6;CEACAM1;TMED10
prerank,myelin maintenance (GO:0043217),-0.4648940182940946,-1.0852725439715192,0.3763837638376384,0.6819929892428362,1.0,6/10,26.51%,SOD1;CLU;ABCD2;EPB41L3;PRX;MYRF
prerank,actin cytoskeleton reorganization (GO:0031532),0.3389427340771273,1.0850952767548585,0.3225806451612903,0.8076921694234959,1.0,9/63,5.14%,AUTS2;PTK7;NRK;KIT;ANTXR1;FER;ANXA1;DTNBP1;RICTOR
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.2837916674326237,-1.084962856928839,0.27486910994764396,0.6820430259710677,1.0,32/88,23.79%,FNIP2;TFRC;DAB2IP;RPS3;RACK1;SH3GLB1;WARS1;TGFB1;MPP7;FAF1;GSK3B;VEGFA;SPIDR;HGS;PIH1D1;TAL1;CLU;CHGA;TPPP;ATP13A2;CDC42EP2;TIRAP;MMP1;SDC4;BIK;VCP;BMF;MTLN;RAB7A;PDCD6IP;RGCC;BAX
prerank,artery development (GO:0060840),-0.376188383665424,-1.084730674455298,0.3522012578616352,0.6819117543024541,1.0,8/23,7.87%,ACVRL1;ENG;TBX1;BMPR2;HES1;STRA6;PDE2A;VEGFA
prerank,aggrephagy (GO:0035973),-0.3581648086705514,-1.0845981564905545,0.34541577825159914,0.6815478527525276,1.0,8/27,15.45%,VIM;UBB;DYNLL2;RPS27A;UBC;WDFY3;CFTR;UBA52
prerank,retinol metabolic process (GO:0042572),0.4631460419311854,1.0843105728347426,0.37,0.8088346374921196,1.0,3/14,15.97%,RBP4;DHRS3;RDH11
prerank,polarized epithelial cell differentiation (GO:0030859),-0.4315030021757051,-1.0841586540763104,0.3614931237721022,0.681948337221523,1.0,3/13,9.24%,MSN;ZDHHC7;RHOA
prerank,reticulophagy (GO:0061709),0.4873429316844846,1.0841232532356595,0.38181818181818183,0.8083542191442505,1.0,3/12,10.75%,UFL1;RETREG1;TEX264
prerank,phagosome maturation (GO:0090382),-0.3395445687583099,-1.0839480118450262,0.33548387096774196,0.6817703951903703,1.0,18/35,26.57%,RAB31;ATP6V0A1;RAB38;ATP6V1A;ATP6V0C;TCIRG1;ATP6V1E1;ATP6V0A4;ATP6V0A2;RAB39A;MREG;ATP6V0D2;RAB7A;ATP6V0E2;RAB14;ATP6V1B2;MCOLN1;ATP6V1H
prerank,regulation of DNA binding (GO:0051101),0.3569450484026132,1.0836552482118078,0.3211805555555556,0.8086537731952028,1.0,6/44,8.99%,IGF1;PRKN;SP100;MMP9;RSF1;CEBPG
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.391144505738718,1.0834711695192376,0.3568702290076336,0.8081281071492998,1.0,4/27,4.86%,JPH1;DMD;ANK2;CACNB4
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.359135582615938,1.083248368775425,0.35714285714285715,0.8077288727208319,1.0,5/45,6.30%,BMP6;BMP7;DAB2;RBPMS;TTK
prerank,response to estrogen (GO:0043627),-0.35068876904269647,-1.0832248789328909,0.344017094017094,0.6829836076516455,1.0,8/31,14.67%,CAV1;ESR1;TRIM25;SERPINB9;ARID5A;WBP2;SFR1;NCOA4
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.4618449073066436,1.083178073842584,0.3677685950413223,0.8068944608067803,1.0,4/14,8.91%,TPP1;ACD;XRCC5;BRCA2
prerank,fatty acid oxidation (GO:0019395),0.3390003042237551,1.0831494944441662,0.347008547008547,0.8059577772871477,1.0,15/57,14.65%,EHHADH;ACADL;ECI2;HSD17B10;CPT2;ACAD11;ECHDC1;ACADS;PHYH;ACAA2;ACAT2;AUH;ACOX1;BDH2;HACL1
prerank,regulation of cytoskeleton organization (GO:0051493),-0.2738551869082912,-1.082678512642606,0.29775280898876405,0.6837097692145435,1.0,26/108,12.26%,EFNA5;CLIC4;RAC1;IQGAP1;PTK2;CORO2B;PHLDB1;F11R;MAP6;RHOB;FAM107A;CAPN2;CCDC88A;GSK3B;GPM6B;HIP1R;TJP1;MTOR;PAK1;ARHGEF19;RHOA;PAK2;ARHGEF5;CRK;SORBS3;MARK2
prerank,homotypic cell-cell adhesion (GO:0034109),0.36365814187238016,1.0821661165305294,0.3648881239242685,0.8077178152266835,1.0,6/39,4.40%,MEGF11;PLPP3;GNAS;MEGF10;TLN1;PDGFRA
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.47227819587339814,1.0820238197202001,0.3649193548387097,0.8070732749613618,1.0,3/12,8.39%,PPARA;ABCA1;ABCA5
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.4490902162873075,-1.081882097741378,0.37475728155339805,0.6850251654094671,1.0,6/12,18.13%,HSP90AA1;HSP90AB1;B4GALT5;EPHB1;SPTBN4;B4GALT6
prerank,negative regulation of viral life cycle (GO:1903901),-0.42118449912551625,-1.0816277695711252,0.3537832310838446,0.6849284410041252,1.0,7/15,22.39%,LY6E;GSN;PPIA;BST2;MID2;IFITM3;CIITA
prerank,hemopoiesis (GO:0030097),-0.2846755094929804,-1.08153665480315,0.2826666666666667,0.6844530225347732,1.0,33/87,22.86%,MECOM;KITLG;TEK;MFAP5;CD34;KDR;TGFB2;RUNX1;JAG1;KIRREL3;TGFBR2;TGFB1;PTPRC;FLT4;NOTCH4;RUNX2;RTKN2;ATF4;TAL1;ARIH2;GLRX5;CSF1R;FLT3;RRAS;TOX;SH2B3;TIRAP;L3MBTL1;BMP4;MKNK2;PRKX;DLL1;CEBPA
prerank,anterograde axonal transport (GO:0008089),-0.3338314224129836,-1.0810343273941418,0.3205944798301486,0.6850752119173996,1.0,18/37,32.76%,DLG2;AP3S1;HSPB1;BLOC1S2;SOD1;AP3M2;KIF1A;KIF3B;NEFL;MAP1A;KIF4A;HAP1;KIF1B;KIF5C;SNAPIN;MAPK8IP3;KIF5B;AP3B2
prerank,cellular response to osmotic stress (GO:0071470),0.4231805886919571,1.080855574909535,0.34782608695652173,0.8092682818427696,1.0,4/21,7.82%,OXSR1;MYLK;LRRC8E;RCSD1
prerank,aortic valve morphogenesis (GO:0003180),0.3838670039304456,1.0808406502514725,0.3606870229007634,0.8082938091265955,1.0,3/30,2.28%,ROBO1;ROCK2;SMAD6
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.36359785068777833,-1.0806812584357193,0.33535353535353535,0.685211771961937,1.0,5/24,5.27%,TEK;KDR;GAS6;RAMP2;GATA2
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.4569345855830633,-1.0803527251575293,0.36345776031434185,0.6853024054187152,1.0,6/10,27.37%,CORO2B;DNAJA1;NDFIP2;NDFIP1;SNX3;PPM1F
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.4704839198934596,-1.0802919828668958,0.38910505836575876,0.6847601484782334,1.0,5/10,26.08%,ACER2;NEXMIF;CYP1B1;JAM3;SNAI2
prerank,protein localization to chromatin (GO:0071168),-0.39965635032441704,-1.0802122673273924,0.3655705996131528,0.684271386168452,1.0,10/18,32.07%,ESR1;LEMD2;PIH1D1;TASOR;MSH2;MCM8;CHMP7;SGF29;PPHLN1;PLK1
prerank,signal peptide processing (GO:0006465),-0.4558368645449368,-1.0797483573440396,0.39165009940357853,0.6847859196636333,1.0,6/11,31.38%,FURIN;PCSK5;CLN5;SEC11A;HM13;SPCS3
prerank,vasculature development (GO:0001944),0.4406184096130407,1.0795868217185913,0.367983367983368,0.8106238519879491,1.0,3/16,4.40%,ERRFI1;PDGFRB;PDGFRA
prerank,acute inflammatory response (GO:0002526),-0.3819913897804651,-1.079567041550583,0.37763713080168776,0.6845322512454075,1.0,11/23,37.54%,F3;LBP;CTNNBIP1;SIGIRR;CEBPB;AHSG;VNN1;MYLK3;HPR;HP;CRP
prerank,response to interferon-alpha (GO:0035455),-0.41693263507671785,-1.0789623541088162,0.3627450980392157,0.6854621502962159,1.0,6/16,22.88%,GAS6;ADAR;BST2;IFITM3;RO60;IFNAR1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.4437336654892975,-1.078814971235712,0.3747645951035782,0.6851447942763537,1.0,3/12,6.03%,RUNX1;CBFB;PTPRC
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.37605906790393323,-1.0786863847181163,0.34249471458773784,0.6847884262650349,1.0,5/21,11.40%,RPL11;RPL23;RPS7;RPL5;RAB1A
prerank,positive regulation of cell killing (GO:0031343),-0.4414379566755865,-1.0782997011872393,0.3849129593810445,0.6851232454286786,1.0,3/13,16.37%,RAC1;MAPK8;DVL2
prerank,dicarboxylic acid metabolic process (GO:0043648),0.3375182140500136,1.0780288494161054,0.3525423728813559,0.8138083156998155,1.0,12/52,15.15%,ADHFE1;ACOT4;MTHFR;HOGA1;FOLR2;IDH2;PHYH;SLC19A1;SHMT1;AADAT;ME3;MTHFS
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.38420307254865005,1.0779598292058175,0.3629489603024575,0.8129667748033668,1.0,4/31,6.47%,RANBP3L;SMAD6;TMEM64;SUFU
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.40165691346995813,1.0779123236545924,0.3797250859106529,0.8120880192129128,1.0,2/26,1.91%,ERRFI1;SNX6
prerank,canonical Wnt signaling pathway (GO:0060070),0.3271443412716054,1.0777488112949922,0.3404255319148936,0.811504230376296,1.0,12/68,10.14%,TCF7L2;WNT4;WNT6;PLPP3;LRRK2;FRAT1;TCF7L1;WNT5B;PTEN;RYK;BCL9;DVL3
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.4498921341209179,-1.0773270947504607,0.3657142857142857,0.6869759955045638,1.0,2/12,5.38%,ESR1;TGFB1
prerank,response to steroid hormone (GO:0048545),-0.34419024566923195,-1.0766957826615635,0.357630979498861,0.6879088744141574,1.0,7/31,5.38%,ABHD2;CAV1;ATP1A1;THBS1;TGFB2;UBE3A;TGFB1
prerank,negative regulation of programmed cell death (GO:0043069),0.2671481740771436,1.0764655973508173,0.2824427480916031,0.8139502574607201,1.0,53/355,11.31%,IL31RA;IGF1;OSR1;FHL2;NOTCH2;ANGPT1;DAB2;BCL2;SMAD6;DKK1;SCX;LTF;IFIT3;CTSH;ANXA1;PDPN;ARAF;SPHK1;ZFAND6;PRKAA2;IGF1R;LRP2;SON;NIBAN2;KRT18;MYO18A;BNIP3;SH3RF1;IL6;NOL3;KANK2;MMP9;PRKAA1;BIRC5;SIAH2;GRK5;BIRC6;CDK1;NUPR1;BCL2L2;YME1L1;ITCH;MED1;NAA35;AXL;PHIP;PRKDC;HDAC1;PIK3R1;RPS6KB1;TFAP2A;TFAP2B;SH3RF2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4311420074562316,1.0764271824395275,0.3826429980276134,0.813053410795632,1.0,5/19,8.85%,CUX1;IL1RAPL1;OBSL1;PTPRD;CUL7
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.4712271480430328,1.0761074490518294,0.37474541751527496,0.8129645730568874,1.0,2/12,9.75%,IL18;IL17D
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.2859958575911811,1.075408507329945,0.2952522255192878,0.8138548733148923,1.0,27/166,12.46%,IGF1;FGFR4;SMOC2;ZEB2;SLC6A9;LPGAT1;SORBS1;PDGFRB;NOS1AP;IGF2;PLD1;SLC45A3;IL6;SMAD3;CCL19;ARNT;SLC27A1;SAMD4A;PRKDC;RPS6KB1;METTL14;NPM2;FXR1;ERBB2;LARP6;PRKD2;PKD2
prerank,mitotic cytokinesis (GO:0000281),0.3522833271151796,1.075197506329065,0.3578767123287671,0.8134865564019915,1.0,7/47,5.85%,ROCK2;KLHDC8B;ARL3;SNX18;SNX9;SNX33;SON
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.32730645073863884,-1.0751161994294511,0.32339449541284404,0.6913033161164298,1.0,10/39,15.46%,MYO1D;ACTN4;FNBP1L;PPFIA2;KIF1A;RAB1A;MYO5A;SYT4;NDE1;BICDL1
prerank,extracellular matrix assembly (GO:0085029),-0.36992068772355385,-1.0750164405264082,0.37327188940092165,0.6908839016088716,1.0,9/23,12.90%,GAS6;RAMP2;TNXB;MYH11;TGFB1;LAMB2;GPM6B;MFAP4;NTN4
prerank,embryonic organ development (GO:0048568),0.332222208483791,1.0746284593727276,0.3554006968641115,0.8140889691964555,1.0,11/61,8.09%,RBPJ;FGFR2;KIT;RBP4;KMT2A;COL13A1;TEAD1;GLI3;SALL1;PBX4;TEAD3
prerank,regulation of cilium assembly (GO:1902017),0.3322661837080679,1.074474968913519,0.3479020979020979,0.8135322177950786,1.0,17/62,18.86%,DCDC2;ODAD3;TBC1D9B;SDCCAG8;ARHGAP35;CROCC;CYLD;TBC1D19;IFT140;CDKL5;TBC1D17;ATG3;CEP120;USP6NL;TBC1D15;CEP97;TBC1D7
prerank,small GTPase mediated signal transduction (GO:0007264),-0.2778047383220934,-1.074455111822916,0.31129476584022037,0.6916669799996619,1.0,33/103,18.23%,ARHGAP31;RAPGEF5;TIAM1;RASGRP3;KRAS;RAC1;SHTN1;RERG;NRAS;G3BP1;PLK2;CCDC88A;ABR;BCR;MRAS;CHP1;JUN;NUCB1;RAB38;RALB;USP50;KSR2;RHEB;GRAP;RUNDC3A;NF1;CCDC88C;PRKD1;USP28;RRAS;USP8;CDK2;RGS19
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.39554135515162914,-1.074269342603256,0.36645962732919257,0.6914359290562466,1.0,8/18,12.33%,RHOJ;KDR;GATA2;JCAD;VEGFA;PTGS2;PIK3C2A;MAP3K3
prerank,positive regulation of cell adhesion (GO:0045785),-0.2899485374986166,-1.0732578073246868,0.32273838630806845,0.6933554034100572,1.0,13/74,8.32%,FRMD5;PTPRJ;ZFHX3;RAC1;TGFB2;VIT;STX3;LIMS1;TGM2;FBLN2;VEGFA;ECM2;NPNT
prerank,neural tube development (GO:0021915),0.4507693578644283,1.0729566780814617,0.3804347826086957,0.8168343461046713,1.0,1/15,0.23%,ALDH1A2
prerank,positive regulation of catabolic process (GO:0009896),-0.29602603507721054,-1.0725749885220939,0.32741116751269034,0.6944670952423921,1.0,15/65,13.03%,WWP1;NSF;NEDD4L;DAB2IP;ATG7;PLK2;GSK3B;FOXO1;DDB1;OAZ1;APC;CDKN1B;NDUFA13;EGLN2;IDE
prerank,cellular response to hypoxia (GO:0071456),0.29617338532798904,1.0723699031157863,0.32727272727272727,0.8174714640060378,1.0,16/126,9.55%,RORA;SLC8A3;EPAS1;BMP7;HIF3A;NDNF;CPEB2;PSME4;PSMA2;BNIP3;PSMA3;NPEPPS;ARNT;ACAA2;MDM2;PSMD8
prerank,cell part morphogenesis (GO:0032990),0.46110327448203536,1.0723254309041055,0.4020408163265306,0.8165912935827542,1.0,2/13,4.45%,PID1;WASF1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.2973218739311808,-1.0723167729266108,0.3255269320843091,0.6944268499418746,1.0,28/62,28.21%,TPT1;ACKR3;DNAJA1;PPIA;CREB3L1;HSPB1;YBX3;BCL2L1;XBP1;RTKN2;NDUFA13;ARHGEF2;CLU;HERPUD1;CXCL12;PLAUR;PINK1;TMBIM6;AKT1;NOC2L;CDKN2D;PTTG1IP;CREB3;URI1;SNAI2;EPO;SYVN1;TMEM161A
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.42614362987208965,-1.0722535497181211,0.35877862595419846,0.6939026159018208,1.0,3/13,6.69%,PDE8A;RACK1;MET
prerank,positive regulation of protein transport (GO:0051222),0.3275001279958749,1.07209228417993,0.33004926108374383,0.8162466763868061,1.0,3/67,1.88%,IGF1;BMP6;FRMD4A
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.23513642216295425,-1.0720559480410112,0.2175732217573222,0.6936984654015882,1.0,102/314,26.17%,WWP1;ATXN3;PPP2R5C;NEDD4L;UBB;FBXL3;STT3B;UBXN1;ZNRF1;BUB3;TRIM25;CTNNB1;HSP90B1;FAF1;ARRB1;BAG6;RPS27A;UBC;RMND5B;UCHL1;CUL3;ECRG4;DERL1;FBXL5;PSMD13;PSMF1;DDB1;UBE2B;RBX1;PSMB10;FBXO31;HSPA5;KCTD17;KCTD13;FBXL20;FEM1A;PSMB6;NSFL1C;PSME3;PSMB5;ERCC8;PSMC3;AGAP3;HERPUD1;PSMD12;PSMB8;RNF34;CUL1;KLHL42;PTTG1;TRIM13;PSME1;ANAPC16;ERLIN2;UBE2G1;UBA52;ZFAND2B;DNAJC10;PSMB3;WFS1;FBXL2;COP1;SPSB3;SPOPL;AUP1;CCNF;FBXL14;CDK2;DCAF12;BUB1B;UBE2D1;RNF5;DNAJB9;ARRB2;TRIM2;SHARPIN;PSMD5;FBXO17;ZSWIM8;SKP1;KCTD5;TMEM129;VCP;RBCK1;RNF103-CHMP3;FBXO9;ANAPC7;PLAA;PSMD9;PELI1;PSMB4;PCNP;HUWE1;CUL2;SPSB4;UBE2J1;BFAR;DMAC2;KIF14;DCAF11;YOD1;PSMD10
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.44983931369757046,-1.0718669908601488,0.3724007561436673,0.6935282729435965,1.0,5/11,22.08%,SCARB1;MFSD2A;NR1H2;CTDNEP1;NR1H3
prerank,glycosaminoglycan catabolic process (GO:0006027),0.34845194081910047,1.0718605870554165,0.369449378330373,0.8158885353445584,1.0,8/55,5.38%,CEMIP;FMOD;SDC2;OGN;GPC6;OMD;PRELP;GPC3
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.4359708680009932,-1.071858485707485,0.38412017167381973,0.6928545809358095,1.0,5/13,15.32%,BMP5;SOD1;BMP2;REST;ERLIN2
prerank,protein neddylation (GO:0045116),-0.42728152959290505,-1.0716859402165844,0.3918918918918919,0.6926264235503711,1.0,4/13,14.54%,NEDD8;RBX1;DCUN1D1;DCUN1D2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.3277544936436054,-1.0715767410267427,0.3546099290780142,0.6922024949926355,1.0,6/39,4.63%,PTPRJ;SH3KBP1;CBL;DAB2IP;PTPN12;LGMN
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3550843851333888,1.0714490317648768,0.3555166374781086,0.8159496552291139,1.0,6/44,4.50%,ROCK2;TPM1;LPAR1;FHOD1;CCN2;PPM1E
prerank,RNA processing (GO:0006396),0.2839391020219237,1.0714190706043762,0.3209700427960057,0.815045879922048,1.0,53/176,19.90%,CELF2;ATXN1;RBMS1;NOVA1;RNASEL;ADAD1;SRPK2;RBPMS;HNRNPC;HNRNPH1;SON;RBMS2;TSEN34;NOL3;RBM5;SLU7;SF3A3;DDX23;RP9;NOL9;PRPF3;TENT2;AKAP8L;PDCD7;TUT1;RBM39;SCAF11;NONO;DICER1;TSEN2;SRRM4;LSM5;SNRNP40;DHX8;CSTF3;HNRNPH3;SNRPA1;DHX15;RNGTT;HNRNPR;U2AF1;TUT4;NUDT21;PRPF6;HNRNPA2B1;RSRC1;LSM3;RBM4;LSM1;SRSF11;LSM4;SNRPF;PPIG
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.42925474376772854,-1.0711822861784475,0.4079696394686907,0.6925267833695277,1.0,8/13,33.89%,GAS6;CD74;IFIH1;TRIM44;DHX9;MAVS;TSLP;IL7
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3835481385069537,1.0709562073697076,0.36666666666666664,0.8153105039777676,1.0,7/30,7.35%,SNTA1;KCNA5;GPD1L;ANK2;CACNA1D;GJA1;CACNA2D1
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.3587254457100843,-1.0708806979681698,0.36585365853658536,0.6926401235033347,1.0,4/29,5.63%,JAM2;GAS6;LGMN;CALR
prerank,negative regulation of kinase activity (GO:0033673),0.33511540398481077,1.0704839228493022,0.33895446880269814,0.8156085788080362,1.0,7/62,6.43%,PRKAG2;PDPK1;DEPTOR;DTNBP1;PPM1E;NPRL2;GNAQ
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.4081649115806779,-1.0701404020467549,0.37601626016260165,0.6938715013210409,1.0,8/15,30.44%,PRKCH;SFRP4;BMP4;NUMA1;ETV4;NME2;SFN;SULT2B1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.46523668389356987,1.0700408681575664,0.3885480572597137,0.8157883839771393,1.0,3/12,13.96%,NINL;CEP19;BICD2
prerank,regulation of actin filament depolymerization (GO:0030834),0.4791435001871236,1.069894783028716,0.39059304703476483,0.8151580171129369,1.0,2/12,7.18%,PLEKHH2;LIMA1
prerank,positive regulation of cellular protein localization (GO:1903829),-0.2875004168552016,-1.0695258697527072,0.32524271844660196,0.6947683905950517,1.0,16/69,11.55%,TFRC;STX3;HSP90AB1;FYN;LIMK2;TGFB1;FERMT2;CCDC88A;GNL3;GSK3B;CARD10;RTN4;SESN2;APC;WWTR1;GPR137B
prerank,regulation of histone acetylation (GO:0035065),-0.34201025760392795,-1.069391408285654,0.35827664399092973,0.6944431748215766,1.0,12/33,21.48%,RPS6KA5;PPARGC1A;HDAC5;ARRB1;SET;GLYR1;NOS1;RPS6KA4;CTBP1;SPI1;NOC2L;MAPK3
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.39800088890909313,1.0682448798872268,0.35619047619047617,0.8186343040867056,1.0,4/23,7.43%,C1QTNF3;BMP7;UACA;NLRC3
prerank,regulation of nervous system development (GO:0051960),-0.33832893585369933,-1.0681616326231724,0.358695652173913,0.6969303100028496,1.0,15/37,25.82%,BHLHE40;HES1;CTNNB1;TNFRSF1B;PRUNE1;TENM4;HEY2;HEYL;CX3CR1;HES6;DLL1;HEY1;GBX1;ZPR1;KIF14
prerank,intermediate filament organization (GO:0045109),-0.4057959019656484,-1.0681296482308962,0.3711340206185567,0.6963367631929538,1.0,6/17,25.93%,VIM;GFAP;MTM1;DSP;NEFL;DNAJB6
prerank,pyruvate metabolic process (GO:0006090),-0.30912540609134276,-1.0680907103621586,0.3534675615212528,0.695739969734253,1.0,12/52,17.38%,BSG;PKM;SLC16A1;ME1;HK1;GAPDH;PDHA1;PFKM;TPI1;ALDOA;LDHA;ALDOC
prerank,negative regulation of defense response (GO:0031348),0.3218937735532592,1.0678784874736873,0.35294117647058826,0.8186149548327994,1.0,15/77,16.16%,RORA;C1QTNF3;PPARA;CACTIN;NLRC3;LYAR;SIRPA;ITCH;ENPP3;PCBP2;MAPKBP1;NLRP12;PTGER4;CDH5;TRAFD1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3408578606748306,-1.0677869311478567,0.33617021276595743,0.6958106645965695,1.0,8/34,11.33%,PTPRB;PTPRJ;DUSP16;PTPN12;UBASH3B;PTPN1;DUSP8;DUSP3
prerank,cellular iron ion homeostasis (GO:0006879),-0.3028739883233862,-1.0670873515344057,0.33827160493827163,0.6968747204724416,1.0,15/55,10.01%,ABCG2;FTH1;TFRC;SCARA5;FTL;IREB2;SLC40A1;SOD1;NEDD8;SLC22A17;ISCU;FBXL5;HMOX2;FRRS1;ATP6V1A
prerank,regulation of autophagy (GO:0010506),0.2764858001100085,1.0669088162628566,0.31886024423337855,0.8202529610685443,1.0,31/216,11.14%,PRKAG2;LEPR;ITPR1;DAPK1;PRKN;PRKAG3;SNX6;BCL2;TRIM5;NEDD4;PRKAA2;UFL1;NPRL2;MTMR3;LRRK2;SLC38A9;BNIP3;OPTN;RNF152;PRKAA1;KAT8;NUPR1;ATP6V0D1;ATP6V0E1;PLEKHF1;GOLGA2;WASHC1;ABL1;MLST8;FLCN;RUBCN
prerank,negative regulation by host of viral transcription (GO:0043922),-0.43446550512221477,-1.0667731040989432,0.3900990099009901,0.6969915733984576,1.0,5/12,20.13%,TARDBP;JUN;REST;PSMC3;TFAP4
prerank,T cell differentiation (GO:0030217),0.3626786752356502,1.0662724239442525,0.38979963570127507,0.8209752747364047,1.0,7/40,12.17%,LEPR;KIT;ANXA1;GLI3;NHEJ1;MR1;SOX13
prerank,telomere maintenance via recombination (GO:0000722),0.47510023302103677,1.0659316046403984,0.38702928870292885,0.8209008177473847,1.0,7/11,28.25%,TEP1;RAD51;TPRKB;RAD50;ERCC4;SMC5;SMC6
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.36523503053035666,1.0657605987568377,0.36363636363636365,0.8203603413686955,1.0,9/38,11.52%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.43382677404849235,-1.0657139441096937,0.3800738007380074,0.6990075406765406,1.0,7/13,27.86%,CD44;CD74;MIF;PTTG1IP;SNAI2;PSMD10;YJU2
prerank,regulation of membrane depolarization (GO:0003254),0.4130814580043713,1.0656063177130584,0.3611111111111111,0.8198135533573663,1.0,6/18,12.39%,GPD1L;LRRK2;CAMK2D;SCN3B;PTPN3;SCN2B
prerank,regulation of cell motility (GO:2000145),-0.2623383549736003,-1.0654201386671744,0.305993690851735,0.6990593220590496,1.0,27/121,10.85%,FRMD5;TMSB4X;SPOCK2;RAC1;CAVIN1;PLXND1;PRAG1;SLK;SERPINE2;DOCK10;TMSB10;CCDC125;MINK1;PLXNA4;FLNA;SPATA13;RHOB;TGFB1;ROBO4;CEACAM1;ABI3;CYRIB;FGF7;SRCIN1;RHOA;CDK6;CRK
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.42150908281043076,1.0652744116343367,0.375,0.8197309855216129,1.0,2/20,0.85%,TGFBR3;RBPJ
prerank,positive regulation of isotype switching (GO:0045830),-0.4208935491088812,-1.065251109962156,0.38155515370705245,0.698851510952347,1.0,8/15,31.50%,TFRC;TGFB1;CD40;KMT5C;CLCF1;SHLD3;RIF1;SHLD2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.28572014742906005,-1.0652507242150995,0.3273657289002558,0.6981640857483582,1.0,17/76,18.48%,ANO1;ESR1;GPR4;TGM2;HOMER1;ADRA1B;GNA14;ADRA1A;HTR2A;GNA11;LPAR6;HRH1;PTGER3;CMKLR1;CX3CR1;AGTR1;CCKBR
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.392315559891401,1.065166964440574,0.3855855855855856,0.8190278143704487,1.0,9/26,12.36%,SMOC2;SPHK1;CCDC57;EIF4EBP1;PRKCA;PKN2;MDM2;RPS6KB1;HSF1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4706585138855351,1.0650877837657553,0.39065817409766457,0.8182406964464592,1.0,1/12,0.19%,ADAMTS12
prerank,purine-containing compound catabolic process (GO:0072523),0.4439678150198345,1.0650778446973446,0.3932135728542914,0.8172865652213668,1.0,1/13,0.43%,DPYD
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.47036789379292865,1.0649658168751455,0.375,0.8166321109912216,1.0,2/11,7.52%,PLA2G10;LIPC
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.4733325580943193,-1.0648527117349835,0.42135922330097086,0.6984667449860308,1.0,6/10,26.46%,SVIP;ERLEC1;INSIG1;UBE2J1;YOD1;UBAC2
prerank,cellular response to UV-A (GO:0071492),0.4789602790995513,1.0647931837858478,0.3952991452991453,0.8161326012301724,1.0,3/11,9.42%,MMP2;MMP9;CERS1
prerank,positive regulation of exocytosis (GO:0045921),-0.33582610678247227,-1.0647625604812094,0.3502415458937198,0.698000308373127,1.0,14/35,31.08%,RAB27A;HGS;CFTR;ATP13A2;SDC4;CLASP2;RAB7A;PDCD6IP;RAB3A;SYTL4;UNC13D;ATP6AP1;VPS4B;RAB15
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.4594366445985062,-1.064702265239971,0.39779005524861877,0.6974504565810813,1.0,6/10,36.68%,GABRG3;GABRA5;GABRE;GABRG2;GABRG1;GABRB2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.4551372719925983,1.064643508976975,0.41702127659574467,0.8155242461038879,1.0,2/13,4.57%,PLXNA2;PLXNC1
prerank,cellular protein modification process (GO:0006464),0.24626629067250982,1.0639148727967247,0.24725274725274726,0.8165616679014989,1.0,152/983,12.60%,PRKAG2;ASB2;ROCK2;OXSR1;PTPN13;B3GALT1;CP;FBN1;APLP2;NRK;EPAS1;WNK4;CDK8;ST3GAL3;DAPK1;PRKAG3;GALNTL5;LARGE1;UST;PDPK1;PDK1;ITIH2;SDC2;LHPP;CEL;BMP2K;TNC;LOXL1;SERPIND1;PPM1M;SPSB1;B3GNT5;PTPN4;UBE2E2;RNASEL;HIF3A;DMPK;FER;MAP4K5;CDK7;PIGU;ANXA1;RAB13;PRKCSH;NAA80;FAM20A;PCSK9;IGFBP4;SRPK2;ST3GAL5;OBSL1;NEURL2;DUSP10;ARAF;PPM1E;MAPK9;FBXW4;ATG10;DDB2;CDC14B;PTPRA;DCAF4;SIK1;PRKAA2;UFL1;GPC3;MTMR3;MSRA;LRRK2;PRKCZ;PTPN9;WIPI1;PSME4;PRKCB;PARP4;MAML1;STK17B;PSMA2;RBBP7;FBXO44;IL6;CAND1;F5;CCDC8;UBE2L3;PTPRD;PSMA3;PRKCA;GRK3;PTEN;PRKAA1;NEK4;NRBP1;CUL9;RYK;CSF1;BIRC5;WWP2;GRK5;USP25;BIRC6;CCNT1;DCAF10;MIA3;CHRDL1;PKN2;FSTL3;CDK1;TGM5;CAMK2D;CUL7;PIK3R4;KLHL11;NEK10;GRK4;FEM1B;FBXO6;ASB3;PSMD8;GOLGA2;VRK2;PARP10;IGFBP7;KBTBD7;UBA7;LATS1;FRK;PMM2;ABL1;PRKDC;PARP9;UBA3;PSMD3;JAK2;COQ8B;ERBB2;SLC35A1;IKBKE;FBXO4;KLHL22;BMPR1A;MAPKAPK2;CUL4B;PTPN3;PRKAG1;HIPK3;CCNE1;PRKD2;FBXO11;SENP8;STK24;SERP1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.2811091021600294,-1.0637846243425597,0.3264781491002571,0.6991282593747161,1.0,18/73,15.86%,KITLG;LMO2;RUNX1;CBFB;GATA2;PSMD13;PSMF1;PSMB10;PSMB6;TAL1;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;TCF3
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.2845016591353144,-1.0637047677348124,0.3392405063291139,0.6986559876853685,1.0,22/79,14.11%,SLIT2;BMPER;THBS1;HTRA3;DAB2IP;NOTCH1;BMPR2;CREB3L1;CRIM1;SMAD9;SMAD5;LEMD2;PTPN1;BMP2;HGS;HHEX;GPC1;EPN2;CASK;SPRY4;CADM4;SKIL
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4483046685796933,1.0636029352069916,0.4081237911025145,0.8163815248622835,1.0,3/14,7.32%,OSR1;ZEB1;MMP9
prerank,RNA 3'-end processing (GO:0031123),-0.288961250098798,-1.0634777035633913,0.3602015113350126,0.6984980442416312,1.0,35/69,35.96%,SRSF2;SRSF1;CPSF7;SRSF5;DDX39B;CPSF3;SRSF9;RBM8A;RNPS1;SRSF6;SYMPK;CLP1;LIN28B;CPSF2;CSTF2T;PCF11;CSTF2;THOC3;SUPV3L1;MAGOH;THOC6;THOC2;EIF4A3;SRSF7;ALYREF;CSTF1;TENT4B;CPSF1;ZC3H11A;MTPAP;DHX38;U2AF1L4;CHTOP;SRSF3;NCBP2
prerank,phagosome acidification (GO:0090383),-0.3612458125987874,-1.0629404062919618,0.375,0.6992556988773185,1.0,15/26,28.77%,ATP6V0A1;RAB38;ATP6V1A;ATP6V0C;TCIRG1;ATP6V1E1;ATP6V0A4;ATP6V0A2;RAB39A;ATP6V0D2;RAB7A;ATP6V0E2;ATP6V1B2;ATP6V1H;RAB20
prerank,positive regulation of type 2 immune response (GO:0002830),0.44200993030704394,1.062847949432914,0.3958333333333333,0.8174315764209643,1.0,3/14,6.76%,IL18;PRKCZ;IL6
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.24314795956312,-1.0625524754185525,0.2766798418972332,0.6995704781314724,1.0,55/234,16.37%,PRKCH;CAV1;ESR1;CD200;TFRC;RPS6KA5;PPARGC1A;PLCG2;UBB;NFKBIA;RPS3;PPIA;NOD1;ROR1;FZD4;TRIM14;IKBKB;HDAC5;EDA;TRIM25;CTNNB1;RPS27A;UBC;TNFRSF11A;LRP8;APP;CARD14;VEGFA;IL1RAP;AIM2;SLCO3A1;ZBTB7A;EDN1;ARHGEF5;CHUK;RTKN2;STAT3;RELN;ARHGEF2;CLU;IRAK3;STK36;PPRC1;TAB3;JUP;TERF2IP;TRIM13;TRAF1;UBA52;CX3CR1;TCF3;CARD16;PRKD1;RPS6KA4;DVL2
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.3454897176709165,1.061790334844768,0.34782608695652173,0.8192725846431937,1.0,5/48,5.98%,ADCY5;ADCY1;AMPD3;NPR2;ADSL
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.4422217252946401,-1.0615875841618854,0.41714285714285715,0.7013458091731123,1.0,9/11,50.09%,CAMK4;SPI1;TYROBP;ITGB2;MAVS;TICAM1;STAP1;F2RL1;CD177
prerank,striated muscle cell development (GO:0055002),-0.4152033118397328,-1.0605897435368017,0.3953488372093023,0.7032416780029953,1.0,1/14,0.29%,PGM5
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.3141423648799787,-1.0604923503858634,0.36936936936936937,0.7027996725414428,1.0,11/48,13.61%,FNIP2;CRIP1;BCL2L1;BAG6;TNFRSF1B;CHEK2;DDIT4;BCL3;MSH2;AEN;RPS27L
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.45168788989360625,-1.0602436705760618,0.38922155688622756,0.7027515212903064,1.0,6/11,22.85%,YBX3;BIRC3;ARHGEF2;CASP8;SLC25A4;PELI1
prerank,lymphocyte proliferation (GO:0046651),-0.3696215587428244,-1.0600330229060626,0.37969094922737306,0.7026394746084096,1.0,8/22,17.60%,MEF2C;MSN;PTPRC;LMBR1L;HSPD1;FLT3;CR2;CD40
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.45873347925965174,-1.0595238057502152,0.3940520446096654,0.7033012698416476,1.0,6/10,49.81%,NCKAP1L;VSIR;TLR4;IL12A;FOXP3;IL12B
prerank,regulation of neurogenesis (GO:0050767),-0.3073194274698018,-1.0594917571814069,0.3459715639810427,0.7026942249420594,1.0,20/55,23.10%,B2M;BHLHE40;NOTCH1;HES1;TGM2;CTNNB1;PRUNE1;SERPINF1;HEY2;HEYL;GPER1;REST;CX3CR1;SPEN;LIG4;HES6;DLL1;SOX11;FAIM;HEY1
prerank,regulation of cell adhesion (GO:0030155),0.295546619624025,1.0594157655709586,0.3524720893141946,0.824789736656416,1.0,11/129,4.57%,EPHA7;PLXNA2;ROCK2;IL18;ANGPT1;TPM1;RHOD;EPHA8;RIPOR2;EPHA4;PLXNC1
prerank,epithelial structure maintenance (GO:0010669),0.46259353304010786,1.0591493168987567,0.39801980198019804,0.8245267687249241,1.0,2/11,7.99%,RBP4;MUC13
prerank,negative regulation of RNA splicing (GO:0033119),-0.3873273519386187,-1.0585661130052493,0.38132295719844356,0.7044382514272889,1.0,7/19,20.15%,SRSF9;RNPS1;SRSF6;RPS26;TMBIM6;PCBP4;PTBP1
prerank,mitochondrion organization (GO:0007005),-0.24727048147997535,-1.05847750725,0.3115727002967359,0.7039771295027258,1.0,55/165,25.13%,DNM3;NOS3;FBXO7;PPARGC1A;CAV2;CXADR;TOMM20;CHCHD2;VPS13C;ATP5F1D;TFB2M;RHOT1;BCL2L1;DNM2;CHCHD3;RAB38;MIEF1;MTM1;STOML2;TOMM22;NDUFS1;DNM1;HSPD1;HIGD2A;PPRC1;TIMM9;MIEF2;SIRT4;MTX3;TIMM10B;TIMM13;MSTO1;BCAP31;ATP5F1B;MTFR1L;VPS13D;PINK1;SUPV3L1;TIMM22;MYH14;SLC25A4;HIGD1A;CYCS;BIK;TOMM7;MFN2;BCS1L;HIGD1B;TIMM50;CHCHD10;BAX;ATCAY;SPG7;RAB5IF;HAP1
prerank,positive regulation of vasculature development (GO:1904018),0.30239191034219104,1.058028014066225,0.3327974276527331,0.8265336165576738,1.0,15/94,7.40%,SASH1;ADAM12;STIM1;SMOC2;PDPK1;HK2;ECM1;CTSH;ANXA3;ITGAX;SPHK1;FGF1;PRKCB;PDCD6;PRKCA
prerank,positive regulation of monooxygenase activity (GO:0032770),0.3932169033287002,1.0573337065336463,0.3803339517625232,0.827410471705096,1.0,2/26,3.14%,NPR3;NOS1AP
prerank,renal filtration (GO:0097205),-0.46343536060986157,-1.0570976993185153,0.4149139579349904,0.7068293077229815,1.0,3/10,7.33%,CD34;MCAM;TBC1D8B
prerank,regulation of organelle organization (GO:0033043),-0.28009404588254,-1.0565875057421354,0.34366925064599485,0.7074504244211147,1.0,28/80,24.31%,MSN;CLIC4;PTK2;F11R;PDE4DIP;CAPN2;RHOT1;PDE2A;PDCD10;TJP1;PAK2;ARHGEF5;MTM1;MYO5A;MARK2;EHD3;MIEF2;ATP13A2;VPS11;ARL6IP1;PREB;STMN3;PINK1;SIRT7;MAPK3;SPEF1;CAMSAP3;SCARB2
prerank,cortical cytoskeleton organization (GO:0030865),0.3578811330100564,1.0564739299368002,0.3778162911611785,0.8287580815865069,1.0,7/41,7.67%,ROCK2;RHOD;FHOD1;RAB13;LLGL2;DLG1;RHOBTB2
prerank,response to muscle stretch (GO:0035994),0.44130645601631746,1.0562431488044677,0.408,0.82838505878605,1.0,3/15,3.07%,DMD;CSRP3;SLC8A1
prerank,regulation of macroautophagy (GO:0016241),0.30178574381657897,1.0561557353486666,0.3543913713405239,0.8276508792316428,1.0,28/105,17.31%,PRKAG2;PRKAG3;SNX6;NEDD4;SESN1;PRKAA2;LRRK2;SLC38A9;BNIP3;PRKAA1;ATP6V0D1;EPM2A;ATP6V0E1;MLST8;GPSM1;PRKAG1;LZTS1;TBK1;MAP3K7;ATP6V1D;RUFY4;EXOC7;EXOC1;LARP1;VPS26A;ATP6V1G2;VPS35;TSC1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.4232145875876306,1.05613756709466,0.3852140077821012,0.8267163547029696,1.0,1/18,0.06%,UNC13C
prerank,positive regulation of heart contraction (GO:0045823),0.4215295459049633,1.0552331122681322,0.41523809523809524,0.8281869722546563,1.0,4/19,11.05%,ATP1A2;ADM;SCN3B;APLN
prerank,axon extension (GO:0048675),0.4013562991892322,1.054420349835687,0.38533834586466165,0.8294599558814324,1.0,2/23,0.61%,ALCAM;AUTS2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3987131981685516,1.0543671453460295,0.3954802259887006,0.8286421194115267,1.0,4/26,8.62%,FBN1;HOXA7;LRRC17;FSTL3
prerank,regulation of lymphocyte migration (GO:2000401),-0.446905788395513,-1.0542924013018102,0.4438305709023941,0.7126754820181178,1.0,2/10,1.66%,MSN;JAM2
prerank,positive regulation of filopodium assembly (GO:0051491),0.3948677242538402,1.0542318579072316,0.38235294117647056,0.8280569704475944,1.0,4/24,5.21%,DOCK11;DPYSL3;RIPOR2;WASL
prerank,synaptic vesicle endocytosis (GO:0048488),-0.3369809961346132,-1.0541823058304052,0.37662337662337664,0.7122523131265305,1.0,13/33,18.94%,DNM3;STON2;SYNJ1;STX1A;ITSN2;DNM2;AMPH;DNM1;CANX;PIP5K1C;SYT2;CDK5;SNAP91
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.45716203071393874,1.0540745189206535,0.40756302521008403,0.826570788863506,1.0,1/12,1.02%,FHL2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.45716203071393874,1.0540745189206535,0.40756302521008403,0.826570788863506,1.0,1/12,1.02%,FHL2
prerank,regulation of calcium ion import (GO:0090279),-0.3760080279558858,-1.0539892637932065,0.3946830265848671,0.7120234870897807,1.0,9/21,26.33%,FYN;CTNNB1;WNK3;SLC30A1;CXCL12;PLN;TRIM27;SPHK2;CCL2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.34178414854944794,1.0539419687959646,0.3675675675675676,0.8259764025714657,1.0,6/51,4.50%,ROCK2;TPM1;LPAR1;FHOD1;CCN2;PPM1E
prerank,ephrin receptor signaling pathway (GO:0048013),0.3154609898915791,1.0532319554911003,0.38102893890675243,0.8269669971907175,1.0,9/82,5.21%,EPHA7;ROCK2;EPHA3;EFNB2;SDC2;EPHA8;MMP2;EPHA4;WASL
prerank,regulation of astrocyte differentiation (GO:0048710),-0.43816328555881773,-1.0530743467055572,0.4148296593186373,0.713725282336455,1.0,6/12,17.66%,NOTCH1;SERPINE2;HES1;BMP2;BIN1;ID2
prerank,negative regulation of response to wounding (GO:1903035),-0.37569613282649145,-1.0529145974556144,0.3962655601659751,0.7134536290192582,1.0,8/19,21.35%,RTN4RL1;CD109;AJAP1;CRK;GIT1;CASK;INPP5F;RTN4R
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.26857594848728594,-1.0526833793098371,0.3333333333333333,0.7133615299651078,1.0,30/101,24.30%,MEF2C;LBP;DAB2IP;VIM;CHMP5;TGFB1;SBNO2;TNFRSF1B;DEFA6;PDCD4;RHOA;MAPK8;XBP1;CD180;GIT1;CX3CR1;CARD16;CD274;PRKCE;ZC3H12A;ADAM9;IRAK1;MYD88;NR1H3;CASP1;TNFAIP3;PLAA;RELA;CD80;CD68
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.31403596554044916,-1.0521056672992308,0.3870246085011186,0.7141767594216424,1.0,14/42,29.61%,WARS2;LARS2;WARS1;SARS1;YARS1;IARS1;NARS1;EEF1E1;FARSA;AARS2;CARS1;KARS1;MARS2;GARS1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.3731469566008594,-1.0520593883536733,0.39711934156378603,0.7136047879287256,1.0,9/21,17.56%,NDST3;HS3ST4;HS6ST2;EXT1;EXTL3;XYLT1;GPC1;HS6ST3;HS3ST5
prerank,cardiac muscle cell development (GO:0055013),0.4101456045985021,1.0518401505058197,0.3754716981132076,0.8297232976472593,1.0,5/20,4.40%,CSRP3;PDGFRB;SLC8A1;OBSL1;PDGFRA
prerank,ESCRT complex disassembly (GO:1904896),-0.4593948053523036,-1.0517089712142274,0.42105263157894735,0.7131102355710087,1.0,7/10,35.03%,CHMP5;CHMP2B;CHMP1B;CHMP1A;CHMP7;VPS4B;IST1
prerank,ESCRT III complex disassembly (GO:1904903),-0.4593948053523036,-1.0517089712142274,0.42105263157894735,0.7131102355710087,1.0,7/10,35.03%,CHMP5;CHMP2B;CHMP1B;CHMP1A;CHMP7;VPS4B;IST1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.3147093927537976,-1.0512530965979443,0.39036144578313253,0.7136398518381293,1.0,17/50,22.01%,THBS1;GAS6;KLF4;NGF;CD44;VEGFA;PAK2;PIH1D1;RPS6KA1;RNF34;MT3;CARD16;RAF1;ARL6IP1;PLAUR;AKT1;CDKN2D
prerank,pre-replicative complex assembly (GO:0036388),-0.2922767099464678,-1.0511160424801673,0.35207823960880197,0.7133093419781049,1.0,17/64,17.26%,UBB;RPS27A;UBC;PSMD13;PSMF1;PSMB10;PSMB6;PSME3;PSMB5;PSMC3;MCM4;PSMD12;PSMB8;PSME1;UBA52;PSMB3;MCM8
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.423252557179834,-1.0510797899990019,0.412,0.7127398655625562,1.0,3/13,9.42%,STX7;CYRIB;PVR
prerank,T cell proliferation (GO:0042098),-0.41580655066816996,-1.0509957753124703,0.42685370741482964,0.7122916925047936,1.0,3/13,9.62%,CADM1;MSN;LMBR1L
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.38655760351398766,1.0508929855652283,0.41398865784499056,0.8313021754946083,1.0,6/26,8.16%,ATP1B3;NEDD4;ANK2;CACNA1D;DLG1;WWP2
prerank,glutamate metabolic process (GO:0006536),-0.3786341307841523,-1.0508486352557047,0.4080808080808081,0.7119814814820217,1.0,4/19,12.48%,GLS;GCLM;ALDH18A1;GAD1
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.39275450617368074,-1.0508231690438672,0.3894523326572008,0.7113724232889405,1.0,4/18,6.19%,MSN;HSP90AA1;DAB2IP;FAF1
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.30280374909624935,-1.0507403221832516,0.3569682151589242,0.7109162223267145,1.0,19/57,23.79%,KDR;FBXO7;PPARGC1A;TNFSF10;CAMKK2;GSK3B;HIP1R;MIEF1;GPER1;BBC3;MIEF2;SPIRE1;PLAUR;PINK1;DCN;BIK;BMF;CHCHD10;BAX
prerank,T cell activation (GO:0042110),0.31919610187637343,1.0499600323493863,0.3631484794275492,0.8328658279056964,1.0,5/69,2.65%,LEPR;KIT;JAML;KIF13B;CTPS1
prerank,regulation of superoxide anion generation (GO:0032928),-0.4160139386299885,-1.049803354727534,0.39341085271317827,0.712631396646711,1.0,7/14,37.54%,TGFB1;SOD1;TYROBP;PRKCD;ITGB2;SYK;CRP
prerank,regulation of intracellular signal transduction (GO:1902531),0.2560513851166121,1.0494697763302931,0.3445692883895131,0.8331789154771895,1.0,47/420,8.73%,ARHGAP28;PRKAG2;ARHGAP24;ARHGAP6;GMIP;PTPN13;ARHGAP29;NRK;FGD4;PRKAG3;PDPK1;RHOD;ARHGAP20;AKAP7;SYDE2;ATRIP;ARAF;MAP2K6;RBBP4;ARHGAP26;SOS2;AKAP13;ARHGAP12;ZFAND6;RICTOR;PRKAA2;UFL1;ARHGAP40;LRRK2;FGF1;ARHGEF11;DLG1;WWC1;RBBP7;WWC2;BANP;OPTN;ARHGAP35;BLM;CHD4;PTEN;PRKAA1;ARHGAP9;MYO9B;GPR143;USP7;CDK1
prerank,central nervous system neuron differentiation (GO:0021953),-0.3328563456461618,-1.0493479563067631,0.3669527896995708,0.7130886212044684,1.0,13/33,30.77%,SOX4;CTNNB1;MDGA2;SPOCK1;NR4A2;KNDC1;TOX;GRID2;NPY;AGTPBP1;LMX1A;FAIM2;SIN3A
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.27320089058097197,-1.0491546894610966,0.36962750716332377,0.7129176984291457,1.0,17/93,8.27%,MAP3K5;RASSF2;TGFB2;ANKRD6;PTK2B;DAB2IP;MID1;MINK1;SH3RF3;TPD52L1;EMC10;APP;FLT4;PDCD10;VEGFA;STK25;WNT16
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.21872899884629335,-1.049034517835549,0.2727272727272727,0.7125304547251713,1.0,139/532,20.46%,FN1;PTPRJ;TMSB4X;ADIPOR2;B2M;ACTN4;MSN;IL33;HSPA8;LIFR;RPS6KA5;MAOA;TNFRSF11B;STX3;HSP90AA1;CBL;F3;ITGB1;LBP;FYN;PTK2B;MID1;VIM;INPP5D;ACKR3;UBB;NFKBIA;S1PR1;PPIA;NOD1;LIMS1;SOCS2;STX1A;LAMA5;IKBKB;TGFB1;EDA;TRIM25;CD44;HSP90B1;SOD1;ST18;BCL2L1;SOCS5;IL1R1;RPS27A;UBC;TNFRSF11A;LRP8;MT2A;CEACAM1;CSK;TNFRSF1B;ARF1;PDCD4;CARD14;VEGFA;BIRC3;IL1RAP;FOXO1;PSMD13;AIM2;PSMF1;PTGS2;APPL1;COMMD7;PAK2;RBX1;RPLP0;TALDO1;ADAR;PSMB10;PIK3CD;CDKN1B;CHUK;ISG15;STAT3;CRK;IFI35;PSMB6;TOLLIP;IL1RL2;PSME3;JUNB;PSMB5;MAP3K3;OAS2;RSAD2;CANX;PSMC3;IRAK3;PSMD12;PSMB8;CUL1;MAP3K8;IL17RE;HNRNPDL;TAB3;MT3;INPPL1;IFNGR1;CSNK2B;TRAF1;CSF1R;PSME1;CAMK2B;CXCL12;UBA52;IL20RB;FLT3;PSMB3;CISH;RPS6KA4;MIF;IL18BP;SOX2;CD40;CCL13;IL15;EIF5A;IRAK1;IL4R;IRF5;SH2B3;PITPNA;BST2;SPI1;JAK3;PSMD5;MYD88;SLA;JAK1;HSPA9;IFITM3;PRKCD;CFL1;AKT1;SKP1;CSF3R
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.30252648533948645,-1.0490156670364927,0.35523114355231145,0.7118884398968499,1.0,8/52,6.77%,SPTBN1;PRKCH;EPB41;STX3;ITGB1;NKD2;GNAI1;WNK3
prerank,outflow tract septum morphogenesis (GO:0003148),0.3903760382947042,1.0485811897907247,0.39399624765478425,0.8346938083962449,1.0,4/24,5.73%,ROBO1;FGFR2;SMAD6;LRP2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.389629946209984,-1.048444691152287,0.39271255060728744,0.7127591754458186,1.0,11/18,28.70%,MSN;HSP90AA1;FAF1;CD81;ATP5IF1;VPS11;ABCA2;CTSC;PTTG1IP;EZR;RNF128
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.3828738869319192,-1.0478178583300755,0.40836653386454186,0.7136820092017775,1.0,6/18,20.09%,SEC14L1;RNF125;PUM2;BIRC3;GPATCH3;NOP53
prerank,skeletal muscle organ development (GO:0060538),-0.34704988039987555,-1.047735136127277,0.3724137931034483,0.7131902251518766,1.0,5/26,6.87%,MEF2C;CAV1;MYL6;STRA6;SIX1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.3539825484808271,-1.0476655958955459,0.38146551724137934,0.712693058078086,1.0,7/26,11.33%,EEF1A1;IQGAP1;PDE8A;DAB2IP;PTPN12;ZFP36L1;DUSP3
prerank,DNA replication initiation (GO:0006270),-0.3282811782225786,-1.0474718080631742,0.3797752808988764,0.7125236357952738,1.0,20/37,36.86%,RPA1;MCM4;TOPBP1;PRIM1;MCM8;POLA1;CDK2;POLE4;POLE;MCM5;MCM10;POLE3;ORC1;RPA3;MCM6;GMNN;CDC6;RPA2;CDC7;CDC34
prerank,regulation of melanin biosynthetic process (GO:0048021),0.4800916532140864,1.0474058593690745,0.3940677966101695,0.8368716713498725,1.0,1/10,1.49%,ZEB2
prerank,synaptic vesicle membrane organization (GO:0048499),-0.3940974597359621,-1.047005193973439,0.39921722113502933,0.7130673731831234,1.0,6/17,26.09%,STX3;STX1A;SNAP25;STX2;SYP;SYNGR2
prerank,inorganic ion transmembrane transport (GO:0098660),-0.43048147517781254,-1.0467049474413481,0.42166344294003866,0.7131454464325374,1.0,4/12,18.75%,ABCC9;CACNA1H;KCNJ8;TRPM4
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.4133073025975106,-1.0463424281665992,0.4069767441860465,0.7133889356784747,1.0,4/15,7.18%,KDR;PTK2B;BMX;AATK
prerank,sulfur compound biosynthetic process (GO:0044272),0.2992931953796035,1.0462220556692776,0.36477987421383645,0.8390476223364906,1.0,13/104,5.86%,ANGPT1;ST3GAL3;FMOD;UST;CBS;OGN;GSTM2;OMD;B4GALT1;GSTT1;PRELP;CHSY1;CHST3
prerank,regulation of hormone secretion (GO:0046883),0.4379545795788917,1.0460262159862184,0.386317907444668,0.8386381018351272,1.0,2/15,3.48%,SNX6;ANXA1
prerank,dendritic spine morphogenesis (GO:0060997),-0.40821136891214643,-1.045632082629167,0.4035433070866142,0.71451658261945,1.0,3/15,3.75%,SHANK3;CTNND2;DOCK10
prerank,folic acid-containing compound metabolic process (GO:0006760),0.40905061028204054,1.0454166868090526,0.4127906976744186,0.8393691537616593,1.0,7/19,20.01%,MTHFR;FOLR2;SLC19A1;SHMT1;MTHFS;DHFR;MTHFD2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.39202681719835886,-1.0450107245538396,0.41505791505791506,0.7154151537011328,1.0,3/16,9.42%,CADM1;LAMP1;PVR
prerank,regulation of nuclear division (GO:0051783),0.4040594891108372,1.044873504824024,0.39723320158102765,0.8398381537612819,1.0,4/20,8.85%,OBSL1;CCDC8;CUL9;CUL7
prerank,regulation of cellular component movement (GO:0051270),0.33438849159267015,1.0447364786651816,0.40484429065743943,0.8392356514036675,1.0,4/49,3.58%,TGFBR3;ROCK2;SP100;PDPN
prerank,Fc receptor signaling pathway (GO:0038093),-0.2669819779694719,-1.0446398387310267,0.35967302452316074,0.7156537413230646,1.0,36/110,23.57%,RAC1;CALM1;PLCG2;IKBKB;NFATC2;NFATC1;JUN;PAK1;PSMD13;PSMF1;MAPK8;PAK2;MAP3K1;PSMB10;CHUK;MAP2K7;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PPP3CA;CUL1;TAB3;PSME1;PSMB3;PPP3R1;NFATC3;PSMD5;SKP1;MAPK3;PSMD9;PSMB4;RELA;MAPK10
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.41262880493914833,-1.0445842046830596,0.4084507042253521,0.7150995309925386,1.0,6/13,27.20%,STAT3;OAS2;CANX;JAK1;STAT1;OASL
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.2527955622646266,1.0443443178556127,0.34647550776583036,0.8393151181135922,1.0,47/509,6.76%,IGF1;ROCK2;SASH1;WLS;ADGRV1;TCF7L2;OSBPL8;KSR1;FGFR2;FGFR4;IL18;KIT;ANGPT1;PRKN;PELI2;LPAR1;PDPK1;BCL2;FNIP1;LTF;PDGFRB;KL;ECM1;NOS1AP;TRIM5;IGF2;NEDD4;EPHA8;NFAT5;GFRAL;PDGFRA;SPHK1;AKAP13;GJA1;RICTOR;PDGFD;IGF1R;FGF1;SLC38A9;DDX60;LRP2;PRKCB;FRS2;CXXC5;WWC1;ADRA1D;IL6
prerank,sulfur compound transport (GO:0072348),0.3864780754118935,1.0439803218806794,0.4007352941176471,0.8393196760841648,1.0,7/27,10.43%,SLC6A13;SLC13A4;SLC35F3;SLC25A11;SLC27A1;SLC19A2;SLC13A1
prerank,phagosome-lysosome fusion (GO:0090385),-0.44873669228352886,-1.0436114047009875,0.41589648798521256,0.7169524763231142,1.0,7/10,38.01%,SYT7;RAB39A;RAB7A;RAB7B;RAB20;PLA2G5;CLN3
prerank,cellular response to amino acid starvation (GO:0034198),-0.2819780465416737,-1.043538191092437,0.3795811518324607,0.7164626914857625,1.0,33/71,27.04%,MAP3K5;SESN3;SH3GLB1;DAPL1;MTOR;MAPK8;SESN2;ATP6V1A;ATP6V0C;WDR59;ATF4;LAMTOR1;RHEB;TCIRG1;ATP6V1E1;DAP;FAS;LAMTOR2;PRKD1;ITFG2;RRAGB;ATP6V0D2;MAPK3;CDKN1A;LAMTOR4;DEPDC5;CEBPB;ATP6V0E2;CASTOR1;ATP6V1B2;WDR24;ATP6V1H;RPTOR
prerank,keratan sulfate metabolic process (GO:0042339),0.3709489572271866,1.0434677155503438,0.40176991150442476,0.8397150466757188,1.0,6/31,5.37%,ST3GAL3;FMOD;OGN;OMD;B4GALT1;PRELP
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4234832954623089,1.0431807688032,0.4215885947046843,0.8395576007884613,1.0,3/18,6.51%,BCL2;SLC25A31;BNIP3
prerank,receptor catabolic process (GO:0032801),0.392269858220647,1.043032462637796,0.4230055658627087,0.8390292064904803,1.0,6/24,9.09%,RNF43;NEDD4;PCSK9;ZNRF3;PIK3R4;UVRAG
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.42419652100557237,-1.0425825395505195,0.4397590361445783,0.7181401770671534,1.0,5/14,28.55%,GAS6;NLRP2B;CARD16;TRAIP;GPS2
prerank,response to UV (GO:0009411),-0.2654449301236733,-1.0424932055678795,0.34986945169712796,0.717739642000937,1.0,33/95,28.21%,RPL26;UVSSA;MAPK8;UBE2B;BCL3;MAP2K7;ATF4;MFAP4;MEN1;MSH2;ERCC8;SDF4;COPS9;POLK;USP28;N4BP1;SPRTN;ATR;PRKCD;AKT1;NOC2L;METTL3;FMR1;CDKN2D;BMF;POLD1;RELA;GTF2H2;DTL;XPA;ERCC5;CAT;TMEM161A
prerank,negative regulation of centrosome duplication (GO:0010826),-0.44078894645655076,-1.042474771857944,0.437137330754352,0.7171247647045682,1.0,7/11,41.68%,MDM1;RBM14;CCNF;NPM1;TMEM67;KAT2A;CENATAC
prerank,lysosome localization (GO:0032418),-0.32459895650022746,-1.0419480063363344,0.40540540540540543,0.7177982874038228,1.0,20/37,31.89%,MAP6;BLOC1S2;MYH9;PIK3CD;LAMTOR1;CHGA;PLEKHM1;SPAG9;HDAC6;S100A13;RAB3A;SYTL4;MILR1;BORCS6;KLC2;SNAPIN;VPS33B;HPS6;NR4A3;KIF5B
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.30353287506438564,1.041788453966127,0.3782894736842105,0.84138334871125,1.0,3/84,1.37%,IGF1;IGF2BP1;DAPK1
prerank,organelle organization (GO:0006996),-0.22477533184563317,-1.0412888482145104,0.2882882882882883,0.7188719314429569,1.0,119/388,25.57%,FMNL2;FGD5;CAV1;ATP8B1;SYNE1;FGD6;NOS3;SEMA6A;MICAL2;SH3KBP1;FNBP1L;PPARGC1A;ARAP3;CAV2;RAB31;STX7;PPIA;SIPA1L3;CXADR;PACSIN2;REEP5;CHMP5;LYSMD3;CHMP2B;CHCHD2;VPS13C;VMP1;TMED5;TFB2M;RHOT1;ZRANB1;SMPD4;TMED2;MICAL1;MARK1;TOR1B;RAB38;LIMD1;LMAN2;SPRYD3;YTHDF3;RAB1A;NSFL1C;PCLO;STOML2;ABCD3;BIN1;CHGA;VPS18;BNIP1;MAST3;LMAN2L;PPRC1;ABCD2;TMED10;MIEF2;SIRT4;TMED3;NEDD9;MTX3;FMNL3;MSTO1;BRWD3;ODF2;ATL2;DIAPH3;PRKD1;TRIP11;GBF1;VPS11;PEX1;ABCA3;PEX11B;BSCL2;AUP1;SEC16B;CCL13;CHMP1B;ABCD4;VPS51;ATP5F1B;PITPNB;LIG4;VPS13D;PINK1;SPTSSB;IRAG2;THY1;MREG;CFL1;CHMP1A;NUMA1;PAK5;ARHGAP10;CYCS;VAPA;MAST1;CHMP3;TNFAIP3;BCS1L;PEX10;SIPA1;CHMP7;CLASP2;TMED7;RAB7A;CHCHD10;PDCD6IP;GEM;HUWE1;RAB2A;KIF4A;PEX16;CDC42BPB;RAB14;CAMSAP1;TMEM135;SEC16A;MCOLN1
prerank,neutrophil migration (GO:1990266),-0.2961707222655579,-1.0412641215242076,0.3732394366197183,0.7182701503262282,1.0,8/58,10.16%,PECAM1;BSG;TGFB2;PPIA;CXADR;EDN1;PPIB;PIK3CD
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.4021595306433805,1.041250689740983,0.39768339768339767,0.8418932196264172,1.0,4/22,9.48%,DMD;NOS1AP;CACNB4;GNB5
prerank,calcium ion import (GO:0070509),-0.3419446668247903,-1.0412178493062239,0.41870824053452116,0.7177357406227552,1.0,11/28,16.38%,CACNA1G;CACNA1E;ATP2A2;TRPC4;SMDT1;CACNA1H;CACNA1C;CACNB2;MCUB;CACNA1I;CACNA1B
prerank,protein acetylation (GO:0006473),0.37051382351661405,1.0412059900515465,0.3948339483394834,0.8410516527888443,1.0,12/30,21.84%,NAA80;SPHK1;AANAT;NAA35;NAA60;ESCO1;CLOCK;CREBBP;DSCC1;KAT2B;KAT5;NAA50
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.4451083525333858,1.04119623774987,0.43004115226337447,0.840117287302196,1.0,4/14,13.59%,MRNIP;WDR48;ARID2;FANCB
prerank,negative regulation of gene expression (GO:0010629),0.2598599434774814,1.0410845554082697,0.3627844712182062,0.8394493492865168,1.0,37/302,11.28%,IGF1;ROBO1;SLC24A3;ROCK2;WNT4;LGR4;NOTCH2;IGF2BP1;DAPK1;PRKN;RBMS3;JARID2;PTBP2;SYT11;RBBP4;TNRC6B;PRKAA2;TNRC6A;SLC2A10;RBBP7;TYMS;ABCC2;PRKAA1;MTF2;RBL2;WWP2;YTHDF2;PICALM;PARP10;SAMD4A;AGO2;PARP9;ATOH8;HDAC1;FLCN;APLN;FXR1
prerank,nuclear membrane organization (GO:0071763),-0.3837717838527404,-1.0409131922846722,0.42213114754098363,0.7178094311845281,1.0,5/19,11.93%,TARDBP;TOR1B;TMEM43;NSFL1C;GPER1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.35709280845796515,-1.0407984826822632,0.38755020080321284,0.7174252339932843,1.0,8/24,13.96%,KLF2;NOTCH1;CREB3L1;VEGFA;SESN2;HSPA5;ATF4;MT3
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2864042829435966,1.0407298053236724,0.3858267716535433,0.8394372721269545,1.0,21/122,12.50%,IGF1;FGFR4;SMOC2;SLC6A9;SORBS1;PDGFRB;IGF2;PLD1;IL6;CCL19;SAMD4A;PRKDC;RPS6KB1;METTL14;NPM2;JAK2;FXR1;ERBB2;LARP6;PRKD2;AR
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.31216244932542353,-1.0405539512952096,0.36065573770491804,0.717409261879942,1.0,17/46,26.16%,MSN;PPIA;SOD1;ARF1;PDCD4;PAK2;RPLP0;TALDO1;HNRNPDL;MIF;PITPNA;JAK1;HSPA9;CFL1;CAPZA1;HNRNPF;IL12RB2
prerank,hydrogen peroxide catabolic process (GO:0042744),0.4714253792435955,1.0405346071596255,0.40080160320641284,0.8390425051561999,1.0,1/11,2.38%,PXDN
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3786181094880085,1.0403575538572398,0.4155597722960152,0.8385522961226702,1.0,8/26,21.65%,KMT2A;SETD1A;SETD2;CTR9;WDR82;SETD4;BEND3;TET3
prerank,mesenchymal cell development (GO:0014031),-0.3892756972859283,-1.040261673174564,0.4109311740890688,0.7175026462957663,1.0,10/18,33.49%,CDH2;NOTCH1;HEY2;HEYL;NOLC1;SOX11;SNAI2;PEF1;TBX20;KBTBD8
prerank,positive regulation of developmental process (GO:0051094),0.27913207377789573,1.0401426741322284,0.375,0.8381461214526803,1.0,29/164,12.83%,SOX5;BMP7;PRKN;ADGRL1;CCN2;SCX;SOX6;PLCB1;GRIP1;FOXD1;GJA1;PTN;PHLDB2;NIBAN2;BNIP3;ENPP2;NCOA3;MCU;DVL3;AGO2;SMURF2;COBL;NEUROD2;DLG4;BMPR1A;RBM19;AR;RAPGEF3;GDNF
prerank,regulation of phagocytosis (GO:0050764),-0.3023123751592145,-1.0400097794401446,0.37220843672456577,0.717497966927217,1.0,11/53,10.49%,GAS6;SCARB1;RACK1;RAB27A;TGM2;GATA2;CALR;DOCK2;PTPRC;DYSF;LMAN2
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.3053011649101414,-1.0397804980197507,0.39663461538461536,0.71741814402105,1.0,23/51,33.86%,HSPB1;APP;AIM2;STAT3;GBP5;USP50;PANX1;TMED10;CASP8;MYD88;TYROBP;S100A13;CASP1;AGER;NLRC4;TLR4;LPL;CD36;IL16;TLR6;NOD2;P2RX7;NLRP3
prerank,receptor recycling (GO:0001881),0.46797695530463607,1.0397456523589068,0.407098121085595,0.8382501035628743,1.0,5/10,14.67%,PLEKHJ1;REP15;ARFGEF2;PHETA1;RAB11B
prerank,stress granule assembly (GO:0034063),-0.36170025654789134,-1.0394953264466187,0.4054621848739496,0.7175410892328351,1.0,5/20,16.43%,RPS23;G3BP1;ATXN2L;YTHDF3;BICD1
prerank,negative regulation of transport (GO:0051051),0.32816639790080293,1.0393152759837931,0.379073756432247,0.8384876540365581,1.0,10/51,12.63%,EPHA3;PRKN;SYT11;SNX33;PTEN;WWP2;SIRPA;RUBCN;SNX12;PACSIN3
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.4325803371514093,-1.0392930078275553,0.44,0.7173976634985311,1.0,7/12,34.32%,SIX1;VEGFA;SIX4;PAX8;AGT;NOG;PAX2
prerank,regulation of isotype switching (GO:0045191),-0.42172029916487525,-1.039152773931338,0.3992673992673993,0.7171005061950737,1.0,10/14,46.31%,TFRC;KMT5C;SHLD3;SLC15A4;RIF1;SHLD2;KMT5B;IL4;MAD2L2;PARP3
prerank,icosanoid biosynthetic process (GO:0046456),-0.4505621284537128,-1.0385591892555304,0.425891181988743,0.7179249787043628,1.0,7/10,44.77%,PLA2G4A;LTA4H;PLA2G5;ALOX5AP;MGST2;FADS1;LTC4S
prerank,vesicle transport along actin filament (GO:0030050),-0.3857154285178437,-1.0384991840261544,0.41478439425051333,0.7174362545758973,1.0,3/19,2.00%,MYO1D;ACTN4;FNBP1L
prerank,C-terminal protein amino acid modification (GO:0018410),-0.4405494729535999,-1.0382493100723078,0.4095238095238095,0.7173927614781976,1.0,4/11,28.41%,ATG7;TTL;ICMT;AGTPBP1
prerank,regulation of response to external stimulus (GO:0032101),0.2913907985562044,1.0380708639008416,0.375,0.8408171962413358,1.0,15/121,7.98%,ADAMTS12;APPL2;EFNB2;NMT2;TRIM5;ANXA1;LACC1;PDGFRA;UFL1;CASP12;PDE6G;SETD6;CAMKMT;DAGLB;RNF135
prerank,regulation of secretion by cell (GO:1903530),-0.29695458957740073,-1.0379906111756279,0.37468354430379747,0.7173974231003825,1.0,25/54,31.08%,MEF2C;NSF;RAB3C;MCTP1;VAMP8;SCG5;RHBDF2;DNAJC1;KCNMB4;RAB3B;CPLX2;FMR1;RAB8A;RAB8B;RAB3A;LGI3;DISP1;CPLX1;HAP1;ARFIP1;VAMP3;RIMS2;SYT1;STXBP5L;RAB15
prerank,neuron projection development (GO:0031175),-0.2444316340056784,-1.0378985211764884,0.34394904458598724,0.7169422063266438,1.0,25/168,8.40%,FRY;SHANK3;PTPRM;TRIO;STX3;CTNND2;PLP1;GRM7;MAP4;DAB2IP;NGF;UBB;DOCK10;MINK1;SHTN1;NCKAP1;BLOC1S2;EHD1;GSK3B;GPM6B;STMN2;DNM2;APP;MYOC;PAK1
prerank,cellular response to interleukin-12 (GO:0071349),-0.30847129441163174,-1.0377101658814516,0.391304347826087,0.7167338835999403,1.0,15/48,20.20%,MSN;PPIA;SOD1;ARF1;PDCD4;PAK2;RPLP0;TALDO1;HNRNPDL;CD47;MIF;PITPNA;JAK1;HSPA9;CFL1
prerank,phosphorylation (GO:0016310),0.2540834522331674,1.037473063158603,0.3606770833333333,0.841403916228384,1.0,71/385,14.24%,PRKAG2;EPHA7;ROCK2;OXSR1;NRK;WNK4;CDK8;DAPK1;PRKAG3;PDPK1;PDK1;BMP2K;RNASEL;DMPK;FER;MAP4K5;CDK7;FAM20A;SRPK2;SPHK1;MAPK9;SIK1;PRKAA2;LRRK2;PRKCZ;PRKCB;MAML1;STK17B;PRKCA;GRK3;PRKAA1;NEK4;NRBP1;RYK;BIRC5;GRK5;BIRC6;CCNT1;PKN2;CDK1;CAMK2D;PIK3R4;NEK10;GRK4;VRK2;LATS1;FRK;ABL1;PRKDC;JAK2;COQ8B;ERBB2;IKBKE;BMPR1A;MAPKAPK2;PRKAG1;HIPK3;CCNE1;PRKD2;STK24;TBK1;ROS1;MAPK1;DCLK1;PRKACB;MORC3;STK26;NIM1K;CDKL5;NLK;CDK15
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4404521159760085,1.0372775279862194,0.42061855670103093,0.8409662768512407,1.0,4/16,10.08%,LHPP;AMPD3;ADSL;GMPS
prerank,nervous system development (GO:0007399),0.2544060114923624,1.0372523820200001,0.3476658476658477,0.8400812165238806,1.0,38/429,5.47%,ALDH1A2;ROBO1;ADGRV1;SDK1;ARNT2;ZIC1;NOTCH2;IGF2BP1;PRKN;ATXN1;ZEB2;LPAR1;NLGN2;IGSF8;ZIC2;SZT2;PCDHA3;B3GNT5;SOX6;FAT4;INTU;AVIL;JARID2;ZIC5;CNTFR;PCSK9;ARTN;OBSL1;GFRAL;PAFAH1B3;ARHGAP26;TEAD1;IGFN1;NRSN2;NDP;DPF2;PMP22;TPP1
prerank,positive regulation of neurogenesis (GO:0050769),0.3115076893575792,1.0371439412836279,0.3694915254237288,0.8394317496608419,1.0,8/68,7.00%,PLXNA2;ROBO1;CUX1;IL1RAPL1;OBSL1;PLXNC1;LRP2;PTPRD
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.33201729835949545,-1.0371158239674694,0.38636363636363635,0.7176143493323431,1.0,7/33,9.17%,ESR1;RUNX1;CBFB;CALR;KDM4C;DDX5;H3-3A
prerank,positive regulation of autophagy (GO:0010508),0.3054120708303634,1.0370817276690416,0.3793103448275862,0.8386427270147541,1.0,22/81,16.62%,DAPK1;PRKN;TRIM5;SESN1;PRKAA2;UFL1;NPRL2;LRRK2;BNIP3;OPTN;RNF152;PRKAA1;EPM2A;PLEKHF1;FLCN;GPSM1;TBK1;MAP3K7;MTDH;RUFY4;LARP1;IRGM
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.43353060998311665,-1.03683792792215,0.42095238095238097,0.7176422313662687,1.0,5/11,22.43%,ITM2B;ITM2A;ITM2C;ABCA2;NECAB3
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.4022317526842462,1.0368282490567884,0.40310077519379844,0.8384108043114128,1.0,2/20,1.82%,PID1;DAB2
prerank,mRNA splice site selection (GO:0006376),0.3706252853656133,1.0365804857880876,0.4195933456561922,0.8381389128842003,1.0,4/30,8.29%,CELF2;NOL3;SLU7;SF3A3
prerank,cellular potassium ion homeostasis (GO:0030007),0.4410208613497816,1.0359854964514743,0.4270833333333333,0.8387321199106239,1.0,2/13,2.26%,ATP1A2;ATP1B3
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.33541560707854157,-1.035785020574229,0.4074074074074074,0.7196850801002342,1.0,10/31,17.99%,KCNB1;STX1A;CACNA1G;CACNA1H;SYT10;REST;SYT4;CACNA1I;SYT2;SYT7
prerank,negative regulation of histone modification (GO:0031057),0.44598507618466504,1.0356736806062607,0.44654088050314467,0.8386079326136777,1.0,2/14,3.15%,AASS;JARID2
prerank,mitochondrial fission (GO:0000266),-0.397559553871778,-1.0353074940578535,0.405189620758483,0.7202359336848193,1.0,4/16,11.96%,DNM3;DNM2;MIEF1;DNM1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.4416082952293665,-1.0349197890736959,0.41467889908256883,0.7205906450117033,1.0,8/10,34.19%,MYD88;AKT1;CD68;TREM2;TLR4;CD36;TLR6;TICAM1
prerank,central nervous system development (GO:0007417),0.2653654447260147,1.0344404510450975,0.38992042440318303,0.8408507525945305,1.0,26/250,7.48%,EPHA7;AFF2;ARNT2;SLC8A3;ZIC1;PRKN;ATXN1;MEIS1;ZIC2;SZT2;B3GNT5;SOX6;SHROOM2;LOXL3;JARID2;ZIC5;PAFAH1B3;NFIB;ZFHX2;TPP1;SYNJ2;PHF8;SETD1A;AMIGO3;PBX4;PTEN
prerank,negative chemotaxis (GO:0050919),0.35958314555285736,1.0342522025442686,0.3951473136915078,0.8404322400447165,1.0,3/33,2.39%,EPHA7;ROBO1;SEMA3B
prerank,protein stabilization (GO:0050821),-0.2500712253105712,-1.0340200103534363,0.34824281150159747,0.7222028130682314,1.0,39/168,13.96%,HIP1;RASSF2;RPL11;HSP90AA1;RPL23;HSP90AB1;PPARGC1A;RPS7;ATP1B1;SOX17;FLNA;SOX4;PDCL3;CALR;BAG6;CDC37;RPL5;CHP1;GAPDH;HIP1R;PDCD10;BAG1;CRYAB;GOLGA7;LAMP1;CHEK2;GRN;UBE2B;PPIB;RTN4;HYPK;STX12;CAMLG;HSPD1;CLU;OTUD3;CDC37L1;MTMR9;MT3
prerank,cGMP metabolic process (GO:0046068),-0.4318800135277391,-1.0339213172693318,0.4312977099236641,0.7217911751989415,1.0,3/12,7.28%,GUCY1B1;GUCY1A1;PDE2A
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.38359752874282627,1.0334372230926978,0.4094488188976378,0.8416171437498896,1.0,12/25,24.83%,SLU7;SF3A3;DDX23;PRPF3;SCAF11;DBR1;SNRNP40;PRPF6;LSM1;SF3B3;KHSRP;SRRM1
prerank,negative regulation of protein metabolic process (GO:0051248),-0.3026718342793345,-1.0328303726758017,0.4067796610169492,0.7239263779497181,1.0,12/48,18.96%,HSP90AB1;FLNA;CRYAB;EDN1;AZIN1;CLU;IRAK3;CYP51A1;IAPP;PFDN6;PRKCG;PFDN5
prerank,negative regulation of blood pressure (GO:0045776),-0.4156271779006624,-1.0327944831348608,0.42913385826771655,0.7233681006151335,1.0,4/13,17.59%,NOS3;BMPR2;NOS1;PRCP
prerank,regulation of protein localization (GO:0032880),-0.2895753726655891,-1.032433408120587,0.41784037558685444,0.723620222262133,1.0,12/58,10.92%,HSP90AA1;HSP90AB1;RACK1;CTSD;RABGAP1L;TRIM14;TRIM25;STX6;MMD2;ZDHHC7;MAPK8;RSL1D1
prerank,positive regulation of lipid transport (GO:0032370),-0.41856480853641514,-1.0323779882670707,0.40977443609022557,0.7231097322710944,1.0,11/12,56.69%,SPP1;ABCA3;DBI;PRELID1;LRP1;ABCB4;TRIAP1;ABCA12;CYP19A1;PRAP1;ADIPOQ
prerank,positive regulation of immune system process (GO:0002684),-0.3920419107543892,-1.0320688224659431,0.4161849710982659,0.723198027507437,1.0,6/16,20.80%,TGFB2;VEGFA;PIK3CD;RSAD2;IL15;NCKAP1L
prerank,negative regulation of signaling (GO:0023057),-0.34846649732373863,-1.0318108549746994,0.40700218818380746,0.7231893003318007,1.0,6/25,10.70%,HHIP;AP1AR;UBASH3B;SOCS5;KIF26A;PTPN1
prerank,regulation of chromatin organization (GO:1902275),0.42655107825587085,1.0314593618845012,0.427734375,0.8459243815826127,1.0,3/14,6.29%,IGF2;METTL4;SETD1A
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.4226290486791183,1.031447656264984,0.4024390243902439,0.8450145112052387,1.0,3/16,5.24%,KLK2;ADM;ACE
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.32893166987932165,-1.031413574382219,0.4201312910284464,0.7234678897853986,1.0,13/36,22.77%,SGMS1;DAB2IP;RPS3;PPIA;TPD52L1;TRAF1;FAS;MADD;CX3CR1;NR4A2;TMBIM6;MAZ;MAPK8IP2
prerank,protein import into peroxisome matrix (GO:0016558),-0.4259534625033455,-1.031338092096826,0.4200743494423792,0.7230188045800554,1.0,6/12,29.54%,PEX5L;PEX1;PEX5;PEX10;PEX16;PEX13
prerank,regulation of inflammatory response (GO:0050727),0.27378745780570246,1.0312182669768601,0.38405797101449274,0.8446624517747656,1.0,19/190,7.58%,RORA;ADAMTS12;C1QTNF3;PPARA;IL18;SNX6;ANXA1;CCN4;LACC1;SPHK1;UFL1;GPSM3;CASP12;SETD6;NAPEPLD;IL6;MMP9;NLRC3;DAGLB
prerank,response to reactive oxygen species (GO:0000302),-0.29961106349293476,-1.0310650978778928,0.3945409429280397,0.7230313941114894,1.0,14/54,13.74%,APOD;FYN;RPS3;PXN;CAMKK2;SOD1;PDCD10;JUN;STK25;MAPK8;CHUK;PDK2;AGAP3;ROMO1
prerank,cholesterol metabolic process (GO:0008203),0.31323782599391453,1.0302350408168197,0.42078364565587734,0.8463153957194768,1.0,12/68,12.24%,CYP27A1;CEL;INSIG2;ABCA1;ABCA5;PMVK;ACAA2;SOAT2;ACAT2;FDPS;RXRA;GBA2
prerank,MAPK cascade (GO:0000165),0.2572423722917848,1.0301522356736132,0.39425587467362927,0.8455852975966085,1.0,23/295,6.48%,IL31RA;IGF1;KSR1;FGFR2;FGFR4;NRK;IL18;KIT;ANGPT1;NCAM1;PDGFRB;KL;CTSH;ARTN;ARAF;PDGFRA;PTPRA;LRRK2;FGF1;PSME4;FRS2;PSMA2;DLG1
prerank,organelle transport along microtubule (GO:0072384),-0.3319179312413495,-1.0300739187818744,0.41202672605790647,0.7248445359311427,1.0,7/31,16.43%,UBB;COPG1;RHOT1;RAB1A;NDE1;BICDL1;BICD1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.42755943076128367,1.0299677187185101,0.43584521384928715,0.8451717832054003,1.0,3/16,9.15%,APPL2;ACADL;APOC1
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.4221672854588833,-1.0297669400099378,0.4218455743879473,0.724973981949274,1.0,6/13,24.10%,NOTCH1;TGFB1;TBX3;BMP4;DLL1;EID2B
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.2975117727537202,-1.0295712921511906,0.3916849015317287,0.7248091587857235,1.0,13/53,14.90%,HSP90AB1;DAB2IP;UBB;PKD1;UCHL5;GNA12;TMF1;PSMF1;FOXF2;PSME3;UBQLN4;PSMC3;PSME1
prerank,positive regulation of binding (GO:0051099),-0.27276272873687163,-1.0294681500745135,0.38419618528610355,0.724422047339515,1.0,18/84,11.31%,CAV1;CLDN5;B2M;EPB41;TIAM1;RPL11;NGF;HES1;PKD1;GSK3B;MET;ADD2;HIP1R;APP;DERL1;RALB;BMP2;MEN1
prerank,response to laminar fluid shear stress (GO:0034616),-0.4461550369558584,-1.0294312123409075,0.4119922630560928,0.7238593264915317,1.0,3/10,3.12%,KLF2;KLF4;SREBF2
prerank,synaptic vesicle transport (GO:0048489),-0.4349275294401077,-1.0292313728905638,0.4446494464944649,0.7237479911448087,1.0,7/11,31.89%,RAB27A;SYNJ1;DNM2;CDK5;KIF5C;SNAPIN;KIF5B
prerank,positive regulation of lipid catabolic process (GO:0050996),0.41086173036879975,1.0289422536401114,0.42213114754098363,0.8469734826904687,1.0,2/19,7.58%,PPARA;DAGLB
prerank,establishment of protein localization to membrane (GO:0090150),0.31469769843677675,1.0288113059081974,0.4135702746365105,0.8463937332698664,1.0,19/66,17.78%,AFDN;PARD3;RAB3IP;SYNE3;ZDHHC1;ARL6;ZDHHC3;MICALL1;OXA1L;VPS37A;VPS37C;RAB3GAP1;PRKCI;RAB11B;ATG3;GRIN3B;VPS37D;SDCBP;TAOK2
prerank,fatty acid elongation (GO:0030497),-0.4176666418806388,-1.0286256228046806,0.441233140655106,0.7246577904002999,1.0,5/13,18.60%,ELOVL7;ELOVL5;ELOVL6;ELOVL1;TECR
prerank,cellular response to leucine starvation (GO:1990253),-0.4449514335949094,-1.0286215530146465,0.46387832699619774,0.7240204439455017,1.0,4/10,18.47%,SESN3;MTOR;SESN2;RRAGB
prerank,regulation of ion transmembrane transport (GO:0034765),-0.3272348612649065,-1.0284834748465992,0.4186991869918699,0.7237335897102541,1.0,8/33,15.48%,KCNJ2;NEDD4L;CHRM3;WNK3;KCNQ1;KCNJ8;KCNJ15;AHCYL1
prerank,regulation of protein localization to centrosome (GO:1904779),-0.4372183060880094,-1.0283727349105751,0.4457831325301205,0.7233604876161877,1.0,4/10,16.43%,GSK3B;APC;NSFL1C;BICD1
prerank,response to amino acid starvation (GO:1990928),-0.27667840595540416,-1.0282963058766452,0.4041994750656168,0.7229332524698238,1.0,33/72,27.04%,MAP3K5;SESN3;SH3GLB1;DAPL1;MTOR;MAPK8;SESN2;ATP6V1A;ATP6V0C;WDR59;ATF4;LAMTOR1;RHEB;TCIRG1;ATP6V1E1;DAP;FAS;LAMTOR2;PRKD1;ITFG2;RRAGB;ATP6V0D2;MAPK3;CDKN1A;LAMTOR4;DEPDC5;CEBPB;ATP6V0E2;CASTOR1;ATP6V1B2;WDR24;ATP6V1H;RPTOR
prerank,positive regulation of exosomal secretion (GO:1903543),-0.3968080856399999,-1.0281146306238707,0.4204081632653061,0.7227198113017679,1.0,6/15,30.92%,HGS;ATP13A2;SDC4;RAB7A;PDCD6IP;VPS4B
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4121307484102119,1.028113070227529,0.40562248995983935,0.847373906781139,1.0,4/16,12.17%,BMP7;NAPEPLD;FLCN;SOX13
prerank,oxoacid metabolic process (GO:0043436),0.37423430337517627,1.027814895930174,0.43738656987295826,0.8472339992328844,1.0,2/27,2.99%,DDO;TPST1
prerank,positive regulation of innate immune response (GO:0045089),-0.33079463551018057,-1.027812808219554,0.44849785407725323,0.7228548554135199,1.0,15/30,35.89%,LBP;RPS19;NLRC5;GBP5;IFI35;SPI1;POLR3D;POLR3F;SLC15A4;FADD;PLA2G5;DHX9;MAVS;CCL5;TLR8
prerank,barbed-end actin filament capping (GO:0051016),-0.3704752963318782,-1.027268730534695,0.4407484407484408,0.7229504798588987,1.0,5/18,8.65%,GSN;CAPZA2;VILL;ADD2;EPS8
prerank,actin filament capping (GO:0051693),-0.3704752963318782,-1.027268730534695,0.4407484407484408,0.7229504798588987,1.0,5/18,8.65%,GSN;CAPZA2;VILL;ADD2;EPS8
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.31093127720198876,1.0272122092124398,0.3977272727272727,0.8479396201913427,1.0,8/72,5.40%,IGF1;IL18;KIT;PDGFRB;NEDD4;PDGFRA;PDGFD;IGF1R
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.4135857119318801,1.0270831481469613,0.4080808080808081,0.847348448047403,1.0,4/18,5.91%,IL34;SLC45A3;SOX1;PTN
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.38100926847453465,-1.0267178769978746,0.4386973180076628,0.7236850757374693,1.0,3/17,9.42%,CADM1;LAMP1;PVR
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.33904290068813464,-1.0266586695489959,0.43817787418655096,0.7231845110142774,1.0,10/28,23.10%,NOTCH3;GATA2;ARRB1;LFNG;ZBTB7A;DLL4;AKT1;METTL3;DLL1;HEY1
prerank,organic substance transport (GO:0071702),0.28756589267180294,1.0266417665333967,0.39221556886227543,0.8476068978859459,1.0,19/121,11.17%,SLC22A4;SLC22A2;ABCA4;SLC35F3;ABCA9;TCN2;ABCA1;ABCA13;SLCO1B1;LRP2;NDC1;ZG16;ABCA5;MIA3;SLC22A6;SLC19A2;SLC19A1;MFSD2B;PLEKHA8
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.4220453229663329,-1.0265496018224651,0.44016227180527384,0.7227967243510991,1.0,5/13,12.48%,NOS3;GLS;DDAH1;NOS1;GAD1
prerank,embryonic digestive tract development (GO:0048566),0.40604655562117664,1.0264810496891243,0.4256619144602851,0.8470798298436933,1.0,4/18,6.81%,FGFR2;PDGFRA;GLI3;SALL1
prerank,regulation of G0 to G1 transition (GO:0070316),0.34572448311143056,1.0260578473626698,0.41154562383612664,0.8472518762415762,1.0,11/38,16.35%,RBBP4;L3MBTL2;MGA;RNF2;RBBP7;E2F6;TFDP2;APAF1;UXT;RAD51;CDKN2B
prerank,myeloid leukocyte differentiation (GO:0002573),0.314834147017216,1.025894679998934,0.42439862542955326,0.8467174530047998,1.0,9/65,11.41%,IL31RA;KIT;MMP9;CCL19;OSTM1;CSF1;BATF2;EPHA2;RXRA
prerank,actin filament-based transport (GO:0099515),0.3943501912086778,1.0252828641660352,0.42300194931773877,0.8474802487573002,1.0,4/21,5.21%,MYO5C;SYNE2;MYO1H;WASL
prerank,folic acid metabolic process (GO:0046655),0.40712282624171053,1.0251877314259117,0.44793713163064836,0.8468026779853872,1.0,7/18,20.01%,MTHFR;FOLR2;SLC19A1;SHMT1;MTHFS;DHFR;MTHFD2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.4443757616078957,-1.0247951819521777,0.44597249508840864,0.7266635693291343,1.0,6/10,31.24%,OGT;PDK2;ZNF692;SIRT7;DGKQ;GNMT
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.381161031778155,1.0246567039231924,0.4238921001926782,0.8473034931108188,1.0,3/24,4.29%,AUTS2;AVIL;ABI2
prerank,base conversion or substitution editing (GO:0016553),-0.4332681484641093,-1.0245336146858814,0.4540229885057471,0.7267132293656018,1.0,5/11,25.10%,ADARB1;ADARB2;ADAR;METTL3;NUDT16
prerank,negative regulation of cyclase activity (GO:0031280),0.42607777201937247,1.0244448891715328,0.41025641025641024,0.8469416841563073,1.0,1/14,0.48%,ADGRV1
prerank,positive regulation of catalytic activity (GO:0043085),0.35578756870891637,1.0239451330145313,0.4185639229422067,0.8473320832769237,1.0,11/37,15.10%,FGFR4;IGF2;AZIN2;XRCC5;XRCC4;SSBP1;NHEJ1;ABL1;PSENEN;CIB1;WRN
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.3886826799396261,-1.023753841498269,0.45368620037807184,0.7273806034990392,1.0,5/16,5.59%,APOD;THBS1;ACVRL1;CORO1C;FAM107A
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.3886826799396261,-1.023753841498269,0.45368620037807184,0.7273806034990392,1.0,5/16,5.59%,APOD;THBS1;ACVRL1;CORO1C;FAM107A
prerank,negative regulation of apoptotic process (GO:0043066),0.2489414747617343,1.0236618612213844,0.39081885856079407,0.8471478744644987,1.0,75/444,13.69%,IL31RA;IGF1;OSR1;FHL2;NOTCH2;ANGPT1;PRKN;DAB2;SNX6;BCL2;FNIP1;SMAD6;DKK1;SCX;LTF;IFIT3;NDNF;CTSH;ANXA1;PDPN;RNF213;ARAF;SPHK1;KDM2B;ZFAND6;CPEB4;PRKAA2;IGF1R;LRP2;SON;NIBAN2;KRT18;MYO18A;BNIP3;SH3RF1;IL6;NOL3;MMP9;PRKCA;PRKAA1;BIRC5;SIAH2;GRK5;BIRC6;TLE1;CDK1;NUPR1;BCL2L2;RETREG1;YME1L1;ITCH;MED1;NAA35;AXL;PHIP;PRKDC;HDAC1;PIK3R1;RPS6KB1;TFAP2A;TFAP2B;SH3RF2;TMBIM4;APOH;CFLAR;HIPK3;GDNF;FSTL1;NFATC4;MAPK1;MRE11;ANXA5;NTSR1;CIB1;SLC30A10
prerank,positive regulation of viral transcription (GO:0050434),0.38220184302495747,1.023375049038979,0.41422594142259417,0.8469365875593221,1.0,5/25,8.49%,POLR2D;POLR2A;RSF1;CCNT1;GTF2F1
prerank,protein homooligomerization (GO:0051260),0.2897261967097143,1.0228543373576384,0.42197452229299365,0.8473561092695872,1.0,17/114,10.46%,ALDH1A2;APPL2;UPB1;ALS2;RNF213;CBY1;IKZF4;HSD17B10;ARC;BLM;SLC1A5;RNF135;SSBP1;GOLGA2;GSDMD;CLYBL;MICU1
prerank,regulation of myoblast differentiation (GO:0045661),0.3611943565874378,1.022522774756875,0.421455938697318,0.8473399280445698,1.0,3/32,3.63%,RANBP3L;PLCB1;RIPOR2
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.43843076226870115,1.022404254954664,0.4227467811158798,0.8467153421543696,1.0,4/12,16.12%,IL34;CSF1;MAPK1;LYN
prerank,protein modification by small protein removal (GO:0070646),-0.2315271668045671,-1.0223706962228538,0.35687732342007433,0.7302192845642093,1.0,56/252,17.81%,ACTB;ESR1;IL33;ATXN3;USP38;OTUD7A;UBB;NFKBIA;UCHL5;TOMM20;EIF3F;COPS7A;NEDD8;RHOT1;USP29;RPS27A;UBC;USP31;UCHL1;ZRANB1;BIRC3;PSMD13;PSMF1;RHOA;PSMB10;APC;OGT;HGS;USP50;PSMB6;PSME3;USP37;PSMB5;ADRB2;OTUD3;PSMC3;UCHL3;OTUB1;PSMD12;FOXK1;PSMB8;OTUD1;PSME1;CFTR;UBA52;COPS8;IFIH1;PSMB3;RUVBL1;MYSM1;USP28;USP9X;ZC3H12A;COPS6;WDR20;USP8
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.4343563818794348,-1.0222137736777868,0.41472868217054265,0.7299790164501596,1.0,2/10,5.02%,CARMIL1;WDR1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.38146747138670983,-1.0219007016796153,0.42337164750957856,0.7300786697906886,1.0,4/17,8.54%,PPIA;HSPB1;SOD1;SFPQ
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.43238840092511555,-1.0218241576388012,0.443359375,0.7296265820185982,1.0,6/11,31.95%,PUM2;LIMD1;STAT3;FMR1;ZFP36;DHX9
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.37297853916910606,-1.0217877555840107,0.4708423326133909,0.729083935468967,1.0,8/20,32.52%,GATM;GCLM;PLOD2;GGT1;GAMT;CHAC2;MGST2;OPLAH
prerank,DNA repair (GO:0006281),0.2552263480321711,1.0213859268103043,0.4057971014492754,0.8484851234882834,1.0,72/284,17.87%,EYA1;FANCA;APEX2;RAD51B;ATRIP;BAZ1B;RAD51AP2;DDB2;HUS1B;RAD51C;TDP2;INIP;PDS5B;PSME4;PARP4;XRCC5;BLM;XRCC4;WDR48;FANCI;CDK1;BRCA2;MGME1;UVRAG;FBXO6;MBD4;MDC1;PDS5A;ABL1;PRKDC;DCLRE1A;PARP9;SMARCA5;ASCC2;TEX264;DCLRE1B;CUL4B;MPG;LIG1;INO80;PRIMPOL;MRE11;USP45;WDR33;FANCB;CIB1;FANCF;APEX1;UBE2V1;MNAT1;RAD23B;FANCE;FAAP100;UBE2A;CENPX;MLH1;BABAM2;WRN;FANCC;RAD18;RAD51;REXO4;BACH1;BRIP1;RNASEH2A;RPAIN;SETD2;TRRAP;XPC;ERCC6L2;DTX3L;FAAP24
prerank,tRNA aminoacylation (GO:0043039),-0.31315116759249195,-1.0209535330463029,0.4139433551198257,0.7305198690551169,1.0,13/37,29.61%,WARS2;LARS2;WARS1;SARS1;YARS1;IARS1;NARS1;EEF1E1;FARSA;CARS1;KARS1;MARS2;GARS1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3901605106046602,1.0208379166045365,0.4306306306306306,0.8490592784124587,1.0,2/23,1.91%,ERRFI1;SNX6
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.38449243166815594,-1.0206969307494085,0.44583333333333336,0.73053632671061,1.0,8/17,26.31%,PODXL;TGFB2;PIEZO1;RET;ADAM9;NCKAP1L;P2RY12;SKAP1
prerank,regulation of RNA metabolic process (GO:0051252),0.3202733881428024,1.0206910731357626,0.4067796610169492,0.8485148116173654,1.0,12/59,11.47%,AFF2;IGF2BP1;NOVA1;PTBP2;HNRNPH1;SON;METTL4;YTHDF2;MITF;RC3H2;MED1;PCBP2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.4194296071547617,-1.0203465623708248,0.44242424242424244,0.7307487007680785,1.0,8/13,34.18%,RPS21;BMS1;TBL3;KRI1;TSR1;ABT1;UTP20;RPP40
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.39368564506552495,-1.0202863398349702,0.4196078431372549,0.7302529814580676,1.0,3/15,4.46%,CSGALNACT1;CSPG4;BGN
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.32759898179283964,1.0202096421394207,0.4383561643835616,0.8488607585803981,1.0,3/57,1.83%,ADCY5;ADCY1;LPAR1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.4042528281943947,-1.0201341272602098,0.4508670520231214,0.7299879636664882,1.0,4/14,12.73%,THBS1;CREB3L1;GPC1;SPRY4
prerank,regulation of dendrite development (GO:0050773),-0.31747085162197103,-1.0198465844580675,0.42437923250564336,0.7300546644848737,1.0,11/37,8.57%,BMP5;NEDD4L;DAB2IP;SEMA4D;ZDHHC15;DCC;GSK3B;LRP8;RTN4IP1;MFSD2A;MARK1
prerank,negative regulation of peptidase activity (GO:0010466),-0.29708118999908273,-1.0195136508955132,0.4110854503464203,0.7302725742160888,1.0,8/47,7.50%,SPOCK2;CST3;SERPINE2;SERPINI1;UBXN1;SERPINF1;SERPINB9;GAPDH
prerank,response to nutrient levels (GO:0031667),-0.3850219181965916,-1.0192689631959324,0.4388185654008439,0.7302325862657078,1.0,5/17,10.68%,KCNB1;FAM107A;MTOR;EIF4G1;ATF4
prerank,multivesicular body organization (GO:0036257),-0.33494694840997274,-1.0191838587500335,0.40461215932914046,0.7298106296489042,1.0,14/31,30.92%,RAB27A;CHMP5;CHMP2B;HGS;MVB12A;CHMP1B;CHMP1A;CHMP3;CHMP7;PDCD6IP;CHMP4C;VPS36;VPS28;VPS4B
prerank,telomere maintenance via telomerase (GO:0007004),-0.3367235145713987,-1.0188084829828528,0.4318181818181818,0.7301206865866722,1.0,9/28,21.04%,HSP90AA1;HSP90AB1;PINX1;RPA1;TERF2IP;TNKS1BP1;ANKRD28;CDK2;NHP2
prerank,I-kappaB phosphorylation (GO:0007252),-0.44258631282603256,-1.018472767187945,0.4646840148698885,0.7303202661422373,1.0,4/10,28.94%,DAB2IP;CHUK;TLR7;TLR4
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.4319472133505676,1.018458127416121,0.43737166324435317,0.8525129238482666,1.0,2/14,9.75%,IL18;IL17D
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.469977549441462,1.0184382325773849,0.44288577154308617,0.8516428614011997,1.0,1/10,0.35%,ERRFI1
prerank,peptidyl-proline modification (GO:0018208),-0.3539736826898848,-1.0183634075152466,0.4517543859649123,0.7299518268321287,1.0,6/25,11.70%,PPIA;P3H2;PPWD1;PPIE;PPIB;NKTR
prerank,ion homeostasis (GO:0050801),-0.33388335072725145,-1.0178388417693054,0.4396551724137931,0.7306698225333996,1.0,6/30,11.07%,SLC4A10;NEDD4L;FHL1;WNK3;SLC4A8;SLC4A2
prerank,regulation of immune response (GO:0050776),-0.24893533812543592,-1.0176096677413102,0.3957703927492447,0.7306694818975884,1.0,31/135,19.88%,FOXP1;B2M;CLEC2D;CD200;CD34;TGFB2;ITGB1;CXADR;DENND1B;ITGA4;LRP8;CSK;AHR;BIRC3;ADCY7;APPL1;PVR;NPDC1;RSAD2;ICAM2;CD81;COL1A1;COL3A1;CASP8;ULBP1;N4BP1;CD40;IL15;PIANP;TIRAP;TYROBP
prerank,regulation of neuron differentiation (GO:0045664),-0.27223907281887294,-1.0171503801105217,0.41330166270783847,0.7311597105718571,1.0,23/76,18.05%,MEF2C;ZFHX3;TIAM1;NGF;HES1;NRCAM;CALR;SIX1;MMD2;RHOA;YWHAG;BMP2;HEYL;BIN1;REST;ARHGEF2;BRINP2;TCF3;DISP3;YWHAH;SOX2;ID2;CASZ1
prerank,ventricular septum development (GO:0003281),0.34169094912182196,1.0171229950801264,0.4265486725663717,0.8541842209415551,1.0,2/37,0.29%,TGFBR3;ROBO1
prerank,protein localization to Golgi apparatus (GO:0034067),-0.34087849213493243,-1.0170229278615721,0.41631799163179917,0.7308034462918583,1.0,10/27,19.61%,VPS13A;VPS13C;ZDHHC15;GBP5;RIPOR1;TMED10;GBF1;VPS13D;SYS1;IFT20
prerank,spinal cord development (GO:0021510),-0.4235122973874077,-1.0167565077936882,0.435361216730038,0.7308610597640127,1.0,8/12,24.55%,VIT;PKD1;SOX4;RELN;NF1;DLL1;SOX11;ZPR1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.3142850455924244,-1.0163343282199493,0.40987654320987654,0.731292794883023,1.0,11/38,14.86%,CAV1;GAS6;PTPRC;LRP8;APP;SRCIN1;NCK2;RELN;PTPN1;NEDD9;CSF1R
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3900561768658962,-1.0159245957076963,0.4606741573033708,0.731698662045589,1.0,3/15,9.32%,NGF;BCAR1;DDIT4
prerank,regulation of cell development (GO:0060284),-0.31849182089025846,-1.0157969134095823,0.41431670281995664,0.731384673132265,1.0,17/36,23.10%,BHLHE40;RPS19;HES1;CTNNB1;PRUNE1;FOXO1;GRN;HEY2;RHEB;HEYL;CX3CR1;HES6;ADGRA2;AKT1;HDAC9;DLL1;HEY1
prerank,response to calcium ion (GO:0051592),-0.2574648966051314,-1.0157434811855712,0.3901734104046243,0.7308928002488929,1.0,29/102,17.99%,MEF2C;CAV1;CLIC4;THBS1;TRPC3;IQGAP1;CALM1;PLCG2;KCNMA1;LGMN;HOMER1;CPNE8;RYR2;CPNE2;CPNE3;KCNMB4;SYT10;SYT4;PPP3CA;ITPR3;KCNIP2;ITPKB;AHCYL1;CALM2;TRPC1;CPNE9;SYT2;ADAM9;SYT7
prerank,estrogen metabolic process (GO:0008210),0.4255943713721753,1.015581027647796,0.45233265720081134,0.8572651340056779,1.0,2/15,5.65%,HSD17B1;HSD17B10
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.38275486828745,1.0152906747233899,0.4411177644710579,0.8570951092441649,1.0,3/22,5.48%,APPL2;KDM2B;LRRK2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.2980087958589177,1.0152428652857648,0.410828025477707,0.8563070869450602,1.0,13/86,11.11%,IGF1;DENND4A;NOTCH2;AKAP13;KANK2;EPS8L1;RALGPS1;MYO9B;ARHGEF18;KBTBD7;DENND4B;FLCN;JAK2
prerank,tube closure (GO:0060606),0.36046797310815,1.0151906370265091,0.4250936329588015,0.8555304205293343,1.0,7/31,11.24%,LMO4;PRICKLE1;MTHFR;LRP2;FOLR1;COBL;IFT122
prerank,negative regulation of defense response to virus (GO:0050687),0.45798107979021985,1.0145677174506584,0.4693446088794926,0.856302358253645,1.0,4/10,19.04%,ITCH;PCBP2;TRAF3IP1;ILRUN
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.35285908727554854,-1.014182945757885,0.45076586433260396,0.7335327149696063,1.0,8/22,22.71%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;ZDHHC4;ZDHHC8;ZDHHC20
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.35285908727554854,-1.014182945757885,0.45076586433260396,0.7335327149696063,1.0,8/22,22.71%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;ZDHHC4;ZDHHC8;ZDHHC20
prerank,nucleosome organization (GO:0034728),0.32565192154316136,1.0136269192812992,0.42424242424242425,0.8578780843984394,1.0,20/55,22.11%,NASP;RSF1;ARID2;KAT6B;SMARCA5;SMARCE1;NAP1L3;INO80;SMARCB1;NAA60;SRCAP;SMARCC1;ACTR6;SMARCD3;NAP1L1;SETD2;BRDT;PAF1;ANP32B;SOX9
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.2510610007639134,-1.0133443828887605,0.40797546012269936,0.7349805652749907,1.0,36/124,25.94%,FRY;PTPRM;RAC1;CARMIL1;STX3;PLP1;MAP4;BLOC1S2;EHD1;GSK3B;GPM6B;STMN2;APP;MYOC;PLEKHA1;STMN1;CSF1R;ODF2;BICDL1;TMEM108;STMN4;NCDN;STMN3;CDK5;SH3GL2;GPM6A;ARFIP2;L1CAM;UHMK1;VAPA;NPY;AGER;ATCAY;CAMSAP1;ADCYAP1;MICALL2
prerank,stress fiber assembly (GO:0043149),-0.38705837826113965,-1.0131672786902186,0.448207171314741,0.7341763617195864,1.0,6/15,10.75%,ITGB1;ARRB1;CUL3;PDCD10;RHOA;KCTD13
prerank,contractile actin filament bundle assembly (GO:0030038),-0.38705837826113965,-1.0131672786902186,0.448207171314741,0.7341763617195864,1.0,6/15,10.75%,ITGB1;ARRB1;CUL3;PDCD10;RHOA;KCTD13
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3750885492426637,1.0130168236556312,0.4411214953271028,0.8586025039443411,1.0,3/26,3.48%,PLCB1;UBE2E2;ANXA1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3687547677209667,1.0122470598848858,0.44789762340036565,0.8597883587099661,1.0,2/26,1.27%,ADCY5;STXBP4
prerank,tRNA 5'-leader removal (GO:0001682),-0.40085549392555136,-1.0121424269785115,0.42722117202268434,0.736212885746898,1.0,7/13,28.40%,SSB;POP5;POP4;RPP21;RPP30;PRORP;POP7
prerank,negative regulation of proteolysis (GO:0045861),0.34672816781244176,1.0120853874977846,0.437847866419295,0.8593015364281356,1.0,8/34,12.57%,TIMP3;ECM1;EPHA4;LRRK2;CST7;PTPN3;SNX12;GAS1
prerank,cellular response to reactive oxygen species (GO:0034614),0.316664849695309,1.012037836474844,0.425569176882662,0.8585352881637898,1.0,10/59,10.44%,OSER1;TPM1;FER;ANXA1;PDGFRA;MAPK9;IL6;MMP9;SIRPA;ABL1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3667325574815039,1.011993873042166,0.45149253731343286,0.8577438051246198,1.0,7/27,8.90%,KIT;PDGFRB;EPHA8;PDGFRA;CCL19;ATG14;PIK3R4
prerank,positive regulation of response to external stimulus (GO:0032103),0.28118276658831265,1.0116162713174628,0.43119266055045874,0.8578329010124961,1.0,13/128,7.68%,BMP6;SASH1;IL18;PDGFRB;CCN4;GPSM3;DDX60;PTN;NAPEPLD;OPTN;PRKCA;CCL19;POLR3G
prerank,triglyceride metabolic process (GO:0006641),0.32632258306547013,1.0114470219951084,0.44165170556552963,0.8573550089261237,1.0,10/48,16.79%,AGMO;LPGAT1;LIPH;LIPC;APOC1;APOH;FABP7;LMF1;FABP4;GK
prerank,DNA metabolic process (GO:0006259),0.2524154862104152,1.0114052254568004,0.43724696356275305,0.8565653826519979,1.0,59/270,17.60%,TCF7L2;CBS;FANCA;SP100;RAD51B;SRPK2;TOP2B;ATRIP;DDB2;HUS1B;RAD51C;INIP;ACD;DMC1;PDS5B;PSME4;PARP4;TYMS;XRCC5;BLM;DDX23;USP7;CDK1;UVRAG;FBXO6;AXIN2;MBD4;PDS5A;PRKDC;RFC1;DCLRE1B;RTEL1;ORC2;MPG;LIG1;INO80;SMARCB1;PRIMPOL;MRE11;USP45;APEX1;TOP1MT;MNAT1;UBE2A;WRN;ORC3;FANCC;STN1;MCM2;RAD18;RAD51;REXO4;BACH1;RNASEH2A;RPAIN;ORC6;TRRAP;XPC;PURA
prerank,positive regulation of axonogenesis (GO:0050772),0.3316305545403405,1.0110813060416524,0.45087719298245615,0.856529330665052,1.0,4/43,4.57%,PLXNA2;ROBO1;MACF1;PLXNC1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3766054206333803,1.0105751736621895,0.4407114624505929,0.8568798833183513,1.0,7/24,16.68%,LPGAT1;PLA2G10;SLC27A1;PLA2G4B;SERAC1;PLA2G12A;CDS2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.3044379340108088,-1.0104748053479855,0.42403628117913833,0.7397356750093291,1.0,11/43,12.32%,TGFB2;KLF4;ETS1;PPARD;GATA2;TGFB1;GNL3;JUN;DDX5;STAT3;REST
prerank,proteasomal protein catabolic process (GO:0010498),-0.23109483418288973,-1.0104025745178953,0.42700729927007297,0.7392697014190908,1.0,66/201,26.17%,WWP1;ATXN3;PPP2R5C;NEDD4L;UBXN1;ZNRF1;CTNNB1;FAF1;ARRB1;BAG6;RMND5B;UCHL1;CUL3;DERL1;PSMD13;CCDC47;PSMF1;DDB1;UBE2B;RBX1;PSMB10;UBXN6;KCTD17;KCTD13;PSMB6;NSFL1C;PSME3;PSMB5;ERCC8;PSMC3;AGAP3;PSMD12;ERLEC1;PSMB8;RNF34;KLHL42;TRIM13;PSME1;UBE2G1;ZFAND2B;PSMB3;COP1;SPSB3;SPOPL;RNF5;ARRB2;TRIM2;SHARPIN;PSMD5;ZSWIM8;KCTD5;VCP;RBCK1;BRSK2;PLAA;PSMD9;PELI1;PSMB4;PCNP;HUWE1;ATE1;SPSB4;BFAR;KIF14;DCAF11;PSMD10
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.2685781545540013,-1.010356998328599,0.4239401496259352,0.7387480635729352,1.0,27/80,23.62%,THBS1;NIBAN1;EEF2;VIM;RACK1;RPL26;SOX4;LRRTM3;RPL5;MTOR;PYM1;EIF3D;BCL3;YTHDF3;RPS4X;CLU;RPS27L;IFNGR1;EIF3C;ABCA2;ABCG1;PRKCD;METTL3;FMR1;EIF6;RELA;PCIF1
prerank,regulation of protein ubiquitination (GO:0031396),-0.2576058827416995,-1.009994656611047,0.42670157068062825,0.7390056670675875,1.0,43/108,25.32%,CAV1;HSP90AA1;HSP90AB1;UBE3A;UBB;RPS3;DNAJA1;IVNS1ABP;UBXN1;PINX1;SOX4;FAM107A;ARRB1;CHP1;CUL3;BIRC3;DERL1;OGT;ISG15;NDFIP2;FOXF2;CAMLG;DCUN1D1;NXN;WFS1;LAPTM5;PRMT3;SPOPL;N4BP1;SPRTN;PRKCG;UBE2D1;PINK1;ARRB2;AKT1;SIRT7;TNFAIP3;NDFIP1;HSPA1B;SPRY2;HUWE1;PTTG1IP;TSPYL5
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.43113780136455543,1.0099224130883955,0.43339960238568587,0.8577264069156699,1.0,1/13,0.48%,ADGRV1
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.2597261112009326,-1.0098497320659952,0.4326647564469914,0.7387144407441011,1.0,32/98,20.29%,SPTBN1;PRKCH;STX3;ITGB1;PPP1R13B;FYN;KCNB1;NKD2;NMT1;YWHAB;WNK3;CHP1;MAPK8;C2CD5;YWHAG;MIEF1;GPER1;BBC3;CD81;MIEF2;MTCL1;CASP8;RHOG;YWHAQ;PRKCE;STAC3;YWHAH;PPP3R1;ANK3;ZDHHC8;AKT1;ATP2B4
prerank,plasma membrane repair (GO:0001778),-0.41191996720891627,-1.0098410083360851,0.44854368932038835,0.7381001164362483,1.0,6/13,24.51%,AHNAK2;MYH9;DYSF;SYT7;RAB3A;SYTL4
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.2928746753667884,-1.0094206586021726,0.4262295081967213,0.7385159349306293,1.0,17/52,20.29%,SPTBN1;PRKCH;STX3;ITGB1;RACK1;NKD2;ATP2C1;WNK3;ZDHHC2;GPER1;RHOG;PRKCE;STAC3;ACSL3;ZDHHC8;AKT1;ATP2B4
prerank,negative regulation of phosphorylation (GO:0042326),0.29504415753164365,1.0091612927905707,0.4186046511627907,0.8588216174302304,1.0,14/85,9.05%,PTPN13;PPARA;PID1;BMP7;PRKN;PLPP3;CACTIN;NPRL2;LRRK2;FBLN1;PTEN;ATG14;NUPR1;SIRPA
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.40913171043667507,-1.0091584706730763,0.4714003944773176,0.7385355763890582,1.0,5/14,10.70%,PTK2;SOCS2;PXN;STAT3;PTPN1
prerank,positive regulation of cell division (GO:0051781),0.34232313508434414,1.0090388364384446,0.4410058027079304,0.8582277370560256,1.0,5/38,8.59%,FGFR2;CXCR5;CDC14B;FGF1;PKN2
prerank,response to nitric oxide (GO:0071731),-0.39924314173156783,-1.009001942097633,0.4521072796934866,0.7383085860208433,1.0,5/13,21.70%,GUCY1B1;FOXO1;MT3;CDK2;KCNC2
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.45277151087531214,1.0087804889231111,0.45770065075921906,0.8580029007824922,1.0,2/11,6.22%,RBBP4;NASP
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.3998466830582447,-1.0085728343911502,0.46123260437375746,0.7387459935669507,1.0,7/14,28.49%,DAB2IP;HSPA5;PTPN1;DNAJB9;BAX;BFAR;TMEM33
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3243894664666798,1.0081518671318495,0.4370860927152318,0.8587260069647804,1.0,9/51,9.11%,NRK;BMP7;GAS7;ALS2;DTNBP1;WASF1;LRRK2;NBL1;MYO16
prerank,negative regulation of organelle assembly (GO:1902116),-0.3182458123298208,-1.0077788193879393,0.462882096069869,0.7400133866602236,1.0,9/35,19.13%,TBC1D30;LIMK2;MDM1;RBM14;MTM1;ODF2L;FEZ2;SMCR8;PINK1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.4128939522016971,-1.0075256704909878,0.44652908067542213,0.7399832518054866,1.0,4/12,20.78%,SMCHD1;HNRNPU;YTHDC1;METTL3
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.4295476400848316,-1.0073298653779976,0.4567669172932331,0.73986207618049,1.0,2/11,10.16%,MEF2C;PIK3CD
prerank,plasma membrane invagination (GO:0099024),0.36513545931261593,1.0071038424633336,0.45454545454545453,0.86050786959633,1.0,6/29,7.84%,GULP1;ARHGAP12;SNX18;SNX9;SNX33;SPIRE2
prerank,positive regulation of protein kinase activity (GO:0045860),-0.24243568743628494,-1.006376989150415,0.42378048780487804,0.7416562056038923,1.0,32/148,12.75%,RAP1A;RASSF2;TGFB2;HSP90AA1;IQGAP1;GAS6;CALM1;HSP90AB1;PTK2;PTK2B;DAB2IP;MINK1;TGFBR2;MTCP1;PTPRC;CCDC88A;LRP8;PDCD10;VEGFA;EMP2;MMD2;PAK1;SRCIN1;RHOA;PAK2;RALB;RELN;PTPN1;PIH1D1;MARK2;CLU;ADRB2
prerank,B cell proliferation (GO:0042100),-0.37714197996887033,-1.006170404985654,0.4620123203285421,0.7415101329311954,1.0,6/17,17.60%,MEF2C;PTPRC;CD180;HSPD1;CR2;CD40
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.3782988300545249,-1.0061408727825838,0.4707112970711297,0.7409611166526653,1.0,7/17,22.05%,SREBF2;SOD1;LPCAT3;ERLIN2;ABCA2;ABCG1;MBTPS1
prerank,negative regulation of neuron projection development (GO:0010977),0.31479172224474516,1.0058217077012508,0.43029259896729777,0.8629538870531058,1.0,7/56,7.48%,EFNB2;LRP4;LPAR1;DPYSL3;EPHA4;PTPN9;PTEN
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.3710471319114799,-1.005644548035716,0.45213849287169044,0.7415695694851606,1.0,7/19,19.74%,NFATC2;NFATC1;EDN1;PPP3CA;HRH1;PPP3R1;NFATC3
prerank,retinal metabolic process (GO:0042574),0.44036911788495087,1.0056427792204574,0.46624472573839665,0.8625130462844947,1.0,4/12,19.50%,ABCA4;RDH11;RDH13;BCO2
prerank,pulmonary valve morphogenesis (GO:0003184),0.4056489938977115,1.005435424089266,0.4649298597194389,0.8621411975940955,1.0,3/17,2.28%,ROBO1;NOTCH2;SMAD6
prerank,sensory perception (GO:0007600),0.3318831004830927,1.0053054330796865,0.44482758620689655,0.8615718042030744,1.0,5/45,9.33%,ADGRV1;GNAS;TTC8;WHRN;RETREG1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.4218396726247222,-1.0047841135104432,0.46846846846846846,0.7431369637249369,1.0,7/11,38.06%,TIRAP;TNFAIP3;TREM2;TLR6;MFHAS1;TLR1;PJA2
prerank,cilium movement (GO:0003341),0.3314867232135724,1.0047169856058913,0.44350758853288363,0.8621705995338765,1.0,9/47,15.00%,ODAD3;DNAI4;DNAH11;TEKT2;SPA17;DNHD1;ODAD1;CFAP70;ODAD2
prerank,positive regulation of calcium ion transport (GO:0051928),-0.31265502443434046,-1.00465163437004,0.4551422319474836,0.7428277545248199,1.0,11/36,17.03%,CAV1;TRPC3;TRPC6;WNK3;STIM2;GRIN1;ATP2B1;CACNB2;CXCL12;WFS1;ORAI1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.3240817501548431,1.0043568149173387,0.4543859649122807,0.8621885529020933,1.0,1/48,0.08%,PRKAG2
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.36770690692883345,1.004170868930674,0.4568627450980392,0.861767757778851,1.0,13/27,22.26%,BRD8;KAT8;KAT6B;CREBBP;NAT8;TRRAP;KAT2B;RUVBL2;KAT5;PHF20;MSL3;NAA50;TAF6L
prerank,DNA geometric change (GO:0032392),0.3729578645690586,1.0040248391690518,0.4646271510516252,0.8612284020288123,1.0,9/24,21.10%,ANXA1;BLM;RTEL1;MRE11;WRN;HNRNPA2B1;RECQL5;RAD50;NBN
prerank,positive regulation of macroautophagy (GO:0016239),-0.2969668978504182,-1.003953942324853,0.4474885844748858,0.7439188608167782,1.0,17/48,23.70%,KDR;SPTLC2;SESN3;SH3GLB1;SESN2;RALB;HSPB8;ADRB2;TRIM13;SMCR8;VPS13D;PINK1;DCN;PIP4K2A;SLC25A4;SPTLC1;SCOC
prerank,regulation of microglial cell activation (GO:1903978),0.41907634872674293,1.0039059744956762,0.4790794979079498,0.8606253459129415,1.0,5/15,15.38%,SYT11;SPHK1;IL6;CST7;CX3CL1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.36150825618621496,-1.0035827038745702,0.4610526315789474,0.7442013776292495,1.0,10/20,35.47%,ADAM10;TGFB1;ADAM9;PSEN1;MBTPS1;RELA;HM13;NGFR;SPPL2B;ADAM17
prerank,positive regulation of vascular permeability (GO:0043117),0.4430898144973508,1.003274478880943,0.47107438016528924,0.8613196147353296,1.0,2/12,1.29%,BMP6;ANGPT1
prerank,regulation of protein kinase B signaling (GO:0051896),0.2663022787600931,1.003213590117693,0.4504881450488145,0.8605911516262216,1.0,22/193,7.56%,TCF7L2;OSBPL8;FGFR2;FGFR4;PPARA;IL18;KIT;ANGPT1;PDPK1;PDGFRB;KL;IGF2;GFRAL;PDGFRA;RICTOR;IGF1R;FGF1;LRP2;FRS2;PDCD6;PTEN;CCL19
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.3200168845854653,-1.002992772468004,0.4572072072072072,0.7450163984332101,1.0,13/33,26.08%,ACER2;TGFB2;PTK2;NEXMIF;DPP4;RET;CYP1B1;ADAM9;JAM3;NCKAP1L;ADA;P2RY12;SNAI2
prerank,cellular biogenic amine catabolic process (GO:0042402),0.4604894011091735,1.002555092842168,0.47489539748953974,0.8614572761668146,1.0,4/10,23.37%,ALDH7A1;LRTOMT;SMOX;COMT
prerank,cellular response to unfolded protein (GO:0034620),-0.3311009193494141,-1.0025511277098011,0.4541577825159915,0.7454725137307994,1.0,13/26,25.95%,HSPA8;DAB2IP;ABCB10;HSPA14;HSPA5;PTPN1;HSPB8;HSPD1;TMBIM6;HSPA9;HSPA1B;BAX;ERN1
prerank,bile acid metabolic process (GO:0008206),0.3679120221828248,1.0025222686281607,0.48406374501992033,0.8606590774828855,1.0,4/27,12.28%,CYP27A1;HSD17B10;GBA2;AMACR
prerank,inorganic anion transport (GO:0015698),-0.2922661739941175,-1.002366198277789,0.45287958115183247,0.7453064703133766,1.0,7/53,6.11%,SLC4A10;SLC26A7;ANO1;ANO4;CLIC4;CLIC5;TTYH3
prerank,regulation of exocytosis (GO:0017157),-0.2931922953664131,-1.0022581460939313,0.43532338308457713,0.7449575464836495,1.0,22/46,31.08%,STXBP6;NSF;RAB3C;RAB27A;RAB3B;CPLX2;CFTR;RAB8A;CHMP3;RAB8B;CLASP2;RAB3A;LGI3;SYTL4;CPLX1;HAP1;RIMS2;SYT1;UNC13D;ATP6AP1;STXBP5L;RAB15
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.3048838606569247,1.002064112792392,0.44821731748726656,0.8609270548420932,1.0,7/75,5.00%,DCDC2;FGFR2;LRP4;SDC2;PARD3;BAIAP2;NTNG2
prerank,protein homotrimerization (GO:0070207),-0.3959610651348686,-1.0017053297617062,0.4704724409448819,0.7451044546084601,1.0,9/14,34.36%,SCARA5;SIGMAR1;MIF;DISP1;SLC1A2;STEAP4;ASIC1;ALOX5AP;P2RX3
prerank,protein trimerization (GO:0070206),-0.3959610651348686,-1.0017053297617062,0.4704724409448819,0.7451044546084601,1.0,9/14,34.36%,SCARA5;SIGMAR1;MIF;DISP1;SLC1A2;STEAP4;ASIC1;ALOX5AP;P2RX3
prerank,macrophage chemotaxis (GO:0048246),0.44282813656365516,1.0010047453026196,0.4816326530612245,0.8627966093416906,1.0,3/10,17.66%,TAFA4;CKLF;EDNRB
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.4386875224213073,1.0009955745138401,0.449438202247191,0.861928618417805,1.0,3/11,12.86%,ARID1B;ZMIZ1;ZMIZ2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.26425890446196043,-1.0009824298682772,0.472,0.746283751703423,1.0,27/84,22.30%,MBNL1;NOVA2;HNRNPK;RBFOX1;QKI;RBFOX3;RBFOX2;HNRNPU;LARP7;DDX5;ZBTB7A;SRSF9;RBM8A;REST;KHDRBS3;RNPS1;SRSF6;SRPK1;RBMXL1;DDX17;YTHDC1;PCBP4;PTBP1;MAGOH;FMR1;TRA2B;RBM24
prerank,error-free translesion synthesis (GO:0070987),-0.34487271305145134,-1.0006836697533656,0.44532803180914515,0.7463910737091932,1.0,8/22,22.49%,UBB;RPS27A;UBC;RPA1;UBA52;SPRTN;VCP;POLD1
prerank,carbohydrate catabolic process (GO:0016052),-0.3144758379631158,-1.0002404051333529,0.4521158129175947,0.7468003314464353,1.0,13/38,23.11%,PKM;HK1;GAPDH;MAN2B1;MAN2C1;PFKM;TPI1;ALDOA;LDHA;ALDOC;MAN2B2;MANBA;PFKFB2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.41290820159316094,-1.0001821938910116,0.4665391969407266,0.7450636021438599,1.0,6/12,36.33%,CUL3;ANAPC7;NSMCE2;DLGAP5;ESPL1;ANAPC4
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.41290820159316094,-1.0001821938910116,0.4665391969407266,0.7450636021438599,1.0,6/12,36.33%,CUL3;ANAPC7;NSMCE2;DLGAP5;ESPL1;ANAPC4
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.41290820159316094,-1.0001821938910116,0.4665391969407266,0.7450636021438599,1.0,6/12,36.33%,CUL3;ANAPC7;NSMCE2;DLGAP5;ESPL1;ANAPC4
prerank,negative regulation of glycolytic process (GO:0045820),0.4422729733354679,1.000141765389914,0.45322245322245325,0.8624290255790444,1.0,5/10,18.58%,PPARA;NUPR1;PFKFB1;NCOR1;HDAC4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4422729733354679,1.000141765389914,0.45322245322245325,0.8624290255790444,1.0,5/10,18.58%,PPARA;NUPR1;PFKFB1;NCOR1;HDAC4
prerank,tRNA metabolic process (GO:0006399),-0.37168123183839513,-0.9998133928930305,0.4772727272727273,0.745382176216343,1.0,8/17,28.40%,SARS1;SSB;POP5;RPP21;RPP30;ADAT1;KARS1;POP7
prerank,neuron projection extension (GO:1990138),0.3544838809978832,0.9995431298478776,0.44095940959409596,0.8630601354662031,1.0,2/32,0.61%,ALCAM;AUTS2
prerank,regulation of potassium ion transport (GO:0043266),0.3491684926892163,0.999493680330148,0.4660714285714286,0.8622920477156946,1.0,5/31,6.48%,KCNIP3;KCNA5;ANK2;CACNA1D;DLG1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3870440661182893,0.9990476150533605,0.4684512428298279,0.8625527036658645,1.0,5/20,9.87%,WNT4;SIK1;ACADL;APOC1;SLC27A1
prerank,mitochondrion transport along microtubule (GO:0047497),-0.4104887188542214,-0.9989367195304659,0.4901185770750988,0.7469446165104853,1.0,2/13,6.40%,UBB;RHOT1
prerank,protein secretion (GO:0009306),0.32065949768265023,0.9988811555781866,0.4494949494949495,0.86208982118825,1.0,9/56,10.02%,WLS;TANGO2;ANXA1;RAB13;ARFGAP3;ABCA1;SLC30A8;MIA3;STEAP3
prerank,myelination in peripheral nervous system (GO:0022011),-0.4091474710256272,-0.9985616700552173,0.4576923076923077,0.7472787711227518,1.0,6/13,19.91%,ADGRG6;SOD1;MYOC;ARHGEF10;NF1;NCMAP
prerank,positive regulation of vasculogenesis (GO:2001214),-0.4383672915483075,-0.9985149166928665,0.4827586206896552,0.7467671053156898,1.0,4/10,6.94%,RAP1A;CD34;KDR;CEACAM1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.33695243518603035,0.9984701601123839,0.44155844155844154,0.8622408845084585,1.0,10/36,16.10%,RBBP4;L3MBTL2;MGA;RNF2;RBBP7;E2F6;TFDP2;APAF1;UXT;RAD51
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.22931697373628848,-0.9981615805055881,0.4482758620689655,0.7470386007324695,1.0,55/198,20.25%,PTPRB;PLPP1;DUSP16;CALM1;PLCG2;PLCB4;INPP5D;TNFAIP8L3;INPP4A;LIMK2;SYNJ1;TGFB1;GPX4;NUDT3;PTPRC;NADK;PGM2L1;HK1;ALPL;MTOR;PAK1;PLCB3;PAK2;CERK;NT5C;PIK3CD;LIMD1;PPP1CA;NUDT4;STAT3;DUSP8;GPD2;DUSP3;TOLLIP;PFKM;PPP3CA;ALDOA;PFKP;INPPL1;PLA2G4A;ITPKB;DUSP12;PGP;ALDOC;CLN8;PPM1A;PRKCG;CDK5;TIGAR;PIP4K2A;PANK2;ACP2;PFKFB3;LCAT;AKT1
prerank,regulation of protein secretion (GO:0050708),0.28105543333493305,0.9976858724358831,0.4555052790346908,0.8634803924820784,1.0,11/119,7.58%,IGF1;BMP6;ITPR1;FRMD4A;KCNA5;LLGL2;CACNA1D;MYO18A;IL6;PRKCA;RAPGEF4
prerank,neuron projection regeneration (GO:0031102),0.44738257132449744,0.9976144637825607,0.47956989247311826,0.8627869629693882,1.0,3/10,8.35%,PTN;FOLR1;NREP
prerank,purine nucleotide metabolic process (GO:0006163),-0.33722778417628674,-0.9974686652259122,0.4726166328600406,0.7481293627864001,1.0,8/24,15.56%,PRPS2;NT5C2;HPRT1;GDA;NT5C;XDH;GUK1;NT5E
prerank,negative regulation of endocytosis (GO:0045806),0.37498117781267276,0.9968811089794447,0.44485981308411215,0.8638230551015564,1.0,7/24,12.63%,EPHA3;SYT11;SNX33;APOC1;PICALM;RUBCN;PACSIN3
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.35073266176582624,0.9963552719685874,0.44886363636363635,0.8642253299392919,1.0,14/32,21.10%,CDC14B;MRNIP;BLM;CDK1;CLSPN;RINT1;MRE11;BABAM2;BRSK1;TAOK3;TRIM39;TAOK2;UIMC1;NBN
prerank,positive regulation of synaptic transmission (GO:0050806),0.29563104690223163,0.996177980818528,0.46568627450980393,0.8637912131944399,1.0,9/72,8.02%,ADCY1;SLC8A3;NLGN2;TSHZ3;DTNBP1;CACNG7;PRKCZ;ARC;ZDHHC3
prerank,cellular amide metabolic process (GO:0043603),0.280623403683937,0.9961026098743693,0.46763754045307443,0.8631187029537151,1.0,10/102,8.19%,AEBP1;PCCA;PLPP3;MCCC2;PM20D1;ACOT4;MTHFR;NAPEPLD;FOLR2;CPXM1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.4075605073868151,0.995897812788597,0.4824742268041237,0.8627941653089908,1.0,5/15,17.11%,WNT6;ANKRD11;HDAC1;GLI2;MSX1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3923191405670694,0.9957698740047244,0.44881889763779526,0.8613607760715871,1.0,2/20,5.01%,GSTM2;GSTT1
prerank,glutathione derivative metabolic process (GO:1901685),0.3923191405670694,0.9957698740047244,0.44881889763779526,0.8613607760715871,1.0,2/20,5.01%,GSTM2;GSTT1
prerank,melanosome organization (GO:0032438),0.353994678978607,0.9957563681462797,0.4727626459143969,0.8605248217023624,1.0,7/26,15.11%,SHROOM2;DTNBP1;GPR143;RAB32;BLOC1S4;AP1M1;AP3B1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.30963766454104835,0.9955198492567768,0.4665551839464883,0.8602738235406275,1.0,17/62,20.95%,POLR2D;CDK7;ELOA;POLR2A;CCNT2;CCNT1;GTF2F1;CDC73;MNAT1;NELFB;TCEA1;SETD2;CTR9;ELL;CDK9;ELP2;PAF1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.2164607169272991,-0.9953254901698011,0.46558704453441296,0.7528181760479206,1.0,98/341,23.00%,WWP1;RNF144B;CBL;ATXN3;PPP2R5C;FBXO7;NEDD4L;OTUD7A;RNF144A;MVB12B;UBXN1;ZNRF1;BUB3;TRIM25;CTNNB1;UBAP1;FAF1;NEDD8;ARRB1;UBE3C;BAG6;RMND5B;UCHL1;RNF125;CUL3;ZRANB1;PSMD13;PSMF1;DDB1;UBE2B;RBX1;PSMB10;XBP1;RNF215;KCTD17;KCTD13;NDFIP2;FEM1A;PSMB6;TOLLIP;NSFL1C;PSME3;RNF150;PSMB5;UBQLN4;PTPN23;ERCC8;PSMC3;AGAP3;HERPUD1;MVB12A;PSMD12;PSMB8;RNF34;KLHL42;PTTG1;ARIH2;TRIM13;PSME1;KCTD21;ANAPC16;UBE2G1;ZFAND2B;PSMB3;COP1;SPSB3;SPOPL;USP9X;UBAP1L;RNF19B;TGFB1I1;FBXL14;BUB1B;UBE2D1;RNF5;PINK1;ARRB2;TRIM2;SHARPIN;PSMD5;ZSWIM8;RNF11;RNF168;KCTD5;UBA1;ARIH1;OTUD7B;VCP;RBCK1;TNFAIP3;RNF19A;ANAPC7;PLAA;UBL7;NDFIP1;PSMD9;PELI1;PSMB4
prerank,secondary palate development (GO:0062009),0.4161871536764486,0.9947203292771589,0.47104247104247104,0.8614274071907654,1.0,1/14,0.24%,TGFBR3
prerank,prostaglandin metabolic process (GO:0006693),-0.3380062390672153,-0.9943982312924773,0.4678111587982833,0.7543879585891042,1.0,10/26,27.00%,PTGIS;PTGS2;EDN1;PTGDS;CD74;PLA2G4A;MIF;PLAA;HPGDS;PRXL2B
prerank,innate immune response (GO:0045087),-0.22863490236672412,-0.9943131247567333,0.4646840148698885,0.753987339564135,1.0,56/217,23.69%,B2M;SERINC5;PTK2;ADAM15;PLCG2;LBP;FYN;PTK2B;GCH1;TRIM14;IKBKB;CAPZA2;PGLYRP1;TRIM25;DEFA6;APP;ANKHD1;NLRC5;ADAR;PIK3CD;CHUK;ISG15;MFAP4;NRROS;CD74;CHGA;SHFL;SRPK1;TRIM13;CYBB;IFIH1;CX3CR1;AKAP1;CR2;RNASE3;STYK1;CD40;YES1;IRAK1;IRF5;BST2;MID2;SERINC3;TRIM27;MYD88;TYROBP;SLA;IFITM3;ANG;SLC11A1;C3;CIITA;OTULIN;RELA;CAPZA1;AGER
prerank,regulation of cell cycle phase transition (GO:1901987),-0.2558559268476942,-0.9942153559786902,0.45077720207253885,0.753613292528673,1.0,27/91,23.55%,BUB3;PSMD13;PSMF1;DDB1;PSMB10;CDKN1B;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;ANAPC16;PSMB3;BUB1B;UBE2D1;PSMD5;TFAP4;ATP2B4;SKP1;CDKN1A;ANAPC7;PSMD9;PSMB4;NEK11
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.34468226792044887,-0.9939472945132194,0.46593406593406594,0.753655884051071,1.0,10/24,18.67%,UBB;NOD1;RPS27A;UBC;RNF34;TAB3;AAMP;CASP8;UBA52;IRAK1
prerank,negative regulation of cellular component movement (GO:0051271),0.4142576597792431,0.9937989956989411,0.4603174603174603,0.8628929931172296,1.0,3/15,6.36%,TGFBR3;SP100;FBLN1
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.3864687883476676,-0.9937543232366407,0.4847908745247148,0.7535496862308374,1.0,2/15,2.50%,PLTP;SCARB1
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3263684396067002,0.9937176602629627,0.46098003629764067,0.8622268374331881,1.0,6/46,9.87%,AGPAT4;GPD1L;PLA2G10;PLD1;LIPH;SLC27A1
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.3794975265552384,-0.9931745611116972,0.4766536964980545,0.7543509284007296,1.0,7/18,20.15%,ESR1;TGFB1;RPS26;ZC3H12A;NRDE2;TMBIM6;PTBP1
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.3488130206325313,-0.993156865437763,0.4759825327510917,0.7537749361547383,1.0,11/22,37.71%,ISCU;CIAPIN1;GLRX5;HSCB;ISCA2;HSPA9;ISCA1;CIAO2B;NFS1;NUBP1;NUBP2
prerank,negative regulation of B cell activation (GO:0050869),-0.35601499000935155,-0.9930310938608539,0.4616977225672878,0.7534689531851111,1.0,9/21,22.88%,TNFRSF21;SAMSN1;LAPTM5;ID2;INHA;TYROBP;CD300A;TNFAIP3;FCGR2B
prerank,negative regulation of lyase activity (GO:0051350),0.4088170193770597,0.9928723964773347,0.45866141732283466,0.8634770833427902,1.0,1/16,0.48%,ADGRV1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.40574336423231777,-0.9928644762984482,0.47184466019417476,0.7532601456909899,1.0,8/12,34.93%,PTK2B;UBASH3B;RYR2;MTLN;CASQ1;TRDN;CASQ2;FKBP1B
prerank,"wound healing, spreading of cells (GO:0044319)",0.36575480591750226,0.9926617042205459,0.47195357833655704,0.8631642441354469,1.0,4/24,7.10%,ARHGAP24;PDPN;DDR1;ARHGAP35
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.44854969090876784,0.9919821641415648,0.4787018255578093,0.8640842985168481,1.0,1/11,0.34%,LEPROT
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.39735725103913766,0.99187193312404,0.46502057613168724,0.8634832701306846,1.0,4/17,6.52%,RBPJ;MAML3;MAML1;WWC1
prerank,cellular response to peptide (GO:1901653),0.30899783523602886,0.9915375634811635,0.45183887915936954,0.863481085552234,1.0,6/56,7.35%,IGF1;SNX6;EPHA4;GJA1;IGF1R;CACNA2D1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.3076512290682558,-0.9915040973655734,0.4690265486725664,0.7559742315486401,1.0,18/37,24.19%,EFNA5;PHLDB1;MAP6;FAM107A;GSK3B;STMN2;MARK2;STMN1;CDK2AP2;TPPP;STMN4;BICD1;STMN3;GAS2L1;MAPRE1;TRIM36;CLASP2;CAMSAP3
prerank,positive regulation of protein catabolic process (GO:0045732),-0.25885258383639514,-0.9911151965509083,0.49595687331536387,0.7562811844085681,1.0,20/84,13.03%,WWP1;MSN;NSF;HSP90AA1;NEDD4L;DAB2IP;ATG7;PLK2;FAF1;GSK3B;TNFRSF1B;FOXO1;DDB1;FURIN;OAZ1;APC;CDKN1B;NDUFA13;EGLN2;IDE
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.43518410882014313,-0.9910969421239552,0.4602587800369686,0.7557078112425025,1.0,8/10,45.29%,SH2B3;INPP5F;SOCS1;PPP2CA;NF2;PPP2R1A;PIBF1;PTPN2
prerank,regulation of response to interferon-gamma (GO:0060330),-0.38192517813038995,-0.9910785315331291,0.47904191616766467,0.7551298760788313,1.0,6/14,24.36%,HSP90AB1;CDC37;IFNGR1;JAK1;SOCS1;STAT1
prerank,positive regulation of cell cycle (GO:0045787),0.30619018361414246,0.9907508647787839,0.46308724832214765,0.8646040113347653,1.0,13/62,12.46%,FGFR2;SMOC2;SRPK2;SPHK1;CCDC57;EIF4EBP1;PRKCA;PKN2;NUPR1;MDM2;RPS6KB1;HSF1;PKD2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.35592193191545907,0.990556532094474,0.4740740740740741,0.8642771086869139,1.0,4/30,9.38%,LEPROT;UBE2L3;NPEPPS;HSPA1L
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2331525748571775,-0.9904569338825027,0.48606811145510836,0.7560969212970018,1.0,27/159,13.36%,STXBP6;HIP1;SGIP1;TIAM1;HSP90AA1;HSP90AB1;RPL38;PDE4DIP;PXN;TGFB1;NCK1;GPX4;VAMP8;HIP1R;PSMD13;AP2M1;POMP;RTN4;NCK2;PIK3C2A;NSG2;BIN1;HSPD1;CLU;ADRB2;HIGD2A;EIF4H
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3757606430998036,0.9903156323555699,0.45294117647058824,0.8640033827197263,1.0,4/23,9.26%,NMT2;PDE6G;CAMKMT;GRK4
prerank,response to interleukin-1 (GO:0070555),0.29812195761110094,0.9900319763527499,0.46178343949044587,0.8638351409944895,1.0,9/73,10.07%,ADAMTS12;ANXA1;IRAK2;CACTIN;ADAMTS7;PRKCA;CCL19;SIRPA;CCL4
prerank,oligosaccharide biosynthetic process (GO:0009312),0.39430856826323357,0.9899606699260911,0.4686868686868687,0.8631656791124211,1.0,3/20,4.55%,B3GALT1;ST3GAL3;B4GALT1
prerank,negative regulation of viral release from host cell (GO:1902187),0.42159538403899327,0.989393985881731,0.48023715415019763,0.8636928676888244,1.0,4/13,16.20%,TRIM5;TRIM35;TRIM26;PML
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.3528246844174501,-0.9889535190593354,0.47283702213279677,0.7592235254252936,1.0,11/20,23.79%,TGM2;ATP2A2;CCDC47;KCTD17;SELENOK;HERPUD1;BCAP31;WFS1;PSEN1;RAP1GDS1;BAX
prerank,phosphatidic acid metabolic process (GO:0046473),0.3204904821098846,0.9888020426986792,0.4717314487632509,0.8643326412199595,1.0,6/48,9.87%,AGPAT4;GPD1L;PLA2G10;PLD1;LIPH;SLC27A1
prerank,positive regulation of JNK cascade (GO:0046330),-0.27377805051790916,-0.9885325410724941,0.5013192612137203,0.7596043575123532,1.0,11/70,8.27%,MAP3K5;RASSF2;ANKRD6;PTK2B;DAB2IP;MINK1;SH3RF3;TPD52L1;APP;FLT4;WNT16
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.4200093845267514,0.988493967605696,0.4658385093167702,0.864247634718165,1.0,2/14,1.48%,WNK4;DMD
prerank,acylglycerol biosynthetic process (GO:0046463),0.37632477216863414,0.9884336823482993,0.47766990291262135,0.863528227911106,1.0,2/23,1.78%,AGMO;LPGAT1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.3622749698954496,0.9881117299971273,0.4681647940074906,0.8634945482249037,1.0,7/24,8.42%,NEDD4;GRB10;PRKCB;NIBAN2;PDCD6;VTN;ARNT
prerank,regulation of peptidase activity (GO:0052547),0.3915070841429358,0.9876706120202603,0.4838095238095238,0.863751088543442,1.0,7/19,10.71%,ECM1;CTSH;A2ML1;NRDC;PSMA3;CST7;HDAC1
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.27725546684642444,-0.9872246784058194,0.4701670644391408,0.7621796667978832,1.0,18/66,20.49%,TFRC;CDH1;FLNA;LIMK2;PINX1;TGFB1;FERMT2;CARD10;LARP7;SESN2;WWTR1;MEPCE;JUP;ZC3H12A;PSEN1;PRKCD;AKT1;RBM22
prerank,transferrin transport (GO:0033572),-0.3117055401740953,-0.9871711775754385,0.46320346320346323,0.7616910969125289,1.0,15/33,26.57%,TFRC;ATP6V0A1;DNM2;ATP6V1A;ATP6V0C;TCIRG1;LMTK2;ATP6V1E1;ATP6V0A4;ATP6V0A2;ATP6V0D2;ATP6V0E2;ATP6V1B2;MCOLN1;ATP6V1H
prerank,protein export from nucleus (GO:0006611),0.35358860941410786,0.9870413909498328,0.4706994328922495,0.8644971055029717,1.0,1/27,0.13%,RANBP3L
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.2779439127609566,0.9868916461983452,0.4849921011058452,0.8640053377821488,1.0,11/110,6.53%,ADCY5;ADCY1;LGR4;ADGRL1;LPAR1;GNAS;ADM;ABCA1;LPAR2;GNAQ;ADRA1D
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3051519538577757,0.9864303151883888,0.4660033167495854,0.8643062837232458,1.0,10/59,10.45%,TCF7L2;CDK8;TNRC6B;TNRC6A;IL6;PTEN;CDK1;MITF;MED1;MED13
prerank,mRNA destabilization (GO:0061157),0.33662591831119154,0.9863951345898445,0.4448462929475588,0.8635383111659213,1.0,5/38,10.80%,ROCK2;POLR2D;YTHDF2;RC3H2;METTL14
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.2705267138027837,-0.9863626316414947,0.49278846153846156,0.7630798046988131,1.0,27/70,31.44%,CEPT1;MBOAT1;MFSD2A;LPCAT3;GPAT4;TMEM86B;LPCAT1;LPIN3;CSNK2B;NR1H2;PLA2G4A;LPIN1;ABCA3;LCAT;NR1H3;SLC44A5;PLA2G4F;SLC44A2;DBI;PLAAT1;PEMT;PLA2G15;CHPT1;PLA2G5;MBOAT2;LPCAT4;STARD10
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.42347142107000946,-0.986000869357619,0.48846153846153845,0.7633613469220294,1.0,3/10,9.97%,PODXL;PIEZO1;DPP4
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.44504324250425975,0.9859186047496379,0.4676113360323887,0.8639356597594955,1.0,2/10,11.50%,JARID2;MYB
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.37796613964133785,-0.9852515596524283,0.4693069306930693,0.7646288171824168,1.0,3/15,4.22%,TIAM1;RSPO3;SFRP4
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.2766869307771949,-0.9852178974440311,0.4819277108433735,0.7640870113924356,1.0,17/63,20.80%,MEF2C;TFRC;SLC7A1;NCK1;NFATC2;CD38;PTPRC;NCK2;CD74;CD81;MIF;CD274;CD40;IL15;JAK3;TIRAP;NCKAP1L
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.36591855507292764,-0.9847778139493999,0.4862204724409449,0.7645490711237303,1.0,10/18,46.36%,BCAR1;BAG6;CMKLR1;LAX1;C5AR2;FPR3;BLK;C5AR1;SLA2;GPLD1
prerank,mRNA export from nucleus (GO:0006406),-0.2524892096829666,-0.9847574186543719,0.5263157894736842,0.7639709286882213,1.0,44/102,35.96%,SRSF2;SRSF1;SRSF5;DDX39B;CPSF3;HHEX;SRSF9;ENY2;RBM8A;RNPS1;SRSF6;NUP37;AGFG1;SYMPK;NXT1;CPSF2;NUP54;SMG5;NUP85;YTHDC1;THOC3;NUP133;MAGOH;POM121;THOC6;EIF4E;DDX25;THOC2;NUP153;EIF4A3;SMG6;SRSF7;ALYREF;NUP42;CPSF1;ZC3H11A;NUP93;IWS1;DHX38;U2AF1L4;CHTOP;NUP35;SRSF3;NCBP2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.4251702309816686,0.984535344403599,0.47551020408163264,0.8666173311445783,1.0,7/12,23.69%,IGF1R;BNIP3;UVRAG;IRGM;SETX;JMJD4;FYCO1
prerank,membrane raft organization (GO:0031579),-0.3850406671023814,-0.984355470630025,0.508,0.7643714494844607,1.0,3/15,12.24%,RFTN1;EMP2;S100A10
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.35890838066886693,-0.9843243818854972,0.4824742268041237,0.7638361577298026,1.0,5/18,10.65%,SHANK3;PTK2B;NRXN1;GRIN1;RELN
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.29423015893568527,0.9841397033402987,0.44983818770226536,0.8667467905619418,1.0,12/75,10.51%,ROCK2;TULP3;NMT2;PLCB1;MGRN1;PDE6G;CAMKMT;ZDHHC3;GRK5;RPGRIP1L;GRK4;GNG7
prerank,positive regulation of protein acetylation (GO:1901985),0.43634382239871566,0.983867207936823,0.4780793319415449,0.8665783316608517,1.0,5/12,20.52%,PRKAA2;PRKAA1;RAPGEF3;DDX3X;KAT5
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.44397271293898827,0.9834807202164241,0.48893360160965793,0.8666826448746472,1.0,2/10,3.92%,LPGAT1;SLC45A3
prerank,regulation of cell morphogenesis (GO:0022604),0.35145048035477344,0.9832761662689458,0.4893203883495146,0.8663749382894972,1.0,8/30,10.48%,SH3D19;PDPN;MACF1;NTNG2;CAPZB;ARC;PHIP;ZMYM4
prerank,regulation of store-operated calcium entry (GO:2001256),0.44780495969206224,0.9831626426632867,0.4815668202764977,0.8658039324666406,1.0,1/10,1.35%,STIM1
prerank,cellular response to organic substance (GO:0071310),0.2726658056331169,0.9831558068553232,0.4809741248097412,0.8649659663828647,1.0,16/116,7.08%,PTPN13;PID1;IL18;PTPN4;DPYSL3;IL1RAPL1;NCOA2;STAT5B;NFAT5;SPHK1;PLK5;LRRK2;PTPN9;LRP2;NCOA3;SMAD3
prerank,regulation of transport (GO:0051049),-0.31475152336042134,-0.9827058849551173,0.48997772828507796,0.7672080705668887,1.0,6/36,4.23%,ACTB;EPB41;ACTG1;ICA1;DNAJA1;REEP5
prerank,aerobic respiration (GO:0009060),-0.3580748371224015,-0.9820051960556723,0.4989816700610998,0.768310197853279,1.0,7/20,22.96%,ATP5F1D;UQCRH;NDUFS7;UQCRC2;UQCRC1;MTFR1L;UQCR10
prerank,T cell activation involved in immune response (GO:0002286),-0.4153170119271814,-0.9817838148547273,0.487758945386064,0.768224960241504,1.0,12/12,58.51%,CD74;SLC11A1;LCP1;MDK;ICAM1;ITGAL;F2RL1;IFNK;TNFSF18;EIF2AK4;LILRB1;FCER1G
prerank,peptide cross-linking (GO:0018149),-0.32616837323695824,-0.9814158892976099,0.48975409836065575,0.7685235703005351,1.0,3/25,4.39%,FN1;THBS1;TGM2
prerank,epithelial cell differentiation (GO:0030855),0.2915806558187332,0.9813185977200617,0.46411483253588515,0.8687934527958098,1.0,17/88,16.63%,MAF;FGFR2;DAB2;ANXA1;TPP1;PTER;CDK1;KDM6B;LATS1;HDAC1;UPK1A;CNN3;FSTL1;BDH2;FZD7;HNRNPH3;ASCL1
prerank,UV protection (GO:0009650),-0.42608820543949727,-0.9807804612729717,0.5070140280561122,0.7694917384273638,1.0,6/10,33.40%,MFAP4;SDF4;XPA;ERCC5;CAT;FEN1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.3615325305439904,0.9806996750027959,0.46833013435700577,0.8694549995765389,1.0,5/26,7.48%,SLC8A3;NLGN2;LRRK2;PRKCZ;PTEN
prerank,Golgi ribbon formation (GO:0090161),0.4260848149789589,0.980528809972525,0.48625792811839325,0.869021285488394,1.0,5/13,11.12%,MYO18A;OPTN;STX16;GOLGA2;VTI1A
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.33714788106601845,-0.9803627462227986,0.48221343873517786,0.7699071975042988,1.0,8/24,14.44%,ITPR2;PLCG2;PTPRC;RYR2;HTR2A;IBTK;ERO1A;ITPR3
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.3889947607052676,0.9802046415670151,0.4990059642147117,0.8689889712858232,1.0,3/18,3.98%,ROCK2;RIPOR2;LLGL2
prerank,cytoskeleton organization (GO:0007010),0.27829268216991265,0.9799788619073313,0.4919614147909968,0.8686722819632497,1.0,15/114,7.74%,MICAL3;SH3D19;FGD4;TPM1;RHOD;OBSL1;ABI2;SYNE3;CNN2;CECR2;CAPZB;ARC;WDPCP;RHOBTB2;WASF3
prerank,gas transport (GO:0015669),-0.43297310169015746,-0.9799584347603454,0.48638132295719844,0.7703237893258925,1.0,2/10,11.41%,CA2;CYGB
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.3124537340910014,-0.9796013000435926,0.4866666666666667,0.7706612290453234,1.0,8/32,12.72%,MEF2C;MCTP1;GSK3B;KCNMB4;SLC30A1;GPER1;CPLX2;VPS18
prerank,cellular response to interleukin-15 (GO:0071350),0.4203182246137257,0.9794501438311217,0.46774193548387094,0.8682206116520753,1.0,2/13,3.68%,PLCB1;STAT5B
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.4203182246137257,0.9794501438311217,0.46774193548387094,0.8682206116520753,1.0,2/13,3.68%,PLCB1;STAT5B
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.33013993097354216,-0.9792126766277897,0.49044585987261147,0.7710197547908272,1.0,10/26,18.67%,UBB;NOD1;RPS27A;UBC;TAB3;AAMP;CASP8;UBA52;IFIH1;IRAK1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.39212088688980185,-0.9790841976686483,0.498046875,0.7707193709400744,1.0,3/13,9.21%,NAMPT;PTGIS;PTGS2
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.306150365419226,-0.979076588123156,0.48523206751054854,0.7701135189217758,1.0,13/35,24.36%,ETS1;ABCB10;ZFP36L1;CDK6;STAT3;TAL1;ANKRD54;SPI1;HSPA9;NCKAP1L;MAPK11;HSPA1B;STAT1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.2440145327390692,0.9790292304617456,0.5123537061118335,0.8684261303452329,1.0,48/348,11.76%,IGF1;PRKAG2;BMP6;LEPR;ROCK2;IL34;CEMIP;BMP7;ANGPT1;PELI2;DAB2;FNIP1;ALS2;IGF2;FAM20A;RBPMS;ARAF;SPHK1;MRNIP;PDGFD;LRRK2;FGF1;SNX9;TTK;IL6;ENPP2;XRCC5;MMP9;DDR2;CCL19;VTN;ATG14;CSF1;MUSK;VEGFB;NEK10;GDF1;AXIN2;DVL3;LATS1;ABL1;FGF9;FLCN;JAK2;FXR1;ERBB2;RAP2A;BMPR1A
prerank,positive chemotaxis (GO:0050918),-0.3688687439175679,-0.9786629212634034,0.4847250509164969,0.7705480455460778,1.0,5/17,11.30%,PTPRJ;MET;VEGFA;FGF7;SCG2
prerank,neuron migration (GO:0001764),0.3219203742907688,0.9784992463368329,0.4864864864864865,0.8688591426214137,1.0,8/48,9.85%,DCDC2;AUTS2;NDNF;SOX1;SDCCAG8;SH3RF1;PAFAH1B1;TUBGCP2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3712416135849674,0.9779513269041371,0.49506903353057197,0.8694337159968837,1.0,8/21,19.40%,HK2;RPE;H6PD;RBKS;DERA;GPI;GCK;SHPK
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.4046491683974408,-0.9777312552485476,0.4942084942084942,0.7721794546647479,1.0,7/13,26.46%,SVIP;ERLEC1;BCAP31;BRSK2;UBE2J1;YOD1;UBAC2
prerank,regulation of cell size (GO:0008361),-0.33427284696016535,-0.9776664720292748,0.46638655462184875,0.7717121344689252,1.0,5/23,9.30%,MSN;RAC1;MTOR;RHOA;EDN1
prerank,negative regulation of protein localization to membrane (GO:1905476),0.36632139829776544,0.9776240781834459,0.4875717017208413,0.8694249315453483,1.0,2/24,1.82%,PID1;DAB2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.41209215237604085,-0.9773992482390645,0.5231660231660231,0.7717397945356793,1.0,4/11,20.48%,TGFB1;DDX5;MAP2K2;BMP4
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3002443478724834,0.9768257753535854,0.4786184210526316,0.870518973153513,1.0,16/60,17.75%,TCF7L2;CDK8;TNRC6B;TNRC6A;IL6;PTEN;CDK1;MED1;MED13;SRF;CDK4;ATF7IP;MOV10;MED10;MED15;MED26
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3729657817145327,-0.9767566740716871,0.4957627118644068,0.7727237036540543,1.0,5/16,9.43%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;ST8SIA1;ST8SIA6
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.3585916297155626,-0.9767153410398293,0.49899799599198397,0.7721979677184305,1.0,9/19,27.36%,PTPRJ;KDR;PTPRC;RYR2;BCAP31;PTGFR;TRPM2;FIS1;SELP
prerank,lipid biosynthetic process (GO:0008610),0.2888657623883665,0.9766576464582798,0.48484848484848486,0.8700656514670785,1.0,8/77,7.55%,AGPAT4;ACSL1;HSD17B1;FDXR;PRKAA2;LIPH;LIPC;PRKAA1
prerank,regulation of fat cell differentiation (GO:0045598),0.2905349918075008,0.9760901812687758,0.4780405405405405,0.8706096775749865,1.0,11/74,10.39%,RORA;MEDAG;RUNX1T1;ANKRD26;TMEM64;IL6;SMAD3;LMO3;SYAP1;TAF8;ASXL2
prerank,cochlea morphogenesis (GO:0090103),-0.42450079537584673,-0.9759338502178804,0.5259259259259259,0.7735172718651454,1.0,8/10,49.88%,TBX1;MYO3B;MYO3A;PAX2;TIFAB;HOXA1;HPN;POU3F4
prerank,skin development (GO:0043588),-0.2738805518127622,-0.9757874608693403,0.5343511450381679,0.773258181251888,1.0,18/65,18.17%,ITGA6;CLIC4;JAG1;LSR;ITGB4;COL5A2;PKD1;MET;BCR;WNT16;HRNR;ALOX12;STMN1;COL1A1;COL3A1;COL5A3;ADAM9;DSP
prerank,post-translational protein modification (GO:0043687),0.24253205513054052,0.9757356166925784,0.5133418043202033,0.870698636882074,1.0,55/332,13.27%,ASB2;CP;FBN1;APLP2;EPAS1;ITIH2;SDC2;TNC;SERPIND1;SPSB1;HIF3A;RAB13;PRKCSH;PCSK9;IGFBP4;OBSL1;NEURL2;FBXW4;DDB2;DCAF4;GPC3;PSME4;PSMA2;RBBP7;FBXO44;IL6;CAND1;F5;CCDC8;PSMA3;CUL9;CSF1;DCAF10;MIA3;CHRDL1;FSTL3;CUL7;KLHL11;FEM1B;FBXO6;ASB3;PSMD8;IGFBP7;KBTBD7;UBA3;PSMD3;FBXO4;KLHL22;CUL4B;FBXO11;SENP8;ASB5;FSTL1;ESCO1;P4HB
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.34979672859978583,-0.9754538002047277,0.4989648033126294,0.7734765667731288,1.0,11/22,31.82%,UBB;RPS27A;UBC;DDB1;RBX1;UBA52;CETN2;GTF2H2;XPA;ERCC3;GTF2H5
prerank,regulation of Golgi organization (GO:1903358),-0.3645964254736105,-0.9753248040117962,0.49903660886319845,0.7731768613934538,1.0,8/17,28.52%,PDE4DIP;PDCD10;MYO5A;EHD3;MAP2K2;MAPK3;CAMSAP3;STX5
prerank,regulation of cell death (GO:0010941),-0.253816816570487,-0.974851948153918,0.5244565217391305,0.7737428203717315,1.0,25/94,16.16%,ACER3;ACER2;PDE8A;UBB;CCN3;SOX4;NCK1;FERMT2;FAF1;DCC;TNFRSF1B;CHP1;CRYAB;WNT16;EIF4G1;APC;CDKN1B;EPHB1;CLU;SRSF6;CCN1;MT3;TRIM13;CTSZ;PRKD1
prerank,calcium ion transport into cytosol (GO:0060402),0.37647849944769235,0.97481882237065,0.4904580152671756,0.8721612473825403,1.0,3/21,7.35%,JPH1;SLC8A1;CACNA2D1
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.23829458328814665,-0.9746504707057281,0.536741214057508,0.7736251922530757,1.0,60/144,28.73%,PRR5L;GAS6;CDH1;PPP1R13B;SREBF2;FYN;SH3GLB1;KCNB1;FLNA;TGFB1;NMT1;YWHAB;GSK3B;CHP1;PDCD10;ZDHHC2;MAPK8;C2CD5;TMEM30A;OAZ1;YWHAG;MIEF1;RIPOR1;BBC3;CD81;JUP;MIEF2;MTCL1;ARIH2;CASP8;VPS11;YWHAQ;YWHAH;ZC3H12A;SEC16B;PINK1;PSEN1;PPP3R1;ANK3;PRKCD;RBM22;TOMM7;HYAL2;ZPR1;HUWE1;HRAS;SEC16A;SORL1;MICALL2;YWHAZ;PCM1;RNF31;PPP3CC;FIS1;ITGB2;ABLIM3;HDAC3;BID;TM9SF4;SFN
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.3568413988909648,0.9744297296105663,0.48653846153846153,0.8722729789030272,1.0,5/26,6.69%,LARGE1;B3GNT5;GAL3ST2;ALG6;ALG2
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.34336872039257593,-0.9744155750965473,0.488659793814433,0.7736226288986584,1.0,4/21,3.28%,MTUS1;THBS1;PTK2;PTK2B
prerank,7-methylguanosine RNA capping (GO:0009452),0.3412040428368077,0.9743449090236288,0.4812623274161736,0.8707948205586137,1.0,4/31,8.49%,POLR2D;CDK7;POLR2A;GTF2F1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3412040428368077,0.9743449090236288,0.4812623274161736,0.8707948205586137,1.0,4/31,8.49%,POLR2D;CDK7;POLR2A;GTF2F1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.41105579957291966,-0.9743038781460089,0.51252408477842,0.773250799488083,1.0,3/11,5.79%,KANK1;CORO1C;CD44
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.4141961778132021,-0.9742569554415172,0.5089108910891089,0.7727444202094408,1.0,1/10,0.19%,PRKCH
prerank,glycine transport (GO:0015816),0.43574350472512346,0.9735044059828307,0.48497854077253216,0.8720148989368443,1.0,3/10,12.76%,SLC6A9;SLC36A2;SLC25A38
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4065711735447035,0.9733900680069001,0.47784200385356457,0.8714488288599246,1.0,3/15,11.22%,LARGE1;CHST3;RENBP
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.29693866087505616,0.9732275870017558,0.5060034305317325,0.8709881153102517,1.0,12/69,12.01%,IGF1;PLCB1;PDGFRB;PDGFRA;IGF1R;PTEN;GPR143;MYO16;PIK3R1;RPS6KB1;ERBB2;PLCD1
prerank,regulation of actin filament-based process (GO:0032970),0.2961854465960451,0.9731954873092943,0.47884940778341795,0.8702244726136187,1.0,9/70,7.67%,ROCK2;EPHA3;RHOD;PDGFRB;BAIAP2;CNN2;RICTOR;ARHGAP35;RHOBTB2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.39652963808246317,-0.9731749816025356,0.5201535508637236,0.7748134008684534,1.0,8/13,32.29%,TMEM30A;CD81;BCAP31;SEC16B;SEC16A;SORL1;TM9SF4;TMEM30B
prerank,actin filament depolymerization (GO:0030042),0.43198825059727336,0.9727449490171625,0.509765625,0.8705194286923752,1.0,1/11,0.33%,MICAL3
prerank,phosphate ion transport (GO:0006817),0.3997649627755166,0.9726698018348192,0.508,0.8698573368217194,1.0,4/16,9.59%,SLC20A2;SLC34A3;SLC25A11;SLC20A1
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.4214811496752334,-0.9724592815004299,0.5091911764705882,0.7759647742565844,1.0,4/10,15.75%,CTNNB1;VEGFA;DISC1;CX3CR1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3728728076584529,0.9724574211645313,0.5009861932938856,0.8695228267936128,1.0,2/20,1.82%,PID1;DAB2
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.378716901604102,-0.9724370911983783,0.5050100200400801,0.7753989040116867,1.0,5/14,27.84%,MSN;RHOA;CAMSAP3;EZR;FOXJ1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3745539239542752,0.9720575770852657,0.4962121212121212,0.8697198942229647,1.0,9/22,18.67%,FTSJ3;ERI3;ERI2;EXOSC8;NOL9;ERI1;NOP9;EXOSC3;NOP14
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3235624498674573,-0.9719435438868559,0.48804780876494025,0.7759993797516707,1.0,8/26,14.44%,ITPR2;PLCG2;PTPRC;RYR2;HTR2A;IBTK;ERO1A;ITPR3
prerank,regulation of JUN kinase activity (GO:0043506),-0.30895672433174043,-0.9717863858826449,0.48366013071895425,0.7757602696112936,1.0,9/33,10.23%,MAP3K5;DAB2IP;RPS3;DNAJA1;TNFRSF11A;PDCD4;PAK1;EDN1;ARHGEF5
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.25482822040279096,0.9715718124301292,0.5268361581920904,0.8700876340259786,1.0,37/208,15.54%,RORA;WLS;PRKN;PELI2;LPAR1;PDPK1;LTF;ECM1;TRIM5;AKAP13;ZFAND6;GJA1;CACTIN;UFL1;PRKCB;CXXC5;OPTN;NLRC3;CCL19;TLE1;SLC20A1;GOLT1B;IKBKE;CFLAR;GPRC5B;TBK1;MAP3K7;UNC5CL;MAPKBP1;UBE2V1;MTDH;NLRP12;NLRX1;BIRC2;TRIM62;CX3CL1;TMEM9B
prerank,B cell mediated immunity (GO:0019724),-0.42988593194021113,-0.9710708297451168,0.5217391304347826,0.7768957331279606,1.0,8/10,54.01%,MSH2;CD74;FCGR2B;TLR8;CARD9;SLA2;CD27;CD19
prerank,regulation of cholesterol esterification (GO:0010872),-0.41988886169190776,-0.9710089222931346,0.5196850393700787,0.7764193358509358,1.0,6/10,31.98%,LAMTOR1;AGTR1;ABCA2;ABCG1;AGT;STARD4
prerank,regulation of muscle cell differentiation (GO:0051147),-0.3105575555986142,-0.9709822532871837,0.5042016806722689,0.7758588812203371,1.0,13/31,22.51%,MEF2C;CDH2;CDON;CTNNB1;BNIP2;BOC;TCF3;ID2;CTNNA1;PTBP1;HDAC9;SPAG9;MAPK11
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.366855722041727,-0.9706555178055899,0.47504621072088726,0.7760302413495197,1.0,6/17,16.98%,JAG1;CD55;STAT3;MSH2;IL18BP;BTN3A3
prerank,regulation of vasculature development (GO:1901342),-0.3286849403302625,-0.9704208712903859,0.4875,0.7760143327699501,1.0,6/26,8.12%,BMPER;PLXND1;ETS1;WARS1;CTNNB1;EMP2
prerank,cellular macromolecule catabolic process (GO:0044265),0.3139808064424281,0.9702392070070506,0.5017361111111112,0.87258298013261,1.0,9/49,14.75%,ADAMTS9;PRKN;FBXO44;SIAH2;FBXO6;SND1;NGLY1;RAB12;HTRA2
prerank,regulation of ion transport (GO:0043269),0.29361827756253545,0.9701393474946625,0.49829931972789115,0.8719910592606783,1.0,9/76,4.99%,PRKN;SNX6;KCNA5;NKAIN4;DTNBP1;NEDD4;SYT11;SYT12;SIK1
prerank,positive regulation of insulin secretion (GO:0032024),0.3345978522999753,0.9700915827909761,0.49554367201426025,0.871274502782893,1.0,5/36,7.95%,TCF7L2;RBP4;NLGN2;MCU;SLC30A8
prerank,protein localization to mitochondrion (GO:0070585),0.4313331878494712,0.9699731431276231,0.5092783505154639,0.8707322925878324,1.0,3/11,6.59%,HK2;LRRK2;MAIP1
prerank,response to hexose (GO:0009746),0.3580139545252596,0.9697799030603411,0.5103578154425612,0.8703940220427324,1.0,1/25,0.51%,TCF7L2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.40808038783537603,0.969108853413184,0.501984126984127,0.8712280061678377,1.0,2/13,1.17%,PPARA;PID1
prerank,sulfation (GO:0051923),0.43359470407014417,0.96891437816757,0.4939516129032258,0.8708598729647274,1.0,2/11,11.32%,UST;SULT4A1
prerank,cellular response to chemical stress (GO:0062197),-0.24911796557337873,-0.9687472129646247,0.5241935483870968,0.779456050994135,1.0,35/96,28.21%,CAV1;PRR5L;LRRC8D;PPARGC1A;PPIA;ATG7;CHCHD2;SOD1;FOXO1;SESN2;ATF4;VKORC1L1;GSR;ERO1A;MT3;FAS;CYBB;PRKD1;ATP13A2;STX2;ZC3H12A;GPX7;PINK1;PYROXD1;CYCS;HSPA1B;PYCR2;PRDX6;KEAP1;PRDX1;GPX8;GPX3;TRPV4;CAT;TMEM161A
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.32019805170611715,-0.9679911694290874,0.510593220338983,0.7806298894471514,1.0,9/27,20.96%,TGFB1;PUM2;DDX5;EIF4G1;LIMD1;STAT3;MAP2K2;BMP4;FMR1
prerank,calcium ion homeostasis (GO:0055074),0.28388127877309843,0.9678950713329325,0.513302034428795,0.8725354305203267,1.0,8/95,3.96%,SLC24A3;SLC8A3;STIM1;CSRP3;SLC8A1;DMPK;FAM20A;ANK2
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.2977941497190376,-0.9670811580687968,0.48370927318295737,0.7822867414353574,1.0,10/40,20.17%,LBP;PGLYRP1;GBP4;DEFA6;CHGA;ROMO1;RNASE3;TIRAP;MYD88;ANG
prerank,response to fatty acid (GO:0070542),0.39297306244333885,0.9670363160608976,0.5205761316872428,0.8738429346240585,1.0,1/17,1.17%,PID1
prerank,male gonad development (GO:0008584),0.32914614813041765,0.9670339833483297,0.5195035460992907,0.8730224185519236,1.0,3/34,5.73%,WNT4;KIT;LRP2
prerank,regulation of B cell activation (GO:0050864),-0.3282953573646221,-0.9669733067393578,0.5334728033472803,0.7819019263637222,1.0,12/25,34.83%,SH3KBP1;AHR;ZFP36L1;SAMSN1;LAPTM5;TNFAIP3;FCGR2B;FOXJ1;IL4I1;NOD2;IKZF3;THEMIS2
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.39443685859665895,-0.9669354299010471,0.5120481927710844,0.7813824151368143,1.0,2/12,1.98%,CSGALNACT1;FUT8
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.4013243484131242,0.966907556941353,0.4767932489451477,0.8724958272639216,1.0,3/13,12.17%,BMP7;NAPEPLD;SOX13
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.263650555871629,0.9668350582272901,0.5128593040847201,0.8718301655888303,1.0,21/148,12.39%,PRKAG2;PRKAG3;PDPK1;ATRIP;MAP2K6;RBBP4;RICTOR;PRKAA2;RBBP7;BANP;BLM;CHD4;PRKAA1;USP7;CDK1;MDM2;MLST8;HDAC1;TAF3;PRKAG1;TTC5
prerank,regulation of phospholipase C activity (GO:1900274),0.4001844400834817,0.9665821420388853,0.48502994011976047,0.8716342050741575,1.0,3/15,4.40%,KIT;PDGFRB;PDGFRA
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.4446041847569382,0.9662368426769281,0.5170212765957447,0.8716525816911854,1.0,1/10,0.98%,APPL2
prerank,positive regulation of cytokine production (GO:0001819),-0.21185395850690708,-0.9656787994347373,0.611353711790393,0.7838994890845357,1.0,78/292,24.18%,SPTBN1;FOXP1;CADM1;PDE4D;LRRFIP1;IL33;CD200;SLC7A5;CD34;RUNX1;F3;PLCG2;MBP;LBP;RPS3;NOD1;RFTN1;G3BP1;TGFB1;CTNNB1;PTPRC;SOD1;IL1R1;GAPDH;APP;FLT4;CYRIB;PTGS2;APPL1;PAEP;XBP1;PIK3CD;ISG15;STAT3;ATF4;GBP5;CRCP;RAB1A;STOML2;CD74;HSPD1;ARHGEF2;TMED10;NR1H4;CSF1R;CYP1B1;IFIH1;LAPTM5;MIF;CD274;CD40;IL15;IRAK1;IRF5;TIRAP;TRIM27;MYD88;TYROBP;TXK;SLC11A1;POLR3D;HPSE;C3;S100A13;MAPK11;HYAL2;CEBPB;NFKB2;AFAP1L2;RELA;HSPA1B;AGER;RGCC;CD80;CRLF2;CCR2;POLR2L;POLR3F
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.27805200263791247,-0.9655520360450105,0.5182648401826484,0.783595893592459,1.0,20/52,22.30%,MBNL1;NOVA2;RBFOX1;RBFOX3;RBFOX2;HNRNPU;DDX5;ZBTB7A;RBM8A;REST;KHDRBS3;RNPS1;SRSF6;DDX17;YTHDC1;PTBP1;MAGOH;FMR1;TRA2B;RBM24
prerank,regulation of cellular catabolic process (GO:0031329),0.2999973967186944,0.9653841065989209,0.4906937394247039,0.8729296652466105,1.0,8/62,10.44%,ITPR1;DAPK1;PRKN;MTMR3;LRRK2;KAT8;NUPR1;ABL1
prerank,rRNA modification (GO:0000154),-0.34390477805949105,-0.9653355174662485,0.5142314990512334,0.7834733378371479,1.0,8/21,21.04%,TFB2M;BUD23;FBL;TSR3;NSUN4;MRM2;THUMPD1;NHP2
prerank,negative regulation of chemokine production (GO:0032682),0.405751939215518,0.9653148037021803,0.4845814977973568,0.8722567468872403,1.0,3/14,9.05%,C1QTNF3;IL6;SIRPA
prerank,linoleic acid metabolic process (GO:0043651),0.39323558980862994,0.9650076496433253,0.4980392156862745,0.8721809796661923,1.0,2/17,2.58%,ACSL1;GSTM2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.3482277274159133,0.9649851867607719,0.4955116696588869,0.87141831496095,1.0,5/30,8.62%,KIT;HOXB4;ACE;UFL1;FSTL3
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.26010239549107816,-0.9635887927377348,0.5319693094629157,0.7871047729641456,1.0,26/75,22.86%,PTPRJ;HEG1;STK38;RASIP1;DAB2IP;LRP5;UCHL1;APC;CDKN1B;PTPN1;HHEX;MEN1;SPRY4;IRAK3;PRKAR1A;NF1;DUSP1;SH2B3;TFAP4;PRKCD;AKT1;BMP4;CD300A;GADD45A;HYAL2;CEBPA
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.40248538446870996,-0.9635130662566398,0.5,0.7866777319343681,1.0,7/11,39.29%,STAT3;CANX;JAK1;STAT1;IL12RB2;IL6ST;IL12A
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.3268340588439796,-0.9634461658347946,0.5160642570281124,0.7862190059733114,1.0,7/26,12.32%,FBXO7;PDE8A;FYN;PPIA;HSPB1;ATF4;REST
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.3983604724864127,-0.963260343494367,0.5125,0.7860397312444121,1.0,6/13,13.40%,DAB2IP;PTPN1;HGS;HHEX;EPN2;CADM4
prerank,regulation of fibroblast proliferation (GO:0048145),0.31701942165829444,0.9632314073060738,0.4850615114235501,0.8748229613329197,1.0,5/45,7.50%,IGF1;PDGFRA;SPHK1;NLRC3;DDR2
prerank,blood vessel diameter maintenance (GO:0097746),0.32962827798706806,0.9629988520503794,0.5099099099099099,0.8745627511639826,1.0,4/34,6.13%,ROCK2;BDKRB2;ACE;SCPEP1
prerank,regulation of protein export from nucleus (GO:0046825),0.36227907692321554,0.9628468483496055,0.503921568627451,0.8741107938054244,1.0,2/23,2.89%,TCF7L2;SP100
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.29778111979411603,-0.962623339274994,0.5205479452054794,0.7869224080397677,1.0,13/31,25.95%,HSPA8;ATXN3;DAB2IP;HSPA14;HSPA5;PTPN1;HSPB8;TMBIM6;HSPA9;HDAC6;HSPA1B;BAX;ERN1
prerank,positive regulation of nervous system development (GO:0051962),-0.29491020880471014,-0.9626048418132627,0.5154867256637168,0.7863598792878831,1.0,17/42,24.82%,TGM2;CLSTN2;SERPINF1;IL1RAP;NRXN1;SYNDIG1;EPHB1;GPER1;CLSTN3;CX3CR1;SPEN;LIG4;GRID2;SOX11;LRRC4B;FAIM;EPHB3
prerank,cellular response to exogenous dsRNA (GO:0071360),0.4336352412577504,0.9625577854286745,0.5010482180293501,0.8740040306257535,1.0,1/12,0.45%,COLEC12
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.33858885331845107,0.9623884087111524,0.4962825278810409,0.8735534440593745,1.0,6/33,12.90%,APPL2;STXBP4;PLK5;PTEN;CDC73;INO80
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3203488510875009,-0.9620250860511838,0.5215605749486653,0.7871764182876835,1.0,6/29,12.72%,ESR1;RUNX1;CBFB;PAK1;WBP2;VPS18
prerank,negative regulation of blood coagulation (GO:0030195),-0.29432729543798525,-0.9617879230211656,0.5162790697674419,0.7871432902325646,1.0,7/38,12.47%,NOS3;CD34;F3;SERPINE2;A2M;EDN1;THBD
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3308160871397138,-0.9616634342687518,0.5,0.7868134217402216,1.0,9/22,23.10%,B2M;HES1;CALR;GSK3B;REST;DISP3;SOX2;DLL1;HEY1
prerank,stem cell development (GO:0048864),-0.36143713126905364,-0.9615909015353561,0.4942528735632184,0.7863692701914695,1.0,9/16,33.49%,CDH2;PTPRC;NOLC1;SOX11;SNAI2;SHH;PEF1;WNT7A;KBTBD8
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.3732369741379017,-0.9614545483248068,0.5352941176470588,0.7860735412590408,1.0,8/15,31.09%,GBP5;USP50;NLRP2B;MYD88;TREM2;TLR4;CD36;TLR6
prerank,negative regulation of DNA binding (GO:0043392),-0.3206439525883212,-0.961434270275121,0.5267857142857143,0.7855116972833096,1.0,8/28,23.10%,LEF1;NFKBIA;JUN;HEY2;SUMO3;TFAP4;SOX11;HEY1
prerank,negative regulation of hemostasis (GO:1900047),0.4215198845756025,0.9613572664641189,0.5126050420168067,0.8752993366761223,1.0,4/12,12.56%,TFPI;VTN;APOH;SERPINE1
prerank,positive regulation of intracellular transport (GO:0032388),-0.29913126075801727,-0.9609541936422136,0.5123042505592841,0.7860344213144207,1.0,21/38,39.03%,PRR5L;EHD1;PDCD10;OAZ1;RIPOR1;NUMA1;MLC1;SPAG5;CAPN10;SORL1;PCM1;CEP131;PGAP1;DYNC1H1;ATP2A1;STK11;PCNT;PLK3;OAZ2;EIPR1;EHD2
prerank,negative regulation of binding (GO:0051100),0.28615246961514623,0.96082639845503,0.49917627677100496,0.875805964098054,1.0,10/81,9.66%,ARHGAP28;DAB2;DKK1;SP100;IFIT2;LRRK2;PSME3IP1;RSF1;GTF2F1;GOLGA2
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.2983277468496944,0.9607476423734185,0.534453781512605,0.8751796342967885,1.0,17/64,20.95%,POLR2D;CDK7;ELOA;POLR2A;CCNT2;CCNT1;GTF2F1;CDC73;MNAT1;NELFB;TCEA1;SETD2;CTR9;ELL;CDK9;ELP2;PAF1
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.3419065539437335,-0.9604328855352718,0.492,0.7866872455138139,1.0,12/21,33.28%,DUSP3;SAMSN1;LAPTM5;JAK3;TNFAIP3;SOX11;FCGR2B;FOXJ1;LAX1;IL4I1;PTPN22;GPNMB
prerank,regulation of lamellipodium assembly (GO:0010591),0.33553400045752235,0.9604154302483933,0.5110294117647058,0.8751346876767838,1.0,7/34,11.05%,AUTS2;AVIL;FER;ABI2;CAPZB;PIK3R1;EPHA2
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.30183170573267165,-0.96013642756854,0.5273522975929978,0.7867846228236748,1.0,12/33,16.38%,NGF;GRIK4;ABR;LRP8;BCR;BTBD9;SLC4A8;PXK;RELN;NRG3;CX3CR1;CACNA1B
prerank,C4-dicarboxylate transport (GO:0015740),0.40397376946691127,0.9592824801400576,0.5203883495145631,0.8771014308894953,1.0,5/14,9.27%,SLC25A18;SLC13A5;LRRC8E;SLC25A11;SLC25A22
prerank,negative regulation of axonogenesis (GO:0050771),-0.32402588814322636,-0.9590910095385434,0.524416135881104,0.7888026775270939,1.0,11/27,21.35%,ARHGDIA;DCC;RHOA;RTN4;SEMA3G;EFNB3;CDKL3;MT3;GDI1;THY1;RTN4R
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.3144646416059624,-0.9586726231719689,0.5480349344978166,0.7891932127652413,1.0,5/29,12.39%,BMP5;DAB2IP;IL17RD;SPRED2;SDHAF2
prerank,apoptotic mitochondrial changes (GO:0008637),0.33583889701862574,0.958600742099726,0.5,0.8779634007767242,1.0,4/32,6.51%,HK2;BCL2;IFIT2;BNIP3
prerank,regulation of biomineral tissue development (GO:0070167),0.3523556921027436,0.958443150779028,0.49714285714285716,0.8775305390929528,1.0,3/26,3.12%,ROCK2;BMP2K;ECM1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.3990263789049157,0.9583561826981924,0.5206286836935167,0.8769390772473965,1.0,1/16,0.34%,LEPROT
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2520789156958542,0.9582588181804479,0.5351506456241033,0.8763503911663474,1.0,21/214,7.56%,EPHA7;TGFBR3;FGFR2;FGFR4;NOTCH2;TIMP3;ANGPT1;MTURN;CCN2;PDGFRB;DUSP10;PDGFRA;GLIPR2;PDGFD;PRKCZ;FBLN1;DLG1;LMO3;PRKCA;PTEN;CCL19
prerank,protein tetramerization (GO:0051262),0.2932903403811837,0.9581096968293731,0.5104166666666666,0.8759177206583267,1.0,11/67,13.99%,ALDH1A2;APPL2;UPB1;CBY1;HSD17B10;SSBP1;GOLGA2;OXA1L;PKD2;SHMT1;CRYZ
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.30910339697396616,-0.9579716250399867,0.5246252676659529,0.7902979070211894,1.0,9/31,14.11%,DLG2;MSN;LIN7A;WDR1;RHOA;MARK2;SYNJ2BP;ERBIN;MTCL1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.2519341441929103,-0.9576936543678733,0.5504087193460491,0.7903826860439175,1.0,30/88,26.17%,FBXL3;FBXL5;PSMD13;PSMF1;RBX1;PSMB10;FBXO31;FBXL20;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;PSMB3;FBXL2;CCNF;FBXL14;PSMD5;FBXO17;SKP1;FBXO9;PSMD9;PSMB4;CUL2;DMAC2;KIF14;PSMD10
prerank,regulation of establishment of cell polarity (GO:2000114),0.39235473658247033,0.9576154628574264,0.5292929292929293,0.8762764790279977,1.0,2/16,3.63%,ROCK2;RIPOR2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.2585180908861359,-0.9575856847744294,0.5413533834586466,0.7900324080035198,1.0,22/74,15.79%,NOTCH1;UBB;RPS27A;UBC;EGLN3;VEGFA;PSMD13;PSMF1;RBX1;PSMB10;LIMD1;PSMB6;PSME3;PSMB5;EGLN2;PSMC3;PSMD12;PSMB8;ELOB;PSME1;UBA52;PSMB3
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.40416690061017546,-0.9574289920272382,0.5178236397748592,0.7897887322920066,1.0,6/11,12.45%,SEMA6A;KLF2;THBS1;CREB3L1;SYNJ2BP;EPN2
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.33903011415181805,0.9570618677348376,0.501984126984127,0.8767666392492403,1.0,4/29,8.73%,TERB2;HORMAD1;TEX11;MAJIN
prerank,natural killer cell activation (GO:0030101),-0.3292472495636287,-0.9567865292235489,0.5379876796714579,0.7907715103529231,1.0,10/23,29.88%,PTPRC;BAG6;PIK3CD;RABL3;CASP8;ULBP1;TOX;SNX27;PRDX1;RASGRP1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.3220300458604237,-0.9565647888900569,0.5126050420168067,0.7907015519291631,1.0,15/27,32.22%,ETS1;CD44;CYRIB;RHOA;HSPD1;CD47;IRAK1;THY1;RELA;CCR2;SKAP1;CCL2;ITGB2;NR4A3;MDK
prerank,bile acid biosynthetic process (GO:0006699),0.35936425510402537,0.9565188179559391,0.5180722891566265,0.877235849556161,1.0,2/24,5.65%,CYP27A1;HSD17B10
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.2911230605730996,-0.9564768304495365,0.5101123595505618,0.7902936095992734,1.0,16/41,29.66%,KCNJ2;KCNMA1;FLNA;KCNQ1;KCNMB4;NOS1;ACE2;KCNN2;KCNJ15;ANK3;KCNH2;KCNJ6;GABBR1;GNB1;KCNJ16;KCNJ10
prerank,positive regulation of synapse assembly (GO:0051965),-0.32089547925903894,-0.9564546115632954,0.5310492505353319,0.7897375818293706,1.0,8/27,12.02%,AGRN;SEMA4D;CLSTN2;IL1RAP;NRXN1;SYNDIG1;EPHB1;CLSTN3
prerank,cellular response to misfolded protein (GO:0071218),-0.33937469818426175,-0.9563876519679693,0.5076923076923077,0.7892786142233853,1.0,7/20,21.92%,ATXN3;BAG6;CUL3;DERL1;AUP1;RNF5;VCP
prerank,negative regulation of response to external stimulus (GO:0032102),0.27617581675635194,0.9557311034519026,0.5319148936170213,0.8783582983048553,1.0,21/105,17.24%,RORA;C1QTNF3;PPARA;LTF;EPHA4;CACTIN;NLRC3;PTEN;LYAR;SIRPA;ITCH;ENPP3;PCBP2;SERPINE1;MAPKBP1;NLRP12;PTGER4;CDH5;TRAFD1;DRD2;VPS35
prerank,positive regulation of protein metabolic process (GO:0051247),-0.2391775681932057,-0.9551797180525078,0.5806451612903226,0.7915866472272116,1.0,26/110,13.03%,WWP1;KLF2;NSF;KLF4;NEDD4L;DAB2IP;NFKBIA;ATG7;TGFB1;PLK2;GSK3B;APP;ABCB10;FOXO1;DDB1;MAPK8;PAEP;EIF4G1;OAZ1;APC;CDKN1B;NDUFA13;RAB1A;EGLN2;CLU;IDE
prerank,phospholipid biosynthetic process (GO:0008654),-0.30111838897181153,-0.9551643008985441,0.5340425531914894,0.7910120399263844,1.0,6/36,8.81%,SGMS1;SGMS2;MBOAT1;CRLS1;FAR1;CPNE3
prerank,protein insertion into membrane (GO:0051205),-0.3013611332910208,-0.9549957189033194,0.5413043478260869,0.7907982468870451,1.0,13/32,32.24%,REEP1;STX1A;APP;CCDC47;SEC61G;GET4;VAPA;OTOF;RTP4;WDR83OS;STX5;SEC61B;UBE2J2
prerank,positive regulation of cilium assembly (GO:0045724),-0.3520223399253627,-0.9548612001241691,0.50390625,0.7904614721456568,1.0,5/18,17.71%,CCDC88A;SEPTIN9;KCTD17;WRAP73;ENTR1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.37871903385814276,0.9548143021562644,0.5264187866927593,0.8798654387833699,1.0,4/18,14.83%,RAD51B;RAD51C;CDK1;CDK4
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.37440038755383326,0.9547638527914001,0.5313807531380753,0.8791779221445213,1.0,4/21,10.46%,SLC8A3;MAIP1;MCU;MICU1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.37248291734847505,-0.9543716250077895,0.5231660231660231,0.7910382067594739,1.0,3/16,9.24%,ST3GAL4;ETS1;RHOA
prerank,carbohydrate biosynthetic process (GO:0016051),0.3756184122906797,0.9538610670262956,0.5098425196850394,0.8805783564996386,1.0,3/21,4.55%,B3GALT1;ST3GAL3;B4GALT1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.24485941139654466,-0.9536768041228765,0.5422343324250681,0.7921364659829472,1.0,23/94,15.67%,MAP3K5;FNIP2;PPP1R13B;DAB2IP;TMEM117;CRIP1;BCL2L1;BAG6;TNFRSF1B;ATP2A3;CUL3;CHEK2;DDX5;ATF4;HINT1;PDK2;MYBBP1A;SELENOK;ERO1A;BBC3;CUL1;CYP1B1;DNAJC10
prerank,positive regulation of histone deacetylation (GO:0031065),-0.3903642022919779,-0.9534253626986264,0.5343811394891945,0.7921539959160443,1.0,5/12,17.35%,VEGFA;APLNR;AKAP8;PRKD1;CTBP1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.41203564220145333,0.9534227647702618,0.5042194092827004,0.8808598490642604,1.0,4/13,13.89%,PPARA;NFIB;NFATC4;SRF
prerank,cellular response to ionizing radiation (GO:0071479),-0.2815956325722094,-0.9533646554800291,0.5346062052505967,0.7916985506021513,1.0,16/47,25.32%,NET1;RPL26;RHOB;EEF1D;CRYAB;SPIDR;TNKS1BP1;RAD9A;ATR;LIG4;TLK2;GADD45A;CDKN1A;TMEM109;HRAS;TSPYL5
prerank,regulation of cell communication (GO:0010646),0.3322450282004261,0.9524580917707364,0.5258467023172906,0.8823176110108748,1.0,10/35,13.12%,SLC8A1;ANXA1;ANK2;GRK3;GRK5;CAMK2D;GRK4;IGFBP7;TSPYL2;VEPH1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3331569576475326,0.9521385375021099,0.5209059233449478,0.8822783753031403,1.0,4/35,6.76%,LEPROT;KIT;PIGU;IL6
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.37144875737307514,0.9521188386828272,0.5346938775510204,0.8815163658296127,1.0,2/19,2.20%,IL34;CAMK1D
prerank,adipose tissue development (GO:0060612),-0.4045523109754557,-0.9520473974954091,0.5477099236641222,0.7941808337552791,1.0,4/11,10.15%,SPTLC2;NAMPT;LRP5;XBP1
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.3295457321013905,-0.9519765458590757,0.5382978723404256,0.7937424355054292,1.0,7/22,25.12%,SLC7A5;TNFRSF1B;LAPTM5;TRPM4;TRIL;CCR2;SPHK2
prerank,digestive tract development (GO:0048565),0.3430784110515846,0.9519499283647825,0.5083179297597042,0.8811027676439053,1.0,6/32,10.55%,FGFR2;KIT;GLI3;SALL1;BBS7;COBL
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.28131493047351463,0.9518820590478857,0.5130718954248366,0.8804673494965395,1.0,10/80,7.56%,AUTS2;DOCK11;DPYSL3;AVIL;RIPOR2;ABI2;WASL;ARHGAP35;EPS8L1;CCL19
prerank,L-amino acid transport (GO:0015807),-0.3148316819696383,-0.9515095927981028,0.5283842794759825,0.7942245873034014,1.0,8/28,12.14%,SLC7A5;SLC7A1;SFXN1;SLC1A1;SLC38A5;SLC3A2;SLC36A1;SLC1A4
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.29310850656855225,-0.9510544086810184,0.5074309978768577,0.7947332378962783,1.0,13/38,18.75%,CAV1;KCNJ2;CACNA1G;KCNQ1;CTNNA3;CACNA1C;BIN1;CACNB2;JUP;DSG2;SCN1B;DSP;TRPM4
prerank,protein depolymerization (GO:0051261),0.3486156172711091,0.9509741003247519,0.5433628318584071,0.8818047095773767,1.0,2/27,1.98%,MICAL3;KIF2A
prerank,action potential (GO:0001508),0.311731376380768,0.9505549400538694,0.5063063063063064,0.8820279383463847,1.0,2/44,1.48%,SCN7A;DMD
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.3294557284831895,-0.9503314365516861,0.5078299776286354,0.7958661870727587,1.0,5/26,12.46%,CAV1;LBP;RTN4;IFI35;RSAD2
prerank,regulation of cilium movement (GO:0003352),0.4364966850981419,0.9501251755415959,0.5372807017543859,0.8822400315705528,1.0,4/10,15.00%,DNAH11;CFAP298;CCDC65;ODAD2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.25397758048507557,-0.9496961498430287,0.559322033898305,0.7968113044441445,1.0,19/73,16.11%,HIP1;ACER2;F3;NGF;RACK1;TNFSF10;NOD1;EGLN3;ATP2A3;HIP1R;XDH;HSPD1;CASP8AP2;RPS27L;BBC3;DAP;FAS;CASP8;LAPTM5
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2405898080818882,-0.9496501719553839,0.5902578796561605,0.7963343606648884,1.0,29/109,15.50%,PIP5K1B;PITPNM2;PLCG2;INPP5D;BMX;PIK3R6;INPP4A;SYNJ1;PIK3C2B;ARF1;CDS1;CDIPT;PLCB3;PLEKHA1;PIK3CD;PIK3C2A;MTM1;MTMR6;PITPNM3;PIK3R5;PIK3C3;MTMR9;INPPL1;SACM1L;PIP5K1C;CSF1R;SBF1;PLA2G4A;PI4KB
prerank,cellular response to nutrient levels (GO:0031669),-0.2665084304569877,-0.9496259675583757,0.5490196078431373,0.7957953538328754,1.0,15/62,12.16%,HSPA8;SREBF2;BMPR2;ATG7;KCNB1;FAM107A;MAP1LC3B;MTOR;MFSD2A;FOXO1;EIF4G1;XBP1;RALB;RIPOR1;PDK2
prerank,positive regulation of interleukin-17 production (GO:0032740),0.36228448790325896,0.9494074722933757,0.5238970588235294,0.8831697941207638,1.0,4/22,8.61%,IL18;SPHK1;IL6;SLAMF6
prerank,pyroptosis (GO:0070269),0.3911721580757527,0.9492718353001314,0.5334685598377282,0.8827050621404272,1.0,4/15,13.35%,GSDMA;GSDMD;GSDME;ZBP1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.3654218656976768,-0.9492605876340421,0.5443548387096774,0.796105021462809,1.0,10/16,48.33%,RBMXL1;TRA2B;PRDX6;DAZAP1;CELF4;CELF3;SF3B4;RBM3;TRA2A;NCBP1
prerank,vesicle organization (GO:0016050),-0.28230764068438025,-0.9490347082554119,0.5235732009925558,0.7960329737872959,1.0,14/46,17.81%,CAV1;CD34;FNBP1L;CAV2;CHMP2B;ALS2CL;SRGN;LAMTOR1;USP50;DNM1;VPS18;HOOK1;VPS11;USP8
prerank,isotype switching (GO:0045190),-0.41202785894058946,-0.9484283865552189,0.541015625,0.796917656374987,1.0,5/10,29.16%,MSH2;HSPD1;LIG4;RNF168;RNF8
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.25281594911876865,-0.9482122684459824,0.550251256281407,0.7968408718375009,1.0,17/70,15.86%,LMO2;RUNX1;CBFB;GATA2;PSMD13;PSMF1;PSMB10;PSMB6;TAL1;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;TCF3
prerank,regulation of stem cell differentiation (GO:2000736),-0.24363797595847209,-0.9473623871252418,0.5641025641025641,0.798264581896916,1.0,21/89,15.86%,LMO2;RUNX1;JAG1;CBFB;NOTCH1;HES1;GATA2;HNRNPU;PSMD13;PSMF1;PSMB10;PSMB6;TAL1;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;TCF3
prerank,regulation of synapse assembly (GO:0051963),-0.2817127999425132,-0.9470790606655359,0.522248243559719,0.7983820058596799,1.0,10/46,12.02%,MEF2C;LRFN5;CLSTN2;APP;IL1RAP;NRXN1;SYNDIG1;EIF4G1;EPHB1;CLSTN3
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.257665490367212,-0.9470021510550518,0.5525,0.7979633096847937,1.0,27/78,23.55%,CAV1;RNF144B;CBFA2T3;RNF144A;RACK1;TRIB2;NKD2;SOCS5;GSK3B;ZYG11B;RBX1;CLU;HERPUD1;ELOB;ARIH2;BCAP31;COP1;RNF19B;NOP53;ARIH1;VCP;RNF19A;USP5;CEBPA;TRIB3;HSPA1B;SIRT6
prerank,cellular component disassembly (GO:0022411),-0.2727012527618348,-0.9469539618529149,0.5608108108108109,0.7974794644462568,1.0,11/53,12.11%,BSG;TLL1;ADAM10;GSN;ADAM15;CD44;CAPN2;A2M;FURIN;ADAMTS4;MMP15
prerank,cellular response to oxidative stress (GO:0034599),0.26677971355612107,0.946916673563694,0.5642633228840125,0.8876575123733638,1.0,23/118,12.54%,TPM1;DAPK1;SOD3;PLA2R1;FER;PDGFRA;CPEB2;MAPK9;PRKAA2;MSRA;LRRK2;MMP9;PRKAA1;ARNT;TXNRD1;TXNRD2;VRK2;CCS;ABL1;EIF2S1;NCF2;PKD2;ADNP2
prerank,extracellular matrix disassembly (GO:0022617),-0.2721825182558376,-0.9467084538020323,0.5365853658536586,0.7975078864300034,1.0,11/53,12.11%,BSG;TLL1;ADAM10;GSN;ADAM15;CD44;CAPN2;A2M;FURIN;ADAMTS4;MMP15
prerank,protein monoubiquitination (GO:0006513),0.3284193919121969,0.9466991330944228,0.515370705244123,0.8873613662934129,1.0,12/36,20.95%,PRKN;MGRN1;KLHL22;CDC73;RNF20;RAD18;OBI1;CTR9;UBE2E1;DTX3L;KLHL12;PAF1
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.23415901122579932,-0.9466820317754905,0.574468085106383,0.7969594329280494,1.0,37/124,20.30%,LEF1;TIAM1;RAC1;CALM1;ROR2;SFRP4;FZD4;AP2A2;FZD6;NFATC1;CTNNB1;ARHGEF19;PLCB3;PSMD13;PSMF1;RHOA;AP2M1;PSMB10;VANGL2;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PPP3CA;PSME1;CCDC88C;TNRC6C;PSMB3;DVL2;PRICKLE2;PPP3R1;ARRB2;PSMD5;AP2B1;AGO3
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.25664707368626377,-0.9465016248241553,0.5807291666666666,0.7967854136451816,1.0,26/72,27.54%,UBB;UVSSA;COPS7A;RPS27A;UBC;PPIE;DDB1;RBX1;RPA1;ERCC8;POLR2C;XAB2;UBA52;COPS8;POLR2G;POLK;COPS6;POLD3;POLD1;GTF2H2;POLR2L;HMGN1;XPA;ERCC5;LIG3;RFC5
prerank,regulation of translational initiation (GO:0006446),-0.2642227994822275,-0.9464638608183084,0.5615763546798029,0.7962736467146816,1.0,22/63,24.25%,HSPB1;NCK1;EIF1B;EIF4G3;EIF4G1;NCK2;ATF4;YTHDF3;EIF4H;EIF3B;EIF2B5;EIF1;POLR2G;EIF2B2;EIF5B;ATF3;FMR1;UHMK1;EIF4B;CEBPB;EIF5;PPP1R15B
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.25015138874557175,-0.9463826502090656,0.5555555555555556,0.7958659941692818,1.0,28/85,23.48%,RNF144B;CBFA2T3;ATXN3;RNF144A;DAB2IP;RACK1;TRIB2;NKD2;SOCS5;BAG6;GSK3B;ZYG11B;RBX1;CLU;PSMC3;ELOB;ARIH2;COP1;RNF19B;NOP53;FMR1;ARIH1;VCP;RNF19A;USP5;CEBPA;TRIB3;HSPA1B
prerank,polyamine metabolic process (GO:0006595),-0.3793568498055403,-0.9463633198811706,0.5515873015873016,0.7953153916709768,1.0,8/13,37.43%,AMD1;HDAC6;SRM;DHPS;SMS;ODC1;HDAC10;OAZ2
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.31444689934573417,0.9461038438315909,0.5056603773584906,0.8880087292039481,1.0,14/43,17.78%,HUS1B;CDC14B;MRNIP;BLM;CDK1;CLSPN;RINT1;MRE11;CHFR;BABAM2;BRSK1;TAOK3;TRIM39;TAOK2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.40785314131617545,-0.9457841928295112,0.556420233463035,0.7961724919391594,1.0,2/10,9.24%,MSN;RHOA
prerank,actomyosin structure organization (GO:0031032),0.28233319158380543,0.9457749310996215,0.5307820299500832,0.8880131620843889,1.0,9/75,6.42%,ROCK2;TPM1;SORBS1;CSRP3;FRMD6;TNNT2;EPB41L5;FAM171A1;MYO18A
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2810555090927711,0.9457123519461683,0.5395799676898223,0.8873673993856779,1.0,9/76,7.56%,SASH1;C1QTNF3;BMP7;NFAT5;SPHK1;UACA;DLG1;NLRC3;CCL19
prerank,negative regulation of protein kinase activity (GO:0006469),0.28126567027042565,0.9455330222915997,0.5463414634146342,0.8869873996758719,1.0,8/88,4.50%,PRKAG2;SLC8A3;PDPK1;DEPTOR;SLC8A1;DTNBP1;DUSP10;PPM1E
prerank,chromatin organization (GO:0006325),0.26182212792539794,0.9454745118485979,0.5778443113772455,0.8863183687417383,1.0,42/132,20.84%,SATB1;JARID2;HDAC8;RBBP4;BAZ1B;SOX1;SETD7;TCF7L1;BAZ1A;MTF2;RSF1;KDM5B;KDM6B;SMARCA5;HDAC1;NPM2;TADA2A;SMARCE1;MYB;EZH1;INO80;SMARCB1;SNAI1;KDM5C;SMARCA2;SMARCC1;INO80C;KDM6A;PHF1;SMARCD3;BAZ2B;SETD2;MPND;SMARCA1;HMGN3;KDM4D;HDAC4;BRDT;KAT2B;RUVBL2;CBX3;BRWD1
prerank,mitochondrial translation (GO:0032543),-0.23818602068315303,-0.9453536956479626,0.5617128463476071,0.7965898764049196,1.0,30/104,26.83%,LARS2;MRRF;GFM1;NDUFA7;MRPL32;MRPL33;MRPS14;MRPL38;ERAL1;MRPS16;MRPL50;MRPS5;MRPL23;MRPL24;MRPS35;MRPS28;MRPL13;MRPL35;MTRF1L;MRPL34;MRPS23;MRPS2;MRPS11;MRPS27;TUFM;MRPL57;MRPL11;MRPS18C;MRPL18;MRPL14
prerank,positive regulation of translational initiation (GO:0045948),0.3692144267568625,0.9452645551192747,0.49700598802395207,0.8860503957382632,1.0,6/18,16.41%,POLR2D;CDC123;YTHDF2;RPS6KB1;BOLL;LARP1
prerank,negative regulation of phagocytosis (GO:0050765),-0.350192416228877,-0.9449639831715141,0.5384615384615384,0.7969354323764996,1.0,8/17,26.99%,RACK1;DYSF;APPL1;CD47;PIP4P2;CD300A;FCGR2B;SNX3
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.26595418822051736,-0.9442669456751754,0.5721271393643031,0.7979425631611117,1.0,20/57,23.72%,MEF2C;DLG2;PTK2B;MINK1;DLGAP1;APP;CACNG3;GRIN1;RELN;CACNG2;LYNX1;CAMK2B;GRIA2;CNIH3;NPTXR;NEFL;NPTX1;SHISA6;MAPK8IP2;SHANK1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.38728812394822554,-0.9441602207785745,0.5316455696202531,0.7975873506688713,1.0,8/12,44.96%,PLK2;BUB1B;ZWINT;BUB1;WEE2;NABP1;ZW10;PRCC
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.29596048050093743,0.9440121650100479,0.5278688524590164,0.8882794704648068,1.0,14/65,13.85%,FBN1;PPARA;FBN2;PDPK1;SNX6;SMAD6;SLC2A10;SMAD3;LEMD3;SMURF2;HTRA4;LDLRAD4;VEPH1;ADAMTSL2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3005336552024708,0.9431399795909462,0.5434027777777778,0.8896377077476053,1.0,9/56,8.85%,ROCK2;ARL3;SNX18;CECR2;SNX9;SNX33;SON;SPIRE2;CUL7
prerank,regulation of centriole replication (GO:0046599),0.37502272535954684,0.9430403433277768,0.5362318840579711,0.8890934656316938,1.0,2/17,2.87%,SPICE1;ALMS1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.2619422331588799,0.9429303212096879,0.5671191553544495,0.8885624276495877,1.0,29/128,16.32%,TGFBR3;BMP6;APPL2;BMP7;SMAD6;PARD3;SLC39A5;SCX;COL1A2;PRKCZ;ZMIZ1;SMAD3;RGMB;GDF1;ARHGEF18;SMURF2;ZFYVE9;BMPR1A;HIVEP1;ZMIZ2;ITGB5;MAP3K7;NLK;FAM83G;CDH5;SKI;SMAD4;CGN;SLC33A1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.4233596557153866,0.9429184146789138,0.5243128964059197,0.8877954775134007,1.0,4/11,13.29%,CTPS2;SLC19A2;ENPP3;THTPA
prerank,spermatid development (GO:0007286),0.3339891802868532,0.9426514829159933,0.5192660550458715,0.8876292792273957,1.0,6/32,14.08%,GALNTL5;ZMYND15;NME5;CEP57;CIB1;NECTIN2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.3851824743481142,0.9420905769901927,0.524731182795699,0.8881239608126217,1.0,2/15,4.40%,FGFR2;PDGFRA
prerank,peptidyl-serine modification (GO:0018209),-0.22421427510605313,-0.942005424715764,0.5819209039548022,0.8022272847688852,1.0,50/166,22.17%,PRKCH;STK38;RPS6KA5;GAS6;GALNT13;PKD1;STK38L;TGFBR2;IKBKB;PLK2;GSK3B;GALNT2;MTOR;MARK1;MAPK8;PAK2;CHUK;RPS6KA1;MARK2;LMTK2;STK32B;STK32A;MAST3;MAP3K12;MASTL;PKN3;GALNT1;VRK3;VRK1;CAMK4;PRKD1;RPS6KA4;POGLUT3;SGK1;PRKCE;CDK2;PRKCG;ATR;CDK5;PINK1;TLK2;PRKCD;AKT1;MKNK2;TTBK2;SBK1;UHMK1;DCLK3;PRKX;MAST1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.33265441173549665,0.9415432471882277,0.5438931297709924,0.888665647532802,1.0,10/34,11.14%,KIT;PDGFRB;EPHA8;PDGFRA;CCL19;ATG14;PIK3R4;WASHC1;PIK3R1;RUBCN
prerank,immunoglobulin mediated immune response (GO:0016064),-0.41657744173534167,-0.941278841667374,0.5291902071563088,0.8033709995218892,1.0,3/10,22.88%,CD74;CD81;FCGR2B
prerank,sulfur amino acid catabolic process (GO:0000098),0.42635927262412443,0.9410429619148455,0.5395833333333333,0.8890619911979335,1.0,1/10,2.11%,CBS
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.2100256670095421,-0.9408921483570059,0.6654135338345865,0.8036642875348734,1.0,58/241,20.78%,HSPA8;NOVA2;HNRNPK;SRSF2;PABPC1;SRSF1;HNRNPU;PPWD1;HNRNPA3;YBX1;PPIE;SF3B1;SF3B2;CPSF7;PHF5A;SFPQ;RBM14;DDX5;SRSF5;DDX39B;CPSF3;HNRNPH2;SRSF9;CWC15;RALY;USP39;RBM8A;POLR2C;XAB2;RNPS1;SNRPC;SRSF6;PRPF40B;FUS;SF3B5;HNRNPA0;SYMPK;CLP1;POLR2G;PRPF4;CPSF2;SPEN;GTF2F2;CSTF2T;ESS2;PCBP1;PCF11;CSTF2;MTREX;HNRNPUL1;YTHDC1;RBM17;PTBP1;CTNNBL1;RBM22;SNIP1;MAGOH;METTL3
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.4168315666775707,-0.9408219262507073,0.5532319391634981,0.8032066237232938,1.0,3/10,12.65%,HSP90AA1;HSP90AB1;CLU
prerank,atrial septum development (GO:0003283),0.4045071479913157,0.940771281187938,0.5456389452332657,0.8889333378841221,1.0,2/13,3.96%,NOTCH2;ANK2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.2896514969154578,0.9404760208331482,0.566006600660066,0.8888397285410304,1.0,15/66,15.04%,APPL2;PLCB1;UBE2E2;ANXA1;PLK5;DLG1;KANK2;PTEN;RBL2;MYO16;CDC73;PKD2;INO80;CDK4;HYAL1
prerank,cellular response to interleukin-6 (GO:0071354),-0.30896227440095425,-0.9404269098786464,0.5829596412556054,0.8035495930023472,1.0,13/26,24.71%,ST3GAL6;CBL;SBNO2;ST18;PTGIS;STAT3;SPI1;JAK1;CEBPA;RELA;STAT1;SELPLG;PTPRT
prerank,double-strand break repair (GO:0006302),0.25342654551588367,0.9403767673222192,0.5786350148367952,0.8882690488281082,1.0,25/158,11.35%,EYA1;RAD51B;BAZ1B;RAD51AP2;RNF138;HUS1B;RAD51C;TDP2;XRCC5;BLM;XRCC4;HELQ;KDM2A;AUNIP;BRCA2;POLM;ZSWIM7;MDC1;NHEJ1;PRKDC;DCLRE1A;PARP9;SMARCA5;DCLRE1B;ZFYVE26
prerank,translational termination (GO:0006415),-0.24070124907526408,-0.9395714810816295,0.581453634085213,0.8049828318298801,1.0,31/95,29.09%,MRRF;MRPL32;MRPL33;APEH;MRPS14;GSPT2;MRPL38;ERAL1;MRPS16;MRPL50;MRPS5;MRPL23;MRPL24;MRPS35;MRPS28;MRPL13;MRPL35;MTRF1L;MRPL34;MRPS23;MRPS2;MRPS11;MRPS27;MRPL57;MRPL11;MRPS18C;MRPL18;MRPL14;ETF1;AURKAIP1;CHCHD1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.3451496484323735,0.939364818241178,0.5390334572490706,0.889973536174491,1.0,6/27,10.77%,PID1;GRB10;PRKCZ;PRKCB;TNS2;RPS6KB1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3088724971011504,-0.9393334421480144,0.5644768856447688,0.8049578676280866,1.0,6/30,11.31%,ACVRL1;DACH1;BMPR2;PINX1;HNRNPU;MEN1
prerank,cellular response to dsRNA (GO:0071359),0.4017697102085112,0.9391113110962193,0.5277777777777778,0.8897508656099974,1.0,1/15,0.45%,COLEC12
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3130823246652819,-0.9388912048508689,0.5670103092783505,0.80533368318769,1.0,4/24,3.91%,ACVRL1;DACH1;RPS3;BMPR2
prerank,negative regulation of cell projection organization (GO:0031345),0.3010857380271847,0.9387550395420975,0.5535117056856187,0.8898141679880418,1.0,6/48,7.48%,EFNB2;LPAR1;DPYSL3;EPHA4;PTPN9;PTEN
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.2727988047372046,-0.9387399597460592,0.5665024630541872,0.8050733793415384,1.0,18/54,23.48%,GAS6;RACK1;IKBKB;BIRC3;CHUK;NLRP2B;TRAF1;CASP8;MADD;CARD16;LAPTM5;SHARPIN;CASP1;RBCK1;TNFAIP3;TRAIP;OTULIN;HSPA1B
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3694440301356308,0.938394004848164,0.5386138613861386,0.8898555955759522,1.0,3/19,6.48%,PARD3B;PARD3;DLG1
prerank,myeloid dendritic cell activation (GO:0001773),-0.3901278574541899,-0.9383512628583345,0.5871212121212122,0.8053588900132471,1.0,3/12,15.69%,TGFBR2;DOCK2;CAMK4
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.30331197100591845,0.9382065305533063,0.5448504983388704,0.8895474631455085,1.0,24/52,24.97%,POLR2D;EXOSC8;RC3H2;SAMD4A;CNOT2;DCP2;LSM5;PARN;CNOT8;CNOT7;CNOT10;EXOSC3;TUT4;LSM3;LSM1;LSM4;DDX6;PDE12;TUT7;EXOSC4;DCP1B;LSM6;DIS3;NT5C3B
prerank,establishment of vesicle localization (GO:0051650),-0.34813298462662323,-0.9377445867867832,0.5278884462151394,0.8061657691813425,1.0,4/18,7.68%,RAB27A;LIMK2;SYNJ1;DNM2
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.4002374986313807,-0.9375384792101797,0.5429141716566867,0.8060637554810423,1.0,4/11,11.40%,TJP2;F11R;TJP1;RAB1A
prerank,methylguanosine-cap decapping (GO:0110156),-0.4053511471071207,-0.9375209946858819,0.5534709193245778,0.8055071415275598,1.0,7/10,35.40%,PATL1;DCPS;EDC3;EDC4;PNRC2;PATL2;DCP1A
prerank,positive regulation of dendrite development (GO:1900006),-0.399565895831827,-0.9368870277582737,0.5596868884540117,0.8064238547810257,1.0,4/10,6.74%,BMP5;DAB2IP;ZDHHC15;LRP8
prerank,regulation of defense response (GO:0031347),0.28112098236957606,0.9365288018559771,0.5550314465408805,0.8926568001788857,1.0,9/76,7.98%,ADAMTS12;APPL2;ANXA1;LACC1;UFL1;CASP12;SETD6;DAGLB;RNF135
prerank,protein auto-ADP-ribosylation (GO:0070213),0.41311788704659963,0.9363462198129247,0.5316973415132924,0.8923161747723284,1.0,6/12,28.03%,PARP10;PARP12;TIPARP;TNKS2;PARP2;TNKS
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.20653667210785956,-0.9361777654844622,0.644,0.8075335760952371,1.0,64/264,20.78%,HSPA8;NOVA2;HNRNPK;SRSF2;PABPC1;SRSF1;HNRNPU;PPWD1;HNRNPA3;YBX1;PPIE;SF3B1;SF3B2;CPSF7;PHF5A;SFPQ;RBM14;DDX5;DDX20;SRSF5;DDX39B;CPSF3;HNRNPH2;SRSF9;CLNS1A;CWC15;RALY;USP39;RBM8A;POLR2C;STRAP;XAB2;RNPS1;SNRPC;SRSF6;PRPF40B;SRPK1;FUS;SF3B5;HNRNPA0;SYMPK;CLP1;POLR2G;PRPF4;CPSF2;SPEN;DCPS;GTF2F2;CSTF2T;ESS2;PCBP1;PCF11;CSTF2;DDX17;MTREX;HNRNPUL1;YTHDC1;RBM17;PTBP1;CTNNBL1;RBM22;SNIP1;MAGOH;METTL3
prerank,positive regulation of neuron differentiation (GO:0045666),-0.2851486740274976,-0.9360768561717459,0.5708154506437768,0.8071481929084944,1.0,11/40,15.86%,MEF2C;NGF;NRCAM;MMD2;RHOA;BMP2;HEYL;REST;ARHGEF2;BRINP2;TCF3
prerank,positive regulation of protein maturation (GO:1903319),0.4165662180113953,0.9353934187240662,0.549889135254989,0.8937574676665442,1.0,2/11,4.05%,TFR2;CCBE1
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.31146537139417396,-0.9353630037788289,0.55741127348643,0.8082524301513198,1.0,6/30,16.96%,CD34;PLCG2;ISG15;STAT3;HSPD1;CD274
prerank,sphingoid metabolic process (GO:0046519),0.40447623694934487,0.9350921899458594,0.5430327868852459,0.893721381742103,1.0,5/12,15.06%,PLPP3;SPHK1;SGPP1;PLPP2;NAAA
prerank,response to estradiol (GO:0032355),0.3339220468610102,0.9350845387072007,0.5357142857142857,0.892940591439052,1.0,6/31,7.77%,ANXA1;STAT5B;CRHBP;SSTR2;NCOA3;STRN3
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3147392144681757,0.9350276914300917,0.5511265164644714,0.8922765285807259,1.0,9/41,13.77%,ACSL1;GSTM2;PLA2G10;PTGR1;DAGLB;FADS3;PLA2G4B;PLA2G4C;ACOX1
prerank,oogenesis (GO:0048477),0.3860619904401499,0.9349406712052953,0.5263157894736842,0.8917032739434908,1.0,2/15,5.91%,HORMAD1;PTN
prerank,response to insulin (GO:0032868),0.2761930785293506,0.9346420352875859,0.5622950819672131,0.8916219632578051,1.0,13/80,10.77%,PDPK1;SORBS1;INSIG2;FER;RAB13;PCSK9;CPEB2;SYAP1;TBC1D4;SLC27A1;PRKDC;PIK3R1;RPS6KB1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.23167369224052872,0.9344395273496541,0.6118421052631579,0.8912843663851426,1.0,64/327,16.70%,RORA;EFEMP1;ARNT2;DENND4A;ATXN1;TULP3;ESRRG;MYBL1;NR1I2;SOX6;PPARGC1B;NFYB;IGF2;SSBP2;NCOA2;SOX1;PERM1;TCF7L1;ZMIZ1;ZFP37;SUFU;THAP1;WWC1;WWC2;GPBP1;UBE2L3;GPBP1L1;MTF2;ZKSCAN5;POLR2A;NFIA;ZNF628;BRCA2;MITF;KAT6B;NFYC;NSD1;NUP107;ABL1;ASCC2;ZBTB11;ZBTB38;MYB;RNF14;SOX13;RNF20;PSPC1;NONO;FOXK2;CLOCK;UBE2V1;CREBBP;NLK;PCGF1;SOX12;SMARCA2;PATZ1;ZNHIT3;FZD7;PML;PHF1;IGSF1;REXO4;BACH1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.3103505809754968,-0.934420833718017,0.5507246376811594,0.8098567919678108,1.0,6/27,15.14%,GPCPD1;SMPD4;GDPD1;GDPD3;PNPLA6;PLA2G4A
prerank,regulation of primary metabolic process (GO:0080090),0.26019540485472425,0.9343928099237723,0.5869894099848714,0.890602570067598,1.0,18/126,11.41%,ROCK2;FGFR4;PPARA;TBL1XR1;NFYB;NCOA2;OAZ3;PSME4;PSMA2;PSMA3;CHD9;PMVK;PSMD8;NFYC;MED1;PSMD3;FDPS;RXRA
prerank,establishment of melanosome localization (GO:0032401),0.3595016476718136,0.9337147656003044,0.5343811394891945,0.8914873451306392,1.0,5/19,14.67%,SHROOM2;ARL6;GPR143;BBS7;RAB11B
prerank,regulation of catecholamine secretion (GO:0050433),0.34620552593607673,0.933511460083289,0.5541044776119403,0.8911666964893662,1.0,4/29,4.13%,PRKN;DTNBP1;SYT11;SYT12
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.3755756381029957,0.9335038311006818,0.5443037974683544,0.8903992462603604,1.0,2/17,1.17%,RBPJ;NOTCH2
prerank,protein localization to cell junction (GO:1902414),-0.3253799568090186,-0.9334304202543592,0.5717344753747323,0.811695455464595,1.0,10/22,20.76%,HEG1;TJP2;FERMT2;TJP1;PAK2;PCLO;BSN;DSP;JAK1;JAM3
prerank,cellular protein localization (GO:0034613),-0.20991464989022454,-0.9333831410067476,0.6951219512195121,0.8112207871260232,1.0,64/285,17.28%,ESAM;OCLN;ID1;NSF;STX3;TBC1D30;TBC1D8;REEP1;RAB31;STX7;RABGAP1L;FLNA;STX1A;ZDHHC15;FERMT2;EHD1;CTNNB1;TMED5;ADPRH;ARF5;GRTP1;SCG5;STX6;SGSM1;ARF1;TBC1D8B;TBC1D1;RAB28;TMED2;EMP2;CD63;SIL1;FGF7;TBC1D13;SEPTIN9;NAPB;SYNDIG1;HEY2;RAB38;STX12;ABHD17A;LAMTOR1;HGS;HHEX;RAB1A;CEP68;EVI5;MESD;TM9SF3;CD74;TBC1D10A;ARHGEF2;PICK1;TMED10;TMED3;KIF13A;RABL3;LAMTOR2;LAPTM5;STX2;BICD1;HERC2;RABGAP1;YWHAH
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.4109428074604337,-0.9329385121717256,0.5547309833024119,0.8117258823053909,1.0,5/10,36.85%,SET;CTBP1;NOC2L;THAP7;TAF7
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.3423732495106868,-0.9321000238049644,0.5594262295081968,0.8131081870419478,1.0,6/20,13.69%,B2M;CD55;DENND1B;IL1R1;RSAD2;CD81
prerank,skeletal muscle contraction (GO:0003009),0.36808063491468157,0.9319534244458412,0.5311284046692607,0.8932463146773187,1.0,3/19,13.74%,TNNC1;RCSD1;CCDC78
prerank,brain morphogenesis (GO:0048854),-0.38568887785160966,-0.9318615669374339,0.5553470919324578,0.8130553253413447,1.0,1/12,0.48%,SHANK3
prerank,positive regulation of inflammatory response (GO:0050729),-0.24349361883386966,-0.9314914944495382,0.6090425531914894,0.8133402245124153,1.0,16/86,14.36%,IL33;ETS1;LBP;NFKBIA;RPS19;GPR4;VAMP8;PDE2A;PDCD4;APP;GRN;FEM1A;IFI35;CD81;NFKBIZ;CD47
prerank,peroxisome organization (GO:0007031),-0.3210603339576175,-0.9314149122500258,0.5758196721311475,0.8129284892882275,1.0,10/25,27.15%,ABCD3;ABCD2;PEX1;PEX11B;SEC16B;ABCD4;PEX10;PEX16;TMEM135;FIS1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.28554011106551874,0.9313707537569236,0.5621019108280255,0.8938689784009333,1.0,15/67,15.63%,DCDC2;ODAD3;FER;PLD1;TBC1D9B;SDCCAG8;CAPZB;EPHA2;FXR1;CYLD;TBC1D19;IFT140;CDKL5;TBC1D17;ATG3
prerank,embryonic hemopoiesis (GO:0035162),-0.3816726483461028,-0.9313378647796582,0.544921875,0.8125124375791432,1.0,5/12,11.47%,KITLG;KDR;TGFBR2;ATF4;TAL1
prerank,in utero embryonic development (GO:0001701),0.3521824497530462,0.9311139025255276,0.5473887814313346,0.8936926506772357,1.0,3/25,3.44%,ARNT2;FGFR2;IGF2
prerank,regulation of ATP metabolic process (GO:1903578),0.29477750427677946,0.9309053934264593,0.5583756345177665,0.8934135135654335,1.0,1/54,0.08%,PRKAG2
prerank,autophagy of mitochondrion (GO:0000422),0.3154299991976952,0.9304885600163815,0.564373897707231,0.8936008748335542,1.0,9/38,15.63%,PRKN;WIPI1;BNIP3;ATG14;FUNDC2;FUNDC1;ATG9A;AMBRA1;ATG3
prerank,regulation of protein kinase activity (GO:0045859),0.2644088598499637,0.9302103424785125,0.5760517799352751,0.8934703814873145,1.0,14/106,9.09%,PRKAG2;PDPK1;DEPTOR;ALS2;DTNBP1;PPM1E;MRNIP;SNX9;GNAQ;XRCC5;DDR2;CCL19;CSF1;UVRAG
prerank,steroid hormone biosynthetic process (GO:0120178),0.33808102892809433,0.9298471584452315,0.533457249070632,0.8935450223048269,1.0,5/29,15.05%,HSD17B1;FDXR;MED1;AKR1B1;HSD17B14
prerank,hexose biosynthetic process (GO:0019319),0.3099245172336935,0.929705338277965,0.5483271375464684,0.893093885364112,1.0,9/42,14.14%,RBP4;SORD;SLC25A11;CHST15;CRY1;AKR1B1;ENO2;PFKFB1;GPI
prerank,cardiac muscle cell differentiation (GO:0055007),-0.3262668128434507,-0.9293321996079558,0.5469728601252609,0.8166157389738381,1.0,5/21,10.79%,MEF2C;CXADR;MYH11;VEGFA;BMP2
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3361006777793032,0.929218237085013,0.5459662288930581,0.8934948936870725,1.0,7/29,8.90%,KIT;PDGFRB;EPHA8;PDGFRA;CCL19;ATG14;PIK3R4
prerank,glycolytic process (GO:0006096),-0.31275335282144506,-0.9287879680621954,0.5813449023861171,0.8173313599000116,1.0,8/28,17.38%,PKM;HK1;GAPDH;PFKM;TPI1;ALDOA;LDHA;ALDOC
prerank,positive regulation of neuron projection development (GO:0010976),0.2744383997963518,0.9287599571562053,0.5795275590551181,0.8938375987054112,1.0,10/85,7.10%,PTK7;EPHA3;BMP7;CAMK1D;DPYSL3;AVIL;NDNF;PLK5;PTN;ARHGAP35
prerank,mitochondrion localization (GO:0051646),-0.3449746299026724,-0.928497249300717,0.5405940594059406,0.81741724761035,1.0,10/19,28.06%,MARK1;MTM1;MARK2;MSTO1;MFN2;TLE6;ATCAY;HAP1;ZBED3;MEF2A
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.38420815715045037,0.9279396704749017,0.5509355509355509,0.8949751736053065,1.0,2/16,2.67%,WNT4;SCX
prerank,regulation of protein import into nucleus (GO:0042306),-0.292150217645549,-0.9277395420704431,0.572961373390558,0.8186465680661655,1.0,14/36,24.55%,APOD;CDH1;FLNA;TGFB1;CHP1;JUP;MDFIC;ZC3H12A;PSEN1;PRKCD;BMP4;RBM22;HYAL2;ZPR1
prerank,ovarian follicle development (GO:0001541),-0.3651897199734261,-0.9273020868492869,0.5577689243027888,0.819039524114586,1.0,8/13,23.01%,SOD1;VEGFA;EIF2B5;EIF2B2;INHA;FOXL2;ANG;CEBPB
prerank,integrated stress response signaling (GO:0140467),-0.3658096173994464,-0.927255364144552,0.5510204081632653,0.8185505796507045,1.0,5/14,30.15%,HSPA5;ATF4;HERPUD1;CCL2;NFE2L2
prerank,cellular response to oxygen-containing compound (GO:1901701),0.23453160952253077,0.9271313563049307,0.6458885941644562,0.8960501097207706,1.0,25/291,7.32%,RORA;ROCK2;PTK7;EPHA3;WNT6;PID1;SLC5A5;TPM1;DAPK1;CXCL13;FER;CRHBP;PDGFRA;MAPK9;CPEB4;CACTIN;AANAT;SSTR2;SLC38A9;IL6;NCOA3;PDCD1LG2;WNT5B;FOLR1;MMP9
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.3097480236279705,0.9269713652676257,0.5629496402877698,0.8956255130757863,1.0,5/41,7.56%,ITPR1;SLC8A3;SLC8A1;CACNA2D1;CCL19
prerank,histone H3-K9 demethylation (GO:0033169),0.4228023330921064,0.9268012192067604,0.5300207039337475,0.8952386134385455,1.0,3/11,9.01%,KDM7A;PHF8;KDM3B
prerank,regulation of neuron apoptotic process (GO:0043523),0.2687101546157271,0.9267810050318968,0.5684380032206119,0.8945169252386824,1.0,9/96,5.04%,EPHA7;PRKN;SNX6;BCL2;NDNF;PCSK9;SRPK2;KDM2B;CPEB4
prerank,regulation of mRNA catabolic process (GO:0061013),-0.23246652987944763,-0.9267791871120293,0.6083086053412463,0.8190311802071253,1.0,36/121,23.00%,PRR5L;HSPA8;VIM;UBB;HSPB1;PABPC1;YWHAB;RPS27A;UBC;PUM2;PSMD13;SET;PSMF1;EIF4G1;ZFP36L1;PSMB10;YTHDF3;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;UBA52;PSMB3;SERBP1;ZC3H12A;PSMD5;PCBP4;PRKCD;AKT1;FMR1;RBM24;PSMD9;PSMB4
prerank,female gamete generation (GO:0007292),0.33512193698364867,0.926423368860692,0.562624254473161,0.8945225654777638,1.0,4/29,5.91%,DIAPH2;HORMAD1;DMC1;PTN
prerank,positive regulation of cellular process (GO:0048522),0.2208297186749393,0.9261658262054728,0.690223792697291,0.8943682067862394,1.0,77/565,12.90%,IL31RA;IGF1;BMP6;COLEC12;IL34;FGFR2;FGFR4;EFNB2;TPM1;MEIS1;RHOD;BCL2;CAMK1D;CCN2;PARD3;DKK1;SCX;PDGFRB;FER;CTSH;IGF2;PDPN;EPHA4;SRPK2;ITGAX;IL13RA1;TULP1;ASH2L;PDGFRA;SPHK1;PRKAA2;PDGFD;UFL1;IGF1R;FGF1;PTN;TET1;TTK;ECHDC3;ADRA1D;CDC123;IL6;FOLR2;PRKCA;PTEN;PRKAA1;CSF1;BIRC5;LYAR;GRK5;RPRD1B;COX17;NUPR1;SIRPA;MDM2;IER5;AXIN2;CST7;PHIP;FGF9;TNFSF13;HDAC1;FLCN;TFAP2B;FXR1;ERBB2;TGFA;KLHL22;PRODH;HSF1;PRKD2;AR;AREG;ADNP2;S100A9;GDNF;INO80
prerank,long-chain fatty acid metabolic process (GO:0001676),0.28843771304049765,0.9261217179840217,0.567062818336163,0.8936875512056316,1.0,13/64,14.65%,ACSL1;GSTM2;PLA2G10;ACOT4;ACADL;CPT2;EPHX2;DAGLB;ACOT1;PLA2G4B;PLA2G4C;ACOX1;HACL1
prerank,mRNA metabolic process (GO:0016071),-0.2401448204949251,-0.925976224382168,0.6365914786967418,0.8202483824664858,1.0,30/90,28.92%,PPARGC1A;SRSF2;SRSF1;SF3B2;SFPQ;DDX5;SRSF5;SSB;CPSF3;KIN;SRSF9;CPSF6;USP39;PRPF18;HNRNPA0;RIDA;RNASE4;PCF11;PTBP1;AGO3;METTL3;SNRPG;HSPA1B;NUDT16;ERN1;RNH1;DIS3L2;AURKAIP1;LSM11;SRSF7
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3716923036943443,0.9256900261262583,0.5474747474747474,0.8939405098327575,1.0,5/18,12.80%,ADCY1;CAMK1D;PRKD2;CRTC1;CRTC3
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.36254673994083547,-0.9255749670991726,0.5581395348837209,0.8205607779788255,1.0,7/15,13.25%,MVB12B;PTPN12;LGMN;CEACAM1;RHBDF2;CDH13;MVB12A
prerank,response to UV-A (GO:0070141),0.3960557418284292,0.9251969504552956,0.5746421267893661,0.8943213137279563,1.0,3/14,9.42%,MMP2;MMP9;CERS1
prerank,negative regulation of bone remodeling (GO:0046851),-0.3832437384944014,-0.925153367057865,0.5608365019011406,0.8209085511980627,1.0,8/11,37.12%,UBASH3B;GPR137B;GPR137;GREM1;TNFAIP3;CALCA;P2RX7;TMEM119
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.26805562871569316,-0.9242843955873109,0.5847665847665847,0.8222926192180277,1.0,17/49,28.42%,CAV1;SGMS1;RACK1;BCL2L1;RTKN2;NDUFA13;HERPUD1;BBC3;BCAP31;PLAUR;PINK1;NOC2L;BMF;BAX;URI1;FIS1;BID
prerank,positive regulation of phagocytosis (GO:0050766),-0.27592112468941565,-0.923831501328779,0.5952380952380952,0.8227662979443533,1.0,8/47,6.03%,PTPRJ;GAS6;RAB31;RAB27A;GATA2;CALR;DOCK2;PTPRC
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.25155149429982376,-0.9234624984033503,0.6263157894736842,0.8230523811857474,1.0,20/72,23.79%,ACER2;RPL26;SOX4;PLK2;PLAGL1;CHEK2;CNOT6L;ING4;SESN2;CDKN1B;BCL3;RPS27L;TNKS1BP1;PCBP4;TFAP4;GADD45A;CDKN1A;E2F7;RGCC;BAX
prerank,mitochondrial translational elongation (GO:0070125),-0.24050042804661007,-0.9225195330536953,0.6176470588235294,0.824650301966873,1.0,28/88,29.09%,GFM1;MRPL32;MRPL33;MRPS14;MRPL38;ERAL1;MRPS16;MRPL50;MRPS5;MRPL23;MRPL24;MRPS35;MRPS28;MRPL13;MRPL35;MRPL34;MRPS23;MRPS2;MRPS11;MRPS27;TUFM;MRPL57;MRPL11;MRPS18C;MRPL18;MRPL14;AURKAIP1;CHCHD1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.22291188755984906,0.922374912638636,0.6840796019900498,0.900270725889976,1.0,68/417,14.05%,TCF7L2;WNT4;RBPJ;NR2F2;BMP7;ATXN1;SNX6;DKK3;ARID5B;RUNX1T1;PRDM5;ZEB1;ZIC2;NR1I2;PLCB1;LOXL3;TSHZ3;JARID2;MIDEAS;VGLL4;PRICKLE1;HOXA7;FOXD1;ZHX2;CBY1;BEND5;L3MBTL2;ARID4A;IKZF4;DPF2;GLI3;SFMBT1;NIBAN2;BCOR;SALL1;XRCC5;BIRC5;WWP2;RSF1;ZMYND15;TLE1;KAT8;KAT6B;MDM2;MBTD1;SMURF2;SCMH1;L3MBTL3;ATOH8;HDAC1;TFAP2A;SMARCE1;TFAP2B;ZNF568;ZBTB38;MYB;CRY1;SOX13;CBFA2T2;PSPC1;NONO;FOXK2;SCML4;TFDP2;CLOCK;ZNF148;KDM5C;CDKN1C
prerank,neutral amino acid transport (GO:0015804),0.3351879344466219,0.9223107664794756,0.5626168224299065,0.899636511667949,1.0,7/28,12.29%,SLC38A3;SLC6A9;LLGL2;SLC43A1;SLC1A5;SLC36A2;SLC38A2
prerank,mitotic metaphase plate congression (GO:0007080),-0.26946706188121416,-0.9222728859204228,0.5966587112171837,0.8246327391218644,1.0,18/51,26.80%,CHMP5;CHMP2B;PINX1;CUL3;RMDN1;BOD1;CHMP1B;CHMP1A;CHMP3;KIFC1;CHMP7;PDCD6IP;NDC80;KIF14;SPDL1;CHMP4C;CDCA8;CEP55
prerank,blood vessel endothelial cell migration (GO:0043534),0.3537886133926521,0.922270148839441,0.5622710622710623,0.8989550229320477,1.0,2/22,1.19%,ROBO1;EFNB2
prerank,regulation of osteoclast differentiation (GO:0045670),0.3271637479808058,0.9216628838281462,0.5617977528089888,0.8996084632821526,1.0,4/33,8.62%,FBN1;LRRC17;CSF1;FSTL3
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.37871632798176,0.9216134425294011,0.5434782608695652,0.8989414160977774,1.0,4/16,5.26%,PDGFRB;FER;PDGFRA;PDGFD
prerank,response to hydrogen peroxide (GO:0042542),-0.27465915931624163,-0.9215651812418527,0.6071428571428571,0.8256522884176885,1.0,9/45,10.10%,MAP3K5;FYN;RPS3;NET1;RHOB;SOD1;PDCD10;STK25;PLEKHA1
prerank,primary neural tube formation (GO:0014020),0.32968061783618074,0.9209792453677238,0.5939849624060151,0.8996038568094926,1.0,6/30,11.24%,LMO4;PRICKLE1;MTHFR;LRP2;COBL;IFT122
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.25061930165293433,-0.9206662679833063,0.6422976501305483,0.8272164765089826,1.0,13/70,15.40%,TGFB2;DAB2IP;NGF;BLOC1S2;TGFB1;DCC;BCL2L1;GSK3B;TNFRSF1B;APPL1;CASP8AP2;FAS;CASP8
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.32607327767002525,-0.920621787469668,0.6023622047244095,0.8267128998873023,1.0,8/21,19.73%,CTNNB1;VEGFA;NES;DISC1;CX3CR1;DISP3;TOX;DLL4
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.3383137918308114,0.9206209935440666,0.5549242424242424,0.899658705745555,1.0,4/27,4.96%,SLC22A2;SLC6A9;SLC1A3;SLC25A18
prerank,fluid transport (GO:0042044),-0.38020329037097167,-0.9204724695542313,0.5482041587901701,0.8264560181422532,1.0,3/12,11.74%,AQP4;AQP11;SLC26A6
prerank,dendrite self-avoidance (GO:0070593),-0.35067744394930145,-0.9201664432282762,0.592901878914405,0.82655767683801,1.0,8/16,27.65%,BSG;ROBO4;CNTN6;NPTN;DSCAML1;VSTM2L;CNTN2;EMB
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.3180937685603422,-0.9199912441395969,0.5905172413793104,0.8263683371839421,1.0,9/25,19.90%,TMTC2;CAV1;GRIN1;KCNA1;MT3;WFS1;ATP13A2;JPH2;ANK3
prerank,positive regulation of viral process (GO:0048524),0.28641381875034005,0.9193545707826215,0.5772646536412078,0.9018404203336172,1.0,10/60,10.30%,PPARA;POLR2D;SRPK2;HACD3;POLR2A;RSF1;CCNT1;GTF2F1;PKN2;AXL
prerank,engulfment of apoptotic cell (GO:0043652),-0.35098041305017647,-0.9192342067797351,0.5541666666666667,0.8274976489268375,1.0,2/15,1.92%,THBS1;RAC1
prerank,inflammatory response (GO:0006954),0.24213261309614748,0.9192062548933987,0.6303387334315169,0.9014089254451845,1.0,27/195,13.75%,ADCY1;BDKRB2;IL18;KIT;LOXL3;TPST1;CXCL13;ANXA1;ADM;CRHBP;PARP4;IL6;FOLR2;CCL19;PTGIR;IL17D;ITCH;CCL4;PTGER1;CDO1;MAPKAPK2;S100A9;NFATC4;TBK1;PLA2G4B;ADORA1;PLA2G4C
prerank,positive regulation of immune effector process (GO:0002699),-0.3116892130031437,-0.9191476427197114,0.5895691609977324,0.8271070223047337,1.0,6/27,13.69%,PTPRJ;LBP;RPS19;PTPRC;XBP1;CD81
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.30493608112483866,0.9188706802715231,0.5860805860805861,0.9013651440735345,1.0,3/46,3.54%,TCF7L2;ZIC1;NEDD4
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.38468260987547254,-0.9185984613851809,0.5884615384615385,0.8277593344576494,1.0,4/12,14.61%,PROM1;VEGFA;STAT3;RORB
prerank,glycoprotein metabolic process (GO:0009100),0.29084014896063465,0.9182823329002591,0.5810344827586207,0.901926578372449,1.0,7/53,7.36%,ADAMTS9;LARGE1;PRKCSH;GAL3ST2;MAN1C1;FBXO44;GANC
prerank,negative regulation of protein processing (GO:0010955),-0.3709392055784032,-0.9181148117854645,0.5673624288425048,0.8283317566850754,1.0,2/12,3.49%,THBS1;SERPINE2
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.391554963274211,0.9180837622046945,0.5432595573440644,0.9016114709055417,1.0,4/13,10.82%,KCNA5;ANK2;GJA1;SCN3B
prerank,cellular response to estrogen stimulus (GO:0071391),-0.37107949042826105,-0.9179792396046744,0.570281124497992,0.8280275092433428,1.0,5/14,14.67%,SERPINB9;ARID5A;WBP2;SFR1;NCOA4
prerank,regulation of ruffle assembly (GO:1900027),0.3468328878866749,0.9175626156580964,0.5315985130111525,0.9020843255866668,1.0,1/23,0.20%,ARHGAP24
prerank,negative regulation of cellular catabolic process (GO:0031330),0.2872839886029902,0.9174828684621119,0.5870307167235495,0.9015006760939223,1.0,14/63,14.04%,LEPR;TIMP3;BCL2;ATRAID;NUPR1;APOC1;GOLGA2;RIC1;WASHC1;RUBCN;KLHL22;PTPN3;FOXK2;PLIN5
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.2347926825938201,0.9173987412159796,0.6707482993197279,0.9009427355752239,1.0,71/259,19.11%,DCDC2;ASAP1;KIT;FGD4;RHOD;MYLK;INTU;AVIL;RAB3IP;ARL3;DYNC2H1;CDC14B;CCDC57;IFT80;PMP22;CC2D2A;ARMC9;WDR19;UBXN10;TTC8;WDPCP;KIF27;WDR35;NTN1;ARL6;CEP19;IQCB1;MTSS1;TEKT2;TCTN1;SCLT1;ATP6V0D1;PARVA;CEP89;BBS7;FBF1;OFD1;WDR11;IFT122;RAP2A;ACTN2;TTC39C;EXOC3;IFT140;CFAP298;STK26;CCDC65;WDR90;CEP164;CFAP70;CFAP410;ATP6V1D;EXOC7;EXOC1;DYNC2I1;CFAP20;SDCBP;SRGAP2;PDE6D;RAB11FIP3;RAP1B;ANO6;ARF4;RP2;TMEM237;BBS1;TRAF3IP1;MAP4K4;IFT81;TNIK;IFT46
prerank,protein-containing complex assembly (GO:0065003),0.23528472961202082,0.9173586832138443,0.6574074074074074,0.9002731086236471,1.0,45/259,12.50%,TCF7L2;PLEKHA7;AFDN;DMD;KMT2A;FANCA;PARD3;PYGO1;ASH2L;SH3PXD2B;TEAD1;WASF1;TLE3;WASL;LRRK2;SNX9;TCF7L1;WDR19;PDCD6;CDC123;CAND1;F5;NOL3;BLM;FOLR1;WASF3;MCU;TLE1;MITF;PICALM;MDM2;GOLGA2;AXIN2;TUBGCP2;GSDMD;BCL9;HDAC1;LLGL1;DLG4;TGFA;CDC73;SAR1B;DNAJB12;HSF1;AREG
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.27625754761789023,-0.9170761716019686,0.5892018779342723,0.8294910159838053,1.0,20/45,33.86%,HSPB1;APP;AIM2;STAT3;GBP5;USP50;PANX1;CASP8;MYD88;TYROBP;CASP1;AGER;NLRC4;TLR4;LPL;CD36;TLR6;NOD2;P2RX7;NLRP3
prerank,glucose metabolic process (GO:0006006),-0.26070073104227176,-0.9170563798275787,0.6206088992974239,0.8289387881045931,1.0,10/58,14.04%,APOD;PPARGC1A;PPARD;LRP5;HECTD4;GAPDH;ATF4;SLC39A14;TPI1;ALDOA
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4075745173599279,0.9158379111887803,0.5840163934426229,0.9030572824691355,1.0,3/12,10.06%,BRD8;CTSH;MED1
prerank,cellular response to calcium ion (GO:0071277),0.2836082117690821,0.9155120696136333,0.5962145110410094,0.903026256079739,1.0,10/67,10.68%,ADGRV1;ADCY1;CRHBP;SYT11;SYT12;PRKAA2;PRKAA1;CAMK2D;CPNE4;NEUROD2
prerank,negative regulation of cellular component organization (GO:0051129),0.27415459143471993,0.915216472034289,0.6113744075829384,0.902938336766096,1.0,13/74,12.83%,BMP6;EPHA3;SYT11;WASL;PRKCZ;SNX33;XRCC5;RUBCN;RTEL1;HSF1;AR;PACSIN3;RAPGEF3
prerank,protein localization to lysosome (GO:0061462),-0.3044050986411296,-0.9151376283485142,0.6203703703703703,0.8327322049634133,1.0,15/28,30.20%,SH3BP4;SNX16;RTN4;HGS;CD81;NCOA4;M6PR;LAPTM5;ATP13A2;LAMTOR4;RAB7A;SCARB2;SORL1;RNF128;ZFYVE16
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.4163428789871651,0.9150806766622518,0.5655913978494623,0.9024991879432288,1.0,4/10,15.68%,KMT2A;RAPGEF3;SMARCB1;SMAD4
prerank,B cell homeostasis (GO:0001782),-0.4006763718662775,-0.9148830451474264,0.5844155844155844,0.8327098159618767,1.0,6/10,22.29%,MEF2C;DOCK10;CAMLG;PPP2R3C;NCKAP1L;TNFAIP3
prerank,cellular response to interleukin-7 (GO:0098761),-0.3376453422810685,-0.914524677992618,0.5631970260223048,0.8323437208082551,1.0,11/17,34.93%,SOCS2;STAT3;CISH;JAK3;JAK1;SOCS1;CRLF2;IL2RG;TSLP;IL7;IL7R
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.3376453422810685,-0.914524677992618,0.5631970260223048,0.8323437208082551,1.0,11/17,34.93%,SOCS2;STAT3;CISH;JAK3;JAK1;SOCS1;CRLF2;IL2RG;TSLP;IL7;IL7R
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3341342915555787,0.9142602792029788,0.5742574257425742,0.9036548599686632,1.0,8/25,18.20%,PRPSAP2;AMPD3;ADSL;GMPS;SHMT1;ADK;APRT;GMPR2
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3161612383358107,0.91425369433493,0.5689655172413793,0.9029011434828923,1.0,6/36,8.45%,AFDN;VAMP5;MACF1;OPTN;GGA2;BLZF1
prerank,histone mRNA catabolic process (GO:0071044),0.37608199421663224,0.9140429272343976,0.5671342685370742,0.9026303354099416,1.0,9/15,23.35%,TENT2;TUT1;DCP2;ERI1;TUT4;LSM1;XRN1;TUT7;EXOSC4
prerank,regulation of phosphate metabolic process (GO:0019220),-0.34605297766239573,-0.9138900111366771,0.6054158607350096,0.8332459608341178,1.0,7/16,28.31%,IKBKB;RAD17;SMG5;TIGAR;PSEN1;SMG6;BARD1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2464550617046629,0.9126944393366384,0.6330827067669172,0.9049767985944296,1.0,20/152,11.66%,ADCY5;ADCY1;LGR4;ADGRL1;LPAR1;GNAS;ADM;ABCA1;LPAR2;CACNA1D;GNAQ;ADRA1D;PTH2R;GRK5;PTGIR;GLP1R;PTGER1;ADRB3;AKAP12;ADGRB3
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4076204652291099,0.9124210094947784,0.5666003976143141,0.9048310154551253,1.0,3/12,10.08%,LHPP;ADSL;GMPS
prerank,nucleotide-excision repair (GO:0006289),-0.22942767896276306,-0.912401502667807,0.6405405405405405,0.8361342482311745,1.0,34/101,27.54%,ATXN3;UBB;UVSSA;COPS7A;RPS27A;UBC;PPIE;DDB1;RBX1;RPA1;OGG1;ERCC8;POLR2C;XAB2;UBA52;COPS8;POLR2G;POLK;POLA1;COPS6;CETN2;LIG4;POLE;POLD3;POLB;POLD1;GTF2H2;POLR2L;HMGN1;XPA;POLL;ERCC5;LIG3;RFC5
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3334810124315835,-0.9123998737026746,0.581573896353167,0.8355400375095786,1.0,6/18,14.23%,SHANK3;PTK2B;CACNG3;NRXN1;RELN;CACNG2
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.2627799803543581,-0.9120360819104788,0.6247086247086248,0.8358330272007087,1.0,13/50,15.79%,PSMD13;PSMF1;OAZ1;PSMB10;PSMB6;AZIN1;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3
prerank,negative regulation of interleukin-6 production (GO:0032715),0.33356374957769735,0.9119580994399256,0.5719557195571956,0.9051283971616845,1.0,7/27,15.71%,C1QTNF3;SYT11;NLRC3;SIRPA;NLRP12;CX3CL1;CD200R1
prerank,positive regulation of integrin activation (GO:0033625),0.4017467053233509,0.9117028698995858,0.5506692160611855,0.9049605673133876,1.0,3/11,6.16%,CXCL13;FERMT1;CDH17
prerank,mitochondrial transport (GO:0006839),-0.2603918027042043,-0.9107316852425831,0.6367816091954023,0.8382771862954514,1.0,24/53,30.52%,HSP90AA1;FBXO7;TOMM20;BCL2L1;ABCB10;TOMM22;TMEM14C;TIMM9;TIMM10B;TIMM13;BCAP31;TIMM22;SLC25A4;TOMM7;MFN2;BCS1L;SPG7;FLVCR1;FIS1;TIMM44;TSPO;AIP;TOMM34;PMAIP1
prerank,response to organonitrogen compound (GO:0010243),-0.28281919887465107,-0.9105917702294573,0.6276849642004774,0.83799796241072,1.0,16/38,27.14%,MTOR;DERL1;CCDC47;UBXN6;IRAK3;ERLEC1;NR1H4;GLRA3;RNF5;IRF5;VCP;BRSK2;GLRA1;MEAK7;TRPM2;SYVN1
prerank,global genome nucleotide-excision repair (GO:0070911),-0.3101620393568223,-0.9105764322285818,0.5991735537190083,0.8374360194179216,1.0,7/26,17.98%,UBB;RPS27A;UBC;DDB1;RBX1;UBA52;CETN2
prerank,response to purine-containing compound (GO:0014074),-0.3403025749726524,-0.9104980165325839,0.5860113421550095,0.8370143455060021,1.0,10/17,34.88%,ABCC9;TRPC3;RYR2;VGF;DGKQ;STAT1;TRPM2;P2RY1;P2RX7;RYR1
prerank,regulation of phosphorylation (GO:0042325),-0.22059841267241587,-0.9102787508519994,0.6845070422535211,0.8369038613228713,1.0,36/120,22.01%,FN1;FNIP2;ITGA6;THBS1;PTK2;HSPB1;CORO1C;IKBKB;CCDC88A;APP;EMP2;ZBTB7A;SESN2;NLRC5;CDKN1B;OGT;KCTD20;RAD17;CADM4;NUP37;CCDC88C;MIF;NUP54;NUP85;PSEN1;INHA;PRKRIP1;NOP53;ANG;NUP133;BMP4;NCKAP1L;POM121;EIF6;CDKN1A;CDKN2D
prerank,monoacylglycerol metabolic process (GO:0046462),-0.36447953427911933,-0.9094144359971349,0.593320235756385,0.8382180336038094,1.0,4/13,21.23%,MGLL;DGAT1;PLA2G4A;ABHD6
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.33198882460888063,0.9093865897581211,0.576171875,0.9096599185950388,1.0,7/27,15.06%,PLA2G10;ETNK2;NAPEPLD;SLC27A1;PISD;CHKA;NAAA
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.28901904010735496,0.909297398802447,0.5862068965517241,0.9090765036622971,1.0,5/56,4.81%,PLCB1;UBE2E2;ANXA1;RAD51B;RAD51C
prerank,positive regulation of lipid localization (GO:1905954),0.4080910273525516,0.9090122534703486,0.5654008438818565,0.908995723280825,1.0,5/11,22.07%,PLA2G10;IKBKE;PLIN5;HILPDA;NFKB1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.311254312663143,-0.9089809252659623,0.6004319654427646,0.8386404556793916,1.0,14/27,30.81%,CD44;SPRED2;DDX5;CD74;MIF;EEF1E1;ATR;PTTG1IP;SNAI2;PSMD10;YJU2;SPRED3;PMAIP1;KMT5A
prerank,development of primary male sexual characteristics (GO:0046546),0.3088777596945019,0.908490580798277,0.5894160583941606,0.9094140186651231,1.0,3/34,5.73%,WNT4;KIT;LRP2
prerank,ubiquinone biosynthetic process (GO:0006744),0.3691214951565687,0.9083572936784624,0.5708502024291497,0.9089609135664463,1.0,5/15,11.44%,FDXR;COQ10A;NDUFA9;COQ8B;COQ6
prerank,cellular response to cAMP (GO:0071320),-0.29657651376670513,-0.9080404635186379,0.5816554809843401,0.8401462121673943,1.0,10/30,17.86%,RAP1A;IGFBP5;AHR;PDE2A;KCNQ1;ZFP36L1;SLC26A6;HCN1;CFTR;HCN2
prerank,regulation of humoral immune response (GO:0002920),0.2968633312856579,0.9071669237363156,0.5856643356643356,0.9108887962570841,1.0,7/44,11.25%,PROS1;CXCL13;C2;CFH;VTN;C8B;C8G
prerank,multivesicular body assembly (GO:0036258),-0.3017801845656336,-0.907043834493637,0.6252631578947369,0.8418332628603833,1.0,13/30,30.92%,CHMP5;CHMP2B;HGS;MVB12A;CHMP1B;CHMP1A;CHMP3;CHMP7;PDCD6IP;CHMP4C;VPS36;VPS28;VPS4B
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.2815001302828797,-0.9070262250550613,0.6165254237288136,0.8412832929879098,1.0,20/35,40.80%,SMUG1;RPA1;OGG1;NEIL1;POLE;POLD3;POLB;NTHL1;POLD1;POLL;LIG3;RFC5;RPA3;FEN1;RPA2;XRCC1;RFC2;POLG;UNG;PCNA
prerank,cellular response to alcohol (GO:0097306),0.3016654451395607,0.9070176420880112,0.6125,0.9104564869608243,1.0,3/42,3.74%,ADCY5;ADCY1;GRAMD1C
prerank,glucose import (GO:0046323),-0.35987848206207185,-0.906991994623261,0.5875486381322957,0.8407610667302827,1.0,2/13,9.10%,SLC2A1;ZDHHC7
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.3182900114648661,-0.9068666583072853,0.5913978494623656,0.8404384791417162,1.0,7/23,24.17%,GAS6;NR1H4;LAPTM5;CD274;ZC3H12A;INHA;VSIR
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.3675345193781425,0.9068387553443928,0.5819327731092437,0.9101243573344077,1.0,1/17,0.39%,ROCK2
prerank,cellular response to type I interferon (GO:0071357),0.3040623755669396,0.9068180778778961,0.5854092526690391,0.9086364209945745,1.0,5/41,5.33%,SP100;IFIT3;IFIT2;RNASEL;IRF8
prerank,type I interferon signaling pathway (GO:0060337),0.3040623755669396,0.9068180778778961,0.5854092526690391,0.9086364209945745,1.0,5/41,5.33%,SP100;IFIT3;IFIT2;RNASEL;IRF8
prerank,positive regulation of collagen metabolic process (GO:0010714),0.3709132172732773,0.9066516817708872,0.5821501014198783,0.9082983262638692,1.0,2/17,2.67%,WNT4;SCX
prerank,P-body assembly (GO:0033962),-0.37204326289483036,-0.9064024109089772,0.5882352941176471,0.8408868226600889,1.0,7/12,35.30%,PATL1;LIMD1;EDC3;ATXN2;PATL2;DYNC1H1;RC3H1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.3312625192456259,-0.9061729641327786,0.5909090909090909,0.8407679654814036,1.0,7/20,22.24%,ENTPD1;HSP90AB1;APP;PSTPIP1;NT5E;C3;CASP1
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.2997252228721747,-0.9059859850666997,0.6029106029106029,0.8406073682193539,1.0,8/29,22.30%,PABPC1;HNRNPU;YBX1;FUS;TENT5A;FMR1;SLC11A1;RBM24
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.36221744697669894,-0.9058255054951984,0.5891472868217055,0.8403750931857087,1.0,2/15,1.93%,STOX2;TGFB2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.3499484273687208,-0.9056445746933723,0.5808270676691729,0.8402221081240515,1.0,10/15,44.58%,RYR2;SRPRB;SEC61G;ZFAND2B;SRP14;SPCS3;RAB10;SEC61A1;SPCS1;SRPRA
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.33037458454278307,0.9056312806971663,0.5860215053763441,0.909852366464345,1.0,5/30,8.30%,ROBO1;LPAR1;AKAP13;ABRA;F2RL2
prerank,piRNA metabolic process (GO:0034587),0.35263455379011466,0.9055447436360392,0.5891783567134269,0.9092900454167986,1.0,19/19,64.78%,MYBL1;DDX4;PIWIL4;TDRD9;TDRD12;PIWIL2;PLD6;PIWIL1;TDRD1;BTBD18;GPAT2;ASZ1;HENMT1;MOV10L1;MAEL;FKBP6;EXD1;TDRKH;TEX15
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.3871361227931454,0.9053333264195129,0.5806451612903226,0.9090217458368766,1.0,4/14,13.77%,EHHADH;ECI2;AMACR;ACOX1
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.41933107475525666,0.9050373619341254,0.5797413793103449,0.9089229542720725,1.0,2/10,8.47%,HK2;GFPT2
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.41510624750496833,0.9049310564757601,0.5711297071129707,0.9083892142081499,1.0,1/10,1.37%,PRKN
prerank,regulation of telomere maintenance (GO:0032204),0.33794708043130994,0.9045583927712826,0.614,0.9084644134457026,1.0,11/26,22.11%,HDAC8;YLPM1;XRCC5;USP7;RTEL1;MRE11;PML;RAD50;NBN;TERF2;SMG1
prerank,response to thyroid hormone (GO:0097066),0.39760960846952853,0.9043553179995965,0.6114519427402862,0.9082007102164718,1.0,3/13,10.06%,BRD8;CTSH;MED1
prerank,regulation of T cell proliferation (GO:0042129),-0.25276016231052845,-0.9042196250976856,0.6461916461916462,0.8427828856032834,1.0,14/61,23.85%,TFRC;SLC7A1;NCK1;PTPRC;TNFRSF21;TNFRSF1B;NCK2;CD274;IL15;JAK3;NCKAP1L;SDC4;CEBPB;CD80
prerank,pentose-phosphate shunt (GO:0006098),0.39792927402038725,0.9038315188749663,0.5820568927789934,0.9086889043737313,1.0,4/11,11.22%,RPE;H6PD;RBKS;DERA
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.40095237413139373,0.9036473454288096,0.5780933062880325,0.9083480405371772,1.0,1/11,3.14%,NOS1AP
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.24212897165318276,-0.9035169606124399,0.6624365482233503,0.8437015528865848,1.0,27/80,22.24%,MAP3K5;THBS1;GAS6;KLF4;NGF;CTSD;TNFSF10;NOD1;CD44;VEGFA;SOX7;NDUFA13;RPS6KA1;GPER1;REST;MT3;BCAP31;CARD16;RAF1;ARL6IP1;SOX2;FOXL2;AKT1;ACVR1C;CYCS;CDKN2D;CASP1
prerank,regulation of actin filament-based movement (GO:1903115),0.4071321993535739,0.9033112466003842,0.5702127659574469,0.9083719585203429,1.0,2/10,3.96%,PDPN;ANK2
prerank,vesicle transport along microtubule (GO:0047496),-0.3111706216790459,-0.903150141433379,0.5883575883575883,0.8439231745468345,1.0,10/23,32.71%,KIF1A;RAB1A;KIF13A;NDE1;BICDL1;KIF3B;HAP1;DYNC1I1;KIF5B;DYNC1H1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.3400496796284871,-0.9030599706115998,0.5895372233400402,0.8435177293633399,1.0,4/17,10.40%,TMSB4X;KLF4;ARRB1;BCL3
prerank,regulation of stem cell proliferation (GO:0072091),0.36547821780509343,0.9029164332643167,0.597165991902834,0.9085128885498484,1.0,3/17,6.36%,GJA1;ACE;FBLN1
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.39988625818161794,0.9028929385415649,0.5717213114754098,0.9078191585973306,1.0,5/12,8.41%,PLCB1;SLAMF8;WASL;NBL1;MIA3
prerank,RNA transport (GO:0050658),-0.24509882463996907,-0.9027866735946012,0.6945812807881774,0.8435479698355731,1.0,36/71,35.96%,RBFOX1;SRSF2;RFTN1;TGFBR2;SRSF1;YBX1;SRSF5;DDX39B;ZFP36L1;SRSF9;RBM8A;RNPS1;SRSF6;RTRAF;CKAP5;THOC3;MAGOH;FMR1;POM121;THOC6;EIF4E;THOC2;NUP153;EIF4A3;KIF5C;SRSF7;ALYREF;ATXN2;ZFP36;ZC3H11A;DHX38;U2AF1L4;CHTOP;HNRNPA1;SRSF3;NCBP2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.328640051111378,-0.902764772569749,0.606694560669456,0.8430128405174158,1.0,5/20,11.70%,PPIA;PPWD1;PPIE;PPIB;NKTR
prerank,histone H4-K5 acetylation (GO:0043981),-0.3521104098180262,-0.9023043556951,0.5762004175365344,0.8428705480455264,1.0,5/15,17.31%,ING4;OGT;JADE1;KANSL3;WDR5
prerank,histone H4-K8 acetylation (GO:0043982),-0.3521104098180262,-0.9023043556951,0.5762004175365344,0.8428705480455264,1.0,5/15,17.31%,ING4;OGT;JADE1;KANSL3;WDR5
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.25966729072079286,-0.9022191899898295,0.6632124352331606,0.8424515780726883,1.0,12/55,15.39%,CAV1;DAB2IP;RPS3;RACK1;TNFSF10;TPD52L1;BCL2L1;PAK2;GPER1;BBC3;FAS;BCAP31
prerank,hyaluronan catabolic process (GO:0030214),-0.33471185897901023,-0.9021250597506943,0.5700389105058365,0.8420818088958988,1.0,6/18,8.91%,TGFB1;CD44;CEMIP2;CHP1;HEXB;HEXA
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.32249429946945024,-0.9019747780444585,0.5903361344537815,0.8418340028381829,1.0,8/22,18.52%,UBB;EDEM3;RPS27A;UBC;TRIM13;MAN1A2;UBA52;RNF5
prerank,hexose metabolic process (GO:0019318),-0.27935733899814985,-0.9017056589766941,0.594847775175644,0.8418433542892877,1.0,15/39,30.91%,APOD;PPARD;HECTD4;HK1;FUCA2;ALDOA;ALDOC;GALT;AKR1A1;FUOM;SLC37A4;GALM;DCXR;GDPGP1;PMM1
prerank,negative regulation of immune system process (GO:0002683),0.3690568574379288,0.9015092805065893,0.5697445972495089,0.9101094411923591,1.0,4/16,9.75%,HOXA7;FCRLB;PDCD1;IL17D
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.4032239081303348,0.9011814218399755,0.5685071574642127,0.9100973886794913,1.0,2/10,4.71%,BMP7;ARHGAP12
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.23133046609773764,-0.9010289145716978,0.6804123711340206,0.8427712375510267,1.0,13/88,9.47%,CST3;DAB2IP;SERPINE2;RPS3;RACK1;CALR;IGFBP5;TOB1;BAG6;GAPDH;YBX1;EDN1;DNAJC1
prerank,presynapse organization (GO:0099172),0.41302466298369633,0.9010048206151086,0.5729166666666666,0.909733869631886,1.0,1/10,2.23%,NLGN2
prerank,lipoprotein localization (GO:0044872),0.4034483846094544,0.9009422569729448,0.5788336933045356,0.9091206328702751,1.0,3/11,8.41%,PRKCB;ZDHHC3;MIA3
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.3405210898384117,-0.9006010140801,0.602020202020202,0.8431489554151584,1.0,9/16,33.53%,SMCHD1;UBQLN4;POLQ;SHLD3;RMI2;CGAS;RIF1;SHLD2;HELB
prerank,protein polyubiquitination (GO:0000209),0.22699877679585756,0.900549622911304,0.6988110964332893,0.9092370983817604,1.0,66/297,17.96%,SASH1;PRKN;PELI2;BCL2;SPSB1;UBE2E2;TRIM5;NEDD4;RNF213;FBXW4;DDB2;ANAPC13;RNF217;PSME4;PSMA2;FBXO44;UBE2L3;PSMA3;NPEPPS;UBR2;RNF152;SPOP;TTC3;TRIM56;RNF135;SIAH2;WWP2;AMFR;RNF216;RC3H2;UBE4A;FBXL17;NHLRC1;FBXO6;MDM2;PSMD8;ITCH;KBTBD7;SMURF2;PSMD3;RBBP6;FBXO4;FBXO38;RNF14;RNF20;FBXO11;CDC26;IFI27;UBE2V1;UBE2A;CHFR;BIRC2;TRIM62;PPIL2;SKP2;UBE2H;HECTD1;HERC6;TRIM69;ANAPC2;UBE2E1;NHLRC3;PELI3;DTX3L;UBE4B;FBXW10
prerank,replication fork processing (GO:0031297),0.30047246466893357,0.9003681943847033,0.6007067137809188,0.9089087623971109,1.0,15/38,23.29%,BLM;BRCA2;ZGRF1;RTEL1;BOD1L1;PRIMPOL;MRE11;CENPX;WRN;RAD51;CDK9;SAMHD1;ETAA1;SMARCAL1;THOC1
prerank,negative regulation of cell cycle (GO:0045786),-0.2431084015027316,-0.9001806094705723,0.674074074074074,0.8435222373435879,1.0,26/73,22.86%,PPP1R13B;RHOB;TGFB1;PDCD4;NR4A1;APC;CDK6;CDKN1B;BTG3;BMP2;HHEX;MEN1;GPER1;NLRP2B;BRINP2;DUSP1;ZBTB17;CAMK2N1;INHA;TFAP4;CHMP1A;BMP4;BTG1;GMNC;SIPA1;CEBPA
prerank,regulation of protein processing (GO:0070613),-0.32046415448270527,-0.8997242142085113,0.6003937007874016,0.8438942157056581,1.0,3/21,5.68%,RUNX1;SERPINE2;NKD2
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.3564139965342306,0.8996911010052621,0.5618860510805501,0.9097825079004997,1.0,5/20,14.05%,NR2F2;PTEN;CDK5RAP1;LATS1;CDKN1C
prerank,regulation of JNK cascade (GO:0046328),0.26257415902720105,0.8996454053098548,0.6189735614307932,0.9091317844645944,1.0,15/101,12.05%,TGFBR3;PRKN;MTURN;CCN2;PLCB1;MBIP;DUSP10;IGF1R;SH3RF1;CCL19;SIRPA;ITCH;SH3RF2;RAP2A;CYLD
prerank,monocyte chemotaxis (GO:0002548),0.31134886691949926,0.8993718557765704,0.5685920577617328,0.9090194049697458,1.0,5/32,10.07%,ANXA1;IL6;FOLR2;CCL19;CCL4
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.31609373956879355,0.8986007539523428,0.5878003696857671,0.9099563287693786,1.0,4/28,6.89%,ADCY1;EPHA4;PTN;ARC
prerank,atrial septum morphogenesis (GO:0060413),-0.3914962950540457,-0.8975175810029493,0.6030534351145038,0.8481792377519237,1.0,4/10,9.37%,TGFB2;BMPR2;SOX4;HEY2
prerank,regulation of RNA splicing (GO:0043484),-0.2412906767277003,-0.8970127367037752,0.6666666666666666,0.8487127293800585,1.0,26/69,25.95%,MBNL1;AHNAK2;HNRNPK;AHNAK;QKI;LARP7;HNRNPH2;KHDRBS3;SRPK1;GRSF1;FUS;RPS26;TMBIM6;YTHDC1;HNRNPLL;PTBP1;RBM22;TRA2B;RBM20;FAM50A;FASTK;HNRNPF;MBNL2;ZPR1;PRX;ERN1
prerank,positive regulation of ruffle assembly (GO:1900029),-0.36115124895194983,-0.8968095604349845,0.6233009708737864,0.8485832185263746,1.0,5/13,25.17%,EPS8L2;EPS8;PLEKHM1;P2RY12;HRAS
prerank,positive regulation of ATPase activity (GO:0032781),0.2991185734558803,0.896783615717372,0.5886654478976234,0.9133180711742913,1.0,3/41,2.80%,TPM1;ATP1B3;TNNT2
prerank,regulation of glycogen metabolic process (GO:0070873),0.3966599743709046,0.8964326092805991,0.5909090909090909,0.9133821612440107,1.0,2/12,10.38%,PPP1R3G;PPP1R3F
prerank,cGMP biosynthetic process (GO:0006182),-0.3886044068441318,-0.8963998326148792,0.6094032549728752,0.8489373877501798,1.0,2/10,4.49%,GUCY1B1;GUCY1A1
prerank,synaptic vesicle exocytosis (GO:0016079),0.3006523088827071,0.8960885352290607,0.5929824561403508,0.9133742016198965,1.0,1/40,0.06%,UNC13C
prerank,regulation of collagen biosynthetic process (GO:0032965),0.35625158568744664,0.8960484653952915,0.5924453280318092,0.912716324241758,1.0,3/19,6.76%,WNT4;SCX;IL6
prerank,regulation of myotube differentiation (GO:0010830),-0.3121352219830758,-0.8956326438850974,0.631578947368421,0.8500504280637667,1.0,7/24,13.46%,NOTCH1;CCN3;HDAC5;PIEZO1;XBP1;ATP11A;SMYD1
prerank,secretory granule organization (GO:0033363),0.41032787010739524,0.8954996352220325,0.5841995841995842,0.913171721693487,1.0,3/10,10.95%,DTNBP1;ABCA1;F2RL3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.3879887500438499,-0.895364049125201,0.6010830324909747,0.8494499581540293,1.0,5/10,19.74%,NFATC2;NFATC1;PPP3CA;PPP3R1;NFATC3
prerank,calcineurin-mediated signaling (GO:0097720),-0.3879887500438499,-0.895364049125201,0.6010830324909747,0.8494499581540293,1.0,5/10,19.74%,NFATC2;NFATC1;PPP3CA;PPP3R1;NFATC3
prerank,phosphatidylserine metabolic process (GO:0006658),0.311498734859695,0.8953465400104414,0.594059405940594,0.9127866214575007,1.0,8/32,18.18%,OSBPL8;PLA2G10;SLC27A1;PLA2G4B;PLA2G12A;OSBPL10;ABHD12;ABHD16A
prerank,response to cholesterol (GO:0070723),-0.3385720496575191,-0.8953375992071436,0.6190476190476191,0.8489112152621797,1.0,4/17,9.08%,TGFBR2;TGFB1;PTCH1;GRAMD1A
prerank,nuclear export (GO:0051168),0.2639440559505049,0.8951775224349077,0.6380471380471381,0.9124169377704159,1.0,3/80,1.73%,RANBP3L;ATXN1;PHAX
prerank,dephosphorylation (GO:0016311),0.2424335455297258,0.8947258202689478,0.6598837209302325,0.9126860587518797,1.0,17/147,7.48%,PTPN13;PXYLP1;PLPP3;LHPP;PPM1M;PTPN4;DUSP10;PPM1E;CDC14B;PTPRA;MTMR3;PTPN9;EPHX2;SGPP1;ACP3;PTPRD;PTEN
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.40039131349395063,0.8946873101537273,0.5835010060362174,0.9120218416329773,1.0,1/12,1.28%,BMP7
prerank,actin crosslink formation (GO:0051764),0.38297587412627343,0.8938499987765248,0.5826612903225806,0.9131521853640375,1.0,3/12,6.45%,DPYSL3;BAIAP2;BAIAP2L2
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.33732758711473,-0.8934843445512319,0.6024590163934426,0.8523790523397671,1.0,3/17,7.65%,FERMT2;PTPRC;HNRNPU
prerank,regulation of cellular protein localization (GO:1903827),-0.2642349057075361,-0.8931301859472852,0.6453900709219859,0.8525717115381017,1.0,20/45,30.79%,HSP90AA1;HSP90AB1;CTNNB1;SPIDR;RALB;PTPN1;GPC1;RAB11FIP5;CCDC66;ATP13A2;GBF1;SUMO3;ABCA2;VCP;MAP1A;PPM1F;TRIM67;LCP1;EGF;SHH
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3692638473539025,-0.8930513033245843,0.6199186991869918,0.8521589886709318,1.0,5/12,32.52%,GCLM;GGT1;CHAC2;MGST2;OPLAH
prerank,signal transduction in response to DNA damage (GO:0042770),-0.2591108104098538,-0.8930132266521306,0.6861313868613139,0.8516577995688992,1.0,17/49,30.01%,ACER2;TIPRL;CHEK2;SESN2;BCL3;DONSON;RAD17;USP28;RAD9A;ATR;GADD45A;DOT1L;E2F7;CHEK1;BID;USP10;NDRG1
prerank,inhibitory synapse assembly (GO:1904862),-0.38277646448104197,-0.892783507643012,0.6200378071833649,0.8515348808924437,1.0,6/11,43.50%,GABRB3;GABRG2;FGF13;GABRB2;LGI2;NPAS4
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.2721739685716409,-0.8926977934020286,0.6387096774193548,0.8511368797940753,1.0,13/38,23.22%,PTPRJ;PPP2R5C;RACK1;PLEKHA1;XDH;GPER1;OTUD3;SH2B3;ARRB2;NOP53;AKT1;HYAL2;TRIB3
prerank,regulation of receptor recycling (GO:0001919),-0.34458677428162265,-0.8921767222002781,0.6162790697674418,0.8516588796643233,1.0,4/16,10.75%,NSF;AP1AR;ECE1;LAMTOR1
prerank,steroid catabolic process (GO:0006706),-0.3912700949670145,-0.8912767283700797,0.6026871401151631,0.8530225301123419,1.0,3/10,17.70%,SPP1;YWHAH;HSD11B1
prerank,carboxylic acid catabolic process (GO:0046395),0.38137582795845804,0.8903320148971788,0.6061855670103092,0.9202572397386856,1.0,3/12,14.34%,ACOT4;RENBP;NPL
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.38587128361678763,0.8903028840363663,0.5783898305084746,0.9195737438289111,1.0,1/12,1.07%,PPARA
prerank,focal adhesion assembly (GO:0048041),-0.31538121815673936,-0.8902692717474247,0.613682092555332,0.8546250252088641,1.0,7/21,15.08%,THSD1;ACTN1;FERMT2;BCR;PEAK1;WHAMM;RCC2
prerank,protein catabolic process (GO:0030163),0.28042135628998316,0.8897154608300543,0.642495784148398,0.9201375437397298,1.0,13/59,14.75%,ADAMTS9;PRKN;CLPX;TPP1;FBXO44;LAMP2;SIAH2;FBXO6;CUL4B;NGLY1;RAB12;TRIM24;HTRA2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.3523298001296841,-0.8889224772241338,0.623721881390593,0.8569662766583289,1.0,8/14,31.30%,CPSF7;CPSF6;CPSF2;CSTF2T;CSTF2;ERN1;CPSF4L;CPSF1
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.2714896121815018,-0.8878080997420044,0.6681818181818182,0.858841215202417,1.0,16/39,23.89%,RAB3C;MIA2;TANGO6;COPG1;OLFM2;RAB3B;SCG2;CANX;TMEM167A;MTTP;PREB;TVP23A;RAB8A;NECAB3;RAB8B;RAB3A
prerank,negative regulation of cation channel activity (GO:2001258),0.33165587919515804,0.8877857184776397,0.5684410646387833,0.9236817646835681,1.0,8/26,19.43%,SLC6A9;GSTM2;MMP9;GNB5;PKD2;DRD2;GPR35;EPHB2
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3135941766284393,0.8873788914182469,0.6087786259541985,0.9238461692117853,1.0,4/32,6.79%,AUTS2;AVIL;ABI2;ENPP2
prerank,cytosolic calcium ion transport (GO:0060401),0.32506835166768683,0.8873776096800458,0.5941499085923218,0.9230981328636039,1.0,6/28,10.46%,JPH1;SLC8A1;MAIP1;CACNA2D1;MCU;MICU1
prerank,positive regulation of transport (GO:0051050),-0.23137542918124296,-0.8870239327946363,0.7261306532663316,0.8600028738740662,1.0,37/85,29.77%,ACTB;GAS6;NEDD4L;RAB27A;GATA2;CALR;DOCK2;GSK3B;CHP1;HIP1R;C2CD5;LMAN2;CD47;SGK1;ACSL3;IL15;FMR1;NUMA1;SLC11A1;MLC1;NR1H3;DLL1;SPAG5;PLAA;CAPN10;FCGR2B;CHCHD10;BAX;SYNGR3;CHRM1;DOC2B;TREM2;BID;IL2RG;ABCA7;TUB;AHSG
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.2843347064127113,-0.8868428785737357,0.6602409638554216,0.8598225522367053,1.0,6/29,13.90%,CAV1;THBS1;TNFSF10;PAK2;GPER1;RET
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.38789640063509706,-0.8868080667123246,0.6175373134328358,0.8593056938982495,1.0,4/10,21.48%,FAS;MAP2K2;GREM1;MAPK3
prerank,lipid droplet formation (GO:0140042),-0.38620504809641876,-0.8866822970011214,0.6173570019723866,0.8589724239786636,1.0,3/10,17.36%,CDS1;BSCL2;AUP1
prerank,axonal transport (GO:0098930),-0.2727296621679137,-0.8862813647429123,0.6512141280353201,0.8592922918745499,1.0,13/36,28.08%,AP3S1;BLOC1S2;SOD1;AP3M2;KIF1A;TMEM108;KIF3B;NEFL;DCTN1;KIF4A;HAP1;KIF1B;SNAPIN
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3628853049630532,0.8858959958938653,0.5836575875486382,0.9257220704077556,1.0,3/16,6.51%,IGF1R;MTRF1;BNIP3
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3072368678505953,0.8855842353424994,0.6310160427807486,0.9256616894323437,1.0,6/37,9.75%,APPL2;PPARA;IL6;NLRC3;SIRPA;IL17D
prerank,positive regulation of potassium ion transport (GO:0043268),-0.2738308669449775,-0.8853660339014201,0.6402714932126696,0.8607043958497295,1.0,8/38,13.92%,KCNJ2;KCNMA1;FHL1;FLNA;KCNQ1;KCNMB4;KCNN2;KCNJ15
prerank,epithelial cell migration (GO:0010631),-0.27898922527734277,-0.8852134289865983,0.6339869281045751,0.8604498321095784,1.0,16/37,24.36%,NOS3;FAP;PLXND1;PXN;KANK1;RHOA;DPP4;SCG2;CDH13;PKN3;CYP1B1;ADGRA2;PLEKHG5;PRKX;PTP4A3;STAT1
prerank,rRNA transcription (GO:0009303),-0.34220043159375985,-0.884940737151591,0.6419753086419753,0.8604622816931395,1.0,8/17,23.04%,CAVIN1;BRF1;GTF3C1;SPIN1;ANG;SIRT7;GTF3C2;GTF3C4
prerank,maintenance of protein localization in organelle (GO:0072595),-0.3219807456682652,-0.8847236825628547,0.64453125,0.86035296026374,1.0,9/19,23.68%,HK1;HNRNPU;ARL2BP;HSPA5;BCL3;PINK1;AKT1;SKP1;CHCHD10
prerank,respiratory electron transport chain (GO:0022904),-0.34397768747252166,-0.8846442304774156,0.597678916827853,0.8599254564176485,1.0,3/14,10.86%,PPARGC1A;NDUFA5;GPD2
prerank,regulation of cation transmembrane transport (GO:1904062),0.3183482916804779,0.8846372425139593,0.6189555125725339,0.9270091602608134,1.0,4/29,6.48%,KCNIP3;SNTA1;CACNA1D;DLG1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.39535138982292206,0.8846107565525172,0.5987525987525988,0.9263158454161187,1.0,1/11,1.07%,PPARA
prerank,regulation of supramolecular fiber organization (GO:1902903),0.34207622781185204,0.8842237849116846,0.615678776290631,0.9264195768769171,1.0,4/22,12.24%,AEBP1;AKAP13;ABL1;GBA2
prerank,positive regulation of lyase activity (GO:0051349),-0.3489186885859943,-0.8841702562983725,0.6127744510978044,0.860329765140911,1.0,6/14,17.03%,NOS3;ISCU;CACNA1C;NOS1;NF1;ORAI1
prerank,mitochondrial gene expression (GO:0140053),-0.26761919138115947,-0.8831427693369163,0.69593147751606,0.861958489501828,1.0,10/42,25.00%,LARS2;TFB2M;NDUFA7;MRPS14;MRPS16;MRPL23;MRPS28;MRPS2;MRPS11;MRPL57
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.3734739094486382,0.8829412082921533,0.6020408163265306,0.9284518176570357,1.0,1/14,1.07%,PPARA
prerank,positive regulation of T cell activation (GO:0050870),-0.24255181874791254,-0.8821496647728024,0.6923076923076923,0.8635353454877666,1.0,17/62,24.03%,TFRC;SLC7A1;NCK1;PTPRC;CYRIB;XBP1;NCK2;HSPD1;CD81;CD47;CD274;IL15;JAK3;THY1;NCKAP1L;CD80;CCR2
prerank,phospholipid dephosphorylation (GO:0046839),0.30318287231694807,0.8815829743455211,0.6230899830220713,0.9307040558101453,1.0,6/37,7.48%,PLPP3;MTMR3;SYNJ2;EPHX2;SGPP1;PTEN
prerank,generation of neurons (GO:0048699),0.2326334531729296,0.8806884894961363,0.6954022988505747,0.9319625316817878,1.0,21/190,10.68%,DCDC2;AUTS2;WNT4;WNT6;ASCL2;IL1RAPL1;NDNF;PCSK9;ARTN;SDCCAG8;SH3RF1;PTPRD;WNT5B;EN1;RYK;YTHDF2;PAFAH1B1;TUBGCP2;IRX1;ATOH8;NEUROD2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.21765708123873703,0.8806377175978009,0.774108322324967,0.9313299395001398,1.0,77/336,17.78%,STXBP4;BCL2;FANCA;UBE2E2;RAD51B;ATRIP;ASH2L;MAP2K6;BAZ1B;DDB2;PLK5;RAD51C;CTLA4;MRNIP;UFL1;INIP;PDS5B;PSME4;SETD7;PARP4;XRCC5;SLF1;BLM;NEK4;WDR48;CDK1;CHCHD6;UVRAG;BCL2L2;FBXO6;IRF3;UBA7;MBD4;PDS5A;ABL1;PRKDC;EPHA2;RTEL1;RBBP6;ZBTB38;IKBKE;MAPKAPK2;CUL4B;CRY1;LIG1;INO80;BOD1L1;MRE11;USP45;CIB1;FANCF;APEX1;BATF;MNAT1;CEP63;UBE2A;HTRA2;BABAM2;WRN;FANCC;BRSK1;RAD18;RAD51;LYN;NIPBL;PML;PHF1;MACROD1;ZDHHC16;REXO4;BACH1;TAOK3;RPAIN;TRRAP;XPC;DTX3L;TAOK2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.23401417250816275,-0.8805238603587732,0.7192513368983957,0.8663959122820033,1.0,32/80,29.31%,NSF;COPG1;ARF5;KIF26A;TMED2;LMAN2;RAB1A;BNIP1;PICK1;ARFGAP2;TMED10;TMED3;GBF1;SCYL1;TAPBP;KIF3B;PITPNB;RAB1B;KIF11;KIF15;TMEM115;TMED7;KIF4A;RAB6B;USE1;KLC2;KDELR3;COPA;KLC1;ARF3;KIF23;DNAJC28
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.33795486538251446,-0.8804932864701317,0.6254826254826255,0.8658620228246232,1.0,5/14,16.11%,SEMA7A;PLCG2;CD74;CAMK4;LAPTM5
prerank,defense response to bacterium (GO:0042742),0.2511089519833975,0.8801815663268445,0.6983154670750383,0.9316140984922539,1.0,13/105,12.82%,COLEC12;GSDMA;LTF;CXCL13;SLAMF8;ANXA3;IL6;OPTN;GSDMD;PGLYRP3;MR1;SERPINE1;S100A9
prerank,cellular response to virus (GO:0098586),-0.28785421618610935,-0.8801226659660377,0.638477801268499,0.8660688467947895,1.0,12/30,26.70%,HSP90AA1;ARF1;CHUK;IFIH1;GBF1;ZC3H12A;EIF5A;FMR1;MAPK11;BAX;VWCE;CXCL10
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.22128095853241056,-0.8800434644113402,0.745398773006135,0.8656569986899404,1.0,28/112,20.22%,PTPRJ;FOXP1;IL33;CD34;THBS1;GAS6;PLCG2;LBP;HSPB1;PTPRC;APP;STAT3;OAS2;ARHGEF2;CLU;IRAK3;IFNGR1;CD47;NR1H4;IFIH1;CX3CR1;MIF;ZC3H12A;PSEN1;TIRAP;TRIM27;TYROBP;FRMD8
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3774425361231636,0.8799804713323365,0.6101364522417154,0.9312781069542109,1.0,5/14,16.88%,LHPP;ADSL;GMPS;ADK;PFAS
prerank,osteoclast differentiation (GO:0030316),-0.30951427583203256,-0.8798465698816048,0.6386554621848739,0.8654976182733959,1.0,3/22,6.66%,FOXP1;SBNO2;TNFRSF11A
prerank,GPI anchor biosynthetic process (GO:0006506),0.3203756439357024,0.8795673436877954,0.6159695817490495,0.9313903362461983,1.0,6/30,12.88%,PIGU;PIGG;PIGV;PIGX;PIGC;PIGQ
prerank,lysosome organization (GO:0007040),0.30565648541713075,0.8794662775070469,0.6453900709219859,0.9308590008202997,1.0,6/36,6.91%,HOOK2;ABCA1;TPP1;LRRK2;ACP3;ATP10B
prerank,pinocytosis (GO:0006907),-0.383068672248457,-0.8789138327486838,0.6393129770992366,0.8669401198706487,1.0,2/10,5.70%,CARMIL1;DOCK2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2632005642694355,-0.8789070758399907,0.6543778801843319,0.8663651187712001,1.0,11/44,17.34%,THBS1;GAS6;KLF4;NGF;CD44;VEGFA;RPS6KA1;MT3;CARD16;RAF1;ARL6IP1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.2813195926142157,0.8787408087820565,0.6363636363636364,0.931697695121468,1.0,13/51,15.68%,FBN1;SMAD6;SPART;LRP2;NBL1;CHRDL1;FSTL3;LEMD3;SMURF2;BMPR1A;FSTL1;SKI;SMAD4
prerank,digestive tract morphogenesis (GO:0048546),0.3714649850640685,0.8786687303867378,0.5923566878980892,0.9310995418999523,1.0,3/14,10.11%,FGFR2;PDGFRA;BBS7
prerank,epidermal cell differentiation (GO:0009913),-0.26373037334533905,-0.8786457106971461,0.6964285714285714,0.8662724166684856,1.0,9/41,20.64%,CLIC4;JAG1;CTNNB1;BCR;WNT16;GLI1;ADAM9;DSP;USH2A
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.30544163406067026,-0.8786073073053098,0.6469387755102041,0.8657616475665973,1.0,10/22,26.69%,CALM1;ATP1B1;VMP1;RYR2;CALM2;STAC3;JPH2;CALM3;HAP1;CASQ1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.2927396534577029,-0.8785184405811657,0.665938864628821,0.865385061475098,1.0,8/27,14.55%,CSGALNACT1;CSPG4;BGN;CHST9;CHST11;XYLT1;VCAN;CHSY3
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.3210955720392519,-0.8781158023868941,0.6400817995910021,0.8656517200352657,1.0,10/19,35.89%,CHUK;HSPD1;IFIH1;IRF5;STAT1;TLR7;TLR4;DHX9;MAVS;TLR8
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.37364117483739956,0.8781069552012291,0.5938864628820961,0.9315969440114484,1.0,5/13,16.02%,ATG10;UBA7;UBA3;DESI2;DESI1
prerank,chromosome organization (GO:0051276),0.2556025574230908,0.8781039060681365,0.6547987616099071,0.9308543407628163,1.0,16/99,12.77%,TCF7L2;SATB1;TOP2B;HDAC8;DDB2;SOX1;MTHFR;SETD7;TCF7L1;MTF2;AXIN2;LATS1;ABL1;HDAC1;CUL4B;EZH1
prerank,endomembrane system organization (GO:0010256),-0.2054779117591604,-0.8780618623123916,0.8038585209003215,0.8651961907133424,1.0,61/178,28.37%,SPTBN1;ATP8B1;SYNE1;REEP3;CAV2;REEP5;LYSMD3;CHMP2B;VMP1;TMED5;ALS2CL;SMPD4;LEMD2;TMED2;SRGN;DYSF;TOR1B;LMAN2;LAMTOR1;USP50;RAB1A;NSFL1C;DNM1;VPS18;BNIP1;LMAN2L;TMED10;TMED3;HOOK1;ATL2;TLCD2;PRKD1;TRIP11;GBF1;VPS11;SEC16B;USP8;VPS51;SUN1;SPTSSB;ANK3;CTDNEP1;VAPA;EXOC8;CLASP2;TMED7;HUWE1;OTOF;SYP;RAB2A;SEC16A;SYNGR2;ANXA8L1;ANXA8;PI4K2B;RNF112;FBXW8;SEC31A;ATL3;RNF26;VPS33B
prerank,negative regulation of coagulation (GO:0050819),0.36754028009238965,0.8778010474643959,0.5855130784708249,0.9307530095495238,1.0,4/14,12.56%,TFPI;VTN;APOH;SERPINE1
prerank,high-density lipoprotein particle assembly (GO:0034380),0.3998597981530364,0.8773640695461068,0.5857740585774058,0.9309452471206415,1.0,2/10,13.56%,ABCA1;PRKACB
prerank,negative regulation of T cell differentiation (GO:0045581),0.40028440504324464,0.8772844253625125,0.5960698689956332,0.9303652549101391,1.0,3/10,13.30%,CTLA4;GLI3;LAG3
prerank,protein autoprocessing (GO:0016540),0.3640929707485923,0.8771976455048787,0.6105476673427992,0.9297782539719307,1.0,4/17,14.90%,PCSK9;MYRFL;HTRA2;OMA1
prerank,regulation of exit from mitosis (GO:0007096),-0.27412316250413726,-0.8771167224476412,0.6550976138828634,0.8665533232069864,1.0,13/38,28.25%,UBB;BUB3;RPS27A;UBC;ANAPC16;UBA52;BUB1B;UBE2D1;ANAPC7;RGCC;KNTC1;CDC14A;MAD2L1BP
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.2977485691123221,0.8764477498860874,0.6486988847583643,0.9306773336798019,1.0,11/36,16.15%,TCF7L2;PLCB1;TNRC6B;TNRC6A;PDE6G;AGO2;FZD2;MAP3K7;NLK;MOV10;GNG2
prerank,melanosome localization (GO:0032400),0.33513796053363026,0.8759128737278823,0.6167664670658682,0.931126908896328,1.0,5/21,14.67%,SHROOM2;ARL6;GPR143;BBS7;RAB11B
prerank,regulation of receptor internalization (GO:0002090),-0.27922480692664925,-0.8754032430532377,0.6592920353982301,0.8696097507071768,1.0,15/35,21.01%,SFRP4;RIN3;ARRB1;ARF1;VEGFA;CD63;ANKRD13A;PICK1;MKLN1;GREM1;ANKRD13B;ARRB2;INSR;FMR1;ATAD1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3293927700932824,0.8753752624400063,0.5935727788279773,0.9315599310892787,1.0,4/24,7.80%,JARID2;RBBP4;RBBP7;MTF2
prerank,response to organic cyclic compound (GO:0014070),0.2817779356162395,0.8753709319998016,0.6487889273356401,0.9308242525115312,1.0,6/52,7.77%,FGFR4;IL18;ANXA1;STAT5B;LRRK2;STRN3
prerank,chemical homeostasis (GO:0048878),-0.24143393590850487,-0.875355049165629,0.6990740740740741,0.8691086232027951,1.0,14/61,17.52%,SLC4A10;NEDD4L;WNK3;ACOX3;AQP4;AQP11;SLC4A8;SLC4A2;NR1D2;TLCD2;VGF;ATP13A2;WNK2;CLN8
prerank,positive regulation of telomere maintenance (GO:0032206),-0.2863433749144117,-0.8752063194129512,0.6738197424892703,0.8688272325799238,1.0,4/31,10.52%,NEK7;GNL3;PPP1R10;MAP2K7
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.326170697405764,0.8750683824810215,0.6247544204322201,0.9307480251385394,1.0,1/25,0.34%,LEPROT
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.3944547442795465,0.8747524483413059,0.589098532494759,0.9306561215447186,1.0,1/10,1.00%,FGFR2
prerank,regulation of mast cell degranulation (GO:0043304),0.35295449084261854,0.873515025703237,0.6018099547511312,0.93266090373257,1.0,5/14,20.04%,FER;GAB2;LYN;CD84;LGALS9
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.32668869507586346,-0.8734844514915633,0.6353166986564299,0.8718728930472849,1.0,9/18,31.56%,APOD;GSK3B;CHP1;MDFIC;CTNNA1;OTUD7B;CABP1;SIN3A;MFHAS1
prerank,positive regulation of myelination (GO:0031643),0.39338627305764157,0.8734229775180777,0.6172839506172839,0.9321138082236397,1.0,4/11,13.79%,PARD3;ITGAX;CST7;DICER1
prerank,negative regulation of protein transport (GO:0051224),-0.3042534258421397,-0.8732167600515834,0.6310272536687631,0.8718449831286654,1.0,11/25,35.14%,CSK;RHBDF2;NDFIP2;RSAD2;CYP51A1;NDFIP1;SNX3;PPM1F;HMGCR;PKDCC;DRD3
prerank,positive regulation of leukocyte migration (GO:0002687),0.3120871240734572,0.8731507414673413,0.6035502958579881,0.9319837879942411,1.0,4/27,8.41%,PTN;IL6;CSF1;MIA3
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3037795085644207,0.8730833071605848,0.6368613138686131,0.9314015928300143,1.0,7/38,14.28%,RORA;CACTIN;NLRC3;TLE1;MAPKBP1;NLRP12;NLRX1
prerank,interstrand cross-link repair (GO:0036297),0.2774370027575507,0.873066444575252,0.6654867256637168,0.9307051697334835,1.0,16/53,17.87%,FANCA;ATRIP;RAD51AP2;WDR48;FANCI;DCLRE1A;DCLRE1B;FANCB;FANCF;FANCE;FAAP100;CENPX;FANCC;RAD51;ERCC6L2;FAAP24
prerank,mRNA 3'-end processing (GO:0031124),-0.23492492189143005,-0.872783160984999,0.7473684210526316,0.8721480465762418,1.0,38/78,34.16%,SRSF2;PABPC1;SRSF1;APP;CPSF7;SRSF5;DDX39B;CPSF3;SRSF9;CPSF6;RBM8A;RNPS1;SRSF6;GRSF1;SYMPK;AHCYL1;CLP1;CPSF2;CSTF2T;PCF11;CSTF2;THOC3;MAGOH;THOC6;THOC2;EIF4A3;LSM11;SRSF7;ALYREF;CSTF1;CPSF4L;TENT4B;CPSF1;ZC3H11A;MTPAP;DHX38;U2AF1L4;CHTOP
prerank,negative regulation of ion transport (GO:0043271),0.33210368867124407,0.8726579449653307,0.6333333333333333,0.9308710142239361,1.0,3/24,4.13%,WNK4;NEDD4;SYT11
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.3721540244487382,0.8726280375613831,0.5973154362416108,0.930197536819077,1.0,3/13,12.86%,ARID1B;ZMIZ1;ZMIZ2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.24045045802049234,0.8725313368426377,0.6875,0.9296977988319275,1.0,26/128,16.72%,NINL;PLCB1;ALMS1;PHLDA1;CDK7;CCDC57;HAUS4;CEP152;SDCCAG8;OPTN;CDK1;PAFAH1B1;FBXL17;LATS1;OFD1;HAUS1;SFI1;CEP57;MNAT1;CEP63;CEP164;BRSK1;SKP2;CDKN2B;BACH1;PPP1R12B
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.36231782615226604,-0.8722026571644668,0.6316758747697975,0.8728062723992888,1.0,6/12,34.75%,MCM4;GINS4;MCM5;MCM6;GINS2;CDC7
prerank,regulation of presynapse organization (GO:0099174),0.3449668147542651,0.8719792715495008,0.6277665995975855,0.9294145169225926,1.0,6/18,18.24%,GPC6;IL1RAPL1;PTPRD;GPC4;VPS35;SNCA
prerank,regulation of presynapse assembly (GO:1905606),0.3449668147542651,0.8719792715495008,0.6277665995975855,0.9294145169225926,1.0,6/18,18.24%,GPC6;IL1RAPL1;PTPRD;GPC4;VPS35;SNCA
prerank,regulation of trophoblast cell migration (GO:1901163),-0.34735425266441955,-0.8710025366667048,0.6496212121212122,0.8746206962462977,1.0,4/14,11.27%,ARHGDIB;CALR;VEGFA;YTHDF3
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2092989098994651,0.8706703433986915,0.8417799752781211,0.9316137365404421,1.0,76/497,14.05%,TCF7L2;WNT4;RBPJ;NR2F2;BMP7;IGF2BP1;DAPK1;ATXN1;SNX6;DKK3;ARID5B;RUNX1T1;PRDM5;ZEB1;ZIC2;NR1I2;PLCB1;LOXL3;TSHZ3;JARID2;MIDEAS;VGLL4;PRICKLE1;HOXA7;FOXD1;ZHX2;CBY1;BEND5;L3MBTL2;ARID4A;IKZF4;DPF2;GLI3;SFMBT1;NIBAN2;BCOR;TYMS;SALL1;XRCC5;BIRC5;WWP2;RSF1;ZMYND15;TLE1;KAT8;KAT6B;MDM2;MBTD1;SAMD4A;SMURF2;PDS5A;SCMH1;L3MBTL3;ATOH8;HDAC1;TFAP2A;SMARCE1;TFAP2B;FXR1;ZNF568;ZBTB38;MYB;CRY1;SOX13;CBFA2T2;PSPC1;SHMT1;TSPYL2;NONO;FOXK2;SCML4;TFDP2;CLOCK;ZNF148;KDM5C;CDKN1C
prerank,protein localization to vacuole (GO:0072665),-0.3592075889719143,-0.8701477258737643,0.6448412698412699,0.8757834247547981,1.0,5/13,16.19%,SH3BP4;SH3GLB1;RTN4;CD81;ATP13A2
prerank,mitochondrial translational termination (GO:0070126),-0.22648553373422303,-0.8700662180940608,0.7602905569007264,0.8753552664395352,1.0,28/88,29.09%,MRRF;MRPL32;MRPL33;MRPS14;MRPL38;ERAL1;MRPS16;MRPL50;MRPS5;MRPL23;MRPL24;MRPS35;MRPS28;MRPL13;MRPL35;MTRF1L;MRPL34;MRPS23;MRPS2;MRPS11;MRPS27;MRPL57;MRPL11;MRPS18C;MRPL18;MRPL14;AURKAIP1;CHCHD1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.30135387981253225,0.869806815836674,0.6357012750455373,0.9327624873542887,1.0,9/35,16.28%,ACSS3;HMGCL;BDH1;GCDH;PAM;BDH2;AWAT2;HMGCLL1;HMGCS2
prerank,response to lipid (GO:0033993),0.24426774968150727,0.8693327515073586,0.6980568011958147,0.9330999213943862,1.0,8/105,3.68%,FGFR4;PPARA;RBP4;SMAD6;FER;CTSH;ANXA1;STAT5B
prerank,proton transmembrane transport (GO:1902600),0.3004757926476365,0.8692768000229437,0.6368421052631579,0.9324816628037939,1.0,5/36,13.19%,ATP1A2;ATP6V0D1;ATP6V0E1;SLC36A2;DMAC2L
prerank,regulation of centrosome duplication (GO:0010824),-0.2863021725744153,-0.8687509753260724,0.6529774127310062,0.8776098254444751,1.0,19/29,35.77%,CHMP5;CHMP2B;PLK2;CEP295NL;CCNF;CHMP1B;CHMP1A;GEN1;CHMP3;PDCD6IP;CEP295;CHMP4C;VPS4B;CEP131;NPM1;STIL;TMEM67;PKHD1;XRCC3
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.3016958921312965,-0.8687322695010313,0.6543478260869565,0.8770608868540158,1.0,10/23,25.31%,SYNJ1;MTM1;MTMR6;MTMR9;SACM1L;MTMR12;INPP5F;PIP4P2;MTMR1;TPTE
prerank,camera-type eye morphogenesis (GO:0048593),0.39609769236228143,0.8686555601068997,0.6329670329670329,0.9331068837337324,1.0,4/10,15.57%,SHROOM2;KDM2B;IFT122;SKI
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.3232384282119695,-0.8685319844983665,0.6350806451612904,0.876892333123921,1.0,4/17,12.45%,SLIT2;SFRP4;TMEM204;CASK
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.23867529321905284,-0.8681853953423112,0.7405541561712846,0.8770291682111129,1.0,31/72,36.62%,UBB;RPS27A;UBC;DDB1;RBX1;RPA1;OGG1;UBA52;POLK;RNASE4;ZC3H12A;EDC3;POLD3;POLD1;GTF2H2;EDC4;XPA;ERCC5;RFC5;ERCC3;PNRC2;GTF2H5;RPA3;ISG20;DNA2;FEN1;RPA2;MEI4;DCP1A;RFC2;DNASE1L1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3447648698646363,0.8680680083507565,0.62217659137577,0.9336715622136319,1.0,6/18,17.82%,PRKN;NOL3;NME5;NONO;HTRA2;TRAP1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.24938351587746144,-0.8680364908786395,0.7325,0.8767372311187712,1.0,13/53,15.79%,PSMD13;PSMF1;OAZ1;PSMB10;PSMB6;AZIN1;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.333313834971704,0.867998466024483,0.6413662239089184,0.933076983055603,1.0,6/20,16.26%,TNRC6B;TNRC6A;AGO2;MOV10;CNOT8;CNOT7
prerank,neutrophil chemotaxis (GO:0030593),-0.25177405698614336,-0.8679545376336737,0.6990521327014217,0.8763146501822526,1.0,7/53,10.16%,BSG;TGFB2;PPIA;CXADR;EDN1;PPIB;PIK3CD
prerank,regulation of T cell activation (GO:0050863),-0.26202614410972574,-0.8676395402348474,0.6802721088435374,0.8764254078641069,1.0,24/42,43.82%,TNFRSF1B;CYRIB;DUSP3;HSPD1;CD47;LAPTM5;JAK3;THY1;METTL3;CCR2;CCL2;LAX1;IL4I1;PTPN22;GPNMB;PRELID1;CCL5;KAT2A;VTCN1;CRTAM;LCK;CCDC88B;TNFSF11;TNFSF9
prerank,positive regulation of signaling (GO:0023056),-0.2656454788943777,-0.8676257443975606,0.6928406466512702,0.8758690038440502,1.0,16/37,29.51%,NSF;HOMER1;CLSTN2;EDN1;ECE1;KCTD13;PTPN23;CLSTN3;INPP5F;GRIK2;SOX11;CD80;VAMP3;CLSTN1;RIMS2;SYT1
prerank,nuclear membrane disassembly (GO:0051081),0.3545602216808611,0.8675839389864524,0.6024340770791075,0.933211794558517,1.0,4/14,10.07%,PRKCB;PRKCA;CDK1;AKAP8L
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.3237182272264924,-0.8674821599564602,0.6378600823045267,0.8755689124869546,1.0,2/18,3.32%,FTH1;DAB2IP
prerank,cell differentiation in hindbrain (GO:0021533),-0.3708608375225164,-0.8672890809752769,0.66,0.8753752645907119,1.0,7/11,40.73%,KNDC1;GRID2;AGTPBP1;FAIM2;NOG;PROX1;OPHN1
prerank,mesoderm formation (GO:0001707),-0.32543037309794587,-0.8663366740594374,0.6574257425742575,0.8767788959112798,1.0,3/17,3.91%,ITGB1;ITGB4;BMPR2
prerank,chemokine-mediated signaling pathway (GO:0070098),0.28782122642040653,0.8663290598859847,0.6466431095406361,0.9352039537927133,1.0,4/42,10.07%,OXSR1;CXCL13;CCL19;CCL4
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3379794571096113,0.8657674169297533,0.6608527131782945,0.9356924164197156,1.0,3/21,8.73%,RAD51B;RAD51C;CDK1
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.3747194655621791,-0.8656073377192512,0.645224171539961,0.8776929146795245,1.0,3/10,7.71%,KDR;RACK1;MYOC
prerank,regulation of interleukin-17 production (GO:0032660),0.30675454475291525,0.8654772350357276,0.6619469026548672,0.935557895218223,1.0,4/31,8.61%,IL18;SPHK1;IL6;SLAMF6
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.25241568808143877,-0.8654414812721937,0.7163120567375887,0.877450537833852,1.0,18/50,24.60%,ACTN4;RPS3;NOD1;LIMS1;PDCD4;APP;RHOA;RTKN2;IFI35;TERF2IP;LAPTM5;NR3C2;IRAK1;PTP4A3;RELA;AGER;LRRC19;TRIM44
prerank,mitochondrion disassembly (GO:0061726),0.297313601468476,0.8652354793378689,0.6333333333333333,0.9353396048514209,1.0,8/34,15.63%,PRKN;WIPI1;BNIP3;FUNDC2;FUNDC1;ATG9A;AMBRA1;ATG3
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.2898860268358484,-0.8651251568905517,0.6441048034934498,0.8775346964681754,1.0,9/25,21.92%,ATXN3;BAG6;CUL3;ZYG11B;DERL1;AUP1;RNF5;VCP;HDAC6
prerank,regulation of cation channel activity (GO:2001257),0.24910429694871497,0.8649818216995263,0.706645056726094,0.9351477467447683,1.0,17/89,12.85%,JPH1;DAPK1;DMD;NLGN2;CRHBP;ANK2;CACNB4;CACNG7;DLG1;MMP9;CAMK2D;DLG4;SELENON;SHISA9;ACTN2;GRIA4;DLG3
prerank,cell cycle G2/M phase transition (GO:0044839),0.23917582577881188,0.8648824205984824,0.7013782542113323,0.9346384097787587,1.0,26/129,16.72%,NINL;PLCB1;ALMS1;PHLDA1;CDK7;CCDC57;HAUS4;CEP152;SDCCAG8;OPTN;CDK1;PAFAH1B1;FBXL17;AKAP8L;LATS1;OFD1;HAUS1;SFI1;CEP57;MNAT1;CEP63;CEP164;BRSK1;SKP2;CDKN2B;PPP1R12B
prerank,negative regulation of autophagosome assembly (GO:1902902),0.370583086546756,0.864871308494493,0.6056338028169014,0.9339313234188228,1.0,4/13,12.88%,LRRK2;NUPR1;TMEM39A;FEZ1
prerank,cytosolic transport (GO:0016482),-0.21603884060121806,-0.8643952312904012,0.78125,0.8784902926385979,1.0,30/108,22.71%,MYO1D;HEATR5A;MON2;VPS13A;VPS13C;VTI1B;STX6;EMP2;LAMP1;BET1L;SNX16;EVI5;PTPN23;TBC1D10A;LMTK2;EHD3;PIK3C3;HOOK1;LAPTM5;GBF1;SNX1;VPS51;TBC1D10B;SYS1;TRIM27;SNX2;DCTN1;SPAG9;CLN5;AP2A1
prerank,membrane depolarization (GO:0051899),0.3045636148606792,0.8642451833762175,0.6367041198501873,0.9345219085693383,1.0,2/32,4.86%,SCN7A;CACNB4
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2121819960081993,0.8637447571523861,0.8,0.93486975437119,1.0,71/366,17.39%,RORA;EFEMP1;ARNT2;DENND4A;ATXN1;TULP3;ESRRG;MYBL1;NR1I2;SOX6;PPARGC1B;NFYB;IGF2;SSBP2;NCOA2;SOX1;PERM1;TCF7L1;ZFP37;SUFU;THAP1;WWC1;WWC2;GPBP1;UBE2L3;GPBP1L1;MTF2;ZKSCAN5;POLR2A;NFIA;ZNF628;BRCA2;MITF;KAT6B;NFYC;NSD1;NUP107;ABL1;ASCC2;ZBTB11;RBBP6;ZBTB38;MYB;RNF14;SOX13;RNF20;PSPC1;NONO;FOXK2;ESCO1;CLOCK;UBE2V1;CREBBP;NLK;PCGF1;SOX12;SMARCA2;ORC3;PATZ1;ZNHIT3;FZD7;PML;PHF1;TCOF1;IGSF1;REXO4;BACH1;OBI1;TSC1;TRRAP;CTR9
prerank,positive regulation of cellular respiration (GO:1901857),-0.36980527658609963,-0.8635571210344243,0.650994575045208,0.8796067582611127,1.0,8/11,40.37%,ISCU;PINK1;VCP;IFNAR1;PRELID1;PARK7;IFNLR1;IL4
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.3389616539959147,0.8621581634331549,0.6238003838771593,0.9375223808071188,1.0,4/19,16.27%,CHRNE;SLC5A7;NQO1;CHRNB2
prerank,protein-containing complex subunit organization (GO:0043933),-0.21630494258989424,-0.8620813215677544,0.7867867867867868,0.88204924394425,1.0,31/109,24.36%,SLC2A1;OCLN;LIN7A;PPARGC1A;PTK2B;REPS2;HES1;WIPF1;CAPZA2;SKAP2;ADD2;CARD10;IL1RAP;APC;CD2AP;ST13;CD74;ELOB;TRAF1;FAS;CD40;NUP54;TAPBP;TFAP4;NUP133;NCKAP1L;KPNA3;CAPZA1;CHCHD10;SHANK1;SPG7
prerank,regulation of viral life cycle (GO:1903900),-0.30221627511907745,-0.8619711724819126,0.6639344262295082,0.8817104377742482,1.0,6/21,19.83%,PPIA;TRIM14;TRIM25;HS3ST5;TYRO3;TRIM27
prerank,negative regulation of biosynthetic process (GO:0009890),0.35410418592246634,0.8610459632167344,0.594541910331384,0.9391798420371739,1.0,5/16,17.82%,PPARA;IL6;SLC30A10;ABCB7;TRAP1
prerank,negative regulation of cholesterol transport (GO:0032375),0.3935036095166522,0.8609045427558234,0.6068548387096774,0.9387496967234781,1.0,2/10,9.15%,PLA2G10;APOC1
prerank,protein N-linked glycosylation (GO:0006487),-0.23880783059111363,-0.8606787402305108,0.7265625,0.8837786070492835,1.0,27/66,31.21%,ST6GAL1;FUT8;MAGT1;STT3B;KRTCAP2;SLC39A8;MCFD2;RPN1;MGAT1;ALG11;ST3GAL1;TMEM165;DDOST;MGAT5;ALG5;ALG14;MGAT2;ALG1;ALG8;DPM1;UBE2J1;DOLPP1;MGAT5B;ALG3;PMM1;DPAGT1;UGGT1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.28860356050063074,0.8605098928841954,0.655,0.9389025651948564,1.0,9/41,13.05%,IL34;EPHA4;ACE;DLG4;TGFA;AREG;DLG3;GPRC5B;DOK7
prerank,rRNA 3'-end processing (GO:0031125),0.39055227064296266,0.8604982572577802,0.6116700201207244,0.9381981117134003,1.0,5/10,18.60%,ERI3;ERI2;EXOSC8;ERI1;EXOSC3
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.36498602309730516,-0.8604209558596921,0.6693548387096774,0.8837031827415479,1.0,7/11,33.00%,BAG6;DERL1;AUP1;RNF5;VCP;UGGT1;RNF185
prerank,regulation of interferon-gamma production (GO:0032649),-0.2408897447438249,-0.8602441209253735,0.7643979057591623,0.8834558750182107,1.0,24/71,30.53%,PDE4D;SLC7A5;GAS6;IL1R1;CYRIB;ISG15;HSPD1;CD47;NR1H4;LAPTM5;CD274;ZC3H12A;INHA;TRIM27;TXK;SLC11A1;CCR2;VSIR;IL12RB2;TLR7;TLR4;RASGRP1;FADD;ZFPM1
prerank,L-serine metabolic process (GO:0006563),0.395144178912898,0.8601077127200402,0.6539278131634819,0.9383133876923501,1.0,3/10,13.02%,CBS;SRR;SHMT1
prerank,regulation of cholesterol storage (GO:0010885),-0.34114975013821575,-0.8600690035316769,0.6772908366533864,0.8832244530905055,1.0,11/15,30.27%,SCARB1;PPARD;SREBF2;EHD1;NR1H2;ABCG1;NR1H3;TTC39B;TREM2;LPL;PPARG
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.3656632580378479,0.860006502772642,0.6328600405679513,0.9377880664179897,1.0,1/13,0.85%,RBPJ
prerank,protein glycosylation (GO:0006486),0.2392898597608079,0.8599569512119294,0.7263157894736842,0.937157370956735,1.0,14/125,8.47%,B3GALT1;ST3GAL3;GALNT18;GALNTL5;LARGE1;B3GNT5;ST3GAL5;B4GALT1;ALG6;MAN1C1;TET1;ALG2;ALG9;GFPT2
prerank,transcription by RNA polymerase III (GO:0006383),-0.28810325183876373,-0.8598016920548273,0.6556016597510373,0.8831717567336305,1.0,12/27,25.43%,IVNS1ABP;BRF1;SNAPC1;ZC3H8;SNAPC4;CRCP;GTF3C1;RO60;GTF3C2;GTF3C4;POLR2L;SNAPC2
prerank,endochondral bone morphogenesis (GO:0060350),-0.37048244957902965,-0.859604610671924,0.6463654223968566,0.8830222121394073,1.0,2/11,3.91%,MEF2C;BMPR2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3281180520247296,-0.8595775255924788,0.6699801192842942,0.882500237121892,1.0,6/15,22.19%,SCARB1;MFSD2A;NR1H2;CTDNEP1;NR1H3;C3
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.35031196118752367,0.8595669786543338,0.6252676659528907,0.9372808635044723,1.0,8/16,20.57%,BLM;SSBP1;WRN;MCM2;RAD51;PURA;MCM7;RECQL5
prerank,response to growth factor (GO:0070848),-0.2624158905797875,-0.859561798587325,0.7202797202797203,0.8819516163658709,1.0,13/41,21.92%,ACVRL1;KLF4;RACK1;BMPR2;TGFBR2;CTNNB1;CPNE3;NOS1;ACVR1;SOX2;AKT1;ACVR1C;HDAC6
prerank,negative regulation of neurogenesis (GO:0050768),0.2978775132032449,0.8595210691386187,0.6790352504638218,0.9366445606180374,1.0,5/34,7.48%,APPL2;LRP4;PTN;IL6;PTEN
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.2989168750982121,0.8594820326989525,0.6655112651646448,0.9360106351695403,1.0,4/40,5.48%,PID1;BCL2;SPART;LRRK2
prerank,regulation of response to oxidative stress (GO:1902882),0.3815553747295808,0.8590903761978563,0.6193693693693694,0.936101994113843,1.0,1/11,1.37%,PRKN
prerank,early endosome to late endosome transport (GO:0045022),-0.3107716333089592,-0.8590728442213675,0.6680942184154176,0.8823724551881889,1.0,6/20,14.88%,EMP2;SNX16;PTPN23;LMTK2;PIK3C3;HOOK1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.23758115021862927,-0.8588798856366159,0.73,0.8821721842251085,1.0,26/69,29.88%,STT3B;TRIM25;HSP90B1;BAG6;DERL1;HSPA5;HERPUD1;TRIM13;ERLIN2;DNAJC10;WFS1;AUP1;RNF5;DNAJB9;FBXO17;TMEM129;VCP;RNF103-CHMP3;UBE2J1;YOD1;SYVN1;FBXO2;RHBDD2;STUB1;FOXRED2;SEC61B
prerank,Notch signaling pathway (GO:0007219),0.2702183589307537,0.8584031916622117,0.6909722222222222,0.9369023444402772,1.0,14/59,14.11%,RBPJ;NOTCH2;GMDS;SUSD5;MAML3;MAML1;WWC1;TRAF7;ITCH;DTX1;MAML2;PSENEN;SNAI1;CREBBP
prerank,neuron remodeling (GO:0016322),-0.37280006667708665,-0.8583918480760447,0.6394686907020873,0.8825819970883279,1.0,6/10,25.70%,SCARF1;ANKS1A;APP;C1QA;C3;RND1
prerank,DNA-dependent DNA replication (GO:0006261),-0.21343244605899475,-0.8583404366479879,0.851123595505618,0.8821062519613391,1.0,58/128,36.86%,UBB;REV3L;RPS27A;UBC;WRNIP1;PSMD13;PSMF1;PSMB10;PSMB6;RPA1;PSME3;PSMB5;PSMC3;MCM4;PSMD12;PSMB8;TOPBP1;PSME1;UBA52;PSMB3;WDHD1;PRIM1;MCM8;POLA1;CDK2;POLE4;RECQL;PSMD5;POLE;POLD3;POLB;SIRT7;POLD1;PSMD9;PSMB4;GINS4;MCM5;PSMD10;MCM10;RFC5;POLE3;ORC1;TWNK;RPA3;MCM6;PSMA7;GMNN;DNA2;CDC6;GINS2;HELB;RPA2;CDC7;PSMC5;PSMC1;PSMC4;RFC2;CDC34
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.24042091909988522,-0.8580706987343643,0.7315789473684211,0.8821245318381792,1.0,34/63,42.61%,RPL26;SOX4;PLK2;PLAGL1;CHEK2;CNOT6L;FBXO31;CDKN1B;RPS27L;TNKS1BP1;CDK2;PCBP4;GADD45A;CDKN1A;E2F7;RGCC;BAX;RFWD3;SFN;PIDD1;AURKA;E2F8;RPA2;CCND1;CNOT1;CNOT9;PLK3;CRADD;CCNB1;PRMT1;PCNA;CDC25C;TFDP1;TRIAP1
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.2737910339315167,-0.8576475260807335,0.7031578947368421,0.8823731326306195,1.0,9/33,21.04%,HSP90AA1;HSP90AB1;PINX1;RPA1;TERF2IP;TNKS1BP1;ANKRD28;CDK2;NHP2
prerank,Golgi to lysosome transport (GO:0090160),-0.3554193584332441,-0.8573668652995735,0.6605839416058394,0.8823772389655101,1.0,3/11,16.11%,LAMP1;EHD3;LAPTM5
prerank,response to chemokine (GO:1990868),0.3627295263331979,0.857019713345227,0.6566265060240963,0.9390254517983608,1.0,2/13,3.63%,OXSR1;RIPOR2
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.28019179967892494,-0.8569629452852026,0.6873706004140787,0.8826297551598692,1.0,9/28,26.33%,SH3KBP1;CYRIB;HSPD1;CD47;TYROBP;THY1;NCKAP1L;CCR2;CCL2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.36803779017283733,0.8569352751219483,0.6257796257796258,0.9384750261539795,1.0,1/12,2.36%,INSIG2
prerank,negative regulation of hydrolase activity (GO:0051346),-0.2538549166522775,-0.8566514603485265,0.725,0.8826704106449516,1.0,13/49,16.46%,LRCH1;CST3;F11R;DAB2IP;SH3BP4;CHP1;TMED2;NOS1;SLC39A14;ZCCHC9;RCC2;ATP5IF1;NEIL1
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.32852630852712217,-0.8558188575144131,0.6653543307086615,0.8837510746525542,1.0,11/16,46.12%,ACACA;FASN;SCD5;ACLY;SCD;HSD17B8;MLYCD;SLC25A1;PPT2;DIP2A;ACSS1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.3045846956875619,0.855652517365393,0.6581352833638026,0.9404416016582994,1.0,6/30,12.50%,DAB2;KLK2;NCOA2;HDAC1;RNF14;AR
prerank,outer dynein arm assembly (GO:0036158),0.3646881388774939,0.8556399902667945,0.6506717850287908,0.9397445482566064,1.0,3/14,15.00%,ODAD3;ODAD1;ODAD2
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.31370793222779425,-0.8556076082575275,0.6796536796536796,0.8836295676446776,1.0,7/20,23.77%,HSP90AA1;CDC37;BIRC3;OGT;CASP8;PELI1;PDCD6IP
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3161427745335432,-0.8548341011673171,0.6606060606060606,0.8845249241500028,1.0,6/18,18.52%,UBB;RPS27A;UBC;TRIM13;UBA52;RNF5
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3097690924423433,-0.8547192457337973,0.6746987951807228,0.8841811081451932,1.0,8/20,23.68%,SYNE1;HNRNPU;ARL2BP;BCL3;RANGAP1;SUN1;SKP1;CHCHD10
prerank,positive regulation of rRNA processing (GO:2000234),-0.37333825331681814,-0.8546632369439872,0.6542056074766355,0.8837030444146523,1.0,3/10,21.07%,BUD23;UTP15;SIRT7
prerank,protein K48-linked ubiquitination (GO:0070936),0.27379106854258184,0.8544724034837964,0.6803418803418804,0.9414464682114672,1.0,15/54,17.61%,PRKN;UBE2E2;RNF152;TTC3;AMFR;RNF216;ITCH;KBTBD7;FBXO38;IFI27;UBE2A;SKP2;UBE2H;UBE2E1;DTX3L
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.31774699167888304,0.8541943179700268,0.6322701688555347,0.9413419749311558,1.0,1/25,0.20%,ARHGAP24
prerank,response to interferon-beta (GO:0035456),-0.29599218610103145,-0.8535663127504902,0.6778947368421052,0.8853245129363757,1.0,6/22,24.36%,AIM2;NDUFA13;SHFL;BST2;IFITM3;STAT1
prerank,mitochondrial membrane organization (GO:0007006),0.30672295926907556,0.8532954868176885,0.675531914893617,0.9425043158774504,1.0,7/32,11.49%,BCL2;SLC25A31;BNIP3;MAIP1;CHCHD6;MTX1;MTX2
prerank,alanine transport (GO:0032328),-0.3595857694437343,-0.8528468548344869,0.6457564575645757,0.8861301396174643,1.0,4/10,16.40%,SLC6A6;SLC36A1;SLC1A4;SLC36A4
prerank,establishment of mitotic spindle localization (GO:0040001),-0.27532129823269696,-0.8526943217364109,0.6817204301075269,0.8858358552076809,1.0,14/28,36.01%,ITGB1;NSFL1C;INSC;NDE1;NUMA1;DCTN1;CLASP2;NDC80;SPDL1;PLK1;ESPL1;PKHD1;CLASP1;NUSAP1
prerank,actin filament network formation (GO:0051639),-0.3615211491478252,-0.8526838331456706,0.6647286821705426,0.8852798347745556,1.0,5/11,16.30%,CARMIL1;ACTN1;PLS3;FHOD3;SPIRE1
prerank,N-terminal protein amino acid modification (GO:0031365),0.36839722547055836,0.8526796641838903,0.6454918032786885,0.943054847003894,1.0,3/14,12.98%,AANAT;NAA35;NAA60
prerank,neurogenesis (GO:0022008),0.2829490024200487,0.8525296032246149,0.6841155234657039,0.9426480372000189,1.0,6/43,7.93%,LPAR1;FAT4;ANXA1;PCSK9;DAGLB;RYK
prerank,protein destabilization (GO:0031648),-0.27284837308708365,-0.8523184018387189,0.7127192982456141,0.8854031310439147,1.0,6/32,9.18%,GSN;FBXL3;SOX17;CUL3;DERL1;SERF2
prerank,regulation of chemotaxis (GO:0050920),0.30163965845820406,0.852167944156623,0.6725490196078432,0.9426596521990124,1.0,4/30,7.56%,EFNB2;PDGFRB;PDGFRA;CCL19
prerank,GPI anchor metabolic process (GO:0006505),0.31654878674450804,0.8519404315048403,0.6476190476190476,0.942466993693812,1.0,5/26,12.88%,PIGU;PIGG;PIGV;PIGC;PIGQ
prerank,apical protein localization (GO:0045176),0.39262485030156585,0.851816940633383,0.6357466063348416,0.9420064043226354,1.0,2/10,2.90%,SHROOM3;SHROOM2
prerank,cGMP-mediated signaling (GO:0019934),0.3627376208489876,0.8514192799596321,0.6465696465696466,0.9421011627311084,1.0,1/13,0.87%,IRAG1
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.35046585178362305,-0.851180912251071,0.6547619047619048,0.8870502695738325,1.0,2/12,2.34%,LY6E;GSN
prerank,keratinocyte differentiation (GO:0030216),-0.27929190425586936,-0.8510202691631883,0.7184873949579832,0.88680133326844,1.0,4/29,8.27%,CLIC4;JAG1;BCR;WNT16
prerank,RNA catabolic process (GO:0006401),-0.2528184174543837,-0.8502831007258222,0.75,0.8876778463614634,1.0,21/46,34.44%,RIDA;RNASE3;MTREX;SUPV3L1;AGO3;METTL3;HSPA1B;ZPR1;NUDT16;ERN1;RNH1;RNASEH2C;HNRNPD;DIS3L2;RNASEH2B;ZFP36;ISG20;DNA2;HSPA1A;FEN1;ZC3H12D
prerank,histone H2A acetylation (GO:0043968),0.34768164245661537,0.8502353992632885,0.648,0.943872896381022,1.0,1/16,1.42%,BRD8
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.23049556283889083,-0.8499936018250065,0.7775,0.8876791749638573,1.0,19/69,19.13%,MEF2C;PPARGC1A;PTK2B;NGF;LGMN;SOD1;FOXQ1;SIX1;GRN;SET;MSH2;MT3;SIX4;CX3CR1;WFS1;PRKCG;TYRO3;LIG4;PINK1
prerank,modulation by host of symbiont process (GO:0051851),-0.272840058379369,-0.8491977665997598,0.6985138004246284,0.8886368824646769,1.0,5/31,15.75%,LEF1;TARDBP;JUN;REST;CX3CR1
prerank,regulation of filopodium assembly (GO:0051489),0.29142001604298523,0.8490129953217336,0.6784511784511784,0.9457182893541194,1.0,7/38,11.28%,DOCK11;DPYSL3;RIPOR2;WASL;CAPZB;PIK3R1;FXR1
prerank,plasma membrane tubulation (GO:0097320),-0.3425330835871099,-0.8489224771160047,0.66015625,0.8886230479175377,1.0,4/13,12.15%,FNBP1L;PACSIN2;CAVIN2;WHAMM
prerank,response to gamma radiation (GO:0010332),-0.29372435761676874,-0.8489088234438463,0.7010752688172043,0.8880710149022432,1.0,10/24,25.32%,RPL26;CRYAB;MEN1;TRIM13;ATR;LIG4;TLK2;TMEM109;HRAS;TSPYL5
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3019897965511028,0.8480498763355339,0.6897880539499036,0.9470026814529936,1.0,2/32,1.89%,CEMIP;PDPK1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.33851028479920214,-0.8480404939778046,0.6553030303030303,0.8891528973163566,1.0,8/13,40.31%,BLOC1S2;RHOT1;BMF;BAX;PMAIP1;BNIP3L;BAD;RHOT2
prerank,cellular lipid catabolic process (GO:0044242),0.3000618595328848,0.8476818205766758,0.6381322957198443,0.9470184738661588,1.0,3/27,6.79%,CEL;ACADL;ENPP2
prerank,positive regulation of cyclase activity (GO:0031281),-0.3348832327553518,-0.8474145948848761,0.655241935483871,0.8898133694506225,1.0,7/14,21.48%,NOS3;MAPK8;CACNA1C;NOS1;NF1;ORAI1;MAPK3
prerank,response to tumor necrosis factor (GO:0034612),0.2464452598209536,0.84735973288853,0.7425897035881436,0.9469841367166429,1.0,11/91,11.11%,ADAMTS12;PID1;CRHBP;SPHK1;ZFAND6;CACTIN;ADAMTS7;CCL19;CCL4;GSDME;JAK2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.34860578861159713,-0.8472980226150656,0.6721311475409836,0.8894711415268169,1.0,7/14,38.65%,TFRC;KMT5C;SHLD3;RIF1;SHLD2;KMT5B;CD226
prerank,plasma membrane organization (GO:0007009),-0.24311098844360512,-0.8471293878056448,0.7416879795396419,0.8892083234187106,1.0,13/61,16.27%,SPTBN1;AHNAK2;NSF;FNBP1L;PACSIN2;CAVIN2;MYH9;DYSF;BIN1;WHAMM;ABCD2;TLCD2;STX2
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.2898079380168981,-0.8468133399445853,0.70020964360587,0.8892267507981942,1.0,9/24,26.70%,SLIT2;LGMN;CCN3;CXCL12;DUSP1;GREM1;CCR2;CREB3;CXCL10
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.32527497180630593,0.8466090752405752,0.6725838264299803,0.9478133433646075,1.0,2/22,2.73%,APPL2;LTF
prerank,positive regulation of DNA replication (GO:0045740),-0.3213512765862586,-0.8464774057507964,0.6837944664031621,0.8893319754610632,1.0,3/16,12.22%,BCAR3;FAF1;GLI1
prerank,water transport (GO:0006833),-0.3527874916423574,-0.8463692955218058,0.6761363636363636,0.8889685332114905,1.0,3/12,15.43%,AQP4;AQP11;CFTR
prerank,regulation of synapse maturation (GO:0090128),-0.3630650897904712,-0.8463216121418563,0.6622641509433962,0.8884783893400323,1.0,5/10,15.07%,DAB2IP;ARHGEF15;NRXN1;RELN;CAMK2B
prerank,morphogenesis of an epithelium (GO:0002009),0.3136164769103578,0.8462600559280955,0.6718446601941748,0.9478051824185245,1.0,3/25,4.95%,FGFR2;ARHGAP12;KDM2B
prerank,neuromuscular process (GO:0050905),-0.31921563803513214,-0.8461918448828527,0.7001972386587771,0.8881210254408137,1.0,4/16,10.74%,GCH1;STRA6;NRXN1;KCNA1
prerank,mitotic recombination (GO:0006312),0.3498957339023478,0.8455990160412141,0.6316831683168317,0.9484784233585442,1.0,6/15,23.61%,DMC1;TEP1;RAD51;TPRKB;RAD50;RAD52
prerank,histone ubiquitination (GO:0016574),0.32067463613337316,0.8455289076044792,0.6554455445544555,0.9479059119476284,1.0,9/21,22.88%,UBR2;CDC73;RNF20;UBE2A;CTR9;UBE2E1;DTX3L;PAF1;WAC
prerank,regulation of hemopoiesis (GO:1903706),-0.3732098968687938,-0.8451982285469871,0.6891385767790262,0.8894989390901537,1.0,2/10,2.22%,RUNX1;CBFB
prerank,positive regulation of cell death (GO:0010942),0.26753121297336047,0.8451967035261754,0.693950177935943,0.9478853914291313,1.0,9/59,11.69%,SLC6A13;EFNB2;DKK1;LRRK2;BNIP3;PICALM;AXIN2;EIF2S1;PRODH
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.247198862448007,-0.8450686690471789,0.7322274881516587,0.8891305598251467,1.0,17/47,26.68%,SPOCK2;SERPINE2;SERPINI1;SERPINF1;SERPINB9;GAPDH;BIN1;MT3;SPOCK1;TIMP2;SERPINA2;AKT1;SPOCK3;SORL1;TIMP1;ANXA8L1;ANXA8
prerank,synaptonemal complex organization (GO:0070193),0.3507709044369711,0.8449805079220067,0.6536082474226804,0.9469282065984904,1.0,2/15,6.34%,HORMAD1;TEX11
prerank,synaptonemal complex assembly (GO:0007130),0.3507709044369711,0.8449805079220067,0.6536082474226804,0.9469282065984904,1.0,2/15,6.34%,HORMAD1;TEX11
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3450139943607206,0.8445449424360268,0.6688172043010753,0.9471172326015377,1.0,2/14,5.48%,PRKN;LRRK2
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.26955462738343566,-0.8445137289218754,0.6989473684210527,0.8895727279721606,1.0,7/33,14.03%,GLS;GCLM;KYAT1;DDAH1;SLC39A8;ALDH18A1;SIRT4
prerank,microtubule polymerization (GO:0046785),0.30356655164863733,0.8442888210667118,0.6842105263157895,0.9469337603756811,1.0,9/28,19.95%,CCDC57;TUBGCP6;GOLGA2;TUBGCP2;RANBP9;TUBG1;AKAP9;TPX2;MAP7D3
prerank,neuron differentiation (GO:0030182),-0.20182820268858132,-0.8442084698641521,0.8792569659442725,0.8895980270993502,1.0,21/165,10.77%,MEF2C;PBX3;TGFB2;RUNX1;ACSL4;WNT9A;TENM2;FZD4;VSX1;SOX4;CTNNB1;MET;ATP8A2;TENM4;VEGFA;WNT16;RUNX2;DDIT4;LHX6;XBP1;IER2
prerank,positive regulation of nervous system process (GO:0031646),0.3381658678054907,0.8441148372702519,0.6840077071290944,0.9465680055888971,1.0,3/18,3.91%,NLGN2;PARD3;ITGAX
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.33746645698090033,-0.8436693269038764,0.7017543859649122,0.8900458005120618,1.0,6/14,20.61%,NOS3;EDN1;ECE1;ACE2;AGTR1;ENPEP
prerank,mRNA processing (GO:0006397),-0.18661452277193608,-0.8434609265059614,0.9521739130434783,0.889865758730622,1.0,89/287,29.46%,HSPA8;NOVA2;HNRNPK;PPARGC1A;SRSF2;PABPC1;SRSF1;HNRNPU;PPWD1;HNRNPA3;YBX1;PPIE;SF3B1;SF3B2;CPSF7;PHF5A;SFPQ;RBM14;DDX5;SRSF5;DDX39B;CPSF3;KIN;HNRNPH2;SRSF9;CPSF6;CWC15;RALY;USP39;RBM8A;POLR2C;XAB2;PRPF18;RNPS1;SNRPC;SRSF6;PRPF40B;FUS;SF3B5;HNRNPA0;SYMPK;CLP1;POLR2G;PRPF4;CPSF2;SPEN;GTF2F2;CSTF2T;ESS2;PCBP1;PCF11;CSTF2;MTREX;HNRNPUL1;YTHDC1;THOC3;RBM17;PTBP1;CTNNBL1;RBM22;SNIP1;MAGOH;METTL3;TRA2B;CMTR2;THOC6;SNRPG;GTF2H2;SNRNP35;RBM4B;POLR2L;HNRNPF;HNRNPM;USP49;THOC2;ERN1;PUF60;HNRNPD;LSM8;RBM6;EIF4A3;TFIP11;AURKAIP1;SRSF7;ALYREF;ZCRB1;BUD31;ERCC3;CSTF1
prerank,regulation of calcium ion transport (GO:0051924),0.2684069848916998,0.8432176151499978,0.7172774869109948,0.9476975736114875,1.0,9/54,12.63%,STIM1;BCL2;MYLK;ANK2;CACNA1D;CACNA2D1;CCL4;PKD2;PACSIN3
prerank,ether lipid biosynthetic process (GO:0008611),-0.36396756012136033,-0.8426154146598022,0.6771217712177122,0.8909015163430448,1.0,5/10,29.81%,FAR1;PLA2G4A;AGPS;DHRS7B;CHPT1
prerank,tRNA 5'-end processing (GO:0099116),-0.3241644452397358,-0.8425581203933844,0.6771037181996086,0.8904302104905317,1.0,8/15,28.40%,SSB;POP5;POP4;RPP21;RPP30;TRMT10C;PRORP;POP7
prerank,regulation of dephosphorylation (GO:0035303),-0.32174421020159516,-0.8424822798077778,0.6891385767790262,0.8900068942834506,1.0,6/15,27.76%,PPP1R16B;MTMR9;PPP1R16A;SMG5;MTMR1;SMG6
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.34177269041026487,0.8424434561540713,0.6519230769230769,0.9486139064395687,1.0,5/16,12.83%,FOXD1;FGF1;SALL1;PKD2;GDNF
prerank,regulation of stem cell population maintenance (GO:2000036),0.33053764647022815,0.8424300172125886,0.6726546906187625,0.9479282755204387,1.0,3/18,11.86%,PTN;NCOA3;CNOT2
prerank,smooth muscle tissue development (GO:0048745),-0.37047792003992297,-0.8423576945968299,0.6752475247524753,0.8896752399831879,1.0,5/10,20.48%,ENG;STRA6;PTCH1;NF1;BMP4
prerank,positive regulation of endopeptidase activity (GO:0010950),0.3087254582133366,0.842323960701494,0.6833333333333333,0.9474501360903878,1.0,2/26,3.71%,ROCK2;EPHA4
prerank,regulation of lamellipodium organization (GO:1902743),0.34912266933373176,0.8421526746091584,0.6574468085106383,0.9470704389485339,1.0,4/14,11.05%,FER;PDPN;CAPZB;EPHA2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2866079978813153,-0.8415465729499912,0.7081632653061225,0.8906403411598791,1.0,9/25,24.36%,ETS1;ABCB10;STAT3;TAL1;ANKRD54;NCKAP1L;MAPK11;HSPA1B;STAT1
prerank,protein acylation (GO:0043543),-0.2605560432498245,-0.841193698807023,0.7330316742081447,0.8907601232806416,1.0,9/38,12.48%,ZDHHC14;ZDHHC15;FOXO1;ZDHHC2;ZDHHC7;ING4;PORCN;HHAT;SELENOK
prerank,positive regulation of calcium ion import (GO:0090280),0.36879653065848667,0.8404424424891364,0.6520833333333333,0.9498622014055143,1.0,1/12,2.95%,PDGFRB
prerank,regulation of mRNA stability (GO:0043488),-0.2026507528473465,-0.8403943647982118,0.8792569659442725,0.8916559769283618,1.0,42/145,23.00%,HSPA8;VIM;UBB;HSPB1;PABPC1;YWHAB;RPS27A;UBC;PUM2;HNRNPU;YBX1;PSMD13;SET;PSMF1;EIF4G1;ZFP36L1;PSMB10;YTHDF3;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;FUS;TENT5A;PSME1;UBA52;RIDA;PSMB3;SERBP1;FASTKD3;PSMD5;PCBP4;PRKCD;AKT1;METTL3;FMR1;SLC11A1;RBM24;PSMD9;PSMB4
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.29874412705011033,-0.8401064458029947,0.6829268292682927,0.8916160867662923,1.0,7/22,18.27%,RASSF2;CALM1;PDGFC;VEGFA;TNKS1BP1;CALM2;GREM1
prerank,regulation of mitotic cell cycle (GO:0007346),-0.19799278310091944,-0.8400595985860326,0.9076923076923077,0.8911392871879977,1.0,46/171,23.55%,NEK7;IQGAP1;TTC28;CAV2;CDK11B;LGMN;BUB3;TGFB1;HNRNPU;APP;PSMD13;PSMF1;DDB1;PSMB10;CDKN1B;BTG3;PSMB6;DUSP3;TAL1;PSME3;PSMB5;PSMC3;TMEM8B;PSMD12;PSMB8;CUL1;BRINP2;PSME1;ANAPC16;PSMB3;GBF1;BUB1B;UBE2D1;PSMD5;TFAP4;SKP1;L3MBTL1;BTG1;TTL;ANAPC7;PSMD9;PSMB4;MKI67;EIF4E;AFAP1L2;NEK11
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.36574822302037463,0.8400376128074596,0.645748987854251,0.9499698196950637,1.0,1/11,1.00%,FGFR2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.3703303957323434,0.8399186236015315,0.6294820717131474,0.9494821040045875,1.0,3/12,9.66%,CDC14B;PTEN;GOLGA2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.31121055387910623,0.8394968103313781,0.6724137931034483,0.949622322470336,1.0,5/27,8.57%,CTPS1;CTPS2;NUDT13;TYMS;TXNRD1
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.21758898811091798,-0.8394895875888709,0.8294117647058824,0.8915786270487535,1.0,27/91,25.20%,HIP1;NSF;SCARB1;STON2;RAB3C;PACSIN2;PTPRC;HIP1R;BET1L;RAB3B;PTPN1;CDH13;CPLX2;MAP2K2;SYT7;INPP5F;RIT2;MAPK3;RAB8A;MBTPS1;CHMP3;RAB8B;RAB3A;LGI3;CPLX1;HAP1;RAB5B
prerank,positive regulation of defense response (GO:0031349),-0.2194288689016976,-0.8392887412458,0.8052631578947368,0.8913738736218467,1.0,12/89,11.15%,MEF2C;IL33;ETS1;NFKBIA;GPR4;PDE2A;PDCD4;APP;GRN;GBP5;FEM1A;IFI35
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.293220888348364,-0.8388343626118222,0.7110655737704918,0.8916133553325933,1.0,10/22,30.92%,MVB12B;UBAP1;PTPN23;MVB12A;UBAP1L;PLAA;VPS36;TOM1L1;VPS28;VPS4B
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.33478129392500433,0.838488075508863,0.6608187134502924,0.9509292561009998,1.0,2/18,3.94%,PRKN;CRHBP
prerank,protein maturation (GO:0051604),-0.2177535524865406,-0.8383120531758952,0.8381962864721485,0.8920301488370851,1.0,24/95,24.16%,ADAM10;F3;CPD;PCSK2;GALNT2;PTCH1;SRGN;TSPAN17;ECE1;FURIN;OGT;CPXM2;HSPD1;DNAJB11;NAA40;GLRX3;PCSK1;ADAMTS3;PSEN1;PCSK5;TYSND1;ISCA1;NNAT;NAA16
prerank,response to glucocorticoid (GO:0051384),-0.2812839867147459,-0.8381485984867015,0.708779443254818,0.8917834401244802,1.0,5/26,12.32%,SLIT2;FAM107A;HNRNPU;ZFP36L1;REST
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.33755271547233007,-0.8380594633369525,0.694672131147541,0.8913753285724273,1.0,5/14,19.02%,CEPT1;LPIN3;ETNK1;LPIN1;ETNPPL
prerank,positive regulation of JUN kinase activity (GO:0043507),0.31102238272809407,0.8376214179755076,0.6830188679245283,0.9519923740959124,1.0,2/23,2.62%,SASH1;DKK1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.36191597298809713,-0.8376029560237405,0.690566037735849,0.8910637024078848,1.0,4/10,32.69%,RACK1;PRKCD;SPHK2;NSMAF
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.36191597298809713,-0.8376029560237405,0.690566037735849,0.8910637024078848,1.0,4/10,32.69%,RACK1;PRKCD;SPHK2;NSMAF
prerank,response to alcohol (GO:0097305),0.3078179030831145,0.837138797784723,0.6829268292682927,0.952218833507539,1.0,3/27,8.52%,TGFBR3;CCL19;PMVK
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.24123139503390745,-0.8371362603936725,0.7395577395577395,0.8913550833659722,1.0,24/52,28.73%,PPP1R13B;SREBF2;SH3GLB1;NMT1;YWHAB;MAPK8;YWHAG;BBC3;ARIH2;CASP8;VPS11;YWHAQ;YWHAH;PINK1;PPP3R1;TOMM7;HUWE1;MICALL2;YWHAZ;RNF31;PPP3CC;ABLIM3;BID;SFN
prerank,ERAD pathway (GO:0036503),-0.22151449201988294,-0.8370779078469969,0.7989276139410187,0.8908992539736419,1.0,32/83,29.88%,ATXN3;STT3B;TRIM25;HSP90B1;BAG6;DERL1;CCDC47;UBXN6;HSPA5;HERPUD1;ERLEC1;TRIM13;ERLIN2;DNAJC10;WFS1;AUP1;RNF5;DNAJB9;GET4;FBXO17;TMEM129;VCP;RNF103-CHMP3;BRSK2;UBE2J1;YOD1;SYVN1;FBXO2;RHBDD2;STUB1;FOXRED2;SEC61B
prerank,organelle assembly (GO:0070925),0.20622193951308768,0.8370000466732952,0.8775252525252525,0.9517858997324343,1.0,94/384,19.40%,DCDC2;ASAP1;INTU;AVIL;TP53INP2;RAB3IP;ARL3;SH3PXD2B;RAB19;DYNC2H1;CDC14B;MAPRE2;CCDC57;IFT80;HAUS4;WIPI1;CC2D2A;ARMC9;WDR19;UBXN10;TTC8;WDPCP;KIF27;WDR35;ARL6;CEP19;UBXN2B;IQCB1;ATG14;VTA1;TUBGCP6;YTHDF2;RAB32;TEKT2;TCTN1;SCLT1;ATP6V0D1;STAM2;GOLGA2;TUBGCP2;PARVA;CEP89;BBS7;FBF1;OFD1;WDR11;HAUS1;IFT122;ATG9A;EIF2S1;CHMP6;VPS37A;VPS37C;TTC39C;EXOC3;INO80;IFT140;PLA2G4C;CFAP298;CCDC65;WDR90;LMOD1;CEP63;RAB43;CEP164;CFAP70;CFAP410;ATP6V1D;AMBRA1;ATG3;MIS12;RUFY4;EXOC7;EXOC1;DYNC2I1;IRGM;CDS2;VPS37D;CFAP20;ATG16L2;PDE6D;RAB11FIP3;NCOR1;ARF4;RP2;TMEM237;BBS1;TRAF3IP1;IFT81;IFT46;LSM3;DDX3X;LSM14A;BBS2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.3474893457613816,-0.8369029427273695,0.7118320610687023,0.8906563388494769,1.0,4/12,16.76%,RPL26;CD44;CD74;MIF
prerank,regulation of interferon-beta production (GO:0032648),0.27760936524731417,0.8365189287794813,0.7035087719298245,0.9520499226158595,1.0,10/46,13.90%,CACTIN;NLRC3;POLR3G;TRIM56;RNF135;RNF216;SIRPA;IRF3;TBK1;POLR3C
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.3615513837940177,0.8364778669559577,0.6434599156118144,0.9514278171685296,1.0,3/11,13.91%,PRKN;P4HB;STK26
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.25237781468998216,0.8364650926000142,0.7495881383855024,0.9507420265441788,1.0,9/71,9.50%,ADAMTS12;PRKN;CLPX;CTSH;ADAMTS7;FBXO44;FBXL17;YME1L1;MDM2
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.3253710645889183,0.8363234430602399,0.6704119850187266,0.9502987068274896,1.0,2/22,4.46%,SASH1;SPHK1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.3175485953585156,-0.8362961833646336,0.6996047430830039,0.8912355583534747,1.0,5/16,22.08%,SCARB1;MFSD2A;NR1H2;CTDNEP1;NR1H3
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.2718296049765375,-0.8361657955909143,0.7350427350427351,0.8908955721517324,1.0,3/29,6.25%,NSF;VTI1B;COPG1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.34205780743134406,-0.8359142476680124,0.692,0.8907899193960525,1.0,5/13,18.45%,CPSF7;CPSF6;CPSF2;CSTF2T;CSTF2
prerank,granulocyte chemotaxis (GO:0071621),-0.24046653661610753,-0.8358749556431835,0.766109785202864,0.8902990633251544,1.0,11/55,17.86%,BSG;TGFB2;PPIA;CXADR;EDN1;PPIB;PIK3CD;SCG2;PIP5K1C;GBF1;CCL13
prerank,histone H3 deacetylation (GO:0070932),-0.3186968578071505,-0.8351941627585892,0.7034883720930233,0.8909895933645247,1.0,8/15,29.49%,SFPQ;PER1;SIRT7;HDAC9;SMARCAD1;SIRT6;HDAC3;PER2
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.32577176174329925,-0.8349764847795962,0.6877394636015326,0.8902618922608663,1.0,3/15,6.82%,AP3S1;BLOC1S2;AP3M2
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.32577176174329925,-0.8349764847795962,0.6877394636015326,0.8902618922608663,1.0,3/15,6.82%,AP3S1;BLOC1S2;AP3M2
prerank,negative regulation of transferase activity (GO:0051348),-0.26567409579069867,-0.8346707133024088,0.7062937062937062,0.890282034409902,1.0,5/28,11.31%,PINX1;GSK3B;HNRNPU;CDKN1B;MEN1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.22668287678802398,-0.8341739951176663,0.8057553956834532,0.8906340171545587,1.0,25/76,23.48%,RNF144B;CBFA2T3;PTK2;RNF144A;RACK1;TRIB2;NKD2;SOCS5;GSK3B;ZYG11B;RBX1;CLU;ELOB;ARIH2;COP1;LAPTM5;RNF19B;NOP53;ARIH1;VCP;RNF19A;USP5;CEBPA;TRIB3;HSPA1B
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.34518487063110725,0.8337851657106771,0.6692307692307692,0.9547459289185841,1.0,3/16,7.40%,PDE6G;ACP3;PRKCA
prerank,negative regulation of innate immune response (GO:0045824),-0.2632474362756504,-0.8336068933512489,0.726890756302521,0.891160555850261,1.0,8/34,12.95%,RPS19;SUSD4;GRN;A2M;NLRC5;ISG15;YTHDF3;IRAK3
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.2789381168151094,0.8335590873474397,0.7095070422535211,0.9544675054807109,1.0,6/44,10.80%,ROCK2;TNRC6B;TNRC6A;YTHDF2;AGO2;METTL14
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.3483406609600363,-0.8334887645573817,0.6802218114602587,0.8908112692157915,1.0,5/11,32.03%,TASOR;SETDB2;SIRT6;DNMT1;PPHLN1
prerank,regulation of cytoplasmic transport (GO:1903649),0.36477696378424745,0.8333774884486791,0.6576763485477178,0.9541096406821289,1.0,3/11,13.40%,LRRK2;USP7;MAPK1
prerank,iron ion transport (GO:0006826),0.2730441558708239,0.8332461608491124,0.7142857142857143,0.9536597711283048,1.0,8/47,10.02%,CP;HEPH;LTF;TFR2;REP15;ATP6V0D1;ATP6V0E1;STEAP3
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.33379847906614113,-0.8332140036122363,0.6971544715447154,0.890740099244637,1.0,5/14,33.63%,ADRB2;PRKAR1A;ATP2B4;PKIG;PRKAR2B
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.316925079013721,0.8330551743830577,0.6468330134357005,0.9533506123665482,1.0,4/22,10.14%,NR2F2;PTEN;CDK5RAP1;LATS1
prerank,negative regulation of GTPase activity (GO:0034260),0.31594846166516793,0.8327513223685761,0.6752475247524753,0.9532662157699164,1.0,3/22,5.48%,GMIP;CPEB2;LRRK2
prerank,peroxisomal membrane transport (GO:0015919),-0.2793257085151605,-0.8322449627856955,0.7463617463617463,0.8919741128481354,1.0,12/27,29.54%,ABCD3;ABCD2;PEX1;PEX11B;ABCD4;PEX5;ATAD1;PEX10;RAB8B;PEX16;FIS1;PEX13
prerank,C21-steroid hormone metabolic process (GO:0008207),0.3326283226150147,0.832044119228171,0.67,0.9539065416567611,1.0,3/20,12.49%,FDXR;HSD17B10;AKR1B1
prerank,negative regulation of developmental growth (GO:0048640),-0.26826736459757133,-0.8320094163943037,0.7266187050359713,0.8918572509871243,1.0,12/30,27.61%,DCC;PTCH1;RTN4;CDKN1B;SEMA3G;CDKL3;MT3;RTN4R;CDKN1A;FGFR3;ULK2;FGF13
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.28482387924329455,-0.8318969229061451,0.734475374732334,0.8914985583253664,1.0,11/26,39.78%,CUL3;DUSP1;ANAPC7;NSMCE2;PLK1;DLGAP5;CDC6;ESPL1;UBE2C;ANAPC4;CCNB1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.3076086779846643,-0.8318691538808053,0.6920077972709552,0.8909884739499285,1.0,8/18,33.20%,MCM4;POLA1;POLE;POLD3;GINS4;LIG3;POLE3;GINS2
prerank,regulation of protein neddylation (GO:2000434),-0.36070666467191626,-0.8302928304139103,0.6804511278195489,0.8932343891519559,1.0,5/10,14.54%,RPL11;RPL5;COPS9;DCUN1D1;DCUN1D2
prerank,transcription preinitiation complex assembly (GO:0070897),-0.34789788320468557,-0.8302383249057887,0.7111553784860558,0.8927779155218055,1.0,8/12,52.74%,TAF11;POLR1E;TAF1B;TAF7;TBP;TAF7L;BDP1;DR1
prerank,regulation of protein localization to cell surface (GO:2000008),0.29053055455574417,0.8293359849329303,0.6990990990990991,0.9585867487006516,1.0,3/33,5.58%,LEPROT;GPD1L;SNX33
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.2925417150174675,-0.8290618633269516,0.7089715536105032,0.8943708473959621,1.0,4/22,10.85%,KLF4;MBP;CD44;GCNT2
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.34465231123358003,0.8289781436654785,0.6782077393075356,0.958590187125793,1.0,1/14,0.98%,PPP2R2B
prerank,histone H4 acetylation (GO:0043967),-0.24165564726873084,-0.8284322189340612,0.7728395061728395,0.894984985668398,1.0,11/47,17.31%,LEF1;MORF4L1;APBB1;ING4;OGT;NAA40;JADE1;KANSL3;RUVBL1;PER1;WDR5
prerank,neurotransmitter transport (GO:0006836),0.24896834259010853,0.8281391685931702,0.7288961038961039,0.9595936540582142,1.0,3/73,2.16%,ATP1A2;SLC22A2;SLC1A3
prerank,peptidyl-serine phosphorylation (GO:0018105),0.22403457029543883,0.8280233360835305,0.796583850931677,0.959118709498785,1.0,29/153,14.45%,ROCK2;PDPK1;CAMK1D;DMPK;SRPK2;MAPK9;RICTOR;LRRK2;PRKCZ;PRKCB;TTK;PRKCA;PKN2;CDK1;CAMK2D;CLSPN;VRK2;LATS1;PRKDC;RPS6KB1;IKBKE;MAPKAPK2;HIPK3;PRKD2;TBK1;MAPK1;MORC3;NLK;PRKCI
prerank,microtubule anchoring (GO:0034453),-0.33916410536026764,-0.8280071595776222,0.6814671814671814,0.8952108247828554,1.0,7/12,35.23%,BICD1;CLASP2;CAMSAP3;SAXO2;PCM1;BCCIP;CLASP1
prerank,mRNA polyadenylation (GO:0006378),-0.2823066579350953,-0.8279591822559358,0.7166324435318275,0.8941708811663392,1.0,9/26,18.37%,PABPC1;APP;CPSF3;GRSF1;SYMPK;AHCYL1;CLP1;CPSF2;PCF11
prerank,RNA polyadenylation (GO:0043631),-0.2823066579350953,-0.8279591822559358,0.7166324435318275,0.8941708811663392,1.0,9/26,18.37%,PABPC1;APP;CPSF3;GRSF1;SYMPK;AHCYL1;CLP1;CPSF2;PCF11
prerank,pseudouridine synthesis (GO:0001522),-0.33718699035474753,-0.8273281052886593,0.7041420118343196,0.8947912977518754,1.0,7/13,29.60%,TRUB2;NHP2;PUS7;PUSL1;RPUSD2;NOP10;PUS1
prerank,aminoglycan metabolic process (GO:0006022),0.3806107304841768,0.8271498976078111,0.6638830897703549,0.9601516323206029,1.0,3/10,9.85%,GAL3ST3;XYLT2;B3GALT6
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.2792282615286538,0.8269750161885877,0.7243697478991596,0.9597715634141215,1.0,7/43,12.50%,ERRFI1;SNX6;STAM2;TGFA;CHMP6;PTPN3;AREG
prerank,V(D)J recombination (GO:0033151),0.36768881562559896,0.8267574465940786,0.6361655773420479,0.9595205179271807,1.0,3/11,12.75%,XRCC4;PRKDC;LIG1
prerank,positive regulation of viral genome replication (GO:0045070),0.29618047614185267,0.8265087316663879,0.7097378277153558,0.9593104148871409,1.0,5/29,8.59%,PPARA;SRPK2;TOP2B;HACD3;PKN2
prerank,positive regulation of peptidase activity (GO:0010952),-0.294422679702609,-0.8261432957019663,0.7118997912317327,0.8964384884160375,1.0,7/20,24.17%,GRN;NDUFA13;PSME3;PSME1;PINK1;VCP;VSIR
prerank,long-chain fatty acid import into cell (GO:0044539),0.3697246610114177,0.826128325321018,0.6590389016018307,0.9593412166447309,1.0,3/10,10.77%,ACSL1;SLC27A1;RPS6KB1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.3328164539825604,-0.826051524371687,0.6944444444444444,0.8960339899918132,1.0,5/13,18.58%,RPL26;SPRED2;DDX5;EEF1E1;ATR
prerank,negative regulation of phosphatase activity (GO:0010923),-0.280726980149682,-0.8259799907047555,0.7130801687763713,0.8956062613948396,1.0,8/25,16.65%,TGFB2;SEMA4D;TIPRL;GSK3B;CHP1;ZCCHC9;MASTL;BOD1
prerank,regulation of gluconeogenesis (GO:0006111),0.30255505893935614,0.8259763221577135,0.690566037735849,0.9589509095210422,1.0,7/27,18.00%,C1QTNF3;SIK1;USP7;CRY1;GCK;NNMT;C1QTNF12
prerank,regulation of acute inflammatory response (GO:0002673),0.33885958301934194,0.8258545698341078,0.6850393700787402,0.9584848571261366,1.0,18/18,66.15%,IL6;OSMR;ADAM8;KLKB1;PTGES;F12;DNASE1L3;C2CD4A;C2CD4B;PLA2G2D;DNASE1;FFAR2;OSM;CREB3L3;GSTP1;IL4;IL6ST;NLRP3
prerank,regulation of mRNA metabolic process (GO:1903311),-0.3547637776746675,-0.825611246652578,0.716796875,0.8957246716338874,1.0,7/11,33.25%,CDK11B;SRPK1;SAFB2;SLTM;SRPK3;DHX9;IWS1
prerank,lytic vacuole organization (GO:0080171),0.2948829571061449,0.8253049171217062,0.7206703910614525,0.9588537471023472,1.0,5/32,6.74%,HOOK2;ABCA1;TPP1;LRRK2;ACP3
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.34797102506468974,-0.8252782038522072,0.7064393939393939,0.8957481055431075,1.0,7/11,51.81%,NFKBIZ;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A
prerank,regulation of chromosome organization (GO:0033044),0.31153493289061557,0.8251929758281698,0.6958250497017893,0.9583546545860449,1.0,3/22,7.05%,HDAC8;YLPM1;XRCC5
prerank,chromatin assembly (GO:0031497),0.2800113728741471,0.8250315464478329,0.7065026362038664,0.9580039627778771,1.0,11/38,22.11%,RBBP4;RSF1;KAT6B;SMARCA5;NAP1L3;EZH1;NAA60;NAP1L1;PAF1;ANP32B;SOX9
prerank,positive regulation of mitochondrial fission (GO:0090141),0.32454308299281487,0.8249256864921031,0.6898608349900597,0.9575009324579662,1.0,3/18,7.85%,PRKN;BNIP3;MCU
prerank,regulation of interleukin-1 beta production (GO:0032651),0.2561223672119449,0.824620684131855,0.7504244482173175,0.9574046267192233,1.0,1/66,0.03%,IGF1
prerank,reverse cholesterol transport (GO:0043691),0.3619677471101443,0.8243977161813951,0.6582278481012658,0.9571518685552782,1.0,3/13,8.39%,ABCA1;LIPC;ABCA5
prerank,positive regulation of actin nucleation (GO:0051127),0.36723243183322385,0.8243631870256025,0.6555772994129159,0.956538984777493,1.0,4/11,13.05%,ABI2;WASF1;WASF3;FCHSD2
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3278249869957493,0.8242755066167491,0.675564681724846,0.9560061695459284,1.0,8/17,21.35%,AKAP13;ADRA1D;ADRB3;DRD2;ADCY9;ADRA2A;GPR101;RAPGEF2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.332075230719692,0.824167283566195,0.683495145631068,0.9555288537921369,1.0,4/20,10.08%,LHPP;AMPD3;ADSL;GMPS
prerank,modification-dependent protein catabolic process (GO:0019941),0.21640807568667758,0.8238594041658645,0.8622222222222222,0.9554468575472497,1.0,29/193,12.80%,ASB2;RNF43;PRKN;SPSB1;NEDD4;RNF213;FBXW4;RNF217;ZNRF3;TRPC4AP;UBE2L3;TTC3;SIAH2;AMFR;BIRC6;RC3H2;UBE4A;MDM2;ITCH;RNF149;SMURF2;PSMD3;RBBP6;KLHL15;RNF14;RNF20;FBXO11;RCHY1;CDC26
prerank,motile cilium assembly (GO:0044458),0.3592592592592592,0.8235854521717014,0.6902834008097166,0.9552616246435034,1.0,12/12,64.10%,DNAAF3;RSPH9;E2F4;MCIDAS;BBOF1;BBS5;SPATA6;ZMYND10;DNAAF1;RSPH6A;CCDC39;CCDC40
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.3582311054590755,-0.8230313548256541,0.6968503937007874,0.8991852830972505,1.0,3/10,8.71%,IQSEC1;MTOR;FGF7
prerank,renal absorption (GO:0070293),0.37003569357951915,0.8227841577563682,0.6659836065573771,0.9560989462442934,1.0,1/10,1.20%,WNK4
prerank,response to interleukin-6 (GO:0070741),-0.3555638294206219,-0.8227415926746448,0.6977611940298507,0.8991494217851135,1.0,3/10,8.87%,ST3GAL6;SBNO2;PTGIS
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.3001525204865304,-0.8227402049067281,0.7046843177189409,0.8985902428618465,1.0,3/19,5.71%,FBXO7;SREBF2;CAMKK2
prerank,substrate-dependent cell migration (GO:0006929),-0.3250829836037236,-0.8225181340495374,0.7217741935483871,0.8984386445789829,1.0,4/14,10.61%,SHTN1;ANKS1A;PTPRC;CD2AP
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.27363613573443973,-0.8225019843529388,0.7494646680942184,0.8979000686135458,1.0,6/29,11.27%,HSP90AB1;CDC37;NLRC5;ISG15;PTPN1;YTHDF3
prerank,negative regulation of autophagy (GO:0010507),0.2615542696711524,0.8223570531034349,0.7202072538860104,0.9562290414146172,1.0,10/54,13.20%,LEPR;BCL2;LRRK2;NUPR1;GOLGA2;WASHC1;RUBCN;KLHL22;LZTS1;FOXK2
prerank,detection of calcium ion (GO:0005513),-0.32409531356573973,-0.8221703249683358,0.7088122605363985,0.8979477619427071,1.0,5/13,15.59%,CALM1;RYR2;KCNMB4;KCNIP2;CALM2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.2419524502786808,0.8218415878358416,0.7726550079491256,0.9565185694897435,1.0,14/82,14.73%,NINL;ALMS1;HAUS4;CEP152;SDCCAG8;CDK1;PAFAH1B1;NEK10;OFD1;HAUS1;SFI1;CEP57;CEP63;CEP164
prerank,response to ionizing radiation (GO:0010212),0.24818080665326894,0.8216967779778255,0.7560192616372392,0.9561256720958236,1.0,14/70,16.10%,EYA1;ANXA1;MRNIP;INIP;BLM;XRCC4;PRKAA1;NHEJ1;INO80;CLOCK;BABAM2;BRSK1;SWI5;RAD51
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.27677016289318557,-0.8216375249005162,0.7317596566523605,0.8982758636719153,1.0,11/24,30.36%,STMN2;STMN1;TPPP;STMN4;TPPP3;STMN3;CKAP5;KIF14;TRPV4;FGF13;NCKAP5L
prerank,early endosome to Golgi transport (GO:0034498),-0.3525421537429104,-0.8212914978630005,0.7247191011235955,0.8982726167448887,1.0,5/11,34.13%,EHD3;SNX1;SNX2;STX5;RBSN
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.3457655364004808,-0.8210396666595,0.7131931166347992,0.8981840901155532,1.0,4/11,21.07%,MTOR;PIH1D1;NOP53;SIRT7
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.3437330816566274,0.820838308219654,0.6561844863731656,0.9571258789543396,1.0,1/14,1.22%,IL18
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.23590428644544403,0.8207366405404598,0.7984496124031008,0.9566262728928622,1.0,12/104,10.44%,KSR1;SLC8A3;LTF;SLC8A1;CDK7;BLM;CCNT2;CCNT1;SYAP1;UVRAG;SLC27A1;ABL1
prerank,muscle cell migration (GO:0014812),0.37776690216785913,0.8205904502885051,0.6777546777546778,0.9561935448688013,1.0,2/10,4.87%,MEGF10;DDR1
prerank,protein localization to organelle (GO:0033365),-0.20304934258543328,-0.8203210641894445,0.8742857142857143,0.8989237282427712,1.0,38/133,21.68%,RPL11;DNAJA1;PACSIN2;STX1A;CALR;EHD1;SIX1;APP;YBX1;LAMP1;CCDC47;ZBTB7A;TSPAN17;TOR1B;TMEM30A;SSB;ISG15;GBP5;HHEX;RPA1;TOLLIP;CEP68;RIPOR1;BBS9;LMNA;COL1A1;SEC61G;SIX4;GBF1;BICD1;AUP1;SYS1;IFT20;GET4;CTDNEP1;BMP4;FAM83H;VAPA
prerank,regulation of endopeptidase activity (GO:0052548),-0.22771277428884087,-0.8200890628893522,0.8193384223918575,0.898774659456374,1.0,15/59,18.57%,SPOCK2;SERPINE2;SERPINI1;SERPINF1;SERPINB9;GAPDH;BIRC3;FURIN;PSME3;PSMB8;SPOCK1;PSME1;ATP13A2;TIMP2;SERPINA2
prerank,negative regulation of cellular metabolic process (GO:0031324),0.27797066945799265,0.8200579587277875,0.7341772151898734,0.9565311355822623,1.0,10/37,18.05%,PRKN;PCSK9;OPTN;TFAP2A;DLG4;PLIN5;SDCBP;EDNRB;TRAP1;NCOR1
prerank,receptor clustering (GO:0043113),0.29676292543168487,0.8199948953004059,0.7224409448818898,0.955960451001251,1.0,8/27,13.67%,LRP4;PTN;DLG1;DNAJA3;MUSK;DLG4;DLG3;MAGI2
prerank,peptidyl-lysine methylation (GO:0018022),0.3036827863785537,0.8193579935505438,0.6988636363636364,0.9564852903069508,1.0,7/26,19.77%,SETD6;SETD7;EEF1AKMT1;SMYD3;N6AMT1;SETD2;SETD4
prerank,organophosphate catabolic process (GO:0046434),0.355909861276756,0.8188611275612009,0.6637168141592921,0.9567638125414363,1.0,11/11,64.43%,ENPP2;ABHD12;PLBD2;PNLIPRP2;APOA2;LIPG;ANGPTL3;PON1;PDXP;NUDT15;PLBD1
prerank,regulation of BMP signaling pathway (GO:0030510),0.24516844123838294,0.8188012040235493,0.759016393442623,0.9561733150762592,1.0,17/73,15.68%,RBPJ;SMAD6;FOXD1;SPART;SULF1;ITGA3;LRP2;NBL1;FSTL3;LEMD3;SMURF2;TFAP2B;BMPR1A;FSTL1;CDH5;SKI;SMAD4
prerank,regulation of cell projection organization (GO:0031344),0.35341206156381155,0.8186452586282834,0.6790123456790124,0.9558014838543003,1.0,5/13,15.34%,MACF1;NTNG2;CCL19;MYO9A;MOV10
prerank,positive regulation of TORC1 signaling (GO:1904263),0.33371018786810003,0.8186344676936467,0.6980392156862745,0.9551310773509675,1.0,9/16,22.74%,GPR137C;FLCN;KLHL22;SIK3;TELO2;LARS1;CLEC16A;LAMTOR5;RRAGD
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.35872459270039436,-0.8183752735650125,0.7281368821292775,0.9012286606543021,1.0,4/10,29.85%,DLGAP1;NPTXR;NPTX1;CACNG5
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.3350049663559858,-0.8180407676544932,0.7021696252465484,0.9012650906329086,1.0,3/12,11.74%,FOXP1;ZBTB7A;HEYL
prerank,regulation of hippo signaling (GO:0035330),0.3296668378911811,0.8179808099732272,0.7261904761904762,0.9557197398502137,1.0,4/17,10.50%,VGLL4;WWC1;WWC2;SCHIP1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.2502109049165368,0.8179374559513259,0.7631160572337043,0.9551206376027438,1.0,22/68,23.60%,PCCA;MCCC2;TCN2;MTHFR;FOLR2;SLC19A2;SLC19A1;FLAD1;SHMT1;THTPA;MTHFS;MMAB;NNMT;DHFR;MTHFD2;PDXK;LMBRD1;TCN1;BTD;SLC52A1;FPGS;HLCS
prerank,defense response to virus (GO:0051607),0.23399098605863256,0.8175555089915941,0.8118022328548644,0.9551485918685396,1.0,11/100,7.98%,BCL2;PLA2G10;IFIT3;IFIT2;RNASEL;TRIM5;ZDHHC1;BNIP3;IL6;TRIM56;RNF135
prerank,determination of bilateral symmetry (GO:0009855),0.3022542061625456,0.8175344154606318,0.7026022304832714,0.9545078786615279,1.0,6/24,15.00%,ODAD3;DNAH11;ARL6;BBS7;PKD2;ODAD2
prerank,aminoglycan catabolic process (GO:0006026),0.29871384816252533,0.8172999447683904,0.6849056603773584,0.9542291075177574,1.0,4/28,7.97%,SDC2;GPC6;GPC3;CTBS
prerank,sensory perception of chemical stimulus (GO:0007606),-0.32549713740793784,-0.8171900372956398,0.7110266159695817,0.9021869211482821,1.0,3/15,10.93%,GNAL;ADCY3;SYT10
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.24297603217080663,-0.8170602985264068,0.8073394495412844,0.9018441614368446,1.0,16/48,22.36%,SLIT2;GAS6;PTPRC;NLRC5;ISG15;YTHDF3;IRAK3;NLRP2B;NR1H2;CARD16;SIGIRR;SH2B3;PADI2;METTL3;NR1H3;TRAIP
prerank,negative regulation of immune effector process (GO:0002698),-0.3316481265280278,-0.8170009935722108,0.7168316831683168,0.9013734195231266,1.0,5/13,14.36%,RPS19;CD55;GRN;APPL1;CD47
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.2955341150159894,-0.8166285826886186,0.7312252964426877,0.9014427864501235,1.0,5/20,14.97%,DCC;BCL2L1;GSK3B;APPL1;FAS
prerank,negative regulation of immune response (GO:0050777),0.2232946228470446,0.8164650380086725,0.8403614457831325,0.9551082832645346,1.0,17/154,11.47%,ADCY5;ADCY1;FER;ADM;FCRLB;CACTIN;PDCD1;IL6;PTH2R;NLRC3;LYAR;PTGIR;GLP1R;ITCH;ADRB3;ENPP3;PCBP2
prerank,regulation of immunoglobulin production (GO:0002637),0.30518137097881815,0.8162725938253808,0.7024291497975709,0.9547834461797624,1.0,2/23,6.76%,RBP4;IL6
prerank,purine nucleotide biosynthetic process (GO:0006164),0.3536729945902057,0.815685995571022,0.6764091858037579,0.9552113066140535,1.0,2/12,5.98%,PRPSAP2;ADSL
prerank,response to glucose (GO:0009749),0.26616227748683713,0.8154814663615529,0.7684391080617495,0.9548985160770841,1.0,6/46,7.95%,TCF7L2;ZBTB20;PRKAA2;IGF1R;PRKAA1;SLC30A8
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.22763292957420375,-0.8154695025612148,0.7955112219451371,0.9028152312338427,1.0,18/59,23.41%,DAB2IP;UBB;NFKBIA;IKBKB;RPS27A;UBC;BIRC3;NKIRAS1;CHUK;BCL3;TBKBP1;TAB3;UBA52;SHARPIN;AKT1;RBCK1;FAIM;RELA
prerank,response to organophosphorus (GO:0046683),-0.3115076813103631,-0.815458214051038,0.7436893203883496,0.9022772322888343,1.0,2/16,1.90%,ABCC9;TRPC3
prerank,organelle disassembly (GO:1903008),0.2866995145993565,0.8154097339705161,0.7089285714285715,0.9543396723744344,1.0,6/33,10.75%,PLK5;UFL1;CDK1;RETREG1;GOLGA2;TEX264
prerank,amide biosynthetic process (GO:0043604),0.2690056085318149,0.8153945192726757,0.7260034904013961,0.9536904701510892,1.0,9/47,12.14%,DMD;PM20D1;CERS6;CERS5;AANAT;ASL;CERS1;PAM;SLC25A2
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.34963033892897866,0.8153711885606567,0.6776180698151951,0.9530493046745204,1.0,3/13,8.14%,ALG6;ALG2;ALG9
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.3707415884926153,0.8151457539070929,0.6707818930041153,0.952777047589371,1.0,3/10,9.87%,EPHA4;ATRAID;RIC1
prerank,positive regulation of organelle organization (GO:0010638),-0.257988748143017,-0.8150904719771033,0.7670940170940171,0.9023486670367505,1.0,8/32,18.89%,PPARGC1A;SYNJ1;GSK3B;C2CD5;SORBS3;ADRB2;SMCR8;LIG4
prerank,lipid homeostasis (GO:0055088),0.25916092917539646,0.8147220224843794,0.735144312393888,0.9529135507846018,1.0,6/57,7.55%,ZBTB20;ABCA1;RBP1;PRKAA2;THADA;PRKAA1
prerank,DNA recombination (GO:0006310),0.2786675048063056,0.8145999660059084,0.7527272727272727,0.9524548243819638,1.0,9/37,17.10%,RAD51B;RAD51C;DMC1;BLM;RTEL1;MRE11;WRN;RAD51;RPAIN
prerank,regulation of inclusion body assembly (GO:0090083),0.3596338856032969,0.8141446847995749,0.6605504587155964,0.9526416114162307,1.0,1/11,2.45%,SNCAIP
prerank,arachidonic acid metabolic process (GO:0019369),-0.25583142320576524,-0.8132747262089152,0.7935034802784223,0.9048776747759993,1.0,8/35,15.18%,MGLL;GPX4;PTGIS;PTGS2;PTGDS;ALOX12;PLA2G4A;CYP1B1
prerank,response to axon injury (GO:0048678),-0.30830743727539933,-0.8131441359494316,0.7111984282907662,0.904516164591983,1.0,9/18,29.17%,APOD;RTN4RL1;SOD1;TYROBP;SARM1;P2RY12;GAP43;TREM2;MAPK8IP3
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.218980587567094,0.8131381520142532,0.8306569343065694,0.9538626446012408,1.0,26/158,15.54%,WLS;PRKN;PELI2;LPAR1;LTF;ECM1;TRIM5;AKAP13;GJA1;PRKCB;CXXC5;CCL19;SLC20A1;GOLT1B;IKBKE;CFLAR;GPRC5B;TBK1;MAP3K7;UNC5CL;UBE2V1;MTDH;BIRC2;TRIM62;CX3CL1;TMEM9B
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.3204002165079135,-0.8124952097428553,0.7165048543689321,0.9050686269933629,1.0,5/14,19.88%,TARDBP;YBX3;HNRNPA0;TIRAP;MYD88
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.34104789406148145,0.8123840503500095,0.6728395061728395,0.9545261291419616,1.0,5/15,16.48%,FSTL3;LEMD3;MAGI2;SKI;IGSF1
prerank,negative regulation of TORC1 signaling (GO:1904262),0.3461014158796677,0.8123635052756347,0.688034188034188,0.9538972095607856,1.0,3/13,7.35%,SZT2;SESN1;RNF152
prerank,protein localization to chromosome (GO:0034502),0.2840175840980893,0.8123252237291231,0.7067395264116576,0.9532807486900311,1.0,6/34,7.25%,MRNIP;TPP1;ACD;XRCC5;SLF1;XRCC4
prerank,neuron apoptotic process (GO:0051402),-0.2981133791160416,-0.812258009367842,0.7200811359026369,0.9049162791352273,1.0,7/19,18.89%,CIT;TNFRSF21;GAPDH;APP;FAS;CDK5;LIG4
prerank,cell differentiation in spinal cord (GO:0021515),0.3623770653075761,0.8119386505305617,0.6823266219239373,0.9532878290273635,1.0,4/10,21.38%,SOX6;SOX13;MDGA1;DRAXIN
prerank,regulation of p38MAPK cascade (GO:1900744),0.2895367696845669,0.8117807040493211,0.730909090909091,0.9529119448284666,1.0,4/35,6.48%,SASH1;DUSP10;SPHK1;DLG1
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.2762327377165965,-0.811597634923365,0.738045738045738,0.9054616359950554,1.0,8/23,26.10%,ITGB1;NSFL1C;INSC;NDE1;NUMA1;DCTN1;NDC80;SPDL1
prerank,nucleotide biosynthetic process (GO:0009165),0.3268297671257626,0.8113282495566194,0.7058823529411765,0.9531045287812603,1.0,3/18,5.98%,PRPSAP2;NMNAT2;ADSL
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.3280621107937073,-0.8108172422603193,0.724950884086444,0.9062258768767263,1.0,9/14,39.62%,RPS3;CD81;RELA;CARD11;KCNN4;TRAT1;CD226;TESPA1;LCK
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.2697189562490048,-0.8103668394468773,0.7895833333333333,0.9064303419045494,1.0,15/29,34.04%,UBB;RPS27A;UBC;DDB1;RBX1;RPA1;UBA52;CETN2;GTF2H2;XPA;ERCC5;ERCC3;GTF2H5;RPA3;RPA2
prerank,cellular response to estradiol stimulus (GO:0071392),0.32980859328662937,0.8097408865058912,0.7137176938369781,0.9553690300517111,1.0,3/18,6.88%,CRHBP;SSTR2;NCOA3
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.2868673829401788,-0.809595367986167,0.7349397590361446,0.9071992153445863,1.0,12/22,33.35%,DUSP16;PPP1CA;DUSP8;DUSP1;PPM1A;DUSP6;DUSP4;DUSP18;PPM1F;PPP2CA;DUSP7;PDP1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.3546450297068967,0.8092614314888689,0.6836283185840708,0.9556063240168593,1.0,1/13,1.22%,IL18
prerank,cellular response to hydrogen peroxide (GO:0070301),0.28039525504234963,0.8090639557347105,0.7124542124542125,0.955293186689088,1.0,5/33,10.44%,OSER1;ANXA1;IL6;SIRPA;ABL1
prerank,hyaluronan metabolic process (GO:0030212),-0.28007717642930274,-0.8086952391735697,0.7439024390243902,0.9082068402400583,1.0,6/23,8.91%,TGFB1;CD44;CEMIP2;CHP1;HEXB;HEXA
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.30033563088867343,0.8083960599186512,0.7316602316602316,0.9558747223722023,1.0,3/25,5.24%,RBPJ;FOXD1;SULF1
prerank,regulation of mitochondrial fission (GO:0090140),0.30045683998348505,0.8080820257001845,0.6912878787878788,0.9557681511929349,1.0,4/24,7.85%,PRKN;LRRK2;BNIP3;MCU
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.25980069905392794,0.8080152503492265,0.7671957671957672,0.9552232277233269,1.0,6/49,6.29%,KMT2A;MTURN;ASH2L;TNRC6B;TNRC6A;SETD1A
prerank,endothelial tube morphogenesis (GO:0061154),-0.36019341398895977,-0.8079706671393929,0.7279279279279279,0.9088402162083606,1.0,5/10,14.38%,ACVRL1;RHOB;CTNNB1;RHOA;CSNK2B
prerank,regulation of interleukin-13 production (GO:0032656),0.3420668315214449,0.8078981150047833,0.6774193548387096,0.954776663846525,1.0,2/13,5.49%,IL18;PRKCZ
prerank,positive regulation of double-strand break repair (GO:2000781),0.27062311099995484,0.8075887644539735,0.7736549165120594,0.9546902161696219,1.0,8/39,13.59%,MRNIP;SLF1;WDR48;SPIRE2;ARID2;PRKDC;PARP9;FANCB
prerank,glucan catabolic process (GO:0009251),0.33061411519473316,0.8070659845054781,0.6798336798336798,0.9549784081660819,1.0,2/15,4.59%,PHKB;MGAM
prerank,cellular response to superoxide (GO:0071451),-0.3475673507424332,-0.8068002968748751,0.718,0.9102382171407185,1.0,3/10,13.96%,NOS3;SOD1;MT3
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.30614101202953725,-0.8061321213442674,0.7354085603112841,0.9108217199317659,1.0,9/16,26.46%,RYR2;HSPA5;BCAP31;GBF1;SEC16B;VAPA;PPP1R15A;SEC16A;UBAC2
prerank,modulation by host of viral genome replication (GO:0044827),0.34285490383962364,0.8060611616440916,0.6811023622047244,0.9560993524620232,1.0,1/13,1.37%,PRKN
prerank,regulation of peptide hormone secretion (GO:0090276),0.24852620676454446,0.8060323977102483,0.7826797385620915,0.955470888011117,1.0,8/67,7.58%,ITPR1;KCNA5;TFR2;CRHBP;CACNA1D;IL6;PRKCA;RAPGEF4
prerank,magnesium ion transport (GO:0015693),0.35489158194338366,0.8060174963394047,0.6918238993710691,0.9548305975839695,1.0,2/12,4.49%,SLC41A1;MMGT1
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.29349745436473706,-0.8059704231989958,0.7211740041928721,0.9105252714331273,1.0,9/18,34.09%,EDN1;RFK;AGTR1;PDP2;POR;AGT;NOD2;PDP1;PARK7
prerank,histone H3 acetylation (GO:0043966),-0.24930367508852325,-0.8059570889462608,0.8022222222222222,0.9099909066513122,1.0,9/40,19.25%,LEF1;ING4;YEATS2;BRPF1;KAT14;JADE1;PER1;WDR5;SPI1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3216883169811665,0.8057421056620225,0.6890243902439024,0.9546872536769966,1.0,4/18,10.71%,DKK1;SOX6;FRS2;HDAC1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.26372062956064374,0.8051957276029352,0.7509025270758123,0.9549757030988113,1.0,4/44,3.96%,WNK4;ATP1B3;NOS1AP;ANK2
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.2691758194698909,-0.8045989026617174,0.7682119205298014,0.9117293582582384,1.0,12/28,23.41%,UBB;NOD1;RPS27A;UBC;TAB3;AAMP;CASP8;UBA52;IRAK1;TNFAIP3;OTULIN;RELA
prerank,negative regulation of transmembrane transport (GO:0034763),0.3696708991466191,0.8039654255322144,0.6902286902286903,0.9565658562416596,1.0,2/10,5.87%,OAZ3;PRKCB
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.30581958400379233,0.8036295114081461,0.6940966010733453,0.9565356793591109,1.0,9/22,25.29%,CCNT2;CCNT1;CDC73;ELL;TCERG1;SUPT4H1;THOC1;BRD4;CDK13
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.34516660471418253,0.8033663073661215,0.7036247334754797,0.9563440389875293,1.0,3/12,8.73%,PRKCB;PRKCA;CDK1
prerank,regulation of NMDA receptor activity (GO:2000310),0.28355705896095434,0.8032259627738535,0.7422480620155039,0.9559197560051991,1.0,8/32,12.85%,DAPK1;SLC6A9;CRHBP;DLG1;DLG4;ACTN2;GRIA4;DLG3
prerank,positive regulation of telomere capping (GO:1904355),-0.3020295064614926,-0.8032063743772191,0.7459677419354839,0.9134309057200223,1.0,2/17,10.52%,NEK7;MAP2K7
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.3144083958568893,0.8031598837810972,0.7140077821011673,0.9553588225202562,1.0,4/18,7.50%,PDPN;IL6;SMAD3;DDR2
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.2860337693571017,-0.8030847432740833,0.7371541501976284,0.9130633929983492,1.0,4/20,12.75%,PDE4D;ADRA1B;ADRA1A;ADRB2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.34330038511774447,-0.8028639277735125,0.7183908045977011,0.9128754534759073,1.0,5/11,20.19%,MAP3K5;PDCD10;STK25;CYP1B1;PRKCD
prerank,membrane lipid metabolic process (GO:0006643),-0.28235167860606847,-0.802657783939364,0.758130081300813,0.9126720881379939,1.0,4/22,9.70%,ST3GAL6;SERINC1;B4GALT4;CERK
prerank,DNA double-strand break processing (GO:0000729),0.3202974340636062,0.802584813291262,0.6901140684410646,0.9556828779706138,1.0,7/18,23.61%,RNF138;BLM;MRE11;KAT5;RAD50;NBN;RAD52
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.32328523931280595,0.8025600880606883,0.7068273092369478,0.9550591061800722,1.0,3/18,13.45%,PPARA;MIA3;PAG1
prerank,ether lipid metabolic process (GO:0046485),0.3387944376499704,0.802320252561249,0.7047817047817048,0.9548212029786253,1.0,2/14,8.84%,AGMO;PAFAH1B1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.2691899142342917,-0.8023187525928216,0.7770700636942676,0.9126716853040505,1.0,7/25,19.26%,RAC1;RIN3;APP;ANKRD13A;ABCA2;ANKRD13B;PSEN1
prerank,positive regulation of sodium ion transport (GO:0010765),-0.3299027545265839,-0.8021798173321417,0.74373795761079,0.9123456421412961,1.0,6/12,19.90%,WNK3;CNKSR3;NOS1;AHCYL1;SCN1B;ANK3
prerank,positive regulation of bone resorption (GO:0045780),-0.33351780055414165,-0.8020892780356144,0.7013487475915221,0.9119303128548515,1.0,3/11,16.00%,SPP1;TNFRSF11A;PLEKHM1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.3365570872799273,-0.8003566565830044,0.7362428842504743,0.9141846645546394,1.0,5/12,21.67%,PTPN14;TGFB1;BMP4;SIRT7;UHMK1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.2617216237566287,-0.800337298395077,0.7943722943722944,0.9136594680026124,1.0,11/31,29.63%,TOMM20;HSPD1;ROMO1;PEX1;PEX5;PEX10;TIMM50;PEX16;TIMM44;CHCHD4;DNLZ
prerank,nucleic acid-templated transcription (GO:0097659),0.26665739018530454,0.8000613613808546,0.775092936802974,0.9582177197012901,1.0,5/42,10.93%,POLR2D;SCX;THAP1;POLR2A;DTX1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.2648006349042436,-0.7999654943199828,0.7678571428571429,0.9137039038979025,1.0,7/28,19.28%,DAB2IP;NGF;BLOC1S2;CASP8AP2;CASP8;SPI1;TNFRSF10B
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.29092685607442725,0.7998711032239222,0.7566607460035524,0.9578897055764087,1.0,15/29,24.97%,EXOSC8;DCP2;LSM5;CNOT8;CNOT7;EXOSC3;LSM3;LSM1;LSM4;DDX6;EXOSC4;DCP1B;LSM6;DIS3;NT5C3B
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.27886908176297276,0.7996696894797004,0.7485822306238186,0.9575848230219103,1.0,3/34,6.76%,RBP4;LACC1;IL6
prerank,polyol biosynthetic process (GO:0046173),0.32411599933400687,0.7993492881909597,0.7140151515151515,0.9574912077974949,1.0,1/16,1.11%,CYP27A1
prerank,NAD biosynthetic process (GO:0009435),0.31757445971533954,0.799083562208538,0.7229862475442044,0.9573266529576931,1.0,8/20,17.84%,NMNAT2;NADSYN1;PARP10;PARP9;NMNAT1;NUDT12;QPRT;NNMT
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.3324580435541779,-0.7985119797040279,0.7437858508604207,0.9154786283157452,1.0,4/11,12.32%,FBXO7;RACK1;ATF4;REST
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.24231625445916222,0.7981948061623709,0.7927631578947368,0.9582050112278764,1.0,18/73,18.72%,JARID2;IGF2;RBBP4;BAZ1B;RBBP7;MTF2;PRMT7;SMARCA5;TAF1A;POLR1F;POLR1A;CGGBP1;TAF1D;PHF1;PHF2;POLR1G;HDAC4;GLMN
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.3470258976501593,0.7980784005609353,0.6942148760330579,0.9577487669431488,1.0,2/12,7.25%,METTL4;BLM
prerank,positive regulation of ion transport (GO:0043270),0.25279367994336416,0.797616123946407,0.7925531914893617,0.957949027476546,1.0,13/48,18.17%,GPD1L;MYLK;ANK2;CACNA1D;DLG1;CCL4;SCN3B;ACTN2;GDNF;CHRNB2;DRD2;ANO6;CAMK2A
prerank,regulation of T cell differentiation (GO:0045580),-0.25724429812403005,-0.7967556908494128,0.7701612903225806,0.9177043478659113,1.0,7/33,15.69%,RUNX1;CBFB;NFATC2;SOD1;XBP1;TCF7;CAMK4
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.3250777101912822,0.7959054919583328,0.6909871244635193,0.9603485653973267,1.0,3/15,6.98%,ANXA1;SSTR2;UBE2L3
prerank,positive regulation of receptor internalization (GO:0002092),-0.2795964057669065,-0.7951536275714218,0.7739872068230277,0.9197114191104236,1.0,10/22,21.01%,SFRP4;ARRB1;VEGFA;CD63;PICK1;GREM1;ARRB2;INSR;FMR1;ATAD1
prerank,response to exogenous dsRNA (GO:0043330),0.3264762566366127,0.794586670580759,0.6762452107279694,0.9620659933873399,1.0,1/18,0.45%,COLEC12
prerank,cellular response to radiation (GO:0071478),-0.24299396992790329,-0.7944995637294073,0.7938388625592417,0.9201877630878468,1.0,9/40,21.70%,NET1;RHOB;EEF1D;SPIDR;TNKS1BP1;RAD9A;LIG4;GADD45A;CDKN1A
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.2901738414062064,-0.7943773312894277,0.7505197505197505,0.9198339248621696,1.0,4/19,14.08%,SLC26A2;PAPSS2;BPNT2;SLC35B2
prerank,transport along microtubule (GO:0010970),-0.3175123390286317,-0.7941196972638573,0.7435387673956262,0.9196697155877133,1.0,5/13,31.36%,COPG1;APP;CAMSAP3;APBA1;DYNC1I1
prerank,phosphate ion transmembrane transport (GO:0035435),0.3460080549557425,0.7939383307144865,0.7078189300411523,0.9625390453468149,1.0,3/12,9.59%,SLC20A2;SLC25A11;SLC20A1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.25456030498667254,0.7939306936926731,0.7546125461254612,0.9618854746613321,1.0,8/47,12.17%,BMP7;MEDAG;TMEM64;NAPEPLD;LMO3;SYAP1;ASXL2;SOX13
prerank,negative regulation of macroautophagy (GO:0016242),0.2953974980977094,0.7938874710497785,0.7773722627737226,0.9612984827446485,1.0,11/26,22.11%,LRRK2;NUPR1;RUBCN;TMEM39A;LZTS1;FEZ1;TSC1;PIK3CA;CLEC16A;TSC2;SMG1
prerank,regulation of innate immune response (GO:0045088),0.24848636508500704,0.7938025629714025,0.8106312292358804,0.9607629307725559,1.0,7/57,8.18%,APPL2;RNASEL;CACTIN;NLRC3;POLR3G;RNF135;LYAR
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.3034722281454452,-0.7935966159082081,0.7696850393700787,0.9193884612942534,1.0,4/15,15.77%,PABPC1;TOB1;ZFP36L1;TNRC6C
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.3034722281454452,-0.7935966159082081,0.7696850393700787,0.9193884612942534,1.0,4/15,15.77%,PABPC1;TOB1;ZFP36L1;TNRC6C
prerank,AMP metabolic process (GO:0046033),0.3405944634019789,0.7929506623052417,0.7072164948453609,0.9615709764054906,1.0,2/13,5.98%,AMPD3;ADSL
prerank,regulation of transferase activity (GO:0051338),0.3168455778021459,0.7926203694948325,0.7251908396946565,0.9614928562773886,1.0,4/17,10.38%,SLAMF8;PARP4;FEM1B;PPP1R3F
prerank,calcium import into the mitochondrion (GO:0036444),0.37284390268925316,0.7924662078196735,0.7081447963800905,0.9610967468795496,1.0,3/10,10.46%,MAIP1;MCU;MICU1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.3032885038242635,-0.7920252161217273,0.7616161616161616,0.921323152147504,1.0,6/16,20.49%,SRSF1;PRPF39;CWC15;SNRPC;DCPS;RBM22
prerank,positive regulation of type I interferon production (GO:0032481),-0.21718652437412966,-0.7917259774696155,0.8891752577319587,0.9212973001668774,1.0,22/73,26.74%,LRRFIP1;HSP90AA1;G3BP1;CTNNB1;GAPDH;CHUK;ISG15;CRCP;OAS2;HSPD1;IFIH1;IRAK1;IRF5;MYD88;POLR3D;NFKB2;RELA;POLR2L;POLR3F;STAT1;CGAS;TLR7
prerank,cellular polysaccharide catabolic process (GO:0044247),0.31998021672985794,0.7917035311232027,0.697286012526096,0.9617495573915316,1.0,2/16,4.59%,PHKB;MGAM
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.2700602290219495,-0.7909886892803517,0.783157894736842,0.9218791325217099,1.0,7/24,14.11%,FYN;KCNB1;CHP1;C2CD5;MIEF1;MIEF2;MTCL1
prerank,regulation of chemokine production (GO:0032642),-0.2522966897532111,-0.7907474566704792,0.7930283224400871,0.921703510919673,1.0,16/36,35.47%,FOXP1;IL33;APP;CD74;CSF1R;SIGIRR;ACKR1;AGER;SNAI2;TLR7;TREM2;TLR4;LPL;TSLP;IL7;ADAM17
prerank,quinone biosynthetic process (GO:1901663),0.3270854994927418,0.7907286209669696,0.7321063394683026,0.9627303356476714,1.0,4/14,11.44%,FDXR;COQ10A;COQ8B;COQ6
prerank,cholesterol transport (GO:0030301),0.2624595055050626,0.7907176582386949,0.7721739130434783,0.9620852207736849,1.0,7/45,10.19%,CEL;ABCA1;LIMA1;LIPC;ABCA5;APOC1;SOAT2
prerank,positive regulation of axon extension (GO:0045773),-0.2749749424791646,-0.7906056068810702,0.7846790890269151,0.9213874735676725,1.0,4/22,11.59%,SEMA7A;SHTN1;VEGFA;DBNL
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.24588984142816447,0.790455985878157,0.8121739130434783,0.9618931894422734,1.0,12/60,16.40%,FGFR4;SMOC2;PDGFRB;ACD;XRCC5;CCT6A;FBXO4;PRKD2;MAPK1;TCP1;PARN;HGF
prerank,regulation of defense response to virus (GO:0050688),0.32858821940101673,0.7902283426705068,0.7280334728033473,0.9616280774261298,1.0,5/14,19.04%,RNF216;ITCH;PCBP2;TRAF3IP1;ILRUN
prerank,regulation of sister chromatid cohesion (GO:0007063),0.33454497369100045,0.7895814532226008,0.7133479212253829,0.9620962791745362,1.0,2/12,9.79%,HDAC8;AXIN2
prerank,nucleic acid metabolic process (GO:0090304),-0.21563394720673412,-0.7886847513169515,0.8878281622911695,0.9238147577315264,1.0,23/69,26.46%,HNRNPK;RBFOX2;HNRNPU;HNRNPA3;HNRNPH2;DDX54;POLR2C;TOPBP1;HNRNPA0;NT5E;POLR2G;GTF2F2;PCBP1;PTBP1;DDX24;METTL3;WDR74;DUSP11;POLR2L;HNRNPF;HNRNPM;HNRNPD;LSM8
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.28246325984284465,0.7883692987463465,0.7524557956777996,0.9634980131203991,1.0,13/30,20.60%,VAMP5;MACF1;KRT18;OPTN;GGA2;BLZF1;GOLPH3L;RAB26;PREPL;BBS1;GOLGA4;BBS2;RAB34
prerank,regulation of cytokine production (GO:0001817),0.21929425984930676,0.7883188342112982,0.864329268292683,0.9629172378215825,1.0,11/126,7.89%,C1QTNF3;LGR4;IGF2BP1;PLA2R1;LTF;ANXA1;CCN4;SYT11;IRF8;IL6;TRIM56
prerank,response to cAMP (GO:0051591),0.2675529174695247,0.7876785256044175,0.7649122807017544,0.9633811087359833,1.0,4/37,5.21%,SLC5A5;DUOX2;CRHBP;AANAT
prerank,histone deacetylation (GO:0016575),0.26425589645660114,0.7866916589957953,0.7863720073664825,0.9644185600467011,1.0,4/43,4.20%,PRDM5;TBL1XR1;MIDEAS;HDAC8
prerank,protein K63-linked deubiquitination (GO:0070536),-0.2576523633024192,-0.7865772909624659,0.802660753880266,0.92656102705306,1.0,10/31,25.91%,ATXN3;OTUD7A;ZRANB1;USP50;OTUD1;USP8;OTUD7B;TNFAIP3;USP33;YOD1
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3223066099728262,-0.7865701181224027,0.7523809523809524,0.9260115891305879,1.0,3/12,13.03%,ELOVL5;FADS2;ELOVL1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.22537133608266546,-0.7864800783114924,0.8496420047732697,0.9255695398725037,1.0,14/54,23.79%,RPL26;SOX4;PLK2;PLAGL1;CHEK2;CNOT6L;CDKN1B;TNKS1BP1;PCBP4;GADD45A;CDKN1A;E2F7;RGCC;BAX
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.300381620572547,0.7859842950193572,0.725609756097561,0.9649606162501951,1.0,5/23,8.68%,CAMK1D;RIPOR2;CCL19;MCU;MOSPD2
prerank,base-excision repair (GO:0006284),-0.22980157301661525,-0.7858213505450822,0.8397129186602871,0.9260027922925578,1.0,23/48,34.76%,SMUG1;RPA1;OGG1;POLQ;NEIL1;NEIL3;POLE;POLD3;POLB;NTHL1;POLD1;HUWE1;XPA;POLL;ERCC5;LIG3;RFC5;NEIL2;RPA3;DNA2;FEN1;RPA2;XRCC1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.23216018774168493,0.7856213093851299,0.8239095315024233,0.9649093228003872,1.0,21/80,18.85%,DENND2A;SNX6;PLEKHJ1;STX16;TMEM87A;RIC1;WASHC1;TMEM87B;VTI1A;SNX12;PHETA1;TRAPPC10;TBC1D17;RAB9A;VPS26A;PREPL;VPS54;VPS35;RHOBTB3;GOSR1;RAB29
prerank,protein-DNA complex assembly (GO:0065004),0.21934906724847963,0.7855637962314188,0.8930232558139535,0.9643530606929835,1.0,24/116,17.37%,TCF4;CDK7;DDB2;DMC1;PSME4;PSMA2;PSMA3;RSF1;KAT6B;PSMD8;SMARCA5;PSMD3;NAP1L3;CUL4B;ORC2;NAA60;MNAT1;RAD23B;ORC3;MCM2;RAD51;NAP1L1;ORC6;XPC
prerank,RNA interference (GO:0016246),-0.2906394726258691,-0.7851312505126034,0.7808219178082192,0.9265018964604386,1.0,7/17,31.95%,CLP1;NRDE2;AGO3;TSN;TSNAX;DROSHA;DHX9
prerank,establishment of protein localization to organelle (GO:0072594),0.23792903056882567,0.7849645120332236,0.803448275862069,0.9647340534517915,1.0,10/72,13.83%,APPL2;IPO13;HK2;PRICKLE1;LAMP2;NUTF2;NUP107;TNPO1;LAMP5;NXT2
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.2983897202473806,-0.7846496918529644,0.7666666666666667,0.9267008976064849,1.0,8/17,28.73%,BCL2L1;CLU;BBC3;TIMM50;BAX;FIS1;BID;SFN
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.27048960583525583,-0.7846332669716711,0.7763440860215054,0.9261690966886674,1.0,8/24,28.53%,TTLL7;VKORC1L1;VKORC1;TTLL8;CEP41;TTLL6;AGTPBP1;TTLL2
prerank,positive regulation of cell communication (GO:0010647),0.28097328983231085,0.7842709248305034,0.753199268738574,0.9652651498947723,1.0,1/28,0.46%,WLS
prerank,UV-damage excision repair (GO:0070914),0.33364586656416895,0.7842198432353613,0.7252747252747253,0.9647005324298699,1.0,4/12,17.37%,DDB2;CUL4B;INO80;XPC
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.28023740051365253,-0.7834367431717236,0.778,0.9268904926112965,1.0,10/21,34.04%,DDB1;RBX1;RPA1;GTF2H2;XPA;ERCC5;ERCC3;GTF2H5;RPA3;RPA2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.28023740051365253,-0.7834367431717236,0.778,0.9268904926112965,1.0,10/21,34.04%,DDB1;RBX1;RPA1;GTF2H2;XPA;ERCC5;ERCC3;GTF2H5;RPA3;RPA2
prerank,protein deacetylation (GO:0006476),-0.23398033161711368,-0.7827568911330334,0.8530066815144766,0.9273541473389207,1.0,14/41,23.55%,FLNA;HDAC5;MORF4L1;RBM14;SIN3B;SIRT4;BRMS1;HDAC11;SIRT7;HDAC7;HDAC9;HDAC6;RCOR3;SIRT6
prerank,cellular response to oxygen levels (GO:0071453),0.3637600264617257,0.782651971085769,0.7204301075268817,0.9667184742068725,1.0,3/10,9.31%,CPEB4;TMEM199;ATP6V0D1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.2712463540739861,0.7822459375842942,0.7644859813084112,0.9667481251087331,1.0,5/33,10.51%,MTURN;STAT5B;ARNT;MED1;PRKDC
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.32471536325167977,-0.7819122814389443,0.7747572815533981,0.9280617425514663,1.0,4/12,20.87%,STMN2;STMN1;TUBB4A;MAPRE1
prerank,negative regulation of nervous system development (GO:0051961),0.30844377663613837,0.7816365508740895,0.7523629489603024,0.9671224889085197,1.0,2/17,6.76%,APPL2;IL6
prerank,import into nucleus (GO:0051170),0.23585299321755074,0.7811622292079947,0.8193979933110368,0.9672410293773025,1.0,17/73,22.00%,APPL2;IPO13;PRICKLE1;NUTF2;SMN1;NUP107;TNPO1;NXT2;RPAIN;IPO9;NUP214;KPNB1;GEMIN5;SNRPF;TSC2;TPR;RANBP17
prerank,microtubule-based transport (GO:0099111),-0.32677183587254904,-0.7806565870712288,0.7587548638132295,0.9294461267741482,1.0,6/12,36.44%,SPAG17;DNAAF2;DYNC1I1;CABYR;CCDC40;DNAAF4
prerank,sulfur compound catabolic process (GO:0044273),0.2711339016977828,0.7804118365858468,0.7741347905282332,0.9678217316133197,1.0,4/38,5.37%,FMOD;OGN;OMD;PRELP
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.3110869262803327,0.7803341855779024,0.7458677685950413,0.9672883989549849,1.0,3/18,6.98%,ANXA1;SSTR2;UBE2L3
prerank,macromolecule catabolic process (GO:0009057),0.2938338388057996,0.7797300233859773,0.779783393501805,0.9676055057228782,1.0,5/26,9.09%,CLPX;NEDD4;TPP1;PIK3R4;UVRAG
prerank,mammary gland development (GO:0030879),0.30305048367345677,0.7785884913408575,0.734251968503937,0.9688437136979056,1.0,5/21,14.39%,WNT4;ARHGAP35;APLN;JAK2;GLI2
prerank,nucleotide metabolic process (GO:0009117),0.293905927023204,0.7781659064639956,0.7263779527559056,0.9688748443424535,1.0,5/23,11.84%,FHIT;CTPS2;NMNAT2;ENPP3;NMNAT1
prerank,cholesterol efflux (GO:0033344),0.30853821887781285,0.7780882688813763,0.7284894837476099,0.9683391820106179,1.0,4/20,10.19%,ABCA1;ABCA5;APOC1;SOAT2
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.1820626447374527,-0.7779476430023711,0.967741935483871,0.9328905717654018,1.0,55/184,26.37%,HSP90AA1;UBB;PKD1;BUB3;RPS27A;UBC;CUL3;PSMD13;PSMF1;DDB1;APPL1;ZFP36L1;PSMB10;YWHAG;TUBB4B;DCTN3;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;TUBA1A;PSME1;ODF2;ANAPC16;NDE1;UBA52;PSMB3;TUBB4A;ID2;CETN2;CDK2;BUB1B;UBE2D1;CKAP5;PSMD5;TFAP4;HAUS6;SKP1;MAPRE1;DCTN1;CEP41;ANAPC7;PSMD9;PSMB4;NEK11;RGCC;HMMR;KIF14;KNTC1;PSMD10;CDC14A;PCM1
prerank,cytoplasmic microtubule organization (GO:0031122),0.24905258736865535,0.7775290918063482,0.8024263431542461,0.9686357333858645,1.0,7/54,9.85%,FIGN;HOOK2;FIGNL2;KATNAL2;DLG1;TUBGCP6;TUBGCP2
prerank,negative regulation of viral process (GO:0048525),-0.2234713688526439,-0.7774337467147571,0.8535353535353535,0.933104137656506,1.0,20/57,24.36%,PPIA;TRIM14;LARP7;ISG15;OAS2;RSAD2;SHFL;SRPK1;TRIM13;IFIH1;FAM111A;N4BP1;BST2;MID2;TRIM27;IFITM3;UBP1;CHMP3;BANF1;STAT1
prerank,nuclear envelope organization (GO:0006998),-0.27638049626264194,-0.7771236244261467,0.7692307692307693,0.9329775715256629,1.0,6/20,20.44%,REEP3;LEMD2;TOR1B;TMEM43;SUN1;CTDNEP1
prerank,protein targeting (GO:0006605),-0.19449284599881117,-0.7768477404726536,0.9382352941176471,0.9328658091989683,1.0,44/118,32.09%,RASSF9;RPL11;FBXO7;TOMM20;ZDHHC14;ZDHHC15;CDC37;GOLGA7;AQP11;CACNG3;ZDHHC2;ZDHHC7;TOMM22;TIMM9;SRPRB;NACA;SEC61G;TIMM10B;TIMM13;BCAP31;ZFAND2B;PEX1;ZDHHC4;TIMM22;TOMM7;MFN2;ZDHHC20;ICMT;SRP14;PEX16;HAP1;RTP4;SEC63;SORL1;FIS1;TIMM44;TSPO;AIP;RABGEF1;TOMM34;ZDHHC18;SPCS3;NACAD;AP4B1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.25245937680187813,-0.7764704864148706,0.8232758620689655,0.9329059437765838,1.0,9/32,20.17%,RPS19;PGLYRP1;DEFA6;GAPDH;RPL30;ROMO1;RNASE3;CCL13;ANG
prerank,regulation of keratinocyte migration (GO:0051547),0.3324123955079912,0.7764319917575385,0.7162698412698413,0.9697909507979162,1.0,3/12,7.48%,MAPRE2;MMP9;PTEN
prerank,regulation of exosomal secretion (GO:1903541),0.30919221570863636,0.7763211025804341,0.7210626185958254,0.9693199598720313,1.0,1/19,1.37%,PRKN
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.3139108830510601,-0.7759323299142346,0.7752808988764045,0.9331502566980595,1.0,4/13,15.17%,APOD;CHP1;RANGAP1;MDFIC
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.2728328030782046,-0.7753907031053051,0.7849462365591398,0.9333769925310788,1.0,6/20,16.43%,YWHAB;MET;RNF157;APLP1;STMN1;BICD1
prerank,apoptotic DNA fragmentation (GO:0006309),0.3201217749981813,0.775333202226233,0.7534246575342466,0.9703106109443057,1.0,4/16,18.67%,CECR2;DICER1;DFFA;KPNB1
prerank,synaptic membrane adhesion (GO:0099560),0.3298116030282685,0.7752237318600078,0.7190775681341719,0.9698228083304331,1.0,3/14,12.62%,GPC6;PTPRD;GPC4
prerank,fatty acid metabolic process (GO:0006631),0.21716561947429863,0.775198206834341,0.8934426229508197,0.9692099612758236,1.0,10/115,8.71%,PPARA;ACADSB;ACSL1;CEL;ACOT4;CPT2;ECHDC3;LIPH;LIPC;AASDH
prerank,protein complex oligomerization (GO:0051259),0.2283389532718161,0.7750025776237763,0.8374792703150912,0.9689034545344458,1.0,17/85,12.71%,UPB1;ALS2;RNF213;IKZF4;NOL3;ARC;BLM;MCU;RNF135;TMEM120B;YME1L1;GSDMD;MICU1;OXA1L;UGDH;PKD2;NINJ1
prerank,tRNA transport (GO:0051031),-0.24371568067571917,-0.7748052186722262,0.8165938864628821,0.933699137357233,1.0,19/35,46.02%,TOMM20;YBX1;SSB;NUP37;NUP54;NUP85;NUP133;POM121;NUP153;NUP42;NOL6;NUP93;NUP35;RAN;SEH1L;NUP160;RAE1;TOMM20L;NUP210
prerank,regulation of cell division (GO:0051302),0.23021543982308498,0.7747316314765563,0.8403508771929824,0.9686985209847868,1.0,20/72,19.42%,FGFR2;PLK5;FGF1;NCOA3;BLM;BIRC6;PIK3R4;UVRAG;FLCN;ZFYVE26;TXNIP;CIB1;MYO19;CSPP1;ORC6;SETD2;KLHL13;RAB11FIP3;PRPF40A;KIF18B
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.24547762398875905,0.7740631187594863,0.8044982698961938,0.9691138058799429,1.0,19/57,21.10%,HUS1B;CDC14B;MRNIP;BLM;CDK1;CLSPN;MDC1;PRKDC;RINT1;MRE11;BABAM2;BRSK1;TAOK3;TRIM39;TAOK2;UIMC1;RAD9B;NBN;STK33
prerank,cellular response to gamma radiation (GO:0071480),-0.2916598838625086,-0.7739683409123919,0.7819253438113949,0.934383466157074,1.0,7/17,25.32%,RPL26;CRYAB;ATR;TLK2;TMEM109;HRAS;TSPYL5
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.33193913427720795,-0.7739254375825588,0.742,0.9333361021900033,1.0,6/10,29.53%,AP2A2;AP2M1;AP2B1;AP2A1;VLDLR;AP2S1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.33193913427720795,-0.7739254375825588,0.742,0.9333361021900033,1.0,6/10,29.53%,AP2A2;AP2M1;AP2B1;AP2A1;VLDLR;AP2S1
prerank,regulation of leukocyte activation (GO:0002694),-0.3095586140155192,-0.7731558243362598,0.776937618147448,0.9339789918612094,1.0,5/14,16.76%,CD200;GPR137B;GPER1;CD74;MIF
prerank,protein localization to nucleus (GO:0034504),-0.19749805183700292,-0.772942708145794,0.9452054794520548,0.9337347391363247,1.0,29/102,21.43%,RPL11;PINX1;CALR;SIX1;HNRNPU;ZBTB7A;PPP1R10;APPL1;TOR1B;ARL2BP;BCL3;STAT3;HHEX;LMNA;COL1A1;SIX4;E2F3;NXT1;HEATR3;CSE1L;NUP85;FAM53C;NOP53;AKT1;SKP1;CTDNEP1;NUP133;BMP4;POM121
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.2530664440506337,0.7728173291156806,0.8006932409012132,0.970509543783713,1.0,8/45,12.19%,NCAM1;SP100;TRIM5;IRF8;CAMK2D;IRF3;JAK2;TRIM26
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.2509109011627567,-0.7727575851320043,0.8100686498855835,0.9334444314721192,1.0,13/33,31.30%,CPSF7;CPSF3;SYMPK;CLP1;CPSF2;CSTF2T;PCF11;CSTF2;MAZ;SNRPG;LSM11;CSTF1;CPSF1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.3182563823324256,-0.7726375660234238,0.7786561264822134,0.9330995490401474,1.0,9/12,54.32%,SLC11A1;CCR2;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,regulation of cytokinesis (GO:0032465),-0.21197651369330725,-0.7717682076230156,0.88,0.9338012308375162,1.0,16/78,17.98%,PKP4;CALM1;SH3GLB1;CIT;PLK2;BCL2L1;CUL3;RHOA;GIT1;PIK3C3;KIF13A;CALM2;PRKCE;KLHL9;ENTR1;CETN2
prerank,lymphocyte chemotaxis (GO:0048247),-0.2432330085996613,-0.7717226652393481,0.8095238095238095,0.933329654046309,1.0,2/34,2.15%,SLC12A2;GAS6
prerank,regulation of embryonic development (GO:0045995),0.26535544218701707,0.7713028952573663,0.779385171790235,0.9723759387368077,1.0,7/34,11.91%,PLCB1;PHLDB2;NIBAN2;WDPCP;CDK1;CCSAP;RBM19
prerank,DNA damage checkpoint signaling (GO:0000077),-0.253155132330211,-0.7710398996236422,0.804932735426009,0.9337912660973656,1.0,9/28,24.74%,TIPRL;CHEK2;DONSON;RAD17;USP28;RAD9A;ATR;DOT1L;CHEK1
prerank,ubiquinone metabolic process (GO:0006743),0.3128710079768039,0.7710391400011617,0.7443762781186094,0.9721370069247821,1.0,4/15,11.44%,FDXR;COQ10A;COQ8B;COQ6
prerank,regulation of complement activation (GO:0030449),0.25699519848492,0.7709446876551296,0.7938144329896907,0.9716427068913526,1.0,6/40,11.25%,PROS1;C2;CFH;VTN;C8B;C8G
prerank,negative regulation of T cell activation (GO:0050868),-0.24852741300738773,-0.7702696956261047,0.8022988505747126,0.934375772453282,1.0,15/35,33.28%,TNFRSF21;CEACAM1;DUSP3;LAPTM5;CD274;JAK3;NCKAP1L;SDC4;FCGR2B;CEBPB;CD80;LAX1;IL4I1;PTPN22;GPNMB
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.3276586576525109,-0.7702008175457344,0.7625482625482626,0.9339231650100415,1.0,5/11,30.96%,LARP7;FBL;EXOSC10;EXOSC5;TENT4B
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.29344816247499717,0.7700258694240061,0.7378048780487805,0.972486141117096,1.0,3/22,5.10%,FANCA;DUSP10;CTLA4
prerank,aspartate family amino acid metabolic process (GO:0009066),0.3109584645649543,0.7698022155310578,0.7278225806451613,0.9722045541143763,1.0,2/18,5.55%,MSRA;MTHFR
prerank,innate immune response in mucosa (GO:0002227),0.3456667129413577,0.7693522559298913,0.7330508474576272,0.9722658006926836,1.0,1/10,2.73%,LTF
prerank,glycerol metabolic process (GO:0006071),-0.33444666529483513,-0.7684543886751961,0.7745454545454545,0.935886222729125,1.0,3/10,18.35%,TPI1;PGP;COQ2
prerank,lipoprotein biosynthetic process (GO:0042158),0.34135895651507553,0.7682313838814608,0.7358490566037735,0.9734226910781785,1.0,2/11,5.75%,ATG10;WIPI1
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.20375190622388129,-0.7678889100276124,0.9187817258883249,0.9361317355002073,1.0,25/80,26.17%,CAV1;UBE3A;UBB;FAM107A;CUL3;RPS2;BIRC3;DERL1;RBX1;NDFIP2;DCUN1D1;DCUN1D2;WFS1;LAPTM5;SPRTN;UBE2D1;PINK1;NDFIP1;TRIB3;HUWE1;SPSB4;ARRDC3;PTTG1IP;TSPYL5;PSMD10
prerank,hexose transmembrane transport (GO:0008645),0.2952549803929351,0.7678840030517617,0.7315175097276264,0.9733190011574129,1.0,3/21,6.09%,SLC2A12;SLC45A3;SLC2A10
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.29026927084791754,0.7678372889805984,0.7722772277227723,0.9727375827369247,1.0,6/22,16.37%,PHF8;LYAR;RASL11A;ERBB2;SMARCB1;NOL11
prerank,non-motile cilium assembly (GO:1905515),0.2712539784061451,0.7677575298653176,0.7647058823529411,0.9722125568010919,1.0,6/30,11.24%,TTC8;TBC1D32;ARL13A;RPGRIP1L;CEP89;IFT122
prerank,Golgi organization (GO:0007030),0.2191699705422372,0.7677516665113733,0.8740279937791602,0.9715692293638322,1.0,19/112,11.12%,TANGO2;OBSL1;DYNC2H1;PLK5;LRRK2;RAB30;FAM174B;MYO18A;OPTN;STX16;UBXN2B;DYM;BLZF1;CDK1;CUL7;TRAPPC8;GOLGA2;TJAP1;VTI1A
prerank,superoxide metabolic process (GO:0006801),0.2803998112762093,0.7677384204038817,0.7763636363636364,0.9709436662101988,1.0,4/29,4.41%,SOD3;DUOX2;TAFA4;SH3PXD2B
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.19379862924468008,-0.7677040495062413,0.9415041782729805,0.9358152131971728,1.0,35/117,28.60%,PLCG2;RAMP2;FYN;ADCY4;PLK2;RHBDF2;MYH9;RAMP1;ADCY7;PTHLH;CYSLTR1;ADCY3;FURIN;CYSLTR2;ADRB2;PRKAR1A;CD81;IAPP;CALCRL;VIPR2;MC5R;YES1;GPR27;HRH2;TSHR;GGT1;GLP2R;NPSR1;ADCYAP1;GNB1;TREM2;GPR20;KARS1;CALCA;CD163
prerank,regulation of protein targeting to membrane (GO:0090313),-0.253135555781872,-0.767661592908002,0.8427947598253275,0.9353266257653375,1.0,9/28,19.90%,FYN;KCNB1;CHP1;C2CD5;MIEF1;MIEF2;MTCL1;GDI1;ANK3
prerank,response to leucine (GO:0043201),-0.33440671395107746,-0.7674663422792013,0.7541899441340782,0.9344997489304694,1.0,3/10,9.55%,SESN3;MTOR;SESN2
prerank,cellular response to leucine (GO:0071233),-0.33440671395107746,-0.7674663422792013,0.7541899441340782,0.9344997489304694,1.0,3/10,9.55%,SESN3;MTOR;SESN2
prerank,regulation of type I interferon production (GO:0032479),0.22794995227930026,0.7672209361523233,0.8664546899841018,0.9711587018350238,1.0,21/84,14.28%,IRF8;XRCC5;POLR3GL;POLR3G;TRIM56;RNF135;RNF216;ITCH;IRF3;UBA7;PRKDC;PCBP2;IKBKE;CYLD;TBK1;ZBP1;MRE11;DDX41;POLR3C;CREBBP;NLRX1
prerank,negative regulation of DNA recombination (GO:0045910),0.25050355194075163,0.7670057650018418,0.7992565055762082,0.9708640214742575,1.0,7/43,13.59%,POLR2D;ACD;BLM;POLR2A;RTEL1;KLHL15;FANCB
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.3255595089965465,0.766496780381048,0.7436440677966102,0.9709830300846813,1.0,1/15,1.27%,STXBP4
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.2418666068953949,0.7664961602787232,0.8293918918918919,0.970336650023462,1.0,3/55,2.95%,PID1;PRKN;PDGFRB
prerank,photoreceptor cell development (GO:0042461),0.32591549069510706,0.7659952018231706,0.7452631578947368,0.9704702916834227,1.0,2/14,4.11%,TULP1;ARL3
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.2865350563183565,0.7657142766375853,0.7723132969034608,0.9702466029685799,1.0,5/23,18.67%,CECR2;DICER1;DFFA;REXO4;KPNB1
prerank,protein localization to synapse (GO:0035418),-0.319759898874043,-0.7656517023657401,0.7624750499001997,0.936519912190117,1.0,4/12,13.54%,ZDHHC15;NRXN1;PCLO;BSN
prerank,snRNA metabolic process (GO:0016073),-0.2838362250835619,-0.7653916208123811,0.8238866396761133,0.9363643068996567,1.0,6/17,23.40%,MEPCE;INTS11;INTS6;INTS1;MTREX;INTS3
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.31652474249357093,0.7650031842914051,0.7400793650793651,0.970678155951391,1.0,4/15,16.97%,NLGN2;ZDHHC3;USP46;DRD2
prerank,recombinational repair (GO:0000725),0.2275215613552823,0.7646747410188413,0.8544,0.9705464979492315,1.0,16/77,16.10%,RAD51B;RAD51AP2;RNF138;HUS1B;RAD51C;BLM;HELQ;AUNIP;BRCA2;ZSWIM7;ZFYVE26;INO80;MRE11;WRN;SWI5;RAD51
prerank,dorsal/ventral pattern formation (GO:0009953),-0.2787450480745165,-0.7645952759951298,0.8153526970954357,0.9369576392724172,1.0,5/20,19.22%,ACVRL1;PTCH1;ACVR1;GREM1;DSCAML1
prerank,selective autophagy (GO:0061912),-0.21600511805040506,-0.7645509220972391,0.8957816377171216,0.9364753509757267,1.0,23/56,35.20%,VIM;UBB;DYNLL2;RPS27A;UBC;MAP1LC3B;WDFY3;CFTR;UBA52;AUP1;PEX5;HDAC6;RAB7A;ULK2;KLHL3;STBD1;DYNC1I1;DYNC1H1;ACBD5;PARK7;PCNT;UFC1;DYNLL1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.3022757273608398,-0.7645362681129102,0.7818181818181819,0.9359529915353313,1.0,13/15,49.81%,CD55;NKAP;CCR2;SHH;SYK;IL12A;IL23A;EBI3;IHH;IL23R;PNP;HSPH1;IL12B
prerank,protein polyglutamylation (GO:0018095),-0.3233748468619355,-0.7640180934987587,0.7736549165120594,0.9361347909442647,1.0,4/11,28.53%,TTLL7;CEP41;TTLL6;TTLL2
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.33113317210634785,0.7635589044894213,0.7268518518518519,0.9716439506648769,1.0,4/11,15.91%,ADM;GRK3;ADRB3;GRK2
prerank,negative regulation of DNA replication (GO:0008156),-0.30749977105527976,-0.7631949511295154,0.7813121272365805,0.936692166155876,1.0,6/13,33.17%,RAD17;S100A11;ATR;GMNC;GMNN;CDC6
prerank,histone acetylation (GO:0016573),-0.20828923262884402,-0.7631245456523148,0.9040404040404041,0.9362504238454127,1.0,13/69,17.31%,LEF1;MORF4L1;APBB1;ING4;MRGBP;YEATS2;NAA40;BRPF1;KAT14;JADE1;RUVBL1;PER1;WDR5
prerank,autophagosome assembly (GO:0000045),0.24581311535177314,0.7629785080064271,0.8486842105263158,0.97191660094489,1.0,14/52,17.14%,TP53INP2;RAB19;WIPI1;UBXN2B;ATG14;TRAPPC8;ATG9A;STX17;RAB43;AMBRA1;ATG3;RUFY4;IRGM;ATG16L2
prerank,regulation of B cell differentiation (GO:0045577),-0.28430416317731777,-0.7628184511928017,0.805668016194332,0.936119156482175,1.0,6/17,20.80%,ZFP36L1;XBP1;ID2;INHA;PPP2R3C;NCKAP1L
prerank,regulation of axon guidance (GO:1902667),-0.3342294914271021,-0.762629111293497,0.768642447418738,0.9358704068985643,1.0,4/10,24.83%,VEGFA;ZSWIM6;ZSWIM8;TUBB2B
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.3156348424807619,0.7626081618557597,0.7594142259414226,0.9718299269214199,1.0,1/14,0.72%,IL34
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.30605520805350356,0.7625436096552709,0.7755102040816326,0.9712918194023705,1.0,4/18,12.36%,PDPK1;IGF2;APLN;COL4A3
prerank,mRNA stabilization (GO:0048255),-0.23292188657709795,-0.7623796086459318,0.8577777777777778,0.9356519937114045,1.0,12/40,22.30%,TARDBP;PABPC1;YBX3;HNRNPU;YBX1;FUS;TENT5A;HNRNPA0;TIRAP;MYD88;SLC11A1;RBM24
prerank,regulation of lymphocyte differentiation (GO:0045619),0.3009929378483087,0.7611206725473716,0.7761806981519507,0.9728030005791224,1.0,3/18,10.51%,SLAMF8;ABL1;PRKDC
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.23836711937633398,0.7606009043958942,0.8375634517766497,0.97294975912267,1.0,17/58,21.10%,XRCC5;XRCC4;KDM2A;UVRAG;POLM;MDC1;NHEJ1;PRKDC;DCLRE1A;DCLRE1B;MRE11;BABAM2;IFFO1;UIMC1;KAT5;RAD50;NBN
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.26823255453510897,0.7605994014951616,0.8036697247706422,0.9723085806187826,1.0,4/30,5.81%,ACSL1;HACD1;ACOT4;HACD3
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.2218638387346221,-0.7602949904603782,0.8954869358669834,0.9380455637622195,1.0,12/47,18.27%,TGFB2;DAB2IP;MID1;PPIA;PDCD10;FOXO1;STK25;EPHB1;FAS;PER1;MAP2K2;GREM1
prerank,regulation of multicellular organismal development (GO:2000026),-0.26320467345131904,-0.7598891127918543,0.8187633262260128,0.9380668641122224,1.0,10/25,25.06%,SOX17;BAG6;SPAAR;OAS2;MYSM1;INSR;HPSE;GBX1;DUSP6;RAB14
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3444511708354836,0.7594292829856806,0.7543103448275862,0.9734726475611615,1.0,1/11,2.18%,BCL2
prerank,positive regulation of transporter activity (GO:0032411),0.32617547458829454,0.7589159492884994,0.732776617954071,0.9736121057627726,1.0,1/13,1.68%,KMT2A
prerank,cellular response to interferon-gamma (GO:0071346),0.21741243871195698,0.7581394177838103,0.8673780487804879,0.9741802589345603,1.0,12/88,12.19%,DAPK1;NCAM1;SP100;TRIM5;IRF8;CCL19;CAMK2D;SIRPA;IRF3;CCL4;JAK2;TRIM26
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.2572814719236347,-0.7577251729497173,0.831858407079646,0.9404881707161271,1.0,8/25,29.16%,HNRNPU;LARP7;NELFCD;NELFE;RNF168;EAPP;EAF2;RNF8
prerank,protein sumoylation (GO:0016925),0.24603388861623043,0.7575581233983976,0.8351063829787234,0.9744317280218624,1.0,4/49,10.15%,EYA1;NDC1;PIAS1;NUP107
prerank,cranial nerve development (GO:0021545),0.3304877283284162,0.7574143398556387,0.7333333333333333,0.9740126952399422,1.0,11/11,66.97%,SALL1;TFAP2A;CHRNB2;ATOH7;CHD7;ERBB3;ISL1;TIFAB;POU4F1;PAX2;TMEM126A
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.2417958131184831,-0.7569861517902768,0.8771929824561403,0.9409191934101636,1.0,10/31,23.34%,KLF4;FHL1;FAM107A;APC;CDK6;JADE1;CDK2AP2;CDKN1A;CDKN2D;E2F7
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.3493474003912306,0.756980117683841,0.7462365591397849,0.9740311755067118,1.0,4/10,16.75%,STAT5B;JAK2;LYN;GHR
prerank,positive regulation of protein deacetylation (GO:0090312),-0.2992815421621635,-0.7559754746417989,0.808,0.9417287363008244,1.0,4/14,17.35%,APLNR;AKAP8;BRMS1;CTBP1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.2697820927382332,0.7558407894160559,0.8067542213883677,0.9750925270081776,1.0,8/31,19.99%,HSD17B1;FDXR;MOCS2;MOCS1;DHRS11;MOCS3;FDFT1;ALOX5
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.2895099486041124,-0.754982557161826,0.8062622309197651,0.9424553252348831,1.0,10/16,45.47%,CLU;CYP51A1;IFNGR1;TREM2;HMGCR;ABCA7;LRP1;IL4;TNF;LRPAP1
prerank,peptidyl-lysine modification (GO:0018205),0.21731642346193122,0.7549207100065569,0.8953125,0.9758766180929223,1.0,8/99,10.15%,EYA1;LOXL1;LOXL3;SENP7;NDC1;PIAS1;EEF1AKMT1;NUP107
prerank,response to peptide (GO:1901652),0.26684896837151867,0.754908591515574,0.8038528896672504,0.9752557311771811,1.0,4/33,7.32%,ANXA1;MMP2;STAT5B;MMP9
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.21935611492408577,-0.7546107681525935,0.8708920187793427,0.9423829229537577,1.0,19/49,27.99%,GSK3B;CRYAB;HSPA5;CLU;SVIP;NLRP2B;IAPP;RPL13A;RAF1;PPM1A;NOP53;PEX5;JAM3;HDAC6;SORL1;KIF14;THRA;TREM2;TFIP11
prerank,regulation of viral transcription (GO:0046782),-0.2338951080548251,-0.7545592882574719,0.8680851063829788,0.941902989699969,1.0,13/39,20.74%,TRIM14;LARP7;POLR2C;NELFCD;TRIM13;MDFIC;POLR2G;GTF2F2;NELFE;MID2;TRIM27;IFITM3;UBP1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.30143384843499826,0.7545143613907328,0.7545638945233266,0.9752139699015253,1.0,3/17,8.14%,ALG6;ALG2;ALG9
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.22737766291968287,-0.7537423036036162,0.8752997601918465,0.9424651257348121,1.0,16/48,30.53%,PDE4D;SLC7A5;IL1R1;CYRIB;ISG15;HSPD1;TRIM27;TXK;SLC11A1;CCR2;IL12RB2;TLR7;TLR4;RASGRP1;FADD;ZFPM1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.22874035715603153,0.7532913511577373,0.8550247116968699,0.9764248357846521,1.0,14/62,16.12%,KMT2A;MEIS1;ASH2L;TNRC6B;TNRC6A;PRKCB;SETD1A;HDAC1;KMT2B;CDC73;CREBBP;MEIS2;MOV10;LYN
prerank,lipid droplet organization (GO:0034389),-0.2652793400774387,-0.7522959468834954,0.8223684210526315,0.9438077714954539,1.0,4/22,17.36%,PPIA;CDS1;BSCL2;AUP1
prerank,regulation of myelination (GO:0031641),0.2791605457312094,0.7520786181608804,0.7844990548204159,0.9776424109778812,1.0,6/25,13.79%,PARD3;ITGAX;PTN;CST7;TMEM98;DICER1
prerank,negative regulation of protein catabolic process (GO:0042177),0.25398868955604065,0.75169638537562,0.8378378378378378,0.9775962010207071,1.0,7/40,12.53%,TIMP3;AZIN2;BANP;ATRAID;RIC1;PTPN3;SNX12
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3508319212392924,0.7508807799144276,0.7354166666666667,0.9781700706130463,1.0,2/10,8.77%,PXYLP1;XYLT2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.3192886397589567,-0.7505538631842043,0.7881188118811882,0.9454850202133978,1.0,5/11,24.02%,UAP1L1;UAP1;GNPDA1;AMDHD2;GNPDA2
prerank,negative regulation of cell division (GO:0051782),0.3294262504381989,0.7502917703314341,0.7484276729559748,0.9783940265438158,1.0,3/11,17.17%,BLM;TXNIP;ORC6
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.33237545528570056,0.7502519729851378,0.7682926829268293,0.9771755580566125,1.0,2/11,7.48%,SYNJ2;PTEN
prerank,inositol phosphate dephosphorylation (GO:0046855),0.33237545528570056,0.7502519729851378,0.7682926829268293,0.9771755580566125,1.0,2/11,7.48%,SYNJ2;PTEN
prerank,antibacterial humoral response (GO:0019731),0.2961643049056794,0.7498233743644117,0.7773512476007678,0.9771693776780155,1.0,1/16,2.73%,LTF
prerank,acute-phase response (GO:0006953),-0.3064183543454468,-0.7497394963568457,0.7794970986460348,0.945988961137455,1.0,4/12,29.77%,LBP;SIGIRR;CEBPB;AHSG
prerank,regulation of DNA replication (GO:0006275),-0.22180902102113698,-0.7494283232722274,0.8878048780487805,0.9458512319640112,1.0,10/49,18.58%,BCAR3;ACVRL1;CCDC88A;FAF1;USP37;GLI1;RAD17;EHMT2;S100A11;ATR
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.2951609221121016,-0.7489199332905035,0.7790927021696252,0.9459481801418288,1.0,8/13,29.56%,STX3;HSP90AB1;TMEM35A;TYROBP;MAP1A;TM9SF4;ABCA7;RANGRF
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.275664500275491,0.7488708260715794,0.8136882129277566,0.9779169525156578,1.0,7/26,13.72%,DAB2;KANK2;STRN3;HDAC1;CRY1;CNOT2;CLOCK
prerank,positive regulation of protein import (GO:1904591),-0.24931064825409702,-0.7487005301196351,0.8471337579617835,0.9456889118310033,1.0,11/30,24.55%,CDH1;FLNA;TGFB1;ARHGEF5;JUP;ZC3H12A;PSEN1;PRKCD;RBM22;HYAL2;ZPR1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.27706168059445774,-0.7483143502133891,0.8253968253968254,0.9456370119391195,1.0,4/18,12.72%,RAP1A;GSK3B;SLC4A8;VPS18
prerank,regulation of cellular response to stress (GO:0080135),0.20860980253594713,0.7471386631736242,0.9210950080515298,0.9798639192762623,1.0,19/115,14.11%,ROCK2;PRKN;CRHBP;NDC1;NEK4;AMFR;CAMK2D;NUPR1;HSPA1L;NUP107;ABL1;MLST8;AKT1S1;NPAS2;MAPKAPK2;SLC38A2;HSF1;MAPK1;CREBBP
prerank,protein-DNA complex disassembly (GO:0032986),-0.28407093789853144,-0.7469177247759133,0.80078125,0.9468404373384486,1.0,3/16,10.76%,RPL23;SET;SMARCD1
prerank,cellular response to UV (GO:0034644),-0.19930637378754382,-0.7464446286782502,0.9575,0.9468952217783365,1.0,25/76,28.21%,RPL26;CRIP1;DDB1;ATF4;MFAP4;COPS9;CARD16;POLK;USP28;N4BP1;ATR;PRKCD;NOC2L;MMP1;METTL3;FMR1;CDKN1A;BMF;POLD1;HYAL2;CHEK1;XPA;TIMP1;OPN3;TMEM161A
prerank,negative regulation of receptor internalization (GO:0002091),-0.30596298086288576,-0.7463817389777081,0.8019417475728156,0.9464241303801193,1.0,7/12,40.90%,RIN3;ANKRD13A;ANKRD13B;ATXN2;WDR54;ANKRD13D;NECAB2
prerank,positive regulation of chromatin organization (GO:1905269),-0.30861243080968515,-0.7462327146134999,0.7861271676300579,0.9460633343475314,1.0,3/12,14.48%,H3-3A;TAL1;TERF2IP
prerank,inositol phosphate catabolic process (GO:0071545),-0.30121414539828834,-0.7458554263097181,0.79296875,0.9460016897469589,1.0,2/12,5.66%,SYNJ1;NUDT3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.25303502771292535,-0.7454250563034333,0.8364389233954451,0.9459659100656188,1.0,13/25,36.88%,TNFSF10;GPER1;BBC3;PLAUR;PINK1;BIK;BMF;BAX;BID;PMAIP1;HRK;DNM1L;BAD
prerank,RNA stabilization (GO:0043489),0.2613506348520363,0.7451449748025555,0.833941605839416,0.982120174194058,1.0,7/33,16.41%,PHAX;TRDMT1;AXIN2;TENT2;GDNF;PARN;LARP1
prerank,RNA splicing (GO:0008380),-0.19084089785469696,-0.7446227051371095,0.9543010752688172,0.9464489681455031,1.0,15/95,14.31%,MBNL1;PPARGC1A;TARDBP;IVNS1ABP;SRSF2;SF3B1;SF3B2;SFPQ;DDX39B;USP39;RBM8A;PRPF18;RNPS1;SRPK1;FUS
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.18798369936978782,-0.7445493965933666,0.946927374301676,0.9460007504413639,1.0,34/116,28.60%,PLCG2;RAMP2;FYN;ADCY4;PLK2;RHBDF2;MYH9;RAMP1;ADCY7;PTHLH;CYSLTR1;ADCY3;FURIN;CYSLTR2;ADRB2;PRKAR1A;IAPP;CALCRL;VIPR2;MC5R;YES1;GPR27;HRH2;TSHR;GGT1;FCGR2B;GLP2R;NPSR1;ADCYAP1;GNB1;TREM2;GPR20;CALCA;CD163
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.3284060118406672,0.7444939167733109,0.7533980582524272,0.9824548098766418,1.0,4/12,13.27%,APOC4;APOC1;SOAT2;P4HB
prerank,regulation of gene silencing by RNA (GO:0060966),0.2376329576076641,0.7440407859017791,0.8724954462659381,0.9818690547825254,1.0,6/50,10.17%,POLR2D;TNRC6A;NDC1;POLR2A;NUP107;AGO2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2376329576076641,0.7440407859017791,0.8724954462659381,0.9818690547825254,1.0,6/50,10.17%,POLR2D;TNRC6A;NDC1;POLR2A;NUP107;AGO2
prerank,amino sugar biosynthetic process (GO:0046349),-0.3061485960499999,-0.7439476304193684,0.7925636007827789,0.9462077169927494,1.0,6/12,28.69%,UAP1L1;UAP1;GNPDA1;AMDHD2;GNPDA2;NANP
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.25889267631312135,0.7435929641582466,0.8267419962335216,0.9818821846681928,1.0,4/33,7.99%,IL34;ACIN1;PRKCA;CSF1
prerank,sulfate transport (GO:0008272),0.31380486353892423,0.7434314494050799,0.7813121272365805,0.981471669101091,1.0,3/14,10.43%,SLC13A4;SLC25A11;SLC13A1
prerank,phospholipid metabolic process (GO:0006644),0.22532169089474186,0.7432727078890213,0.8573943661971831,0.9810657982783577,1.0,3/71,2.68%,AGPAT4;PLPP3;PLA2G10
prerank,response to interferon-gamma (GO:0034341),-0.20485764791178485,-0.7431305835506735,0.9325,0.9466595617779741,1.0,18/67,22.39%,GCH1;GBP4;GAPDH;AQP4;GBP5;SLC26A6;CD74;SHFL;GBP3;CD47;RPL13A;CD40;CCL13;BST2;IFITM3;SLC11A1;CASP1;CIITA
prerank,icosanoid metabolic process (GO:0006690),-0.2245579511801924,-0.7430931835038707,0.8811659192825112,0.9461547727860853,1.0,8/40,15.18%,MGLL;GPX4;PTGIS;PTGS2;PON2;ALOX12;PLA2G4A;CYP1B1
prerank,spindle assembly (GO:0051225),-0.20678654017075077,-0.7429882284508901,0.9258373205741627,0.9457598094377868,1.0,18/67,23.33%,NEK7;STARD9;RPS3;SMC1A;FLNA;CHEK2;RHOA;ARHGEF10;MZT1;TOGARAM1;WRAP73;KIF3B;KIF11;HAUS6;MAPRE1;NUMA1;KIFC1;CLASP2
prerank,protein ADP-ribosylation (GO:0006471),0.27442718036400354,0.7422745456347382,0.8104448742746615,0.9818475360099619,1.0,12/28,25.62%,PARP4;PARP10;PARP12;PARP9;SIRT3;ARF4;TIPARP;PARP14;SIRT5;TNKS2;ART4;PARP2
prerank,glutathione metabolic process (GO:0006749),0.25483328137295236,0.7420139406399037,0.8247787610619469,0.9815727181483361,1.0,3/38,5.01%,GSTM2;GSTT4;GSTT1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3010144497864961,0.7413965200529947,0.7996146435452793,0.981811033270921,1.0,6/16,21.84%,PDS5B;MAU2;PDS5A;NIPBL;DSCC1;NAA50
prerank,regulation of immune effector process (GO:0002697),0.2457815589389456,0.7413762292291832,0.8497409326424871,0.9812004334929091,1.0,6/41,11.25%,PROS1;C2;CFH;VTN;C8B;C8G
prerank,leukotriene metabolic process (GO:0006691),-0.2713370821637897,-0.7411585542041775,0.8183716075156576,0.9474834091375383,1.0,10/19,37.39%,ALOX12;PLA2G4A;GGT1;LTA4H;PLA2G5;ALOX5AP;MGST2;DPEP1;ABCC1;GGT5
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.28136214607392374,0.7406482165594889,0.8316633266533067,0.9815732927621994,1.0,2/21,5.48%,PRKN;LRRK2
prerank,gene silencing by miRNA (GO:0035195),0.2606766288143261,0.7404932748298882,0.8354661791590493,0.9811467095022536,1.0,11/32,21.37%,ZC3H7B;TNRC6B;TNRC6A;AGO2;DICER1;MOV10;CNOT8;CNOT7;RBM4;XPO5;AGO1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.321305472245479,-0.7401238860011315,0.8131021194605009,0.9481947202397227,1.0,4/10,22.59%,MFSD2A;MTMR9;ABCA3;MTMR1
prerank,nuclear pore complex assembly (GO:0051292),0.33556742334818557,0.7393200970782726,0.7866108786610879,0.9821503914686317,1.0,2/10,10.15%,NDC1;NUP107
prerank,regulation of leukocyte migration (GO:0002685),0.31084741321257514,0.739129187468576,0.7943548387096774,0.9817859049771508,1.0,3/16,8.41%,ANXA1;HOXA7;MIA3
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.24296898187500068,-0.7390694228674791,0.8568548387096774,0.9489988719620163,1.0,14/29,36.05%,LPCAT3;TMEM86B;LPCAT1;NR1H2;PLA2G4A;NR1H3;PLA2G4F;DBI;PLA2G5;MBOAT2;LPCAT4;PLBD1;PLAAT3;PLB1
prerank,regulation of neuroblast proliferation (GO:1902692),0.30726125504638147,0.7390459149402034,0.7799564270152506,0.9812689468446468,1.0,6/15,16.97%,LRRK2;PTN;DCT;CX3CL1;SMARCD3;DRD2
prerank,intracellular sterol transport (GO:0032366),0.3190163120755525,0.7390247342995999,0.7440860215053764,0.9806727349542691,1.0,6/13,26.47%,ABCA1;SERAC1;RELCH;ARV1;OSBP;VPS4A
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.29740387080176817,-0.7387448984177499,0.8148854961832062,0.94887117487939,1.0,8/13,44.25%,NUP54;KPNA4;KPNA3;RGPD1;KPNA2;NUP35;KPNA1;KPNA7
prerank,regulation of neutrophil migration (GO:1902622),-0.32408366459226307,-0.738340393995558,0.7953216374269005,0.9487980894927337,1.0,4/10,20.80%,RAC1;RHOG;JAM3;NCKAP1L
prerank,protein import (GO:0017038),0.215454485453603,0.7382256157220021,0.9106239460370995,0.9811325220589134,1.0,11/84,13.83%,APPL2;IPO13;PXMP2;PRICKLE1;SNX33;LAMP2;NUTF2;NUP107;PXMP4;TNPO1;NXT2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.25850105836863174,0.7381120439556695,0.8043875685557587,0.9806729196146643,1.0,10/33,16.35%,PLK5;DLG1;KANK2;PTEN;RBL2;MYO16;CDC73;PKD2;CDK4;CDKN2B
prerank,DNA catabolic process (GO:0006308),0.32565438453329987,0.7380167065624583,0.7795275590551181,0.9801702421190488,1.0,11/11,67.46%,REXO4;DFFB;MUS81;DNASE1L3;SETMAR;DNASE1L2;DNASE1;FBH1;XRN2;DNASE1L1;ISG20
prerank,mitotic spindle assembly (GO:0090307),-0.22488518466503693,-0.7379550794330476,0.8971553610503282,0.9487020338190221,1.0,17/42,29.89%,SMC1A;FLNA;CHEK2;RHOA;ARHGEF10;MZT1;TOGARAM1;WRAP73;KIF3B;KIF11;KIFC1;CLASP2;KIF4A;KIFC2;SMC3;KIF23;ABRAXAS2
prerank,defense response to symbiont (GO:0140546),0.21437067048255298,0.7376002502492369,0.9271844660194175,0.980131382252256,1.0,9/92,7.89%,BCL2;PLA2G10;IFIT3;IFIT2;RNASEL;TRIM5;BNIP3;IL6;TRIM56
prerank,histone deubiquitination (GO:0016578),0.2955431447578246,0.7373376946425988,0.8026030368763557,0.9798780006699341,1.0,5/18,21.27%,EPOP;USP7;TRRAP;UIMC1;USP21
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3236496375247111,-0.7373160743141794,0.792156862745098,0.9489529836431316,1.0,2/10,7.67%,DNAJA1;PDCD4
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.2381857808923145,-0.7370888212727607,0.8612836438923396,0.9486931961379946,1.0,12/31,33.97%,PLCG2;HSPD1;LAPTM5;CD40;IRF5;TIRAP;MAPK11;AGER;TLR4;IL16;MDK;SYK
prerank,striated muscle cell differentiation (GO:0051146),0.3082127744665345,0.7361971365951898,0.7952586206896551,0.9808615706422342,1.0,4/16,8.94%,CBY1;AKAP13;SIK1;KDM6B
prerank,cellular response to chemokine (GO:1990869),0.2415627231814832,0.7360888523737543,0.8445229681978799,0.9803809732750753,1.0,3/46,3.63%,OXSR1;CXCL13;RIPOR2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.29161753654021516,-0.7360428256425593,0.8087954110898662,0.9494175801683802,1.0,10/13,34.93%,HES1;PTPRC;JAK3;MGAT5;DOT1L;CRLF2;PTPRT;EGF;TSLP;IL7R
prerank,regulation of regulated secretory pathway (GO:1903305),0.25846930412631625,0.7356579967287047,0.8348457350272233,0.9803113180652729,1.0,4/34,5.48%,DTNBP1;SYT11;SYT12;LRRK2
prerank,neuromuscular synaptic transmission (GO:0007274),0.293942705454325,0.7354703475118288,0.7921810699588477,0.9799476926204239,1.0,5/18,16.98%,DTNA;FCHSD2;SLC5A7;CHRNB2;ERC2
prerank,copper ion transport (GO:0006825),-0.31341242154564664,-0.7351706377068309,0.8186714542190305,0.9499366770828488,1.0,2/11,6.52%,ATOX1;SLC31A1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.25731579401478644,-0.735002910869401,0.8384615384615385,0.949588651021212,1.0,14/23,44.96%,PLK2;BUB1B;INTS3;CHEK1;CHMP4C;ZWINT;CDK5RAP3;BUB1;PLK3;WEE2;NABP1;AURKB;ZW10;PRCC
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.2992979432859727,-0.7347987105155108,0.8227091633466136,0.9493233507069783,1.0,6/13,35.30%,PRR5L;ZC3H12A;GTPBP1;ZC3HAV1;CNOT1;RC3H1
prerank,positive regulation of lipid storage (GO:0010884),-0.2647299307815615,-0.7345867693222976,0.8199566160520607,0.9490137057573687,1.0,3/21,5.98%,SCARB1;SREBF2;EHD1
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.3229549959525146,-0.7341039939443235,0.7934362934362934,0.9490671333270037,1.0,2/10,15.96%,KYAT1;QDPR
prerank,regulation of microtubule-based process (GO:0032886),0.2579839357924707,0.734039303378724,0.8228782287822878,0.9813483392230373,1.0,9/36,14.78%,EPHA3;MACF1;PRKAA2;PHLDB2;PRKAA1;ERBB2;CYLD;BICD2;MEMO1
prerank,regulation of viral release from host cell (GO:1902186),-0.2595582012645075,-0.7336206574489194,0.8147368421052632,0.9491001125651753,1.0,6/21,22.28%,CHMP2B;TRIM25;DDB1;TRIM13;MID2;CHMP3
prerank,telomere maintenance via telomere trimming (GO:0090737),0.3260254911136943,0.7336109763770818,0.7780126849894292,0.9800459525230409,1.0,4/10,23.17%,BLM;WRN;NBN;SMARCAL1
prerank,t-circle formation (GO:0090656),0.3260254911136943,0.7336109763770818,0.7780126849894292,0.9800459525230409,1.0,4/10,23.17%,BLM;WRN;NBN;SMARCAL1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.3260254911136943,0.7336109763770818,0.7780126849894292,0.9800459525230409,1.0,4/10,23.17%,BLM;WRN;NBN;SMARCAL1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.24043195747636886,0.7331972909690749,0.8548951048951049,0.9799698422866349,1.0,8/46,10.86%,TIMP3;DUSP10;FBLN1;DLG1;LMO3;PTEN;SIRPA;FLCN
prerank,dendritic cell differentiation (GO:0097028),0.2770538233608727,0.732538654484148,0.8108108108108109,0.9802653358765375,1.0,7/22,16.12%,IRF8;CCL19;BATF2;AXL;BATF;PRTN3;LYN
prerank,cell junction maintenance (GO:0034331),0.30874632156638576,0.7320481551610257,0.806,0.9802913825168494,1.0,1/14,2.23%,NLGN2
prerank,histone H4-K16 acetylation (GO:0043984),0.28830760327844607,0.7314627613307192,0.7933579335793358,0.9804581913931264,1.0,3/19,10.66%,KMT2A;KAT8;KANSL1
prerank,regulation of B cell apoptotic process (GO:0002902),-0.30791834711225474,-0.7314549552181627,0.8375241779497099,0.9511317759098794,1.0,1/12,0.81%,FOXP1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.3201591810292385,-0.7308939218764148,0.8147448015122873,0.9511985396735361,1.0,3/10,23.45%,CALM1;FMR1;CALM3
prerank,presynaptic endocytosis (GO:0140238),0.26972158947473407,0.7307779159799165,0.8089887640449438,0.98077644908019,1.0,3/24,6.00%,CEL;NLGN2;SYNJ2
prerank,positive regulation of cell growth (GO:0030307),0.21435445885142465,0.7302619652521719,0.9145038167938931,0.9808672403759574,1.0,4/96,4.46%,IGF1;BCL2;MACF1;SPHK1
prerank,endodermal cell fate commitment (GO:0001711),-0.31440116445002153,-0.7297704519121975,0.8169811320754717,0.9519858287768806,1.0,2/10,17.50%,SOX17;SOX2
prerank,cellular response to interferon-beta (GO:0035458),-0.2864536319301446,-0.7294989687189944,0.8288659793814434,0.9517621734068284,1.0,7/14,43.21%,AIM2;NDUFA13;STAT1;IFITM2;CDC34;UBE2G2;IRF1
prerank,positive regulation of reproductive process (GO:2000243),0.25935993084091535,0.7294860104028371,0.8214285714285714,0.9813040469926119,1.0,6/31,15.99%,PLA2G10;PLCB1;AGO2;SMURF2;TACR3;SYDE1
prerank,regulation of chromatin binding (GO:0035561),0.33197199543195066,0.7291230804224011,0.767590618336887,0.9811785514486984,1.0,4/10,24.43%,PARP9;DTX3L;KDM4D;MED25
prerank,negative regulation of dephosphorylation (GO:0035305),-0.2654405592398461,-0.7277354664175465,0.823404255319149,0.9531517669242279,1.0,9/18,31.56%,PPP1R16B;YWHAB;CHP1;ZCCHC9;PPP1R15A;URI1;PPP1R35;ARPP19;MFHAS1
prerank,negative regulation of JNK cascade (GO:0046329),0.2618999806140948,0.7275388582691036,0.8615664845173042,0.9826206114009324,1.0,7/31,12.30%,PRKN;DUSP10;SIRPA;ITCH;SH3RF2;CYLD;HIPK3
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.23440654545453687,0.7268463844283592,0.8793706293706294,0.9829146333404497,1.0,12/52,13.17%,TLN1;TATDN2;TPP1;WIPI1;EXTL1;CUL7;ATP6V0D1;FKBP14;SERP1;EDEM1;TSPYL2;PLA2G4B
prerank,DNA packaging (GO:0006323),0.3008829689453809,0.7261117026706262,0.7984189723320159,0.9832461949745156,1.0,6/16,27.59%,RBBP4;BANF2;AIFM1;NAA10;TP53;KAT6A
prerank,establishment of spindle localization (GO:0051293),-0.28664856748741463,-0.7260696135956007,0.8,0.9544566025410395,1.0,10/14,38.02%,MAP4;CFL1;CLASP2;TLE6;ZBED3;DYNC1H1;ESPL1;CLASP1;NUSAP1;NLRP5
prerank,neuron projection fasciculation (GO:0106030),0.3266238557206262,0.7259120402728957,0.7896907216494845,0.9828821083790432,1.0,2/10,7.10%,EPHA4;ARHGAP35
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.28784900187986734,0.7246844040727805,0.837160751565762,0.9839166586510993,1.0,4/18,11.42%,PHF8;LYAR;RASL11A;ERBB2
prerank,regulation of myoblast fusion (GO:1901739),0.32179616538277245,0.7242623361700773,0.7558886509635975,0.9838375699836863,1.0,2/11,12.18%,RIPOR2;CFLAR
prerank,mitotic spindle organization (GO:0007052),-0.1756504410515909,-0.7242057865457652,0.9848942598187311,0.956023931471878,1.0,63/153,35.23%,MAP4;SMC1A;CLIP1;FLNA;BUB3;PLK2;DYNLL2;EFHC2;CENPO;RPS27;CHEK2;RHOA;CENPK;ARHGEF10;MZT1;RANGAP1;NUP37;STMN1;TOGARAM1;RCC2;NDE1;RMDN1;WRAP73;CENPU;KIF3B;BUB1B;NUP85;CKAP5;KIF11;PPP1CC;NUP133;MAPRE1;B9D2;VCP;KIFC1;CLASP2;NDC80;KIF4A;KNL1;KIFC2;KNTC1;SPDL1;CDCA8;CEP126;SMC3;KIF23;ZWINT;ABRAXAS2;DYNC1I1;PLK1;BCCIP;NUDC;DLGAP5;DYNC1H1;AURKA;NEK9;TOGARAM2;STIL;PCNT;CDC20;BUB1;DYNLL1;CLASP1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.32870421113934817,0.7238769960965034,0.7983014861995754,0.9837167529279623,1.0,1/10,2.89%,SP100
prerank,regulation of intracellular transport (GO:0032386),-0.22373122555496242,-0.7232742741363567,0.9187358916478555,0.9564764510261392,1.0,11/38,25.13%,REEP5;CRYAB;LAMP1;PTPN1;ATP13A2;INPP5F;NUMA1;MLC1;SPAG5;CAPN10;HAP1
prerank,regulation of cytoplasmic translation (GO:2000765),-0.2838821564661123,-0.7232569298970885,0.8376237623762376,0.9559491694459645,1.0,8/14,31.95%,PKM;YBX3;CPEB1;FMR1;RBM24;CNBP;CPEB3;DHX9
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.22671417740687874,0.722755711688871,0.8880866425992779,0.9845592606499061,1.0,6/51,8.79%,IL34;PTN;IL6;CSF1;MOSPD2;VEGFB
prerank,regulation of viral genome replication (GO:0045069),0.2273689102967396,0.722421812679887,0.8689883913764511,0.9843528705764119,1.0,7/56,9.82%,PPARA;LTF;RNASEL;SRPK2;HACD3;PKN2;PARP10
prerank,negative regulation of catabolic process (GO:0009895),0.23496463653863678,0.7222517244571807,0.8747884940778342,0.9839494338742895,1.0,6/47,9.15%,PPARA;AZIN2;BANP;PRKAA1;NUPR1;APOC1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.28331793118530385,-0.7217201562112178,0.8425531914893617,0.9571183192513699,1.0,9/15,37.86%,APPL1;STAT3;GBP5;MYD88;TLR4;TLR6;NOD2;TICAM1;HIF1A
prerank,mitotic sister chromatid segregation (GO:0000070),-0.18464340716563465,-0.7215738379660039,0.9662921348314607,0.9567438545711099,1.0,37/98,32.47%,SMC1A;CHMP5;CHMP2B;PINX1;CUL3;SET;CENPK;CSNK2B;BOD1;WRAP73;CHMP1B;CHMP1A;SMC4;KNSTRN;NCAPH;CHMP3;SPAG5;TEX14;NCAPD3;KIFC1;CHMP7;PDCD6IP;NDC80;REC8;KIF14;SPDL1;CHMP4C;DIS3L2;CDCA8;CEP55;KIF23;ZWINT;KMT5A;VPS4B;PLK1;NUDC;DLGAP5
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.2148021433135068,-0.7215053979508554,0.8973747016706444,0.956267307284122,1.0,22/45,39.28%,PUM2;APP;GCNT2;PER1;ZC3H7A;EIF2A;NOLC1;YTHDC1;PUM3;EIF4E;PCIF1;RBM4B;DDX25;RPL10;ATXN2;METTL18;MATR3;RC3H1;MAPKAPK5;MTPN;TRIM71;ZC3H10
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.28612946282565466,-0.7208914207961119,0.8487903225806451,0.9564420447030784,1.0,3/14,19.43%,ADAM10;PSEN1;ABCG1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.20657577837304625,0.7206266185928466,0.9266770670826833,0.9854371823972033,1.0,19/95,16.18%,RAD51B;RAD51AP2;RNF138;HUS1B;RAD51C;BLM;HELQ;AUNIP;BRCA2;ZSWIM7;ZFYVE26;INO80;MRE11;FANCB;WRN;MCM2;SWI5;RAD51;NIPBL
prerank,heterocycle biosynthetic process (GO:0018130),-0.28748999720797613,-0.7201455745459838,0.8313953488372093,0.9567271920332175,1.0,6/14,34.12%,GCH1;GPHN;LIAS;PYCR2;PYCR1;NFS1
prerank,nucleosome disassembly (GO:0006337),0.30270779282412486,0.7200038986435684,0.79957805907173,0.984991799090663,1.0,5/14,16.33%,ARID2;SMARCE1;SMARCB1;SMARCC1;SMARCD3
prerank,chromatin disassembly (GO:0031498),0.30270779282412486,0.7200038986435684,0.79957805907173,0.984991799090663,1.0,5/14,16.33%,ARID2;SMARCE1;SMARCB1;SMARCC1;SMARCD3
prerank,histone H4 deacetylation (GO:0070933),0.32519417044038024,0.7188527181858059,0.8063157894736842,0.9858052026578259,1.0,2/10,10.71%,HDAC8;HDAC1
prerank,myeloid cell differentiation (GO:0030099),-0.21279566950038029,-0.7183810326746589,0.8870967741935484,0.9581307352806155,1.0,16/47,26.32%,RUNX1;RPS19;RPS14;KMT2E;IKZF1;TAL1;ATP5IF1;SPI1;INHA;JAK3;TIRAP;HSPA9;PRKX;CEBPA;FLVCR1;EPO
prerank,macrophage migration (GO:1905517),0.3068934420564862,0.718179361120031,0.7948717948717948,0.9859938876309811,1.0,3/13,17.66%,TAFA4;CKLF;EDNRB
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.3086713556578228,0.7181745313032949,0.7948207171314741,0.9853767209265988,1.0,2/13,11.32%,TPST1;SULT4A1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.21897102030536236,-0.7179234835172564,0.9072398190045249,0.9581033577326069,1.0,23/42,39.87%,SMCHD1;SPIDR;UBQLN4;ACTR2;FUS;TERF2IP;POLQ;PPP4R2;SIRT6;CHEK1;SHLD3;RMI2;CGAS;RIF1;SHLD2;PPP4C;HELB;RPA2;FIGNL1;WAS;WRAP53;RADX;TIMELESS
prerank,intracellular protein transport (GO:0006886),0.18200021990083945,0.7175692760255302,0.9907407407407407,0.9855193183085754,1.0,62/304,18.85%,RANBP3L;WLS;APPL2;IPO13;KIF13B;SNX6;ARFGAP3;PRICKLE1;RAB19;ACD;SNX9;ARL5A;TBC1D9B;MAIP1;PDCD6;ARL6;STX16;LAMP2;GGA2;SLU7;TBC1D4;RAB32;DNAJC27;NUTF2;RAB22A;RIC1;NUP107;WDR11;IFT27;STX8;OXA1L;SAR1B;TNPO1;TECPR2;STX17;NXT2;ARL4C;TRAK1;RAB43;ARL5B;AP3B1;TBC1D17;CCHCR1;TRAK2;DESI1;COPB2;COPZ2;VPS26A;RPAIN;IPO9;NUP214;VPS35;STX11;IFT22;USP6NL;TBC1D9;TBC1D15;FAM91A1;ARF4;AP4M1;KPNB1;RAB29
prerank,positive regulation of transmembrane transport (GO:0034764),0.30495774622646166,0.7174244964162254,0.7983870967741935,0.9850557276028374,1.0,2/13,6.46%,ACSL1;AZIN2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.2668519009635859,-0.7174079492597099,0.8380952380952381,0.958124596076329,1.0,7/18,33.16%,GSK3B;HIP1R;SLC35F6;CHCHD10;BAX;BID;HSPA1A
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.266617049350677,-0.7172038665400315,0.8349514563106796,0.9577901430295375,1.0,9/18,39.20%,CORO2B;CHP1;PTP4A3;CEP295;TREM2;CCT3;CCT4;WRAP53;CCT2
prerank,histone methylation (GO:0016571),0.26602602320024993,0.7170115250213461,0.8280373831775701,0.9849651957415636,1.0,8/26,20.80%,SETD6;PRMT7;NSD1;SMYD3;CREBBP;N6AMT1;NSD3;CARM1
prerank,defense response to protozoan (GO:0042832),-0.2924483578951744,-0.7161094077322934,0.835030549898167,0.9584153229379015,1.0,4/12,21.21%,GBP4;CD40;MYD88;SLC11A1
prerank,positive regulation of macrophage migration (GO:1905523),0.2770832813423172,0.716095287276855,0.826,0.9855180988215413,1.0,1/19,0.72%,IL34
prerank,regulation of cell aging (GO:0090342),-0.3122920848536894,-0.7158277761157453,0.8158379373848987,0.9582045446054466,1.0,3/11,16.76%,RSL1D1;LMNA;MIF
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.29202979510632254,0.7157137947350537,0.8229166666666666,0.985397288636058,1.0,3/17,13.44%,PRKN;MDM2;SNAI1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.2809787045942279,0.714719667166662,0.8188679245283019,0.9860042800410875,1.0,1/20,1.22%,IL18
prerank,erythrocyte development (GO:0048821),-0.3117387065749384,-0.714662514451625,0.8429906542056075,0.9589081075067445,1.0,4/10,20.80%,ABCB10;ZBTB7A;SH2B3;NCKAP1L
prerank,regulation of synapse organization (GO:0050807),0.2688520718908448,0.7146544440304159,0.8471698113207548,0.9854556228409893,1.0,8/26,17.77%,IL1RAPL1;NEDD4;EPHA4;ABL1;CDKL5;GRIPAP1;CHRNB2;PDLIM5
prerank,cellular response to catecholamine stimulus (GO:0071870),0.2666148781152931,0.7142251856610184,0.831041257367387,0.9853628566404511,1.0,7/23,19.93%,PRKN;LRRK2;ABL1;MAPK1;GNG2;SNCA;SLC9A1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.3252294659381481,0.7141499588030998,0.7961783439490446,0.984841918041102,1.0,2/10,7.35%,NOS1AP;CACNA2D1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2168829653025983,0.7139209831170197,0.922945205479452,0.9844999751774155,1.0,15/68,17.07%,CDK7;SSU72;MTERF2;POLR2A;SMN1;TAF1A;POLR1F;POLR1A;TAF1D;WDR33;MNAT1;FIP1L1;CSTF3;POLR1G;CPSF4
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.24901005742802543,0.7137621088958456,0.8666666666666667,0.9840792480988048,1.0,7/36,12.05%,PRKN;DUSP10;DLG1;SIRPA;ITCH;SH3RF2;CYLD
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.24388670037642649,-0.713323829283634,0.8903803131991052,0.9598097011122168,1.0,11/27,28.40%,ZC3H12C;TRIR;CPSF3;RNASE4;RPP30;ZC3H12A;PCF11;NHP2;NUDT16;ERN1;POP7
prerank,T cell differentiation in thymus (GO:0033077),-0.2733692102858205,-0.7130572663698095,0.8781925343811395,0.9595462994621127,1.0,4/14,18.89%,PTPRC;ZFP36L1;RABL3;LIG4
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.2872604690386699,0.7129829691607694,0.7865384615384615,0.9844365481116272,1.0,4/17,13.05%,ABI2;WASF1;WASF3;FCHSD2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.3130180685640304,0.712773289167449,0.7932489451476793,0.9840768536917752,1.0,1/11,2.89%,SP100
prerank,DNA dealkylation (GO:0035510),0.32493445587829095,0.7122816167052408,0.8,0.98344629625553,1.0,4/10,24.76%,ASCC2;MPG;ASCC1;ALKBH3
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.32493445587829095,0.7122816167052408,0.8,0.98344629625553,1.0,4/10,24.76%,ASCC2;MPG;ASCC1;ALKBH3
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.2677647240741162,-0.711522046363525,0.8732394366197183,0.9606495168876298,1.0,9/16,47.12%,TUBB4B;ULBP1;CORO1A;KIF5B;RAET1E;SLAMF7;PLEKHM2;KLRK1;LYST
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.2761068702156017,0.7112987386935908,0.8252032520325203,0.9840360466926958,1.0,4/20,12.45%,SMOC2;SULF1;APLN;PRKD2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.258857552861064,0.7111896652107542,0.8411214953271028,0.9835529269594505,1.0,3/25,9.92%,B3GALT1;HAS1;NDST2
prerank,lymphocyte migration (GO:0072676),-0.2249151822134516,-0.7111305258133455,0.8995633187772926,0.9605015146210881,1.0,2/32,3.56%,MSN;S1PR1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.2517759925841052,0.7109418680100048,0.8490230905861457,0.9832422279473696,1.0,2/34,5.06%,LGR4;CACTIN
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.25524297101131066,-0.7108132640255043,0.8785425101214575,0.9602651627087682,1.0,11/21,35.17%,BUB3;APC;BUB1B;TEX14;KNTC1;TRIP13;ZWINT;PLK1;IK;CDC20;BUB1
prerank,regulation of cell cycle process (GO:0010564),0.20010967783807193,0.7107778140293375,0.9472,0.9828288908559838,1.0,25/104,18.81%,OBSL1;HORMAD1;PLK5;CCDC8;CUL9;RPRD1B;BIRC6;YTHDF2;CUL7;PIK3R4;UVRAG;SND1;FLCN;MAD1L1;ZFYVE26;TXLNG;MYO19;CDKN2B;IHO1;SETD2;KLHL13;RAB11FIP3;USP19;PRPF40A;SFRP1
prerank,regulation of histone deacetylation (GO:0031063),0.3071046254731371,0.7106353637901177,0.7947686116700201,0.9823885004899081,1.0,4/13,16.18%,CAMK2D;AKAP8L;SAP30BP;NIPBL
prerank,positive regulation of TOR signaling (GO:0032008),0.24207488722772275,0.7101823553212463,0.8631578947368421,0.982318640438682,1.0,14/40,20.64%,FNIP1;RICTOR;SLC38A9;GPR137C;MLST8;FLCN;KLHL22;SIK3;TELO2;LARS1;MIOS;PIK3CA;CLEC16A;LAMTOR5
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.26080990184888175,-0.7093951000724779,0.884,0.9601123454781643,1.0,11/20,35.17%,BUB3;APC;BUB1B;TEX14;KNTC1;TRIP13;ZWINT;PLK1;IK;CDC20;BUB1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.26080990184888175,-0.7093951000724779,0.884,0.9601123454781643,1.0,11/20,35.17%,BUB3;APC;BUB1B;TEX14;KNTC1;TRIP13;ZWINT;PLK1;IK;CDC20;BUB1
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.26080990184888175,-0.7093951000724779,0.884,0.9601123454781643,1.0,11/20,35.17%,BUB3;APC;BUB1B;TEX14;KNTC1;TRIP13;ZWINT;PLK1;IK;CDC20;BUB1
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.2542217353218097,-0.7090707188276469,0.871900826446281,0.959899292451984,1.0,7/20,24.15%,SREBF2;LPCAT3;NR1H4;ABCA2;MBTPS1;TTC39B;DGKQ
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.26335939478050585,-0.7083628774366361,0.8443983402489627,0.9600664684828821,1.0,6/17,21.96%,SMUG1;OGG1;TERF2IP;NEIL1;NEIL3;NTHL1
prerank,DNA conformation change (GO:0071103),0.278623428984921,0.7080366018224623,0.8134171907756813,0.9842156263862168,1.0,3/17,14.12%,TOP2B;ABL1;TOP1MT
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.2202721174087674,-0.7080092977894522,0.897196261682243,0.9598830864115427,1.0,15/36,35.47%,SHANK3;ITGB1;EDN1;RELN;ADRB2;GREM1;HDAC6;CCR2;CCL2;BTC;BUD31;EGF;PARK7;NCF1;ADAM17
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.3159633861509284,0.7079547243952424,0.7894736842105263,0.9836932043355179,1.0,2/11,9.10%,ANXA1;RC3H2
prerank,myeloid cell development (GO:0061515),0.2832037454492271,0.7071208306569466,0.8294117647058824,0.9840817504038308,1.0,3/18,10.06%,KIT;LYAR;MED1
prerank,endocytic recycling (GO:0032456),-0.20123461831903713,-0.7070096754599431,0.9373549883990719,0.9603145904179228,1.0,15/50,26.99%,EHD4;DENND1B;EHD1;STX6;PTPN23;LMTK2;EHD3;ANKRD50;ENTR1;VPS51;RAB7A;SNX27;RAB14;MICALL2;SNX3
prerank,phospholipid homeostasis (GO:0055091),0.3221127606815086,0.7069491857445828,0.7870563674321504,0.9836711161721902,1.0,1/11,4.04%,ABCA1
prerank,protein alkylation (GO:0008213),-0.24903481776489897,-0.7066451629405025,0.8708333333333333,0.960168772458935,1.0,11/22,43.48%,PCMT1;PRMT8;PRMT3;ETFBKMT;ETF1;FAM98B;FAM98A;PRMT1;VCPKMT;METTL21C;METTL21A
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.28032680584632014,-0.706422738016655,0.8316008316008316,0.9598550977833067,1.0,5/13,21.96%,SMUG1;NT5C;OGG1;NEIL1;NTHL1
prerank,ruffle organization (GO:0031529),0.28559287893368923,0.7052827566806424,0.8115079365079365,0.9849588503252561,1.0,2/16,7.18%,TPM1;LIMA1
prerank,negative regulation of double-strand break repair (GO:2000780),-0.2298137664334134,-0.7045644945744575,0.9017094017094017,0.9612740967120369,1.0,12/30,33.53%,SMCHD1;OGG1;UBQLN4;OTUB1;POLQ;SHLD3;RMI2;CGAS;TFIP11;RIF1;SHLD2;HELB
prerank,necroptotic process (GO:0070266),0.2895265603415797,0.7043137394403103,0.8194174757281554,0.9855206643110468,1.0,16/16,71.08%,CYLD;CD14;PGAM5;ITPK1;TRPM7;FASLG;LY96;IPMK;RIPK3;TLR3;MLKL;TICAM2;DNM1L;RIPK1;TICAM1;TLR4
prerank,determination of left/right symmetry (GO:0007368),0.23951389059050013,0.7041289375278921,0.8716577540106952,0.9851194188314839,1.0,7/36,15.00%,ODAD3;DNAH11;ARL6;BBS7;OFD1;PKD2;ODAD2
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.2862774517277952,-0.7040803258213546,0.8553971486761711,0.9612178297937484,1.0,5/13,24.02%,UAP1L1;UAP1;GNPDA1;AMDHD2;GNPDA2
prerank,cellular component maintenance (GO:0043954),0.3091500557424602,0.7038159261708931,0.7933194154488518,0.9848826020321718,1.0,2/12,5.54%,IGF1R;ITGA3
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.2569446490932755,-0.7034361191269909,0.8725701943844493,0.9613181398825567,1.0,7/18,24.36%,CBL;ST18;STAT3;SPI1;JAK1;CEBPA;STAT1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.28814272336922025,-0.7027395454098178,0.8757396449704142,0.9614494985040716,1.0,4/12,23.22%,WDTC1;CEACAM1;ERLIN2;TRIB3
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.22352772198563373,0.7021496283803936,0.9059674502712477,0.9862021769434087,1.0,12/48,18.28%,BAZ1B;ARID1B;ZMIZ1;SMARCA5;TAF1A;POLR1F;POLR1A;ZMIZ2;TAF1D;PHF2;POLR1G;ATAD2B
prerank,negative regulation of T cell proliferation (GO:0042130),-0.23442124703756748,-0.7020785787231376,0.9134199134199135,0.9615184238252387,1.0,12/28,39.57%,TNFRSF21;PRKAR1A;CD274;SDC4;CEBPB;CD80;IL4I1;GPNMB;RC3H1;VTCN1;ARG1;CRTAM
prerank,regulation of TORC1 signaling (GO:1903432),0.2422045027905388,0.7019140416109921,0.8812949640287769,0.9858521056116846,1.0,12/33,20.64%,SZT2;SESN1;RNF152;GPR137C;FLCN;KLHL22;SIK3;TELO2;LARS1;CLEC16A;KPTN;LAMTOR5
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.3126584570310076,0.7014198994350131,0.8138075313807531,0.9858386557147742,1.0,4/10,21.84%,SLC45A3;SNCA;IRS2;IRS1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.21149432278797986,0.7010910846921107,0.936026936026936,0.9856120259331496,1.0,22/76,19.55%,ANGPT1;PRICKLE1;SPHK1;LRRK2;UBE2L3;RWDD3;WDR48;FANCI;PIAS1;FBXO4;MYCBP2;CRY1;RCHY1;CENPX;BIRC2;AXIN1;TRAF6;HDAC4;TBC1D7;PIAS3;XIAP;DCUN1D5
prerank,RNA modification (GO:0009451),-0.19878976523114486,-0.7007180032874185,0.9498861047835991,0.9623100150351074,1.0,22/54,32.59%,ADARB1;ADAR;SSB;MEPCE;QTRT1;TSR3;NSUN4;MRM2;THUMPD1;METTL3;ELP5;METTL1;AARS2;PUS7;ADAT2;CDKAL1;QTRT2;NOP10;RBM15;JMJD6;NSUN5;CTU1
prerank,regulation of DNA recombination (GO:0000018),-0.2239489309022185,-0.7004829287150046,0.9140969162995595,0.9620206353970915,1.0,15/32,34.93%,SPIDR;MSH2;TERF2IP;PPP4R2;SMARCAD1;SIRT6;CHEK1;ALYREF;ZCWPW1;SHLD2;PPP4C;KPNA2;RPA2;FIGNL1;IL7R
prerank,serine family amino acid biosynthetic process (GO:0009070),0.3081833363549111,0.7000419725498782,0.8271334792122538,0.9862022384942143,1.0,2/12,8.27%,CBS;SRR
prerank,regulation of sensory perception of pain (GO:0051930),-0.29328634291340283,-0.7000157627897403,0.83,0.9619573003499031,1.0,2/11,5.09%,MGLL;CCN3
prerank,protein localization to microtubule organizing center (GO:1905508),-0.2733577724627436,-0.6990280714427788,0.8219461697722568,0.9623943245210258,1.0,5/15,33.73%,CEP83;SPAG5;PCM1;CEP131;STIL
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.258230542977887,-0.6977490517325119,0.8658280922431866,0.9631178239596758,1.0,9/18,44.78%,ADAM10;PSEN1;ABCG1;ACHE;ADAM17;CLN3;LDLRAP1;NSG1;PSEN2
prerank,protein import into peroxisome membrane (GO:0045046),-0.24439366717520447,-0.6975146922852696,0.8773946360153256,0.9628124986413307,1.0,9/22,29.54%,ABCD3;ABCD2;PEX11B;PEX5;ATAD1;RAB8B;PEX16;FIS1;PEX13
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.25782327352482853,-0.6966572581231687,0.8830897703549061,0.9631428426875508,1.0,8/18,26.99%,MSN;PTPN23;VPS11;MAP2K2;MAPK3;CHMP3;EZR;SNX3
prerank,protein kinase A signaling (GO:0010737),0.3143022395851996,0.6962476763108678,0.8297872340425532,0.9899494844374748,1.0,2/12,13.56%,RAB13;PRKACB
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.26571748651491844,0.6955918129905218,0.8249097472924187,0.9900761473771107,1.0,1/22,1.28%,BMP7
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.26735170133512554,0.6954877416224006,0.8565965583173997,0.9895791185140245,1.0,8/20,22.18%,MEIS1;CDC73;CIB1;MEIS2;CTR9;LDB1;PAF1;HOXA5
prerank,lipoprotein transport (GO:0042953),0.3128173567402526,0.6954400709516986,0.8103448275862069,0.9890226133499578,1.0,2/10,8.41%,PRKCB;MIA3
prerank,endosome organization (GO:0007032),0.2377141668648532,0.6945478096948018,0.8998272884283247,0.9894226298758056,1.0,11/41,16.50%,HOOK2;ALS2;SNX33;PLEKHJ1;RAB22A;ARFGEF2;PLEKHF1;EEA1;PHETA1;WASHC4;PI4K2A
prerank,somite development (GO:0061053),-0.29379390416033807,-0.6933983257418147,0.8699029126213592,0.9657696472296365,1.0,2/11,7.46%,MEOX2;PTCH1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.24117599124906525,-0.6931452995777445,0.8774193548387097,0.965487527236435,1.0,3/23,3.96%,PTK2B;NOTCH1;HES1
prerank,ureteric bud morphogenesis (GO:0060675),-0.25915637633482264,-0.6928328288701663,0.8793456032719836,0.9652366909572203,1.0,8/16,34.32%,SIX1;NPNT;BMP2;BMP4;PAX8;FGF2;SHH;PAX2
prerank,establishment of spindle orientation (GO:0051294),0.2530184715869914,0.6925630162050319,0.8696461824953445,0.9910146834976644,1.0,5/28,11.33%,LLGL2;GJA1;UBXN2B;PAFAH1B1;LLGL1
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.23226262177200846,-0.6905231654952905,0.9178947368421052,0.9668538403389215,1.0,10/28,24.55%,CDH1;FLNA;TGFB1;JUP;ZC3H12A;PSEN1;PRKCD;RBM22;HYAL2;ZPR1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.2671418204492545,-0.6893860920422327,0.8926441351888668,0.9673765398078223,1.0,5/15,21.92%,ZC3H12A;GSTO2;ATF3;MKNK2;VCP
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.24519166863334776,-0.6873110213433302,0.8927835051546392,0.9687130584488591,1.0,4/21,19.26%,ADAM10;MYH9;ADAM9;PSEN1
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.262358156219718,-0.6864430253270469,0.8974358974358975,0.968934402521203,1.0,6/17,22.08%,FURIN;NR1H2;PCSK5;ANGPTL4;HDAC9;NR1H3
prerank,embryonic axis specification (GO:0000578),0.286361772501841,0.6861347890178525,0.8387096774193549,0.9974169432208029,1.0,5/15,20.61%,SMAD6;COBL;HOXD8;CXXC4;SMAD2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.2684435460389526,0.6849017497762266,0.861271676300578,0.9981257490475938,1.0,5/20,16.27%,PLCB1;GNAQ;LY6G6D;GRK2;CHRNB2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.24716132279329522,-0.6838809115163191,0.8757894736842106,0.9706725458730914,1.0,4/18,15.65%,AGRN;CHRM3;GNA11;RGS10
prerank,purine-containing compound salvage (GO:0043101),0.2862758395575348,0.683232957213939,0.8453389830508474,0.9992973902596287,1.0,4/12,18.20%,AMPD3;ADK;APRT;GMPR2
prerank,natural killer cell mediated immunity (GO:0002228),-0.2609708296270503,-0.6829313381082007,0.9025844930417495,0.9710283762041652,1.0,9/15,47.12%,TUBB4B;ULBP1;KIF5B;RAET1E;SLAMF7;PLEKHM2;KLRD1;KLRK1;LYST
prerank,negative regulation of bone mineralization (GO:0030502),0.29509964475844874,0.6827888820955447,0.8143712574850299,0.9991377468462609,1.0,2/13,6.35%,ECM1;BCOR
prerank,organophosphate biosynthetic process (GO:0090407),0.23569035519625212,0.6823253532862992,0.9127272727272727,0.9990253889002615,1.0,11/37,21.25%,AGPAT4;MOCS2;PPIP5K2;ITPKA;MOCS1;GK;MOCS3;GK5;PIP5K1A;IP6K2;PCYT2
prerank,tRNA modification (GO:0006400),0.21308098808987117,0.682045872326638,0.9332247557003257,0.9986977981894888,1.0,14/62,18.44%,TRMT9B;PUS3;THADA;LCMT2;TRDMT1;OSGEP;WDR4;MTO1;THUMPD3;DUS2;DTWD1;TYW5;TPRKB;MOCS3
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.26085290509087306,0.6819084182524778,0.8827977315689981,0.9982156819160101,1.0,2/21,4.78%,PPP4R4;PTPA
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.2360505055165949,-0.68140546172795,0.9018789144050104,0.9718175675527851,1.0,10/24,34.29%,HSP90AA1;AIM2;ZC3H12A;STAT1;TRIM44;CGAS;SIN3A;MAVS;PTPN22;PQBP1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.22651929256819417,-0.6812646833751541,0.9144050104384134,0.9714070906648589,1.0,8/28,21.03%,PTK2;DAB2IP;CLU;PSMC3;ATP5IF1;LAPTM5;FMR1;CTSC
prerank,negative regulation of viral genome replication (GO:0045071),0.22865872817565436,0.6802054578765403,0.8982456140350877,0.9993239550835668,1.0,3/40,3.90%,LTF;RNASEL;SRPK2
prerank,mitotic cell cycle phase transition (GO:0044772),0.17709925880743113,0.6792927155272396,0.9958391123439667,0.9996671292319879,1.0,24/203,12.45%,NINL;PLCB1;ALMS1;PHLDA1;CDK7;CCDC57;EIF4EBP1;HAUS4;CEP152;NASP;PHF8;SDCCAG8;OPTN;CDK1;PAFAH1B1;FBXL17;LATS1;OFD1;HAUS1;RPS6KB1;SFI1;CUL4B;CCNE1;CEP57
prerank,acyl-CoA metabolic process (GO:0006637),0.22961859479388547,0.6776830515322518,0.9102564102564102,1.0,1.0,2/35,4.01%,SUCLG2;ACOT4
prerank,cell-cell junction maintenance (GO:0045217),0.2972926134645188,0.6771463798883667,0.8401639344262295,1.0,1.0,1/11,2.23%,NLGN2
prerank,regulation of mitochondrion organization (GO:0010821),0.2194639852428915,0.6757323062220062,0.9200680272108843,1.0,1.0,9/47,17.24%,PID1;PRKN;LRRK2;FLCN;PISD;HTRA2;OMA1;MYO19;VPS35
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.29135522937750213,0.6746380260924016,0.8622047244094488,1.0,1.0,2/13,8.90%,IRAK2;PIK3R4
prerank,regulation of response to stress (GO:0080134),-0.2899792169626791,-0.674534355004976,0.8754578754578755,0.9766444382651885,1.0,2/10,9.74%,CORO2B;EIF4G1
prerank,programmed necrotic cell death (GO:0097300),0.2706606380306459,0.6734817991647862,0.8601941747572815,1.0,1.0,18/18,72.96%,CYLD;CD14;PGAM5;ITPK1;TRPM7;FASLG;PPIF;LY96;IPMK;RIPK3;TLR3;MLKL;TICAM2;DNM1L;RIPK1;TICAM1;TLR4;ALKBH7
prerank,regulation of spindle organization (GO:0090224),-0.24881392363791693,-0.6721918464648472,0.9156118143459916,0.9780593691897624,1.0,8/18,46.31%,GNAI1;NUMA1;DCTN1;DYNC1H1;PSRC1;SENP6;RAE1;PARP3
prerank,termination of RNA polymerase I transcription (GO:0006363),0.23815836859413184,0.6719023555793139,0.902970297029703,1.0,1.0,7/30,16.97%,CDK7;TAF1A;POLR1F;POLR1A;TAF1D;MNAT1;POLR1G
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.28986653167623233,0.6718850951810967,0.8582834331337326,1.0,1.0,5/13,22.24%,LRRK2;RHOQ;RAB23;AK4;AK3
prerank,regulation of axon regeneration (GO:0048679),-0.2771924275245926,-0.6718366343105735,0.8849206349206349,0.9777895704153706,1.0,5/12,21.35%,SCARF1;RTN4RL1;GRN;INPP5F;RTN4R
prerank,mitochondrial protein processing (GO:0034982),0.30514832739417547,0.6710556395793253,0.8574181117533719,1.0,1.0,3/11,16.90%,YME1L1;OMA1;IMMP1L
prerank,coenzyme A biosynthetic process (GO:0015937),-0.2837573349676249,-0.6709915749880888,0.8882466281310212,0.9768725557021276,1.0,3/11,29.33%,PPCDC;PANK2;PANK3
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.2837573349676249,-0.6709915749880888,0.8882466281310212,0.9768725557021276,1.0,3/11,29.33%,PPCDC;PANK2;PANK3
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.2837573349676249,-0.6709915749880888,0.8882466281310212,0.9768725557021276,1.0,3/11,29.33%,PPCDC;PANK2;PANK3
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.3028985464411696,0.6709669218188719,0.8225806451612904,1.0,1.0,1/10,6.02%,PDE6G
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.23906157341202966,0.6708921382017411,0.882661996497373,1.0,1.0,15/31,24.97%,EXOSC8;DCP2;LSM5;CNOT8;CNOT7;EXOSC3;LSM3;LSM1;LSM4;DDX6;EXOSC4;DCP1B;LSM6;DIS3;NT5C3B
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.2342818595490916,-0.6708058875723006,0.9137931034482759,0.9764891339544992,1.0,14/23,36.09%,SIX1;VEGFA;PIK3CD;SIX4;BMP4;PAX8;SIRT6;FGF2;EGF;AGT;MDK;NOG;PAX2;LIF
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.2181904982639955,0.6702082477467072,0.9184782608695652,1.0,1.0,8/45,14.63%,BMP7;TOM1L2;SMAD3;TRIM35;PTPN3;GAS1;CDKN1C;CHFR
prerank,intracellular cholesterol transport (GO:0032367),0.2817460203598521,0.6696235157159584,0.8530701754385965,1.0,1.0,3/15,17.13%,ABCA1;SERAC1;RELCH
prerank,RNA methylation (GO:0001510),-0.18668114383389015,-0.6693263350930024,0.9768637532133676,0.9771375665030558,1.0,15/60,23.62%,TFB2M;TRMT61B;MEPCE;BUD23;FBL;ALKBH8;NSUN4;TRMT44;MRM2;TRMT12;METTL3;TYW3;TRMT10C;METTL1;PCIF1
prerank,autophagosome organization (GO:1905037),0.2172891516622477,0.6693060730727829,0.9437086092715232,1.0,1.0,12/50,17.14%,TP53INP2;RAB19;WIPI1;UBXN2B;ATG14;ATG9A;RAB43;AMBRA1;ATG3;RUFY4;IRGM;ATG16L2
prerank,regulation of lipid storage (GO:0010883),0.25741645344237124,0.6689892263016258,0.8856088560885609,1.0,1.0,4/22,14.04%,PLA2G10;IL6;IKBKE;PLIN5
prerank,regulation of autophagosome maturation (GO:1901096),0.28044536563904,0.6682951901352806,0.856,1.0,1.0,7/13,25.44%,UVRAG;RUBCN;TMEM39A;IRGM;CLEC16A;FYCO1;PHF23
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.2840580275833069,-0.6681926537234522,0.8992673992673993,0.977467435464786,1.0,6/11,37.74%,PLCG2;CDH13;TREM2;P2RX5;P2RX3;TRAT1
prerank,regulation of lipid kinase activity (GO:0043550),0.30080067817945033,0.6681796650251564,0.81419624217119,1.0,1.0,2/11,10.73%,RBL2;PIK3R1
prerank,GTP metabolic process (GO:0046039),-0.26292111766419024,-0.6675596860515227,0.891566265060241,0.9774001544052408,1.0,3/15,13.98%,ENTPD7;IMPDH1;IMPDH2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.2579893381312609,-0.6666771889085105,0.9001848428835489,0.9775824118976271,1.0,5/15,36.29%,PTTG1;ANAPC7;PLK1;CDC6;UBE2C
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.2720903655192418,-0.6666341068001381,0.8752362948960303,0.9770746834226186,1.0,7/13,32.22%,ETS1;RHOA;IRAK1;FUT9;RELA;ITGB2;MDK
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.25529444911444243,0.6666302386433832,0.8783783783783784,1.0,1.0,2/22,6.76%,KIT;IL6
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.2814197622615337,0.6650819360189022,0.8629032258064516,1.0,1.0,3/13,10.17%,TNRC6B;TNRC6A;AGO2
prerank,synaptic vesicle recycling (GO:0036465),0.23539895158919474,0.6646695478614493,0.9043321299638989,1.0,1.0,3/31,6.00%,CEL;NLGN2;SYNJ2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.22380414097715381,-0.6644683173466949,0.9088937093275488,0.9782408243331255,1.0,7/27,19.97%,BHLHE40;FBXL3;PPP1CA;PER1;ID2;PPP1CB;PPP1CC
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.21501286745026052,-0.6637892351573026,0.9117647058823529,0.9782197728740513,1.0,8/29,20.78%,PUM2;ADAR;DGCR8;LIN28B;ZC3H7A;AGO3;SNIP1;METTL3
prerank,positive regulation of mRNA processing (GO:0050685),-0.23820927314954204,-0.6633929004307437,0.9323770491803278,0.9779956965695892,1.0,12/21,48.33%,RBMXL1;TRA2B;PRDX6;DAZAP1;CELF4;NCBP2;CELF3;LEO1;SF3B4;RBM3;TRA2A;NCBP1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.2626108683227762,-0.6633025700443983,0.8868274582560297,0.9775438678920422,1.0,2/14,5.06%,CMPK1;ME1
prerank,homologous chromosome segregation (GO:0045143),0.25221668057608543,0.6631771682176789,0.8918918918918919,1.0,1.0,2/20,8.73%,TERB2;MAJIN
prerank,tryptophan catabolic process (GO:0006569),-0.2881129247807585,-0.6630809715003727,0.8840304182509505,0.9771725648823045,1.0,4/11,32.08%,KYAT1;KMO;IL4I1;HAAO
prerank,sensory perception of taste (GO:0050909),0.29525483304042177,0.6629461757959874,0.8343815513626834,1.0,1.0,10/10,70.49%,ASIC3;TAS1R2;PKD2L1;ASIC2;TAS1R3;GNAT3;PKD1L3;TAS1R1;CD36;ASIC1
prerank,negative regulation of synaptic transmission (GO:0050805),-0.2331083536402937,-0.6622743136326308,0.9300847457627118,0.9772663240312789,1.0,5/23,13.07%,PLK2;ARF1;SLC24A2;SLC30A1;PICK1
prerank,kinetochore organization (GO:0051383),-0.26356214163306413,-0.6618880929555354,0.8910133843212237,0.9770237321434228,1.0,10/13,53.80%,NDC80;DLGAP5;CENPW;CENPT;CENPF;CDT1;CENPC;CENPH;NUF2;CENPA
prerank,regulation of response to biotic stimulus (GO:0002831),0.2426099061089959,0.6613655872896461,0.8917910447761194,1.0,1.0,2/28,3.24%,APPL2;TRIM5
prerank,heterochromatin assembly (GO:0031507),-0.23299597848649817,-0.6607449172283092,0.9151138716356108,0.9773187428529516,1.0,4/20,19.01%,SMCHD1;H3-3A;BAHD1;NRDE2
prerank,axoneme assembly (GO:0035082),0.23649671962518784,0.6605949355950984,0.9196940726577438,1.0,1.0,6/30,14.91%,DNAI4;SPAG1;CFAP74;TTC12;CCDC65;DNAAF3
prerank,positive regulation of protein sumoylation (GO:0033235),0.3045760940531475,0.6601609146857258,0.8034934497816594,1.0,1.0,4/10,19.02%,RWDD3;PIAS1;HDAC4;PIAS3
prerank,regulation of lymphocyte activation (GO:0051249),0.2850596359070935,0.6600525293781537,0.8487229862475442,1.0,1.0,12/12,71.52%,PAG1;LAT;SIT1;CD4;CD19;LCK;CRTAM;KAT2A;CCL5;THEMIS2;IKZF3;DCAF15
prerank,negative regulation of protein depolymerization (GO:1901880),0.2485416837161895,0.6599161893417704,0.8819188191881919,1.0,1.0,2/24,7.18%,PLEKHH2;LIMA1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.2592461820075888,0.6589322294577681,0.8733205374280231,1.0,1.0,7/19,21.02%,GFPT2;PMM2;RENBP;UGDH;PGM3;MPI;GMPPB
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.1891188382885777,-0.6566346901485391,0.9710144927536232,0.9799018088295279,1.0,11/50,22.31%,ACTB;HSP90AB1;CDC37;CDKN1B;CCNF;CAMK2N1;CCNG2;GADD45A;CDKN1A;CDKN2D;CCNB2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.2871759462682819,0.6566155956948809,0.8398268398268398,1.0,1.0,11/11,71.30%,CCT6A;TCP1;DKC1;CCT5;CCT7;CCT8;TERF1;CCT2;WRAP53;CCT4;CCT3
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.17778122489546946,0.6562333360726648,0.9954954954954955,1.0,1.0,17/145,11.40%,NINL;ALMS1;RAD51B;RAD51C;HAUS4;CEP152;PSME4;PSMA2;SDCCAG8;PSMA3;CDK1;PAFAH1B1;PSMD8;OFD1;HAUS1;PSMD3;SFI1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.2488297010613579,-0.6558043504584635,0.9252525252525252,0.9799993549072407,1.0,7/17,35.25%,LGMN;CXCL12;CCR2;CREB3;CXCL10;CXCL17;CCL5
prerank,gluconeogenesis (GO:0006094),0.22349396713745612,0.6553660083828571,0.941398865784499,1.0,1.0,6/39,14.14%,RBP4;SLC25A11;CRY1;ENO2;PFKFB1;GPI
prerank,insulin secretion (GO:0030073),0.25521496923690135,0.653845261141896,0.9013539651837524,1.0,1.0,5/19,17.49%,ANXA1;SLC30A8;RAB11FIP2;RAB11B;CYB5R4
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.287157921164951,0.6529649005665787,0.8318777292576419,1.0,1.0,10/10,71.30%,CCT6A;TCP1;DKC1;CCT5;CCT7;CCT8;CCT2;WRAP53;CCT4;CCT3
prerank,protein lipidation (GO:0006497),0.20520317661737736,0.6527866067975888,0.9570446735395189,1.0,1.0,9/59,12.88%,PIGU;ZDHHC1;ATG10;PIGG;WIPI1;ZDHHC3;PIGV;PIGC;PIGQ
prerank,positive regulation of secretion (GO:0051047),-0.27034531253498684,-0.6526985705283993,0.8735632183908046,0.9817195609720969,1.0,2/11,17.75%,XBP1;ACSL3
prerank,protein import into nucleus (GO:0006606),0.20030950499038722,0.6524047808205448,0.9655765920826161,1.0,1.0,11/66,17.22%,APPL2;IPO13;PRICKLE1;NUTF2;NUP107;TNPO1;NXT2;CBLB;RPAIN;IPO9;NUP214
prerank,regulation of integrin activation (GO:0033623),0.271021253826838,0.6513002141309168,0.8673076923076923,1.0,1.0,2/15,4.14%,CXCL13;FERMT1
prerank,Golgi inheritance (GO:0048313),0.2878733444493628,0.6506690186204456,0.8608349900596421,1.0,1.0,3/11,9.66%,PLK5;CDK1;GOLGA2
prerank,secondary alcohol biosynthetic process (GO:1902653),0.23296319368610013,0.6501116532307462,0.9254901960784314,1.0,1.0,5/30,11.27%,INSIG2;PMVK;ACAA2;ACAT2;FDPS
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.28054072488231346,0.6498848614639332,0.8812877263581489,1.0,1.0,1/12,1.72%,UST
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.24761718680124672,-0.6495928363556142,0.9141104294478528,0.9834208486846411,1.0,1/17,1.62%,SLC7A5
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.23870749376336936,-0.6495820859045983,0.920892494929006,0.982894071823635,1.0,10/18,37.49%,AQP4;CFAP53;SPAG17;RFX3;DNAAF2;ODAD4;CABYR;CCDC40;DNAAF4;CCDC39
prerank,prostanoid metabolic process (GO:0006692),0.27386753674467035,0.6486873985677379,0.8614457831325302,1.0,1.0,3/13,18.80%,PTGR1;ACOX1;PTGR2
prerank,regulation of RNA export from nucleus (GO:0046831),-0.2827719369288379,-0.6484501955264012,0.8982725527831094,0.9831605996759722,1.0,6/11,35.96%,CPSF6;NRDE2;NUP153;DHX9;IWS1;NCBP2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.25018904529549757,0.6473484346275253,0.8904109589041096,1.0,1.0,4/18,12.75%,COX19;COX17;OXA1L;COX20
prerank,indolalkylamine catabolic process (GO:0046218),-0.29048437127826576,-0.646550630017189,0.9036608863198459,0.9839347828459492,1.0,4/10,32.08%,KYAT1;KMO;IL4I1;HAAO
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.2695428245015963,-0.6463669392974055,0.9063670411985019,0.9835239661636703,1.0,1/11,2.15%,GAS6
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.18198158439429057,-0.6459998885725435,0.982051282051282,0.9832465142409428,1.0,24/53,40.92%,CHRM3;HTR2A;HRH1;CALCRL;MC5R;NPY1R;HRH2;TSHR;NPY;HTR2C;CCL2;CHRM1;AGT;HTR1A;HTR1B;HTR1F;OPRM1;HRH3;CHRM5;CCR1;HTR6;CNR2;HTR1D;SSTR1
prerank,fatty acid transport (GO:0015908),0.25529523353453165,0.6449001999993668,0.8988095238095238,1.0,1.0,2/17,9.87%,ACSL1;SLC27A1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.2858859178808413,0.6444574841589289,0.8531914893617021,1.0,1.0,5/10,21.35%,CCL19;AXL;LYN;LGALS9;RAPGEF2
prerank,DNA duplex unwinding (GO:0032508),0.20751827232249997,0.6442305985907553,0.956989247311828,1.0,1.0,17/50,21.10%,ANXA1;DDB2;BLM;SSBP1;RTEL1;CUL4B;MRE11;RAD23B;WRN;MCM2;RAD51;XPC;PURA;MCM7;RECQL5;RAD50;NBN
prerank,DNA strand elongation (GO:0022616),0.25205274368425784,0.6434178546884376,0.8957055214723927,1.0,1.0,8/18,23.20%,DCLRE1B;MRE11;POLD2;MCM7;RAD50;GINS3;NBN;RFC4
prerank,eye photoreceptor cell development (GO:0042462),-0.2515304797123913,-0.6432134221571171,0.904397705544933,0.9846253794080997,1.0,4/15,20.04%,RP1;VEGFA;RORB;THY1
prerank,regulation of protein sumoylation (GO:0033233),0.2649580572725394,0.6431951851735437,0.8795918367346939,1.0,1.0,3/17,8.19%,ZMIZ1;RWDD3;PIAS1
prerank,negative regulation of intracellular protein transport (GO:0090317),0.244448638384837,0.6423875056435545,0.9029126213592233,1.0,1.0,3/22,6.47%,SP100;LRRK2;SUFU
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.2969288191522791,0.6412087902664259,0.8784313725490196,1.0,1.0,4/10,20.51%,TGFA;AREG;HBEGF;ADRA2A
prerank,protein processing (GO:0016485),0.18371094569832208,0.6410783300653944,0.9874411302982732,1.0,1.0,5/102,4.11%,AEBP1;KLK2;CTSH;PCSK9;MYRFL
prerank,cardiolipin metabolic process (GO:0032048),-0.25747845065729513,-0.6406573826644885,0.9043824701195219,0.985788731995934,1.0,2/13,15.14%,CRLS1;PLA2G4A
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.24642547280016586,0.640608674627916,0.8918918918918919,1.0,1.0,6/19,18.62%,AMPD3;TYMS;ADK;APRT;GMPR2;POLD2
prerank,positive regulation of chemokine production (GO:0032722),-0.19352859293161817,-0.6404989104496754,0.968609865470852,0.9853438681935283,1.0,16/44,35.47%,IL33;MBP;APP;CD74;CSF1R;TIRAP;AGER;ADCYAP1;TLR7;TLR4;LPL;MAVS;TSLP;IL7;SYK;ADAM17
prerank,DNA integrity checkpoint signaling (GO:0031570),0.22241443032254987,0.640118696502515,0.9434628975265018,1.0,1.0,10/36,21.10%,ATRIP;HUS1B;CLSPN;FBXO6;CLOCK;CEP63;BRIP1;RAD9B;MAP3K20;NBN
prerank,regulation of defense response to virus by host (GO:0050691),-0.21190950806305692,-0.6394108156834576,0.9655172413793104,0.9854972252252621,1.0,13/30,35.50%,HSP90AA1;AIM2;ZC3H12A;TNFAIP3;STAT1;TRIM44;CGAS;SIN3A;DHX9;MAVS;PTPN22;PQBP1;IFNLR1
prerank,regulation of telomere capping (GO:1904353),-0.22086139619875694,-0.6383819075511733,0.9354166666666667,0.9856346784211859,1.0,1/23,0.72%,NEK7
prerank,coenzyme A metabolic process (GO:0015936),-0.25308863949423677,-0.638022424518549,0.9210526315789473,0.9853297616035089,1.0,4/14,29.33%,PPCDC;ACLY;PANK2;PANK3
prerank,positive regulation of RNA splicing (GO:0033120),-0.21004418129766877,-0.6372477980808945,0.95,0.9852936290954417,1.0,11/29,33.16%,RBMXL1;HNRNPLL;RBM22;TRA2B;RBM20;ZPR1;PRDX6;ERN1;DAZAP1;CELF4;HSPA1A
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.24486629243077934,0.6356570077867967,0.914396887159533,1.0,1.0,4/21,13.89%,MITF;MED1;MED13;SRF
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.22595377408582257,0.6349549313743053,0.936046511627907,1.0,1.0,7/28,18.39%,MRNIP;AUNIP;PRKDC;PARP9;HSF1;DTX3L;KDM4D
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.28022955926516474,0.6343181901787663,0.876984126984127,1.0,1.0,2/12,7.55%,CLCN2;H6PD
prerank,protein localization to condensed chromosome (GO:1903083),0.27457782428987804,0.6329205039331612,0.8987068965517241,1.0,1.0,3/12,15.71%,TTK;CDK1;MIS12
prerank,regulation of lipid catabolic process (GO:0050994),0.256287126335047,0.6327053963180488,0.8886756238003839,1.0,1.0,5/19,20.88%,PRKAA1;APOC1;ADRA2A;LONP2;RARRES2
prerank,mucosal immune response (GO:0002385),0.2651047199466621,0.6317316270856318,0.8991769547325102,1.0,1.0,1/15,2.73%,LTF
prerank,positive regulation of T cell differentiation (GO:0045582),-0.19933725659487903,-0.6311889610825939,0.9714912280701754,0.9885582087486473,1.0,18/36,40.85%,LEF1;SOX4;XBP1;NKAP;NCKAP1L;SOCS1;VSIR;IL4I1;SHH;VNN1;MDK;IL7;ZAP70;GATA3;TESPA1;IL12RB1;IL4;BCL6
prerank,regulation of protein acetylation (GO:1901983),-0.25850000582433724,-0.629132312228868,0.9015151515151515,0.9892970721171522,1.0,3/12,24.08%,GSK3B;TERF2IP;CEP295
prerank,tRNA methylation (GO:0030488),0.2208158877930525,0.6287662416866956,0.9315068493150684,1.0,1.0,7/34,17.60%,HSD17B10;THADA;LCMT2;TRDMT1;MTO1;THUMPD3;TRMT1L
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.2545757206742541,0.6285149567558831,0.9070247933884298,1.0,1.0,1/17,3.14%,NOS1AP
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.2395855882688549,0.6268571520172138,0.9194499017681729,1.0,1.0,3/22,7.12%,PSME4;PSMA2;PSMA3
prerank,sister chromatid segregation (GO:0000819),0.2238060724125184,0.6268484272147042,0.9272727272727272,1.0,1.0,11/31,20.37%,TOP2B;LATS1;NSL1;KLHL22;DSN1;INO80;MIS12;TUBG1;KIF18A;KIF18B;NCAPG2
prerank,defense response to fungus (GO:0050832),-0.23341452314940453,-0.6267758460709655,0.9302788844621513,0.990135943823609,1.0,3/17,15.75%,PLCG2;GAPDH;CX3CR1
prerank,regulation of pH (GO:0006885),0.2763516217744582,0.6262851978655667,0.8817427385892116,1.0,1.0,1/11,3.68%,LACC1
prerank,phasic smooth muscle contraction (GO:0014821),-0.2727306975575381,-0.6260020859759716,0.9092627599243857,0.9900490234559683,1.0,2/10,13.78%,EDN1;PTGER3
prerank,transcription by RNA polymerase I (GO:0006360),0.2185731315181442,0.6259712482444112,0.955078125,1.0,1.0,8/34,16.97%,CDK7;TAF1A;POLR1F;POLR1A;TAF1D;MNAT1;TCOF1;POLR1G
prerank,spliceosomal snRNP assembly (GO:0000387),0.2080593648534967,0.6251970658159389,0.9466911764705882,1.0,1.0,9/38,19.87%,PRMT7;SMN1;PRPF3;COIL;USP4;PRPF6;GEMIN5;LSM4;SNRPF
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.2469356193021614,-0.6251241558499601,0.9277566539923955,0.9900068183828743,1.0,5/14,33.63%,CMPK1;AK5;NME2;ITPA;DCTPP1
prerank,axonal transport of mitochondrion (GO:0019896),-0.267396506407683,-0.6249617463461135,0.9148514851485149,0.9895650925243367,1.0,3/11,25.13%,ACTR10;NEFL;HAP1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.2290579753417088,0.6248663137369693,0.9247104247104247,1.0,1.0,1/26,1.07%,PPARA
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.26410844204932027,-0.6236686347924092,0.9121863799283154,0.9892218739195987,1.0,2/11,10.34%,LARP7;MEPCE
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.26410844204932027,-0.6236686347924092,0.9121863799283154,0.9892218739195987,1.0,2/11,10.34%,LARP7;MEPCE
prerank,positive regulation of growth (GO:0045927),0.19356756019484508,0.623289098891148,0.9785478547854786,1.0,1.0,17/64,20.46%,BCL2;PLCB1;SPHK1;ERBB2;KLHL22;ADNP2;S100A9;INO80;CIB1;HYAL1;N6AMT1;SDCBP;SFRP1;DDX3X;TAF9B;USP47;DERL2
prerank,glycogen catabolic process (GO:0005980),0.26006871796456565,0.6230916499912581,0.8968421052631579,1.0,1.0,1/15,1.70%,PHKB
prerank,dermatan sulfate metabolic process (GO:0030205),0.2665805804521497,0.6226232587899635,0.8973305954825462,1.0,1.0,1/13,1.72%,UST
prerank,aromatic amino acid family catabolic process (GO:0009074),0.2599563139132116,0.6218860206983623,0.9124236252545825,1.0,1.0,3/15,15.20%,FAH;AADAT;GSTZ1
prerank,replicative senescence (GO:0090399),-0.2588845725302917,-0.621699696749386,0.9210526315789473,0.9897566239785417,1.0,5/12,24.74%,WNT16;CHEK2;ROMO1;ATR;CHEK1
prerank,pigment granule transport (GO:0051904),0.2441536829764635,0.6206093389765014,0.9123505976095617,1.0,1.0,4/18,14.67%,ARL6;GPR143;BBS7;RAB11B
prerank,melanosome transport (GO:0032402),0.2441536829764635,0.6206093389765014,0.9123505976095617,1.0,1.0,4/18,14.67%,ARL6;GPR143;BBS7;RAB11B
prerank,photoperiodism (GO:0009648),-0.20804771047172302,-0.6205768981778759,0.9568034557235421,0.989864430082302,1.0,7/28,19.97%,BHLHE40;FBXL3;PPP1CA;PER1;ID2;PPP1CB;PPP1CC
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.24945545852875967,-0.6188408537864318,0.924,0.9902762461122686,1.0,4/14,18.45%,RTCB;RTRAF;CLP1;CSTF2
prerank,cholesterol biosynthetic process (GO:0006695),0.21963553206831948,0.6182279411836553,0.9339805825242719,1.0,1.0,5/31,11.27%,INSIG2;PMVK;ACAA2;ACAT2;FDPS
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.18483613318128272,0.6181285675623639,0.9834983498349835,1.0,1.0,12/78,14.18%,NR2F2;CDK7;BLM;PTEN;CCNT2;CCNT1;CDK5RAP1;LATS1;CCNE1;PKD2;CDKN1C;MNAT1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.1711785117650129,0.6179758076876808,0.9923664122137404,1.0,1.0,16/125,12.78%,EML4;KIF2A;ITGB3BP;PTPA;CENPI;TTK;BIRC5;PAFAH1B1;SKA2;NUP107;NSL1;MAD1L1;CENPQ;DSN1;DCTN6;SUN2
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.24091360412158475,0.616244623813723,0.9145631067961165,1.0,1.0,4/19,15.56%,HNRNPC;ACD;DCP2;STN1
prerank,negative regulation of hormone secretion (GO:0046888),0.2744456503867031,0.6160076678594645,0.8781512605042017,1.0,1.0,3/10,17.69%,GJA1;IL11;RAB11FIP3
prerank,mRNA methylation (GO:0080009),-0.24045066557824893,-0.6157109818867232,0.9412915851272016,0.9914517291323044,1.0,4/15,23.62%,TRMT61B;METTL3;TRMT10C;PCIF1
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.2592404267744358,-0.6155735924206566,0.9200779727095516,0.9909928785043249,1.0,8/11,50.44%,ZFP36L1;AHCYL1;BARD1;NCBP2;LEO1;PAPOLA;NCBP1;ZC3H3
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.23992213738501283,0.6151488489248015,0.9330708661417323,1.0,1.0,2/23,6.13%,GSTM2;EPHX2
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.25269420456725483,0.6149698832618901,0.92,1.0,1.0,3/15,10.17%,TNRC6B;TNRC6A;AGO2
prerank,peptide hormone secretion (GO:0030072),0.2229170090317913,0.6139378745546145,0.9236234458259325,1.0,1.0,3/26,7.95%,ANXA1;IL6;SLC30A8
prerank,androgen metabolic process (GO:0008209),0.2450668779931559,0.6136296078627174,0.9155470249520153,1.0,1.0,2/18,10.06%,HSD17B10;MED1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.24972354815820008,0.613599905004491,0.9134808853118712,1.0,1.0,3/15,13.43%,HUS1B;MDC1;MRE11
prerank,DNA modification (GO:0006304),-0.2131964508078678,-0.6132713597049515,0.9453781512605042,0.9916788540985169,1.0,6/22,21.96%,SMUG1;OGG1;TERF2IP;NEIL1;NEIL3;NTHL1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.24681709833950566,0.6131990758163756,0.9247967479674797,1.0,1.0,7/17,19.37%,CCNT1;HSF1;RNF20;ZC3H14;CTR9;NUDT21;CDK9
prerank,cellular response to light stimulus (GO:0071482),-0.16854642421682056,-0.6122360498978855,0.9903846153846154,0.991660588942122,1.0,23/66,36.28%,RPL26;ATF4;COPS9;POLK;USP28;N4BP1;ATR;PRKCD;NOC2L;METTL3;FMR1;BMF;POLD1;GNB1;OPN3;TMEM161A;GPR52;SAG;NPM1;YY1;CDC25A;CASP9;PTPRK
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.26931064719336784,-0.6111689189108522,0.9343629343629344,0.9916783088741897,1.0,3/10,23.62%,PIH1D1;RUVBL1;PIH1D2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.2619537504444881,-0.6111015867862107,0.9117082533589251,0.9911711963723031,1.0,2/11,16.90%,CTNNB1;NR4A2
prerank,eosinophil migration (GO:0072677),-0.2384645976920875,-0.6105999991351119,0.9418386491557224,0.9903854204987231,1.0,10/14,50.77%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),-0.2384645976920875,-0.6105999991351119,0.9418386491557224,0.9903854204987231,1.0,10/14,50.77%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,covalent chromatin modification (GO:0016569),0.2536827614020642,0.6096657245386397,0.8951781970649895,1.0,1.0,2/14,10.71%,UFL1;HDAC1
prerank,membrane protein proteolysis (GO:0033619),-0.19022086491802198,-0.6094324233983996,0.9743589743589743,0.9904749649094747,1.0,8/37,23.41%,ADAM10;TGFB1;MYH9;RET;ADAM9;PSEN1;MBTPS1;RELA
prerank,membrane lipid catabolic process (GO:0046466),-0.26709573747879783,-0.6093085952656339,0.9309664694280079,0.9900120302875569,1.0,2/10,15.18%,SGPL1;CYP1B1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.2240179490693421,0.6088883221304974,0.9276437847866419,1.0,1.0,6/27,18.86%,LPAR1;F2RL2;F2RL3;GPR157;DRD2;GPR35
prerank,glycogen biosynthetic process (GO:0005978),0.2647560072752214,0.6073419068167765,0.8972162740899358,1.0,1.0,2/12,9.46%,GYS1;NHLRC1
prerank,glucan biosynthetic process (GO:0009250),0.2647560072752214,0.6073419068167765,0.8972162740899358,1.0,1.0,2/12,9.46%,GYS1;NHLRC1
prerank,epithelial cell development (GO:0002064),-0.22037475174701812,-0.6069357104066658,0.9568788501026694,0.9906364384015706,1.0,2/20,6.95%,SIPA1L3;ACTA2
prerank,regulation of gene silencing by miRNA (GO:0060964),0.18398461415324058,0.605689525506805,0.9759450171821306,1.0,1.0,7/62,11.28%,POLR2D;TNRC6A;NDC1;POLR2A;NUP107;AGO2;FXR1
prerank,cobalamin metabolic process (GO:0009235),0.250806125098297,0.6055819665809399,0.9384920634920635,1.0,1.0,4/17,21.30%,TCN2;MMAB;LMBRD1;TCN1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.2669152702796146,-0.6048194505606782,0.9011406844106464,0.9911873220686153,1.0,1/10,6.01%,CTNNB1
prerank,protein targeting to membrane (GO:0006612),0.177904842066315,0.6043782237595179,0.9865092748735245,1.0,1.0,16/83,17.78%,PARD3;RAB3IP;PXMP2;ZDHHC1;ARL6;ZDHHC3;MICALL1;PXMP4;VPS37A;VPS37C;PRKCI;ATG3;VPS37D;SDCBP;SGTA;TAOK2
prerank,DNA replication (GO:0006260),0.171350654084322,0.6040927802639288,0.989329268292683,1.0,1.0,29/105,21.10%,RBMS1;ATRIP;BAZ1A;BLM;NT5M;CDK1;CLSPN;REV1;RFC1;ORC2;CDK2AP1;MRE11;TOP1MT;WRN;ORC3;MCM2;NAP1L1;BRIP1;RNASEH2A;RPAIN;ORC6;POLD2;MCM7;POLG2;RAD9B;KAT5;RECQL5;RAD50;NBN
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.25810881180496337,-0.6040618115857053,0.9147727272727273,0.9904899529184144,1.0,6/11,33.97%,PTK2B;JAK3;JAK1;IL2RA;IL2RG;SYK
prerank,cellular response to interleukin-2 (GO:0071352),-0.25810881180496337,-0.6040618115857053,0.9147727272727273,0.9904899529184144,1.0,6/11,33.97%,PTK2B;JAK3;JAK1;IL2RA;IL2RG;SYK
prerank,negative regulation of B cell proliferation (GO:0030889),-0.257319119647926,-0.6035486509851486,0.9310344827586207,0.9902077098928297,1.0,4/11,22.88%,TNFRSF21;TYROBP;CD300A;FCGR2B
prerank,ncRNA 3'-end processing (GO:0043628),0.2489851495258782,0.6034060405254168,0.9140461215932913,1.0,1.0,4/14,17.80%,TRNT1;INTS8;ERI1;INTS14
prerank,neuron fate commitment (GO:0048663),0.2520453900011069,0.6021318588793774,0.9175050301810865,1.0,1.0,1/14,3.21%,EPOP
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.21518468698170073,-0.6020919386928696,0.9559118236472945,0.9903715017716227,1.0,6/20,21.75%,PUM2;ZC3H7A;AGO3;SNIP1;TSN;TSNAX
prerank,alpha-amino acid metabolic process (GO:1901605),0.20035607269565803,0.6017558854067808,0.9750889679715302,1.0,1.0,7/45,14.79%,CBS;MTHFR;SRR;RIMKLB;KYAT3;AADAT;ASPA
prerank,neuromuscular process controlling balance (GO:0050885),0.264837186546249,0.6015774256712151,0.89738430583501,1.0,1.0,2/12,8.84%,TPP1;PAFAH1B1
prerank,autophagy of nucleus (GO:0044804),0.25047904556591133,0.6015393798935482,0.9223107569721115,1.0,1.0,3/16,15.63%,WIPI1;ATG9A;ATG3
prerank,rRNA methylation (GO:0031167),-0.21427630383172847,-0.6015208130870969,0.9695121951219512,0.9900943882163522,1.0,6/22,23.15%,TFB2M;BUD23;FBL;NSUN4;MRM2;MRM3
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.23311030954329942,-0.6011414201996916,0.9290060851926978,0.9897586394585377,1.0,2/14,9.26%,PPARGC1A;DDB1
prerank,amyloid-beta metabolic process (GO:0050435),0.24193994065250773,0.601138744391111,0.9315068493150684,1.0,1.0,4/16,16.62%,ACE;PSENEN;NAT8;BACE1
prerank,RNA biosynthetic process (GO:0032774),0.21230468588961254,0.6011212171573903,0.9490566037735849,1.0,1.0,4/31,10.63%,POLR2A;RSF1;SMN1;SMARCA5
prerank,cellular response to hydroxyurea (GO:0072711),-0.2655399549080624,-0.6010508196967701,0.9483747609942639,0.989274512510524,1.0,3/10,21.98%,SPIDR;FMR1;RTF2
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.24905042287256302,-0.6009517523834567,0.931640625,0.9887891180783422,1.0,4/12,23.80%,IREB2;SIRT4;ACLY;IDH3A
prerank,tRNA processing (GO:0008033),0.19045385565495676,0.600332407374924,0.9822064056939501,1.0,1.0,13/61,17.07%,TRMT9B;PUS3;TSEN34;TRNT1;LCMT2;TRDMT1;ZBTB8OS;WDR4;FARS2;TSEN2;DTWD1;TYW5;CPSF4
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.1942285879632298,-0.6002245852435053,0.9642105263157895,0.9885960482093948,1.0,14/29,40.08%,RPS2;FEM1A;DCUN1D1;DCUN1D2;PINK1;TRIB3;ARRDC3;SMAD7;PLK1;PARK7;DCUN1D3;FBXW7;DCUN1D4;LIMK1
prerank,extracellular transport (GO:0006858),0.2595518839447271,0.599974857117421,0.8852140077821011,1.0,1.0,2/12,11.67%,WWP2;SPA17
prerank,positive regulation of immunoglobulin production (GO:0002639),0.2106176072893542,0.599473107554808,0.9575757575757575,1.0,1.0,2/31,6.76%,RBP4;IL6
prerank,regulation of lysosomal lumen pH (GO:0035751),0.2617592985700486,0.598741052081246,0.898406374501992,1.0,1.0,2/12,9.02%,LRRK2;TMEM199
prerank,ncRNA export from nucleus (GO:0097064),0.20565306165542047,0.5985552962517499,0.9581818181818181,1.0,1.0,3/36,10.15%,PHAX;NDC1;NUP107
prerank,positive regulation of cytokinesis (GO:0032467),0.2110725375370081,0.5984617465504815,0.9601593625498008,1.0,1.0,3/32,8.59%,CXCR5;CDC14B;PKN2
prerank,regulation of interferon-alpha production (GO:0032647),-0.20978078285422627,-0.5984132205901167,0.9594017094017094,0.9889312457539863,1.0,9/23,32.19%,CHUK;HSPD1;IFIH1;IRF5;STAT1;TLR7;TLR4;DHX9;MAVS
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.20820078513555296,0.5982645539324336,0.9536679536679536,1.0,1.0,8/35,15.46%,ACD;XRCC5;CCT6A;RTEL1;FBXO4;MAPK1;TCP1;PARN
prerank,snRNA processing (GO:0016180),-0.22570506754615954,-0.5969606110350906,0.9349112426035503,0.9890778901262709,1.0,5/16,23.40%,INTS6L;INTS11;INTS6;INTS1;INTS3
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.2622567033466029,-0.5959993167380654,0.9222222222222223,0.9890024606833536,1.0,7/10,50.23%,NFKBIZ;ZC3H12A;SMAD7;RC3H1;IL4;FOXP3;TBX21
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.20840359246783666,0.5955729942657274,0.9590643274853801,1.0,1.0,7/32,16.97%,CDK7;TAF1A;POLR1F;POLR1A;TAF1D;MNAT1;POLR1G
prerank,positive regulation of organelle assembly (GO:1902117),0.19619011453429547,0.5937785354683006,0.9680284191829485,1.0,1.0,8/44,17.07%,ASAP1;ARHGAP35;STX18;CROCC;CNOT2;RAB3GAP1;CEP120;SDCBP
prerank,zymogen activation (GO:0031638),0.20136611317202513,0.5924230727365999,0.9556737588652482,1.0,1.0,2/39,3.31%,KLK2;CTSH
prerank,ncRNA metabolic process (GO:0034660),0.19832734592718346,0.5923578174698728,0.9635701275045537,1.0,1.0,11/37,21.92%,DTD2;AGO2;DICER1;NIFK;PARN;DTD1;TUT4;DDX4;XPO5;PIWIL4;TUT7
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2429411648055047,0.5914312661636866,0.9164882226980728,1.0,1.0,1/16,4.05%,TOP2B
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.24315299833043597,-0.5895128076480678,0.926605504587156,0.9913093824454537,1.0,5/11,40.37%,XBP1;CIITA;TAF7;PF4;IL4
prerank,mRNA modification (GO:0016556),0.22280550911040808,0.5895068719595716,0.9382239382239382,1.0,1.0,3/22,10.80%,PUS3;METTL8;METTL14
prerank,response to hydroxyurea (GO:0072710),-0.24989845460190846,-0.5893536690632184,0.9406130268199234,0.9908570547790172,1.0,3/11,21.98%,SPIDR;FMR1;RTF2
prerank,regulation of endocytic recycling (GO:2001135),-0.23909867214437774,-0.589185368386601,0.9538461538461539,0.9903969139620385,1.0,6/11,41.67%,EHD1;INPP5F;SORL1;EIPR1;EHD2;PLA2G3
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.22125834940408262,0.5888772415316572,0.9537815126050421,1.0,1.0,4/23,15.33%,PLA2G10;PLA2G4B;PLA2G4C;PLA2G12A
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.22800892702685774,-0.5870943465558671,0.95,0.9907431133042207,1.0,3/15,11.27%,NLRC5;ISG15;YTHDF3
prerank,negative regulation of telomere maintenance (GO:0032205),-0.22465197183495517,-0.5870718295346687,0.9574468085106383,0.9902296687148765,1.0,2/15,14.48%,PINX1;TERF2IP
prerank,mitotic nuclear division (GO:0140014),0.1805902869256738,0.5855209473602396,0.9916387959866221,1.0,1.0,18/71,20.69%,SPICE1;KIF2A;KLHDC8B;GOLGA2;OFD1;NSL1;KLHL22;DSN1;INO80;MIS12;TUBG1;KIF18A;KPNB1;LSM14A;KIF18B;TPX2;NCAPG2;SPAST
prerank,respiratory chain complex IV assembly (GO:0008535),-0.2096020199996681,-0.5854920812821997,0.9607438016528925,0.9903614757936045,1.0,9/21,29.04%,SMIM20;COA6;FASTKD3;BCS1L;COA3;COA8;COX15;COX16;COA5
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.2554139727575167,0.5848655216836336,0.9176954732510288,1.0,1.0,11/11,74.48%,TAS1R2;PKD2L1;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;PKD1L3;RTP3;LPO;RTP4
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.21675062574907403,0.5842499687989489,0.9579524680073126,1.0,1.0,4/24,15.56%,HNRNPC;ACD;DCP2;STN1
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.22446335149521557,-0.5833664607854614,0.9553398058252427,0.990679949849767,1.0,2/16,7.28%,TNFRSF1B;AHR
prerank,calcium-ion regulated exocytosis (GO:0017156),0.2137687005502413,0.5811837042889235,0.9690346083788707,1.0,1.0,2/27,4.13%,SYT11;SYT12
prerank,gastrulation (GO:0007369),0.2375786643143678,0.5808282158633523,0.9392156862745098,1.0,1.0,6/15,25.93%,GPC3;UGDH;SMAD2;LMBRD1;NPHP3;MKKS
prerank,tRNA wobble uridine modification (GO:0002098),0.24733121432051655,0.5807263299049255,0.931958762886598,1.0,1.0,3/14,18.44%,TRMT9B;MTO1;MOCS3
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.22308668926503294,0.5795514692187561,0.9668508287292817,1.0,1.0,7/21,18.63%,SAMD4A;CNOT2;PARN;CNOT8;CNOT7;CNOT10;TUT4
prerank,mitochondrial transcription (GO:0006390),0.26831874308735665,0.5795256116088385,0.9191011235955057,1.0,1.0,4/10,23.82%,MTERF2;MRPL12;POLRMT;TFB1M
prerank,nuclear transport (GO:0051169),0.2359151558543358,0.5792645442098034,0.9059304703476483,1.0,1.0,4/16,18.98%,NUTF2;NXT2;PSIP1;RSRC1
prerank,regulation of cholesterol transport (GO:0032374),0.2233800845076922,0.5788349254429057,0.9573643410852714,1.0,1.0,3/20,9.15%,ABCA13;ABCA5;APOC1
prerank,tryptophan metabolic process (GO:0006568),-0.2513200656439998,-0.5788162725828244,0.9426877470355731,0.9919901190205883,1.0,4/11,32.08%,KYAT1;KMO;IL4I1;HAAO
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.25923630910021367,0.5787531751394467,0.9254658385093167,1.0,1.0,4/10,20.95%,CDC73;HSF1;NUDT21;PAF1
prerank,microtubule depolymerization (GO:0007019),0.23628801236208877,0.5770998872260972,0.9273084479371316,1.0,1.0,1/17,1.98%,KIF2A
prerank,smoothened signaling pathway (GO:0007224),-0.18525999946904415,-0.5770391249256216,0.9745958429561201,0.9921638932277246,1.0,9/32,23.92%,PTCH1;DISP2;GLI1;STK36;PTCHD1;DISP3;TTBK2;PTCH2;TCTN3
prerank,purine ribonucleotide metabolic process (GO:0009150),0.17692953621593055,0.5763750343733364,0.9900497512437811,1.0,1.0,18/68,23.63%,TPST1;AMPD3;ACOT4;LRRK2;EPHA2;SULT4A1;ACOT1;RHOQ;GMPR2;ACBD6;ACOT11;BPNT1;RAB23;ACOT13;AK4;AK3;ACOT6;ACAT1
prerank,placenta development (GO:0001890),0.2500165786495717,0.5751473516566911,0.9352226720647774,1.0,1.0,2/12,8.85%,ASCL2;CUL7
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.179460213080451,-0.5683675519008419,0.9894736842105263,0.994828219274778,1.0,17/35,42.42%,CDH11;ATP2C1;CDH13;PCDHB14;CDH12;SELP;CDH10;CDH8;PCDHB5;PCDHB9;PCDHB13;PCDHB3;CDH7;CDH20;PCDHB4;CDH19;DCHS1
prerank,regulation of biosynthetic process (GO:0009889),0.2512083359487792,0.5672916616805781,0.919661733615222,1.0,1.0,11/11,74.90%,SNCA;ALOX5;PIKFYVE;PCK1;UCP1;MID1IP1;CCN6;GSTP1;SLC25A33;THRSP;SPHK2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.18880713382259937,0.5663982566822628,0.9736842105263158,1.0,1.0,6/42,12.56%,LTF;IL6;OPTN;GSDMD;MR1;SERPINE1
prerank,cell proliferation in forebrain (GO:0021846),0.2582224453929199,0.5663391001261866,0.9224318658280922,1.0,1.0,10/10,74.19%,CEP120;AKNA;DOCK7;NUMBL;NUMB;WNT3A;HOOK3;WNT7A;PCM1;KIF14
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.22228166096330135,-0.5660536874251856,0.9443298969072165,0.9951283183091394,1.0,4/15,18.45%,RTCB;RTRAF;CLP1;CSTF2
prerank,apoptotic nuclear changes (GO:0030262),0.21166163939285734,0.5658741639101921,0.9555555555555556,1.0,1.0,4/24,14.92%,ACIN1;CECR2;DICER1;DFFA
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.2188218881906578,-0.5650407504336105,0.9724409448818898,0.9949570115305968,1.0,4/15,25.12%,RACK1;ORMDL2;PRKCD;SPHK2
prerank,tRNA export from nucleus (GO:0006409),-0.18091250942242712,-0.5633918699766409,0.9823399558498896,0.9944741760150667,1.0,16/32,46.02%,SSB;NUP37;NUP54;NUP85;NUP133;POM121;NUP153;NUP42;NOL6;NUP93;NUP35;RAN;SEH1L;NUP160;RAE1;NUP210
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.18091250942242712,-0.5633918699766409,0.9823399558498896,0.9944741760150667,1.0,16/32,46.02%,SSB;NUP37;NUP54;NUP85;NUP133;POM121;NUP153;NUP42;NOL6;NUP93;NUP35;RAN;SEH1L;NUP160;RAE1;NUP210
prerank,miRNA metabolic process (GO:0010586),0.21756663621152417,0.5633714359568706,0.9568627450980393,1.0,1.0,7/20,21.92%,SND1;AGO2;DICER1;PARN;TUT4;XPO5;TUT7
prerank,peptidyl-lysine acetylation (GO:0018394),0.25805323214726494,0.563009133272879,0.9253112033195021,1.0,1.0,4/10,20.52%,ESCO1;CREBBP;KAT2B;KAT5
prerank,protein localization to centrosome (GO:0071539),-0.21051535802796,-0.562746303021746,0.9570552147239264,0.9941680933203451,1.0,5/17,33.73%,CEP83;SPAG5;PCM1;CEP131;STIL
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.22418838244354203,0.5625279080268019,0.9640831758034026,1.0,1.0,7/19,23.08%,POLR3G;ICE2;AR;POLR3C;ELL;NAB2;ICE1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.23184754429216434,0.5623746555510161,0.946360153256705,1.0,1.0,6/16,22.24%,NUPR1;COX7A2L;PDE12;COX7A2;ATP7A;AK4
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.22345193006939623,-0.5618701583464966,0.9664031620553359,0.993948233203641,1.0,5/14,33.20%,RAB1A;SEC23A;SEC31A;SEC23B;SEC31B
prerank,sensory perception of pain (GO:0019233),-0.1977575242381569,-0.5617007370026521,0.9683544303797469,0.9934869194692013,1.0,9/21,37.05%,TRPA1;CCR2;CCL2;ALOXE3;P2RX7;NIPSNAP1;KCNA2;PROK2;OPRM1
prerank,tetrapyrrole metabolic process (GO:0033013),0.22741356026393916,0.5608853486335242,0.9596153846153846,1.0,1.0,1/18,3.74%,TCN2
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.2446064802446684,0.5601936481801428,0.9465811965811965,1.0,1.0,2/12,9.35%,HUS1B;CLSPN
prerank,cell cycle G1/S phase transition (GO:0044843),0.17201727984450033,0.559107837309548,0.9933993399339934,1.0,1.0,10/61,14.83%,CDK7;EIF4EBP1;NASP;PHF8;LATS1;RPS6KB1;CUL4B;CCNE1;MNAT1;CDK4
prerank,tRNA wobble base modification (GO:0002097),0.2363580511999755,0.5582327914974431,0.9516806722689075,1.0,1.0,3/14,18.44%,TRMT9B;MTO1;MOCS3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.2506529835177677,0.5541599264390437,0.9379014989293362,1.0,1.0,1/11,2.58%,GSTM2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.2506529835177677,0.5541599264390437,0.9379014989293362,1.0,1.0,1/11,2.58%,GSTM2
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.21698505245831334,-0.5503222245142266,0.9720149253731343,0.9965001799982329,1.0,1/13,2.90%,RPS15
prerank,neuropeptide signaling pathway (GO:0007218),-0.15389525741606716,-0.5480162279533344,0.9975669099756691,0.9966653756157048,1.0,12/58,25.74%,SORCS2;CYSLTR1;CYSLTR2;NXPH2;GPR149;GLRA3;SORCS1;NPY;PNOC;SORL1;ADCYAP1;GLRA1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.2454038574094079,0.5474864358278783,0.9334811529933481,1.0,1.0,2/10,13.79%,AGO2;DICER1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.1942013654827458,0.547103307109804,0.9774859287054409,1.0,1.0,3/31,6.94%,CTLA4;LST1;PDCD1LG2
prerank,response to light stimulus (GO:0009416),0.17100474287159342,0.5468071798507803,0.998330550918197,1.0,1.0,12/55,17.80%,DDB2;AANAT;REV1;DCT;CRY1;PRIMPOL;CLOCK;UBE2A;GPR88;BRSK1;DRD2;UBE4B
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.23902468524342002,-0.5442570602735011,0.9642857142857143,0.9972231763123787,1.0,1/10,3.24%,PDE8A
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.19323351337497652,0.5435825950012073,0.96,1.0,1.0,4/31,9.66%,CDC14B;UBE2L3;PTEN;GOLGA2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.2499294970245415,0.5428036747544146,0.9513888888888888,1.0,1.0,1/10,2.73%,LTF
prerank,snRNA 3'-end processing (GO:0034472),0.2128880039607101,0.5426000751321747,0.9665354330708661,1.0,1.0,5/19,18.60%,INTS8;EXOSC8;TUT1;INTS14;EXOSC3
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.21576039022130114,0.5424088260931927,0.9726315789473684,1.0,1.0,6/18,20.24%,CCT6A;DCP2;TCP1;PARN;SHQ1;RUVBL2
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.2294518164035082,-0.5423210298179943,0.9690522243713733,0.9967006933050055,1.0,4/11,21.52%,NOTCH4;TNRC6C;AGO3;EIF6
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.2294518164035082,-0.5423210298179943,0.9690522243713733,0.9967006933050055,1.0,4/11,21.52%,NOTCH4;TNRC6C;AGO3;EIF6
prerank,regulation of mast cell activation (GO:0033003),0.24002008536279182,0.5416143746009654,0.9392624728850325,1.0,1.0,10/10,76.01%,NECTIN2;LYN;CD84;CD300LF;PLSCR1;HAVCR1;CD226;TSLP;MILR1;CRLF2
prerank,mitochondrial RNA metabolic process (GO:0000959),0.23120139720871896,0.5405973015642013,0.9508547008547008,1.0,1.0,4/14,23.82%,MTERF2;MRPL12;POLRMT;TFB1M
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.18989533338927866,0.5385105044927189,0.98635477582846,1.0,1.0,7/32,15.46%,ACD;XRCC5;CCT6A;FBXO4;MAPK1;TCP1;PARN
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.21904527272050411,-0.5371144768138356,0.9776951672862454,0.9976034463326259,1.0,9/13,54.50%,DUSP1;GEN1;NDC80;XRCC3;CCNB1;PCID2;DYNC1LI1;LCMT1;USP44
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.18071814731419517,0.5367499246458761,0.9875666074600356,1.0,1.0,7/40,14.02%,NEK4;FEM1B;ABL1;FXR1;NPAS2;CRY1;UBE2V1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.1565398272902104,0.5353912902654646,1.0,1.0,1.0,18/83,19.76%,CDK7;EIF4EBP1;NASP;PHF8;TYMS;LATS1;RPS6KB1;CUL4B;CCNE1;TFDP2;MNAT1;CDK15;CDK4;BACH1;NPAT;CAMK2A;DHFR;CCNE2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.1827917697672837,0.53512876548813,0.9873188405797102,1.0,1.0,5/36,13.35%,PRKN;CSF1;AXL;PARP9;ZBP1
prerank,regulation of microtubule-based movement (GO:0060632),-0.22637979617318457,-0.5348905546475994,0.9639278557114228,0.9976399064033562,1.0,4/11,29.62%,LAMP1;HDAC6;HAP1;DYNLT2B
prerank,mesenchymal to epithelial transition (GO:0060231),0.23913185329276726,0.533426068782243,0.952191235059761,1.0,1.0,2/10,15.68%,SALL1;FZD7
prerank,protein targeting to peroxisome (GO:0006625),0.1891764914130804,0.5320781500496528,0.9763313609467456,1.0,1.0,5/29,15.19%,PXMP2;ZFAND6;PXMP4;HACL1;PEX7
prerank,mitochondrion distribution (GO:0048311),0.22712202540104018,0.5316263538371258,0.946611909650924,1.0,1.0,3/12,15.36%,LRRK2;TRAK1;TRAK2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.22218460656831285,0.5305061835428491,0.9580838323353293,1.0,1.0,3/15,15.24%,ZC3H12B;DICER1;NYNRIN
prerank,chromosome condensation (GO:0030261),0.1816155914679874,0.5270155821936198,0.9947275922671354,1.0,1.0,9/36,20.37%,ACIN1;PHF8;CDK1;AKAP8L;BANF2;MCPH1;AIFM1;SMC2;NCAPG2
prerank,dendritic cell migration (GO:0036336),-0.2015429556729663,-0.5266768106509133,0.9823874755381604,0.9990653047302113,1.0,7/16,39.71%,EPS8;TRPM4;CCR2;TRPM2;CCL5;PIK3CG;CCR1
prerank,long-term memory (GO:0007616),0.20281263480145706,0.5263750680639748,0.9716981132075472,1.0,1.0,5/19,20.44%,ARC;NFATC4;SLC2A4;CALB1;RASGRF1
prerank,dopaminergic neuron differentiation (GO:0071542),-0.1950026516823492,-0.5259562442448199,0.9778225806451613,0.9987193666782048,1.0,7/19,36.00%,CTNNB1;VEGFA;NR4A2;LMX1A;SHH;MANF;LMX1B
prerank,autophagy of peroxisome (GO:0030242),-0.21177432371275928,-0.525251346534457,0.974609375,0.9983439587951438,1.0,3/12,20.38%,MAP1LC3B;PIK3C3;PEX5
prerank,positive regulation of chromosome organization (GO:2001252),-0.20611320426917806,-0.5248779314542504,0.9803921568627451,0.9979122335088831,1.0,4/15,23.55%,GNL3;PPP1R10;LIG4;SIRT6
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.19337250870124922,-0.5241890542131191,0.9801980198019802,0.9975429012595065,1.0,10/19,40.37%,GAS6;XBP1;PPP2R3C;NCKAP1L;MDK;IL7;SYK;ZAP70;GATA3;IL4
prerank,regulation of rRNA processing (GO:2000232),0.21546108217329513,0.5239028254622757,0.9674134419551935,1.0,1.0,5/16,19.96%,YTHDF2;DIMT1;SHQ1;RIOK1;KAT2B
prerank,pre-miRNA processing (GO:0031054),0.22182273461255975,0.5199179589635843,0.9678714859437751,1.0,1.0,5/14,21.92%,AGO2;DICER1;TUT4;AGO1;TUT7
prerank,regulation of double-strand break repair (GO:2000779),-0.1584897971298457,-0.5184354315481977,0.9978021978021978,0.9982573467896163,1.0,15/39,34.12%,SPIDR;ACTR2;OTUB1;TERF2IP;SPIRE1;PPP4R2;SIRT7;SIRT6;CHEK1;ZCWPW1;SHLD2;PPP4C;MGMT;RPA2;FIGNL1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.23567306862744672,0.5183211052593906,0.9651639344262295,1.0,1.0,2/10,12.90%,SSBP1;INO80
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.16553639276104978,0.5159324887994103,0.9946996466431095,1.0,1.0,10/51,15.56%,HNRNPC;ACD;XRCC5;CCT6A;FBXO4;DCP2;MAPK1;TCP1;PARN;STN1
prerank,DNA methylation or demethylation (GO:0044728),-0.190814076003861,-0.5158625398460306,0.9836065573770492,0.9977131784515093,1.0,7/19,41.07%,KMT2E;EHMT2;DNMT1;HELLS;TEX15;SPOCD1;DNMT3B
prerank,DNA alkylation (GO:0006305),-0.190814076003861,-0.5158625398460306,0.9836065573770492,0.9977131784515093,1.0,7/19,41.07%,KMT2E;EHMT2;DNMT1;HELLS;TEX15;SPOCD1;DNMT3B
prerank,protein methylation (GO:0006479),0.1724161757056412,0.514429052294808,0.9929824561403509,1.0,1.0,4/40,9.91%,CAMKMT;PRMT7;EEF1AKMT1;NSD1
prerank,rRNA catabolic process (GO:0016075),-0.1930475698285077,-0.5124314110796059,0.9848812095032398,0.9978776963078461,1.0,8/16,40.49%,TRIR;PELO;EXOSC10;EXOSC5;DEDD2;EXOSC2;ERN2;EXOSC9
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.22638917417331472,0.5116160433055055,0.9631147540983607,1.0,1.0,2/12,10.51%,PLK5;PRKDC
prerank,regulation of platelet activation (GO:0010543),-0.18301451863256182,-0.5113877787962611,0.9874739039665971,0.9975425680030404,1.0,1/21,0.98%,NOS3
prerank,ncRNA catabolic process (GO:0034661),-0.16734133377952395,-0.510137902953749,0.9954545454545455,0.997261381033532,1.0,14/28,41.78%,TRIR;LIN28B;MTREX;EXOSC10;NUDT16;DIS3L2;EXOSC5;TENT4B;NUDT16L1;DEDD2;EXOSC2;ERN2;EXOSC9;ZCCHC8
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.22143100710381186,0.5084472454768987,0.9711934156378601,1.0,1.0,2/12,12.49%,FDXR;AKR1B1
prerank,positive regulation of DNA recombination (GO:0045911),0.18369597077400618,0.5079835623897176,0.9859719438877755,1.0,1.0,3/27,8.47%,MRNIP;WDR48;ARID2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.21005805355271434,0.5078473198563355,0.9548133595284872,1.0,1.0,1/14,5.66%,DDX60
prerank,protein localization to kinetochore (GO:0034501),0.2122816757003888,0.5068012809060388,0.9588744588744589,1.0,1.0,3/14,15.71%,TTK;CDK1;MIS12
prerank,positive regulation of interferon-beta production (GO:0032728),0.18151381401017747,0.5064168846702269,0.9981343283582089,1.0,1.0,6/33,13.90%,POLR3G;TRIM56;RNF135;IRF3;TBK1;POLR3C
prerank,DNA replication checkpoint signaling (GO:0000076),0.20475504750566625,0.5045059882662686,0.9766536964980544,1.0,1.0,2/16,9.35%,HUS1B;CLSPN
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.2041267851288754,-0.5043416468519283,0.9761029411764706,0.9977752020680027,1.0,5/13,40.37%,LAMP1;SPHK2;ITGB2;SYK;IL4
prerank,protein import into mitochondrial matrix (GO:0030150),-0.18513895896859336,-0.5021806494641834,0.980276134122288,0.9976431547327561,1.0,5/18,29.63%,TOMM20;ROMO1;TIMM50;TIMM44;DNLZ
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.2058795838761732,-0.5010322895280869,0.9734848484848485,0.9973315304874405,1.0,7/12,45.42%,RMDN1;BOD1;NDC80;KIF2C;SEH1L;CDT1;CENPC
prerank,peptidyl-amino acid modification (GO:0018193),-0.2191187547075069,-0.5003811242547179,0.98635477582846,0.9969138537181916,1.0,10/10,78.11%,FKBP10;PDF;APOA1;METAP1D;APOA2;METAP1;METAP2;TTLL4;FKBP7;ATP7A
prerank,negative regulation of lipid catabolic process (GO:0050995),0.20336006454987454,0.49984797775311474,0.9757009345794393,1.0,1.0,3/17,14.04%,PRKAA1;APOC1;PLIN5
prerank,primary miRNA processing (GO:0031053),-0.21638832818349757,-0.49980161094567416,0.9742173112338858,0.9964902213135058,1.0,4/10,30.37%,DGCR8;METTL3;SMAD1;DROSHA
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.20158293780686082,0.4975600340722209,0.9730290456431535,1.0,1.0,2/17,8.73%,TTK;CDK1
prerank,histone mRNA metabolic process (GO:0008334),0.18006813197626573,0.4966963843637106,0.9981751824817519,1.0,1.0,10/27,23.35%,TENT2;TUT1;DCP2;ERI1;TUT4;LSM1;SNRPF;XRN1;TUT7;EXOSC4
prerank,nuclear pore organization (GO:0006999),0.20926723134343228,0.4965824544386242,0.9667359667359667,1.0,1.0,2/14,10.15%,NDC1;NUP107
prerank,mRNA catabolic process (GO:0006402),0.16620073960263249,0.49352175214732996,0.9981851179673321,1.0,1.0,15/44,23.70%,YTHDF2;NBDY;DHX34;DCP2;NUDT12;LSM5;CNOT10;TUT4;PDE12;AGO1;XRN1;TUT7;THRAP3;EXOSC4;LSM6
prerank,cellular response to pH (GO:0071467),-0.18678334292737941,-0.49208340318558,0.9852941176470589,0.9971854432491949,1.0,4/17,29.52%,CHP1;RAB11FIP5;MCOLN1;ASIC1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.20329043054542728,0.49100081384044586,0.9686847599164927,1.0,1.0,1/15,3.63%,RIPOR2
prerank,acetyl-CoA metabolic process (GO:0006084),-0.1919750363634795,-0.49098730502396826,0.9920948616600791,0.9968317573014244,1.0,3/15,19.50%,ACACA;HMGCS1;ACLY
prerank,regulation of DNA metabolic process (GO:0051052),-0.14591308432905264,-0.49075562668319084,0.9976470588235294,0.9963508200597205,1.0,17/44,34.93%,WDR70;WRNIP1;TERF2IP;UBE2V2;SMG5;SIRT7;SMARCAD1;HNRNPD;TOM1L1;SMG6;ALYREF;SUB1;PIF1;HELB;KPNA2;TICRR;IL7R
prerank,regulation of lipase activity (GO:0060191),0.20658185211281216,0.4892149625964497,0.9681528662420382,0.9998992161482283,1.0,4/13,18.24%,LIPC;PLIN5;LMF1;SNCA
prerank,fibrinolysis (GO:0042730),0.21326667692555612,0.4892011259261852,0.9783037475345168,0.999348973075342,1.0,12/13,59.72%,SERPINE1;PLAU;HRG;PLG;SERPINF2;FGG;PLAT;KRT1;F2;GP1BA;CPB2;SERPINB2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.1833714457890761,0.4889615300456879,0.9928952042628775,0.9988426889743419,1.0,6/25,23.29%,CCNT2;CCNT1;ELL;LDB1;SUPT4H1;THOC1
prerank,vitamin D metabolic process (GO:0042359),-0.18893255816550159,-0.48793747360327455,0.9901768172888016,0.9962170951731666,1.0,1/13,4.63%,LGMN
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.20340618321410406,-0.487526406969017,0.9813780260707635,0.9957572593078893,1.0,10/12,52.59%,GNL3;CCT3;GNL3L;CCT4;WRAP53;CCT2;CCT8;CCT7;CCT5;DKC1
prerank,mitotic DNA replication (GO:1902969),-0.20767516154190133,-0.4857465477273677,0.972972972972973,0.9955162535041504,1.0,2/10,17.39%,MCM4;POLA1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.2223545800965096,0.4835403935354192,0.970954356846473,0.9993240234800438,1.0,4/10,23.29%,FEM1B;CRY1;ETAA1;THOC1
prerank,mitochondrial genome maintenance (GO:0000002),-0.20718322195635105,-0.4814457132932357,0.9922027290448343,0.9955956203356173,1.0,3/11,28.06%,TOP3A;SLC25A4;MEF2A
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.19889502762430927,0.47591570492884305,0.9857723577235772,1.0,1.0,14/14,80.13%,CSF1;TRAF6;POU4F2;IFNG;IL12B;IL23R;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;ATP6AP1;TYROBP
prerank,DNA methylation (GO:0006306),-0.16398298581296808,-0.47438115367953987,0.9958246346555324,0.9959798178877057,1.0,6/23,27.17%,KMT2E;PICK1;EHMT2;ZFP57;DNMT1;HELLS
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.20792314934840472,0.47316513698276624,0.9788583509513742,1.0,1.0,2/12,15.27%,TET1;ATF7IP
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.2000017153390295,0.46824492723812366,0.9767441860465116,1.0,1.0,3/13,18.69%,PRPF3;USP4;PRPF6
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.1521809521679827,-0.46701626570009125,0.9978260869565218,0.9962895967184299,1.0,14/32,42.57%,CDK17;POLA1;ID2;CDK5;E2F7;ZPR1;ORC1;CDC6;ESRRB;RRM2;PCNA;CDK18;TFDP1;CDC45
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.17799988845656062,-0.4664067341023969,0.9979253112033195,0.995833805084516,1.0,1/16,5.20%,PINX1
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.18362634226785907,-0.46624916663403365,0.9957356076759062,0.9953380479376499,1.0,2/14,13.78%,PTGS2;PTGER3
prerank,peptidyl-methionine modification (GO:0018206),0.20163214061519158,0.4601997158489143,0.982,1.0,1.0,12/12,79.85%,NAA60;NAA20;NAA15;METAP2;NAA25;METAP1;APOA2;METAP1D;APOA1;PDF;NAA16;NAA30
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.19986738808807214,0.4545865584118255,0.9794661190965093,1.0,1.0,4/11,21.15%,PRKCA;LYN;RDX;PRKCQ
prerank,regulation of chromosome segregation (GO:0051983),0.17841666568262932,0.4462681726112483,0.9875259875259875,1.0,1.0,3/16,17.09%,HORMAD1;RAD18;IHO1
prerank,dendritic cell chemotaxis (GO:0002407),0.18753139126067303,0.443589225450953,0.991701244813278,1.0,1.0,14/14,81.26%,CCL19;CCR6;GPR183;HMGB1;CXCR4;CCR7;CXCR2;CCR5;CCR1;PIK3CG;CCL5;TRPM2;CCR2;TRPM4
prerank,mismatch repair (GO:0006298),0.16133289425689332,0.440481211062919,1.0,1.0,1.0,7/27,18.62%,ABL1;LIG1;MLH1;RNASEH2A;SETD2;XPC;POLD2
prerank,cilium-dependent cell motility (GO:0060285),0.16870719705709483,0.43465657443401523,0.9920948616600791,1.0,1.0,3/22,14.01%,DNAH2;TEKT2;CCDC65
prerank,mitotic chromosome condensation (GO:0007076),0.15928040535469284,0.4327480073753724,0.9962546816479401,1.0,1.0,6/26,20.37%,PHF8;CDK1;AKAP8L;MCPH1;SMC2;NCAPG2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.15363341038165754,0.43250540901194273,1.0,0.9996835670003072,1.0,7/29,23.63%,ACOT4;ACOT1;ACBD6;ACOT11;ACOT13;ACOT6;ACAT1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.15363341038165754,0.43250540901194273,1.0,0.9996835670003072,1.0,7/29,23.63%,ACOT4;ACOT1;ACBD6;ACOT11;ACOT13;ACOT6;ACAT1
prerank,activin receptor signaling pathway (GO:0032924),0.17548160009950065,0.4260354309016123,0.9918367346938776,0.9996863260084069,1.0,1/15,7.08%,SMAD3
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.19040425347153445,0.4254128323125441,0.9960079840319361,0.9991924195509092,1.0,1/11,7.25%,BLM
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.13935423707582978,0.42066775836186615,1.0,0.9990275114249654,1.0,11/40,23.29%,BLM;RTEL1;BOD1L1;PRIMPOL;CENPX;WRN;RAD51;CDK9;ETAA1;SMARCAL1;THOC1
prerank,glycine metabolic process (GO:0006544),-0.17350970700531082,-0.41796694463134876,0.9961832061068703,0.9983255857995819,1.0,3/12,28.72%,RIDA;GCAT;GLDC
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.18876373084768566,0.4060596359365965,0.9872881355932204,0.9994665183811786,1.0,1/10,6.94%,PDCD1LG2
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.16151382616121768,0.40483587455363634,1.0,0.9989888375310338,1.0,5/16,22.02%,PRKDC;PARP9;DTX3L;KDM4D;SHLD1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.16261693978778186,0.3905747728650024,0.9933774834437086,0.9991749129053812,1.0,15/15,83.75%,CCT6A;TCP1;SHQ1;RUVBL2;DKC1;CCT5;CCT7;NAF1;CCT8;CCT2;CCT4;NOP10;CCT3;NHP2;RUVBL1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.15783067319674227,0.35476497204569535,1.0,0.9995899560927745,1.0,3/11,20.89%,PPIP5K2;ITPKA;IP6K2
